Citrus Sinensis ID: 010736
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 502 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.697 | 0.334 | 0.379 | 9e-73 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.691 | 0.309 | 0.393 | 1e-62 | |
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.691 | 0.318 | 0.362 | 2e-49 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.685 | 0.312 | 0.359 | 3e-48 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.649 | 0.261 | 0.362 | 8e-48 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.583 | 0.281 | 0.372 | 6e-46 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.727 | 0.311 | 0.329 | 8e-46 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.549 | 0.220 | 0.374 | 3e-45 | |
| Q9C9H7 | 847 | Receptor-like protein 12 | no | no | 0.691 | 0.409 | 0.370 | 5e-45 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.553 | 0.252 | 0.369 | 1e-44 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 274 bits (701), Expect = 9e-73, Method: Compositional matrix adjust.
Identities = 172/453 (37%), Positives = 239/453 (52%), Gaps = 103/453 (22%)
Query: 18 SETNEEADALLKWKASLQIH-NRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINIS 76
S T EEA+ALLKWK++ + S LSSW+ N SS + +W G++C+ G +I ++
Sbjct: 45 SATVEEANALLKWKSTFTNQTSSSKLSSWVN--PNTSSFCT--SWYGVACS-LGSIIRLN 99
Query: 77 LRGVGLKGKLHAFSFSSFPHLA------------------------YLDLRDNKLFGTIP 112
L G++G F FSS P+L Y DL N+L G IP
Sbjct: 100 LTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIP 159
Query: 113 PQISNLTNLSILSLGGNQFSGNIPHEVGLMSH------------------------LKIL 148
P++ +L+NL L L N+ +G+IP E+G ++ L L
Sbjct: 160 PELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNL 219
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
Y+ N L GSIP E+G L ++ EL L NNL G +P S GNL +++L + +N SG IP
Sbjct: 220 YLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIP 279
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL--------- 259
P+IGN+ ++ LSL N+ +GPIP +LGN+ L L N L GSIPP L
Sbjct: 280 PEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDL 339
Query: 260 ---------------------------DNLV-------------LTKLSLDDNHFTSYLP 279
DN + LT L LD N+FT +LP
Sbjct: 340 EISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLP 399
Query: 280 QNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFI 339
ICRGG L+ T+ +N F+G +PKSLR+C SLIRVR GN+ +G+IS+AFG+YP L FI
Sbjct: 400 DTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFI 459
Query: 340 DLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
DLS NNF+G++S+N+ + KL A +S N+ITG
Sbjct: 460 DLSNNNFHGQLSANWEQSQKLVAFILSNNSITG 492
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 138/351 (39%), Positives = 202/351 (57%), Gaps = 4/351 (1%)
Query: 23 EADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVGL 82
EA+ALLKWK++ N S LSSW+ D +N ++ S +W G+SCN G + ++L G+
Sbjct: 33 EANALLKWKSTFT--NSSKLSSWVHD-ANTNTSFSCTSWYGVSCNSRGSIEELNLTNTGI 89
Query: 83 KGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLM 142
+G F F S +LAY+DL N L GTIPPQ NL+ L L N +G I +G +
Sbjct: 90 EGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNL 149
Query: 143 SHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNS 202
+L +LY+ N L IP E+G + SM +LAL N L GS+P SLGNL + +L+L++N
Sbjct: 150 KNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENY 209
Query: 203 FSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNL 262
+G IPP++GN++S++ L+L+ N+ +G IP +LGNL NL L N L G IPP + N+
Sbjct: 210 LTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNM 269
Query: 263 -VLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNN 321
+T L+L N T +P ++ L + ++ +N G IP L N S+I + L N
Sbjct: 270 ESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNK 329
Query: 322 LTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
LTG+I + G NLT + L N G I G + L ++ N +TG
Sbjct: 330 LTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTG 380
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 129/356 (36%), Positives = 181/356 (50%), Gaps = 9/356 (2%)
Query: 21 NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGV 80
+++ ALL WK+ L I + S + DTS PC W G+ CN G V I L+G+
Sbjct: 26 DQQGQALLSWKSQLNISGDAFSSWHVADTS-------PCNWVGVKCNRRGEVSEIQLKGM 78
Query: 81 GLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG 140
L+G L S S L L L L G IP +I + T L +L L N SG+IP E+
Sbjct: 79 DLQGSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIF 138
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
+ LK L +++N L+G IP+E+G LS +VEL LF N L+G +P S+G L + +L
Sbjct: 139 RLKKLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGG 198
Query: 201 N-SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL 259
N + G +P +IGN +++ +L LA SG +P S+GNL ++ ++ + L G IP +
Sbjct: 199 NKNLRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEI 258
Query: 260 DNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
L L L N + +P I LQ + +N G IP L NC L +
Sbjct: 259 GYCTELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFS 318
Query: 319 GNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDF 374
N LTG I ++FG NL + LS N G I C KL L I N ITG+
Sbjct: 319 ENLLTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEI 374
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 193 bits (490), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 127/353 (35%), Positives = 182/353 (51%), Gaps = 9/353 (2%)
Query: 21 NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGV 80
NEE LL++KA L N L+SW + SN PC W+GI+C V ++ L G+
Sbjct: 25 NEEGRVLLEFKAFLNDSN-GYLASWNQLDSN------PCNWTGIACTHLRTVTSVDLNGM 77
Query: 81 GLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG 140
L G L L L++ N + G IP +S +L +L L N+F G IP ++
Sbjct: 78 NLSGTLSPL-ICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLT 136
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
++ LK LY+ N L GSIP ++G LSS+ EL ++SNNL G +P S+ L Q+ ++
Sbjct: 137 MIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGR 196
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD 260
N FSG IP +I +S+ +L LA N G +P L L NL L N L G IPPS+
Sbjct: 197 NGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVG 256
Query: 261 NL-VLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDG 319
N+ L L+L +N+FT +P+ I + ++ + N+ G IP+ + N +
Sbjct: 257 NISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSE 316
Query: 320 NNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
N LTG I K FG NL + L N G I GE L L++S N + G
Sbjct: 317 NQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNG 369
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (486), Expect = 8e-48, Method: Compositional matrix adjust.
Identities = 120/331 (36%), Positives = 181/331 (54%), Gaps = 5/331 (1%)
Query: 53 SSKISPCAWSGISCNDAG--RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGT 110
S I+ C+W+G++C++ G RVI ++L G+GL G + + F F +L +LDL N L G
Sbjct: 52 SDNINYCSWTGVTCDNTGLFRVIALNLTGLGLTGSISPW-FGRFDNLIHLDLSSNNLVGP 110
Query: 111 IPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170
IP +SNLT+L L L NQ +G IP ++G + +++ L I N+L G IP +G L ++
Sbjct: 111 IPTALSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQ 170
Query: 171 ELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP 230
LAL S L G +P LG L ++ L L DN G IP ++GN +++ + A N +G
Sbjct: 171 MLALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGT 230
Query: 231 IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNL-VLTKLSLDDNHFTSYLPQNICRGGALQ 289
IP LG L NL+ +L N+L G IP L + L LSL N +P+++ G LQ
Sbjct: 231 IPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQ 290
Query: 290 IFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF-GIYPNLTFIDLSRNNFYG 348
+S N G IP+ N + L+ + L N+L+G++ K+ NL + LS G
Sbjct: 291 TLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSG 350
Query: 349 EISSNFGECPKLGALNISRNNITGDFGIAKF 379
EI +C L L++S N++ G A F
Sbjct: 351 EIPVELSKCQSLKQLDLSNNSLAGSIPEALF 381
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 185 bits (470), Expect = 6e-46, Method: Compositional matrix adjust.
Identities = 110/295 (37%), Positives = 156/295 (52%), Gaps = 2/295 (0%)
Query: 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGN 134
++ G +G++ A ++ L ++ L N L G +PP++ LT L + +G N F+GN
Sbjct: 182 LNFGGSYFEGEIPA-AYGGLQRLKFIHLAGNVLGGKLPPRLGLLTELQHMEIGYNHFNGN 240
Query: 135 IPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQIS 194
IP E L+S+LK + + L GS+P E+G LS++ L LF N G +P S NL +
Sbjct: 241 IPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTGEIPESYSNLKSLK 300
Query: 195 MLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGS 254
+L N SG IP LK+++ LSL N SG +P +G L L L NN G
Sbjct: 301 LLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPELTTLFLWNNNFTGV 360
Query: 255 IPPSL-DNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLI 313
+P L N L + + +N FT +P ++C G L + N F+G +PKSL C SL
Sbjct: 361 LPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEGELPKSLTRCESLW 420
Query: 314 RVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368
R R N L G I FG NLTF+DLS N F +I ++F P L LN+S N
Sbjct: 421 RFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVLQYLNLSTN 475
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 185 bits (469), Expect = 8e-46, Method: Compositional matrix adjust.
Identities = 123/373 (32%), Positives = 189/373 (50%), Gaps = 8/373 (2%)
Query: 4 LVDLSIARFLVAVSSETNE-EADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWS 62
++ L+ F +A++ ++ E E +AL +K + +LS W + + C W+
Sbjct: 10 ILTLTFFFFGIALAKQSFEPEIEALKSFKNGISNDPLGVLSDW-----TIIGSLRHCNWT 64
Query: 63 GISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLS 122
GI+C+ G V+++SL L+G L + ++ +L LDL N G IP +I LT L+
Sbjct: 65 GITCDSTGHVVSVSLLEKQLEGVLSP-AIANLTYLQVLDLTSNSFTGKIPAEIGKLTELN 123
Query: 123 ILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGS 182
L L N FSG+IP + + ++ L + +N L G +P E+ + SS+V + NNL G
Sbjct: 124 QLILYLNYFSGSIPSGIWELKNIFYLDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGK 183
Query: 183 VPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLK 242
+P LG+L + M N +G IP IG L +++ L L+ NQ +G IP GNL NL+
Sbjct: 184 IPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQ 243
Query: 243 QFSLVYNNLYGSIPPSLDNL-VLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGT 301
L N L G IP + N L +L L DN T +P + LQ + +N+ +
Sbjct: 244 SLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSS 303
Query: 302 IPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLG 361
IP SL T L + L N+L G IS+ G +L + L NNF GE + L
Sbjct: 304 IPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLT 363
Query: 362 ALNISRNNITGDF 374
L + NNI+G+
Sbjct: 364 VLTVGFNNISGEL 376
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 183 bits (464), Expect = 3e-45, Method: Compositional matrix adjust.
Identities = 104/278 (37%), Positives = 158/278 (56%), Gaps = 2/278 (0%)
Query: 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQL 155
L L L +N L GT+ ISNLTNL +L N G +P E+G + L+I+Y+ N+
Sbjct: 386 ELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRF 445
Query: 156 DGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLK 215
G +P+E+G + + E+ + N L+G +P S+G L ++ L L +N G IP +GN
Sbjct: 446 SGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCH 505
Query: 216 SISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHF 274
++++ LA NQ SG IP S G LT L+ F + N+L G++P SL NL LT+++ N F
Sbjct: 506 QMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKF 565
Query: 275 TSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYP 334
+ +C + F V+EN F+G IP L T+L R+RL N TG I + FG
Sbjct: 566 NGSISP-LCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKIS 624
Query: 335 NLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
L+ +D+SRN+ G I G C KL ++++ N ++G
Sbjct: 625 ELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSG 662
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C9H7|RLP12_ARATH Receptor-like protein 12 OS=Arabidopsis thaliana GN=RLP12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 5e-45, Method: Compositional matrix adjust.
Identities = 133/359 (37%), Positives = 196/359 (54%), Gaps = 12/359 (3%)
Query: 21 NEEADALLKWKASLQIH-NRSLLSSWIKDTSNVSSKISPCAWSGISCND-AGRVINISLR 78
+++ DALL+++ I+ + +++ W + N S+ C W+G++CND +G+VI++ +
Sbjct: 36 DDQRDALLEFRGEFPINASWHIMNQW-RGPWNKSTDC--CLWNGVTCNDKSGQVISLDIP 92
Query: 79 GVGLKGKLHA-FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPH 137
L L S +L +LDL + L+G IP + NL++L++++L N+F G IP
Sbjct: 93 NTFLNNYLKTNSSLFKLQYLRHLDLTNCNLYGEIPSSLGNLSHLTLVNLYFNKFVGEIPA 152
Query: 138 EVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLF 197
+G ++ L+ L + +N L G IP +G LS +V L LFSN L G +P S+G+L Q+ L
Sbjct: 153 SIGNLNQLRHLILANNVLTGEIPSSLGNLSRLVNLELFSNRLVGKIPDSIGDLKQLRNLS 212
Query: 198 LHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP 257
L N+ G IP +GNL ++ L L NQ G +P S+GNL L+ S N+L G+IP
Sbjct: 213 LASNNLIGEIPSSLGNLSNLVHLVLTHNQLVGEVPASIGNLIELRVMSFENNSLSGNIPI 272
Query: 258 SLDNLVLTKLS---LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIR 314
S N LTKLS L N+FTS P ++ L+ F VS N F G PKSL SL
Sbjct: 273 SFAN--LTKLSIFVLSSNNFTSTFPFDMSIFHNLEYFDVSYNSFSGPFPKSLLLIPSLES 330
Query: 315 VRLDGNNLTGNISKA-FGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
+ L N TG I A L + L RN +G I + L L+IS NN TG
Sbjct: 331 IYLQENQFTGPIEFANTSSSTKLQDLILGRNRLHGPIPESISRLLNLEELDISHNNFTG 389
|
Involved in the perception of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristems maintenance. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (459), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 103/279 (36%), Positives = 151/279 (54%), Gaps = 1/279 (0%)
Query: 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLD 156
L+ + L +N+ G IP +ISN T+L L+L NQ G IP E+G + L+ LY+ N L+
Sbjct: 243 LSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLN 302
Query: 157 GSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKS 216
G+IP E+G LS +E+ N L G +P LGN+ + +L+L +N +G IP ++ LK+
Sbjct: 303 GTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKN 362
Query: 217 ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFT 275
+S L L+IN +GPIPL L L L N+L G+IPP L L L + DNH +
Sbjct: 363 LSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLS 422
Query: 276 SYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPN 335
+P +C + I + N G IP + C +L+++RL NNL G N
Sbjct: 423 GRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVN 482
Query: 336 LTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDF 374
+T I+L +N F G I G C L L ++ N TG+
Sbjct: 483 VTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGEL 521
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 502 | ||||||
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.721 | 0.348 | 0.436 | 3e-88 | |
| 224146237 | 825 | predicted protein [Populus trichocarpa] | 0.683 | 0.415 | 0.458 | 1e-85 | |
| 224107159 | 938 | predicted protein [Populus trichocarpa] | 0.687 | 0.367 | 0.464 | 1e-85 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.721 | 0.335 | 0.430 | 5e-85 | |
| 224148440 | 625 | predicted protein [Populus trichocarpa] | 0.687 | 0.552 | 0.464 | 8e-85 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.715 | 0.346 | 0.404 | 1e-84 | |
| 224108393 | 968 | predicted protein [Populus trichocarpa] | 0.639 | 0.331 | 0.481 | 3e-84 | |
| 224108397 | 968 | predicted protein [Populus trichocarpa] | 0.639 | 0.331 | 0.464 | 2e-81 | |
| 359484862 | 991 | PREDICTED: probable LRR receptor-like se | 0.701 | 0.355 | 0.489 | 7e-81 | |
| 356574018 | 961 | PREDICTED: probable LRR receptor-like se | 0.725 | 0.378 | 0.455 | 2e-80 |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 332 bits (851), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 205/470 (43%), Positives = 257/470 (54%), Gaps = 108/470 (22%)
Query: 16 VSSETNEEADALLKWKASLQIHNRSLLSSW-------IKDTSNVSSKISPCAWSGISCND 68
VSS +NEE ALLKWKASLQ HN S L SW ++++ + SPC W GISCN
Sbjct: 27 VSSYSNEETQALLKWKASLQNHNHSSLLSWDLYPNNSTNSSTHLGTATSPCKWYGISCNH 86
Query: 69 AGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGG 128
AG VI I+L GL G L FSFSSFP+LAY+D+ N L G IPPQI L L L L
Sbjct: 87 AGSVIKINLTESGLNGTLMDFSFSSFPNLAYVDISMNNLSGPIPPQIGLLFELKYLDLSI 146
Query: 129 NQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLG 188
NQFSG IP E+GL+++L++L++ NQL+GSIP E+GQL+S+ ELAL++N L GS+P SLG
Sbjct: 147 NQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIGQLASLYELALYTNQLEGSIPASLG 206
Query: 189 NLT------------------------------------------------QISMLFLHD 200
NL+ ++++L+L +
Sbjct: 207 NLSNLASLYLYENQLSGSIPPEMGNLTNLVEIYSNNNNLTGPIPSTFGNLKRLTVLYLFN 266
Query: 201 NSFSGFIPPDIGNLKSI------------------------SILSLAINQFSGPIPLSLG 236
NS SG IPP+IGNLKS+ ++L L NQ SGPIP +G
Sbjct: 267 NSLSGPIPPEIGNLKSLQELSLYENNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIG 326
Query: 237 NLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQN-------------- 281
NL +L L N L GSIP SL NL L L L DN + Y+PQ
Sbjct: 327 NLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLEIDT 386
Query: 282 ----------ICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFG 331
IC+ G+L F VS+N G IPKSL+NC +L R GN LTGNIS+ G
Sbjct: 387 NQLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISEVVG 446
Query: 332 IYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG----DFGIA 377
PNL FIDLS N F+GE+S N+G CP+L L I+ NNITG DFGI+
Sbjct: 447 DCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGIS 496
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224146237|ref|XP_002325931.1| predicted protein [Populus trichocarpa] gi|222862806|gb|EEF00313.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 323 bits (828), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 184/401 (45%), Positives = 243/401 (60%), Gaps = 58/401 (14%)
Query: 21 NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCA-WSGISCNDAGRVINISLRG 79
N EA+ALL+WKASL ++SLLSSW+ ISPC W GI+C+++G V N++L+
Sbjct: 416 NTEAEALLQWKASLDNQSQSLLSSWVG--------ISPCINWIGITCDNSGSVTNLTLQS 467
Query: 80 VGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV 139
GL+G L+ +FSSFP+L +L L +N L GTIP +I L NLS L+L NQ SG+IP +
Sbjct: 468 FGLRGTLYDLNFSSFPNLLFLVLPNNSLSGTIPHEIGKLRNLSFLALSWNQLSGSIPSSI 527
Query: 140 GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
G + L +LY+ NQL GSIP +G ++ + LAL+ NNL GS+P +GNLT +S L L
Sbjct: 528 GNLKSLSVLYLWDNQLSGSIPFSIGNMTMLTGLALYQNNLTGSIPSFIGNLTSLSELNLW 587
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL 259
N SG IP +IG L+S++IL LA N +G IP S+G L NL L YN L G IP S+
Sbjct: 588 GNKLSGSIPQEIGLLESLNILDLADNVLTGRIPYSIGKLRNLFFLGLSYNQLSGLIPSSI 647
Query: 260 DNLV-------------------------------------------------LTKLSLD 270
NL L L+LD
Sbjct: 648 KNLTSVSEFYLEKNKLSSPIPQEIGLLESLHVLALAGNKFHGPLPSEMNNLTHLHGLALD 707
Query: 271 DNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF 330
N FT +LP ++C GG L+I T S N F G+IP+SL+NCT L RVRLD N LTGNIS+ F
Sbjct: 708 GNEFTGHLPVDLCHGGVLKICTASNNYFSGSIPESLKNCTGLYRVRLDRNQLTGNISEVF 767
Query: 331 GIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
GIYP+L +IDLS NNFYGE+SS +G+C + +L IS+NN++
Sbjct: 768 GIYPHLNYIDLSYNNFYGELSSKWGDCRNMTSLQISKNNVS 808
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224107159|ref|XP_002333557.1| predicted protein [Populus trichocarpa] gi|222837233|gb|EEE75612.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 323 bits (828), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 176/379 (46%), Positives = 244/379 (64%), Gaps = 34/379 (8%)
Query: 21 NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCA-WSGISCNDAGRVINISLRG 79
N EA+ALL+WKASL ++SLLSSW+ ISPC W GI+C+++G V N++L+
Sbjct: 48 NSEAEALLQWKASLDNQSQSLLSSWVG--------ISPCINWIGITCDNSGSVTNLTLQS 99
Query: 80 VGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV 139
GL+G L+ F+FSSFP+L +LDL+ N L GTIP + L NLS L L N SG IP +
Sbjct: 100 FGLRGTLYDFNFSSFPNLFWLDLQKNSLSGTIPREFGKLRNLSYLDLSINHLSGPIPSSI 159
Query: 140 GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
G M+ L +L + N L GSIP +G +S+ L L+SN L+GS+P +G L +++L L
Sbjct: 160 GNMTMLTVLALSHNNLTGSIPSFIGNFTSLSGLYLWSNKLSGSIPQEIGLLESLNILDLA 219
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQF--------------- 244
DN +G IP IG L+++ L L++NQ SG IP S+ NLT++ +F
Sbjct: 220 DNVLTGRIPYSIGKLRNLFFLGLSMNQLSGLIPSSIKNLTSVSEFYLEKNKLSSPIPQEI 279
Query: 245 ---------SLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVS 294
+L N +G +P ++NL L L+LD N FT +LP ++C GG L+I T S
Sbjct: 280 GLLESLHVLALAGNKFHGPLPSEMNNLTHLHGLALDGNEFTGHLPVDLCHGGVLKICTAS 339
Query: 295 ENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNF 354
N F G+IP+SL+NCT L RVRLD N LTGNIS+ FGIYP+L +IDLS NNFYGE+SS +
Sbjct: 340 NNYFSGSIPESLKNCTGLYRVRLDRNQLTGNISEVFGIYPHLNYIDLSYNNFYGELSSKW 399
Query: 355 GECPKLGALNISRNNITGD 373
G+C + +L IS+NN++G+
Sbjct: 400 GDCRNMTSLQISKNNVSGE 418
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 321 bits (823), Expect = 5e-85, Method: Compositional matrix adjust.
Identities = 194/451 (43%), Positives = 253/451 (56%), Gaps = 89/451 (19%)
Query: 16 VSSETNEEADALLKWKASLQIHNRSLLSSWI-----KDTSNVSSK----ISPCAWSGISC 66
+ S++NEE ALLKWK++L HN S L SW +++N S+ PC W GISC
Sbjct: 53 MKSDSNEETQALLKWKSTLHNHNHSFLLSWTLYPDPNNSTNSSTHHGTATGPCKWYGISC 112
Query: 67 NDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSL 126
N AG VI I+L GL+G L AFSFSSFP+LAY+D+ N L G IPPQI L+ L L L
Sbjct: 113 NHAGSVIRINLTESGLRGTLQAFSFSSFPNLAYVDVCINNLSGPIPPQIGLLSKLKYLDL 172
Query: 127 GGNQFSGNIPHEVGLMSHLKIL---------------------------YIDSNQLDGSI 159
NQFSG IP E+GL+++L++L Y+ NQL GSI
Sbjct: 173 STNQFSGGIPPEIGLLTNLEVLHLLALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSI 232
Query: 160 PLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSI-- 217
P E+G L+++VE+ +NNL G +P + GNL +++ L+L +N SG IPP+IGNL S+
Sbjct: 233 PPEMGNLANLVEIYSDTNNLTGLIPSTFGNLKRLTTLYLFNNQLSGHIPPEIGNLTSLQG 292
Query: 218 ----------------------SILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSI 255
++L L NQ SGPIP +GNL +L L N L GSI
Sbjct: 293 ISLYANNLSGPIPASLGDLSGLTLLHLYANQLSGPIPPEIGNLKSLVDLELSENQLNGSI 352
Query: 256 PPSLDNLV-LTKLSLDDNHFTSY------------------------LPQNICRGGALQI 290
P SL NL L L L DNH + Y LP+ IC+GG+L
Sbjct: 353 PTSLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGICQGGSLVR 412
Query: 291 FTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEI 350
FTVS+N G IPKS++NC +L R GN LTGNIS+ G PNL +IDLS N F+GE+
Sbjct: 413 FTVSDNLLSGPIPKSMKNCRNLTRALFGGNQLTGNISEVVGDCPNLEYIDLSYNRFHGEL 472
Query: 351 SSNFGECPKLGALNISRNNITG----DFGIA 377
S N+G CP+L L ++ N+ITG DFGI+
Sbjct: 473 SHNWGRCPQLQRLEMAGNDITGSIPEDFGIS 503
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224148440|ref|XP_002336653.1| predicted protein [Populus trichocarpa] gi|222836449|gb|EEE74856.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 320 bits (821), Expect = 8e-85, Method: Compositional matrix adjust.
Identities = 176/379 (46%), Positives = 244/379 (64%), Gaps = 34/379 (8%)
Query: 21 NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCA-WSGISCNDAGRVINISLRG 79
N EA+ALL+WKASL ++SLLSSW+ ISPC W GI+C+++G V N++L+
Sbjct: 48 NTEAEALLQWKASLHNQSQSLLSSWVG--------ISPCINWIGITCDNSGSVTNLTLQS 99
Query: 80 VGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV 139
GL+G L+ F+FSSFP+L +LDL+ N L GTIP + L NLS L L N SG IP +
Sbjct: 100 FGLRGTLYDFNFSSFPNLFWLDLQKNSLSGTIPREFGKLRNLSYLDLSINHLSGPIPSSI 159
Query: 140 GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
G M+ L +L + N L GSIP +G +S+ L L+SN L+GS+P +G L +++L L
Sbjct: 160 GNMTMLTVLALSHNNLTGSIPSFIGNFTSLSGLYLWSNKLSGSIPQEIGLLESLNILDLA 219
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQF--------------- 244
DN +G IP IG L+++ L L++NQ SG IP S+ NLT++ +F
Sbjct: 220 DNVLTGRIPYSIGKLRNLFFLGLSMNQLSGLIPSSIKNLTSVSEFYLEKNKLSSPIPQEI 279
Query: 245 ---------SLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVS 294
+L N +G +P ++NL L L+LD N FT +LP ++C GG L+I T S
Sbjct: 280 GLLESLHVLALAGNKFHGPLPSEMNNLTHLHGLALDGNEFTGHLPVDLCHGGVLKICTAS 339
Query: 295 ENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNF 354
N F G+IP+SL+NCT L RVRLD N LTGNIS+ FGIYP+L +IDLS NNFYGE+SS +
Sbjct: 340 NNYFSGSIPESLKNCTGLYRVRLDRNQLTGNISEVFGIYPHLNYIDLSYNNFYGELSSKW 399
Query: 355 GECPKLGALNISRNNITGD 373
G+C + +L IS+NN++G+
Sbjct: 400 GDCRNMTSLQISKNNVSGE 418
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 320 bits (820), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 197/487 (40%), Positives = 254/487 (52%), Gaps = 128/487 (26%)
Query: 16 VSSETNEEADALLKWKASLQIHNRSLLSSWI-------KDTSNVSSKISPCAWSGISCND 68
VSS +NEE ALLKWKA+L HN S L SW ++++ +++SPC W GISCN
Sbjct: 27 VSSYSNEETQALLKWKATLHNHNHSSLLSWTLYPNNFTNSSTHLGTEVSPCKWYGISCNH 86
Query: 69 AGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGG 128
AG VI I+L GL G L AFSFSSFP+LAY+D+ N L G IPPQI L+ L L L
Sbjct: 87 AGSVIRINLTESGLGGTLQAFSFSSFPNLAYVDISMNNLSGPIPPQIGLLSKLKYLDLSI 146
Query: 129 NQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSL- 187
NQFSG IP E+GL+++L++L++ NQL+GSIP E+GQL+S+ ELAL++N L GS+P SL
Sbjct: 147 NQFSGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEIGQLTSLYELALYTNQLEGSIPASLG 206
Query: 188 -----------------------------------------------GNLTQISMLFLHD 200
GNL +++L+L +
Sbjct: 207 NLSNLASLYLYENQLSGSIPPEMGNLTNLVQLYSDTNNLTGPIPSTFGNLKHLTVLYLFN 266
Query: 201 NSFSGFIPPDIGNLKSI------------------------SILSLAINQFSGPIPLSLG 236
NS SG IPP+IGNLKS+ ++L L NQ SGPIP +G
Sbjct: 267 NSLSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIG 326
Query: 237 NLTNLKQFSLVYNNLYGSIPPSLDNLV-------------------------LTKLSLDD 271
NL +L L N L GSIP SL NL L L +D
Sbjct: 327 NLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQEIGKLHKLVVLEIDT 386
Query: 272 NHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFG 331
N LP+ IC+GG+L+ FTVS+N G IPKSL+NC +L R GN LTGN+S+ G
Sbjct: 387 NQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNVSEVVG 446
Query: 332 IYPNLTFIDLSRNNFYGEISSNFGECPKLGALNI------------------------SR 367
PNL FIDLS N F+GE+S N+G CP+L L I S
Sbjct: 447 DCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSS 506
Query: 368 NNITGDF 374
N++ G+
Sbjct: 507 NHLVGEI 513
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108393|ref|XP_002333399.1| predicted protein [Populus trichocarpa] gi|222836439|gb|EEE74846.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 318 bits (816), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 170/353 (48%), Positives = 230/353 (65%), Gaps = 32/353 (9%)
Query: 22 EEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCA-WSGISCNDAGRVINISLRGV 80
+EA+ALLKWKASL ++SLLSSW+ SPC W GI+C+ +G V N++
Sbjct: 61 KEAEALLKWKASLDNQSQSLLSSWVG--------TSPCIDWIGITCDGSGSVANLTFPHF 112
Query: 81 GLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG 140
GL+G L+ F+FSSFP+L+ LDL +N + GT+P I NL+ ++ L L N +G+IP E+G
Sbjct: 113 GLRGTLYDFNFSSFPNLSVLDLSNNSIHGTLPSHIGNLSKITQLGLCYNDLTGSIPSEIG 172
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
+ + L + N GSIP E+G+L+S+ L+L NNL GS+P S+GNL +S LFL D
Sbjct: 173 SLKSITDLVLCRNLFSGSIPHEIGKLTSLSRLSLAVNNLTGSIPSSIGNLKNLSNLFLWD 232
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD 260
N SG IP +IG LKS+ LSLA N+ GP+PL + NLT+LKQF L
Sbjct: 233 NKLSGRIPSEIGQLKSLVGLSLANNKLHGPLPLEMNNLTHLKQFHL-------------- 278
Query: 261 NLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGN 320
DN FT +LPQ +C GG L+ TV+ N F G+IPKSL+NCTSL R+RLD N
Sbjct: 279 ---------SDNEFTGHLPQEVCHGGVLENLTVANNYFSGSIPKSLKNCTSLHRLRLDRN 329
Query: 321 NLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373
LTGNIS+ FGIYP+L ++DLS NNFYGE+S +G+ + +L IS NN++G+
Sbjct: 330 QLTGNISEDFGIYPHLDYVDLSYNNFYGELSLKWGDYRNITSLKISNNNVSGE 382
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108397|ref|XP_002333400.1| predicted protein [Populus trichocarpa] gi|222836440|gb|EEE74847.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 310 bits (793), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 164/353 (46%), Positives = 230/353 (65%), Gaps = 32/353 (9%)
Query: 22 EEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCA-WSGISCNDAGRVINISLRGV 80
+E +ALLKWKASL ++SLLSSW+ SPC W GI+C+ +G V N++
Sbjct: 61 KETEALLKWKASLDNQSQSLLSSWVG--------TSPCINWIGITCDGSGSVANLTFPNF 112
Query: 81 GLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG 140
GL+G L+ F+FSSFP+L+ LDL +N + GTIP I NL+ ++ L L N +G+IP E+G
Sbjct: 113 GLRGTLYDFNFSSFPNLSILDLSNNSIHGTIPSHIGNLSKITQLGLCYNDLTGSIPSEIG 172
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
+ + L + N L GSIP E+G+L+S+ L+L NNL GS+P S+GNL ++S+LFL
Sbjct: 173 SLKSITDLVLCRNLLSGSIPHEIGKLTSLSRLSLAVNNLTGSIPSSIGNLKKLSILFLWG 232
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD 260
N+ SG IP +IG LKS+ +SLA N+ GP+PL + NLT+LK
Sbjct: 233 NNLSGHIPSEIGQLKSLVSMSLANNKLHGPLPLEMNNLTHLK------------------ 274
Query: 261 NLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGN 320
+L + +N FT +LPQ +C GG L+ T + N F G+IP+SL+NCTSL R+RLDGN
Sbjct: 275 -----QLHVSENEFTGHLPQEVCHGGVLENLTAANNYFSGSIPESLKNCTSLHRLRLDGN 329
Query: 321 NLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373
LTGNIS+ FGIYP+L ++DLS NNFYGE+S + + + +L IS NN+ G+
Sbjct: 330 QLTGNISEDFGIYPHLDYVDLSYNNFYGELSLKWEDYCNITSLKISNNNVAGE 382
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484862|ref|XP_002274094.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 307 bits (787), Expect = 7e-81, Method: Compositional matrix adjust.
Identities = 178/364 (48%), Positives = 232/364 (63%), Gaps = 12/364 (3%)
Query: 13 LVAVSSETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCA-WSGISC--NDA 69
LV ++ EA ALL+WKASL +++ LSSW SPC W GI+C A
Sbjct: 43 LVGGETQERNEAVALLRWKASLDNESQTFLSSWFGS--------SPCNNWVGIACWKPKA 94
Query: 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGN 129
G V +++L G G +G L SFSSF +L +L +N +GTIP +S L+ L+ L L N
Sbjct: 95 GSVTHLNLSGFGFRGTLQNLSFSSFSNLLSFNLYNNSFYGTIPTHVSKLSKLTYLDLSFN 154
Query: 130 QFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGN 189
G+IP +G + +L LY+ NQL GSIP E+G L S++ L L NNLNG++PHS+GN
Sbjct: 155 HLVGSIPASIGNLGNLTALYLHHNQLSGSIPSEIGLLKSLIILDLSYNNLNGTIPHSIGN 214
Query: 190 LTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYN 249
L+ ++ L+L N G IP +IG L+S++ LSL N F+GPIP SLG L NL + N
Sbjct: 215 LSNLATLYLTGNKLFGSIPWEIGQLRSLTGLSLTNNSFTGPIPSSLGKLVNLTVLCFLNN 274
Query: 250 NLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRN 308
L G IP ++NL+ L L L +N F+ +LPQ IC GGAL+ FT N F G IPKSLRN
Sbjct: 275 KLSGPIPSKMNNLIHLKVLQLGENKFSGHLPQQICLGGALENFTAHNNNFTGPIPKSLRN 334
Query: 309 CTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368
C++L RVRL+ N LTGNIS+ GIYPNL +IDLS NN YGE+S +G C L LNIS N
Sbjct: 335 CSTLFRVRLESNQLTGNISEDLGIYPNLNYIDLSNNNLYGELSYKWGLCKNLTFLNISNN 394
Query: 369 NITG 372
NI+G
Sbjct: 395 NISG 398
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574018|ref|XP_003555150.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 306 bits (783), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 170/373 (45%), Positives = 239/373 (64%), Gaps = 9/373 (2%)
Query: 1 MHRLVDLSIARFLVAVSSETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCA 60
+H + S A +SSE EA+ALLKWKASL +++ LSSWI + +PC
Sbjct: 19 LHVMYFCSFAMAASPISSEIALEANALLKWKASLDNQSQASLSSWIGN--------NPCN 70
Query: 61 WSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTN 120
W GI+C+ + V NI+L VGL+G L + +FS P++ L++ N L G+IPPQI L+N
Sbjct: 71 WLGITCDVSNSVSNINLTRVGLRGTLQSLNFSLLPNILILNISYNSLSGSIPPQIDALSN 130
Query: 121 LSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN 180
L+ L L N+ SG+IP+ +G +S L+ L + +N L GSIP EVG L+S++ +FSNNL+
Sbjct: 131 LNTLDLSTNKLSGSIPNTIGNLSKLQYLNLSANGLSGSIPNEVGNLNSLLTFDIFSNNLS 190
Query: 181 GSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTN 240
G +P SLGNL + + + +N SG IP +GNL +++LSL+ N+ +G IP S+GNLTN
Sbjct: 191 GPIPPSLGNLPHLQSIHIFENQLSGSIPSTLGNLSKLTMLSLSSNKLTGSIPPSIGNLTN 250
Query: 241 LKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQ 299
K + N+L G IP L+ L L L L DN+F +PQN+C GG L+ FT N F
Sbjct: 251 AKVICFIGNDLSGEIPIELEKLTGLECLQLADNNFIGQIPQNVCLGGNLKYFTAGNNNFT 310
Query: 300 GTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPK 359
G IP+SLR C SL R+RL N L+G+I+ F + PNL +IDLS NNF+G IS +G+
Sbjct: 311 GQIPESLRKCYSLKRLRLQQNLLSGDITDFFDVLPNLNYIDLSENNFHGHISPKWGKFHS 370
Query: 360 LGALNISRNNITG 372
L +L IS NN++G
Sbjct: 371 LTSLMISNNNLSG 383
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 502 | ||||||
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.593 | 0.266 | 0.44 | 4.7e-95 | |
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.599 | 0.288 | 0.412 | 1.2e-94 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.685 | 0.312 | 0.345 | 1e-67 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.689 | 0.317 | 0.352 | 3.5e-65 | |
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.683 | 0.314 | 0.354 | 7.5e-65 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.701 | 0.281 | 0.328 | 1.6e-64 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.725 | 0.330 | 0.321 | 5.7e-64 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.697 | 0.311 | 0.306 | 1.4e-63 | |
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.611 | 0.294 | 0.346 | 2.8e-63 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.613 | 0.304 | 0.332 | 3.9e-61 |
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 632 (227.5 bits), Expect = 4.7e-95, Sum P(2) = 4.7e-95
Identities = 132/300 (44%), Positives = 186/300 (62%)
Query: 74 NISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQXXXXXXXXXXXXXXXQFSG 133
N++L L G + + S + +L L L N L G IPP+ + +G
Sbjct: 274 NLALSQNKLTGSIPS-SLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTG 332
Query: 134 NIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQI 193
+IP +G + +L ILY+ N L G IP E+G + SM++L L +N L GS+P S GNL +
Sbjct: 333 SIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNL 392
Query: 194 SMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYG 253
+ L+L+ N +G IP ++GN++S+ L L+ N+ +G +P S GN T L+ L N+L G
Sbjct: 393 TYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSG 452
Query: 254 SIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSL 312
+IPP + N LT L LD N+FT + P+ +C+G LQ ++ N +G IPKSLR+C SL
Sbjct: 453 AIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSL 512
Query: 313 IRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
IR R GN TG+I +AFGIYP+L FID S N F+GEISSN+ + PKLGAL +S NNITG
Sbjct: 513 IRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITG 572
|
|
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 1.2e-94, Sum P(2) = 1.2e-94
Identities = 125/303 (41%), Positives = 187/303 (61%)
Query: 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQXXXXXXXXXXXXXXXQ 130
+V I++ L G + + SF + L L L N L G+IP +
Sbjct: 191 KVTEIAIYDNLLTGPIPS-SFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNN 249
Query: 131 FSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNL 190
+G IP G + ++ +L + NQL G IP E+G ++++ L+L +N L G +P +LGN+
Sbjct: 250 LTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNI 309
Query: 191 TQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250
+++L L+ N +G IPP++G ++S+ L ++ N+ +GP+P S G LT L+ L N
Sbjct: 310 KTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQ 369
Query: 251 LYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNC 309
L G IPP + N LT L LD N+FT +LP ICRGG L+ T+ +N F+G +PKSLR+C
Sbjct: 370 LSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDC 429
Query: 310 TSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNN 369
SLIRVR GN+ +G+IS+AFG+YP L FIDLS NNF+G++S+N+ + KL A +S N+
Sbjct: 430 KSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNS 489
Query: 370 ITG 372
ITG
Sbjct: 490 ITG 492
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 485 (175.8 bits), Expect = 1.0e-67, Sum P(2) = 1.0e-67
Identities = 122/353 (34%), Positives = 174/353 (49%)
Query: 21 NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGV 80
NEE LL++KA L N L+SW + SN PC W+GI+C V ++ L G+
Sbjct: 25 NEEGRVLLEFKAFLNDSN-GYLASWNQLDSN------PCNWTGIACTHLRTVTSVDLNGM 77
Query: 81 GLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQXXXXXXXXXXXXXXXQFSGNIPHEVG 140
L G L L L++ N + G IP +F G IP ++
Sbjct: 78 NLSGTLSPL-ICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLT 136
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
++ LK LY+ N L GSIP ++G LSS+ EL ++SNNL G +P S+ L Q+ ++
Sbjct: 137 MIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGR 196
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD 260
N FSG IP +I +S+ +L LA N G +P L L NL L N L G IPPS+
Sbjct: 197 NGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVG 256
Query: 261 NLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDG 319
N+ L L+L +N+FT +P+ I + ++ + N+ G IP+ + N +
Sbjct: 257 NISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSE 316
Query: 320 NNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
N LTG I K FG NL + L N G I GE L L++S N + G
Sbjct: 317 NQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNG 369
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 513 (185.6 bits), Expect = 3.5e-65, Sum P(2) = 3.5e-65
Identities = 125/355 (35%), Positives = 176/355 (49%)
Query: 21 NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGV 80
+E+ ALL WK+ L I +L SSW SN PC W GI CN+ G+V I L+ +
Sbjct: 29 DEQGLALLSWKSQLNISGDAL-SSWKASESN------PCQWVGIKCNERGQVSEIQLQVM 81
Query: 81 GLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQXXXXXXXXXXXXXXXQFSGNIPHEVG 140
+G L A + L L L L G+IP + SG IP ++
Sbjct: 82 DFQGPLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLDLADNSLSGEIPVDIF 141
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
+ LKIL +++N L+G IP E+G L +++EL LF N L G +P ++G L + +
Sbjct: 142 KLKKLKILSLNTNNLEGVIPSELGNLVNLIELTLFDNKLAGEIPRTIGELKNLEIFRAGG 201
Query: 201 N-SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL 259
N + G +P +IGN +S+ L LA SG +P S+GNL ++ +L + L G IP +
Sbjct: 202 NKNLRGELPWEIGNCESLVTLGLAETSLSGRLPASIGNLKKVQTIALYTSLLSGPIPDEI 261
Query: 260 DNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
N L L L N + +P ++ R LQ + +N G IP L C L V L
Sbjct: 262 GNCTELQNLYLYQNSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTELGTCPELFLVDLS 321
Query: 319 GNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373
N LTGNI ++FG PNL + LS N G I C KL L I N I+G+
Sbjct: 322 ENLLTGNIPRSFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEIDNNQISGE 376
|
|
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 7.5e-65, Sum P(2) = 7.5e-65
Identities = 127/358 (35%), Positives = 177/358 (49%)
Query: 21 NEEADALLKWKASLQIHNRSLLSSW-IKDTSNVSSKISPCAWSGISCNDAGRVINISLRG 79
+++ ALL WK+ L I + SSW + DTS PC W G+ CN G V I L+G
Sbjct: 26 DQQGQALLSWKSQLNISGDAF-SSWHVADTS-------PCNWVGVKCNRRGEVSEIQLKG 77
Query: 80 VGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQXXXXXXXXXXXXXXXQFSGNIPHEV 139
+ L+G L S S L L L L G IP + SG+IP E+
Sbjct: 78 MDLQGSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEI 137
Query: 140 GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
+ LK L +++N L+G IP+E+G LS +VEL LF N L+G +P S+G L + +L
Sbjct: 138 FRLKKLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAG 197
Query: 200 DN-SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS 258
N + G +P +IGN +++ +L LA SG +P S+GNL ++ ++ + L G IP
Sbjct: 198 GNKNLRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDE 257
Query: 259 LDNLV-LTKLSLDDNHFTSYLPQNICRGGA--LQIFTVSENRFQGTIPKSLRNCTSLIRV 315
+ L L L N + +P I GG LQ + +N G IP L NC L +
Sbjct: 258 IGYCTELQNLYLYQNSISGSIPTTI--GGLKKLQSLLLWQNNLVGKIPTELGNCPELWLI 315
Query: 316 RLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373
N LTG I ++FG NL + LS N G I C KL L I N ITG+
Sbjct: 316 DFSENLLTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGE 373
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 1.6e-64, Sum P(2) = 1.6e-64
Identities = 120/365 (32%), Positives = 182/365 (49%)
Query: 21 NEEADALLKWKASLQIHNRS--LLSSWIKDTSNVSSKISPCAWSGISCNDAG--RVINIS 76
N + LL+ K SL + + L W D N C+W+G++C++ G RVI ++
Sbjct: 24 NNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINY------CSWTGVTCDNTGLFRVIALN 77
Query: 77 LRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQXXXXXXXXXXXXXXXQFSGNIP 136
L G+GL G + + F F +L +LDL N L G IP Q +G IP
Sbjct: 78 LTGLGLTGSISPW-FGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIP 136
Query: 137 HEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISML 196
++G + +++ L I N+L G IP +G L ++ LAL S L G +P LG L ++ L
Sbjct: 137 SQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSL 196
Query: 197 FLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIP 256
L DN G IP ++GN +++ + A N +G IP LG L NL+ +L N+L G IP
Sbjct: 197 ILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIP 256
Query: 257 PSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRV 315
L + L LSL N +P+++ G LQ +S N G IP+ N + L+ +
Sbjct: 257 SQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDL 316
Query: 316 RLDGNNLTGNISKAF-GIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDF 374
L N+L+G++ K+ NL + LS GEI +C L L++S N++ G
Sbjct: 317 VLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSI 376
Query: 375 GIAKF 379
A F
Sbjct: 377 PEALF 381
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 463 (168.0 bits), Expect = 5.7e-64, Sum P(2) = 5.7e-64
Identities = 122/379 (32%), Positives = 183/379 (48%)
Query: 1 MHRLVDLSIARFLVAVSSET---NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKIS 57
M +L I+ L+ + SET N E LL+ K+ + + L +W SN S
Sbjct: 5 MMKLAVFFISLLLILLISETTGLNLEGQYLLEIKSKF-VDAKQNLRNW---NSNDSV--- 57
Query: 58 PCAWSGISCNDAG---RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQ 114
PC W+G+ C++ V++++L + L GKL S HL LDL N L G IP +
Sbjct: 58 PCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSP-SIGGLVHLKQLDLSYNGLSGKIPKE 116
Query: 115 XXXXXXXXXXXXXXXQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELAL 174
QF G IP E+G + L+ L I +N++ GS+P+E+G L S+ +L
Sbjct: 117 IGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVT 176
Query: 175 FSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLS 234
+SNN++G +P S+GNL +++ N SG +P +IG +S+ +L LA NQ SG +P
Sbjct: 177 YSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKE 236
Query: 235 LGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTV 293
+G L L Q L N G IP + N L L+L N +P+ + +L+ +
Sbjct: 237 IGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYL 296
Query: 294 SENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN 353
N GTIP+ + N + I + N LTG I G L + L N G I
Sbjct: 297 YRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVE 356
Query: 354 FGECPKLGALNISRNNITG 372
L L++S N +TG
Sbjct: 357 LSTLKNLSKLDLSINALTG 375
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 443 (161.0 bits), Expect = 1.4e-63, Sum P(2) = 1.4e-63
Identities = 110/359 (30%), Positives = 180/359 (50%)
Query: 61 WSGISCNDAGRVINISLRGVG---LKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQXXX 117
+SG + G+ +N+ L G+ + G+L L + L NK G IP
Sbjct: 217 FSGNIPTEIGKCLNLKLLGLAQNFISGELPK-EIGMLVKLQEVILWQNKFSGFIPKDIGN 275
Query: 118 XXXXXXXXXXXXQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177
G IP E+G M LK LY+ NQL+G+IP E+G+LS ++E+ N
Sbjct: 276 LTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSEN 335
Query: 178 NLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGN 237
L+G +P L ++++ +L+L N +G IP ++ L++++ L L+IN +GPIP N
Sbjct: 336 LLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQN 395
Query: 238 LTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSEN 296
LT+++Q L +N+L G IP L L + +N + +P IC+ L + + N
Sbjct: 396 LTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSN 455
Query: 297 RFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGE 356
R G IP + C SL+++R+ GN LTG NL+ I+L +N F G + G
Sbjct: 456 RIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGT 515
Query: 357 CPKLGALNISRNNITGDFG--IAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDV 413
C KL L+++ N + + I+K + N + + T G I E+A K+ ++ D+
Sbjct: 516 CQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLT-GPIPSEIA-NCKMLQRLDL 572
|
|
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 2.8e-63, Sum P(2) = 2.8e-63
Identities = 108/312 (34%), Positives = 155/312 (49%)
Query: 61 WSGISCNDAGRVI---NISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQXXX 117
+ G+ +D R+ ++ G +G++ A ++ L ++ L N L G +PP+
Sbjct: 165 FEGLLPSDVSRLRFLEELNFGGSYFEGEIPA-AYGGLQRLKFIHLAGNVLGGKLPPRLGL 223
Query: 118 XXXXXXXXXXXXQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177
F+GNIP E L+S+LK + + L GS+P E+G LS++ L LF N
Sbjct: 224 LTELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQN 283
Query: 178 NLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGN 237
G +P S NL + +L N SG IP LK+++ LSL N SG +P +G
Sbjct: 284 GFTGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGE 343
Query: 238 LTNLKQFSLVYNNLYGSIPPSL-DNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSEN 296
L L L NN G +P L N L + + +N FT +P ++C G L + N
Sbjct: 344 LPELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSN 403
Query: 297 RFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGE 356
F+G +PKSL C SL R R N L G I FG NLTF+DLS N F +I ++F
Sbjct: 404 MFEGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFAT 463
Query: 357 CPKLGALNISRN 368
P L LN+S N
Sbjct: 464 APVLQYLNLSTN 475
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 3.9e-61, Sum P(2) = 3.9e-61
Identities = 104/313 (33%), Positives = 158/313 (50%)
Query: 62 SGISCNDAGRVINIS---LRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQXXXX 118
SG D G ++++ LRG +G L + SF + L +L L N L G +P
Sbjct: 153 SGNLTEDLGNLVSLEVLDLRGNFFQGSLPS-SFKNLQKLRFLGLSGNNLTGELPSVLGQL 211
Query: 119 XXXXXXXXXXXQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNN 178
+F G IP E G ++ LK L + +L G IP E+G+L S+ L L+ NN
Sbjct: 212 PSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENN 271
Query: 179 LNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNL 238
G++P +G++T + +L DN+ +G IP +I LK++ +L+L N+ SG IP ++ +L
Sbjct: 272 FTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSL 331
Query: 239 TNLKQFSLVYNNLYGSIPPSLD-NLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENR 297
L+ L N L G +P L N L L + N F+ +P +C G L + N
Sbjct: 332 AQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNT 391
Query: 298 FQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGEC 357
F G IP +L C SL+RVR+ N L G+I FG L ++L+ N G I + +
Sbjct: 392 FTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDS 451
Query: 358 PKLGALNISRNNI 370
L ++ SRN I
Sbjct: 452 VSLSFIDFSRNQI 464
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XIX000625 | hypothetical protein (825 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 502 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-61 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-56 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-24 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-10 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-09 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-09 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-08 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-08 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-08 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-07 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-06 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-05 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-05 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-05 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-04 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.001 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.001 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.001 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.001 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.002 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.002 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.002 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 0.002 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.002 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 0.002 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.002 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 0.002 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.002 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 0.002 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.003 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.003 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.003 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.003 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 0.003 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.003 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.003 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.003 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.003 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 7e-61
Identities = 123/318 (38%), Positives = 161/318 (50%), Gaps = 32/318 (10%)
Query: 93 SFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDS 152
SF L LDL N L G IP ++NLT+L L+L NQ G IP E+G M LK +Y+
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY 221
Query: 153 NQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIG 212
N L G IP E+G L+S+ L L NNL G +P SLGNL + LFL+ N SG IPP I
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281
Query: 213 NLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV--------- 263
+L+ + L L+ N SG IP + L NL+ L NN G IP +L +L
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341
Query: 264 ----------------LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLR 307
LT L L N+ T +P+ +C G L + N +G IPKSL
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401
Query: 308 NCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISR 367
C SL RVRL N+ +G + F P + F+D+S NN G I+S + P L L+++R
Sbjct: 402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR 461
Query: 368 NNITGDFGIAKFLKPDSS 385
N G PDS
Sbjct: 462 NKFFGGL-------PDSF 472
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 8e-56
Identities = 131/353 (37%), Positives = 188/353 (53%), Gaps = 13/353 (3%)
Query: 22 EEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVG 81
EE + LL +K+S+ LS+W +S C W GI+CN++ RV++I L G
Sbjct: 29 EELELLLSFKSSIN-DPLKYLSNW-------NSSADVCLWQGITCNNSSRVVSIDLSGKN 80
Query: 82 LKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLT-NLSILSLGGNQFSGNIPHEVG 140
+ GK+ + F P++ ++L +N+L G IP I + +L L+L N F+G+IP G
Sbjct: 81 ISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--G 137
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
+ +L+ L + +N L G IP ++G SS+ L L N L G +P+SL NLT + L L
Sbjct: 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS 197
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD 260
N G IP ++G +KS+ + L N SG IP +G LT+L LVYNNL G IP SL
Sbjct: 198 NQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG 257
Query: 261 NLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDG 319
NL L L L N + +P +I L +S+N G IP+ + +L + L
Sbjct: 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS 317
Query: 320 NNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
NN TG I A P L + L N F GEI N G+ L L++S NN+TG
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG 370
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-41
Identities = 99/278 (35%), Positives = 141/278 (50%), Gaps = 2/278 (0%)
Query: 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLD 156
L +LDL N L G IP + NL NL L L N+ SG IP + + L L + N L
Sbjct: 238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297
Query: 157 GSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKS 216
G IP V QL ++ L LFSNN G +P +L +L ++ +L L N FSG IP ++G +
Sbjct: 298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357
Query: 217 ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL-DNLVLTKLSLDDNHFT 275
+++L L+ N +G IP L + NL + L N+L G IP SL L ++ L DN F+
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 276 SYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPN 335
LP + + +S N QG I + SL + L N G + +FG
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKR 476
Query: 336 LTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373
L +DLSRN F G + G +L L +S N ++G+
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGE 514
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-41
Identities = 95/276 (34%), Positives = 143/276 (51%)
Query: 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLD 156
L L L N G IP +++L L +L L N+FSG IP +G ++L +L + +N L
Sbjct: 310 LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369
Query: 157 GSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKS 216
G IP + ++ +L LFSN+L G +P SLG + + L DNSFSG +P + L
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429
Query: 217 ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTS 276
+ L ++ N G I ++ +L+ SL N +G +P S + L L L N F+
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSG 489
Query: 277 YLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNL 336
+P+ + L +SEN+ G IP L +C L+ + L N L+G I +F P L
Sbjct: 490 AVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVL 549
Query: 337 TFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
+ +DLS+N GEI N G L +NIS N++ G
Sbjct: 550 SQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 65/194 (33%), Positives = 108/194 (55%), Gaps = 5/194 (2%)
Query: 65 SCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSIL 124
+C RV L+ G+L + F+ P + +LD+ +N L G I + ++ +L +L
Sbjct: 402 ACRSLRRV---RLQDNSFSGELPS-EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQML 457
Query: 125 SLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVP 184
SL N+F G +P G L+ L + NQ G++P ++G LS +++L L N L+G +P
Sbjct: 458 SLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516
Query: 185 HSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQF 244
L + ++ L L N SG IP + +S L L+ NQ SG IP +LGN+ +L Q
Sbjct: 517 DELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV 576
Query: 245 SLVYNNLYGSIPPS 258
++ +N+L+GS+P +
Sbjct: 577 NISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 40/121 (33%), Positives = 58/121 (47%), Gaps = 12/121 (9%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430
DFG+AK L SS+ T F GT Y+APE L K DV+S GV++ E++ GK P
Sbjct: 140 ADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP- 198
Query: 431 DFLSSTSSPSLNTDIALDEMLDPRLPVP---SCSVQEKLISIMEVGFSCLKESPESRPTM 487
F + L+ + +L P L S E+ +++ CL + P RPT
Sbjct: 199 -F---SGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK---KCLNKDPSKRPTA 251
Query: 488 K 488
+
Sbjct: 252 E 252
|
Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 23/162 (14%)
Query: 13 LVAVSSETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCA-----WSGISC- 66
+ A S EE AL K+SL + R W D PC WSG C
Sbjct: 363 ITAESKTLLEEVSALQTLKSSLGLPLRF---GWNGD---------PCVPQQHPWSGADCQ 410
Query: 67 --NDAGR--VINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLS 122
+ G+ + + L GL+G + S HL ++L N + G IPP + ++T+L
Sbjct: 411 FDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSLGSITSLE 469
Query: 123 ILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVG 164
+L L N F+G+IP +G ++ L+IL ++ N L G +P +G
Sbjct: 470 VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 7e-14
Identities = 31/119 (26%), Positives = 51/119 (42%), Gaps = 13/119 (10%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+A+ L P T F GT Y+APE+ + D++S GV++ E++ GK P
Sbjct: 139 ADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP-- 195
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCS--VQEKLISIMEVGFSCLKESPESRPTMK 488
F ++ P+ P P + + ++ L + PE R T +
Sbjct: 196 FPGDD-----QLLELFKKIGKPKPPFPPPEWDISPEAKDLIR---KLLVKDPEKRLTAE 246
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 33/89 (37%), Positives = 53/89 (59%)
Query: 124 LSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSV 183
L L G IP+++ + HL+ + + N + G+IP +G ++S+ L L N+ NGS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 184 PHSLGNLTQISMLFLHDNSFSGFIPPDIG 212
P SLG LT + +L L+ NS SG +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 45/123 (36%), Positives = 63/123 (51%), Gaps = 7/123 (5%)
Query: 193 ISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY 252
I L L + GFIP DI L+ + ++L+ N G IP SLG++T+L+ L YN+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 253 GSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGAL---QIFTVSENRFQGTIPKSLRN 308
GSIP SL L L L+L+ N + +P + GG L F ++N IP LR
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL--GGRLLHRASFNFTDNAGLCGIP-GLRA 536
Query: 309 CTS 311
C
Sbjct: 537 CGP 539
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 172 LALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI 231
L L + L G +P+ + L + + L NS G IPP +G++ S+ +L L+ N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 232 PLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVL--TKLSLDDN 272
P SLG LT+L+ +L N+L G +P +L +L + DN
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 35/89 (39%), Positives = 56/89 (62%)
Query: 148 LYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFI 207
L +D+ L G IP ++ +L + + L N++ G++P SLG++T + +L L NSF+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 208 PPDIGNLKSISILSLAINQFSGPIPLSLG 236
P +G L S+ IL+L N SG +P +LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 21/52 (40%), Positives = 29/52 (55%), Gaps = 1/52 (1%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVLVLE 422
DFG++K L D S GT Y+APE L +EK D++S GV++ E
Sbjct: 135 ADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 40/144 (27%), Positives = 56/144 (38%), Gaps = 35/144 (24%)
Query: 365 ISRNNIT--GDFGIAKFLKPDSSN----------WTGFAGTYGYIAPELAYTMKITEKCD 412
+ N + DFG+++ L D W APE K T K D
Sbjct: 135 VGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM---------APESLKEGKFTSKSD 185
Query: 413 VYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPS-CSVQEKLISIM 470
V+SFGVL+ E+ G+ P +S N ++ RLP P C +L +M
Sbjct: 186 VWSFGVLLWEIFTLGEQPYPGMS-------NEEVLEYLKNGYRLPQPPNCP--PELYDLM 236
Query: 471 EVGFSCLKESPESRPTMKIVSQQL 494
C E PE RPT + + L
Sbjct: 237 L---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 40/144 (27%), Positives = 56/144 (38%), Gaps = 35/144 (24%)
Query: 365 ISRNNIT--GDFGIAKFLKPDSSN----------WTGFAGTYGYIAPELAYTMKITEKCD 412
+ N + DFG+++ L D W APE K T K D
Sbjct: 136 VGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM---------APESLKEGKFTSKSD 186
Query: 413 VYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPS-CSVQEKLISIM 470
V+SFGVL+ E+ G+ P +S N ++ RLP P C +L +M
Sbjct: 187 VWSFGVLLWEIFTLGEEPYPGMS-------NAEVLEYLKKGYRLPKPPNCP--PELYKLM 237
Query: 471 EVGFSCLKESPESRPTMKIVSQQL 494
C E PE RPT + + L
Sbjct: 238 L---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 3e-09
Identities = 37/144 (25%), Positives = 53/144 (36%), Gaps = 50/144 (34%)
Query: 372 GDFGIAKFLKPDSS-----------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLV 420
DFG+++ + D W APE K T K DV+SFGVL+
Sbjct: 144 SDFGLSRDIYEDDYYRKRGGGKLPIKWM---------APESLKDGKFTSKSDVWSFGVLL 194
Query: 421 LEVI-------KGKHPRDFLSSTSSPSLNTDIALDEMLD--PRLPVP-SCSVQEKLISIM 470
E+ G + L E+L+ RLP P +C ++L +M
Sbjct: 195 WEIFTLGEQPYPGMSNEEVL---------------ELLEDGYRLPRPENCP--DELYELM 237
Query: 471 EVGFSCLKESPESRPTMKIVSQQL 494
C PE RPT + + L
Sbjct: 238 L---QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 41/153 (26%)
Query: 360 LGALNI--SRNNI--TGDFGIAKFLKPDSSN----------WTGFAGTYGYIAPELAYTM 405
L A N+ NNI DFG+A+ +K D WT APE A
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT---------APEAALYN 179
Query: 406 KITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCS 461
+ + K DV+SFG+L+ E++ G+ P P + T+ + + +D R+P P C
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMP--------YPGM-TNAEVLQQVDQGYRMPCPPGCP 230
Query: 462 VQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
+ L IM C KE P+ RPT + + +L
Sbjct: 231 KE--LYDIM---LDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-08
Identities = 18/47 (38%), Positives = 29/47 (61%), Gaps = 6/47 (12%)
Query: 21 NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCN 67
N++ DALL +K+SL LSSW +S+ PC+W+G++C+
Sbjct: 2 NDDRDALLAFKSSLNGDPSGALSSWNPSSSD------PCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 40/127 (31%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 364 NI---SRNNIT-GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
NI + NN+ GDFG+AK L DSS + GT Y++PE M EK D++S G L
Sbjct: 140 NIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCL 199
Query: 420 VLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKE 479
+ E+ P ++ + L + I E R+P S ++I S L
Sbjct: 200 IYELCALSPP---FTARNQLQLASKIK--EGKFRRIPYRYSSELNEVIK------SMLNV 248
Query: 480 SPESRPT 486
P+ RP+
Sbjct: 249 DPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 41/127 (32%), Positives = 61/127 (48%), Gaps = 19/127 (14%)
Query: 373 DFGIAKFLKPD---SSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGKH 428
DFG+A+++ D SS T F + PE+ + + K DV+SFGVL+ EV +GK
Sbjct: 143 DFGLARYVLDDQYTSSQGTKFPVKWA--PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM 200
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTM 487
P + S N+++ RL P ++ +IM +SC E PE RP
Sbjct: 201 PYERFS-------NSEVVESVSAGYRLYRPKLAP--TEVYTIM---YSCWHEKPEDRPAF 248
Query: 488 KIVSQQL 494
K + QL
Sbjct: 249 KKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 6/105 (5%)
Query: 396 YIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN------TDIALDE 449
Y+APE T ITEK D+Y FG++++E++ GK P D + +D LD
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903
Query: 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
+DP + Q +++ +M + C P +RP V + L
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 39/122 (31%), Positives = 63/122 (51%), Gaps = 19/122 (15%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGT---YGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGK 427
DFG+A+ + + + +T G + APE A + T K DV+SFG+L+ E++ KG+
Sbjct: 144 ADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
Query: 428 HPRDFLSSTSSPSLNTDIALDEM-LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
P P +N L+++ R+P P Q+ IS+ E+ C K+ PE RPT
Sbjct: 202 VP--------YPGMNNREVLEQVERGYRMPCP----QDCPISLHELMLQCWKKDPEERPT 249
Query: 487 MK 488
+
Sbjct: 250 FE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 2e-08
Identities = 38/138 (27%), Positives = 56/138 (40%), Gaps = 36/138 (26%)
Query: 372 GDFGIAKFLKPDSSN-----------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLV 420
DFG+++ + D W APE T K DV+SFGVL+
Sbjct: 147 SDFGLSRDVYDDDYYRKKTGGKLPIRWM---------APESLKDGIFTSKSDVWSFGVLL 197
Query: 421 LEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP-RLPVPS-CSVQEKLISIMEVGFSCL 477
E+ G P P L+ + L+ + RLP P C ++L +M SC
Sbjct: 198 WEIFTLGATP--------YPGLSNEEVLEYLRKGYRLPKPEYCP--DELYELML---SCW 244
Query: 478 KESPESRPTMKIVSQQLR 495
+ PE RPT + ++L
Sbjct: 245 QLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 2e-08
Identities = 38/129 (29%), Positives = 57/129 (44%), Gaps = 15/129 (11%)
Query: 364 NI---SRNNIT-GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
NI S + GDFGI+K L GT Y++PEL K D++S G +
Sbjct: 133 NIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCV 192
Query: 420 VLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKE 479
+ E+ KHP F + L I + P+PS E L +++ S L++
Sbjct: 193 LYELCTLKHP--F-EGENLLELALKI----LKGQYPPIPSQYSSE-LRNLVS---SLLQK 241
Query: 480 SPESRPTMK 488
PE RP++
Sbjct: 242 DPEERPSIA 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 13/118 (11%)
Query: 372 GDFGIAKFLKPDSSNWTG---FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH 428
DFG AK L D G GT ++APE+ + D++S G V+E+ GK
Sbjct: 143 ADFGCAKRLG-DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
P L + + +L + E P +P + E+ + CL+ P+ RPT
Sbjct: 202 PWSELGNPMA-ALYKIGSSGEP--PEIP---EHLSEEAKDFLR---KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 32/114 (28%), Positives = 48/114 (42%), Gaps = 7/114 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFGI+K L+ F GT Y++PE + D++S G+ +LE GK P
Sbjct: 143 DFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLP 202
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
S L I P LP S + + +CL++ P+ RP+
Sbjct: 203 PGQPSFFELMQAICDGP--PPSLPAEEFS--PEFRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 60/205 (29%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 100 LDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSI 159
LDL N+L I + LTNL+ L L N + P L S+LK L + N++ S+
Sbjct: 98 LDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESL 155
Query: 160 PLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF------------- 206
P + L ++ L L N+L+ +P L NL+ ++ L L N S
Sbjct: 156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEEL 214
Query: 207 ---------IPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP 257
+ + NLK++S L L+ N+ +P S+GNL+NL+ L NN SI
Sbjct: 215 DLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDL-SNNQISSISS 272
Query: 258 SLDNLVLTKLSLDDNHFTSYLPQNI 282
L +L L N ++ LP
Sbjct: 273 LGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 38/134 (28%), Positives = 56/134 (41%), Gaps = 32/134 (23%)
Query: 372 GDFGIAKFLK-----PDSSN----WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLE 422
DFG+A+ +K WT APE A + K DV+SFG+L+ E
Sbjct: 146 ADFGLARLIKEDVYLSSDKKIPYKWT---------APEAASHGTFSTKSDVWSFGILLYE 196
Query: 423 VI-KGKHPRDFLSSTSSPSLNTDIALDE-MLDPRLPVPSCSVQEKLISIMEVGFSCLKES 480
+ G+ P P +N D+ R+P P+ QE + IM C
Sbjct: 197 MFTYGQVP--------YPGMNNHEVYDQITAGYRMPCPAKCPQE-IYKIM---LECWAAE 244
Query: 481 PESRPTMKIVSQQL 494
PE RP+ K + ++L
Sbjct: 245 PEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 42/144 (29%), Positives = 61/144 (42%), Gaps = 39/144 (27%)
Query: 360 LGALNI--SRNNI--TGDFGIAKFLKPDSSN----------WTGFAGTYGYIAPELAYTM 405
L A NI N + DFG+A+ ++ D WT APE A
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT---------APEAANYG 179
Query: 406 KITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDE-MLDPRLPVPS-CSV 462
+ T K DV+SFG+L+ E++ G+ P P + L++ R+P P C
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVP--------YPGMTNREVLEQVERGYRMPRPPNCP- 230
Query: 463 QEKLISIMEVGFSCLKESPESRPT 486
E+L +M C + PE RPT
Sbjct: 231 -EELYDLML---QCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 13/115 (11%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
GD G+AK L +++ GT Y++PEL EK DV++ GV++ E GKHP D
Sbjct: 143 GDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
Query: 432 FLSSTSSPSLNTDIAL-DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP 485
N AL +++ P S ++L +++ CL + RP
Sbjct: 203 ---------ANNQGALILKIIRGVFPPVSQMYSQQLAQLID---QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 17/122 (13%)
Query: 373 DFGIAKFLKPD---SSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKH 428
DFG+++++ D SS + F + PE+ K + K DV++FGVL+ EV GK
Sbjct: 143 DFGLSRYVLDDEYTSSVGSKFPVRWS--PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
P + + N++ RL P + EK+ +IM +SC E E RPT +
Sbjct: 201 PYERFN-------NSETVEKVSQGLRLYRPHLA-SEKVYAIM---YSCWHEKAEERPTFQ 249
Query: 489 IV 490
+
Sbjct: 250 QL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 43/126 (34%), Positives = 64/126 (50%), Gaps = 17/126 (13%)
Query: 373 DFGIAKFLKPD---SSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGKH 428
DFG+ +F+ D SS T F + +PE+ K + K DV+SFGVL+ EV +GK
Sbjct: 143 DFGMTRFVLDDQYTSSTGTKFPVKWS--SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
P + + ++S + T A + PRL S S+ E+ C KE PE RP+
Sbjct: 201 PYE--NRSNSEVVETINAGFRLYKPRL----ASQ-----SVYELMQHCWKERPEDRPSFS 249
Query: 489 IVSQQL 494
++ QL
Sbjct: 250 LLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 35/114 (30%), Positives = 61/114 (53%), Gaps = 7/114 (6%)
Query: 373 DFGIAK-FLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
D+G+ K L+P + + F GT YIAPE+ D ++ GVL+ E++ G+ P D
Sbjct: 139 DYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
Query: 432 FLSSTSSPSLNT-DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESR 484
+ S+ +P NT D +L+ ++ +P S+ K S+++ S L + P+ R
Sbjct: 198 IVGSSDNPDQNTEDYLFQVILEKQIRIPR-SLSVKAASVLK---SFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 15/141 (10%)
Query: 360 LGALNI--SRNNIT--GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYS 415
+ LNI ++ + GDFGI+K L + S GT Y++PEL +K K D+++
Sbjct: 127 IKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWA 186
Query: 416 FGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFS 475
G ++ E++ K R F +T+ +L I + PV S E LIS++ S
Sbjct: 187 LGCVLYELLTLK--RTF-DATNPLNLVVKI----VQGNYTPVVSVYSSE-LISLVH---S 235
Query: 476 CLKESPESRPTMKIVSQQLRI 496
L++ PE RPT V Q +
Sbjct: 236 LLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 24/67 (35%), Positives = 33/67 (49%), Gaps = 1/67 (1%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DF IA + PD+ T +GT GY+APE+ + D +S GV E ++GK P
Sbjct: 142 TDFNIATKVTPDTLT-TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
Query: 432 FLSSTSS 438
S T
Sbjct: 201 GHSRTIR 207
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 6/173 (3%)
Query: 199 HDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS 258
++ +P + L S+ +LS + S +L NL L L N L +I
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNISEL 112
Query: 259 LDNLVLTKLSLDDNHFTSYLPQNICR-GGALQIFTVSENRFQGTIPKSLRNCTSLIRVRL 317
L+ LT L LD+N+ T +P I L+ +S+N+ + ++P LRN +L + L
Sbjct: 113 LELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170
Query: 318 DGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNI 370
N+L+ ++ K NL +DLS N ++ L L++S N+I
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 17/126 (13%)
Query: 373 DFGIAKFLKPD---SSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGKH 428
DFG+ +++ D SS+ F + PE+ K + K DV+SFGVL+ EV +GK
Sbjct: 143 DFGMTRYVLDDEYTSSSGAKFP--VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKM 200
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
P F ++ + + P+L +++ EV +SC E PE RPT
Sbjct: 201 P--FEKKSNYEVVEMISRGFRLYRPKLAS---------MTVYEVMYSCWHEKPEGRPTFA 249
Query: 489 IVSQQL 494
+ + +
Sbjct: 250 ELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 32/117 (27%), Positives = 51/117 (43%), Gaps = 16/117 (13%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG++ L + T GT ++APE+ K D++S G+ +E+ +GK P
Sbjct: 141 DFGLSAQLSDTKARNT-MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSE 199
Query: 433 LSSTSSPSLNTDIALDEMLD---PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
L AL ++ P L P E ++ CL+++PE RPT
Sbjct: 200 LPPMK--------ALFKIATNGPPGLRNPEKWSDE-FKDFLK---KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 44/149 (29%), Positives = 64/149 (42%), Gaps = 29/149 (19%)
Query: 360 LGALNI---SRNNIT-GDFGIAKFLKPDSSNWTGFAGTYG-----YIAPELAYTMKITEK 410
L A N+ +R+ DFG+++ L S + A T G + APE K + K
Sbjct: 121 LAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECINYGKFSSK 178
Query: 411 CDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKL 466
DV+S+GV + E G P + ++ ML+ RLP P C +++
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPYGEMK-------GAEVI--AMLESGERLPRPEECP--QEI 227
Query: 467 ISIMEVGFSCLKESPESRPTMKIVSQQLR 495
SIM SC K PE RPT + R
Sbjct: 228 YSIML---SCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 19/122 (15%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGT---YGYIAPELAYTMKITEKCDVYSFGVLVLEV-IKGK 427
DFG+A+ + + + +T G + APE A + T K DV+SFG+L+ E+ KG+
Sbjct: 144 ADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
Query: 428 HPRDFLSSTSSPSLNTDIALDEM-LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
P P + LD++ R+P P E S+ ++ C ++ PE RPT
Sbjct: 202 VP--------YPGMVNREVLDQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPT 249
Query: 487 MK 488
+
Sbjct: 250 FE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 5/126 (3%)
Query: 299 QGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECP 358
+G IP + L + L GN++ GNI + G +L +DLS N+F G I + G+
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 359 KLGALNISRNNITGDFGIA---KFLKPDSSNWTGFAGTYGYIA-PELAYTMKITEKCDVY 414
L LN++ N+++G A + L S N+T AG G + + K +
Sbjct: 491 SLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGI- 549
Query: 415 SFGVLV 420
+FGV V
Sbjct: 550 AFGVSV 555
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 68/288 (23%), Positives = 105/288 (36%), Gaps = 28/288 (9%)
Query: 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGL-------MSH 144
S+ H + N + N L++ S ++ + L +S
Sbjct: 23 SNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISS 82
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L N L ++L L N S L NLT + + +
Sbjct: 83 LDGSENLLNLLPLP----------SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIP 132
Query: 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV- 263
I NLK + + I P+ NL NLK L +N+L +P L NL
Sbjct: 133 PLIGLLKSNLKELDLSDNKIESLPSPL----RNLPNLKNLDLSFNDL-SDLPKLLSNLSN 187
Query: 264 LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLT 323
L L L N + LP I AL+ +S N + SL N +L + L N L
Sbjct: 188 LNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE 245
Query: 324 GNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
++ ++ G NL +DLS N S+ G L L++S N+++
Sbjct: 246 -DLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLS 290
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 30/107 (28%), Positives = 52/107 (48%), Gaps = 1/107 (0%)
Query: 263 VLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNL 322
+ L LD+ ++P +I + LQ +S N +G IP SL + TSL + L N+
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 323 TGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGA-LNISRN 368
G+I ++ G +L ++L+ N+ G + + G A N + N
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 17/127 (13%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGT---YGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GK 427
DFG+A+ ++ + +T G + APE T K DV+SFG+L+ E++ GK
Sbjct: 145 ADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK 202
Query: 428 HPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487
P +S N+D+ R+P + ++L IM+ +C KE E RPT
Sbjct: 203 IPYPGMS-------NSDVMSALQRGYRMPRME-NCPDELYDIMK---TCWKEKAEERPTF 251
Query: 488 KIVSQQL 494
+ L
Sbjct: 252 DYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 7e-06
Identities = 23/57 (40%), Positives = 32/57 (56%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG+AK L + S F GT Y+APE+ + D +S GVL+ E++ GK P
Sbjct: 136 DFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 33/119 (27%), Positives = 50/119 (42%), Gaps = 15/119 (12%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+A L F GT ++APE+ K D++S G+ +E+ KG+ P
Sbjct: 143 ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP-- 200
Query: 432 FLSSTSSPSLNTDIALDEML--DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
N+D+ +L P+ P+ E E +CL + P RPT K
Sbjct: 201 ----------NSDMHPMRVLFLIPKNNPPTL-TGEFSKPFKEFIDACLNKDPSFRPTAK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 24/65 (36%), Positives = 32/65 (49%), Gaps = 7/65 (10%)
Query: 372 GDFGIAKFLKPDS----SNWTGFAGTYGYIAPELAYTMKITEK---CDVYSFGVLVLEVI 424
GDFG A LK ++ AGT Y+APE+ K D++S G +VLE+
Sbjct: 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200
Query: 425 KGKHP 429
GK P
Sbjct: 201 TGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 37/128 (28%), Positives = 63/128 (49%), Gaps = 19/128 (14%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGT---YGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGK 427
DFG+A+ + + + +T G + APE A + T K DV+SFG+L+ E++ KG+
Sbjct: 144 ADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
Query: 428 HPRDFLSSTSSPSLNTDIALDEM-LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
P P + L+++ R+P P E L +M++ C K+ P+ RPT
Sbjct: 202 VP--------YPGMVNREVLEQVERGYRMPCPQ-GCPESLHELMKL---CWKKDPDERPT 249
Query: 487 MKIVSQQL 494
+ + L
Sbjct: 250 FEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 23/63 (36%), Positives = 36/63 (57%), Gaps = 6/63 (9%)
Query: 373 DFGIAKFLKPDSSNWT------GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKG 426
DFGI+K L+ +S + G+ ++APE+ T K D++S G LV+E++ G
Sbjct: 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
Query: 427 KHP 429
KHP
Sbjct: 209 KHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 46.7 bits (109), Expect = 2e-05
Identities = 30/126 (23%), Positives = 54/126 (42%), Gaps = 10/126 (7%)
Query: 373 DFGIAKFLKPDSSN------WTGFAGTYGYIAPELAYTM---KITEKCDVYSFGVLVLEV 423
DFG+AK L S + GT GY+APE+ + + D++S G+ + E+
Sbjct: 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204
Query: 424 IKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLIS-IMEVGFSCLKESPE 482
+ G P + ++S+ S I L+ S S E + ++ L + P+
Sbjct: 205 LTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPK 264
Query: 483 SRPTMK 488
+R +
Sbjct: 265 NRLSSS 270
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 34/118 (28%), Positives = 51/118 (43%), Gaps = 21/118 (17%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITE------KCDVYSFGVLVLEVIKG 426
DFG+A L +SS + F GT ++APE+ ITE K D++S G+ + E+ G
Sbjct: 144 DFGVAALLNQNSSKRSTFVGTPYWMAPEV-----ITEGKYYDTKADIWSLGITIYEMATG 198
Query: 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESR 484
+ P + D ML P+ P + E +CL E P+ R
Sbjct: 199 ----------NPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 40/123 (32%), Positives = 54/123 (43%), Gaps = 17/123 (13%)
Query: 370 ITGDFGIAKFLKPDSSNWTGFAGTY--GYIAPELAYTMKITEKCDVYSFGVLVLEVIK-G 426
IT DFG+AK L D + G ++A E T K DV+S+GV V E++ G
Sbjct: 150 IT-DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFG 208
Query: 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPS-CSVQEKLISIMEVGFSCLKESPESRP 485
P + + + P L + E RLP P C+ I + V C ESRP
Sbjct: 209 AKPYEGIPAVEIPDL---LEKGE----RLPQPPICT-----IDVYMVLVKCWMIDAESRP 256
Query: 486 TMK 488
T K
Sbjct: 257 TFK 259
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 38/121 (31%), Positives = 58/121 (47%), Gaps = 15/121 (12%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG+AK K S T GT Y PE+ EK DV++FG ++ ++ + P
Sbjct: 157 DFGLAK-QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP--- 212
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLIS--IMEVGFSCLKESPESRPTMKIV 490
ST+ SL T I ++ + +P + E + S + +V SCL E+RP + V
Sbjct: 213 FYSTNMLSLATKI-VEAVYEP--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
Query: 491 S 491
S
Sbjct: 264 S 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 37/115 (32%), Positives = 62/115 (53%), Gaps = 9/115 (7%)
Query: 373 DFGIAK-FLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
D+G+ K ++P + T F GT YIAPE+ D ++ GVL+ E++ G+ P D
Sbjct: 139 DYGMCKEGIRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
Query: 432 FLSSTSSPSLNT-DIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESR 484
+ + +P NT D +L+ ++ +P S SV K S+++ GF L + P+ R
Sbjct: 198 IVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSV--KASSVLK-GF--LNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 35/114 (30%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 373 DFGIAK-FLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
D+G+ K L P + T F GT YIAPE+ + D ++ GVL+ E++ G+ P D
Sbjct: 139 DYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
Query: 432 FLSSTSSPSLNT-DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESR 484
+ T +P +NT D +L+ + +P + K +++ GF L + P+ R
Sbjct: 198 II--TDNPDMNTEDYLFQVILEKPIRIPR-FLSVKASHVLK-GF--LNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 25/63 (39%), Positives = 33/63 (52%), Gaps = 11/63 (17%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEK-----CDVYSFGVLVLEVIKG 426
DFG AK LK WT F GT Y+APE+ I K D +S G+L+ E++ G
Sbjct: 135 VDFGFAKKLKSGQKTWT-FCGTPEYVAPEI-----ILNKGYDFSVDYWSLGILLYELLTG 188
Query: 427 KHP 429
+ P
Sbjct: 189 RPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 23/57 (40%), Positives = 33/57 (57%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG+ K + + F GT YIAPE+ +K T D +SFGVL+ E++ G+ P
Sbjct: 139 DFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 23/57 (40%), Positives = 31/57 (54%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG+ K + F GT YIAPE+ K E D +SFGVL+ E++ G+ P
Sbjct: 139 DFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 6e-05
Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 25/123 (20%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP-- 429
DFG A L + S GT ++APE+ K D++S G++ +E+ +G+ P
Sbjct: 158 ADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL 217
Query: 430 RD------FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPES 483
R+ FL +T P L P + + CL + PE
Sbjct: 218 REPPLRALFLITTKGI-------------PPLKNPE-KWSPEFKDFLN---KCLVKDPEK 260
Query: 484 RPT 486
RP+
Sbjct: 261 RPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 32/116 (27%), Positives = 50/116 (43%), Gaps = 11/116 (9%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG+A L S + GT ++APE+ + D++S G V+E++ G P +
Sbjct: 142 DFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP--Y 199
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+L I D+ P LP S + K + C ++ P RPT K
Sbjct: 200 YDLNPMAAL-FRIVQDDH--PPLP-EGISPELK-----DFLMQCFQKDPNLRPTAK 246
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 23/140 (16%)
Query: 359 KLGALNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGV 418
K+ +SR G + ++ LK WT APE + T + DV+S+G+
Sbjct: 133 KISDFGMSREEEGGIYTVSDGLKQIPIKWT---------APEALNYGRYTSESDVWSYGI 183
Query: 419 LVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPSCSVQEKLISIMEVGFSC 476
L+ E L T P ++ E ++ R+P P E++ +M C
Sbjct: 184 LLWETFS-------LGDTPYPGMSNQQT-RERIESGYRMPAPQ-LCPEEIYRLML---QC 231
Query: 477 LKESPESRPTMKIVSQQLRI 496
PE+RP+ + +L+I
Sbjct: 232 WAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 34/131 (25%), Positives = 63/131 (48%), Gaps = 13/131 (9%)
Query: 365 ISRNNI--TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLE 422
++R NI GD GIA+ L+ + GT Y++PEL K DV++ G V E
Sbjct: 135 LTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYE 194
Query: 423 VIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPE 482
+ KH + ++ +N+ + +++ +LP +L ++ + L + PE
Sbjct: 195 MATLKH------AFNAKDMNSLVY--RIIEGKLPPMPKDYSPELGELIA---TMLSKRPE 243
Query: 483 SRPTMKIVSQQ 493
RP++K + +Q
Sbjct: 244 KRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 33/122 (27%), Positives = 52/122 (42%), Gaps = 17/122 (13%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG++ L ++ F GT Y++PE K T K DV+S G+ ++E+ GK P F
Sbjct: 147 DFGVSGELINSIAD--TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204
Query: 433 LSSTSSPSLNTDIALDEMLD-------PRLPVPSCS-VQEKLISIMEVGFSCLKESPESR 484
+ + + + ++L PRLP + CL + P R
Sbjct: 205 SNIDDDGQDDP-MGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDA------CLLKDPTER 257
Query: 485 PT 486
PT
Sbjct: 258 PT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 36/123 (29%), Positives = 53/123 (43%), Gaps = 22/123 (17%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG++ L S F GT ++APE+ EK D++S G+ +E+ KG+ P
Sbjct: 140 ADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP-- 197
Query: 432 FLSSTSSPSLNTDIALDEM----LDPRLPVPSCSVQEKLISIMEVGF--SCLKESPESRP 485
LS L M L P+ PS ++ S F CL + P+ RP
Sbjct: 198 -LSD-----------LHPMRVLFLIPKNNPPS--LEGNKFSKPFKDFVSLCLNKDPKERP 243
Query: 486 TMK 488
+ K
Sbjct: 244 SAK 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 24/62 (38%), Positives = 35/62 (56%), Gaps = 2/62 (3%)
Query: 372 GDFGIAKFLKPDSSNWTG--FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
GDFG +K S+ G F GT Y+APE+ ++K D++S GVL+ E++ K P
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
Query: 430 RD 431
D
Sbjct: 245 FD 246
|
Length = 496 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 29/116 (25%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG++ L + F GT Y+APE + K D++S G+ ++E+ G+ P
Sbjct: 144 DFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ + PRLP S + + CL + P RP+ K
Sbjct: 202 ENDPPDGIFELLQYIVNEPPPRLPSGKFS--PDFQDFVNL---CLIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 17/118 (14%)
Query: 373 DFGIAKFLKPDSSNWTGFAGT---YGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKH 428
DFG+A+ ++ + +T G + APE T K DV+SFG+L+ E++ G+
Sbjct: 145 DFGLARLIEDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRI 202
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
P ++ N ++ + R+P P +E L +M C KE PE RPT
Sbjct: 203 PYPGMT-------NPEVIQNLERGYRMPRPDNCPEE-LYELM---RLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 16/126 (12%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTY--GYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHP 429
DFG+A+ L+ D + G ++A E + K T + DV+S+GV + E++ G P
Sbjct: 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
Query: 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMK 488
D + + P L L++ RLP P C++ ++ + C +SRP K
Sbjct: 212 YDGIPTREIPDL-----LEK--GERLPQPPICTIDVYMVMV-----KCWMIDADSRPKFK 259
Query: 489 IVSQQL 494
++ +
Sbjct: 260 ELAAEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 45/146 (30%), Positives = 73/146 (50%), Gaps = 28/146 (19%)
Query: 360 LGALNISRN-NIT---GDFGIAKFLKPDSSNWTGFAGTYGYI-----APELAYTMKITEK 410
L A NI N N+ DFG+++FL+ D+S+ T + G I APE K T
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA 191
Query: 411 CDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI--ALDEMLDPRLPVP-SCSVQEKL 466
DV+S+G+++ EV+ G+ P +S N D+ A+++ D RLP P C
Sbjct: 192 SDVWSYGIVMWEVMSYGERPYWDMS-------NQDVINAIEQ--DYRLPPPMDCPT---- 238
Query: 467 ISIMEVGFSCLKESPESRPTM-KIVS 491
++ ++ C ++ +RP +IVS
Sbjct: 239 -ALHQLMLDCWQKDRNARPKFGQIVS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 17/118 (14%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM---KITEKCDVYSFGVLVLEVIKGKH 428
DFG A + P +S F GT ++APE+ M + K DV+S G+ +E+ + K
Sbjct: 157 ADFGSASLVSPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
P L + ++ S IA ++ P L S + + ++ SCL++ P+ RP+
Sbjct: 213 P---LFNMNAMSALYHIAQND--SPTLSSNDWS--DYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 27/82 (32%), Positives = 36/82 (43%), Gaps = 3/82 (3%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG+ K + F GT YIAPE+ K D +SFGVL+ E++ G+ P
Sbjct: 139 DFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP--- 195
Query: 433 LSSTSSPSLNTDIALDEMLDPR 454
L I +D PR
Sbjct: 196 FHGHDEEELFQSIRMDNPCYPR 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 18/57 (31%), Positives = 32/57 (56%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG + P+ S + GT ++APE+ K D++S G++ +E+I+G+ P
Sbjct: 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 21/131 (16%)
Query: 373 DFGIAKFLKPDSSNWT--GFAG-TYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG+A+ ++ DS N+ G A ++APE + T + DV+S+G+L+ E+
Sbjct: 257 DFGLARDIRNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS---- 311
Query: 430 RDFLSSTSSPSLNTDIALDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487
L S+ P + D +M+ R+ P C+ E + IM+ SC P RPT
Sbjct: 312 ---LGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE-MYDIMK---SCWDADPLKRPTF 364
Query: 488 K----IVSQQL 494
K ++ QQL
Sbjct: 365 KQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 26/72 (36%), Positives = 41/72 (56%), Gaps = 11/72 (15%)
Query: 360 LGALN--ISRNNI--TGDFGIAKFLKPDSSNWTGFAGT---YGYIAPE-LAYTMKITEKC 411
L A N + N++ DFG+++ + D+ +T AG + APE LAY K + K
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KFSIKS 186
Query: 412 DVYSFGVLVLEV 423
DV++FGVL+ E+
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 20/58 (34%), Positives = 30/58 (51%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
GDFG A+ L + + GT Y+ PE+ M K D++S G ++ E+ KHP
Sbjct: 142 GDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 17/57 (29%), Positives = 32/57 (56%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG + P+ S + GT ++APE+ K D++S G++ +E+++G+ P
Sbjct: 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 21/77 (27%), Positives = 34/77 (44%), Gaps = 20/77 (25%)
Query: 373 DFGIAKFLKPDSSNWTG--------------------FAGTYGYIAPELAYTMKITEKCD 412
DFG AK L P+SS + F GT Y++PEL + D
Sbjct: 145 DFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSD 204
Query: 413 VYSFGVLVLEVIKGKHP 429
+++ G ++ +++ GK P
Sbjct: 205 LWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 39/137 (28%), Positives = 60/137 (43%), Gaps = 20/137 (14%)
Query: 372 GDFGIAKFLKPDSSNWT----GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI--- 424
GDFG+ K L D + G + + Y APE K + DV+SFGV++ E+
Sbjct: 150 GDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYS 208
Query: 425 -KGKHP-RDFLSSTSSPSLNTDIA--LDEMLDP--RLPVP-SCSVQEKLISIMEVGFSCL 477
K P +F+ + I L E+L RLP P C ++ +IM+ C
Sbjct: 209 DKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCP--AEIYAIMK---ECW 263
Query: 478 KESPESRPTMKIVSQQL 494
P RP+ ++ Q+
Sbjct: 264 NNDPSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 17/57 (29%), Positives = 32/57 (56%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG + P+ S + GT ++APE+ K D++S G++ +E+++G+ P
Sbjct: 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 20/57 (35%), Positives = 31/57 (54%), Gaps = 1/57 (1%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G+A + P+ G GT GY+APE+ + T D ++ G L+ E+I G+ P
Sbjct: 145 DLGLAVHV-PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 33/120 (27%), Positives = 54/120 (45%), Gaps = 16/120 (13%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTY--GYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHP 429
DFG+A+ L D + + G ++A E + T + DV+S+GV V E++ G P
Sbjct: 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
Query: 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMK 488
D + + P L L++ RLP P C++ +I + C E RP +
Sbjct: 212 YDGIPAREIPDL-----LEK--GERLPQPPICTIDVYMIMV-----KCWMIDSECRPRFR 259
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 17/57 (29%), Positives = 32/57 (56%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG + P+ S + GT ++APE+ K D++S G++ +E+++G+ P
Sbjct: 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 21/57 (36%), Positives = 31/57 (54%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G+A LK S G+AGT G++APEL + D ++ GV + E+I + P
Sbjct: 140 DLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 21/57 (36%), Positives = 29/57 (50%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG+ K D F GT Y+APEL T+ D ++ GVL+ E++ G P
Sbjct: 136 DFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 32/125 (25%), Positives = 49/125 (39%), Gaps = 27/125 (21%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+A L F GT ++APE+ K D++S G+ +E+ KG+ P
Sbjct: 143 ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS 202
Query: 432 --------FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPES 483
FL ++P P + + L +E +CL + P
Sbjct: 203 ELHPMKVLFLIPKNNP----------------PTLEGNYSKPLKEFVE---ACLNKEPSF 243
Query: 484 RPTMK 488
RPT K
Sbjct: 244 RPTAK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 19/57 (33%), Positives = 27/57 (47%), Gaps = 1/57 (1%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G+A L G AGT GY+APE+ D ++ G + E+I G+ P
Sbjct: 138 DLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 13/116 (11%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
GD GI+K LK + + GT Y+APE+ + K D++S G L+ E+ P
Sbjct: 145 GDLGISKVLKKNMAKTQ--IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP-- 200
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487
+ S L + + P +P + I S L+ P+ RP
Sbjct: 201 -FEARSMQDLRYKVQRGKY--PPIPPIYSQDLQNFIR------SMLQVKPKLRPNC 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 26/97 (26%), Positives = 41/97 (42%), Gaps = 21/97 (21%)
Query: 396 YIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEML---- 451
++APE + K DV+SFGVL+ EV + P ++ +E+L
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEV---------FTQGELP--FYGLSDEEVLNRLQ 232
Query: 452 --DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
LPVP +L +M C +P+ RP+
Sbjct: 233 AGKLELPVPE-GCPSRLYKLMT---RCWAVNPKDRPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 37/126 (29%), Positives = 60/126 (47%), Gaps = 19/126 (15%)
Query: 372 GDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH 428
GDFG +K DS + + F GT Y+APEL + ++K D++S GV++ E++
Sbjct: 211 GDFGFSKQYS-DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
P PS +I + P P C V + ++++ L ++P RPT
Sbjct: 270 P------FKGPS-QREIMQQVLYGKYDPFP-CPVSSGMKALLD---PLLSKNPALRPT-- 316
Query: 489 IVSQQL 494
+QQL
Sbjct: 317 --TQQL 320
|
Length = 478 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 21/57 (36%), Positives = 31/57 (54%), Gaps = 1/57 (1%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G+A + P+ G GT GY+APE+ + T D + G L+ E+I+GK P
Sbjct: 145 DLGLAVEI-PEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 21/57 (36%), Positives = 30/57 (52%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG++K F GT Y+APE+ T+ D +SFGVL+ E++ G P
Sbjct: 141 DFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 34/127 (26%), Positives = 57/127 (44%), Gaps = 17/127 (13%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGT---YGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GK 427
DFG+A+ + + + +T G + APE T K DV+SFG+L++E++ G+
Sbjct: 144 ADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
Query: 428 HPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487
P +S N ++ R+P P +E + + C K PE RPT
Sbjct: 202 IPYPGMS-------NPEVIRALERGYRMPRPENCPEE----LYNIMMRCWKNRPEERPTF 250
Query: 488 KIVSQQL 494
+ + L
Sbjct: 251 EYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 37/122 (30%), Positives = 61/122 (50%), Gaps = 17/122 (13%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM---KITEKCDVYSFGVLVLEVIKGKH 428
GDFG A + P + F GT ++APE+ M + K DV+S G+ +E+ + K
Sbjct: 157 GDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
P L + ++ S IA +E P L S E + ++ SCL++ P+ RPT +
Sbjct: 213 P---LFNMNAMSALYHIAQNE--SPALQ--SGHWSEYFRNFVD---SCLQKIPQDRPTSE 262
Query: 489 IV 490
++
Sbjct: 263 VL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 25/132 (18%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYG-----YIAPELAYTMKITEKCDVYSFGVLVLEVIK-G 426
DFG++K L D + + A T+G + APE K + K DV+SFGVL+ E G
Sbjct: 138 DFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYG 195
Query: 427 KHPRDFLSSTSSPSLNTDIALDEMLD--PRLPVPS-CSVQEKLISIMEVGFSCLKESPES 483
+ P + + +M++ R+ P C + + +M++ C +
Sbjct: 196 QKPYKGMKGNE---------VTQMIESGERMECPQRCPPE--MYDLMKL---CWTYGVDE 241
Query: 484 RPTMKIVSQQLR 495
RP +V +LR
Sbjct: 242 RPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 38/135 (28%), Positives = 57/135 (42%), Gaps = 19/135 (14%)
Query: 360 LGALNI--SRNNITG--DFGIAK--FLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDV 413
L A NI S NN+ DFG+A+ + PD ++APE + T + DV
Sbjct: 199 LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDV 258
Query: 414 YSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLP--VPSCSVQEKLISIME 471
+SFGVL+ E+ L ++ P + +DE RL + + I
Sbjct: 259 WSFGVLLWEIFS-------LGASPYPGVQ----IDEEFCRRLKEGTRMRAPEYATPEIYS 307
Query: 472 VGFSCLKESPESRPT 486
+ C +PE RPT
Sbjct: 308 IMLDCWHNNPEDRPT 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 21/60 (35%), Positives = 31/60 (51%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+ K D F GT YIAPE+ + D ++FGVL+ E++ G+ P +
Sbjct: 143 ADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 41/146 (28%), Positives = 62/146 (42%), Gaps = 27/146 (18%)
Query: 360 LGALNI---SRNNIT-GDFGIAKFLKPDS----SNWTGFAGTYGYIAPELAYTMKITEKC 411
L A NI S + + DFG+AK L D G + + Y APE T K +
Sbjct: 135 LAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSAS 193
Query: 412 DVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEML----------DPRLPVP-SC 460
DV+SFGV + E+ + S + IA +M+ RLP P SC
Sbjct: 194 DVWSFGVTLYELF--TYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSC 251
Query: 461 SVQEKLISIMEVGFSCLKESPESRPT 486
+++ +M+ C + P+ RP+
Sbjct: 252 P--DEVYDLMK---LCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 21/57 (36%), Positives = 31/57 (54%), Gaps = 1/57 (1%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G+A + P+ G GT GY+APE+ K T D + G L+ E+I+G+ P
Sbjct: 145 DLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 33/119 (27%), Positives = 50/119 (42%), Gaps = 15/119 (12%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+A L F GT ++APE+ K D++S G+ +E+ KG+ P
Sbjct: 143 ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP-- 200
Query: 432 FLSSTSSPSLNTDIALDEM--LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
N+D+ + L P+ P+ Q E +CL + P RPT K
Sbjct: 201 ----------NSDLHPMRVLFLIPKNSPPTLEGQYSK-PFKEFVEACLNKDPRFRPTAK 248
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 22/60 (36%), Positives = 33/60 (55%), Gaps = 2/60 (3%)
Query: 373 DFGIAK-FLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+ K + + T F GT YIAPE+ + D ++FGVL+ E++ G+ P D
Sbjct: 144 DFGMCKENIFGGKTTRT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 20/58 (34%), Positives = 29/58 (50%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
GDFGIA+ L GT Y++PE+ K D++S G ++ E+ KHP
Sbjct: 144 GDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 33/120 (27%), Positives = 54/120 (45%), Gaps = 10/120 (8%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
GD G+ +F ++ GT Y++PE + K D++S G L+ E+ + P
Sbjct: 148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF- 206
Query: 432 FLSSTSSPSLNTDIALDEMLD-PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIV 490
+ + SL I E D P P+PS E+L ++ + C+ PE RP + V
Sbjct: 207 YGDKMNLYSLCKKI---EQCDYP--PLPSDHYSEELRQLVNM---CINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 38/139 (27%), Positives = 58/139 (41%), Gaps = 26/139 (18%)
Query: 360 LGALNI---SRNNIT-GDFGIAKFLKPDSSNWTG-------FAGTYGYIAPELAYTMKIT 408
L A NI S + + GDFG+ + L + ++ FA + APE T +
Sbjct: 123 LAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WCAPESLRTRTFS 178
Query: 409 EKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLI 467
DV+ FGV + E+ G+ P + + S L +D+ + RL P Q+
Sbjct: 179 HASDVWMFGVTLWEMFTYGEEP--WAGLSGSQILKK---IDKEGE-RLERPEACPQD--- 229
Query: 468 SIMEVGFSCLKESPESRPT 486
I V C +P RPT
Sbjct: 230 -IYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 19/57 (33%), Positives = 28/57 (49%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG+ K + F GT YIAPE+ D ++ GVL+ E++ G+ P
Sbjct: 139 DFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 19/129 (14%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYG-----YIAPELAYTMKITEKCDVYSFGVLVLEVIK-G 426
DFG++K L D S + A + G + APE K + + DV+S+G+ + E G
Sbjct: 138 DFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYG 195
Query: 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
+ P P + + I + LD P C ++ ++M+ C E RP
Sbjct: 196 QKP---YKKMKGPEVMSFIEQGKRLD--CP-AECP--PEMYALMK---DCWIYKWEDRPN 244
Query: 487 MKIVSQQLR 495
V +++R
Sbjct: 245 FAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 20/133 (15%)
Query: 360 LGALNIS-RNNI--TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSF 416
L A NI +NN+ GDFG+++ L T F GT Y++PE K D++S
Sbjct: 132 LKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSL 191
Query: 417 GVLVLEVIKGKHP---RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVG 473
G ++ E+ H ++FLS + L + P +P ++ L SIM+
Sbjct: 192 GCILYEMCCLAHAFEGQNFLS----------VVLRIVEGPTPSLPETYSRQ-LNSIMQ-- 238
Query: 474 FSCLKESPESRPT 486
S L + P RP+
Sbjct: 239 -SMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 38/143 (26%), Positives = 58/143 (40%), Gaps = 19/143 (13%)
Query: 360 LGALNI--SRNNITG--DFGIAK--FLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDV 413
L A NI S NN+ DFG+A+ + PD ++APE + T + DV
Sbjct: 205 LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 264
Query: 414 YSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLD--PRLPVPSCSVQEKLISIME 471
+SFGVL+ E+ L ++ P + D L R+ P + E + +
Sbjct: 265 WSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQ 313
Query: 472 VGFSCLKESPESRPTMKIVSQQL 494
C P RPT + + L
Sbjct: 314 TMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 31/129 (24%), Positives = 45/129 (34%), Gaps = 29/129 (22%)
Query: 372 GDFGIAKFLKPDSSNWTG----FAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKG 426
DFG++ L F GT ++APE+ + K D++SFG+ +E+ G
Sbjct: 144 ADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203
Query: 427 KHPRDFLS---------STSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCL 477
P PSL T K+IS CL
Sbjct: 204 AAPYSKYPPMKVLMLTLQNDPPSLETGADYK---------KYSKSFRKMIS------LCL 248
Query: 478 KESPESRPT 486
++ P RPT
Sbjct: 249 QKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 21/60 (35%), Positives = 31/60 (51%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+ K D F GT YIAPE+ + D +++GVL+ E++ G+ P D
Sbjct: 143 ADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 29/100 (29%), Positives = 42/100 (42%), Gaps = 20/100 (20%)
Query: 394 YGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLD- 452
++APE + T + DV+SFGVL+ E+ L + P I ++E+
Sbjct: 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-------LGGSPYPG----IPVEELFKL 246
Query: 453 ----PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
R+ P QE L +M C E P RPT K
Sbjct: 247 LKEGYRMEKPQNCTQE-LYHLMR---DCWHEVPSQRPTFK 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 20/57 (35%), Positives = 32/57 (56%), Gaps = 1/57 (1%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G+A + P+ + G GT GY+APE+ + T D + G L+ E+I+G+ P
Sbjct: 145 DLGLAVKI-PEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 20/129 (15%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGT----YGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-G 426
GDFG+A+ + S++ G ++APE K T + DV+SFGVL+ E++ G
Sbjct: 153 GDFGLARDIY--KSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLG 210
Query: 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRL-PVPSCSVQEKLISIMEVGFSCLKESPESRP 485
+ P L+ N ++ RL +C +K+ +M +C + P RP
Sbjct: 211 QQPYPALN-------NQEVLQHVTAGGRLQKPENCP--DKIYQLMT---NCWAQDPSERP 258
Query: 486 TMKIVSQQL 494
T + + L
Sbjct: 259 TFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 20/52 (38%), Positives = 30/52 (57%), Gaps = 1/52 (1%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEV 423
GDFGI+K L S +T GT YI+PEL +K D+++ G ++ E+
Sbjct: 144 GDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 502 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.95 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.87 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.85 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.84 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.84 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.58 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.57 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.53 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.47 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.42 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.4 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.39 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.35 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.34 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.34 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.32 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.31 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.3 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.29 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.28 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.27 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.27 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.27 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.27 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.26 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.26 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.26 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.26 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.26 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.26 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.25 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.25 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.25 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.24 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.24 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.24 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.24 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.24 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.24 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.24 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.23 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.23 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.23 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.23 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.23 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.22 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.22 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.22 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.22 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.22 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.22 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.22 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.21 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.21 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.21 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.21 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.21 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.21 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.21 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.21 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.2 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.2 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.2 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.2 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.19 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.19 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.19 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.19 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.19 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.19 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.19 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.19 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.18 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.18 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.18 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.18 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.18 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.18 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.18 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.18 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.17 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.17 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.17 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.17 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.17 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.17 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.17 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.17 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.17 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.16 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.16 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.16 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.16 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.16 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.16 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.15 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.15 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.15 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.15 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.15 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.14 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.14 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.14 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.14 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.14 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.13 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.13 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.13 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.13 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.13 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.13 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.13 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.13 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.13 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.12 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.12 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.12 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.12 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.12 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.12 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.11 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.11 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.11 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.11 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.11 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.11 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.11 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.1 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.1 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.1 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.1 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.1 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.1 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.1 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.1 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.1 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.1 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.09 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.09 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.09 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.09 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.09 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.09 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.09 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.08 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.08 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.08 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.08 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.08 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.08 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.08 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.08 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.07 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.07 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.07 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.07 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.07 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.07 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.07 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.07 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.07 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.07 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.07 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.07 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.07 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.07 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.06 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.06 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.06 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.06 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.06 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.06 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.05 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.05 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.05 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.05 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.05 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.05 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.05 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.05 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.05 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.05 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.05 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.04 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.04 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.03 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.03 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.03 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.03 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.03 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.03 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.03 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.03 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.02 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.02 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.02 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.02 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.02 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.02 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.02 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.02 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.01 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.01 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.01 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.01 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.0 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.99 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 98.99 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 98.99 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 98.99 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 98.99 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 98.99 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 98.98 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 98.98 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 98.98 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 98.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 98.98 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 98.98 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 98.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 98.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 98.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 98.97 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 98.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 98.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 98.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 98.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 98.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 98.96 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 98.96 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 98.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 98.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 98.95 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 98.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 98.95 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 98.95 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 98.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 98.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 98.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 98.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 98.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 98.94 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 98.94 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 98.94 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 98.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 98.93 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 98.93 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 98.93 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 98.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 98.93 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 98.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 98.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 98.92 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 98.92 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 98.92 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 98.91 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.91 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 98.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 98.9 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 98.9 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 98.9 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 98.9 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 98.89 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.89 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 98.89 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 98.89 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 98.89 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 98.89 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 98.88 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 98.88 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 98.88 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 98.87 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 98.87 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 98.86 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 98.86 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 98.86 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 98.86 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 98.86 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 98.86 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 98.86 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 98.85 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.85 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.85 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 98.85 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 98.84 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 98.84 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 98.84 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 98.84 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 98.84 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 98.84 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 98.83 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 98.83 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 98.83 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 98.83 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 98.83 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 98.82 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 98.82 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 98.82 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 98.81 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 98.81 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 98.81 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 98.8 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 98.8 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 98.8 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.8 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 98.79 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 98.79 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 98.79 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 98.79 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 98.79 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 98.79 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 98.78 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 98.78 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 98.78 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 98.78 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 98.78 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 98.77 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.77 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 98.76 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.75 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 98.75 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 98.74 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 98.74 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 98.74 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 98.74 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 98.73 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 98.73 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.73 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 98.72 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 98.71 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 98.7 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 98.7 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 98.7 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 98.69 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 98.69 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 98.69 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 98.68 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 98.68 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 98.67 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 98.67 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 98.67 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 98.66 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 98.64 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 98.61 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 98.61 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 98.58 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 98.57 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 98.57 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 98.56 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 98.56 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 98.56 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 98.56 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 98.55 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 98.54 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 98.53 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 98.53 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 98.49 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 98.49 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 98.48 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 98.47 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 98.46 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 98.43 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 98.42 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 98.41 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 98.41 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 98.4 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 98.38 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.37 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 98.34 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 98.33 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 98.33 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.31 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 98.31 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 98.31 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.3 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 98.26 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 98.25 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.24 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 98.23 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 98.21 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.16 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 98.15 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 98.13 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.09 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 98.07 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.06 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 98.06 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.05 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 98.04 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 98.03 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.99 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 97.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 97.86 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 97.86 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 97.85 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 97.84 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.79 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 97.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 97.75 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 97.73 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 97.72 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 97.72 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 97.65 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 97.64 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.63 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 97.61 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.59 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.54 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 97.5 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 97.48 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 97.37 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 97.36 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 97.3 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 97.25 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 97.18 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 96.99 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 96.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 96.9 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 96.87 | |
| KOG2123 | 388 | consensus Uncharacterized conserved protein [Funct | 96.84 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 96.82 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 96.76 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 96.52 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 96.48 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 96.43 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 96.42 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 96.35 | |
| KOG2123 | 388 | consensus Uncharacterized conserved protein [Funct | 96.35 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 95.96 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 95.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.67 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 95.6 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 95.57 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 95.46 | |
| KOG0473 | 326 | consensus Leucine-rich repeat protein [Function un | 94.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 94.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 94.35 | |
| KOG0473 | 326 | consensus Leucine-rich repeat protein [Function un | 94.24 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 93.45 | |
| PF13504 | 17 | LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO | 92.8 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 92.13 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 91.17 | |
| TIGR00864 | 2740 | PCC polycystin cation channel protein. Note: this | 91.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 90.93 | |
| KOG4308 | 478 | consensus LRR-containing protein [Function unknown | 90.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 90.3 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 89.95 | |
| smart00370 | 26 | LRR Leucine-rich repeats, outliers. | 89.61 | |
| smart00369 | 26 | LRR_TYP Leucine-rich repeats, typical (most popula | 89.61 | |
| KOG4308 | 478 | consensus LRR-containing protein [Function unknown | 89.19 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 89.17 | |
| smart00370 | 26 | LRR Leucine-rich repeats, outliers. | 87.67 | |
| smart00369 | 26 | LRR_TYP Leucine-rich repeats, typical (most popula | 87.67 | |
| PF13516 | 24 | LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI | 82.58 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-57 Score=508.29 Aligned_cols=237 Identities=36% Similarity=0.606 Sum_probs=142.0
Q ss_pred HHHHHHHhhccCCCHHHHHHHHHHHhhcCcCCCCCCCCCCCCCCCCCCCCCCCccceeeeCCCCCEEEEEecCCCCceec
Q 010736 7 LSIARFLVAVSSETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVGLKGKL 86 (502)
Q Consensus 7 ~~~~~~~~~~~~~~~~d~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l 86 (502)
+.++.|.+..+....+|+.||++||+++. +|.+.+.+|+.. .++|.|.||+|+..++|+.|+|++++++|.+
T Consensus 14 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~w~~~-------~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~ 85 (968)
T PLN00113 14 FMLFFLFLNFSMLHAEELELLLSFKSSIN-DPLKYLSNWNSS-------ADVCLWQGITCNNSSRVVSIDLSGKNISGKI 85 (968)
T ss_pred HHHHHHHHHccCCCHHHHHHHHHHHHhCC-CCcccCCCCCCC-------CCCCcCcceecCCCCcEEEEEecCCCccccC
Confidence 33334444455557789999999999996 466778899654 5799999999987789999999999888877
Q ss_pred CcccCCCCCCCCEEECCCCcccccCCccCc-CCCCCCEEEccCCcC----------------------cCCCCcccCCCC
Q 010736 87 HAFSFSSFPHLAYLDLRDNKLFGTIPPQIS-NLTNLSILSLGGNQF----------------------SGNIPHEVGLMS 143 (502)
Q Consensus 87 ~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~-~l~~L~~L~Ls~N~l----------------------~~~~p~~l~~l~ 143 (502)
++. |..+++|++|+|++|+++|.+|..+. ++++|++|+|++|++ ++.+|..+++++
T Consensus 86 ~~~-~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~ 164 (968)
T PLN00113 86 SSA-IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFS 164 (968)
T ss_pred ChH-HhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCC
Confidence 654 66777777777777666665554432 334444444333333 334444455555
Q ss_pred CCcEEEccCCcCcccCCcccCCCCCCcEEEcccCccccc------------------------CCcCCCCCCCCCeEEcc
Q 010736 144 HLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGS------------------------VPHSLGNLTQISMLFLH 199 (502)
Q Consensus 144 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~------------------------~p~~~~~l~~L~~L~L~ 199 (502)
+|++|++++|.+.+.+|..++++++|++|++++|++++. +|..++++++|++|+++
T Consensus 165 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 244 (968)
T PLN00113 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244 (968)
T ss_pred CCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECc
Confidence 555555555555555554444444555555444444444 44444444555555555
Q ss_pred cccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccc
Q 010736 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 200 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 252 (502)
+|.+++.+|..++++++|+.|++++|++++.+|..+.++++|+.|++++|.+.
T Consensus 245 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~ 297 (968)
T PLN00113 245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297 (968)
T ss_pred CceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeec
Confidence 55555555555555556666666555555444444444444444444444333
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=317.21 Aligned_cols=277 Identities=36% Similarity=0.571 Sum_probs=183.6
Q ss_pred CCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccC-CCCCCcEEEccCCcCcccCCcccCCCCCCcEE
Q 010736 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG-LMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 172 (502)
..+++.|+|++|.++|.+|..|..+++|++|+|++|+++|.+|..+. .+++|++|+|++|++++.+|. +.+++|++|
T Consensus 68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L 145 (968)
T PLN00113 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL 145 (968)
T ss_pred CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence 35789999999999999999999999999999999999999997754 778888888888777765553 234555555
Q ss_pred EcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCccc--------------------
Q 010736 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIP-------------------- 232 (502)
Q Consensus 173 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-------------------- 232 (502)
++++|.+++.+|..++++++|++|++++|.+.+.+|..++++++|++|++++|.+++.+|
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 555555555555555555555555555555554555555555555555555555444444
Q ss_pred ----ccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccc
Q 010736 233 ----LSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLR 307 (502)
Q Consensus 233 ----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 307 (502)
..++++++|+.|++++|.+++.+|..+.. ..|+.|++++|++++.+|..+..+++|+.|++++|.+.+.+|..+.
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 305 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence 44444555555555555554444444443 3455555555555555555555566666666666666666666666
Q ss_pred cCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCcccc
Q 010736 308 NCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 308 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
.+++|+.|++++|.+.+..|..+..+++|+.|++++|++.+.+|..++.+++|+.|++++|++.+
T Consensus 306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~ 370 (968)
T PLN00113 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG 370 (968)
T ss_pred CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEe
Confidence 66666666666666666666666777777777777777777777777777888888888887753
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=287.84 Aligned_cols=312 Identities=20% Similarity=0.203 Sum_probs=190.0
Q ss_pred CCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEE
Q 010736 69 AGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148 (502)
Q Consensus 69 ~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 148 (502)
.++++.|+|.+|-++ .+....++.++.|+.||||.|.|+.+.-..|..-.++++|+|++|.|+..--..|..+.+|..|
T Consensus 124 sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred ccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence 367888998888776 3334446667777777777777765444556665667777777777765555666666677777
Q ss_pred EccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCC------------------------CCCeEEccccccc
Q 010736 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLT------------------------QISMLFLHDNSFS 204 (502)
Q Consensus 149 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~------------------------~L~~L~L~~N~l~ 204 (502)
.|++|+++...+..|.++++|+.|+|..|++.-.---.|..++ ++++|+|+.|+++
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~ 282 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ 282 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence 7777777655555566666666666666666522122344444 4445555555555
Q ss_pred ccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCcccc
Q 010736 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNIC 283 (502)
Q Consensus 205 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~ 283 (502)
..-.+++.++++|+.|++|+|.|....++.+...++|+.|+|++|+++...+..+.. ..|++|+|++|.++..-...|.
T Consensus 283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~ 362 (873)
T KOG4194|consen 283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV 362 (873)
T ss_pred hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH
Confidence 444444555555555555555555555555555555555555555555433333333 3455555555555554444455
Q ss_pred CCCCCcEEEccCCccccccCc---ccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCC
Q 010736 284 RGGALQIFTVSENRFQGTIPK---SLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKL 360 (502)
Q Consensus 284 ~~~~L~~L~ls~n~l~~~~~~---~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L 360 (502)
.+++|+.|||++|.+++.+.+ .|.++++|+.|++.+|++..+...+|.++++|++|||.+|.|...-+.+|..+ .|
T Consensus 363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~L 441 (873)
T KOG4194|consen 363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-EL 441 (873)
T ss_pred HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hh
Confidence 556666666666666554432 35556666666666666665555666666666666666666666666666666 66
Q ss_pred CeeeecCCccccccCcccccCC
Q 010736 361 GALNISRNNITGDFGIAKFLKP 382 (502)
Q Consensus 361 ~~L~l~~N~l~~dfGl~~ll~~ 382 (502)
+.|.++...+.|||.+.|+.++
T Consensus 442 k~Lv~nSssflCDCql~Wl~qW 463 (873)
T KOG4194|consen 442 KELVMNSSSFLCDCQLKWLAQW 463 (873)
T ss_pred hhhhhcccceEEeccHHHHHHH
Confidence 6666666677899999988654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=275.57 Aligned_cols=300 Identities=22% Similarity=0.209 Sum_probs=216.1
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
..++++++..|.|+ .||.. .+...+|+.|+|.+|.|+.+-..++..++.|+.||||.|.|+...-..|..-.++++|+
T Consensus 102 ~nLq~v~l~~N~Lt-~IP~f-~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~ 179 (873)
T KOG4194|consen 102 PNLQEVNLNKNELT-RIPRF-GHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLN 179 (873)
T ss_pred Ccceeeeeccchhh-hcccc-cccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEe
Confidence 56888999999887 67763 44456699999999999988888999999999999999999955555777778999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
|++|+|+..--..|..+.+|..|.|+.|+++...+..|.++++|+.|+|..|+|.-..--.|.++++|+.|.+..|.+..
T Consensus 180 La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k 259 (873)
T KOG4194|consen 180 LASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK 259 (873)
T ss_pred eccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc
Confidence 99999998888899999999999999999998777888899999999999999875434456666666666666666654
Q ss_pred cccccccCCCCCcEEEeeCccc------------------------cccCCCCCcc-ccccEEECcCCcCcccCCccccC
Q 010736 230 PIPLSLGNLTNLKQFSLVYNNL------------------------YGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICR 284 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L~l~~N~l------------------------~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~ 284 (502)
.-...|..+.++++|+|+.|++ ...-+..+.. .+|++|+|++|+++...+..|..
T Consensus 260 L~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~ 339 (873)
T KOG4194|consen 260 LDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRV 339 (873)
T ss_pred ccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHH
Confidence 4444455555555555555554 4443444333 44555555555555555555555
Q ss_pred CCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccC---cccCCCCCCcEEEccCcccccccCccccCCCCCC
Q 010736 285 GGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNIS---KAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLG 361 (502)
Q Consensus 285 ~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 361 (502)
+..|+.|+|++|+++......|..+++|+.|+|++|.++..+. ..|..++.|+.|+|.+|++......+|..+++|+
T Consensus 340 L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE 419 (873)
T KOG4194|consen 340 LSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALE 419 (873)
T ss_pred HHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccc
Confidence 5555555555555554444455566666666666666665443 2455677777777777777665566777777777
Q ss_pred eeeecCCccc
Q 010736 362 ALNISRNNIT 371 (502)
Q Consensus 362 ~L~l~~N~l~ 371 (502)
+|||.+|.|.
T Consensus 420 ~LdL~~Naia 429 (873)
T KOG4194|consen 420 HLDLGDNAIA 429 (873)
T ss_pred eecCCCCcce
Confidence 7777777764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-30 Score=253.96 Aligned_cols=288 Identities=24% Similarity=0.379 Sum_probs=199.2
Q ss_pred EEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccc-cCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 72 VINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFG-TIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 72 v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
+..|.++.|+|. .++.. ++.++.|+.+++..|++.. -+|+.+..+..|+.||||+|++. +.|..+..-+++-.|+|
T Consensus 57 LEHLs~~HN~L~-~vhGE-Ls~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNL 133 (1255)
T KOG0444|consen 57 LEHLSMAHNQLI-SVHGE-LSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNL 133 (1255)
T ss_pred hhhhhhhhhhhH-hhhhh-hccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEc
Confidence 444445555443 22221 4444555555555555432 24444455555555555555555 44555555555555555
Q ss_pred cCCcCcccCCc-ccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEccccccc-------------------------
Q 010736 151 DSNQLDGSIPL-EVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS------------------------- 204 (502)
Q Consensus 151 s~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------------------- 204 (502)
|+|+|. .||. -|.+++.|-.|+|++|++. .+|..+..+..|++|.|++|.+.
T Consensus 134 S~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl 211 (1255)
T KOG0444|consen 134 SYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTL 211 (1255)
T ss_pred ccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchh
Confidence 555554 2332 2444555555555555554 33444444444555555544332
Q ss_pred ccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCcccc
Q 010736 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNIC 283 (502)
Q Consensus 205 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~ 283 (502)
..+|.++..+.+|..+|+|.|.+. ..|+.+.++.+|+.|+|++|+|+ .+....+. ..+++|++|+|+++. +|..+|
T Consensus 212 ~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~-LP~avc 288 (1255)
T KOG0444|consen 212 DNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTV-LPDAVC 288 (1255)
T ss_pred hcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhcc-chHHHh
Confidence 247788888899999999999998 78899999999999999999998 33333333 679999999999986 789999
Q ss_pred CCCCCcEEEccCCcccc-ccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCe
Q 010736 284 RGGALQIFTVSENRFQG-TIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGA 362 (502)
Q Consensus 284 ~~~~L~~L~ls~n~l~~-~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 362 (502)
++++|+.|.+.+|+++- -+|..++.+.+|+.+..++|.+. .+|+.+..++.|+.|.|++|++. .+|.++.-++.|+.
T Consensus 289 KL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~v 366 (1255)
T KOG0444|consen 289 KLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKV 366 (1255)
T ss_pred hhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcce
Confidence 99999999999999863 47888999999999999999887 88999999999999999999987 68899999999999
Q ss_pred eeecCCc
Q 010736 363 LNISRNN 369 (502)
Q Consensus 363 L~l~~N~ 369 (502)
||+..|+
T Consensus 367 LDlreNp 373 (1255)
T KOG0444|consen 367 LDLRENP 373 (1255)
T ss_pred eeccCCc
Confidence 9999986
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-29 Score=245.17 Aligned_cols=292 Identities=23% Similarity=0.334 Sum_probs=190.3
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCc-CCCCcccCCCCCCcEEE
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFS-GNIPHEVGLMSHLKILY 149 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~ 149 (502)
+++.|.|...+|. .+|.. ++.+.+|++|.+++|++. .+-..++.++.|+.+++.+|++. .-||..+-.+..|..||
T Consensus 33 ~~~WLkLnrt~L~-~vPeE-L~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lD 109 (1255)
T KOG0444|consen 33 QMTWLKLNRTKLE-QVPEE-LSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILD 109 (1255)
T ss_pred heeEEEechhhhh-hChHH-HHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeee
Confidence 4445555444443 34443 555556666666666655 23334555666666666666553 23455555666666666
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
||+|+++ ..|..+..-+++..|+|++|+|..+...-|.+++.|-+|+|++|++. .+|..+..+..|++|+|++|.+..
T Consensus 110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~h 187 (1255)
T KOG0444|consen 110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNH 187 (1255)
T ss_pred cchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhH
Confidence 6666665 55666666666666666666665322233455666666666666665 344455556666666666665543
Q ss_pred cccccccCCCCCcEEEeeCcccc-ccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccc
Q 010736 230 PIPLSLGNLTNLKQFSLVYNNLY-GSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLR 307 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 307 (502)
.--..+..+++|+.|.+++.+-+ ..+|.++.. .+|..+|+|.|.+.. +|..+.++.+|+.|+||+|+++ .+.....
T Consensus 188 fQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~-vPecly~l~~LrrLNLS~N~it-eL~~~~~ 265 (1255)
T KOG0444|consen 188 FQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPI-VPECLYKLRNLRRLNLSGNKIT-ELNMTEG 265 (1255)
T ss_pred HHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCc-chHHHhhhhhhheeccCcCcee-eeeccHH
Confidence 22223334555556666554322 346666655 578888899998875 7888888899999999999888 4555566
Q ss_pred cCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccc-cccCccccCCCCCCeeeecCCcc
Q 010736 308 NCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFY-GEISSNFGECPKLGALNISRNNI 370 (502)
Q Consensus 308 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~~~~L~~L~l~~N~l 370 (502)
...+|+.|++++|+++ .+|.++.++++|+.|.+.+|++. .-+|..++.+.+|+.+..++|++
T Consensus 266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L 328 (1255)
T KOG0444|consen 266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL 328 (1255)
T ss_pred HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccc
Confidence 7788889999999988 67888889999999999999886 34788889999999999998887
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-28 Score=227.94 Aligned_cols=288 Identities=25% Similarity=0.388 Sum_probs=227.2
Q ss_pred EEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEcc
Q 010736 72 VINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID 151 (502)
Q Consensus 72 v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 151 (502)
...++..+|+++ .+|+. +.++.+|..|++.+|+++...|..+ +++.|++||...|.+. .+|+.++.+.+|..|||.
T Consensus 139 l~dl~~~~N~i~-slp~~-~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~ 214 (565)
T KOG0472|consen 139 LEDLDATNNQIS-SLPED-MVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLR 214 (565)
T ss_pred hhhhhccccccc-cCchH-HHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhh
Confidence 445556666666 45554 8888888889999998885544444 4899999999999887 788899999999999999
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCC-CCCCCCeEEcccccccccCCccCcCCccCCccccccccccCc
Q 010736 152 SNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLG-NLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP 230 (502)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 230 (502)
+|++. ..| +|..+..|.+|+++.|+++ .+|.... +++++..|||..|+++ ..|+.+.-+++|++||+++|.++ .
T Consensus 215 ~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~ 289 (565)
T KOG0472|consen 215 RNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-S 289 (565)
T ss_pred hcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-c
Confidence 99997 666 8999999999999999998 5666554 8999999999999998 67899999999999999999999 5
Q ss_pred ccccccCCCCCcEEEeeCcccccc-------------------------------------CCC-CCc------------
Q 010736 231 IPLSLGNLTNLKQFSLVYNNLYGS-------------------------------------IPP-SLD------------ 260 (502)
Q Consensus 231 ~p~~~~~l~~L~~L~l~~N~l~~~-------------------------------------~p~-~~~------------ 260 (502)
.|..++++ .|+.|.+.+|.+... .|. .+.
T Consensus 290 Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~ 368 (565)
T KOG0472|consen 290 LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILD 368 (565)
T ss_pred CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhc
Confidence 78899999 899999998875310 000 000
Q ss_pred -----------------c-ccccEEECcCCcCcc-----------------------cCCccccCCCCCcEEEccCCccc
Q 010736 261 -----------------N-LVLTKLSLDDNHFTS-----------------------YLPQNICRGGALQIFTVSENRFQ 299 (502)
Q Consensus 261 -----------------~-~~L~~L~ls~N~l~~-----------------------~~~~~~~~~~~L~~L~ls~n~l~ 299 (502)
. .-+..++++.|++.. .+|..++.+++|..|++++|.+.
T Consensus 369 ~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln 448 (565)
T KOG0472|consen 369 VSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN 448 (565)
T ss_pred ccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh
Confidence 0 013445566555432 34556677889999999998887
Q ss_pred cccCcccccCCCCcEEeCCCCccccc-----------------------cCcccCCCCCCcEEEccCcccccccCccccC
Q 010736 300 GTIPKSLRNCTSLIRVRLDGNNLTGN-----------------------ISKAFGIYPNLTFIDLSRNNFYGEISSNFGE 356 (502)
Q Consensus 300 ~~~~~~l~~l~~L~~L~l~~N~l~~~-----------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 356 (502)
.+|..++.+..|+.+++++|+|... .+..+..+.+|..|||.+|.+. .+|..+++
T Consensus 449 -~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lgn 526 (565)
T KOG0472|consen 449 -DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGN 526 (565)
T ss_pred -hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhcc
Confidence 7788888888899999998887521 2233677899999999999997 78889999
Q ss_pred CCCCCeeeecCCccc
Q 010736 357 CPKLGALNISRNNIT 371 (502)
Q Consensus 357 ~~~L~~L~l~~N~l~ 371 (502)
|.+|++|++++|+|.
T Consensus 527 mtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 527 MTNLRHLELDGNPFR 541 (565)
T ss_pred ccceeEEEecCCccC
Confidence 999999999999985
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-27 Score=219.24 Aligned_cols=326 Identities=21% Similarity=0.208 Sum_probs=234.2
Q ss_pred EEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccC-
Q 010736 74 NISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDS- 152 (502)
Q Consensus 74 ~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~- 152 (502)
.++-++.+|+ .+|.. + -+.-+.++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|++|.++++|..|-+-+
T Consensus 50 ~VdCr~~GL~-eVP~~-L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~ 125 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPAN-L--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN 125 (498)
T ss_pred eEEccCCCcc-cCccc-C--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence 3455555555 33322 1 12456788888888877778888888888888888888888888888888877665544
Q ss_pred CcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC---
Q 010736 153 NQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG--- 229 (502)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--- 229 (502)
|+|+......|+++..|+.|.+.-|++.-.....|..+++|..|.+..|.+...-...|..+.+++.+.+..|.+..
T Consensus 126 NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 126 NKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred CchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc
Confidence 88886555678888888888888888887777778888888888888888875544578888888888888877431
Q ss_pred ---------cccccccCCCCCcEEEeeCccccccCCCCCccc--cc-cEEECcCCcCcccCCccccCCCCCcEEEccCCc
Q 010736 230 ---------PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNL--VL-TKLSLDDNHFTSYLPQNICRGGALQIFTVSENR 297 (502)
Q Consensus 230 ---------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~--~L-~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~ 297 (502)
..|..++...-.....+.++++...-+..+... .+ ..+....+.........|.++++|+.|++++|+
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~ 285 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK 285 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence 122333333333333444444442222222211 11 111122222222223467899999999999999
Q ss_pred cccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCcc
Q 010736 298 FQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIA 377 (502)
Q Consensus 298 l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~ 377 (502)
++++-+.+|.+...++.|+|..|++.......|..+..|+.|+|.+|+|+...|.+|..+..|..|++-.|++.|||-++
T Consensus 286 i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 286 ITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA 365 (498)
T ss_pred cchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence 99999999999999999999999999887788999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccccccc
Q 010736 378 KFLKPDSSNWTGFAGTYGYIAPELAYTM 405 (502)
Q Consensus 378 ~ll~~~~~~~~~~~gt~gy~aPE~~~~~ 405 (502)
++.+|..... +.|-+.+-+|-.....
T Consensus 366 wl~~Wlr~~~--~~~~~~Cq~p~~~~~~ 391 (498)
T KOG4237|consen 366 WLGEWLRKKS--VVGNPRCQSPGFVRQI 391 (498)
T ss_pred HHHHHHhhCC--CCCCCCCCCCchhccc
Confidence 9987644322 3444455555444433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-28 Score=225.26 Aligned_cols=237 Identities=27% Similarity=0.407 Sum_probs=133.0
Q ss_pred EEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEcc
Q 010736 72 VINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID 151 (502)
Q Consensus 72 v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 151 (502)
.+.+++.++++. ++|+. ++.+..++.|+.++|++. .+|+.++.+.+|+.|+.++|.+. .+|+.++.+..|..++..
T Consensus 70 l~vl~~~~n~l~-~lp~a-ig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 70 LTVLNVHDNKLS-QLPAA-IGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred eeEEEeccchhh-hCCHH-HHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 566677777766 44543 666666777777777766 56666777777777777777766 556666666666666666
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcc
Q 010736 152 SNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI 231 (502)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 231 (502)
+|+++ ..|..++.+.+|..+++.+|++....|. .-+++.|++++...|.+. .+|+.++.+.+|..|++..|++. ..
T Consensus 146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~-~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~l 221 (565)
T KOG0472|consen 146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPEN-HIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FL 221 (565)
T ss_pred ccccc-cCchHHHHHHHHHHhhccccchhhCCHH-HHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cC
Confidence 66665 4555555555555555555555532222 223555555555555444 44555555555555555555555 33
Q ss_pred cccccCCCCCcEEEeeCccccccCCCCCcc--ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccC
Q 010736 232 PLSLGNLTNLKQFSLVYNNLYGSIPPSLDN--LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNC 309 (502)
Q Consensus 232 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l 309 (502)
| .|.++..|++|+++.|++. .+|..... ..+..||+..|+++. .|..+|.+++|..||+|+|.++ .+|..++++
T Consensus 222 P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke-~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl 297 (565)
T KOG0472|consen 222 P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKE-VPDEICLLRSLERLDLSNNDIS-SLPYSLGNL 297 (565)
T ss_pred C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecccccccc-CchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence 4 4555555555555555544 33333332 345555555555554 4555555555555555555555 334444444
Q ss_pred CCCcEEeCCCCc
Q 010736 310 TSLIRVRLDGNN 321 (502)
Q Consensus 310 ~~L~~L~l~~N~ 321 (502)
+|+.|-+.+|.
T Consensus 298 -hL~~L~leGNP 308 (565)
T KOG0472|consen 298 -HLKFLALEGNP 308 (565)
T ss_pred -eeeehhhcCCc
Confidence 44444444443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=210.40 Aligned_cols=320 Identities=23% Similarity=0.336 Sum_probs=233.8
Q ss_pred HHhhccCCCHHHHHHHHHHHhhcCcCCCCCCCC----CCCCCCCCCCCCCCCccce----------------eeeCCCCC
Q 010736 12 FLVAVSSETNEEADALLKWKASLQIHNRSLLSS----WIKDTSNVSSKISPCAWSG----------------ISCNDAGR 71 (502)
Q Consensus 12 ~~~~~~~~~~~d~~aLl~~k~~~~~~~~~~l~~----W~~~~~~~~~~~~~C~W~G----------------v~C~~~~~ 71 (502)
++.+...++..|...+.++.+.+..+ +.+.+ |++. .++|.-.. |.|.. +.
T Consensus 53 ~~~~~~~~~~~~~~~~~~~~~~l~~p--~~~~~~~~~~~~~-------~~fc~~~~~~~~~l~~~~~~~~~tv~~~~-~~ 122 (754)
T PRK15370 53 LCHPPETASPEEIKSKFECLRMLAFP--AYADNIQYSRGGA-------DQYCILSENSQEILSIVFNTEGYTVEGGG-KS 122 (754)
T ss_pred HhCCCCCCCHHHHHHHHHHHHHhcCC--chhhccccccCCC-------CcccccCCcchhhheeeecCCceEEecCC-Cc
Confidence 34566778889999999999998642 45566 8765 46773322 67753 45
Q ss_pred EEEEEecCCCCceec--------------------Ccc-------c-----CCCCCCCCEEECCCCcccccCCccCcCCC
Q 010736 72 VINISLRGVGLKGKL--------------------HAF-------S-----FSSFPHLAYLDLRDNKLFGTIPPQISNLT 119 (502)
Q Consensus 72 v~~L~L~~~~l~g~l--------------------~~~-------~-----~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~ 119 (502)
|+.+..-+....... +.. . -+-..+.+.|++++++++ .+|..+. +
T Consensus 123 vt~l~~~g~~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~ 199 (754)
T PRK15370 123 VTYTRVTESEQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--E 199 (754)
T ss_pred ccccccccccccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--c
Confidence 666655442221110 000 0 011245789999999998 5676554 5
Q ss_pred CCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcc
Q 010736 120 NLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199 (502)
Q Consensus 120 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 199 (502)
.|+.|+|++|+|+ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|++++|++. .+|..+. .+|+.|+++
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 8999999999999 5676554 58999999999998 5676553 47999999999998 6777654 579999999
Q ss_pred cccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCC
Q 010736 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLP 279 (502)
Q Consensus 200 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~ 279 (502)
+|+++. +|..+. ++|+.|++++|++++ +|..+. ++|+.|++++|.++. +|..+. .+|+.|++++|.+++ +|
T Consensus 271 ~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~-~sL~~L~Ls~N~Lt~-LP 341 (754)
T PRK15370 271 HNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP-PGLKTLEAGENALTS-LP 341 (754)
T ss_pred CCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc-ccceeccccCCcccc-CC
Confidence 999984 676554 589999999999985 554443 478899999999984 554433 578999999999987 56
Q ss_pred ccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCcc----cc
Q 010736 280 QNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN----FG 355 (502)
Q Consensus 280 ~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~ 355 (502)
..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+++. +|..+. ..|+.|++++|++. .+|.. ..
T Consensus 342 ~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~ 412 (754)
T PRK15370 342 ASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRG 412 (754)
T ss_pred hhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhh
Confidence 5554 68999999999998 5666553 689999999999984 454443 46899999999997 44543 34
Q ss_pred CCCCCCeeeecCCccc
Q 010736 356 ECPKLGALNISRNNIT 371 (502)
Q Consensus 356 ~~~~L~~L~l~~N~l~ 371 (502)
.++.+..+++.+|++.
T Consensus 413 ~~~~l~~L~L~~Npls 428 (754)
T PRK15370 413 EGPQPTRIIVEYNPFS 428 (754)
T ss_pred cCCCccEEEeeCCCcc
Confidence 4588899999999986
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.8e-22 Score=207.95 Aligned_cols=258 Identities=26% Similarity=0.337 Sum_probs=204.4
Q ss_pred EEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEcc
Q 010736 72 VINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID 151 (502)
Q Consensus 72 v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 151 (502)
-..|+|+.++|+ .+|+. +. ++|+.|++++|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~-l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCCCC-cCCcc-hh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 456899999998 67774 54 489999999999994 664 3589999999999999 56643 4689999999
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcc
Q 010736 152 SNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI 231 (502)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 231 (502)
+|.++ .+|.. ..+|+.|++++|+++ .+|.. .++|+.|++++|++++ +|.. ..+|+.|++++|++++ +
T Consensus 271 ~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 271 SNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-L 337 (788)
T ss_pred CCchh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-c
Confidence 99998 45543 357889999999998 45653 4789999999999996 3442 2467889999999985 5
Q ss_pred cccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCC
Q 010736 232 PLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTS 311 (502)
Q Consensus 232 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~ 311 (502)
|.. ..+|+.|++++|+|++ +|... ..++.|++++|++++ +|.. ..+|+.|++++|++++ +|.. .++
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls~-LP~lp--~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~ 403 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLAS-LPTLP--SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSE 403 (788)
T ss_pred ccc---ccccceEecCCCccCC-CCCCC--cccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccC
Confidence 542 2579999999999984 55432 468889999999986 5543 3578999999999984 5543 357
Q ss_pred CcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccc
Q 010736 312 LIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373 (502)
Q Consensus 312 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~d 373 (502)
|+.|++++|+++. +|.. ..+|+.|++++|+|+ .+|..+..++.|+.+++++|++.+.
T Consensus 404 L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 404 LKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred CCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCch
Confidence 9999999999985 4543 357889999999998 6888899999999999999999753
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=204.34 Aligned_cols=136 Identities=38% Similarity=0.554 Sum_probs=104.9
Q ss_pred eeecCCccccccCcccccCC-CCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCC---C
Q 010736 363 LNISRNNITGDFGIAKFLKP-DSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS---S 438 (502)
Q Consensus 363 L~l~~N~l~~dfGl~~ll~~-~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~---~ 438 (502)
||=..+..++|||+++..+. ..+..+...||.||+||||..++.+|+|+||||||||++|++|||+|.|...... .
T Consensus 210 LD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 210 LDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred ECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 44445556899999988876 4443332289999999999999999999999999999999999999988543111 1
Q ss_pred CCC----CcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 439 PSL----NTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 439 ~~~----~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..| ..+..+.+++||++........+++.+++++|+.|++.+|++||+|.||+++|+.+.
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 111 223357899999987321111268899999999999999999999999999997764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-24 Score=201.10 Aligned_cols=138 Identities=22% Similarity=0.335 Sum_probs=121.2
Q ss_pred eeeCCC----------CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccC-CcCc
Q 010736 64 ISCNDA----------GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGG-NQFS 132 (502)
Q Consensus 64 v~C~~~----------~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~-N~l~ 132 (502)
|.|+.. ...++|+|..|+++ .||+.+|+.+++|+.||||+|+|+.+-|++|.++++|..|-+.+ |+|+
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 778753 25889999999998 78888899999999999999999999999999999998876666 9999
Q ss_pred CCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEccccc
Q 010736 133 GNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNS 202 (502)
Q Consensus 133 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 202 (502)
...-..|++|..|+.|.+.-|++.......|..+++|..|.+..|.+...--..|..+..++.+.+..|.
T Consensus 130 ~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np 199 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNP 199 (498)
T ss_pred hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCc
Confidence 6666689999999999999999998888899999999999999999984444478888899988888876
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-20 Score=207.66 Aligned_cols=266 Identities=21% Similarity=0.248 Sum_probs=132.3
Q ss_pred CCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEE
Q 010736 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELA 173 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 173 (502)
..+|+.|++++|++. .+|..+..+++|+.|+|++|...+.+| .++.+++|+.|+|++|.....+|..+..+++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 455666666666655 345555566666666666554433455 255566666666666554455566666666666666
Q ss_pred cccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccc-
Q 010736 174 LFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY- 252 (502)
Q Consensus 174 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~- 252 (502)
+++|...+.+|..+ ++++|+.|++++|...+.+|.. ..+|+.|++++|.++ .+|..+ .+++|+.|++..+...
T Consensus 688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~ 761 (1153)
T PLN03210 688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK 761 (1153)
T ss_pred CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh
Confidence 66554333455433 4556666666655444333322 234555555555554 233322 2333333333321110
Q ss_pred --c----cCCCCCc-cccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCC--------------
Q 010736 253 --G----SIPPSLD-NLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTS-------------- 311 (502)
Q Consensus 253 --~----~~p~~~~-~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~-------------- 311 (502)
+ ..+.... ...|+.|++++|.....+|..+..+++|+.|++++|...+.+|..+ ++++
T Consensus 762 l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~ 840 (1153)
T PLN03210 762 LWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRT 840 (1153)
T ss_pred ccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccc
Confidence 0 0000000 0245555555555555555555556666666665543333444332 3344
Q ss_pred -------CcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCc
Q 010736 312 -------LIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNN 369 (502)
Q Consensus 312 -------L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~ 369 (502)
|+.|++++|.++ .+|..+..+++|+.|++++|+-...+|.....++.|+.++++++.
T Consensus 841 ~p~~~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 841 FPDISTNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ccccccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 445555555554 344555556666666665532222344455555566666655543
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-20 Score=206.82 Aligned_cols=264 Identities=21% Similarity=0.262 Sum_probs=208.1
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
..++.|+++++.+. .++.. +..+++|+.|+|+++...+.+|. ++.+++|++|+|++|.....+|..++++++|+.|+
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~-~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDG-VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred cCCcEEECcCcccc-ccccc-cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 35778888888876 45554 78899999999998876567774 88899999999999877778899999999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccC------------------
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI------------------ 211 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~------------------ 211 (502)
+++|...+.+|..+ ++++|+.|++++|...+.+|.. ..+|+.|++++|.+.. +|..+
T Consensus 688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l 762 (1153)
T PLN03210 688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKL 762 (1153)
T ss_pred CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccccccccccccccccchhhc
Confidence 99876556777765 7888999999888765566643 3567788888887653 33321
Q ss_pred ------------cCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCC
Q 010736 212 ------------GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLP 279 (502)
Q Consensus 212 ------------~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~ 279 (502)
...++|+.|++++|...+.+|..++++++|+.|++++|..-+.+|.......|+.|++++|.....+|
T Consensus 763 ~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p 842 (1153)
T PLN03210 763 WERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFP 842 (1153)
T ss_pred cccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccc
Confidence 12346888888888877789999999999999999988655578877655789999999976555455
Q ss_pred ccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcc
Q 010736 280 QNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNN 345 (502)
Q Consensus 280 ~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 345 (502)
.. ..+|+.|++++|.++ .+|.++..+++|+.|++++|+--..++.....+++|+.++++++.
T Consensus 843 ~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 843 DI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 43 368999999999998 688899999999999999844333577778889999999998874
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.4e-23 Score=210.13 Aligned_cols=266 Identities=26% Similarity=0.341 Sum_probs=169.1
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALF 175 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 175 (502)
+|+.|+.++|.++...+. ..-.+|+++++++|+++ .+|+.++.+.+|+.++..+|+++ .+|..+...++|+.|.+.
T Consensus 220 ~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA 295 (1081)
T ss_pred chheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence 445555555555422211 22346777777777777 55677777777777777777775 677777777777777777
Q ss_pred cCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCcc-CCccccccccccCcccccccCCCCCcEEEeeCcccccc
Q 010736 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKS-ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGS 254 (502)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 254 (502)
+|.++ .+|.....++.|++|+|..|++....+..+..+.. |..|+.+.|++....-..=..++.|+.|.+.+|.++..
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~ 374 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDS 374 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccccc
Confidence 77777 56666667777778888777776443333332222 55555566655532211122344566677777777654
Q ss_pred CCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCC
Q 010736 255 IPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIY 333 (502)
Q Consensus 255 ~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 333 (502)
.-+.+.. ..|+.|+|++|++.......+.++..|+.|+||+|+++ .+|..+..+..|++|...+|++. ..| .+..+
T Consensus 375 c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l 451 (1081)
T KOG0618|consen 375 CFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQL 451 (1081)
T ss_pred chhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhc
Confidence 4333333 66777777777777655556667777777777777777 66677777777777777777776 344 66677
Q ss_pred CCCcEEEccCcccccccCccccCCCCCCeeeecCCc
Q 010736 334 PNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNN 369 (502)
Q Consensus 334 ~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~ 369 (502)
+.|+.+|++.|+++...-......++|++||+++|.
T Consensus 452 ~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 452 PQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred CcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 777777777777764332222222677777777776
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=196.76 Aligned_cols=243 Identities=25% Similarity=0.332 Sum_probs=194.3
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
.++.|++++|+++. +|. ..++|++|+|++|+|+. +|.. .++|+.|+|++|.++ .+|.. ..+|+.|++
T Consensus 223 ~L~~L~L~~N~Lt~-LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~L 289 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA----LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT-HLPAL---PSGLCKLWI 289 (788)
T ss_pred CCCEEEccCCcCCC-CCC----CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh-hhhhc---hhhcCEEEC
Confidence 57899999999984 554 25899999999999994 5643 468999999999998 55643 357899999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCc
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP 230 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 230 (502)
++|+++ .+|.. .++|+.|++++|++++ +|... .+|+.|++++|.+++ +|.. ..+|+.|++++|+|++
T Consensus 290 s~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~- 356 (788)
T PRK15387 290 FGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS- 356 (788)
T ss_pred cCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-
Confidence 999998 45542 4789999999999995 55432 467889999999985 4532 2579999999999995
Q ss_pred ccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCC
Q 010736 231 IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCT 310 (502)
Q Consensus 231 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~ 310 (502)
+|.. ..+|+.|++++|+++ .+|... ..|+.|++++|++++ +|.. .++|+.|++++|++++ +|.. ..
T Consensus 357 LP~l---p~~L~~L~Ls~N~L~-~LP~l~--~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~ 422 (788)
T PRK15387 357 LPTL---PSELYKLWAYNNRLT-SLPALP--SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PS 422 (788)
T ss_pred CCCC---Ccccceehhhccccc-cCcccc--cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hh
Confidence 5543 357888999999998 466543 468999999999987 4543 3679999999999984 6653 34
Q ss_pred CCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccc
Q 010736 311 SLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNF 354 (502)
Q Consensus 311 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 354 (502)
+|+.|++++|+++ .+|..+..+++|+.++|++|++++..+..+
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 6888999999998 678889999999999999999998877655
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=196.73 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=201.7
Q ss_pred cceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccC
Q 010736 61 WSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG 140 (502)
Q Consensus 61 W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 140 (502)
+.-..|-. ...+.+++++++++ .+|.. + .++|+.|+|++|+|+ .+|..+. ++|++|++++|+|+ .+|..+.
T Consensus 170 ~r~~~Cl~-~~~~~L~L~~~~Lt-sLP~~-I--p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~ 240 (754)
T PRK15370 170 QRMRDCLK-NNKTELRLKILGLT-TIPAC-I--PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP 240 (754)
T ss_pred HHHHhhcc-cCceEEEeCCCCcC-cCCcc-c--ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh
Confidence 44446753 46789999999998 45543 3 257999999999999 5676554 58999999999999 6676654
Q ss_pred CCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCcc
Q 010736 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISIL 220 (502)
Q Consensus 141 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 220 (502)
.+|+.|+|++|+++ .+|..+. .+|+.|++++|+++ .+|..+. ++|++|++++|++++ +|..+. ++|+.|
T Consensus 241 --~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L 309 (754)
T PRK15370 241 --DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHL 309 (754)
T ss_pred --ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHH
Confidence 47999999999998 6777664 58999999999999 5777654 589999999999995 455443 579999
Q ss_pred ccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCcccc
Q 010736 221 SLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQG 300 (502)
Q Consensus 221 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~ 300 (502)
++++|+++. +|..+ .++|+.|++++|.+++ +|..+. ..|+.|++++|+++. +|..+. ++|+.|++++|+++
T Consensus 310 ~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~-~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt- 380 (754)
T PRK15370 310 NVQSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP-PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALT- 380 (754)
T ss_pred HhcCCcccc-CCccc--cccceeccccCCcccc-CChhhc-CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCC-
Confidence 999999985 55544 3689999999999984 666554 689999999999985 565553 68999999999998
Q ss_pred ccCcccccCCCCcEEeCCCCccccccCcc----cCCCCCCcEEEccCcccc
Q 010736 301 TIPKSLRNCTSLIRVRLDGNNLTGNISKA----FGIYPNLTFIDLSRNNFY 347 (502)
Q Consensus 301 ~~~~~l~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~ 347 (502)
.+|..+. ..|+.|++++|++++ +|.. +...+.+..+++.+|.++
T Consensus 381 ~LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 381 NLPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence 5666554 368999999999984 4443 345688999999999886
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-22 Score=205.08 Aligned_cols=289 Identities=27% Similarity=0.322 Sum_probs=226.6
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
+.+.|..+.|.+.-..+ -..-.+|+++++++|+++ .+|+.++.+.+|+.++..+|+|+ .+|..+...++|+.|.+
T Consensus 220 ~l~~L~a~~n~l~~~~~---~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDV---HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSA 294 (1081)
T ss_pred chheeeeccCcceeecc---ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence 34444455555541111 223357999999999999 56799999999999999999996 88999999999999999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcccccCCcC-CCCCCC-CCeEEcccccccccCCccCcCCccCCcccccccccc
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHS-LGNLTQ-ISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFS 228 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 228 (502)
.+|.+. -+|....+++.|++|+|..|++. ..|+. +..+.. |..|+.+.|++.....-.=...+.|+.|.+.+|.++
T Consensus 295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Lt 372 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLT 372 (1081)
T ss_pred hhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccc
Confidence 999998 77888889999999999999998 45543 333333 677888888877433222224567999999999999
Q ss_pred CcccccccCCCCCcEEEeeCccccccCCCCCc-c-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCccc
Q 010736 229 GPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD-N-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSL 306 (502)
Q Consensus 229 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l 306 (502)
...-..+-++.+|+.|+|++|++. .+|...- + ..|++|+||+|+++. +|..+..++.|++|....|++. ..| .+
T Consensus 373 d~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fP-e~ 448 (1081)
T KOG0618|consen 373 DSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFP-EL 448 (1081)
T ss_pred ccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-ech-hh
Confidence 887778889999999999999997 5665433 3 579999999999987 6799999999999999999998 677 78
Q ss_pred ccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCcc
Q 010736 307 RNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNI 370 (502)
Q Consensus 307 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l 370 (502)
..++.|+.+|++.|+++...-..-...|+|++|||++|.-.-.....+..+..+...++.-|+.
T Consensus 449 ~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~~~ 512 (1081)
T KOG0618|consen 449 AQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLNNT 512 (1081)
T ss_pred hhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccCCC
Confidence 9999999999999999865433333348999999999974323344556666676677766644
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-22 Score=165.55 Aligned_cols=165 Identities=35% Similarity=0.648 Sum_probs=142.7
Q ss_pred CCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCc
Q 010736 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 170 (502)
+-++++++.|.||+|+++ .+|+.+..+.+|+.|++++|++. .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 556677888999999998 67778999999999999999998 78889999999999999999987 8899999999999
Q ss_pred EEEcccCccc-ccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCc
Q 010736 171 ELALFSNNLN-GSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYN 249 (502)
Q Consensus 171 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 249 (502)
.|||.+|+++ ..+|..|..++.|+.|+|+.|.+. .+|..++.+++|+.|.+..|.+- .+|..++.++.|++|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 9999999886 467888888889999999999987 67888899999999999999887 68888999999999999999
Q ss_pred cccccCCCCCcc
Q 010736 250 NLYGSIPPSLDN 261 (502)
Q Consensus 250 ~l~~~~p~~~~~ 261 (502)
+++ .+|+.++.
T Consensus 184 rl~-vlppel~~ 194 (264)
T KOG0617|consen 184 RLT-VLPPELAN 194 (264)
T ss_pred eee-ecChhhhh
Confidence 998 66665543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-21 Score=190.51 Aligned_cols=277 Identities=21% Similarity=0.245 Sum_probs=152.3
Q ss_pred EEecCCCCceecCcccCCCCCCCCEEECCCCccccc----CCccCcCCCCCCEEEccCCcCcC------CCCcccCCCCC
Q 010736 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGT----IPPQISNLTNLSILSLGGNQFSG------NIPHEVGLMSH 144 (502)
Q Consensus 75 L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~~ 144 (502)
|+|..+.+++.--...|..+.+|++|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 455566665322222255666677888887777432 45556667777777777777652 22344556667
Q ss_pred CcEEEccCCcCcccCCcccCCCCC---CcEEEcccCcccc----cCCcCCCCC-CCCCeEEccccccccc----CCccCc
Q 010736 145 LKILYIDSNQLDGSIPLEVGQLSS---MVELALFSNNLNG----SVPHSLGNL-TQISMLFLHDNSFSGF----IPPDIG 212 (502)
Q Consensus 145 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~ 212 (502)
|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 777777777776544444444433 7777777766652 122233344 5666666666666532 122233
Q ss_pred CCccCCccccccccccCc----ccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCC
Q 010736 213 NLKSISILSLAINQFSGP----IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGAL 288 (502)
Q Consensus 213 ~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L 288 (502)
.+++|+.|++++|.+++. ++..+..+++|+.|++++|.+++... ..+...+...++|
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~-------------------~~l~~~~~~~~~L 223 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA-------------------SALAETLASLKSL 223 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH-------------------HHHHHHhcccCCC
Confidence 344555555555555421 12222333445555555444432111 0112234455677
Q ss_pred cEEEccCCccccccCcccc-----cCCCCcEEeCCCCcccc----ccCcccCCCCCCcEEEccCcccccc----cCcccc
Q 010736 289 QIFTVSENRFQGTIPKSLR-----NCTSLIRVRLDGNNLTG----NISKAFGIYPNLTFIDLSRNNFYGE----ISSNFG 355 (502)
Q Consensus 289 ~~L~ls~n~l~~~~~~~l~-----~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~ 355 (502)
+.|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|+++++++|.+... ....+.
T Consensus 224 ~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~ 303 (319)
T cd00116 224 EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLL 303 (319)
T ss_pred CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHh
Confidence 7777777776642222221 23678888888887752 1223444557788888888887744 333344
Q ss_pred CC-CCCCeeeecCCcc
Q 010736 356 EC-PKLGALNISRNNI 370 (502)
Q Consensus 356 ~~-~~L~~L~l~~N~l 370 (502)
.. +.|+.+++.+|++
T Consensus 304 ~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 304 EPGNELESLWVKDDSF 319 (319)
T ss_pred hcCCchhhcccCCCCC
Confidence 44 6777788777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-18 Score=181.26 Aligned_cols=151 Identities=32% Similarity=0.551 Sum_probs=117.0
Q ss_pred cCCCHHHHHHHHHHHhhcCcCCCCCCCCCCCCCCCCCCCCCCC-----ccceeeeCCC-----CCEEEEEecCCCCceec
Q 010736 17 SSETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPC-----AWSGISCNDA-----GRVINISLRGVGLKGKL 86 (502)
Q Consensus 17 ~~~~~~d~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~C-----~W~Gv~C~~~-----~~v~~L~L~~~~l~g~l 86 (502)
..+...|+.||+++|+++..+ . ..+|.++ || .|.||.|+.. .+|+.|+|+++++.|.+
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~-~--~~~W~g~---------~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~i 434 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLP-L--RFGWNGD---------PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFI 434 (623)
T ss_pred cccCchHHHHHHHHHHhcCCc-c--cCCCCCC---------CCCCcccccccceeeccCCCCceEEEEEECCCCCccccC
Confidence 355678999999999999642 2 2479643 55 7999999531 24888888888888888
Q ss_pred CcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCC
Q 010736 87 HAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQL 166 (502)
Q Consensus 87 ~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 166 (502)
|.. ++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+|..++.+
T Consensus 435 p~~-i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~ 513 (623)
T PLN03150 435 PND-ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513 (623)
T ss_pred CHH-HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc
Confidence 875 8888888888888888888888888888888888888888888888888888888888888888888888776653
Q ss_pred -CCCcEEEcccCccc
Q 010736 167 -SSMVELALFSNNLN 180 (502)
Q Consensus 167 -~~L~~L~L~~N~l~ 180 (502)
.++..+++.+|...
T Consensus 514 ~~~~~~l~~~~N~~l 528 (623)
T PLN03150 514 LLHRASFNFTDNAGL 528 (623)
T ss_pred cccCceEEecCCccc
Confidence 35566666666543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.9e-20 Score=155.07 Aligned_cols=162 Identities=27% Similarity=0.477 Sum_probs=148.6
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
..++.+.|+.|.++ .+|+. ++.+.+|+.|++++|++. .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+.||
T Consensus 33 s~ITrLtLSHNKl~-~vppn-ia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPN-IAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhcccCcee-ecCCc-HHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 57899999999998 56665 999999999999999998 78999999999999999999998 8999999999999999
Q ss_pred ccCCcCcc-cCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCcccccccccc
Q 010736 150 IDSNQLDG-SIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFS 228 (502)
Q Consensus 150 Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 228 (502)
|++|++.. .+|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+..|.+. .+|..++.++.|+.|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 99999974 57889999999999999999998 88999999999999999999988 67899999999999999999999
Q ss_pred CcccccccCC
Q 010736 229 GPIPLSLGNL 238 (502)
Q Consensus 229 ~~~p~~~~~l 238 (502)
.+|..++++
T Consensus 187 -vlppel~~l 195 (264)
T KOG0617|consen 187 -VLPPELANL 195 (264)
T ss_pred -ecChhhhhh
Confidence 566666654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4e-18 Score=167.42 Aligned_cols=120 Identities=30% Similarity=0.495 Sum_probs=87.8
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccc--cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY--TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~--~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
.-.+||||+++.........+...||..|||||... ...++.|+|||||||++|||+||+.|+......... . .
T Consensus 182 ~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~---~-~ 257 (362)
T KOG0192|consen 182 TLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA---S-A 257 (362)
T ss_pred EEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH---H-H
Confidence 334799999998865433445578999999999999 569999999999999999999999998644321110 0 0
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
....-.-|.++. .....+..+++ .||+.+|++||++.|++.+|+.+
T Consensus 258 v~~~~~Rp~~p~---~~~~~l~~l~~---~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 258 VVVGGLRPPIPK---ECPPHLSSLME---RCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred HHhcCCCCCCCc---cCCHHHHHHHH---HhCCCCCCcCCCHHHHHHHHHHH
Confidence 001111122221 13456777777 79999999999999999999976
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.9e-19 Score=173.79 Aligned_cols=256 Identities=19% Similarity=0.223 Sum_probs=174.6
Q ss_pred CEEEEEecCCCCcee----cCcccCCCCCCCCEEECCCCcccc------cCCccCcCCCCCCEEEccCCcCcCCCCcccC
Q 010736 71 RVINISLRGVGLKGK----LHAFSFSSFPHLAYLDLRDNKLFG------TIPPQISNLTNLSILSLGGNQFSGNIPHEVG 140 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~----l~~~~~~~l~~L~~L~Ls~N~l~g------~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 140 (502)
.++.++++++.+++. ++.. +...+.+++|+++++.+.+ .++..+..+++|++|++++|.+.+..+..+.
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~-l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~ 102 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASA-LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHH-HhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHH
Confidence 388999999998542 4433 6778889999999998872 3456678899999999999999876666666
Q ss_pred CCCC---CcEEEccCCcCcc----cCCcccCCC-CCCcEEEcccCccccc----CCcCCCCCCCCCeEEccccccccc--
Q 010736 141 LMSH---LKILYIDSNQLDG----SIPLEVGQL-SSMVELALFSNNLNGS----VPHSLGNLTQISMLFLHDNSFSGF-- 206 (502)
Q Consensus 141 ~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~-- 206 (502)
.+.+ |++|++++|++++ .+...+..+ ++|++|++++|.+++. ++..+..+++|++|++++|.+++.
T Consensus 103 ~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 182 (319)
T cd00116 103 SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGI 182 (319)
T ss_pred HHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHH
Confidence 5555 9999999999873 233445667 8999999999999843 334466778999999999999842
Q ss_pred --CCccCcCCccCCccccccccccCc----ccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCc
Q 010736 207 --IPPDIGNLKSISILSLAINQFSGP----IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQ 280 (502)
Q Consensus 207 --~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~ 280 (502)
++..+...++|+.|++++|.+++. ++..+..+++|+.|++++|.+++.....+.. .
T Consensus 183 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~------------------~ 244 (319)
T cd00116 183 RALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALAS------------------A 244 (319)
T ss_pred HHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHH------------------H
Confidence 333455567999999999998743 3344566788888888888776421111100 0
Q ss_pred cccCCCCCcEEEccCCcccc----ccCcccccCCCCcEEeCCCCccccc----cCcccCCC-CCCcEEEccCcc
Q 010736 281 NICRGGALQIFTVSENRFQG----TIPKSLRNCTSLIRVRLDGNNLTGN----ISKAFGIY-PNLTFIDLSRNN 345 (502)
Q Consensus 281 ~~~~~~~L~~L~ls~n~l~~----~~~~~l~~l~~L~~L~l~~N~l~~~----~~~~~~~l-~~L~~L~Ls~N~ 345 (502)
.......|+.|++++|.++. .+...+..+++|+++++++|.+... ....+... +.|+.+++.+|.
T Consensus 245 ~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 245 LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 00012455666666665541 2233445556777777777777643 22233333 567777776664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.7e-16 Score=150.75 Aligned_cols=116 Identities=32% Similarity=0.502 Sum_probs=82.3
Q ss_pred ccccCcccccCCCCCC-cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSSN-WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~-~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
++||||||...++... ..+-.-.+-|.|||.+...+++.|+|||||||+|+|++| ||.|+......+ .+.
T Consensus 344 IsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------v~~ 415 (468)
T KOG0197|consen 344 ISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------VLE 415 (468)
T ss_pred EcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------HHH
Confidence 7999999966544322 122333568999999999999999999999999999999 899965322110 011
Q ss_pred cc-cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 449 EM-LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 449 ~~-~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.+ -.-+++.+ ...++++.++++ .||+.+|++|||++.....++...
T Consensus 416 ~le~GyRlp~P-~~CP~~vY~lM~---~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 416 LLERGYRLPRP-EGCPDEVYELMK---SCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HHhccCcCCCC-CCCCHHHHHHHH---HHhhCCcccCCCHHHHHHHHHHhh
Confidence 11 11244433 234567777766 999999999999998888887653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.8e-16 Score=152.64 Aligned_cols=118 Identities=31% Similarity=0.556 Sum_probs=86.3
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
+||||-++.+... +....++||..|||||.......++|.||||||||||||+||..|+..+.......-+.. ..
T Consensus 253 IsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs----Ns 327 (904)
T KOG4721|consen 253 ISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS----NS 327 (904)
T ss_pred eccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC----Cc
Confidence 6999999988665 333458999999999999999999999999999999999999999854332211000110 11
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
+ .|+.+. ..++-..-+++ +||...|..||++++++.-|+...|
T Consensus 328 L--~LpvPs-tcP~GfklL~K---qcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 328 L--HLPVPS-TCPDGFKLLLK---QCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred c--cccCcc-cCchHHHHHHH---HHHhcCCCCCccHHHHHHHHhhcCH
Confidence 1 122221 12344556677 9999999999999999999877544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.9e-15 Score=148.70 Aligned_cols=137 Identities=22% Similarity=0.319 Sum_probs=92.4
Q ss_pred CCCCCeeeecCCcc---------ccccCcccccCC--CCCCcccccccccccCcccccc---ceecccceeeeeceeeee
Q 010736 357 CPKLGALNISRNNI---------TGDFGIAKFLKP--DSSNWTGFAGTYGYIAPELAYT---MKITEKCDVYSFGVLVLE 422 (502)
Q Consensus 357 ~~~L~~L~l~~N~l---------~~dfGl~~ll~~--~~~~~~~~~gt~gy~aPE~~~~---~~~s~k~Dvysfgv~llE 422 (502)
.+++.|-||+.||| ++||||+..-.- .........|+..|||||.... ..++..+|||+||||++|
T Consensus 506 AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YE 585 (678)
T KOG0193|consen 506 AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYE 585 (678)
T ss_pred hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHH
Confidence 46788889999997 799999865321 1111223568899999999863 468999999999999999
Q ss_pred hhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCC
Q 010736 423 VIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPS 500 (502)
Q Consensus 423 lltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~ 500 (502)
|+||.-|+........--++..+ +-+.|.... ......+|.+++. .||..++++||.+.+++.+|+++.++
T Consensus 586 Lltg~lPysi~~~dqIifmVGrG--~l~pd~s~~--~s~~pk~mk~Ll~---~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 586 LLTGELPYSIQNRDQIIFMVGRG--YLMPDLSKI--RSNCPKAMKRLLS---DCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred HHhCcCCcCCCChhheEEEeccc--ccCccchhh--hccCHHHHHHHHH---HHHhcCcccCccHHHHHHHHHHhhhc
Confidence 99999998521111110011111 112222211 1122345555554 99999999999999999999988664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.4e-14 Score=136.51 Aligned_cols=124 Identities=28% Similarity=0.461 Sum_probs=89.1
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p 429 (502)
++.|.|++-.|+ +||||.++.+... ....+.||..||+||...+..++.++||||||+.++|+.+||.|
T Consensus 199 ~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP 276 (364)
T KOG0581|consen 199 KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFP 276 (364)
T ss_pred CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCC
Confidence 445555555443 7999999987543 23457899999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCCcccccccccC---CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 430 RDFLSSTSSPSLNTDIALDEMLD---PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~d---~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+-.... ....+. .....+++ |+++... -..|+...+. .|.+.+|.+||+.+|..+
T Consensus 277 ~~~~~~-~~~~~~--~Ll~~Iv~~ppP~lP~~~--fS~ef~~FV~---~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 277 YPPPNP-PYLDIF--ELLCAIVDEPPPRLPEGE--FSPEFRSFVS---CCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCcCC-CCCCHH--HHHHHHhcCCCCCCCccc--CCHHHHHHHH---HHhcCCcccCCCHHHHhc
Confidence 754311 111111 11234455 3444321 2357888888 999999999999888754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.1e-14 Score=148.45 Aligned_cols=117 Identities=26% Similarity=0.393 Sum_probs=82.3
Q ss_pred ccccCcccccCCCCC-Cc-ccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDSS-NW-TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~-~~-~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
++||||+|-.-..+. .. ....-.+-||+||.....++|+++|||||||||||++| |+.|+...... ..+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--------EVI 715 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--------EVI 715 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--------HHH
Confidence 689999986532211 10 01123468999999999999999999999999999998 99997432221 122
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..+-+.++..-++..+.++..++. .||+..|++||+++||...|+...
T Consensus 716 e~i~~g~lL~~Pe~CP~~vY~LM~---~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 716 ECIRAGQLLSCPENCPTEVYSLML---ECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHcCCcccCCCCCCHHHHHHHH---HHhhcCcccCCCHHHHHHHHHHHH
Confidence 233333333222334455665555 999999999999999999999863
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.1e-15 Score=146.50 Aligned_cols=171 Identities=26% Similarity=0.412 Sum_probs=79.0
Q ss_pred CCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEccc
Q 010736 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFS 176 (502)
Q Consensus 97 L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 176 (502)
-...||+.|.+. .+|..+..+..|+.+.|..|.+. .+|..++++..|++|||+.|+++ ..|..+..++ |+.|-+++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEec
Confidence 344455555554 44444444445555555555554 44444555555555555555554 3444444433 44444455
Q ss_pred CcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCC
Q 010736 177 NNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIP 256 (502)
Q Consensus 177 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 256 (502)
|+++ .+|..++.+..|..|+.+.|.+. .+|..++.+.+|+.|.+..|++. .+|..++.+ .|..||++.|++. .+|
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLP 227 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecc
Confidence 5444 34444444444444555555444 23344444444444444444444 233333322 2444444444444 344
Q ss_pred CCCcc-ccccEEECcCCcCcc
Q 010736 257 PSLDN-LVLTKLSLDDNHFTS 276 (502)
Q Consensus 257 ~~~~~-~~L~~L~ls~N~l~~ 276 (502)
-.|.+ ..|++|-|.+|.+.+
T Consensus 228 v~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hhhhhhhhheeeeeccCCCCC
Confidence 44433 334444444444443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.9e-14 Score=139.21 Aligned_cols=115 Identities=22% Similarity=0.325 Sum_probs=79.6
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccccc--ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.+|||+++.+.... ....|+..|+|||+... ..++.++|||||||+++||+||+.|++..... .+... ...
T Consensus 164 l~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~-i~~ 236 (283)
T PHA02988 164 IICHGLEKILSSPP---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDL-IIN 236 (283)
T ss_pred EcccchHhhhcccc---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHH-HHh
Confidence 58999998764322 23457889999999876 67899999999999999999999998632111 00000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.-..+.++ ....+++.++++ .||+.+|++||+|+||++.|+..+
T Consensus 237 ~~~~~~~~---~~~~~~l~~li~---~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 237 KNNSLKLP---LDCPLEIKCIVE---ACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred cCCCCCCC---CcCcHHHHHHHH---HHhcCCcccCcCHHHHHHHHHHHH
Confidence 00111111 112355666666 999999999999999999998765
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.8e-15 Score=146.05 Aligned_cols=181 Identities=28% Similarity=0.484 Sum_probs=161.8
Q ss_pred cCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCe
Q 010736 116 SNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISM 195 (502)
Q Consensus 116 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 195 (502)
-.++--...||+.|++. ++|..+..+..|+.+.|..|.+. .+|..+.++..|..|+|+.|+++ ..|..++.++ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34556677899999999 89999999999999999999998 89999999999999999999999 6777777765 899
Q ss_pred EEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCc
Q 010736 196 LFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFT 275 (502)
Q Consensus 196 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~ 275 (502)
|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|+.+....|..||++.|+++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis 224 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS 224 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee
Confidence 999999998 67888998899999999999998 67888999999999999999998 6777777889999999999998
Q ss_pred ccCCccccCCCCCcEEEccCCccccccCcc
Q 010736 276 SYLPQNICRGGALQIFTVSENRFQGTIPKS 305 (502)
Q Consensus 276 ~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~ 305 (502)
. +|..|++++.|++|.|.+|.++ ..|..
T Consensus 225 ~-iPv~fr~m~~Lq~l~LenNPLq-SPPAq 252 (722)
T KOG0532|consen 225 Y-LPVDFRKMRHLQVLQLENNPLQ-SPPAQ 252 (722)
T ss_pred e-cchhhhhhhhheeeeeccCCCC-CChHH
Confidence 6 8999999999999999999998 44443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.6e-14 Score=151.99 Aligned_cols=116 Identities=30% Similarity=0.423 Sum_probs=80.7
Q ss_pred ccccCcccccCCCCCCcccccc--cccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAG--TYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~g--t~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
++||||||-+...+.....-.+ ...|||||...++.+|.|+|||||||++||++| |..|+......... .
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-------~ 915 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-------L 915 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-------H
Confidence 6999999944322111111112 258999999999999999999999999999999 89997543322110 0
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.-.-+.+|..+ ...++.+++++. .||+.+|++||++.++++++..+
T Consensus 916 ~~~~ggRL~~P-~~CP~~ly~lM~---~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 916 DVLEGGRLDPP-SYCPEKLYQLML---QCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred HHHhCCccCCC-CCCChHHHHHHH---HHccCChhhCccHHHHHhhhhhh
Confidence 01122344422 344566666665 99999999999999999988876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-13 Score=140.66 Aligned_cols=115 Identities=24% Similarity=0.457 Sum_probs=86.0
Q ss_pred ccccCcccccCCCCCC-ccccc--ccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 371 TGDFGIAKFLKPDSSN-WTGFA--GTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~-~~~~~--gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
++||||+|+++++... .+... -.+.|.|||.....++|..+||||||||+||.++ |.+|+..+..++ .
T Consensus 772 VsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--------V 843 (996)
T KOG0196|consen 772 VSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------V 843 (996)
T ss_pred eccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--------H
Confidence 6899999999776532 22222 2467999999999999999999999999999987 999974332221 1
Q ss_pred cccc-cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEM-LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~-~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+..+ .+-+|+.+- +|-..+.++++.||+.+-.+||++.|+|..|...
T Consensus 844 IkaIe~gyRLPpPm----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 844 IKAIEQGYRLPPPM----DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHHHHhccCCCCCC----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 2222 233555332 3445677788899999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.4e-14 Score=137.94 Aligned_cols=120 Identities=22% Similarity=0.325 Sum_probs=79.0
Q ss_pred ccccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++.+...... .....++..|+|||......++.++|||||||+++||+| |+.|+....... ..
T Consensus 213 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~---- 286 (338)
T cd05102 213 VKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF---- 286 (338)
T ss_pred EEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH----
Confidence 346899999876432211 112345678999999988889999999999999999997 999975321110 00
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
...+.+...........+++.. +...|++.+|++||+|.||+++|+.+.
T Consensus 287 -~~~~~~~~~~~~~~~~~~~l~~---li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 287 -CQRLKDGTRMRAPENATPEIYR---IMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred -HHHHhcCCCCCCCCCCCHHHHH---HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0011111110011112234444 444999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.5e-13 Score=140.39 Aligned_cols=109 Identities=37% Similarity=0.566 Sum_probs=95.4
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALF 175 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 175 (502)
.++.|+|++|.++|.+|..++++++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCcCCCCC-CCCCeEEccccccc
Q 010736 176 SNNLNGSVPHSLGNL-TQISMLFLHDNSFS 204 (502)
Q Consensus 176 ~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~ 204 (502)
+|+++|.+|..++.+ .++..+++.+|...
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccc
Confidence 999999999887653 45667777777543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.6e-13 Score=134.76 Aligned_cols=198 Identities=32% Similarity=0.464 Sum_probs=126.0
Q ss_pred EEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCC-CCcEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 010736 99 YLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMS-HLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177 (502)
Q Consensus 99 ~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 177 (502)
.++++.|.+... +..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 466666665422 223455566777777777777 5555555553 7777777777776 45556667777777777777
Q ss_pred cccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCC
Q 010736 178 NLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP 257 (502)
Q Consensus 178 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 257 (502)
+++ .+|...+.+++|+.|++++|+++ .+|........|+++.+++|++. ..+..+.++.++..+.+..|++.. .+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 776 44544446677777777777776 34444444555777777777533 344556667777777777776652 233
Q ss_pred CCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcc
Q 010736 258 SLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKS 305 (502)
Q Consensus 258 ~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~ 305 (502)
.+.. ..++.|++++|.++...+ +....+++.|++++|.+....+..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 3333 447777777777776433 677777888888888777555543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.4e-13 Score=131.35 Aligned_cols=116 Identities=22% Similarity=0.368 Sum_probs=77.8
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......++..|+|||+......+.++|||||||+++||+| |+.|+...... ..
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~----- 235 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV----- 235 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH-----
Confidence 4689999986533211 1223345778999999988889999999999999999998 99997532111 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
...+..............++.+++. .||+.+|++||+++||++.|+.
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~l~~---~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSRQLLPCPEDCPARVYALMI---ECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcCCCcccCCHHHHHHHH---HHccCChhhCcCHHHHHHHHhc
Confidence 0011111111111112345555555 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-13 Score=123.44 Aligned_cols=115 Identities=24% Similarity=0.258 Sum_probs=73.9
Q ss_pred cCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc--c
Q 010736 374 FGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM--L 451 (502)
Q Consensus 374 fGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~--~ 451 (502)
||++++..... ..|+..|+|||...+..++.++|||||||+++||+||+.|+....... ..... ....+ .
T Consensus 53 fG~~~~~~~~~-----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~-~~~~~~~~ 124 (176)
T smart00750 53 DGSVAFKTPEQ-----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEI-LLNGMPAD 124 (176)
T ss_pred ccceEeecccc-----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHH-HHHHhccC
Confidence 88887765432 257899999999999999999999999999999999999975321110 00000 00000 1
Q ss_pred CCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 452 DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 452 d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
++.-....... .+...+.++.-.|+..+|++||++.|+++.+...
T Consensus 125 ~~~~~~~~~~~-~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 125 DPRDRSNLESV-SAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred CccccccHHHH-HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11100000011 1101244444499999999999999999988765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.1e-13 Score=130.42 Aligned_cols=119 Identities=24% Similarity=0.377 Sum_probs=79.3
Q ss_pred ccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.+|||+++....... ......++..|+|||+......+.++||||||++++||+| |+.|+....... . .
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~-----~ 235 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V-----I 235 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H-----H
Confidence 689999876543221 1223446778999999988889999999999999999999 999974321110 0 0
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCC
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPS 500 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~ 500 (502)
..+..............++.+++. .|++.+|++||+|++|+++|+++.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQGRVLERPRVCPKEVYDIML---GCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCCCCCccCCHHHHHHHH---HHcccChhhCcCHHHHHHHHHHHHhh
Confidence 001111111000111234444444 99999999999999999999998553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.5e-12 Score=130.37 Aligned_cols=117 Identities=26% Similarity=0.401 Sum_probs=82.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.++||||++.-......-....-..-|+|||...+..++.|+|||||||++||+++ |..|+........ ..
T Consensus 302 KISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--------~~ 373 (474)
T KOG0194|consen 302 KISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--------KA 373 (474)
T ss_pred EeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH--------HH
Confidence 37999998876422211111234568999999999999999999999999999998 8889753221110 01
Q ss_pred cc-cCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 449 EM-LDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 449 ~~-~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.+ .+. +.+ .+...+.++..+++ .||..+|++||+|.+|++.++.+.
T Consensus 374 kI~~~~~r~~-~~~~~p~~~~~~~~---~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 374 KIVKNGYRMP-IPSKTPKELAKVMK---QCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred HHHhcCccCC-CCCCCHHHHHHHHH---HhccCChhhccCHHHHHHHHHHHH
Confidence 11 111 111 11234567777777 999999999999999999999874
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.9e-12 Score=130.03 Aligned_cols=200 Identities=30% Similarity=0.439 Sum_probs=137.2
Q ss_pred CEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCC-CCcEEEcccCcccccCCcCCCCCCCCCeEEccc
Q 010736 122 SILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLS-SMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200 (502)
Q Consensus 122 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 200 (502)
..++++.|.+...+ ..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++
T Consensus 96 ~~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 35777777775332 23455577888888888887 5666666664 8888888888887 5555677888888888888
Q ss_pred ccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCC
Q 010736 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLP 279 (502)
Q Consensus 201 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~ 279 (502)
|+++. +|...+.++.|+.|++++|+++ .+|........|+++.+++|.+. ..+..+.. ..+..+.+.+|++... +
T Consensus 173 N~l~~-l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~ 248 (394)
T COG4886 173 NDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-P 248 (394)
T ss_pred chhhh-hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-c
Confidence 88874 3444446777888888888887 45555555566888888888543 23333333 5566666777777652 5
Q ss_pred ccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCccc
Q 010736 280 QNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF 330 (502)
Q Consensus 280 ~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 330 (502)
..+..+.+++.|++++|.++. ++. +....+++.|++++|.+....+...
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred chhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhhh
Confidence 566777778888888888873 333 7777888888888888776555433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=5e-13 Score=133.43 Aligned_cols=111 Identities=25% Similarity=0.436 Sum_probs=79.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
.+||||||..+..+...-.+.+||+.|+|||......-+..+||||.||+++.|++|++|++-..-. .....+...+
T Consensus 158 KIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk---ety~~Ik~~~ 234 (592)
T KOG0575|consen 158 KIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK---ETYNKIKLNE 234 (592)
T ss_pred EecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH---HHHHHHHhcC
Confidence 4899999999987655556789999999999999888899999999999999999999998632110 0011111122
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..-|+- ...+...++. .-.+.+|.+||+..+|++
T Consensus 235 Y~~P~~------ls~~A~dLI~---~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 YSMPSH------LSAEAKDLIR---KLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccccc------cCHHHHHHHH---HHhcCCcccCCCHHHHhc
Confidence 222221 1123344444 556799999999999975
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.29 E-value=6.9e-13 Score=133.49 Aligned_cols=119 Identities=26% Similarity=0.380 Sum_probs=78.6
Q ss_pred ccccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
...+|||+++.+...... .....++..|+|||+.....++.++|||||||+++||+| |+.|+....... ....
T Consensus 251 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~-- 326 (374)
T cd05106 251 AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK-- 326 (374)
T ss_pred EEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH--
Confidence 346899999866432211 112334567999999988889999999999999999997 999975321110 0000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
....-..+..+ .....++..++. .|++.+|++||++.||+++|+++
T Consensus 327 ~~~~~~~~~~~---~~~~~~l~~li~---~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 327 MVKRGYQMSRP---DFAPPEIYSIMK---MCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHcccCccCC---CCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHH
Confidence 00000111111 111245556655 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.1e-12 Score=124.26 Aligned_cols=117 Identities=27% Similarity=0.393 Sum_probs=76.7
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+..... ......++.+|+|||.......+.++|||||||+++|+++ |..|+...... .....
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~-- 246 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---ELFKL-- 246 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---HHHHH--
Confidence 4689999987754321 1122335678999999988889999999999999999998 88886421110 00000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
... ......+ .....+ +.++...|+..+|++||+|+||++.|+.+
T Consensus 247 ~~~--~~~~~~~-~~~~~~---~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 247 LKE--GYRMEKP-QNCTQE---LYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHc--CCcCCCC-CCCCHH---HHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 000 0000101 111233 44555599999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.2e-12 Score=122.28 Aligned_cols=118 Identities=27% Similarity=0.467 Sum_probs=78.2
Q ss_pred CCccccccCcccccCCC---CCCcccccccccccCccccccceec-ccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 367 RNNITGDFGIAKFLKPD---SSNWTGFAGTYGYIAPELAYTMKIT-EKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 367 ~N~l~~dfGl~~ll~~~---~~~~~~~~gt~gy~aPE~~~~~~~s-~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
+.-.++|||+++..... ......+.||+.|||||....+... .++||||+||+++||+||++|.... .......
T Consensus 155 ~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~ 232 (313)
T KOG0198|consen 155 GDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEAL 232 (313)
T ss_pred CeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHH
Confidence 34457999999987631 1112347899999999999864333 4899999999999999999996532 0000000
Q ss_pred cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 443 TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 443 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
....... .-|.++. ...++..+.+. .|...+|++|||+.+.++.
T Consensus 233 ~~ig~~~-~~P~ip~---~ls~~a~~Fl~---~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 233 LLIGRED-SLPEIPD---SLSDEAKDFLR---KCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred HHHhccC-CCCCCCc---ccCHHHHHHHH---HHhhcCcccCcCHHHHhhC
Confidence 0000011 2233332 23456777777 9999999999999998754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.2e-12 Score=124.24 Aligned_cols=114 Identities=27% Similarity=0.466 Sum_probs=77.1
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.+...........|+..|+|||+..+...+.++|+||||++++||+||+.|+...... ..... ...
T Consensus 140 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~-~~~ 215 (256)
T cd08529 140 VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILK-IIR 215 (256)
T ss_pred EEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-HHc
Confidence 34689999887754333333456888999999999888999999999999999999999997532110 00000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
... +.+.. ....++.++++ .|++.+|++||+|.|+++.
T Consensus 216 ~~~-~~~~~---~~~~~~~~~i~---~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 GVF-PPVSQ---MYSQQLAQLID---QCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCC-CCCcc---ccCHHHHHHHH---HHccCCcccCcCHHHHhhC
Confidence 111 11111 12234555555 9999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.2e-12 Score=121.07 Aligned_cols=125 Identities=23% Similarity=0.309 Sum_probs=83.2
Q ss_pred CCCeeeecCCcc------------ccccCcccccCCCCCCcccccccccccCccccccceecc---cceeeeeceeeeeh
Q 010736 359 KLGALNISRNNI------------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITE---KCDVYSFGVLVLEV 423 (502)
Q Consensus 359 ~L~~L~l~~N~l------------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~---k~Dvysfgv~llEl 423 (502)
++.|.||+.-|| ++|||+||+.... +-+.+.+||++|+|||...+..++. |.|+||.||||+-+
T Consensus 296 GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvc 374 (475)
T KOG0615|consen 296 GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVC 374 (475)
T ss_pred CcccccCCcceEEeccCCcceEEEecccchhhccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEE
Confidence 455556655444 6899999998633 3345689999999999997665443 66999999999999
Q ss_pred hcCCCCCCcccCCCC-CCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 424 IKGKHPRDFLSSTSS-PSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 424 ltg~~p~~~~~~~~~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+||-.|+........ .+-+..+.+ .+.|... ....++...+++ .-...+|++||+..|+++
T Consensus 375 LsG~pPFS~~~~~~sl~eQI~~G~y--~f~p~~w---~~Iseea~dlI~---~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 375 LSGYPPFSEEYTDPSLKEQILKGRY--AFGPLQW---DRISEEALDLIN---WMLVVDPENRPSADEALN 436 (475)
T ss_pred eccCCCcccccCCccHHHHHhcCcc--cccChhh---hhhhHHHHHHHH---HhhEeCcccCcCHHHHhc
Confidence 999999853322210 000011110 1121111 123466667777 778899999999999864
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=6e-13 Score=129.49 Aligned_cols=122 Identities=16% Similarity=0.162 Sum_probs=81.2
Q ss_pred CccccccCcccccCCCC-------CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCC-C
Q 010736 368 NNITGDFGIAKFLKPDS-------SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS-P 439 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~-------~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~-~ 439 (502)
+...+|||+++...... .......||..|+|||...+..++.++|||||||+++||+||+.|+........ .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 34479999998764221 111235699999999999988899999999999999999999999864321110 0
Q ss_pred CCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 440 SLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 440 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
..........+..+.+..+ ....++.++++ .|+..+|++||++.++.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIK--NANKFIYDFIE---CVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhhhccC--CCCHHHHHHHH---HHHhCCCCCCCCHHHHHHhh
Confidence 0000000111121221111 12356777777 99999999999999998876
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.4e-13 Score=126.37 Aligned_cols=114 Identities=25% Similarity=0.377 Sum_probs=75.0
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
-..+|||+++.+...........|+..|+|||+.. ...++.++|||||||+++||+||+.|++........
T Consensus 150 ~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~---- 225 (272)
T cd06637 150 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---- 225 (272)
T ss_pred EEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH----
Confidence 34789999987654333334567899999999975 335778999999999999999999997532111000
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
........+..... ....++.+++. .|+..+|.+||++.||++
T Consensus 226 -~~~~~~~~~~~~~~--~~~~~~~~li~---~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 -FLIPRNPAPRLKSK--KWSKKFQSFIE---SCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -HHHhcCCCCCCCCC--CcCHHHHHHHH---HHcCCChhhCCCHHHHhh
Confidence 00000111111111 12244556665 999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.6e-13 Score=128.45 Aligned_cols=116 Identities=25% Similarity=0.439 Sum_probs=72.6
Q ss_pred CccccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcc
Q 010736 368 NNITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~ 444 (502)
.-..+|||+++........ .....+...|+|||.......+.++||||||++++|++| |+.|+...... .
T Consensus 141 ~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~---- 213 (259)
T PF07714_consen 141 QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---E---- 213 (259)
T ss_dssp EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---H----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c----
Confidence 3346899999877322111 112346678999999999999999999999999999999 67886422110 0
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
....+.+.............+..+++ .||+.+|++||+|.|++++|
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~~li~---~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 214 -IIEKLKQGQRLPIPDNCPKDIYSLIQ---QCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -HHHHHHTTEETTSBTTSBHHHHHHHH---HHT-SSGGGS--HHHHHHHH
T ss_pred -ccccccccccceeccchhHHHHHHHH---HHcCCChhhCcCHHHHHhcC
Confidence 01111111111111112245666665 99999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.4e-12 Score=129.78 Aligned_cols=111 Identities=27% Similarity=0.506 Sum_probs=77.4
Q ss_pred ccccCcccccCCCCCCcc---cccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 371 TGDFGIAKFLKPDSSNWT---GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~---~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
+|||||.|.+........ ...-.+.|.|||.....+++.++|||.|||.+|||+| |..|.-.... ..
T Consensus 253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------~q 323 (1039)
T KOG0199|consen 253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------IQ 323 (1039)
T ss_pred eecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------HH
Confidence 799999999865433221 1233578999999999999999999999999999999 6777421111 11
Q ss_pred cccccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 447 LDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 447 ~~~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
+.+-+|. +|+.+. ...+.++.|++ .||+..|++||++..+++.+
T Consensus 324 IL~~iD~~erLpRPk-~csedIY~imk---~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 ILKNIDAGERLPRPK-YCSEDIYQIMK---NCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHhccccccCCCCC-CChHHHHHHHH---HhccCCccccccHHHHHHhH
Confidence 2222332 344332 33455555554 99999999999999998443
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.3e-12 Score=125.02 Aligned_cols=122 Identities=25% Similarity=0.359 Sum_probs=81.7
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............|+..|+|||+..+...+.++|+||||++++|++||+.|+...... ...+.. .+.
T Consensus 145 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~--~~~ 221 (267)
T cd08228 145 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQ--KIE 221 (267)
T ss_pred EEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHH--HHh
Confidence 34689999887754332223456788999999998888899999999999999999999996421100 000000 011
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
....+..... ...+++.+++. .|++.+|++||++.||++.++..+
T Consensus 222 ~~~~~~~~~~--~~~~~~~~li~---~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 222 QCDYPPLPTE--HYSEKLRELVS---MCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred cCCCCCCChh--hcCHHHHHHHH---HHCCCCcccCcCHHHHHHHHHHhc
Confidence 1112222111 11234555555 999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.1e-12 Score=122.41 Aligned_cols=122 Identities=24% Similarity=0.347 Sum_probs=82.8
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.-..+|||+++.............|+..|+|||+......+.++|+||||++++||+||+.|+...... ...... ..
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~--~~ 220 (267)
T cd08229 144 VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK--KI 220 (267)
T ss_pred CEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhh--hh
Confidence 344689999887754333233456888999999998888999999999999999999999997421110 000000 11
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.+...+.+.. ....+++..++. .|++.+|++||+|.+|++++++.
T Consensus 221 ~~~~~~~~~~--~~~~~~~~~li~---~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 221 EQCDYPPLPS--DHYSEELRQLVN---MCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred hcCCCCCCCc--ccccHHHHHHHH---HhcCCCcccCCCHHHHHHHHhhh
Confidence 1122222221 112345555555 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.8e-12 Score=125.71 Aligned_cols=119 Identities=23% Similarity=0.323 Sum_probs=77.9
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......++..|+|||.......+.++|||||||+++||+| |+.|+....... ......
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i~ 236 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECIT 236 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH
Confidence 4689999886643221 1122345678999999988889999999999999999999 888864321100 000000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
.. ..+... .....++.++ ...|++.+|.+||+|.||.+.|+.+..
T Consensus 237 -~~-~~~~~~---~~~~~~l~~l---i~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 237 -QG-RVLQRP---RTCPKEVYDL---MLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -cC-CcCCCC---CCCCHHHHHH---HHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 00 001111 1112344444 449999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-12 Score=128.86 Aligned_cols=112 Identities=28% Similarity=0.460 Sum_probs=80.1
Q ss_pred ccccCcccccCCCCCCcccccc---cccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAG---TYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~g---t~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
++||||+|++..+.. |..+| .+.|.|||-.....++.|+|||+|||+|||+.| |..|+....- ..
T Consensus 406 vADFGLsRlMtgDTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---------Sq 474 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------SQ 474 (1157)
T ss_pred eeccchhhhhcCCce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------HH
Confidence 689999999987643 33334 468999999999999999999999999999998 8888642111 11
Q ss_pred cccccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+++.+.. ++.++ .+....+. ++...||+.+|.+||+++|+.+.++..
T Consensus 475 VY~LLEkgyRM~~P-eGCPpkVY---eLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 475 VYGLLEKGYRMDGP-EGCPPKVY---ELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHHHhccccccCC-CCCCHHHH---HHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 1222222 22221 23334444 444599999999999999999988764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.6e-12 Score=122.19 Aligned_cols=114 Identities=31% Similarity=0.464 Sum_probs=74.4
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
...+|||+++....... ......++..|+|||+......+.++||||||++++|++| |+.|+....... .
T Consensus 139 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~----- 210 (256)
T cd05114 139 VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---V----- 210 (256)
T ss_pred EEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H-----
Confidence 34689999886532211 1223345668999999988889999999999999999999 899975321110 0
Q ss_pred cccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 447 LDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 447 ~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
...+... ....+ .....++ .+++..|++.+|++||+|+|++++|
T Consensus 211 ~~~i~~~~~~~~~-~~~~~~~---~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 211 VEMISRGFRLYRP-KLASMTV---YEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHCCCCCCCC-CCCCHHH---HHHHHHHccCCcccCcCHHHHHHhh
Confidence 0001100 01001 1112334 4555599999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-12 Score=125.06 Aligned_cols=116 Identities=20% Similarity=0.300 Sum_probs=76.0
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+..... ......++..|+|||.......+.++||||||++++||+| |+.|+...... . .
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~-----~ 235 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D-----V 235 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---H-----H
Confidence 4689999887643221 1122345678999999988889999999999999999998 77776421110 0 1
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
...+.++..........+++..++. .|++.+|++||+|+||++.|+.
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~li~---~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQVLPCPDDCPAWVYTLML---ECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHH---HHhCCCcccCCCHHHHHHHhhC
Confidence 1111121111001112344555544 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.3e-12 Score=122.65 Aligned_cols=116 Identities=26% Similarity=0.393 Sum_probs=78.2
Q ss_pred cccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++.+...... .+...++..|+|||.......+.++|+|||||+++|++| |+.|+...........
T Consensus 135 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---- 210 (257)
T cd05116 135 KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM---- 210 (257)
T ss_pred EECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 36899999876433221 112234578999999888888899999999999999998 9999753211100000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
+..-.-+..+ ....+++.++++ .|++.+|++||+|.+|+++|+.
T Consensus 211 -i~~~~~~~~~---~~~~~~l~~li~---~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 211 -IESGERMECP---QRCPPEMYDLMK---LCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -HHCCCCCCCC---CCCCHHHHHHHH---HHhccCchhCcCHHHHHHHHhc
Confidence 0000001111 122356777777 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.2e-12 Score=127.60 Aligned_cols=114 Identities=29% Similarity=0.466 Sum_probs=73.1
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc-
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL- 447 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~- 447 (502)
-..+|||+++.............||..|+|||+..+...+.++|||||||+++||+||+.|++................
T Consensus 135 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 214 (329)
T cd05618 135 IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 214 (329)
T ss_pred EEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH
Confidence 3468999998643322223346789999999999988889999999999999999999999864322111110000000
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~ 486 (502)
..+......-+. ....++..+++ .|++.+|++||+
T Consensus 215 ~~i~~~~~~~p~-~~~~~~~~ll~---~~L~~dP~~R~~ 249 (329)
T cd05618 215 QVILEKQIRIPR-SLSVKAASVLK---SFLNKDPKERLG 249 (329)
T ss_pred HHHhcCCCCCCC-CCCHHHHHHHH---HHhcCCHHHcCC
Confidence 111111111111 12244556666 999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.6e-12 Score=127.44 Aligned_cols=118 Identities=26% Similarity=0.372 Sum_probs=78.6
Q ss_pred ccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.+|||+++.+...... .....++..|+|||+......+.++|||||||+++|++| |+.|+....... .+.. .+
T Consensus 214 L~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~--~~ 289 (337)
T cd05054 214 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR--RL 289 (337)
T ss_pred EeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH--HH
Confidence 5899999876432221 122445678999999999999999999999999999998 999974211100 0000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.+-.-+..+ ....+ ++.+++..|++.+|++||++.||+++|+..-
T Consensus 290 ~~~~~~~~~---~~~~~---~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 290 KEGTRMRAP---EYATP---EIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred hccCCCCCC---ccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000000111 11112 3556666999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.24 E-value=2e-12 Score=122.75 Aligned_cols=115 Identities=23% Similarity=0.405 Sum_probs=76.5
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
...+|||++..............++..|++||+..+...+.++|||||||+++||+||+.|++.......... ..
T Consensus 138 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-----~~ 212 (256)
T cd06612 138 AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IP 212 (256)
T ss_pred EEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-----hc
Confidence 4578999988765433222345578899999999888899999999999999999999999763221110000 00
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+.+..+ ....+++.++++ .|++.+|++||++.||++
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~i~---~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 213 NKPPPTLSDP-EKWSPEFNDFVK---KCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCCCCCCCch-hhcCHHHHHHHH---HHHhcChhhCcCHHHHhc
Confidence 0011111111 011234555555 999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.6e-12 Score=129.43 Aligned_cols=118 Identities=26% Similarity=0.404 Sum_probs=76.8
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....++..|+|||.......+.++|||||||+++||+| |+.|+....... .+.. .
T Consensus 254 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~--~ 329 (375)
T cd05104 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK--M 329 (375)
T ss_pred EEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH--H
Confidence 36899999876433221 112334567999999998899999999999999999998 888875321110 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+.+-..+..+ .....++.+++. .|++.+|++||+|+||+++|++.
T Consensus 330 ~~~~~~~~~~---~~~~~~l~~li~---~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 330 IKEGYRMLSP---ECAPSEMYDIMK---SCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHhCccCCCC---CCCCHHHHHHHH---HHccCChhHCcCHHHHHHHHHhh
Confidence 0000000111 112244555555 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.3e-12 Score=123.26 Aligned_cols=118 Identities=24% Similarity=0.389 Sum_probs=79.0
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
...+|||+++.+..... ..+...++.+|++||+......+.++|||||||+++|++| |+.|+...............
T Consensus 148 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05111 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227 (279)
T ss_pred EEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 35799999987654322 2234567789999999988889999999999999999998 99997532111000000000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.....+.. ....+. ++...|+..+|++||+|.|+.++|+.+
T Consensus 228 --~~~~~~~~------~~~~~~---~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 228 --ERLAQPQI------CTIDVY---MVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred --CcCCCCCC------CCHHHH---HHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 00111111 112333 344499999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.8e-12 Score=123.64 Aligned_cols=115 Identities=26% Similarity=0.391 Sum_probs=75.9
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......++..|+|||+......+.++|||||||+++||+| |+.|+...... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~---- 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVI---- 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----
Confidence 3689999876533211 1123345678999999998899999999999999999999 99997422111 000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
..+..............++..+++ .|++.+|++||++.||.++|+
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 -ECITQGRLLQRPRTCPSEVYDIML---GCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHHcCCcCCCCCCCCHHHHHHHH---HHcCCCcccCCCHHHHHHHhh
Confidence 001111111011112244555555 999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.2e-12 Score=122.10 Aligned_cols=118 Identities=24% Similarity=0.399 Sum_probs=78.2
Q ss_pred ccccccCcccccCCCCCC-cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSSN-WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~-~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
-..+|||+++........ .....++.+|++||+..+...+.++|||||||+++||+| |+.|++..... .... .
T Consensus 143 ~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~--~ 217 (263)
T cd05052 143 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE--L 217 (263)
T ss_pred EEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH--H
Confidence 346899999876543221 112234568999999988889999999999999999998 88887421110 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
......+..+ .....++.+++. .|++.+|++||+|.|+.++|+.+
T Consensus 218 ~~~~~~~~~~---~~~~~~~~~li~---~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 218 LEKGYRMERP---EGCPPKVYELMR---ACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHCCCCCCCC---CCCCHHHHHHHH---HHccCCcccCCCHHHHHHHHHhh
Confidence 0010111111 112345555555 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.8e-12 Score=122.28 Aligned_cols=127 Identities=20% Similarity=0.252 Sum_probs=79.1
Q ss_pred ccccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCC--C---
Q 010736 369 NITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSP--S--- 440 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~--~--- 440 (502)
...+|||+++........ .....++..|++||.......+.++||||||++++||+||+.|.......... .
T Consensus 146 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 225 (283)
T cd05080 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ 225 (283)
T ss_pred EEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccc
Confidence 346899999876532211 11223456799999998888999999999999999999999996532110000 0
Q ss_pred -CCcccccccccCCCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 441 -LNTDIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 441 -~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
........+.++.....+ ......++.++ ...|++.+|++||+|++|+++|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---i~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 226 GQMTVVRLIELLERGMRLPCPKNCPQEVYIL---MKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccchhhhhhhhhcCCCCCCCCCCCHHHHHH---HHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000001111111111100 01122344444 44999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.6e-12 Score=121.53 Aligned_cols=116 Identities=29% Similarity=0.430 Sum_probs=76.7
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++....... ......++..|+|||+......+.++|||||||+++||+| |+.|+....... ... .+
T Consensus 143 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~--~~ 217 (261)
T cd05072 143 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMS--AL 217 (261)
T ss_pred EECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHH--HH
Confidence 4689999987653221 1123345678999999988888999999999999999999 999974211100 000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
......... ....+++.+++. .|+..+|++||+|+++.+.|+.
T Consensus 218 ~~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 218 QRGYRMPRM---ENCPDELYDIMK---TCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HcCCCCCCC---CCCCHHHHHHHH---HHccCCcccCcCHHHHHHHHhc
Confidence 011111111 112234445444 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-12 Score=135.33 Aligned_cols=114 Identities=29% Similarity=0.441 Sum_probs=77.3
Q ss_pred ccccccCcccccCCCC--CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
-..+|||+++...... .......||.+|+|||+.....++.++|||||||+++||+||+.|++.... ...... .
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~~~~-~ 257 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVMHK-T 257 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHH-H
Confidence 3468999998764321 112346789999999999988899999999999999999999999753110 000000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
.....++ ++ .....++..+++ .|++.+|++||++.++++.
T Consensus 258 ~~~~~~~-~~---~~~~~~l~~li~---~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRYDP-LP---PSISPEMQEIVT---ALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCCCC-CC---CCCCHHHHHHHH---HHcccChhhCcCHHHHHhC
Confidence 0001111 11 112345666666 9999999999999998753
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.9e-12 Score=121.32 Aligned_cols=118 Identities=30% Similarity=0.368 Sum_probs=75.2
Q ss_pred cccccCcccccCCCCC----CcccccccccccCccccccceecccceeeeeceeeeehhcCCC-CCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH-PRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~-p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++.+..... ......++..|+|||+......+.++|||||||+++||+||+. |+...... ..
T Consensus 138 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~--- 211 (262)
T cd05058 138 KVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DI--- 211 (262)
T ss_pred EECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH---
Confidence 4689999886543211 1123456678999999988889999999999999999999654 44321100 00
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
...+.............+.+. ++...|++.+|++||++.||+++|+++.
T Consensus 212 --~~~~~~~~~~~~~~~~~~~~~---~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 212 --TVYLLQGRRLLQPEYCPDPLY---EVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --HHHHhcCCCCCCCCcCCHHHH---HHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 000111100000011123344 4445999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.22 E-value=5e-12 Score=121.30 Aligned_cols=118 Identities=22% Similarity=0.290 Sum_probs=77.4
Q ss_pred ccccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
...+|||+++.+...... .....++..|++||+......+.++||||||++++|+++ |+.|+....... .
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~---- 224 (273)
T cd05035 152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I---- 224 (273)
T ss_pred EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H----
Confidence 357999999876533221 112334678999999988889999999999999999999 888874321110 0
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
...+.+...........+++.+ +...|++.+|++||++.||++.|+.+
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~---li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 225 -YDYLRHGNRLKQPEDCLDELYD---LMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -HHHHHcCCCCCCCcCCCHHHHH---HHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111111110000112234444 44499999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.5e-12 Score=128.59 Aligned_cols=116 Identities=24% Similarity=0.385 Sum_probs=74.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-----ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-----MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-----~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++.+...........|+..|+|||.... ...+.++|||||||+++||++|+.|+..............
T Consensus 208 kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~ 287 (353)
T PLN00034 208 KIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA 287 (353)
T ss_pred EEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH
Confidence 46899999887543333334578999999998643 2234689999999999999999999862211110000000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
.... ..+... .....++.++++ .|++.+|++||+++||++.
T Consensus 288 ~~~~--~~~~~~---~~~~~~l~~li~---~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 ICMS--QPPEAP---ATASREFRHFIS---CCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred Hhcc--CCCCCC---CccCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence 0000 011111 122345667777 9999999999999999763
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.3e-12 Score=123.54 Aligned_cols=116 Identities=28% Similarity=0.423 Sum_probs=79.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
...+|||++....... ......|+..|++||+......+.++||||||++++|++||+.|+...... .. ..
T Consensus 153 ~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~-----~~ 223 (269)
T cd08528 153 VTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SL-----AT 223 (269)
T ss_pred EEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HH-----HH
Confidence 3468999988765432 233456888999999999888999999999999999999999997421100 00 00
Q ss_pred cccCCCCCC-CCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 449 EMLDPRLPV-PSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 449 ~~~d~~l~~-~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
.+.+..... .......++.++++ .|++.+|++||+|.||..++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~l~~li~---~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 224 KIVEAVYEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHhhccCCcCCcccCCHHHHHHHH---HHCCCCCccCCCHHHHHHHhcC
Confidence 111111100 00012244555555 9999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.1e-12 Score=123.24 Aligned_cols=116 Identities=20% Similarity=0.285 Sum_probs=74.7
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....++..|+|||+......+.++|||||||+++|++| |+.|+...... ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~----- 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QV----- 230 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH-----
Confidence 36899998865432211 112234678999999988889999999999999999999 68886422110 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
...+.............+++.++ ...|++.+|++||++.|++++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~l---i~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 LRFVMEGGLLDKPDNCPDMLFEL---MRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHH---HHHHcCCChhhCcCHHHHHHHhhC
Confidence 00011111111111122344444 449999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.5e-12 Score=121.55 Aligned_cols=116 Identities=25% Similarity=0.450 Sum_probs=77.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++.............++.+|++||.......+.++||||||++++|++| |+.|+....... ... ...
T Consensus 144 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~--~~~ 218 (261)
T cd05148 144 KVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYD--QIT 218 (261)
T ss_pred EEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH--HHH
Confidence 36899999877543332333456678999999988889999999999999999998 899975321100 000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
.-..+.. + ....+.+. +++..|+..+|++||+|+++.+.|+.
T Consensus 219 ~~~~~~~--~-~~~~~~~~---~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 219 AGYRMPC--P-AKCPQEIY---KIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred hCCcCCC--C-CCCCHHHH---HHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0011111 1 11123344 45559999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.6e-12 Score=122.55 Aligned_cols=115 Identities=25% Similarity=0.410 Sum_probs=77.8
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
+-..+|||+++.+...........++..|++||+..+...+.++|||||||+++|++||+.|++...... ... .+
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~--~~ 210 (274)
T cd06609 136 DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLF--LI 210 (274)
T ss_pred CEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHH--Hh
Confidence 3456899999887654333344567889999999998889999999999999999999999975322110 000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+.+... ...+++..+++ .|+..+|++||+|+++++
T Consensus 211 ~~~~~~~~~~~--~~~~~~~~~l~---~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 211 PKNNPPSLEGN--KFSKPFKDFVS---LCLNKDPKERPSAKELLK 250 (274)
T ss_pred hhcCCCCCccc--ccCHHHHHHHH---HHhhCChhhCcCHHHHhh
Confidence 01111222111 02234555555 899999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.22 E-value=6e-12 Score=120.30 Aligned_cols=124 Identities=24% Similarity=0.344 Sum_probs=81.7
Q ss_pred CCccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 367 RNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 367 ~N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
++-..+|||+++.+...........++..|.|||+..+...+.++|+|||||+++|++||+.|+...... ...... .
T Consensus 143 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~--~ 219 (267)
T cd08224 143 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK--K 219 (267)
T ss_pred CcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh--h
Confidence 3445689999887654332233456888999999998888999999999999999999999997421100 000000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
...-.-+..+. ....+++..+++ .|+..+|++||++.+|+++|+...
T Consensus 220 ~~~~~~~~~~~--~~~~~~~~~~i~---~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 220 IEKCDYPPLPA--DHYSEELRDLVS---RCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhcCCCCCCCh--hhcCHHHHHHHH---HHcCCCcccCCCHHHHHHHHHHhc
Confidence 00001111111 012234555555 999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.2e-12 Score=120.83 Aligned_cols=118 Identities=24% Similarity=0.370 Sum_probs=77.0
Q ss_pred ccccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
...+|||+++........ .....++..|++||+......+.++||||||++++|++| |+.|+....... .
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~---- 217 (266)
T cd05033 145 CKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---V---- 217 (266)
T ss_pred EEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---H----
Confidence 346899999887522111 112344678999999988889999999999999999998 999974221100 0
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
...+.+...........+.+ .++...|++.+|++||+|.||.++|+++
T Consensus 218 -~~~~~~~~~~~~~~~~~~~l---~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 218 -IKAVEDGYRLPPPMDCPSAL---YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -HHHHHcCCCCCCCCCCCHHH---HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111110000001112334 4555599999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.6e-12 Score=120.88 Aligned_cols=117 Identities=26% Similarity=0.468 Sum_probs=76.4
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
...+|||+++....... ...+...+..|+|||+......+.++||||||++++|++| |+.|+....... ... .
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~--~ 216 (261)
T cd05068 142 CKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ--Q 216 (261)
T ss_pred EEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--H
Confidence 34699999987753221 1112233468999999998889999999999999999999 898875321100 000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
+........+ ....+. +.+++..|++.+|++||+|.+++++|++
T Consensus 217 ~~~~~~~~~~---~~~~~~---~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 217 VDQGYRMPCP---PGCPKE---LYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHcCCCCCCC---CcCCHH---HHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0000000011 111233 4455559999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.5e-12 Score=122.10 Aligned_cols=114 Identities=26% Similarity=0.396 Sum_probs=76.5
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
...+|||+++.+...........|+..|++||+..+...+.++|||||||+++|++||+.|+.......... .+.
T Consensus 140 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~ 214 (277)
T cd06642 140 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----LIP 214 (277)
T ss_pred EEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----hhh
Confidence 346899998876543322334567889999999988889999999999999999999999975321111000 001
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
+-..+.+.. ....++.+++. .|++.+|++||+|.||++.
T Consensus 215 ~~~~~~~~~---~~~~~~~~li~---~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 215 KNSPPTLEG---QYSKPFKEFVE---ACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cCCCCCCCc---ccCHHHHHHHH---HHccCCcccCcCHHHHHHh
Confidence 111122211 11234444544 9999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.9e-12 Score=128.79 Aligned_cols=121 Identities=23% Similarity=0.364 Sum_probs=79.6
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......++..|+|||...+...+.++|||||||+++||+| |+.|+....... .... .
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~~--~ 352 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFYN--K 352 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHHH--H
Confidence 4689999987643222 1122346778999999988889999999999999999997 899975321110 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCC
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPS 500 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~ 500 (502)
+..-..+..+ .....+ +.++...|++.+|++||+|.+|+++|+.+.++
T Consensus 353 ~~~~~~~~~~---~~~~~~---l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~~ 400 (400)
T cd05105 353 IKSGYRMAKP---DHATQE---VYDIMVKCWNSEPEKRPSFLHLSDIVESLLPS 400 (400)
T ss_pred HhcCCCCCCC---ccCCHH---HHHHHHHHCccCHhHCcCHHHHHHHHHHHcCC
Confidence 0000001111 111233 44455599999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.4e-12 Score=125.88 Aligned_cols=121 Identities=18% Similarity=0.202 Sum_probs=73.9
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhcC--CCCCCcccCCCCCCCCcc
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKG--KHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg--~~p~~~~~~~~~~~~~~~ 444 (502)
-..+|||+++.+..... ......++..|+|||+......+.++||||||++++||+++ +.|+..............
T Consensus 177 ~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 256 (304)
T cd05096 177 IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGE 256 (304)
T ss_pred EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHH
Confidence 34799999987643221 11123457789999998888899999999999999999874 455532111100000000
Q ss_pred c---ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 445 I---ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 445 ~---~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
. ....+. +..+ ....+.+.++ ...|++.+|++||+|.||++.|++
T Consensus 257 ~~~~~~~~~~-~~~~---~~~~~~~~~l---i~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 257 FFRDQGRQVY-LFRP---PPCPQGLYEL---MLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred Hhhhcccccc-ccCC---CCCCHHHHHH---HHHHccCCchhCcCHHHHHHHHhC
Confidence 0 000000 0000 1112344444 459999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.9e-12 Score=122.75 Aligned_cols=117 Identities=24% Similarity=0.397 Sum_probs=76.3
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++....... ......++..|+|||+......+.++|||||||+++|++| |+.|+........ ..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~-- 235 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IE-- 235 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HH--
Confidence 34689999876543221 1112335678999999988889999999999999999999 8888642211100 00
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
.......+..+ ......+.+++. .|++.+|++||+++||.+.|++
T Consensus 236 ~~~~~~~~~~~---~~~~~~~~~li~---~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQGRELERP---RTCPPEVYAIMQ---GCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcCccCCCC---CCCCHHHHHHHH---HHccCChhhCCCHHHHHHHHhC
Confidence 00000011111 112244556665 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.6e-12 Score=119.31 Aligned_cols=114 Identities=27% Similarity=0.431 Sum_probs=76.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.+...........|+..|+|||.......+.++|+||||++++||++|+.|++..... ....... .
T Consensus 139 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~-~ 214 (255)
T cd08219 139 VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLILKVC-Q 214 (255)
T ss_pred EEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHHHHHh-c
Confidence 34689999887654322223456888999999998888999999999999999999999997532110 0000000 0
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
.... .++ .....++..++. .|++.+|++||++.|++.+
T Consensus 215 ~~~~-~~~---~~~~~~~~~li~---~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 GSYK-PLP---SHYSYELRSLIK---QMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCC-CCC---cccCHHHHHHHH---HHHhCCcccCCCHHHHhhc
Confidence 0011 111 112234555665 9999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.9e-12 Score=133.74 Aligned_cols=116 Identities=25% Similarity=0.433 Sum_probs=78.6
Q ss_pred ccccCcccccCCCCCCc-ccccc--cccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 371 TGDFGIAKFLKPDSSNW-TGFAG--TYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~-~~~~g--t~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
+||||++|-........ ....| ...|||||......++.|+|||||||+|||++| |..|+..... ..+.
T Consensus 459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~------~~~l- 531 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP------TEEL- 531 (609)
T ss_pred EccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc------HHHH-
Confidence 79999999765433221 22222 346999999999999999999999999999999 8888742110 0000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
..-+.+......+....+++..+++ .||+.+|++||+..|.++.++.
T Consensus 532 ~~~l~~G~r~~~P~~c~~eiY~iM~---~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 532 LEFLKEGNRMEQPEHCSDEIYDLMK---SCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHH---HHhCCCcccCCCHHHHHHHHHH
Confidence 1111222211112222456766666 9999999999999999998876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=5e-12 Score=125.34 Aligned_cols=128 Identities=23% Similarity=0.385 Sum_probs=92.0
Q ss_pred CCCCCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcC
Q 010736 356 ECPKLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKG 426 (502)
Q Consensus 356 ~~~~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg 426 (502)
...++.|+||+.-+| ++|||++..+.......+.+.||+.|||||......+..|.||||+||+.+||+-|
T Consensus 386 H~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG 465 (550)
T KOG0578|consen 386 HARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG 465 (550)
T ss_pred HhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC
Confidence 345677777766554 68999998887766666678999999999999999999999999999999999999
Q ss_pred CCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 427 ~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..|+=.......... +..---|++..+. ....++.+.+. .|.+.++++||+.+|+++
T Consensus 466 EPPYlnE~PlrAlyL-----Ia~ng~P~lk~~~-klS~~~kdFL~---~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 466 EPPYLNENPLRALYL-----IATNGTPKLKNPE-KLSPELKDFLD---RCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCCccCCChHHHHHH-----HhhcCCCCcCCcc-ccCHHHHHHHH---HHhhcchhcCCCHHHHhc
Confidence 999732111000011 1111223333221 12246777888 999999999999999864
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.8e-12 Score=123.11 Aligned_cols=119 Identities=28% Similarity=0.402 Sum_probs=78.4
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+...... .....++..|+|||...+..++.++||||||++++|++| |+.|+...... .+...
T Consensus 177 kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~-- 251 (304)
T cd05101 177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---ELFKL-- 251 (304)
T ss_pred EECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH--
Confidence 36899999877532211 122345678999999988889999999999999999999 77776422110 00000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
+.+ +.....+ ....+++.+++. .|++.+|++||+|.||++.|+.+..
T Consensus 252 ~~~--~~~~~~~-~~~~~~~~~li~---~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 252 LKE--GHRMDKP-ANCTNELYMMMR---DCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHc--CCcCCCC-CCCCHHHHHHHH---HHcccChhhCCCHHHHHHHHHHHHH
Confidence 000 0000001 112245555555 9999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.1e-12 Score=120.75 Aligned_cols=113 Identities=27% Similarity=0.408 Sum_probs=76.4
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............++..|+|||.......+.++||||||++++|++||+.|++..... .. ..
T Consensus 141 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~-----~~ 212 (257)
T cd08223 141 IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SL-----VY 212 (257)
T ss_pred EEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HH-----HH
Confidence 34689999987754333333456888999999999888999999999999999999999997531100 00 00
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+....++........++.++++ .|++.+|++||+|.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 213 RIIEGKLPPMPKDYSPELGELIA---TMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHhcCCCCCccccCHHHHHHHH---HHhccCcccCCCHHHHhc
Confidence 11111111111112245555555 999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.4e-12 Score=120.55 Aligned_cols=117 Identities=26% Similarity=0.320 Sum_probs=76.7
Q ss_pred ccccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
...+|||+++.+...... .....++..|++||+......+.++||||||++++|+++ |+.|+....... ..
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~--- 224 (272)
T cd05075 151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY--- 224 (272)
T ss_pred EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---
Confidence 346899999876432211 112345667999999988889999999999999999999 788874321100 00
Q ss_pred ccccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..+... ....+ ....+.+.++ ...|++.+|++||+|.|+++.|+.+
T Consensus 225 --~~~~~~~~~~~~-~~~~~~~~~l---i~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 --DYLRQGNRLKQP-PDCLDGLYSL---MSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --HHHHcCCCCCCC-CCCCHHHHHH---HHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000 01101 1112334444 4499999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.8e-12 Score=120.72 Aligned_cols=118 Identities=25% Similarity=0.342 Sum_probs=77.5
Q ss_pred CccccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcc
Q 010736 368 NNITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~ 444 (502)
....+|||+++.+..... ......++..|+|||.......+.++|||||||+++|++| |+.|+....... .
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~--- 230 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---V--- 230 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---H---
Confidence 345689999886643221 1123346788999999988889999999999999999999 888874211100 0
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
...+.+............++..+++ .|++.+|++||++.|+++.|++
T Consensus 231 --~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 231 --LKFVIDGGHLDLPENCPDKLLELMR---MCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --HHHHhcCCCCCCCCCCCHHHHHHHH---HHcCCChhhCCCHHHHHHHhcC
Confidence 0001111111011112344555555 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.2e-12 Score=132.87 Aligned_cols=112 Identities=27% Similarity=0.436 Sum_probs=76.3
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++.+..... ......||.+|+|||+.....++.++|||||||+++||+||+.|+...... . ..
T Consensus 209 kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~-----~~ 280 (478)
T PTZ00267 209 KLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---E-----IM 280 (478)
T ss_pred EEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---H-----HH
Confidence 3689999987653221 123456999999999999889999999999999999999999997521110 0 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+..............++..+++ .|++.+|++||++.+++.
T Consensus 281 ~~~~~~~~~~~~~~~s~~~~~li~---~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 281 QQVLYGKYDPFPCPVSSGMKALLD---PLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhCCCCCCCccCCHHHHHHHH---HHhccChhhCcCHHHHHh
Confidence 111111111011122245666666 999999999999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.7e-12 Score=119.51 Aligned_cols=116 Identities=23% Similarity=0.387 Sum_probs=76.9
Q ss_pred ccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 371 TGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
.+|||+++.+...... .+...++..|+|||.......+.++|||||||+++|+++ |+.|+..............
T Consensus 136 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-- 213 (257)
T cd05115 136 ISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-- 213 (257)
T ss_pred eccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC--
Confidence 5899999876433221 112233568999999888888999999999999999996 9999753221100000000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.. -+..+ ....+++.+++. .||..+|++||+|.+|.+.|+..
T Consensus 214 -~~--~~~~~---~~~~~~l~~li~---~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 -GK--RLDCP---AECPPEMYALMK---DCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CC--CCCCC---CCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHhhh
Confidence 00 01111 112356666666 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.6e-12 Score=123.46 Aligned_cols=118 Identities=25% Similarity=0.399 Sum_probs=78.4
Q ss_pred ccccccCcccccCCCCCCcc--cccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSNWT--GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~--~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++.+.......+ ...++..|++||+......+.++|||||||+++|++| |+.|++...........
T Consensus 148 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~--- 224 (316)
T cd05108 148 VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--- 224 (316)
T ss_pred EEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---
Confidence 35799999998754332221 2234668999999998889999999999999999998 99997532110000000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
. .+...+.+. .... .+.++...|++.+|++||+|.+++..+...
T Consensus 225 --~--~~~~~~~~~-~~~~---~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 225 --E--KGERLPQPP-ICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred --h--CCCCCCCCC-CCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 001111111 1112 344555699999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.8e-12 Score=121.24 Aligned_cols=115 Identities=24% Similarity=0.407 Sum_probs=76.7
Q ss_pred ccccccCcccccCCCC--CCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++.+.... .......++..|++||+......+.++||||||++++||+| |+.|+......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--------- 233 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------- 233 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence 3468999998764322 11223345678999999988889999999999999999999 88886421110
Q ss_pred ccccccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 446 ALDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 446 ~~~~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
.+.+.++. .+..+ ....+++..++. .|++.+|++||++.+|.++|+.
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~li~---~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMVRKRQLLPCS-EDCPPRMYSLMT---ECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcCCcCCCC-CCCCHHHHHHHH---HHcccCcccCcCHHHHHHHhhc
Confidence 00111111 01111 112244555555 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.8e-12 Score=121.47 Aligned_cols=119 Identities=24% Similarity=0.337 Sum_probs=79.2
Q ss_pred ccccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
...+|||+++.+...... .....++..|+|||+......+.++||||||++++|++| |+.|++...... +..
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~-- 230 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA-- 230 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH--
Confidence 346899999866433221 122446778999999988889999999999999999999 999975321111 000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
....-. ..... ....+++.++++ .|+..+|++||++.||+++|+...
T Consensus 231 ~~~~~~--~~~~~-~~~~~~~~~li~---~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 231 YLKDGY--RLAQP-INCPDELFAVMA---CCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHHcCC--CCCCC-CcCCHHHHHHHH---HHcCCChhhCCCHHHHHHHHHHHH
Confidence 000000 11111 111244555554 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.3e-12 Score=119.41 Aligned_cols=117 Identities=26% Similarity=0.439 Sum_probs=77.8
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
...+|||+++....... ......++..|++||+......+.++|+|||||+++|++| |+.|+....... ... .
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~--~ 215 (260)
T cd05069 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLE--Q 215 (260)
T ss_pred EEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--H
Confidence 45689999987643221 1122345678999999988889999999999999999999 888874321100 000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
......+..+ .....++.++++ .|++.+|++||+|++|.+.|++
T Consensus 216 ~~~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 216 VERGYRMPCP---QGCPESLHELMK---LCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHcCCCCCCC---cccCHHHHHHHH---HHccCCcccCcCHHHHHHHHhc
Confidence 0000111111 112245555655 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.7e-12 Score=125.00 Aligned_cols=109 Identities=25% Similarity=0.353 Sum_probs=73.3
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............||..|+|||...+...+.++|||||||+++||+||+.|+..... ... ..
T Consensus 132 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~~-----~~ 203 (312)
T cd05585 132 IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NEM-----YR 203 (312)
T ss_pred EEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---HHH-----HH
Confidence 3468999998754433333456799999999999988899999999999999999999999752110 000 01
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~ 489 (502)
.+......-+ ....+++.++++ .|++.+|++||+..+
T Consensus 204 ~~~~~~~~~~-~~~~~~~~~li~---~~L~~dp~~R~~~~~ 240 (312)
T cd05585 204 KILQEPLRFP-DGFDRDAKDLLI---GLLSRDPTRRLGYNG 240 (312)
T ss_pred HHHcCCCCCC-CcCCHHHHHHHH---HHcCCCHHHcCCCCC
Confidence 1111111101 112345666666 999999999986433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.8e-12 Score=120.32 Aligned_cols=119 Identities=26% Similarity=0.448 Sum_probs=77.9
Q ss_pred CccccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCc
Q 010736 368 NNITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~ 443 (502)
+-..+|||+++.+...... .....++.+|++||+......+.++||||||++++||+| |+.|++...... ...
T Consensus 135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~ 211 (257)
T cd05040 135 KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK 211 (257)
T ss_pred EEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 3346899999877542211 112457789999999998889999999999999999999 999975321110 000
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
.. .. .......+ ......+.+++. .|++.+|++||++.||++.|.+
T Consensus 212 ~~--~~-~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 212 KI--DK-EGERLERP-EACPQDIYNVML---QCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred HH--Hh-cCCcCCCC-ccCCHHHHHHHH---HHCCCCcccCCCHHHHHHHhcC
Confidence 00 00 00111111 111234444444 9999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.8e-12 Score=124.61 Aligned_cols=118 Identities=25% Similarity=0.446 Sum_probs=75.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCC-Ccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSL-NTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~-~~~~~~~ 448 (502)
..+|||+++.............||..|+|||...+...+.++|+|||||+++||+||+.|++.......... ..+....
T Consensus 136 kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~ 215 (329)
T cd05588 136 KLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ 215 (329)
T ss_pred EECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH
Confidence 368999987532222223346789999999999988899999999999999999999999874322111100 0000011
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC------HHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT------MKIVS 491 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~------m~~v~ 491 (502)
.+.......+. ....++..+++ .|++.+|++||+ +.||+
T Consensus 216 ~~~~~~~~~p~-~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 216 VILEKQIRIPR-SLSVKASSVLK---GFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred HHHcCCCCCCC-CCCHHHHHHHH---HHhccCHHHcCCCCCCCCHHHHh
Confidence 11221111111 12245566666 999999999997 56664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.18 E-value=1e-11 Score=122.68 Aligned_cols=111 Identities=27% Similarity=0.372 Sum_probs=75.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||...+...+.++|||||||+++||+||+.|+...... .......
T Consensus 136 kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~--- 209 (325)
T cd05594 136 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELIL--- 209 (325)
T ss_pred EEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHh---
Confidence 4689999886543333334467999999999998888999999999999999999999997421110 0000000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
.....++. ....++.++++ .|++.+|++|+ +.+|+++
T Consensus 210 ~~~~~~p~---~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 210 MEEIRFPR---TLSPEAKSLLS---GLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred cCCCCCCC---CCCHHHHHHHH---HHhhcCHHHhCCCCCCCHHHHhc
Confidence 01111111 12345667777 89999999996 8888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-12 Score=118.21 Aligned_cols=122 Identities=25% Similarity=0.341 Sum_probs=82.6
Q ss_pred eecCCccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 364 NISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 364 ~l~~N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
+-.++-..|||||+|++..+..-.....||+.||.||......++.|+||||.||+++||..=+.|+... +..++..
T Consensus 162 ~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~ 238 (375)
T KOG0591|consen 162 TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCK 238 (375)
T ss_pred cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHH
Confidence 3333444699999999976655445678999999999999999999999999999999999999997421 1111111
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
. +..---|.++. ....+++..++. .|.+++|+.||+....+..+.
T Consensus 239 K--I~qgd~~~~p~--~~YS~~l~~li~---~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 239 K--IEQGDYPPLPD--EHYSTDLRELIN---MCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred H--HHcCCCCCCcH--HHhhhHHHHHHH---HHccCCcccCCCcchHHHHHH
Confidence 1 11111122321 112234444444 999999999999655555443
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.3e-12 Score=121.01 Aligned_cols=120 Identities=24% Similarity=0.398 Sum_probs=74.7
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccccc-------eecccceeeeeceeeeehhc-CCCCCCcccCCCC
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTM-------KITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSS 438 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~-------~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~ 438 (502)
-..+|||+++....... ......++..|+|||+.... ..+.++|+||||++++|++| |+.|+........
T Consensus 139 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 139 VKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred EEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 34689999876533221 11234567889999987532 35789999999999999996 9999753221110
Q ss_pred CCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 439 PSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 439 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
...........+.+|.+.. ...+.+..+++ .|+ .+|++||+++||++.|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~---~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 219 LTYTVREQQLKLPKPRLKL---PLSDRWYEVMQ---FCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHhhcccCCCCCCccCC---CCChHHHHHHH---HHh-cCcccCCCHHHHHHHhc
Confidence 0000000111222333221 12345666776 898 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.6e-12 Score=124.61 Aligned_cols=110 Identities=25% Similarity=0.352 Sum_probs=74.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||...+...+.++|||||||+++||+||+.|+...... ..... +..
T Consensus 136 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~--i~~ 210 (316)
T cd05592 136 KIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDS--ILN 210 (316)
T ss_pred EEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHH--HHc
Confidence 3689999986543333334567999999999998888999999999999999999999997532110 00000 000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~ 491 (502)
..+.++ .....++..+++ .|++.+|++||++.+.+
T Consensus 211 -~~~~~~---~~~~~~~~~ll~---~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 211 -DRPHFP---RWISKEAKDCLS---KLFERDPTKRLGVDGDI 245 (316)
T ss_pred -CCCCCC---CCCCHHHHHHHH---HHccCCHHHcCCChHHH
Confidence 011111 112345666666 99999999999986433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.9e-12 Score=123.32 Aligned_cols=112 Identities=25% Similarity=0.355 Sum_probs=76.1
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............||..|+|||......++.++||||+||+++||+||+.|+...... ........
T Consensus 134 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~~~~- 209 (323)
T cd05571 134 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILM- 209 (323)
T ss_pred EEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHHHHc-
Confidence 34689999986433333334567999999999998888999999999999999999999997421110 00000000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
-+..++. ...+++.++++ .|++.+|++|| +..|+++
T Consensus 210 --~~~~~p~---~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 210 --EEIRFPR---TLSPEAKSLLA---GLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --CCCCCCC---CCCHHHHHHHH---HHccCCHHHcCCCCCCCHHHHHc
Confidence 1112221 12355667777 99999999999 7777753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.4e-12 Score=119.16 Aligned_cols=117 Identities=26% Similarity=0.450 Sum_probs=76.4
Q ss_pred ccccccCcccccCCCCC-Ccc--cccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcc
Q 010736 369 NITGDFGIAKFLKPDSS-NWT--GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~--~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~ 444 (502)
-..+|||+++....... ..+ ....+..|++||+......+.++|||||||+++|++| |+.|+...... ...
T Consensus 146 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~-- 220 (268)
T cd05063 146 CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVM-- 220 (268)
T ss_pred EEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH--
Confidence 34689999887643221 111 1223457999999988888999999999999999998 99997432110 000
Q ss_pred cccccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 445 IALDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 445 ~~~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..+... ..+.. ..... .+.+++..|++.+|++||+|.+|++.|+++
T Consensus 221 ---~~i~~~~~~~~~-~~~~~---~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 221 ---KAINDGFRLPAP-MDCPS---AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---HHHhcCCCCCCC-CCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011110 11101 11112 345666699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.4e-12 Score=121.46 Aligned_cols=118 Identities=25% Similarity=0.388 Sum_probs=77.4
Q ss_pred ccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.+|||+++........ .....++..|++||+..+...+.++||||||++++||+| |+.|++..... .+.. ..
T Consensus 168 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~--~~ 242 (290)
T cd05045 168 ISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---RLFN--LL 242 (290)
T ss_pred eccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH--HH
Confidence 5899999866432221 122345678999999888889999999999999999999 99887421110 0000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
.....+..+ ....+++..+ +..|++.+|++||+|+|++++|+..-.
T Consensus 243 ~~~~~~~~~---~~~~~~~~~~---i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 243 KTGYRMERP---ENCSEEMYNL---MLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred hCCCCCCCC---CCCCHHHHHH---HHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 000111111 1112344444 449999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.1e-11 Score=120.80 Aligned_cols=116 Identities=25% Similarity=0.323 Sum_probs=74.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++....... ......+..|++||+......+.++|||||||+++||+| |+.|+....... ... ...
T Consensus 159 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~--~~~ 232 (297)
T cd05089 159 KIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE--KLP 232 (297)
T ss_pred EECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH--HHh
Confidence 4689999875432111 111223457999999988888999999999999999998 999974321100 000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.-..+..+ .....++.+++. .|++.+|.+||++.+|+++|+..
T Consensus 233 ~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 233 QGYRMEKP---RNCDDEVYELMR---QCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred cCCCCCCC---CCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHH
Confidence 00111111 112234444444 99999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.2e-12 Score=122.45 Aligned_cols=117 Identities=26% Similarity=0.393 Sum_probs=77.2
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.-..+|||+++.............|+..|+|||+......+.++|||||||+++|++||+.|+....... .+.. ...
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~-~~~ 230 (296)
T cd06654 154 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL-IAT 230 (296)
T ss_pred CEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH-Hhc
Confidence 3457899998876543333334568889999999988888999999999999999999999975322110 0000 000
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
...+.+..+ ......+..++. .|+..+|++||++.||++.
T Consensus 231 --~~~~~~~~~-~~~~~~l~~li~---~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 231 --NGTPELQNP-EKLSAIFRDFLN---RCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCCCCCCCc-cccCHHHHHHHH---HHCcCCcccCcCHHHHhhC
Confidence 001111111 112234455554 9999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.8e-12 Score=123.03 Aligned_cols=109 Identities=27% Similarity=0.379 Sum_probs=70.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++.............||..|+|||..... ..+.++||||+||+++||+||+.|+...... ........
T Consensus 136 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~~~i~~- 211 (330)
T cd05586 136 ALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMYRNIAF- 211 (330)
T ss_pred EEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHHHHHHc-
Confidence 468999987653332233356799999999988654 4789999999999999999999997421110 00000000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~ 489 (502)
.+.+++.. ...+++..+++ .|++.+|++||+..+
T Consensus 212 --~~~~~~~~--~~~~~~~~li~---~~L~~~P~~R~~~~~ 245 (330)
T cd05586 212 --GKVRFPKN--VLSDEGRQFVK---GLLNRNPQHRLGAHR 245 (330)
T ss_pred --CCCCCCCc--cCCHHHHHHHH---HHcCCCHHHCCCCCC
Confidence 01112111 12245566666 999999999995443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.5e-12 Score=119.70 Aligned_cols=114 Identities=23% Similarity=0.329 Sum_probs=73.1
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
.+|||+++...... .......+..|+|||+......+.++|||||||+++||+| |+.|+....... . ...
T Consensus 153 l~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~-----~~~ 223 (270)
T cd05047 153 IADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L-----YEK 223 (270)
T ss_pred ECCCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---H-----HHH
Confidence 68999886432111 1111233567999999988889999999999999999997 999974221100 0 000
Q ss_pred ccC-CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 450 MLD-PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 450 ~~d-~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+.. .....+ .....++. +++..|+..+|.+||++.|++++|+.+
T Consensus 224 ~~~~~~~~~~-~~~~~~~~---~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 224 LPQGYRLEKP-LNCDDEVY---DLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HhCCCCCCCC-CcCCHHHH---HHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 000 011101 11123344 445599999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.5e-12 Score=119.13 Aligned_cols=115 Identities=29% Similarity=0.462 Sum_probs=74.9
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++....... ......++..|++||+.....++.++|||||||+++||+| |+.|+....... ... .+
T Consensus 140 kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~--~~ 214 (256)
T cd05113 140 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE--KV 214 (256)
T ss_pred EECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH--HH
Confidence 4689999887643322 1123345678999999988889999999999999999999 999975322110 000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
.....+..+ ....+++.+++. .|++.+|++||++.++++.|+
T Consensus 215 ~~~~~~~~~---~~~~~~~~~li~---~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 215 SQGLRLYRP---HLASEKVYAIMY---SCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred hcCCCCCCC---CCCCHHHHHHHH---HHcCCCcccCCCHHHHHHhhC
Confidence 000000011 011234445444 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.1e-11 Score=119.71 Aligned_cols=126 Identities=24% Similarity=0.349 Sum_probs=76.8
Q ss_pred ccccccCcccccCCCCCCc---ccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc-
Q 010736 369 NITGDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD- 444 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~---~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~- 444 (502)
...+|||+++.+....... ....++..|++||+..+...+.++|+|||||+++|++||+.|...............
T Consensus 147 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05081 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK 226 (284)
T ss_pred EEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccc
Confidence 3468999998775432211 112234469999999888899999999999999999999876432111000000000
Q ss_pred ------cccccccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 445 ------IALDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 445 ------~~~~~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
....+.+.. ..+. ......++.+ +...|++.+|++||+|+||+++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 227 QGQMIVYHLIELLKNNGRLPA-PPGCPAEIYA---IMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred ccccchHHHHHHHhcCCcCCC-CCCCCHHHHH---HHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000011111 1111 1112234444 445999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.17 E-value=7e-12 Score=121.93 Aligned_cols=121 Identities=23% Similarity=0.336 Sum_probs=75.0
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc--CCCCCCcccCCCCCCCCcc
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK--GKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt--g~~p~~~~~~~~~~~~~~~ 444 (502)
-..+|||+++.+..... ......++..|+|||+......+.++|||||||+++|++| |..|+........ +...
T Consensus 169 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~--~~~~ 246 (296)
T cd05051 169 IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV--IENA 246 (296)
T ss_pred eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH--HHHH
Confidence 34689999887643221 1123445778999999988889999999999999999998 5666542211100 0000
Q ss_pred cccccccCCC--CCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 445 IALDEMLDPR--LPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 445 ~~~~~~~d~~--l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
.....-.+.. ...+ ....++ +.+++..|++.+|++||+|.||++.|+
T Consensus 247 ~~~~~~~~~~~~~~~~-~~~~~~---l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 247 GHFFRDDGRQIYLPRP-PNCPKD---IYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HhccccccccccCCCc-cCCCHH---HHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 0000000000 0001 111233 455556999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.1e-11 Score=118.05 Aligned_cols=116 Identities=27% Similarity=0.429 Sum_probs=75.7
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++.+..... ......++..|+|||+......+.++|+||||++++|++| |+.|+...... .... .+
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~--~~ 216 (260)
T cd05070 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLE--QV 216 (260)
T ss_pred EeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHH--HH
Confidence 4689999987653221 1112335668999999988889999999999999999999 88887432110 0000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
.....+..+ .....++.+++. .|++.+|++||+|+++.+.|+.
T Consensus 217 ~~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ERGYRMPCP---QDCPISLHELML---QCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HcCCCCCCC---CcCCHHHHHHHH---HHcccCcccCcCHHHHHHHHhc
Confidence 000011111 111234444444 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.8e-12 Score=124.75 Aligned_cols=124 Identities=28% Similarity=0.532 Sum_probs=85.6
Q ss_pred CCCeeeecCCcc--------ccccCcccccCCCCCCcc--cccccccccCcccccc-----------ceecccceeeeec
Q 010736 359 KLGALNISRNNI--------TGDFGIAKFLKPDSSNWT--GFAGTYGYIAPELAYT-----------MKITEKCDVYSFG 417 (502)
Q Consensus 359 ~L~~L~l~~N~l--------~~dfGl~~ll~~~~~~~~--~~~gt~gy~aPE~~~~-----------~~~s~k~Dvysfg 417 (502)
++.|=||+--|+ .-|||+|+.++.++.... ...||+.||+||.... .++..++||||.|
T Consensus 480 gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 480 GIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred ceeecCCCcccEEEEeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 455666666554 359999999987765432 3579999999998743 3577899999999
Q ss_pred eeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCC--CCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 418 VLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRL--PVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 418 v~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l--~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
|++++|+.||.|+...... + ..+..+.||.- .-+.-....+++.|++ .|.+.+|.+||++.|+++
T Consensus 560 CILYqMvYgktPf~~~~n~----~---aKl~aI~~P~~~Iefp~~~~~~~li~~mK---~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQIINQ----I---AKLHAITDPNHEIEFPDIPENDELIDVMK---CCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hHHHHHHhcCCchHHHHHH----H---HHHHhhcCCCccccccCCCCchHHHHHHH---HHHhcCcccCCCcHHHhc
Confidence 9999999999998532211 0 11233444422 1111112234667777 999999999999999864
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.16 E-value=8.5e-12 Score=118.64 Aligned_cols=114 Identities=22% Similarity=0.346 Sum_probs=75.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++...... ....++.+|+|||+......+.++||||||++++||+| |+.|+..... ..... .+.
T Consensus 142 kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~--~~~ 213 (256)
T cd05082 142 KVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP--RVE 213 (256)
T ss_pred EecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHH--HHh
Confidence 468999988654322 22345678999999988889999999999999999998 8988642110 00000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.-..+... .....++..++. .|++.+|++||+|++++++|+++
T Consensus 214 ~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 214 KGYKMDAP---DGCPPVVYDVMK---QCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred cCCCCCCC---CCCCHHHHHHHH---HHhcCChhhCcCHHHHHHHHhcC
Confidence 00011111 112234555555 99999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.1e-11 Score=121.16 Aligned_cols=119 Identities=29% Similarity=0.417 Sum_probs=78.6
Q ss_pred ccccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++.+...... .....++..|++||+..+...+.++|||||||+++|++| |+.|+..........+..
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-- 225 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-- 225 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Confidence 346899999877533221 123345678999999988889999999999999999998 888874321110000000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.....+.+. . +..++.++...|+..+|++||+|+||+++++++.
T Consensus 226 -----~~~~~~~~~-~---~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 226 -----KGERLPQPP-I---CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -----CCCCCCCCC-C---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001111111 1 1123445556999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.7e-11 Score=118.55 Aligned_cols=115 Identities=25% Similarity=0.387 Sum_probs=73.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++.+...........|+.+|+|||+.. ....+.++|||||||+++|++||+.|+....... ....
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~- 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK- 240 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh-
Confidence 3689999887654332333456889999999874 2346889999999999999999999975321110 0000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
......+.+..+. ...+++..++. .|++.+|++||++.||++.
T Consensus 241 --~~~~~~~~~~~~~-~~~~~~~~li~---~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 --IPRNPPPTLHQPE-LWSNEFNDFIR---KCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --ccccCCCcccCCC-CcCHHHHHHHH---HHccCCcccCCCHHHHhhc
Confidence 0001111111111 11234555555 9999999999999999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.1e-11 Score=120.14 Aligned_cols=120 Identities=24% Similarity=0.332 Sum_probs=78.2
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....++..|++||+......+.++|||||||+++|+++ |+.|+...... ..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------QV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence 46899999876432211 112234678999999988889999999999999999999 68786421110 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh-cCC
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS-APS 500 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~-~~~ 500 (502)
...+.+...........+++.++++ .|++.+|++||+|.|+++.+++. -|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 231 LKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 1111111111111112244555555 99999999999999999999873 444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.1e-11 Score=117.82 Aligned_cols=118 Identities=25% Similarity=0.376 Sum_probs=77.4
Q ss_pred cccccCcccccCCCCCCc---ccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~---~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++.+....... ....++..|++||.......+.++|+|||||+++|++| |+.|++...........
T Consensus 135 kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~--- 211 (257)
T cd05060 135 KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML--- 211 (257)
T ss_pred EeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---
Confidence 468999998764332211 12234567999999988889999999999999999998 99997532211000000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
........+ .....++.+ +...|+..+|++||++.+|++.|+...
T Consensus 212 --~~~~~~~~~---~~~~~~l~~---li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 212 --ESGERLPRP---EECPQEIYS---IMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --HcCCcCCCC---CCCCHHHHH---HHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 000000111 111234444 444999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.8e-11 Score=118.13 Aligned_cols=127 Identities=23% Similarity=0.293 Sum_probs=79.3
Q ss_pred CccccccCcccccCCCCCCc---ccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCC--CCC
Q 010736 368 NNITGDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSP--SLN 442 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~---~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~--~~~ 442 (502)
.-..+|||+++......... ....++..|++||+......+.++||||||++++||+||+.|+......... ...
T Consensus 147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 226 (284)
T cd05038 147 LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA 226 (284)
T ss_pred CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc
Confidence 34578999998775322111 1234456799999998888999999999999999999999986532111100 000
Q ss_pred c----ccccccccCCCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 443 T----DIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 443 ~----~~~~~~~~d~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
. .....+.+......+ .....+ ++.+++..|+..+|++||+|.||+++|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 227 QGQMIVTRLLELLKEGERLPRPPSCPD---EVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccHHHHHHHHHcCCcCCCCccCCH---HHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0 000011111111100 011123 355566699999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.3e-11 Score=116.78 Aligned_cols=116 Identities=19% Similarity=0.297 Sum_probs=74.6
Q ss_pred ccccccCcccccCCCCCCcc-cccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSSNWT-GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~-~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
-..+|||+++.......... ...++..|+|||+......+.++||||||++++|++| |+.|+....... ... .
T Consensus 132 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~--~ 206 (250)
T cd05085 132 LKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---ARE--Q 206 (250)
T ss_pred EEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH--H
Confidence 35689999876543221111 2234568999999988889999999999999999999 898974321100 000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
+........+ ...... +.++...|+..+|++||+|.||+++|.
T Consensus 207 ~~~~~~~~~~---~~~~~~---~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 207 VEKGYRMSCP---QKCPDD---VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHcCCCCCCC---CCCCHH---HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0000111111 111233 444555999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.3e-11 Score=121.71 Aligned_cols=112 Identities=24% Similarity=0.384 Sum_probs=75.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............|+..|+|||+......+.++|||||||+++||+||+.|+...... ....
T Consensus 139 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~ 210 (323)
T cd05584 139 VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTID 210 (323)
T ss_pred EEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHH
Confidence 34789999886533333333467999999999998888899999999999999999999997532110 0011
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
.+.......+. ....++..+++ .|++.+|++|| ++.++.+
T Consensus 211 ~~~~~~~~~~~-~~~~~~~~li~---~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 211 KILKGKLNLPP-YLTPEARDLLK---KLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHcCCCCCCC-CCCHHHHHHHH---HHcccCHhHcCCCCCCCHHHHhc
Confidence 11111111111 12245666666 99999999999 6666643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-11 Score=116.87 Aligned_cols=118 Identities=29% Similarity=0.378 Sum_probs=78.7
Q ss_pred CCccccccCcccccCCCC--CCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCc
Q 010736 367 RNNITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 367 ~N~l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~ 443 (502)
++-..+|||.++...... .......++..|+|||.......+.++||||+|++++|++| |+.|++...... .
T Consensus 142 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~-- 216 (262)
T cd00192 142 LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---V-- 216 (262)
T ss_pred CcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---H--
Confidence 344578999998775432 12234567889999999988889999999999999999999 699875431110 0
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
...+.+............++..+++ .|++.+|++||++.|+++.|+
T Consensus 217 ---~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 217 ---LEYLRKGYRLPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---HHHHHcCCCCCCCccCChHHHHHHH---HHccCCcccCcCHHHHHHhhC
Confidence 0111111100001112244555555 999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.1e-11 Score=116.73 Aligned_cols=124 Identities=22% Similarity=0.314 Sum_probs=76.2
Q ss_pred cccccCcccccCCCCC---CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCC-------CC
Q 010736 370 ITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS-------SP 439 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~-------~~ 439 (502)
..+|||+++.+..... ......++..|+|||+......+.++||||||++++|++||+.|........ ..
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05079 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG 228 (284)
T ss_pred EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc
Confidence 4689999987643221 1123456677999999888888999999999999999999887642110000 00
Q ss_pred CCCcccccccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 440 SLNTDIALDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 440 ~~~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..........+.+. ..+.+ ....+++.+++ ..|++.+|++||+++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li---~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 229 QMTVTRLVRVLEEGKRLPRP-PNCPEEVYQLM---RKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccHHHHHHHHHcCccCCCC-CCCCHHHHHHH---HHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000000011 11111 11223444444 499999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.9e-11 Score=116.78 Aligned_cols=117 Identities=25% Similarity=0.407 Sum_probs=76.3
Q ss_pred ccccccCcccccCCCCCC-cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSSN-WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~-~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
-..+|||+++.+...... .....++..|++||+.....++.++||||||++++|++| |+.|++..... .... .
T Consensus 141 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~--~ 215 (262)
T cd05071 141 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD--Q 215 (262)
T ss_pred EEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH--H
Confidence 346899999876532221 112345678999999988889999999999999999999 78786422110 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
+......... ....+. +.++...|++.+|++||+++++.+.|++
T Consensus 216 ~~~~~~~~~~---~~~~~~---l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 216 VERGYRMPCP---PECPES---LHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred HhcCCCCCCc---cccCHH---HHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0000000110 011233 4455559999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.14 E-value=1e-11 Score=118.02 Aligned_cols=113 Identities=22% Similarity=0.354 Sum_probs=75.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............|+..|+|||+..+...+.++|+|||||+++|++||+.|+..... .. ...
T Consensus 140 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~-----~~~ 211 (256)
T cd08218 140 IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KN-----LVL 211 (256)
T ss_pred EEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---HH-----HHH
Confidence 3468999988764432222234578899999999888899999999999999999999999752110 00 001
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
++.....+........++.++++ .|++.+|.+||+|+||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 212 KIIRGSYPPVSSHYSYDLRNLVS---QLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHhcCCCCCCcccCCHHHHHHHH---HHhhCChhhCcCHHHHhh
Confidence 11111111001112245556665 999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.1e-11 Score=118.21 Aligned_cols=114 Identities=31% Similarity=0.432 Sum_probs=77.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............++..|++||.......+.++|+||||++++|++||+.|++..... .+.. .+.
T Consensus 149 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~--~~~ 223 (265)
T cd08217 149 VKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLAS--KIK 223 (265)
T ss_pred EEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHH--HHh
Confidence 34689999887765443233456888999999998888999999999999999999999997532110 0000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
....+.++ .....++..+++ .|++.+|++||+|+||++.
T Consensus 224 ~~~~~~~~---~~~~~~~~~l~~---~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 EGKFRRIP---YRYSSELNEVIK---SMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCCCCCCc---cccCHHHHHHHH---HHccCCcccCCCHHHHhhC
Confidence 00111111 112244555555 9999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.8e-11 Score=117.97 Aligned_cols=114 Identities=25% Similarity=0.427 Sum_probs=75.7
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............++..|++||+..+...+.++|+|||||+++||+||+.|+........... ..
T Consensus 140 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-----~~ 214 (277)
T cd06640 140 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-----IP 214 (277)
T ss_pred EEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-----hh
Confidence 4468999998765433323345678899999999888899999999999999999999999753211100000 00
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
....+.+. ......+.++++ .|++.+|++||+++||++.
T Consensus 215 ~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 215 KNNPPTLT---GEFSKPFKEFID---ACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred cCCCCCCc---hhhhHHHHHHHH---HHcccCcccCcCHHHHHhC
Confidence 00011111 112233444444 9999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.14 E-value=9.9e-12 Score=120.51 Aligned_cols=62 Identities=24% Similarity=0.311 Sum_probs=51.4
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++..... .......|+..|+|||.......+.++|||||||+++||+||+.|+.
T Consensus 149 ~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 149 IKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred EEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 346899999876543 22334678999999999988888999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-11 Score=122.65 Aligned_cols=117 Identities=15% Similarity=0.212 Sum_probs=76.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.... ......|+..|+|||+..+..++.++|||||||+++||+||+.|++............. ....
T Consensus 141 kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~ 216 (333)
T cd05600 141 KLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY-WKET 216 (333)
T ss_pred EEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh-cccc
Confidence 3689999986643 22345789999999999988999999999999999999999999853211100000000 0000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
...|....+.....+++..+++ .|+...|++||+++|+++.
T Consensus 217 ~~~~~~~~~~~~~s~~~~~li~---~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 217 LQRPVYDDPRFNLSDEAWDLIT---KLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCCCCCccccccCHHHHHHHH---HHhhChhhhcCCHHHHHhC
Confidence 0111111000012345666766 8999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-11 Score=117.89 Aligned_cols=118 Identities=19% Similarity=0.240 Sum_probs=74.2
Q ss_pred ccccccCcccccCCCCCC-cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSSN-WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~-~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
...+|||.+......... .....++..|+|||.......+.++|||||||+++|+++ |+.|+....... ... .
T Consensus 146 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~--~ 220 (266)
T cd05064 146 CKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK--A 220 (266)
T ss_pred EEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH--H
Confidence 345788877654322111 112334578999999988899999999999999999775 999975321110 000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+.+...+..+ ......+.+ +...||+.+|++||+|.|+.+.|+..
T Consensus 221 ~~~~~~~~~~---~~~~~~~~~---li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 VEDGFRLPAP---RNCPNLLHQ---LMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHCCCCCCCC---CCCCHHHHH---HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0010111111 112233444 44499999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.8e-11 Score=118.07 Aligned_cols=118 Identities=25% Similarity=0.390 Sum_probs=77.6
Q ss_pred cccccCcccccCCCCCCc--ccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNW--TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~--~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+....... ....++..|++||......++.++||||||++++|++| |+.|++..........
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----- 223 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL----- 223 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----
Confidence 468999998875432211 12334678999999988889999999999999999999 8898753221100000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
+.....+..+ .....++. ++...|++.+|++||++.|+++.|+..+
T Consensus 224 ~~~~~~~~~~---~~~~~~~~---~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 224 LEKGERLPQP---PICTIDVY---MIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HHCCCcCCCC---ccCCHHHH---HHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0000000111 01113344 4444999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.6e-12 Score=120.73 Aligned_cols=114 Identities=25% Similarity=0.299 Sum_probs=75.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....|+.+|+|||......++.++|||||||+++||+||+.|++........ ......
T Consensus 142 kl~Dfg~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~----~~~~~~ 216 (285)
T cd05631 142 RISDLGLAVQIPEGET-VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR----EEVDRR 216 (285)
T ss_pred EEeeCCCcEEcCCCCe-ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH----HHHHHH
Confidence 3689999987643322 23456899999999999889999999999999999999999998632211000 000001
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-----HHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-----MKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-----m~~v~~ 492 (502)
+..+...-+ ....+++..+++ .|++.+|++||+ ++|+.+
T Consensus 217 ~~~~~~~~~-~~~s~~~~~li~---~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 217 VKEDQEEYS-EKFSEDAKSICR---MLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred hhcccccCC-ccCCHHHHHHHH---HHhhcCHHHhcCCCCCCHHHHhc
Confidence 111111000 112245666666 999999999997 777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.1e-12 Score=121.63 Aligned_cols=115 Identities=23% Similarity=0.382 Sum_probs=76.1
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............++..|++||.......+.++|||||||+++|++||+.|+........ . . ...
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~-~--~~~ 228 (296)
T cd06655 154 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L-Y--LIA 228 (296)
T ss_pred EEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-H--HHH
Confidence 3468999988765443333345688899999999888899999999999999999999999753211000 0 0 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...-+.+..+ .....++..+++ .|+..+|++||++.+|++
T Consensus 229 ~~~~~~~~~~-~~~~~~~~~li~---~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 229 TNGTPELQNP-EKLSPIFRDFLN---RCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred hcCCcccCCc-ccCCHHHHHHHH---HHhhcChhhCCCHHHHhh
Confidence 0000111111 112234555555 999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.13 E-value=2e-11 Score=120.11 Aligned_cols=109 Identities=26% Similarity=0.387 Sum_probs=73.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............|+..|+|||.......+.++|||||||+++||+||+.|++...... ...
T Consensus 137 ~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--------~~~ 208 (318)
T cd05582 137 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--------TMT 208 (318)
T ss_pred EEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--------HHH
Confidence 346899999876443333345678999999999988888999999999999999999999975321100 001
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~ 489 (502)
.+.......+ .....++..+++ .|++.+|++||++.+
T Consensus 209 ~i~~~~~~~p-~~~~~~~~~li~---~~l~~~P~~R~~a~~ 245 (318)
T cd05582 209 MILKAKLGMP-QFLSPEAQSLLR---ALFKRNPANRLGAGP 245 (318)
T ss_pred HHHcCCCCCC-CCCCHHHHHHHH---HHhhcCHhHcCCCCC
Confidence 1111111101 112245666776 999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-11 Score=120.95 Aligned_cols=119 Identities=28% Similarity=0.408 Sum_probs=76.7
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ..+...++..|+|||...+...+.++|||||||+++||+| |+.|+..... ......
T Consensus 180 kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~~~~~-- 254 (307)
T cd05098 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EELFKL-- 254 (307)
T ss_pred EECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH--
Confidence 3589999876643211 1112234468999999988888999999999999999998 8888642110 000000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
... ......+ .....++.+++. .|+..+|++||+|.||++.|+++.+
T Consensus 255 ~~~--~~~~~~~-~~~~~~~~~li~---~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 255 LKE--GHRMDKP-SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHc--CCCCCCC-CcCCHHHHHHHH---HHcccChhhCcCHHHHHHHHHHHHH
Confidence 000 0000101 112245555555 9999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.7e-11 Score=118.34 Aligned_cols=116 Identities=23% Similarity=0.338 Sum_probs=74.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
...+|||+++....... .....++..|++||+......+.++|||||||+++|++| |+.|+...... .. .
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~-----~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL-----Y 233 (303)
T ss_pred EEeCccccCcccchhhh-cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HH-----H
Confidence 34789999874322111 111234567999999988888999999999999999998 99997422111 00 0
Q ss_pred ccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 448 DEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 448 ~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..+... ....+ .....++.+++ ..|++.+|++||++.+++++|+.+
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~li---~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQGYRLEKP-LNCDDEVYDLM---RQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcCCcCCCC-CCCCHHHHHHH---HHHcCCChhhCcCHHHHHHHHHHH
Confidence 001000 11001 11123444444 499999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.5e-11 Score=121.55 Aligned_cols=113 Identities=24% Similarity=0.321 Sum_probs=75.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||...+...+.++|||||||+++||+||+.|+...... .. ...
T Consensus 136 kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~-----~~~ 207 (325)
T cd05604 136 VLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EM-----YDN 207 (325)
T ss_pred EEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HH-----HHH
Confidence 3689999876433233334567999999999999888999999999999999999999997521110 00 011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
+....+.... ....++.++++ .|++.+|++||++++.++++
T Consensus 208 ~~~~~~~~~~-~~~~~~~~ll~---~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 208 ILHKPLVLRP-GASLTAWSILE---ELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HHcCCccCCC-CCCHHHHHHHH---HHhccCHHhcCCCCCCHHHH
Confidence 1111111111 12245566666 89999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.12 E-value=2e-11 Score=119.20 Aligned_cols=117 Identities=24% Similarity=0.392 Sum_probs=77.1
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....++..|+|||.......+.++|||||||+++|++| |+.|+....... .
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------~ 252 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------K 252 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--------H
Confidence 36899999866432211 112345678999999988889999999999999999998 999974321110 0
Q ss_pred cccccCCCCC-CCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLP-VPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~-~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..+.++.... .......+++.++++ .|+..+|++||++.||++.|++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~li~---~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 FYKLIKEGYRMAQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHH---HHcCCCchhCcCHHHHHHHHHhh
Confidence 0111111110 000112245555555 99999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.4e-11 Score=116.34 Aligned_cols=116 Identities=28% Similarity=0.448 Sum_probs=75.8
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+..... ......++..|++||+......+.++|||||||+++||+| |+.|+........ .. .
T Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~--~ 225 (269)
T cd05044 151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQ--H 225 (269)
T ss_pred EECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HH--H
Confidence 3589999876532211 1112345678999999998899999999999999999998 9998742211000 00 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
+. .......+ ....+.+.++++ .|+..+|++||+|++|.+.|++
T Consensus 226 ~~--~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 VT--AGGRLQKP-ENCPDKIYQLMT---NCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Hh--cCCccCCc-ccchHHHHHHHH---HHcCCCcccCCCHHHHHHHHhC
Confidence 00 00011111 122345555555 9999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.5e-11 Score=121.25 Aligned_cols=110 Identities=24% Similarity=0.413 Sum_probs=74.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||.......+.++|||||||+++||+||+.|++...... ....
T Consensus 136 kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--------~~~~ 207 (321)
T cd05591 136 KLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--------LFES 207 (321)
T ss_pred EEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--------HHHH
Confidence 46899998764333333345678999999999988889999999999999999999999985321110 0011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-------CHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-------TMKIVS 491 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-------~m~~v~ 491 (502)
+.......+ .....++..+++ .|++.+|++|| ++.++.
T Consensus 208 i~~~~~~~p-~~~~~~~~~ll~---~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 208 ILHDDVLYP-VWLSKEAVSILK---AFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred HHcCCCCCC-CCCCHHHHHHHH---HHhccCHHHcCCCCCCCCCHHHHh
Confidence 111111001 112245666776 89999999999 666664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.8e-11 Score=118.91 Aligned_cols=118 Identities=25% Similarity=0.356 Sum_probs=76.6
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....++..|++||.......+.++|||||||+++|++| |+.|+...... .....
T Consensus 174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~-- 248 (314)
T cd05099 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---ELFKL-- 248 (314)
T ss_pred EEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--
Confidence 46899999876432211 111234467999999988889999999999999999999 88886421110 00000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..+-..+..+ .....++..++. .|+..+|++||++.|+++.|++..
T Consensus 249 ~~~~~~~~~~---~~~~~~l~~li~---~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 249 LREGHRMDKP---SNCTHELYMLMR---ECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHcCCCCCCC---CCCCHHHHHHHH---HHcCCCcccCcCHHHHHHHHHHHH
Confidence 0000000111 112234555554 999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.9e-11 Score=116.25 Aligned_cols=115 Identities=29% Similarity=0.468 Sum_probs=74.8
Q ss_pred ccccccCcccccCCCCCC-cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSSN-WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~-~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
-..+|||+++........ .....++..|++||+......+.++|+||||++++|++| |+.|++...... ... .
T Consensus 139 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~--~ 213 (256)
T cd05059 139 VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE--S 213 (256)
T ss_pred EEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH--H
Confidence 346899998876432211 112234567999999988889999999999999999999 788875321110 000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
......+..+. ....++.+ ++..|+..+|++||+|.||+++|
T Consensus 214 ~~~~~~~~~~~---~~~~~~~~---li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 214 VSAGYRLYRPK---LAPTEVYT---IMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHcCCcCCCCC---CCCHHHHH---HHHHHhcCChhhCcCHHHHHHHh
Confidence 11111111111 11234444 44499999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.2e-11 Score=116.06 Aligned_cols=118 Identities=28% Similarity=0.436 Sum_probs=78.1
Q ss_pred CccccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 368 NNITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
.-..+|||+++....... ......++..|++||+......+.++|+||||++++|++| |+.|+...... ....
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~-- 214 (260)
T cd05067 140 CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ-- 214 (260)
T ss_pred CEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH--
Confidence 345689999887653221 1123445678999999988888999999999999999999 99997522110 0000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
..........+ ....+++.+++. .|+..+|++||++.++.+.|+.
T Consensus 215 ~~~~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 215 NLERGYRMPRP---DNCPEELYELMR---LCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHcCCCCCCC---CCCCHHHHHHHH---HHccCChhhCCCHHHHHHHhhc
Confidence 00000111111 112245555555 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-11 Score=121.92 Aligned_cols=61 Identities=26% Similarity=0.436 Sum_probs=50.7
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.+.... .....|+..|+|||...+...+.++|||||||+++||+||+.|+.
T Consensus 143 ~kl~Dfg~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 143 IKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred EEEccCcccccccccc--cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 3468999988664321 234568999999999998889999999999999999999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.11 E-value=2e-11 Score=118.30 Aligned_cols=116 Identities=18% Similarity=0.300 Sum_probs=74.4
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
...+|||+++.+..... .......+..|+|||.......+.++|||||||+++||+| |..|+...... .
T Consensus 169 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---~----- 240 (288)
T cd05050 169 VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---E----- 240 (288)
T ss_pred eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H-----
Confidence 34689999876543211 1112234567999999888889999999999999999998 88786321110 0
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
....+.+............++.. +...|++.+|++||++.|+++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~---li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYN---LMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHH---HHHHHcccCcccCCCHHHHHHHhh
Confidence 01111111111101111234444 445999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.2e-11 Score=120.38 Aligned_cols=111 Identities=25% Similarity=0.354 Sum_probs=75.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||.......+.++|||||||+++||+||+.|+...... .......
T Consensus 135 kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~~--- 208 (328)
T cd05593 135 KITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELIL--- 208 (328)
T ss_pred EEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHhc---
Confidence 4689999886543333334467999999999998888999999999999999999999997422110 0000000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
..+..++. ....++.++++ .|++.+|++|| +..|+.+
T Consensus 209 ~~~~~~p~---~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 209 MEDIKFPR---TLSADAKSLLS---GLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred cCCccCCC---CCCHHHHHHHH---HHcCCCHHHcCCCCCCCHHHHhc
Confidence 01112221 12345667777 99999999997 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.3e-11 Score=121.62 Aligned_cols=107 Identities=24% Similarity=0.406 Sum_probs=72.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............||..|+|||.......+.++|||||||+++||+||+.|+...... .. ..
T Consensus 135 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~-----~~ 206 (320)
T cd05590 135 CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DL-----FE 206 (320)
T ss_pred EEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HH-----HH
Confidence 34689999886533323334567999999999998888999999999999999999999998532110 00 01
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
.+.......+ .....++.++++ .|++.+|++||+.
T Consensus 207 ~i~~~~~~~~-~~~~~~~~~li~---~~L~~dP~~R~~~ 241 (320)
T cd05590 207 AILNDEVVYP-TWLSQDAVDILK---AFMTKNPTMRLGS 241 (320)
T ss_pred HHhcCCCCCC-CCCCHHHHHHHH---HHcccCHHHCCCC
Confidence 1111111101 112345666666 9999999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-11 Score=121.25 Aligned_cols=109 Identities=28% Similarity=0.397 Sum_probs=74.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||......++.++||||+||+++||+||+.|+...... ...... .
T Consensus 136 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~---~ 209 (316)
T cd05620 136 KIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESI---R 209 (316)
T ss_pred EeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---H
Confidence 4689999875433223334567999999999999888999999999999999999999997532110 000000 0
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHH-HH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK-IV 490 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~-~v 490 (502)
...+.++. ....++..+++ .|++.+|++||++. ++
T Consensus 210 ~~~~~~~~---~~~~~~~~li~---~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 210 VDTPHYPR---WITKESKDILE---KLFERDPTRRLGVVGNI 245 (316)
T ss_pred hCCCCCCC---CCCHHHHHHHH---HHccCCHHHcCCChHHH
Confidence 01122221 12345667777 99999999999985 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-11 Score=121.24 Aligned_cols=107 Identities=22% Similarity=0.343 Sum_probs=72.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||...+...+.++|||||||+++||+||+.|+...... .. ...
T Consensus 136 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~-----~~~ 207 (323)
T cd05575 136 VLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EM-----YDN 207 (323)
T ss_pred EEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HH-----HHH
Confidence 4689999876433233334567899999999998888999999999999999999999997521110 00 011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~ 488 (502)
+.......+ .....++.++++ .|++.+|++||+++
T Consensus 208 i~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~R~~~~ 242 (323)
T cd05575 208 ILNKPLRLK-PNISVSARHLLE---GLLQKDRTKRLGAK 242 (323)
T ss_pred HHcCCCCCC-CCCCHHHHHHHH---HHhhcCHHhCCCCC
Confidence 111111101 112345667777 89999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.1e-11 Score=118.11 Aligned_cols=119 Identities=24% Similarity=0.369 Sum_probs=75.9
Q ss_pred CCccccccCcccccCCCCCCcccccccccccCccccccc---eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 367 RNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM---KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 367 ~N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~---~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
++...+|||++..............++..|++||..... ..+.++|+||||++++||+||+.|+........ ..
T Consensus 138 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~~ 214 (262)
T cd06613 138 GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---LF 214 (262)
T ss_pred CCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 344579999987664322222345678889999998776 788999999999999999999999753211000 00
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+...+.+... .....++.++++ .|+..+|++||++.||++
T Consensus 215 ~~~~~~~~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 215 LISKSNFPPPKLKDK-EKWSPVFHDFIK---KCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHhccCCCccccch-hhhhHHHHHHHH---HHcCCChhhCCCHHHHhc
Confidence 000011111111111 112234555555 999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.9e-11 Score=118.00 Aligned_cols=115 Identities=23% Similarity=0.344 Sum_probs=73.7
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
-..+|||+++.............++..|++||+.. ....+.++|||||||+++||++|+.|+....... ...
T Consensus 142 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~ 218 (282)
T cd06643 142 IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLL 218 (282)
T ss_pred EEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHH
Confidence 34689999876543322223456888999999873 3456789999999999999999999975321100 000
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.......+.+..+. ...+++.++++ .|++.+|++||++.++++
T Consensus 219 --~~~~~~~~~~~~~~-~~~~~~~~li~---~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 219 --KIAKSEPPTLAQPS-RWSSEFKDFLK---KCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --HHhhcCCCCCCCcc-ccCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 00001111111111 12245666666 999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.3e-11 Score=117.19 Aligned_cols=116 Identities=23% Similarity=0.320 Sum_probs=74.6
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+...... ......+..|+|||+..+...+.++|||||||+++||+| |+.|++...... ... .
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~--~ 233 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VME--F 233 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH--H
Confidence 36899999876432111 111223467999999998889999999999999999997 999975321110 000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
+.....+..+ .....++.++++ .|++.+|++||++.+|++.|++
T Consensus 234 ~~~~~~~~~~---~~~~~~~~~~i~---~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 234 VTGGGRLDPP---KGCPGPVYRIMT---DCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHcCCcCCCC---CCCCHHHHHHHH---HHcCCCcccCcCHHHHHHHhhC
Confidence 0000000111 112234555555 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.9e-11 Score=116.92 Aligned_cols=114 Identities=24% Similarity=0.392 Sum_probs=73.5
Q ss_pred CccccccCcccccCCCC---CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 368 NNITGDFGIAKFLKPDS---SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~---~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
....+|||+++.+.... .......++.+|+|||+..+...+.++|||||||+++|++||+.|+...... ... ..
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--~~~-~~ 220 (266)
T cd06651 144 NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--AAI-FK 220 (266)
T ss_pred CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--HHH-HH
Confidence 34579999998664311 1122356888999999998888899999999999999999999997532110 000 00
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.......+.++. ...+.+..+ +.|+..+|++||+|+||++
T Consensus 221 -~~~~~~~~~~~~---~~~~~~~~l----i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 221 -IATQPTNPQLPS---HISEHARDF----LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred -HhcCCCCCCCch---hcCHHHHHH----HHHhcCChhhCcCHHHHhc
Confidence 000111222221 112233333 3688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.4e-11 Score=116.59 Aligned_cols=63 Identities=29% Similarity=0.388 Sum_probs=51.6
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.+..... ......|+..|+|||...+...+.++|||||||+++||+||+.|+.
T Consensus 139 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 139 LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred EEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 34789999987653221 2234568999999999988889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.2e-11 Score=115.69 Aligned_cols=113 Identities=30% Similarity=0.435 Sum_probs=77.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|.|||+..+...+.++||||||++++||++|+.|++..... .. ..+
T Consensus 141 kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~-----~~~ 212 (256)
T cd08221 141 KLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NL-----VVK 212 (256)
T ss_pred EECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HH-----HHH
Confidence 3689999887754332334456889999999998888899999999999999999999997531110 00 011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
+..............++..++. .|+..+|++||+++|+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~i~---~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 213 IVQGNYTPVVSVYSSELISLVH---SLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHcCCCCCCccccCHHHHHHHH---HHcccCcccCCCHHHHhhC
Confidence 1111111111112245566666 9999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.10 E-value=3e-11 Score=114.75 Aligned_cols=114 Identities=32% Similarity=0.504 Sum_probs=74.5
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
-..+|||+++....... ......++.+|++||+......+.++||||||++++|+++ |+.|++..... .......
T Consensus 139 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~ 215 (256)
T cd05112 139 VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETIN 215 (256)
T ss_pred EEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHh
Confidence 34689999876543221 1112335678999999988889999999999999999998 89997532110 0000000
Q ss_pred -cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 447 -LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 447 -~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
.....++++ ..+++.+ ++..|++.+|++||+|.||+++|
T Consensus 216 ~~~~~~~~~~------~~~~~~~---l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 216 AGFRLYKPRL------ASQSVYE---LMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCCC------CCHHHHH---HHHHHcccChhhCCCHHHHHHhh
Confidence 001111221 1234444 55599999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.10 E-value=3e-11 Score=122.30 Aligned_cols=116 Identities=25% Similarity=0.397 Sum_probs=77.8
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......++..|++||.......+.++|||||||+++|+++ |+.|+....... .
T Consensus 279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--------~ 350 (401)
T cd05107 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--------Q 350 (401)
T ss_pred EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--------H
Confidence 4689999987543221 1122356788999999988888999999999999999998 888864321100 0
Q ss_pred cccccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..+.+.. +...+ .....++.++++ .||+.+|++||+|+||++.|+.+
T Consensus 351 ~~~~~~~~~~~~~p-~~~~~~l~~li~---~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 FYNAIKRGYRMAKP-AHASDEIYEIMQ---KCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHcCCCCCCC-CCCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHH
Confidence 0011111 11111 112245555555 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.1e-11 Score=116.72 Aligned_cols=119 Identities=20% Similarity=0.328 Sum_probs=74.8
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
+-..+|||+++.+...........|+..|++||... ....+.++|||||||+++||+||+.|+.......... .
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~ 220 (267)
T cd06646 144 DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---L 220 (267)
T ss_pred CEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---e
Confidence 344689999987643222223356788999999874 3447789999999999999999999974222111000 0
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
........+..... .....++.++++ .|+..+|++||+++++++.
T Consensus 221 ~~~~~~~~~~~~~~-~~~~~~~~~li~---~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 221 MSKSNFQPPKLKDK-TKWSSTFHNFVK---ISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred eecCCCCCCCCccc-cccCHHHHHHHH---HHhhCChhhCcCHHHHhcC
Confidence 00011111111111 112245566666 9999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.10 E-value=3e-11 Score=115.65 Aligned_cols=114 Identities=24% Similarity=0.408 Sum_probs=73.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccce--ecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK--ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~--~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++.............|+..|+|||+..... .+.++|||||||+++|++||+.|+..........+. ...
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~--~~~ 226 (268)
T cd06624 149 KISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--VGM 226 (268)
T ss_pred EEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh--hhh
Confidence 4689998876643322233346788999999986543 778999999999999999999997532111000000 000
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
. -..+.++. ...+++..+++ .|++.+|++||+|.||++
T Consensus 227 ~-~~~~~~~~---~~~~~~~~li~---~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 F-KIHPEIPE---SLSAEAKNFIL---RCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred h-ccCCCCCc---ccCHHHHHHHH---HHcCCCchhCCCHHHHHh
Confidence 0 01122221 12245666665 999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.8e-11 Score=119.09 Aligned_cols=119 Identities=20% Similarity=0.290 Sum_probs=73.3
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhcC--CCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKG--KHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg--~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++.+...... .....++..|+|||+......+.++|||||||+++||+|+ ..|++...... ....
T Consensus 169 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~- 244 (295)
T cd05097 169 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VIEN- 244 (295)
T ss_pred EecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HHHH-
Confidence 46899998866432211 1123446789999999888899999999999999999984 45554221100 0000
Q ss_pred ccccccC---CCC-CCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 446 ALDEMLD---PRL-PVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 446 ~~~~~~d---~~l-~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
..+..+ ... ........+. +.+++..|++.+|++||+|.+|++.|++
T Consensus 245 -~~~~~~~~~~~~~~~~~~~~~~~---l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 245 -TGEFFRNQGRQIYLSQTPLCPSP---VFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHhhhhccccccCCCCCCCCHH---HHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 000000 000 0000011233 4455559999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.3e-11 Score=117.41 Aligned_cols=113 Identities=24% Similarity=0.379 Sum_probs=73.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++.............|+..|+|||... ....+.++|||||||+++||+||+.|+........ ..
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~-- 236 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LF-- 236 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hh--
Confidence 4689999876543222233456888999999865 34577899999999999999999999743211100 00
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.......+.... .....++.++++ .|+..+|++||+..|+++
T Consensus 237 -~~~~~~~~~~~~--~~~~~~~~~li~---~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -LIPRNPPPKLKS--KKWSKKFIDFIE---GCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hHhhCCCCCCcc--cccCHHHHHHHH---HHhCCChhhCcCHHHHhc
Confidence 001111111111 112245666666 999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.2e-11 Score=115.65 Aligned_cols=112 Identities=26% Similarity=0.364 Sum_probs=74.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||.+..............|+..|+|||+......+.++|+|||||+++|++||+.|+...... .. ..+
T Consensus 142 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~-----~~~ 213 (257)
T cd08225 142 KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---QL-----VLK 213 (257)
T ss_pred EecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HH-----HHH
Confidence 3689998877654332223346888999999998888999999999999999999999997522110 00 011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..............+++.+++. .|+..+|++||+|.||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~i~---~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 214 ICQGYFAPISPNFSRDLRSLIS---QLFKVSPRDRPSITSILK 253 (257)
T ss_pred HhcccCCCCCCCCCHHHHHHHH---HHhccChhhCcCHHHHhh
Confidence 1111111000112245556655 899999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.1e-11 Score=116.74 Aligned_cols=116 Identities=24% Similarity=0.401 Sum_probs=77.1
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.-..+|||+++.............++..|++||+......+.++|+|||||+++|++||+.|+........ ... ...
T Consensus 153 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~-~~~ 229 (297)
T cd06656 153 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL-IAT 229 (297)
T ss_pred CEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee-ecc
Confidence 34579999988765443333345688899999999888889999999999999999999999853211110 000 000
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
. ..+....+ ......+..+++ .|++.+|++||+|+||++
T Consensus 230 ~--~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 230 N--GTPELQNP-ERLSAVFRDFLN---RCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred C--CCCCCCCc-cccCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 0 01111111 111234455555 999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.1e-11 Score=119.76 Aligned_cols=124 Identities=25% Similarity=0.428 Sum_probs=83.3
Q ss_pred CCeeeecCCcc----------ccccCcccccCCCCCCcccccccccccCccccccc--eecccceeeeeceeeeehhcCC
Q 010736 360 LGALNISRNNI----------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM--KITEKCDVYSFGVLVLEVIKGK 427 (502)
Q Consensus 360 L~~L~l~~N~l----------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~--~~s~k~Dvysfgv~llElltg~ 427 (502)
+.|.|+++-|. ++|||-+|-+..-..-.-++.||..|||||....+ .+-..+|+|||||.+.||.|||
T Consensus 696 IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGr 775 (1226)
T KOG4279|consen 696 IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGR 775 (1226)
T ss_pred eeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCC
Confidence 34456766553 68999988775433333467899999999998755 3667899999999999999999
Q ss_pred CCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 428 HPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 428 ~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+|+-..+......+ .- ... -+.|.++. ....+....+ +.|-+++|.+||+.+++++
T Consensus 776 PPF~ElgspqAAMF-kV-Gmy-KvHP~iPe---elsaeak~Fi---lrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 776 PPFVELGSPQAAMF-KV-GMY-KVHPPIPE---ELSAEAKNFI---LRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCeeecCChhHhhh-hh-cce-ecCCCCcH---HHHHHHHHHH---HHHcCCCcccCccHHHhcc
Confidence 99854433222111 11 111 14555542 1223333333 4899999999999998754
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.3e-11 Score=115.36 Aligned_cols=118 Identities=27% Similarity=0.453 Sum_probs=76.7
Q ss_pred ccccccCcccccCCCCCCc---ccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcc
Q 010736 369 NITGDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~---~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~ 444 (502)
...+|||+++.+....... ....++..|++||+......+.++||||||++++|+++ |+.|+....... ...
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~- 220 (267)
T cd05066 145 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIK- 220 (267)
T ss_pred EEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHH-
Confidence 3468999998775432211 12223567999999998889999999999999999887 999974321110 000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.+.+.. +.+.. ....+.+..++ ..|++.+|++||+|.+|++.|++.
T Consensus 221 -~~~~~~--~~~~~-~~~~~~~~~li---~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 221 -AIEEGY--RLPAP-MDCPAALHQLM---LDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -HHhCCC--cCCCC-CCCCHHHHHHH---HHHcccCchhCCCHHHHHHHHHhh
Confidence 000000 11111 11223444444 499999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.9e-11 Score=118.94 Aligned_cols=118 Identities=25% Similarity=0.315 Sum_probs=76.2
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....++..|+|||.......+.++||||||++++||++ |+.|+...... .+.
T Consensus 174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~---- 246 (334)
T cd05100 174 KIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---ELF---- 246 (334)
T ss_pred EECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHH----
Confidence 46899999876432211 112234567999999988889999999999999999999 88886421110 000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..+..............++..+ ...|++.+|++||+|.|+++.|+.+.
T Consensus 247 -~~~~~~~~~~~~~~~~~~l~~l---i~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 247 -KLLKEGHRMDKPANCTHELYMI---MRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -HHHHcCCCCCCCCCCCHHHHHH---HHHHcccChhhCcCHHHHHHHHHHHh
Confidence 0000000000001112344444 44999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.4e-11 Score=114.18 Aligned_cols=117 Identities=25% Similarity=0.361 Sum_probs=74.7
Q ss_pred ccccccCcccccCCCCCCcc--cccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSNWT--GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~--~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++.......... ...++..|+|||+......+.++||||||++++|+++ |+.|++.........
T Consensus 133 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~----- 207 (252)
T cd05084 133 LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE----- 207 (252)
T ss_pred EEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-----
Confidence 34689999876543221111 1123457999999988889999999999999999998 888875321110000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
..........+ ....+++.++++ .|++.+|++||++.||.++|++
T Consensus 208 ~~~~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 208 AIEQGVRLPCP---ELCPDAVYRLME---RCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHcCCCCCCc---ccCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHhC
Confidence 00000011111 111244555555 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.3e-11 Score=119.37 Aligned_cols=116 Identities=22% Similarity=0.396 Sum_probs=74.3
Q ss_pred ccccccCcccccCCCC-CCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
-..+|||+++...... .......||..|+|||...+. ..+.++|||||||+++||+||+.|++............. .
T Consensus 144 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-~ 222 (332)
T cd05614 144 VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR-R 222 (332)
T ss_pred EEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH-H
Confidence 3478999998653322 222346799999999998765 367899999999999999999999853221111000000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
+. -.++.++. ....++..+++ .|++.+|++|| +.+|+.+
T Consensus 223 ~~-~~~~~~~~---~~~~~~~~li~---~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 223 IL-KCDPPFPS---FIGPEAQDLLH---KLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred Hh-cCCCCCCC---CCCHHHHHHHH---HHcCCCHHHcCCCCCCCHHHHHc
Confidence 00 12223321 12245566666 99999999999 6666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-11 Score=120.43 Aligned_cols=110 Identities=25% Similarity=0.384 Sum_probs=75.8
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............|+..|+|||.......+.++|||||||+++||+||+.|+....... ...
T Consensus 134 ~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~ 205 (323)
T cd05595 134 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFE 205 (323)
T ss_pred EEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHH
Confidence 346899998864333333334678999999999988889999999999999999999999974221100 000
Q ss_pred ccc--CCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 449 EML--DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 449 ~~~--d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
.+. +..++. ....++.++++ .|++.+|++|| +..++++
T Consensus 206 ~~~~~~~~~p~---~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 206 LILMEEIRFPR---TLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHhcCCCCCCC---CCCHHHHHHHH---HHccCCHHHhCCCCCCCHHHHHc
Confidence 111 111211 12355667777 89999999998 7777754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.2e-11 Score=117.37 Aligned_cols=120 Identities=21% Similarity=0.332 Sum_probs=73.0
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc--CCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK--GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt--g~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++.+..... ......++..|++||......++.++|||||||+++||+| |+.|+....... .....
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~~ 246 (296)
T cd05095 170 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---VIENT 246 (296)
T ss_pred EeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---HHHHH
Confidence 4689999986643221 1112233567999998888889999999999999999998 566754221110 00000
Q ss_pred -c-cccc-cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 446 -A-LDEM-LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 446 -~-~~~~-~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
. .... .....+.+. .....+ .++...|++.+|++||+|.||++.|+.
T Consensus 247 ~~~~~~~~~~~~~~~~~-~~~~~~---~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 247 GEFFRDQGRQVYLPKPA-LCPDSL---YKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHhhccccccCCCCC-CCCHHH---HHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 0000 000011111 112334 445559999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.8e-11 Score=120.52 Aligned_cols=111 Identities=26% Similarity=0.382 Sum_probs=74.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||...+...+.++|||||||+++||+||+.|++..... .. ...
T Consensus 136 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~-----~~~ 207 (318)
T cd05570 136 KIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---EL-----FQS 207 (318)
T ss_pred EecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HH-----HHH
Confidence 3689999876433222233456899999999999889999999999999999999999997532110 00 001
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH-----HHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM-----KIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m-----~~v~~ 492 (502)
+.......+ ....+++.++++ .|++.+|++||++ .++.+
T Consensus 208 i~~~~~~~~-~~~~~~~~~li~---~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 208 ILEDEVRYP-RWLSKEAKSILK---SFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHcCCCCCC-CcCCHHHHHHHH---HHccCCHHHcCCCCCCCHHHHhc
Confidence 111111001 112245666776 9999999999998 77753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.1e-11 Score=120.43 Aligned_cols=113 Identities=20% Similarity=0.308 Sum_probs=75.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||...+...+.++||||+||+++||+||+.|+...... . ....
T Consensus 136 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~-----~~~~ 207 (325)
T cd05602 136 VLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---E-----MYDN 207 (325)
T ss_pred EEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---H-----HHHH
Confidence 4689999986533333334567999999999999888999999999999999999999997521110 0 0011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
+........ .....++.++++ .|++.+|.+||+..+.++++
T Consensus 208 i~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 208 ILNKPLQLK-PNITNSARHLLE---GLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred HHhCCcCCC-CCCCHHHHHHHH---HHcccCHHHCCCCCCCHHHH
Confidence 111111101 112245667777 89999999999987654443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.4e-11 Score=117.26 Aligned_cols=116 Identities=25% Similarity=0.330 Sum_probs=76.0
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.+...........|+..|+|||...+...+.++|||||||+++||+||+.|+......... .....
T Consensus 136 ~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~ 211 (280)
T cd05608 136 VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQ 211 (280)
T ss_pred EEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHH
Confidence 34689999987654333334567899999999999889999999999999999999999997532211000 00001
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
.+.......+ .....++..++. .|++.+|++|| +++|+.+
T Consensus 212 ~~~~~~~~~~-~~~~~~~~~li~---~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 212 RILNDSVTYP-DKFSPASKSFCE---ALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred hhcccCCCCc-ccCCHHHHHHHH---HHhcCCHHHhcCCCCCCHHHHhc
Confidence 1111111101 112244555665 89999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.9e-11 Score=114.56 Aligned_cols=95 Identities=22% Similarity=0.342 Sum_probs=69.1
Q ss_pred cccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHH
Q 010736 391 AGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISI 469 (502)
Q Consensus 391 ~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 469 (502)
.....||+||......+++.+|||||||++|||+| |+.|+-.....+.+ .-+.|.....++.+.++|+..+
T Consensus 459 nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--------~ylkdGyRlaQP~NCPDeLf~v 530 (563)
T KOG1024|consen 459 NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--------HYLKDGYRLAQPFNCPDELFTV 530 (563)
T ss_pred CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH--------HHHhccceecCCCCCcHHHHHH
Confidence 34678999999999999999999999999999998 99996322211111 1123332222333445666555
Q ss_pred HHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 470 MEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 470 ~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
+. .||+..|++||+.+|++.-|.+
T Consensus 531 Ma---cCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 531 MA---CCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HH---HHHhcCcccCCCHHHHHHHHHH
Confidence 54 9999999999999999998876
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.5e-11 Score=113.91 Aligned_cols=115 Identities=26% Similarity=0.410 Sum_probs=75.5
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
.-..+|||+++.+...........|+..|+|||+.... ..+.++|+|||||+++||+||+.|++....... .. .
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~--~ 213 (277)
T cd06917 139 NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MM--L 213 (277)
T ss_pred CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hh--c
Confidence 33568999998775543333445688899999987654 468899999999999999999999753211110 00 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+.+... ....++.+++ ..|+..+|++||++.|+++
T Consensus 214 ~~~~~~~~~~~~--~~~~~~~~~i---~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 214 IPKSKPPRLEDN--GYSKLLREFV---AACLDEEPKERLSAEELLK 254 (277)
T ss_pred cccCCCCCCCcc--cCCHHHHHHH---HHHcCCCcccCcCHHHHhh
Confidence 011112222211 1123444444 4999999999999999965
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.9e-11 Score=114.36 Aligned_cols=120 Identities=23% Similarity=0.354 Sum_probs=79.5
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
-..+|||+++....... ..+...++..|+|||.......+.++||||||++++|+++ |+.|+........ .. .
T Consensus 146 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~--~ 220 (270)
T cd05056 146 VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IG--R 220 (270)
T ss_pred eEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH--H
Confidence 34689999987654322 1122334568999999888889999999999999999986 9999753221110 00 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
+........+ .....++.+++. .|+..+|++||++.|++++|+++..
T Consensus 221 ~~~~~~~~~~---~~~~~~~~~li~---~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 221 IENGERLPMP---PNCPPTLYSLMT---KCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHcCCcCCCC---CCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000001111 112245566655 9999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.9e-11 Score=114.41 Aligned_cols=116 Identities=28% Similarity=0.408 Sum_probs=76.8
Q ss_pred cccccCcccccCCCCCCcc--cccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNWT--GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~--~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+........ ...++..|++||......++.++|+||||++++|++| |+.|++..... .+..
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~--- 222 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPD--- 222 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH---
Confidence 4689999988754332221 1223567999999988889999999999999999999 99997532211 0000
Q ss_pred cccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.+... ....+. .....+. ++...|+..+|.+||++.++++.|+..
T Consensus 223 --~~~~~~~~~~~~-~~~~~~~---~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 223 --LLEKGERLPQPP-ICTIDVY---MVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred --HHhCCCCCCCCC-CCCHHHH---HHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01110 011111 1112333 444499999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.7e-11 Score=119.54 Aligned_cols=106 Identities=25% Similarity=0.402 Sum_probs=72.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||.......+.++|||||||+++||+||+.|++...... ....
T Consensus 141 kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--------~~~~ 212 (323)
T cd05616 141 KIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQS 212 (323)
T ss_pred EEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--------HHHH
Confidence 36899999865433333345678999999999998889999999999999999999999985321110 0111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
+......-+ ....+++..+++ .|++.+|++|++.
T Consensus 213 i~~~~~~~p-~~~s~~~~~li~---~~l~~~p~~R~~~ 246 (323)
T cd05616 213 IMEHNVAYP-KSMSKEAVAICK---GLMTKHPGKRLGC 246 (323)
T ss_pred HHhCCCCCC-CcCCHHHHHHHH---HHcccCHHhcCCC
Confidence 111111111 112245555555 9999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.5e-11 Score=117.76 Aligned_cols=115 Identities=22% Similarity=0.284 Sum_probs=72.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccc-----eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-----KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-----~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
-..+|||+++.............|+..|++||..... ..+.++|||||||+++||+||+.|+....... . ..
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~-~~ 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--T-LF 243 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--H-HH
Confidence 3468999988765433223345688899999987543 36789999999999999999999974321100 0 00
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+.....+.+..+ .....++. ++...|++.+|++||+|.|+++
T Consensus 244 --~~~~~~~~~~~~~-~~~~~~l~---~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 --KIPRNPPPTLLHP-EKWCRSFN---HFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HHhcCCCCCCCcc-cccCHHHH---HHHHHHhhcChhhCcCHHHHhc
Confidence 0000011111111 11112344 4445999999999999999865
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.4e-11 Score=114.02 Aligned_cols=115 Identities=27% Similarity=0.432 Sum_probs=83.6
Q ss_pred CCccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 367 RNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 367 ~N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
++--.+|||.+-.+..+.....++.||+-|||||......++.|+|+||+||..+||.+|..|......... --.
T Consensus 148 g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----lfl 222 (467)
T KOG0201|consen 148 GDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----LFL 222 (467)
T ss_pred CcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----EEe
Confidence 455579999998887655444678999999999999988999999999999999999999999743222110 001
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+.+-..|.+.+. ...-+.+.++ .|...+|+.||+.++.++
T Consensus 223 Ipk~~PP~L~~~---~S~~~kEFV~---~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 223 IPKSAPPRLDGD---FSPPFKEFVE---ACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccCCCCCccccc---cCHHHHHHHH---HHhhcCcccCcCHHHHhh
Confidence 122233444331 1123566667 899999999999999865
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.5e-11 Score=104.37 Aligned_cols=109 Identities=24% Similarity=0.376 Sum_probs=32.5
Q ss_pred CCCCCCCCEEECCCCcccccCCccCc-CCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCccc-CCCCC
Q 010736 91 FSSFPHLAYLDLRDNKLFGTIPPQIS-NLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEV-GQLSS 168 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 168 (502)
+.+..++++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+. ++ .+..+++|++|++++|+|+. +...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 44555677788888877632 2355 46777888888888773 33 46667777788888887773 33333 34677
Q ss_pred CcEEEcccCcccccCC-cCCCCCCCCCeEEccccccc
Q 010736 169 MVELALFSNNLNGSVP-HSLGNLTQISMLFLHDNSFS 204 (502)
Q Consensus 169 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 204 (502)
|++|++++|++...-. ..+..+++|+.|++.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 7777777777753211 23445666666666666665
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-11 Score=116.13 Aligned_cols=116 Identities=26% Similarity=0.378 Sum_probs=76.2
Q ss_pred CccccccCcccccCCCCCCc---ccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 368 NNITGDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~---~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
+-..+|||+++......... ....|+..|+|||...+...+.++||||+|++++|++||+.|+........ ...
T Consensus 142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~ 218 (263)
T cd06625 142 NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IFK 218 (263)
T ss_pred CEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HHH
Confidence 44578999988664322111 234577899999999988899999999999999999999999742211000 000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
.. ..-..+.++. ....++..+++ .|+..+|++||++.|+++.
T Consensus 219 ~~-~~~~~~~~~~---~~~~~~~~li~---~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 IA-TQPTNPQLPS---HVSPDARNFLR---RTFVENAKKRPSAEELLRH 260 (263)
T ss_pred Hh-ccCCCCCCCc---cCCHHHHHHHH---HHhhcCcccCCCHHHHhhC
Confidence 00 0001111111 12245666666 9999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.6e-11 Score=113.53 Aligned_cols=115 Identities=25% Similarity=0.407 Sum_probs=75.9
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
.-..+|||+++...... ....++.+|.+||+......+.++||||||++++|+++ |+.|+....... ... .
T Consensus 140 ~~~l~d~g~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~--~ 211 (256)
T cd05039 140 VAKVSDFGLAKEASQGQ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP--H 211 (256)
T ss_pred CEEEccccccccccccc---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--H
Confidence 33568999988763221 12345678999999988889999999999999999997 998874221100 000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
......+..+ ....+++.++++ .|+..+|++||+++||.++|+.
T Consensus 212 ~~~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 212 VEKGYRMEAP---EGCPPEVYKVMK---DCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HhcCCCCCCc---cCCCHHHHHHHH---HHhccChhhCcCHHHHHHHHhc
Confidence 0000001111 112244555555 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.7e-11 Score=118.76 Aligned_cols=113 Identities=23% Similarity=0.402 Sum_probs=72.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||+..+...+.++|||||||+++||+||+.|++.......... .+.....
T Consensus 136 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~-~~~~~~~ 214 (327)
T cd05617 136 KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT-EDYLFQV 214 (327)
T ss_pred EEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc-HHHHHHH
Confidence 468999988543222223346789999999999888899999999999999999999999864222111000 0000011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
+.......+. ....++..+++ .|++.+|++||++
T Consensus 215 ~~~~~~~~p~-~~~~~~~~li~---~~L~~dP~~R~~~ 248 (327)
T cd05617 215 ILEKPIRIPR-FLSVKASHVLK---GFLNKDPKERLGC 248 (327)
T ss_pred HHhCCCCCCC-CCCHHHHHHHH---HHhccCHHHcCCC
Confidence 1111111111 12244556666 8999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.8e-11 Score=118.04 Aligned_cols=118 Identities=22% Similarity=0.280 Sum_probs=76.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||++....... ......|+..|+|||+......+.++||||+||+++||+||+.|+........ ......
T Consensus 134 ~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~ 208 (277)
T cd05607 134 CRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKR 208 (277)
T ss_pred EEEeeceeeeecCCCc-eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHH
Confidence 3468999988764322 22345688999999999888899999999999999999999999753211000 000001
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
...............+++.++++ .|++.+|++||+++|+++..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~li~---~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 209 RTLEDEVKFEHQNFTEESKDICR---LFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HhhccccccccccCCHHHHHHHH---HHhccCHhhCCCCccchhhh
Confidence 11111111011112345666666 99999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.3e-11 Score=112.12 Aligned_cols=116 Identities=32% Similarity=0.523 Sum_probs=75.5
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++....... ......++..|++||+......+.++|+|||||+++|++| |+.|+....... ... .+
T Consensus 142 ~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~--~~ 216 (260)
T cd05073 142 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR--AL 216 (260)
T ss_pred EECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHH--HH
Confidence 4689998876643221 1122345677999999988889999999999999999999 898875321100 000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
.. +...... .....++..++. .|++.+|++||++.++.++|+.
T Consensus 217 ~~--~~~~~~~-~~~~~~~~~~i~---~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 217 ER--GYRMPRP-ENCPEELYNIMM---RCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred hC--CCCCCCc-ccCCHHHHHHHH---HHcccCcccCcCHHHHHHHHhc
Confidence 00 0011111 112234555544 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.1e-11 Score=119.87 Aligned_cols=109 Identities=29% Similarity=0.403 Sum_probs=73.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||...+...+.++|||||||+++||+||+.|+...... ...... .
T Consensus 136 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i---~ 209 (316)
T cd05619 136 KIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSI---R 209 (316)
T ss_pred EEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHH---H
Confidence 3689999875432222233467899999999998888999999999999999999999997532110 000000 0
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHH-HH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK-IV 490 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~-~v 490 (502)
...+..+. ....++..++. .|++.+|++||++. ++
T Consensus 210 ~~~~~~~~---~~~~~~~~li~---~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 210 MDNPCYPR---WLTREAKDILV---KLFVREPERRLGVKGDI 245 (316)
T ss_pred hCCCCCCc---cCCHHHHHHHH---HHhccCHhhcCCChHHH
Confidence 11122211 12245556666 89999999999997 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.2e-11 Score=118.77 Aligned_cols=62 Identities=29% Similarity=0.345 Sum_probs=50.8
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++...... ..+...||..|+|||...+..++.++||||+||+++||+||+.|+.
T Consensus 162 ~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 162 LKILDFGLARTACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred EEEecCCCccccccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 3468999998653322 2234568899999999998889999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-11 Score=121.63 Aligned_cols=63 Identities=35% Similarity=0.488 Sum_probs=49.5
Q ss_pred ccccccCcccccCCCC---CCcccccccccccCcccccc--ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDS---SNWTGFAGTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~---~~~~~~~gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++...... ..+....|+..|+|||.... ...+.++|||||||+++||+||+.|+.
T Consensus 142 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 142 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 3468999998653221 12234568999999998765 578899999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.1e-11 Score=118.61 Aligned_cols=61 Identities=28% Similarity=0.328 Sum_probs=50.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++...... ......|+..|+|||...+...+.++|||||||+++||+||+.|+.
T Consensus 159 kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 159 KILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred EEeeCcccccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 468999998764321 2234568899999999988889999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.2e-11 Score=117.81 Aligned_cols=112 Identities=29% Similarity=0.443 Sum_probs=84.3
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.||||++|.+..+......+.||+.|+.||...+..+..|+|+||+||.++||.+=|++++.... ..++. .+...
T Consensus 147 LgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~--ki~~~ 221 (426)
T KOG0589|consen 147 LGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELIL--KINRG 221 (426)
T ss_pred ecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHH--HHhhc
Confidence 59999999998776555568899999999999999999999999999999999999998753211 11111 11111
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
.-..++. ....++..+++ .|+..+|+.||+..+++++
T Consensus 222 ~~~Plp~---~ys~el~~lv~---~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPS---MYSSELRSLVK---SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCc---cccHHHHHHHH---HHhhcCCccCCCHHHHhhC
Confidence 1111221 22356778888 9999999999999999876
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.4e-11 Score=115.37 Aligned_cols=118 Identities=24% Similarity=0.406 Sum_probs=76.8
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.-..+|||+++...... .....|+..|+|||+......+.++||||||++++||+||+.|+.......... ......
T Consensus 133 ~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~ 209 (279)
T cd06619 133 QVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLL 209 (279)
T ss_pred CEEEeeCCcceeccccc--ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHH
Confidence 34578999987664322 234578899999999988889999999999999999999999985422111100 000000
Q ss_pred ccc---cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 448 DEM---LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 448 ~~~---~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
..+ ..+.++.. ....++.+++. .|++.+|++||+++||++.
T Consensus 210 ~~~~~~~~~~~~~~--~~~~~~~~li~---~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 210 QCIVDEDPPVLPVG--QFSEKFVHFIT---QCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhccCCCCCCCC--cCCHHHHHHHH---HHhhCChhhCCCHHHHhcC
Confidence 111 11222111 12234445554 8999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.6e-11 Score=119.25 Aligned_cols=115 Identities=23% Similarity=0.374 Sum_probs=77.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||++..............|+..|+|||+......+.++|||||||+++|++||+.|+....... . . ..+..
T Consensus 158 kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~-~--~~~~~ 232 (292)
T cd06658 158 KLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--A-M--RRIRD 232 (292)
T ss_pred EEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H-H--HHHHh
Confidence 46899998766433322234568889999999988888999999999999999999999974211100 0 0 00111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
...+...... ...+++..+++ .|+..+|++||+++|+++.
T Consensus 233 ~~~~~~~~~~-~~~~~~~~li~---~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 233 NLPPRVKDSH-KVSSVLRGFLD---LMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCCCcccccc-ccCHHHHHHHH---HHccCChhHCcCHHHHhhC
Confidence 1222222111 12245566666 8999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.2e-11 Score=115.56 Aligned_cols=118 Identities=24% Similarity=0.387 Sum_probs=72.2
Q ss_pred cccccCcccccCCCC--CCcccccccccccCcccccc-------ceecccceeeeeceeeeehhcC-CCCCCcccCCCC-
Q 010736 370 ITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYT-------MKITEKCDVYSFGVLVLEVIKG-KHPRDFLSSTSS- 438 (502)
Q Consensus 370 l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~-------~~~s~k~Dvysfgv~llElltg-~~p~~~~~~~~~- 438 (502)
..+|||+++...... .......++..|+|||+... ...+.++|||||||+++||+|+ +.|++.......
T Consensus 139 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 218 (268)
T cd05086 139 KVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL 218 (268)
T ss_pred EecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 468999886532211 11223567889999998742 2457899999999999999974 667642211000
Q ss_pred CCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 439 PSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 439 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
.... ........+|.+... ..+.+.++++ .|| .+|++||+|+||++.|.
T Consensus 219 ~~~~-~~~~~~~~~~~~~~~---~~~~~~~l~~---~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 219 NHVI-KDQQVKLFKPQLELP---YSERWYEVLQ---FCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHH-hhcccccCCCccCCC---CcHHHHHHHH---HHh-hCcccCCCHHHHHHHhc
Confidence 0000 011123344444322 2244555665 798 56999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.5e-11 Score=106.49 Aligned_cols=122 Identities=25% Similarity=0.325 Sum_probs=83.1
Q ss_pred eeeecCCccccccCcccccCCCCCCcccccccccccCccccccc---eecccceeeeeceeeeehhcCCCCCCcccCCCC
Q 010736 362 ALNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM---KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS 438 (502)
Q Consensus 362 ~L~l~~N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~---~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~ 438 (502)
-+|-++|=..||||++-.+.+..+ .+..+|+..|||||..... ++..++|||||||.+.|+.||+.|+...... .
T Consensus 224 LlDe~GniKlCDFGIsGrlvdSkA-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-F 301 (391)
T KOG0983|consen 224 LLDERGNIKLCDFGISGRLVDSKA-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-F 301 (391)
T ss_pred EEccCCCEEeecccccceeecccc-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-H
Confidence 366677777899999987755433 3567899999999998643 6888999999999999999999998532111 0
Q ss_pred CCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 439 PSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 439 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.. .. .+.+-..|.++... .-.....+.++ .|...++.+||.-.++++
T Consensus 302 e~-lt--kvln~ePP~L~~~~-gFSp~F~~fv~---~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 302 EV-LT--KVLNEEPPLLPGHM-GFSPDFQSFVK---DCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HH-HH--HHHhcCCCCCCccc-CcCHHHHHHHH---HHhhcCcccCcchHHHhc
Confidence 00 00 01111224444221 11234556666 899999999999777643
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.6e-11 Score=114.04 Aligned_cols=116 Identities=22% Similarity=0.391 Sum_probs=75.8
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+..... ......++..|++||.......+.++||||||++++|+++ |+.|+...... ...
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~---- 225 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIY---- 225 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHH----
Confidence 4689999887643221 1122345567999999888888999999999999999999 88886421110 000
Q ss_pred cccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..+... ....+. .... .+.+++..|++.+|++||++.||.+.|+++
T Consensus 226 -~~~~~~~~~~~~~-~~~~---~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 226 -NYLIKGNRLKQPP-DCLE---DVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -HHHHcCCcCCCCC-CCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000 111011 1112 345556699999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.06 E-value=7.5e-11 Score=113.01 Aligned_cols=117 Identities=28% Similarity=0.519 Sum_probs=74.7
Q ss_pred cccccCcccccCCCCCC--cc-ccc--ccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCc
Q 010736 370 ITGDFGIAKFLKPDSSN--WT-GFA--GTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~-~~~--gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~ 443 (502)
..+|||+++.+...... .. ... .+..|++||+......+.++|||||||+++|+++ |+.|+....... ...
T Consensus 146 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~ 222 (269)
T cd05065 146 KVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIN 222 (269)
T ss_pred EECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHH
Confidence 35799998876432211 11 111 2357999999998889999999999999999887 999975321110 000
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.+.. +...+.+. ....++ .++...|++.+|++||+|.+|+++|+..
T Consensus 223 --~i~~--~~~~~~~~-~~~~~~---~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 223 --AIEQ--DYRLPPPM-DCPTAL---HQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --HHHc--CCcCCCcc-cCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 11111111 112334 4445599999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.3e-11 Score=104.87 Aligned_cols=120 Identities=27% Similarity=0.372 Sum_probs=82.3
Q ss_pred CccccccCcccccCCC---CC------CcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccC
Q 010736 368 NNITGDFGIAKFLKPD---SS------NWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSS 435 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~---~~------~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~ 435 (502)
-++..|||-+....-. ++ .|+.-..|+.|.|||.+. ....+++.||||+||++++|+.|..|++...+
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 3456788877655321 00 123346789999999985 45689999999999999999999999985433
Q ss_pred CCCCCCCcccccccccCCCC--CCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 436 TSSPSLNTDIALDEMLDPRL--PVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 436 ~~~~~~~~~~~~~~~~d~~l--~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
. ..++. ..+..+.+ +... ...+.+.++++ .|.+.+|.+||+..|++..+..+
T Consensus 247 ~-GgSla-----LAv~n~q~s~P~~~-~yse~l~~lik---~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 Q-GGSLA-----LAVQNAQISIPNSS-RYSEALHQLIK---SMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred c-CCeEE-----EeeeccccccCCCC-CccHHHHHHHH---HHhcCCcccCCCHHHHHHHHHhh
Confidence 1 11111 11222222 1111 23467788888 99999999999999999988765
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-11 Score=125.36 Aligned_cols=128 Identities=24% Similarity=0.310 Sum_probs=58.8
Q ss_pred CCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEE
Q 010736 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELA 173 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 173 (502)
+..++.+.+..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|++++|+|+...+ +..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhhe
Confidence 3444445555555542 22234555555555555555552 22224445555555555555553322 33444455555
Q ss_pred cccCcccccCCcCCCCCCCCCeEEcccccccccCC-ccCcCCccCCcccccccccc
Q 010736 174 LFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP-PDIGNLKSISILSLAINQFS 228 (502)
Q Consensus 174 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~ 228 (502)
+++|.++. + ..+..++.|+.+++++|++....+ . ...+.+++.+.+..|.+.
T Consensus 147 l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 147 LSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred eccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 55555542 1 123334555555555555543322 1 233444444444444443
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.6e-11 Score=113.49 Aligned_cols=115 Identities=24% Similarity=0.412 Sum_probs=74.6
Q ss_pred cccccCcccccCCCCCC----cccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSSN----WTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~----~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||++..+...... .....|+.+|++||+.... ..+.++|+|||||+++||+||+.|+........ . ..
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~-~~ 218 (267)
T cd06610 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--L-ML 218 (267)
T ss_pred EEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--H-HH
Confidence 46899998776543221 1234688899999998776 788999999999999999999999753221100 0 00
Q ss_pred cccccccCCCCCCCC--cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 445 IALDEMLDPRLPVPS--CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~--~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
. . .-..+.+.... ....+++..+++ .|++.+|++||+++|+++
T Consensus 219 ~-~-~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 219 T-L-QNDPPSLETGADYKKYSKSFRKMIS---LCLQKDPSKRPTAEELLK 263 (267)
T ss_pred H-h-cCCCCCcCCccccccccHHHHHHHH---HHcCCChhhCcCHHHHhh
Confidence 0 0 00111111100 012244555655 999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.2e-11 Score=114.58 Aligned_cols=63 Identities=30% Similarity=0.425 Sum_probs=49.7
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.+.......+...++..|++||+..+ ...+.++|||||||+++|++||+.|+.
T Consensus 139 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 139 VKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred EEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 346899998876544333344567889999999864 456789999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.7e-11 Score=114.23 Aligned_cols=116 Identities=22% Similarity=0.357 Sum_probs=72.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||++..+...........|+..|+|||+.. ...++.++|+||+||+++|++||+.|+........ . ....
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~-~~~~ 222 (267)
T cd06645 146 KLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L-FLMT 222 (267)
T ss_pred EECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H-Hhhh
Confidence 4689999876643222223456889999999874 44578899999999999999999999642211100 0 0000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+..... ....+.+..+++ .|++.+|++||++++|++
T Consensus 223 ~~~~~~~~~~~~-~~~~~~~~~li~---~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 223 KSNFQPPKLKDK-MKWSNSFHHFVK---MALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCCccccc-CCCCHHHHHHHH---HHccCCchhCcCHHHHhc
Confidence 001111111110 011234555555 899999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.1e-11 Score=118.89 Aligned_cols=95 Identities=24% Similarity=0.329 Sum_probs=63.1
Q ss_pred cccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHH
Q 010736 389 GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLIS 468 (502)
Q Consensus 389 ~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 468 (502)
...||..|+|||.......+.++|||||||+++||+||+.|+.............. ..... .++.. .....++..
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~---~~p~~-~~~~~~~~~ 263 (350)
T cd05573 189 STVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN-WKESL---RFPPD-PPVSPEAID 263 (350)
T ss_pred ccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhc-cCCcc---cCCCC-CCCCHHHHH
Confidence 45689999999999988999999999999999999999999753211000000000 00001 11111 112345666
Q ss_pred HHHHhhccCCcCCCCCCC-HHHHHH
Q 010736 469 IMEVGFSCLKESPESRPT-MKIVSQ 492 (502)
Q Consensus 469 ~~~val~C~~~~p~~Rp~-m~~v~~ 492 (502)
+++ .|+. +|++||+ ++|+++
T Consensus 264 li~---~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 264 LIC---RLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHH---HHcc-ChhhcCCCHHHHhc
Confidence 766 7886 8999999 999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.5e-11 Score=112.42 Aligned_cols=113 Identities=26% Similarity=0.448 Sum_probs=74.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++..... ......+..|++||+......+.++|+|||||+++||++ |+.|+...... .... .+.
T Consensus 140 kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~--~~~ 211 (254)
T cd05083 140 KVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKE--CVE 211 (254)
T ss_pred EECCCccceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHH--HHh
Confidence 46899998765321 122334568999999988889999999999999999998 89887432110 0000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
.-. ... ......+++.+++. .|++.+|++||+|++|+..|++
T Consensus 212 ~~~--~~~-~~~~~~~~~~~li~---~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 212 KGY--RME-PPEGCPADVYVLMT---SCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCC--CCC-CCCcCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHcc
Confidence 000 000 01112244555554 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.2e-11 Score=113.07 Aligned_cols=117 Identities=29% Similarity=0.459 Sum_probs=76.2
Q ss_pred CccccccCcccccCCCCCCc----ccccccccccCccccccce---ecccceeeeeceeeeehhcCCCCCCcccCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNW----TGFAGTYGYIAPELAYTMK---ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPS 440 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~----~~~~gt~gy~aPE~~~~~~---~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~ 440 (502)
+-..+|||++.......... ....++..|++||+..... .+.++||||||++++|+++|+.|++.....
T Consensus 137 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---- 212 (264)
T cd06626 137 VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---- 212 (264)
T ss_pred CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----
Confidence 34578999988775432211 1356788999999988766 889999999999999999999998532110
Q ss_pred CCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 441 LNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 441 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+...........+.++... .....+..+++ .|++.+|++||++.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~---~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 213 FQIMFHVGAGHKPPIPDSL-QLSPEGKDFLD---RCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHhcCCCCCCCccc-ccCHHHHHHHH---HHccCCcccCCCHHHHhc
Confidence 0000001111222232111 11244555555 999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.2e-11 Score=118.99 Aligned_cols=62 Identities=31% Similarity=0.335 Sum_probs=51.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++...... ..+...|+..|+|||...+..++.++|||||||+++||+||+.|+.
T Consensus 165 ~kL~DfG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 165 LKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred EEEEeCCCccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 3468999998764322 2234568899999999998889999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.4e-11 Score=115.47 Aligned_cols=114 Identities=25% Similarity=0.375 Sum_probs=72.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-----ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-----MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-----~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||++..............|+..|+|||.... ...+.++|||||||+++|++||+.|+....... . ..
T Consensus 153 ~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-~~- 228 (275)
T cd06608 153 KLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--A-LF- 228 (275)
T ss_pred EECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--H-HH-
Confidence 36899988766433222234568889999998643 346788999999999999999999974221100 0 00
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+.....+.+... ....+++.++++ .|+..+|++||++.||++
T Consensus 229 -~~~~~~~~~~~~~-~~~~~~~~~li~---~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 -KIPRNPPPTLKSP-ENWSKKFNDFIS---ECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -HhhccCCCCCCch-hhcCHHHHHHHH---HHhhcChhhCcCHHHHhc
Confidence 0000011111111 111235566666 999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.4e-11 Score=117.33 Aligned_cols=117 Identities=22% Similarity=0.383 Sum_probs=77.3
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
....+|||+++.............|+.+|+|||+......+.++|||||||+++||+||+.|+........ . . .+
T Consensus 155 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~-~--~~ 229 (297)
T cd06659 155 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--M-K--RL 229 (297)
T ss_pred cEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-H--HH
Confidence 34579999987665433323345688999999999888899999999999999999999999752111000 0 0 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
.....+..... ....+++..+++ .|++.+|++||++.||++.
T Consensus 230 ~~~~~~~~~~~-~~~~~~l~~~i~---~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 230 RDSPPPKLKNA-HKISPVLRDFLE---RMLTREPQERATAQELLDH 271 (297)
T ss_pred hccCCCCcccc-CCCCHHHHHHHH---HHhcCCcccCcCHHHHhhC
Confidence 00001111100 112244556666 9999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.6e-11 Score=117.78 Aligned_cols=120 Identities=24% Similarity=0.351 Sum_probs=77.3
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++....... ......++..|++||.......+.++||||||++++|+++ |..|+....... ....
T Consensus 218 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~-- 293 (343)
T cd05103 218 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR-- 293 (343)
T ss_pred EEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH--
Confidence 34689999887643221 1112345677999999988889999999999999999997 888874321100 0000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
...+-..+..+ . ....+ +.++...|++.+|++||++.||++.|+.+.
T Consensus 294 ~~~~~~~~~~~--~-~~~~~---~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 294 RLKEGTRMRAP--D-YTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHhccCCCCCC--C-CCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000001111 1 11123 455566999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.7e-11 Score=113.60 Aligned_cols=113 Identities=27% Similarity=0.483 Sum_probs=76.8
Q ss_pred ccccccCcccccCCCCCC------cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSN------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~------~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
-..+|||+++........ .....|+..|++||+......+.++|+||||++++|++||+.|++...... ..
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~- 221 (267)
T cd06628 145 IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI- 221 (267)
T ss_pred EEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH-
Confidence 346899998877532111 112457889999999988888999999999999999999999985321110 00
Q ss_pred cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 443 TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 443 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+...+.++. ...+++..+++ .|++.+|++||++.||++
T Consensus 222 --~~~~~~~~~~~~~---~~~~~~~~li~---~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 --FKIGENASPEIPS---NISSEAIDFLE---KTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --HHHhccCCCcCCc---ccCHHHHHHHH---HHccCCchhCcCHHHHhh
Confidence 0011112222221 12356667777 999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.6e-11 Score=112.41 Aligned_cols=117 Identities=25% Similarity=0.392 Sum_probs=78.3
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............++..|++||...+...+.++|+||||++++|++||+.|+.......... ...
T Consensus 139 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~-----~~~ 213 (264)
T cd06623 139 VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE-----LMQ 213 (264)
T ss_pred EEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHH-----HHH
Confidence 346899998877544333334567889999999988889999999999999999999999975432100000 001
Q ss_pred cccCCCCCCCCcc-hHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 449 EMLDPRLPVPSCS-VQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 449 ~~~d~~l~~~~~~-~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
.+........... ..+.+..+++ .|++.+|++||++.|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~l~~li~---~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 AICDGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHhcCCCCCCCcccCCHHHHHHHH---HHccCChhhCCCHHHHHhC
Confidence 1111111111111 2245556666 8999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-11 Score=116.27 Aligned_cols=113 Identities=26% Similarity=0.463 Sum_probs=74.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||.+......... ...++.+|++||+..+...+.++||||||++++|++||+.|+........ ... .....
T Consensus 141 ~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~--~~~~~ 215 (265)
T cd06605 141 KLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIF--ELLQY 215 (265)
T ss_pred EEeecccchhhHHHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHH--HHHHH
Confidence 46799988765322111 15688899999999888999999999999999999999999754321100 000 00111
Q ss_pred ccC---CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLD---PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d---~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+.. +.++.. ....++.++++ .|+..+|++||++.|+++
T Consensus 216 ~~~~~~~~~~~~--~~~~~~~~li~---~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 216 IVNEPPPRLPSG--KFSPDFQDFVN---LCLIKDPRERPSYKELLE 256 (265)
T ss_pred HhcCCCCCCChh--hcCHHHHHHHH---HHcCCCchhCcCHHHHhh
Confidence 111 111111 02244556665 999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.5e-11 Score=111.29 Aligned_cols=133 Identities=26% Similarity=0.296 Sum_probs=81.6
Q ss_pred CcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCC
Q 010736 115 ISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQIS 194 (502)
Q Consensus 115 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 194 (502)
+.....|+.||||+|.|+ .+.++..-++.++.|++|+|.+... ..+..+++|+.|||++|.++ .+...-.++-+++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 334456667777777766 5555666666777777777766522 22666667777777777666 3333444566667
Q ss_pred eEEcccccccccCCccCcCCccCCccccccccccCcc-cccccCCCCCcEEEeeCccccc
Q 010736 195 MLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI-PLSLGNLTNLKQFSLVYNNLYG 253 (502)
Q Consensus 195 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~ 253 (502)
+|.|+.|.+... ..++.+-+|..||+++|++.... -..+++++.|+.+.+.+|.+.+
T Consensus 356 tL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 356 TLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 777777766532 23555666677777777665321 2346677777777777776653
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.03 E-value=8.1e-11 Score=111.71 Aligned_cols=110 Identities=25% Similarity=0.343 Sum_probs=73.5
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.+|||+++....... .....|+..|++||.......+.++||||||++++|++||+.|++..... ..... ...-
T Consensus 143 l~d~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~--~~~~ 216 (256)
T cd08220 143 IGDFGISKILSSKSK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLK--IMSG 216 (256)
T ss_pred EccCCCceecCCCcc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHH--HHhc
Confidence 589999887643322 22356788999999998888899999999999999999999997532110 00000 0000
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+.++. ....++..++. .|++.+|++||+|.|+++
T Consensus 217 ~~~~~~~---~~~~~l~~li~---~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 217 TFAPISD---RYSPDLRQLIL---SMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCC---CcCHHHHHHHH---HHccCChhhCCCHHHHhh
Confidence 0011111 11234555555 999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.03 E-value=4e-11 Score=118.38 Aligned_cols=106 Identities=26% Similarity=0.408 Sum_probs=70.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||+..+...+.++||||+||+++||+||+.|++...... ....
T Consensus 141 kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~ 212 (324)
T cd05587 141 KIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQS 212 (324)
T ss_pred EEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHH
Confidence 36899998754322222334678999999999998888999999999999999999999985321100 0011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
+......-+ .....++..+++ .|++.+|++||+.
T Consensus 213 i~~~~~~~~-~~~~~~~~~li~---~~l~~~P~~R~~~ 246 (324)
T cd05587 213 IMEHNVSYP-KSLSKEAVSICK---GLLTKHPAKRLGC 246 (324)
T ss_pred HHcCCCCCC-CCCCHHHHHHHH---HHhhcCHHHcCCC
Confidence 111111101 112245556666 8999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.3e-11 Score=116.64 Aligned_cols=115 Identities=25% Similarity=0.397 Sum_probs=74.7
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||++..............++.+|++||+......+.++|||||||+++|++||+.|+........ .......
T Consensus 155 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~~~~~~~ 231 (286)
T cd06614 155 VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---LFLITTK 231 (286)
T ss_pred EEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhc
Confidence 3468999876654332222345578899999998888889999999999999999999999742211000 0000000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.. +..... .....++..+++ .|++.+|.+||++.+|++
T Consensus 232 ~~--~~~~~~-~~~~~~l~~li~---~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 232 GI--PPLKNP-EKWSPEFKDFLN---KCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CC--CCCcch-hhCCHHHHHHHH---HHhccChhhCcCHHHHhh
Confidence 00 011100 112245666666 999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.2e-11 Score=116.81 Aligned_cols=108 Identities=21% Similarity=0.306 Sum_probs=71.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............|+..|+|||......++.++|||||||+++||+||+.|+..... .. ...
T Consensus 135 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~-----~~~ 206 (321)
T cd05603 135 VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQ-----MYD 206 (321)
T ss_pred EEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HH-----HHH
Confidence 3468999988643222223346789999999999888899999999999999999999999742110 00 011
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~ 488 (502)
.+....+..+. ....++..+++ .|++.+|++||+..
T Consensus 207 ~i~~~~~~~~~-~~~~~~~~li~---~~l~~~p~~R~~~~ 242 (321)
T cd05603 207 NILHKPLQLPG-GKTVAACDLLV---GLLHKDQRRRLGAK 242 (321)
T ss_pred HHhcCCCCCCC-CCCHHHHHHHH---HHccCCHhhcCCCC
Confidence 11111111111 12234555655 99999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.03 E-value=8.8e-11 Score=113.74 Aligned_cols=119 Identities=24% Similarity=0.321 Sum_probs=74.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||++........ ....++..|++||...+...+.++||||+|++++||+||+.|++.................
T Consensus 144 ~~l~dfg~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd06621 144 VKLCDFGVSGELVNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV 221 (287)
T ss_pred EEEeecccccccccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh
Confidence 34689999876532211 2345778999999998888999999999999999999999998643210000000000000
Q ss_pred cccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+.+.... ....+++.++++ .|++.+|++||+|.||++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 222 NMPNPELKDEPGNGIKWSEEFKDFIK---QCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCchhhccCCCCCCchHHHHHHHHH---HHcCCCcccCCCHHHHHh
Confidence 11111111100 012234555555 999999999999999976
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.7e-11 Score=117.24 Aligned_cols=107 Identities=26% Similarity=0.384 Sum_probs=71.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||.......+.++|||||||+++||+||+.|+...... . ....
T Consensus 141 kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~-----~~~~ 212 (324)
T cd05589 141 KIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---E-----VFDS 212 (324)
T ss_pred EeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---H-----HHHH
Confidence 4689999876433333333467899999999998888999999999999999999999997521110 0 0011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~ 488 (502)
+.......+ .....++..+++ .|++.+|.+||+++
T Consensus 213 i~~~~~~~p-~~~~~~~~~li~---~~L~~dP~~R~~~~ 247 (324)
T cd05589 213 IVNDEVRYP-RFLSREAISIMR---RLLRRNPERRLGSG 247 (324)
T ss_pred HHhCCCCCC-CCCCHHHHHHHH---HHhhcCHhHcCCCC
Confidence 111111101 112245566666 99999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.3e-11 Score=116.50 Aligned_cols=111 Identities=25% Similarity=0.433 Sum_probs=72.0
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++...... ...++..|+|||... ....+.++||||||++++|++||+.|+...... .....
T Consensus 154 ~kL~dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~~~~- 225 (307)
T cd06607 154 VKLADFGSASLVSPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYH- 225 (307)
T ss_pred EEEeecCcceecCCCC----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HHHHH-
Confidence 3468999987764332 346788999999874 356788999999999999999999997421100 00000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
+..-..+.+... ...+++..+++ .|++.+|++||+|.+|++.
T Consensus 226 -~~~~~~~~~~~~--~~~~~~~~li~---~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 226 -IAQNDSPTLSSN--DWSDYFRNFVD---SCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -HhcCCCCCCCch--hhCHHHHHHHH---HHhcCChhhCcCHHHHhcC
Confidence 000001111110 11234556665 9999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-10 Score=116.05 Aligned_cols=116 Identities=25% Similarity=0.433 Sum_probs=83.4
Q ss_pred ccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.+||||+|.+++++. ..+..+-.+.||+||-..-.++|..+|||=|||-+||++. |.+|+..+...+. +.. +.
T Consensus 532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---I~~--iE 606 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---IGH--IE 606 (974)
T ss_pred ecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce---EEE--ec
Confidence 589999999976543 2233445678999999999999999999999999999986 9999865443221 110 10
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
-..+++-++ ..+..+..++. .||+.+|.+||...|++..|..+
T Consensus 607 --nGeRlP~P~-nCPp~LYslms---kcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 607 --NGERLPCPP-NCPPALYSLMS---KCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred --CCCCCCCCC-CCChHHHHHHH---HHhccCcccCCcHHHHHHHHHHH
Confidence 112333222 22344556655 89999999999999999988775
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.1e-11 Score=114.94 Aligned_cols=121 Identities=15% Similarity=0.203 Sum_probs=74.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCC----------
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS---------- 437 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~---------- 437 (502)
-..+|||+++.............++..|+|||...+ ...+.++||||+||+++||+||+.|+.......
T Consensus 142 ~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 221 (288)
T cd07871 142 LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG 221 (288)
T ss_pred EEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 347899999876433333334567899999998764 567899999999999999999999974211000
Q ss_pred ---CCCCC---cccccccccCCCCCCC-----CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 ---SPSLN---TDIALDEMLDPRLPVP-----SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 ---~~~~~---~~~~~~~~~d~~l~~~-----~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+. ......+...|..... .....++..++++ .|+..+|.+|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~---~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLS---SLLLYETKSRISAEAALR 284 (288)
T ss_pred CCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHH---HhcCcCcccCCCHHHHhc
Confidence 00000 0000011111111000 0011234556666 899999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.2e-10 Score=115.13 Aligned_cols=114 Identities=25% Similarity=0.336 Sum_probs=72.1
Q ss_pred ccccccCcccccCCCCCC-cccccccccccCccccc------cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSN-WTGFAGTYGYIAPELAY------TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSL 441 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~-~~~~~gt~gy~aPE~~~------~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~ 441 (502)
-..+|||+++.+...... .....||..|+|||... ....+.++|||||||+++||+||+.|+....... .
T Consensus 141 ~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~ 217 (330)
T cd05601 141 IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---T 217 (330)
T ss_pred EEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---H
Confidence 347899999877543322 22346899999999986 4456789999999999999999999975321100 0
Q ss_pred Cccc-ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 442 NTDI-ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 442 ~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.... ...... ..+.. .....++..+++ .|+. +|++||++.++++
T Consensus 218 ~~~i~~~~~~~--~~~~~-~~~~~~~~~li~---~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 218 YNNIMNFQRFL--KFPED-PKVSSDFLDLIQ---SLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHcCCCcc--CCCCC-CCCCHHHHHHHH---HHcc-ChhhCCCHHHHhC
Confidence 0000 000000 01111 112345666666 6776 9999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.3e-11 Score=112.94 Aligned_cols=114 Identities=27% Similarity=0.423 Sum_probs=75.7
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
...+|||+++.+...........++..|++||+..+...+.++|+|||||+++|++||+.|+....... ... .+.
T Consensus 140 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~--~~~ 214 (277)
T cd06641 140 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLF--LIP 214 (277)
T ss_pred EEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHH--HHh
Confidence 346899998876543322333567889999999988888999999999999999999999975321110 000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
....+.+.. ....++.+++. .|++.+|.+||+|+|+++.
T Consensus 215 ~~~~~~~~~---~~~~~~~~~i~---~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 215 KNNPPTLEG---NYSKPLKEFVE---ACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCCCCCCCc---ccCHHHHHHHH---HHccCChhhCcCHHHHHhC
Confidence 000111111 11234445544 9999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.2e-11 Score=113.55 Aligned_cols=61 Identities=25% Similarity=0.307 Sum_probs=50.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++...... ..+...|+..|+|||...+...+.++||||+||+++||++|+.|+.
T Consensus 148 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 148 KLADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred EECccCccccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 368999998765322 2234567889999999988889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.02 E-value=8.4e-11 Score=103.21 Aligned_cols=128 Identities=27% Similarity=0.373 Sum_probs=46.8
Q ss_pred cCcCCCCCCEEEccCCcCcCCCCcccC-CCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCC-CCCC
Q 010736 114 QISNLTNLSILSLGGNQFSGNIPHEVG-LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSL-GNLT 191 (502)
Q Consensus 114 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~ 191 (502)
.+.+..++++|+|++|.|+. +. .++ .+.+|+.|+|++|.|+.. + .+..+++|++|++++|+++. +...+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLP 88 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-T
T ss_pred cccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCc-cccchHHhCC
Confidence 35666788999999999984 43 455 578999999999999843 2 57788999999999999984 43334 3578
Q ss_pred CCCeEEcccccccccC-CccCcCCccCCccccccccccCcc---cccccCCCCCcEEEe
Q 010736 192 QISMLFLHDNSFSGFI-PPDIGNLKSISILSLAINQFSGPI---PLSLGNLTNLKQFSL 246 (502)
Q Consensus 192 ~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~---p~~~~~l~~L~~L~l 246 (502)
+|+.|++++|+|...- -..+..+++|+.|++.+|.++... ...+..+++|+.||-
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 9999999999887532 134556777888888888776331 123455677777764
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.02 E-value=8e-11 Score=111.48 Aligned_cols=116 Identities=24% Similarity=0.405 Sum_probs=73.6
Q ss_pred cccccCcccccCCCCCCc--ccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNW--TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~--~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++......... ....++..|++||...+...+.++|+|||||+++|++| |+.|+........ .. .
T Consensus 133 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~~--~ 207 (251)
T cd05041 133 KISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RE--R 207 (251)
T ss_pred EEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---HH--H
Confidence 468999988664222111 11233567999999988889999999999999999999 7888643211000 00 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
+... .....+ .....++.+++ ..|+..+|++||++.||++.|++
T Consensus 208 ~~~~--~~~~~~-~~~~~~~~~li---~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 208 IESG--YRMPAP-QLCPEEIYRLM---LQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HhcC--CCCCCC-ccCCHHHHHHH---HHHhccChhhCcCHHHHHHHhhC
Confidence 0000 011101 11223444444 49999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.4e-11 Score=115.80 Aligned_cols=114 Identities=22% Similarity=0.373 Sum_probs=74.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|++||...+...+.++|||||||+++|++||+.|+...... .... .+..
T Consensus 155 ~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~--~~~~ 229 (285)
T cd06648 155 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMK--RIRD 229 (285)
T ss_pred EEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHH--HHHh
Confidence 3689998876544322222345888999999998888899999999999999999999997421100 0000 0011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+..... .....++..+++ .|++.+|++||++.|+++
T Consensus 230 ~~~~~~~~~-~~~~~~l~~li~---~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 230 NLPPKLKNL-HKVSPRLRSFLD---RMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCCCCccc-ccCCHHHHHHHH---HHcccChhhCcCHHHHcc
Confidence 111111111 112245666666 999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.02 E-value=4e-11 Score=115.90 Aligned_cols=121 Identities=19% Similarity=0.161 Sum_probs=72.7
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCC----------
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS---------- 437 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~---------- 437 (502)
-..+|||+++.............++..|+|||...+ ...+.++|||||||+++|++||+.|+.......
T Consensus 140 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~ 219 (285)
T cd07861 140 IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG 219 (285)
T ss_pred EEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence 347899998866433222233456789999998764 346889999999999999999999975211000
Q ss_pred ---CCCCCccc---ccc----cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 ---SPSLNTDI---ALD----EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 ---~~~~~~~~---~~~----~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...|.... ... ....+.+........+++.++++ .|++.+|++||++.||++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLE---KMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHH---HHhcCChhhCCCHHHHhc
Confidence 00000000 000 00000000000112245556666 999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.8e-11 Score=114.03 Aligned_cols=116 Identities=22% Similarity=0.377 Sum_probs=72.3
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
+-..+|||+++.............++..|++||+.. ....+.++|||||||+++||+||+.|+...... ...
T Consensus 148 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~ 224 (292)
T cd06644 148 DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVL 224 (292)
T ss_pred CEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHH
Confidence 345789998876433222223456788999999874 334677899999999999999999997421110 000
Q ss_pred cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 443 TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 443 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
........+....+. ....++..+++ .|++.+|++||++.||++
T Consensus 225 --~~~~~~~~~~~~~~~-~~~~~~~~li~---~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 225 --LKIAKSEPPTLSQPS-KWSMEFRDFLK---TALDKHPETRPSAAQLLE 268 (292)
T ss_pred --HHHhcCCCccCCCCc-ccCHHHHHHHH---HHhcCCcccCcCHHHHhc
Confidence 000111111111111 11234455555 899999999999999965
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.6e-11 Score=117.06 Aligned_cols=108 Identities=24% Similarity=0.306 Sum_probs=73.7
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++...... ....|+..|+|||.......+.++|||||||+++||+||+.|+...... . ...
T Consensus 157 ~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~-----~~~ 225 (329)
T PTZ00263 157 VKVTDFGFAKKVPDRT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---R-----IYE 225 (329)
T ss_pred EEEeeccCceEcCCCc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---H-----HHH
Confidence 3468999998765432 2357899999999998888899999999999999999999997421100 0 001
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-----HHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-----MKIVS 491 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-----m~~v~ 491 (502)
.+....+.-+ .....++.++++ .|++.+|++||+ ++|+.
T Consensus 226 ~i~~~~~~~p-~~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 226 KILAGRLKFP-NWFDGRARDLVK---GLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred HHhcCCcCCC-CCCCHHHHHHHH---HHhhcCHHHcCCCCCCCHHHHh
Confidence 1111111111 112245666666 999999999996 56654
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.8e-10 Score=112.04 Aligned_cols=116 Identities=23% Similarity=0.391 Sum_probs=76.4
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
...+|||++..............|+..|++||+......+.++|+|||||+++|++||+.|+.............. .
T Consensus 154 ~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~---~ 230 (293)
T cd06647 154 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---N 230 (293)
T ss_pred EEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc---C
Confidence 4468999887665433333345688899999998888889999999999999999999999853221110000000 0
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
. -+....+ .....++..+++ .|++.+|++||++.|++..
T Consensus 231 ~--~~~~~~~-~~~~~~l~~li~---~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 G--TPELQNP-EKLSAIFRDFLN---RCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C--CCCCCCc-cccCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence 0 0011101 111234555555 9999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.3e-11 Score=112.03 Aligned_cols=108 Identities=22% Similarity=0.420 Sum_probs=69.7
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCC-CCCCcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGK-HPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~-~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.+|||++...... ....++..|+|||+.... ..+.++|||||||+++|+++|+ .|+....... .....
T Consensus 149 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~~~~ 218 (258)
T cd05078 149 LSDPGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KLQFY 218 (258)
T ss_pred ecccccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HHHHH
Confidence 4688877654321 235678899999998764 5788999999999999999995 5543211100 00000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
. -...++. ....++.+++. .|++.+|++||+|+|++++|+
T Consensus 219 ~-~~~~~~~---~~~~~~~~li~---~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 E-DRHQLPA---PKWTELANLIN---QCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred H-ccccCCC---CCcHHHHHHHH---HHhccChhhCCCHHHHHHhcC
Confidence 0 0111221 11234555555 999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.1e-10 Score=126.22 Aligned_cols=121 Identities=22% Similarity=0.338 Sum_probs=76.4
Q ss_pred CccccccCcccccCCCC------------------CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCC
Q 010736 368 NNITGDFGIAKFLKPDS------------------SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~------------------~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p 429 (502)
....+|||+++...... .......||..|+|||...+...+.++|||||||+++||+||+.|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 33468999998762110 001124689999999999988899999999999999999999999
Q ss_pred CCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-CHHHHHHHHHhh
Q 010736 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-TMKIVSQQLRIS 497 (502)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-~m~~v~~~l~~~ 497 (502)
+....... .... ..+.+|.-..+.......+.+ ++..|++.+|++|| ++.++.+.|+..
T Consensus 231 F~~~~~~k---i~~~---~~i~~P~~~~p~~~iP~~L~~---LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 231 YRRKKGRK---ISYR---DVILSPIEVAPYREIPPFLSQ---IAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred CCCcchhh---hhhh---hhccChhhccccccCCHHHHH---HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 75321110 0000 111111111011112233444 44599999999995 677777777654
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.00 E-value=9e-11 Score=111.82 Aligned_cols=116 Identities=29% Similarity=0.521 Sum_probs=74.6
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++.+..... ......++..|++||...+...+.++|+||||++++|++| |+.|+...... .... .+
T Consensus 143 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~--~~ 217 (261)
T cd05034 143 KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLE--QV 217 (261)
T ss_pred EECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--HH
Confidence 3689999887643211 1112334568999999988889999999999999999999 99997421110 0000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
.... ....+ ....+++.+++ ..|+..+|++||+++++.+.|+.
T Consensus 218 ~~~~--~~~~~-~~~~~~~~~~i---~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 218 ERGY--RMPRP-PNCPEELYDLM---LQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HcCC--CCCCC-CCCCHHHHHHH---HHHcccCcccCCCHHHHHHHHhc
Confidence 0000 11111 11124444444 49999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.3e-10 Score=113.52 Aligned_cols=64 Identities=20% Similarity=0.283 Sum_probs=49.8
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDF 432 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~ 432 (502)
-..+|||+++.............|+..|+|||...+ ...+.++||||+||+++||+||+.|+..
T Consensus 142 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 142 LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred EEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 347899999865433333334567889999998754 3578889999999999999999999853
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.1e-10 Score=111.23 Aligned_cols=112 Identities=29% Similarity=0.401 Sum_probs=75.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|++||+......+.++|+||||++++|++||+.|++.... .... .....
T Consensus 145 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~--~~~~~ 219 (260)
T cd08222 145 KIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVV--LRIVE 219 (260)
T ss_pred eecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHH--HHHHc
Confidence 358999988775433333345678899999998888888999999999999999999999742110 0000 00011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
-..+..+ .....++..+++ .|+..+|++||++.|+++
T Consensus 220 ~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 GPTPSLP---ETYSRQLNSIMQ---SMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCc---chhcHHHHHHHH---HHhcCChhhCcCHHHHhh
Confidence 1112221 112245556665 999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.7e-11 Score=117.20 Aligned_cols=60 Identities=27% Similarity=0.458 Sum_probs=49.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.+.... .....|+..|+|||...+...+.++|||||||+++|+++|+.|++
T Consensus 144 kL~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 144 KLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred EEeeCCcchhhhhhc--cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 468999987654321 123568899999999988889999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.3e-11 Score=114.30 Aligned_cols=116 Identities=26% Similarity=0.304 Sum_probs=74.8
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccc---eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM---KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~---~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++.+..... .....|+..|++||..... ..+.++|||||||+++|++||+.|+...... ... ..
T Consensus 147 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~-~~-- 221 (288)
T cd06616 147 IKLCDFGISGQLVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-FDQ-LT-- 221 (288)
T ss_pred EEEeecchhHHhccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-HHH-Hh--
Confidence 45789999876543221 2334678899999998765 6888999999999999999999997532100 000 00
Q ss_pred ccccccCCCCCCCC-cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 446 ALDEMLDPRLPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 446 ~~~~~~d~~l~~~~-~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.......+.+.... .....++.++++ .|++.+|++||++.||++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 222 QVVKGDPPILSNSEEREFSPSFVNFIN---LCLIKDESKRPKYKELLE 266 (288)
T ss_pred hhcCCCCCcCCCcCCCccCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 00000112221110 112345566666 999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.00 E-value=1e-10 Score=112.96 Aligned_cols=64 Identities=22% Similarity=0.307 Sum_probs=48.5
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
+-..+|||+++.+.......+...++..|+|||+..+. ..+.++|+||||++++||+||+.|+.
T Consensus 137 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 137 ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 34568999987664332222334567889999987654 46889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.2e-10 Score=110.55 Aligned_cols=115 Identities=29% Similarity=0.397 Sum_probs=74.7
Q ss_pred ccccccCcccccCCCCCCcc-cccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSSNWT-GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~-~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
-..+|||+++.......... ...++..|++||.......+.++|+||+|++++|+++ |+.|++..... ..
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~----- 213 (258)
T smart00219 142 VKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EV----- 213 (258)
T ss_pred EEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HH-----
Confidence 45789999887654322111 2336788999999988889999999999999999999 77886431110 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
...+..............++.++++ .|+..+|++||++.|++++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~i~---~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 214 LEYLKKGYRLPKPENCPPEIYKLML---QCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHhcCCCCCCCCcCCHHHHHHHH---HHCcCChhhCcCHHHHHhhC
Confidence 0000000000001112344555555 99999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.7e-10 Score=111.54 Aligned_cols=63 Identities=27% Similarity=0.397 Sum_probs=50.8
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++....... ......++..|+|||+..+. ..+.++||||||++++|++||+.|+.
T Consensus 139 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 139 LKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred EEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 34689999888754332 22345678889999999887 78899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.3e-11 Score=114.55 Aligned_cols=119 Identities=29% Similarity=0.441 Sum_probs=75.9
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc---c
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD---I 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~---~ 445 (502)
-..+|||+++...... .....|+..|++||...+...+.++|+|||||+++|++||+.|++............. .
T Consensus 143 ~~l~d~gl~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd06620 143 IKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220 (284)
T ss_pred EEEccCCcccchhhhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH
Confidence 3468999886553221 1235688999999998888889999999999999999999999864322100000000 0
Q ss_pred cccccc---CCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 446 ALDEML---DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 446 ~~~~~~---d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
....+. .+.+... ....++..++. .|++.+|++||++.||+++.
T Consensus 221 ~~~~~~~~~~~~~~~~--~~~~~~~~li~---~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 221 LLQQIVQEPPPRLPSS--DFPEDLRDFVD---ACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHhhccCCCCCch--hcCHHHHHHHH---HHhcCCcccCcCHHHHhcCc
Confidence 011111 1111111 11234444444 99999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.8e-11 Score=119.99 Aligned_cols=264 Identities=24% Similarity=0.219 Sum_probs=176.0
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEc
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELAL 174 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 174 (502)
+.++.++...+.+.+.--. ...+..++.+++..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|++
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDL 125 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheec
Confidence 3455566655544322111 1456777888888888873 33457788899999999999984 3333677889999999
Q ss_pred ccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCccc-ccccCCCCCcEEEeeCccccc
Q 010736 175 FSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIP-LSLGNLTNLKQFSLVYNNLYG 253 (502)
Q Consensus 175 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 253 (502)
++|.|+...+ +..++.|+.|++++|.++.. ..+..++.|+.+++++|+++..-+ . ...+.+++.+.+..|.+..
T Consensus 126 s~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 126 SFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE 200 (414)
T ss_pred cccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence 9999985443 56777799999999998854 355668889999999998885444 2 4677788888898888762
Q ss_pred cCCCCCccccccEEECcCCcCcccCCccccCCC--CCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccC
Q 010736 254 SIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGG--ALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFG 331 (502)
Q Consensus 254 ~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~--~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 331 (502)
+...-....+..+++..|.++..-+ +.... .|+.+++++|++. ..+..+..+..+..+++..|++.... .+.
T Consensus 201 -i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~ 274 (414)
T KOG0531|consen 201 -IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLE 274 (414)
T ss_pred -ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--ccc
Confidence 2111111345555778888776432 22222 3788888888887 33355667788888888888876442 334
Q ss_pred CCCCCcEEEccCcccccc---cCcc-ccCCCCCCeeeecCCcccc
Q 010736 332 IYPNLTFIDLSRNNFYGE---ISSN-FGECPKLGALNISRNNITG 372 (502)
Q Consensus 332 ~l~~L~~L~Ls~N~l~~~---~~~~-~~~~~~L~~L~l~~N~l~~ 372 (502)
..+.+..+.+..|.+... .... ....+.+....+..|++..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 275 RLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred ccchHHHhccCcchhcchhhhhccccccccccccccccccCcccc
Confidence 455666667777766522 1111 4456677777777777643
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-10 Score=114.47 Aligned_cols=62 Identities=21% Similarity=0.359 Sum_probs=49.0
Q ss_pred cccccCcccccCCCCC---CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++....... ......||..|+|||...+ ...+.++|||||||+++||+||+.|+.
T Consensus 152 kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 152 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred EEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 4689999987643221 1234568899999998866 457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-10 Score=110.81 Aligned_cols=109 Identities=26% Similarity=0.415 Sum_probs=71.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc--eecccceeeeeceeeeehhcC-CCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM--KITEKCDVYSFGVLVLEVIKG-KHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~--~~s~k~Dvysfgv~llElltg-~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+... ....++..|++||+.... ..+.++|+|||||+++|+++| ..|+...........
T Consensus 148 kl~Dfg~a~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~----- 218 (259)
T cd05037 148 KLSDPGIPITVLSR----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF----- 218 (259)
T ss_pred EeCCCCcccccccc----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-----
Confidence 46899998865431 123466789999998776 788999999999999999994 666543221110000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
. . .....+.+ ....+.++++ .|+..+|++||++.||++.|+
T Consensus 219 ~-~-~~~~~~~~---~~~~~~~li~---~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 Y-Q-DQHRLPMP---DCAELANLIN---QCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred H-h-cCCCCCCC---CchHHHHHHH---HHhccChhhCCCHHHHHHhcC
Confidence 0 0 00111111 1134555555 999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-10 Score=112.44 Aligned_cols=62 Identities=21% Similarity=0.336 Sum_probs=48.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccce-ecccceeeeeceeeeehhcCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~-~s~k~Dvysfgv~llElltg~~p~ 430 (502)
-..+|||+++.............++..|+|||...+.. .+.++|||||||+++||+||+.|.
T Consensus 138 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 138 LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred EEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 34689999986644333333455788999999876643 688999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.8e-11 Score=113.60 Aligned_cols=115 Identities=23% Similarity=0.377 Sum_probs=73.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
-..+|||++..............++..|++||... ....+.++|+||||++++||+||+.|+....... ...
T Consensus 142 ~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~ 218 (280)
T cd06611 142 VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLL 218 (280)
T ss_pred EEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHH
Confidence 34689998876543332333456888999999864 3446789999999999999999999975321100 000
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.......+.+..+ .....++.++++ .|++.+|++||++.+|++
T Consensus 219 --~~~~~~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 219 --KILKSEPPTLDQP-SKWSSSFNDFLK---SCLVKDPDDRPTAAELLK 261 (280)
T ss_pred --HHhcCCCCCcCCc-ccCCHHHHHHHH---HHhccChhhCcCHHHHhc
Confidence 0000011111111 112245556666 999999999999999965
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=8.7e-11 Score=120.67 Aligned_cols=61 Identities=31% Similarity=0.374 Sum_probs=50.2
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
.++|||+++.+..... ......||..|++||+..+..++.++|||||||+++||++|+.|.
T Consensus 300 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred EEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 4789999987754322 123467999999999999989999999999999999999988764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1e-10 Score=120.30 Aligned_cols=115 Identities=31% Similarity=0.492 Sum_probs=82.0
Q ss_pred ccccCcccccCCCCCCcc--cccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDSSNWT--GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~--~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
+.|||+++++.++....+ ..+-.+.|||-|.....+++.++|||||||.+||++| |.+|++.....+.+.+.+.
T Consensus 839 itdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~--- 915 (1177)
T KOG1025|consen 839 ITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK--- 915 (1177)
T ss_pred EEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc---
Confidence 579999999987654333 2334567888888889999999999999999999999 9999875433222222111
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
..+|..++ -+-.+|..+.+.||..++..||++++...+..+
T Consensus 916 ----geRLsqPp----iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 916 ----GERLSQPP----ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ----cccCCCCC----CccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 11343322 233445555668999999999999999887765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.98 E-value=6.3e-11 Score=115.05 Aligned_cols=109 Identities=22% Similarity=0.287 Sum_probs=73.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.+.... ....|+..|+|||...+...+.++|||||||+++||+||+.|+...... . ...
T Consensus 140 ~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~-----~~~ 208 (291)
T cd05612 140 IKLTDFGFAKKLRDRT---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---G-----IYE 208 (291)
T ss_pred EEEEecCcchhccCCc---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H-----HHH
Confidence 3468999998764322 2356899999999998888899999999999999999999997532110 0 001
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-----HHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-----MKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-----m~~v~~ 492 (502)
.+......-+ .....++..+++ .|++.+|.+||+ +.|+.+
T Consensus 209 ~i~~~~~~~~-~~~~~~~~~li~---~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 209 KILAGKLEFP-RHLDLYAKDLIK---KLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHhCCcCCC-ccCCHHHHHHHH---HHcCCCHHHccCCccCCHHHHhc
Confidence 1111111101 112245666776 999999999995 666643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.1e-10 Score=115.90 Aligned_cols=108 Identities=21% Similarity=0.329 Sum_probs=73.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.+... .....||..|+|||...+...+.++|||||||+++||+||+.|+...... .....
T Consensus 171 kL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~ 239 (340)
T PTZ00426 171 KMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQK 239 (340)
T ss_pred EEecCCCCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHH
Confidence 46899999876432 23457899999999998888899999999999999999999998531110 00011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
+......-+ ....+++..+++ .|++.+|++|+ +++|+.+
T Consensus 240 i~~~~~~~p-~~~~~~~~~li~---~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 240 ILEGIIYFP-KFLDNNCKHLMK---KLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HhcCCCCCC-CCCCHHHHHHHH---HHcccCHHHcCCCCCCCHHHHHc
Confidence 111111101 112245566666 89999999995 7777754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.1e-10 Score=113.99 Aligned_cols=114 Identities=25% Similarity=0.343 Sum_probs=79.2
Q ss_pred CCccccccCcccccCCCCCCcccccccccccCccccccce-ec-ccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 367 RNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-IT-EKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 367 ~N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~-~s-~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
.|-.++|||+++..+..........||..|+|||...+.. ++ .++||||+||+++.|++|+.|++..... .+...
T Consensus 158 ~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~k 234 (370)
T KOG0583|consen 158 GNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYRK 234 (370)
T ss_pred CCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHHH
Confidence 5566899999998852223345688999999999999877 76 7899999999999999999999751110 00011
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~ 491 (502)
....++.-|... . ..+...+++ .|...+|.+|+++.|+.
T Consensus 235 i~~~~~~~p~~~---~--S~~~~~Li~---~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 IRKGEFKIPSYL---L--SPEARSLIE---KMLVPDPSTRITLLEIL 273 (370)
T ss_pred HhcCCccCCCCc---C--CHHHHHHHH---HHcCCCcccCCCHHHHh
Confidence 111111111111 0 234556666 89999999999999997
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=98.98 E-value=9.8e-11 Score=112.36 Aligned_cols=118 Identities=21% Similarity=0.368 Sum_probs=73.3
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccccce--ecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMK--ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~--~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
...+|||+++....... ......|+..|++||...... .+.++|+||||++++|+++|+.|+..............
T Consensus 147 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 226 (272)
T cd06629 147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN 226 (272)
T ss_pred EEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc
Confidence 34689999876543211 123456888999999987654 78999999999999999999999752211000000000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+++.... ....++.+++. .|+..+|++||+|+||++
T Consensus 227 ~~~~~~~~~~~~~---~~~~~~~~li~---~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 KRSAPPIPPDVSM---NLSPVALDFLN---ACFTINPDNRPTARELLQ 268 (272)
T ss_pred cccCCcCCccccc---cCCHHHHHHHH---HHhcCChhhCCCHHHHhh
Confidence 0001111111110 11244555555 999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-10 Score=113.76 Aligned_cols=63 Identities=17% Similarity=0.291 Sum_probs=48.4
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.............++..|++||...+. ..+.++|||||||+++||+||+.|+.
T Consensus 143 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 143 LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred EEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 3478999998654333223334568899999987643 46789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=6.9e-11 Score=111.74 Aligned_cols=61 Identities=33% Similarity=0.500 Sum_probs=54.2
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.+||||+|..-.+.....+++||.-|||||+.....++..+|-||.||+++||+||++|+.
T Consensus 166 LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 166 LTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred EeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 6899999976554444556899999999999999999999999999999999999999985
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.2e-10 Score=114.06 Aligned_cols=110 Identities=28% Similarity=0.474 Sum_probs=72.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||++...... ....++..|+|||+.. ....+.++|||||||+++|++||+.|+....... ....
T Consensus 155 kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~-- 225 (308)
T cd06634 155 KLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH-- 225 (308)
T ss_pred EECCcccceeecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHH--
Confidence 46899998776432 2346788999999974 3457889999999999999999999964221100 0000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
...-..+.... .....++..+++ .|++.+|++||++.+|++.
T Consensus 226 ~~~~~~~~~~~--~~~~~~~~~li~---~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 226 IAQNESPALQS--GHWSEYFRNFVD---SCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HhhcCCCCcCc--ccccHHHHHHHH---HHhhCCcccCCCHHHHhhC
Confidence 00000111111 112244566666 9999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.6e-10 Score=119.90 Aligned_cols=59 Identities=24% Similarity=0.311 Sum_probs=49.6
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~ 432 (502)
++|||++.... ...+...||..|+|||...+..++.++|||||||+++||+||+.|++.
T Consensus 289 l~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 289 ICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 58999875432 223456799999999999988999999999999999999999999863
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.2e-10 Score=117.84 Aligned_cols=61 Identities=30% Similarity=0.428 Sum_probs=49.8
Q ss_pred cccccCcccccCCC-CCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCC
Q 010736 370 ITGDFGIAKFLKPD-SSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 370 l~~dfGl~~ll~~~-~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
.++|||+++..... ........||..|+|||+......+.++|||||||+++||+||+.|+
T Consensus 222 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred EEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 36899999865322 12233467999999999998888999999999999999999999885
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.1e-11 Score=114.05 Aligned_cols=160 Identities=22% Similarity=0.218 Sum_probs=83.9
Q ss_pred CCCCCCCEEECCCCcccccCC--ccCcCCCCCCEEEccCCcCcCCC--CcccCCCCCCcEEEccCCcCcccCCcc-cCCC
Q 010736 92 SSFPHLAYLDLRDNKLFGTIP--PQISNLTNLSILSLGGNQFSGNI--PHEVGLMSHLKILYIDSNQLDGSIPLE-VGQL 166 (502)
Q Consensus 92 ~~l~~L~~L~Ls~N~l~g~~p--~~l~~l~~L~~L~Ls~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l 166 (502)
+++.+|+...|.+..... .+ .....|++++.||||.|-|...- -.-...+++|+.|+|+.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 345566666666665541 22 24455667777777777665321 122345666777777777665322221 1234
Q ss_pred CCCcEEEcccCccccc-CCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcc-cccccCCCCCcEE
Q 010736 167 SSMVELALFSNNLNGS-VPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI-PLSLGNLTNLKQF 244 (502)
Q Consensus 167 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~L 244 (502)
++|+.|.|+.|.++.. +-..+..+++|+.|+|..|............+..|+.|||++|++-... -...+.++.|..|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 5666666666666521 1112334566666666666432222233344555666666666654221 1334556666666
Q ss_pred EeeCcccc
Q 010736 245 SLVYNNLY 252 (502)
Q Consensus 245 ~l~~N~l~ 252 (502)
+++.+.+.
T Consensus 277 nls~tgi~ 284 (505)
T KOG3207|consen 277 NLSSTGIA 284 (505)
T ss_pred hccccCcc
Confidence 66666554
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-10 Score=117.13 Aligned_cols=43 Identities=35% Similarity=0.567 Sum_probs=39.8
Q ss_pred cccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 389 GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 389 ~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
...||..|+|||.......+.++|||||||+++||+||+.|+.
T Consensus 195 ~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 195 STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 3569999999999988889999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=98.96 E-value=2e-10 Score=110.96 Aligned_cols=61 Identities=28% Similarity=0.471 Sum_probs=48.5
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.+|||+++.+...........++..|++||+..+ ...+.++|+|||||+++||+||+.|+.
T Consensus 141 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 141 LCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred ECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 6899999877543322233457788999998765 457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=98.96 E-value=1e-10 Score=110.35 Aligned_cols=114 Identities=25% Similarity=0.400 Sum_probs=75.4
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||.+........ .....++..|++||+......+.++|+||||++++|++||+.|++........ . ...
T Consensus 137 ~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~--~~~ 210 (253)
T cd05122 137 VKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL---F--KIA 210 (253)
T ss_pred EEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH---H--HHH
Confidence 34688998877654332 23456888999999998888999999999999999999999997532111000 0 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...-+.+... .....++.++++ .|+..+|++||++.||++
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~i~---~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 211 TNGPPGLRNP-EKWSDEFKDFLK---KCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred hcCCCCcCcc-cccCHHHHHHHH---HHccCChhhCCCHHHHhc
Confidence 0001111111 001244556665 999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.7e-10 Score=110.07 Aligned_cols=61 Identities=23% Similarity=0.349 Sum_probs=49.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++....... .....++..|++||+......+.++|+||||++++||+||+.|++
T Consensus 147 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 147 KIADFGLARIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred EEeccCcceeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 3689999887643322 123457788999999998889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.2e-10 Score=117.44 Aligned_cols=105 Identities=23% Similarity=0.325 Sum_probs=76.8
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.+|||.++.++.+ ..+-+-|..|.|||.....-+++.+|+||+||+|+||+||+.|+.....+ ..+ ...+
T Consensus 457 ltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei-----~~~i 526 (612)
T KOG0603|consen 457 LTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI-----HTRI 526 (612)
T ss_pred EEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH-----HHhh
Confidence 5799999988654 12345678999999999999999999999999999999999998643222 000 1112
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~ 491 (502)
..+... ....++...+++ .|.+.+|.+||+|+|+.
T Consensus 527 ~~~~~s---~~vS~~AKdLl~---~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 527 QMPKFS---ECVSDEAKDLLQ---QLLQVDPALRLGADEIG 561 (612)
T ss_pred cCCccc---cccCHHHHHHHH---HhccCChhhCcChhhhc
Confidence 222221 123356777888 89999999999999974
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.6e-10 Score=113.70 Aligned_cols=111 Identities=28% Similarity=0.462 Sum_probs=72.4
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++..... ....|+..|++||+.. ....+.++|||||||+++||+||+.|+...... .
T Consensus 164 ~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~----- 231 (317)
T cd06635 164 VKLADFGSASIASPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---S----- 231 (317)
T ss_pred EEEecCCCccccCCc----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---H-----
Confidence 346899988765432 2346788999999974 456889999999999999999999996421100 0
Q ss_pred ccccccCCCCC-CCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 446 ALDEMLDPRLP-VPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 446 ~~~~~~d~~l~-~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
....+...... .......+++..+++ .|++.+|++||++.||++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 232 ALYHIAQNESPTLQSNEWSDYFRNFVD---SCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred HHHHHHhccCCCCCCccccHHHHHHHH---HHccCCcccCcCHHHHHhCh
Confidence 00011111100 001112234555555 99999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.3e-11 Score=113.18 Aligned_cols=60 Identities=35% Similarity=0.671 Sum_probs=54.1
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
++|||+||.+++... ..+++|++-|||||.....+++.|+|.||.|++++|++||+.|++
T Consensus 156 IADFGfAR~L~~~~~-a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 156 IADFGFARFLQPGSM-AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred ecccchhhhCCchhH-HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 699999999985432 235799999999999999999999999999999999999999997
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.8e-11 Score=108.87 Aligned_cols=139 Identities=23% Similarity=0.210 Sum_probs=95.9
Q ss_pred CCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCc
Q 010736 133 GNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIG 212 (502)
Q Consensus 133 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 212 (502)
|..-..+...+.|+.+|||+|.|+ .+..+..-++.++.|++++|.+.. + ..+..+++|+.|||++|.++.. -++-.
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~ 349 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAEC-VGWHL 349 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhHhh-hhhHh
Confidence 333334445567888888888887 566677777888888888888873 3 2377888888888888888743 33444
Q ss_pred CCccCCccccccccccCcccccccCCCCCcEEEeeCccccccC-CCCCcc-ccccEEECcCCcCccc
Q 010736 213 NLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSI-PPSLDN-LVLTKLSLDDNHFTSY 277 (502)
Q Consensus 213 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~-~~L~~L~ls~N~l~~~ 277 (502)
.+.+++.|.++.|.+... ..++++-+|..||+++|++...- -..++. +.|+.+.|.+|.+.+.
T Consensus 350 KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 567788888888887632 24566677888888888876221 122333 5677888888888764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.6e-11 Score=116.79 Aligned_cols=118 Identities=26% Similarity=0.416 Sum_probs=76.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc-cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||.+..............++..|.|||... ....+.++||||+|++++||++|+.|+..................
T Consensus 138 ~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~ 217 (260)
T PF00069_consen 138 KLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR 217 (260)
T ss_dssp EESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence 4689999876533233344567889999999998 888999999999999999999999997532000000000000000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.. ....... .....++.++++ .|++.+|++||+|.|+++
T Consensus 218 ~~-~~~~~~~-~~~~~~l~~li~---~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 PL-PSSSQQS-REKSEELRDLIK---KMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HH-HHHTTSH-TTSHHHHHHHHH---HHSSSSGGGSTTHHHHHT
T ss_pred cc-ccccccc-chhHHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 00 0010000 011256666666 999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.6e-10 Score=108.33 Aligned_cols=63 Identities=21% Similarity=0.391 Sum_probs=48.1
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccc-cceecccceeeeeceeeeehhcCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-TMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.-..+|||+++....... .+...++..|+|||... ....+.++|+||||++++|++||+.|+.
T Consensus 137 ~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~ 200 (283)
T cd07830 137 VVKIADFGLAREIRSRPP-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200 (283)
T ss_pred CEEEeecccceeccCCCC-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccC
Confidence 344689999887643221 22345778899999774 4457899999999999999999998874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=98.95 E-value=2e-10 Score=112.86 Aligned_cols=62 Identities=21% Similarity=0.364 Sum_probs=49.3
Q ss_pred cccccCcccccCCCCC---CcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++....... ......||..|+|||+..+. ..+.++||||+||+++||+||+.|+.
T Consensus 152 kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 152 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred EEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 4689999987753221 12345688999999988764 57889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.9e-10 Score=80.92 Aligned_cols=60 Identities=35% Similarity=0.504 Sum_probs=35.2
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcC
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQL 155 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 155 (502)
+|++|++++|+++...+..|.++++|++|++++|.++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666655555556666666666666666555555556666666666665543
|
... |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.6e-10 Score=109.61 Aligned_cols=64 Identities=19% Similarity=0.332 Sum_probs=49.0
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
+-..+|||+++.............++..|+|||+..+. ..+.++|||||||+++|++||+.|++
T Consensus 141 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 141 ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred cEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 34578999988654332222334568899999998653 47889999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.4e-10 Score=111.99 Aligned_cols=63 Identities=24% Similarity=0.330 Sum_probs=48.3
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccce-ecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~-~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.+...........++..|+|||...+.+ .+.++|||||||+++|++||+.|+.
T Consensus 139 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 139 IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred EEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 34689999887654333233345678999999876544 5788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.2e-10 Score=117.77 Aligned_cols=61 Identities=30% Similarity=0.349 Sum_probs=49.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.++|||+++.+..... .....||..|+|||...+ ..++.++|||||||+++||+||+.|+.
T Consensus 211 kL~DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred eeeccccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 3799999987654322 223567899999998764 468899999999999999999999975
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.4e-10 Score=112.20 Aligned_cols=113 Identities=25% Similarity=0.310 Sum_probs=72.9
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.+|||+++....... .....|+..|++||.......+.++|||||||+++|+++|+.|+....... ... .+...
T Consensus 143 l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~--~~~~~ 216 (285)
T cd05605 143 ISDLGLAVEIPEGET-IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KRE--EVERR 216 (285)
T ss_pred EeeCCCceecCCCCc-cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHH--HHHHH
Confidence 589999987643222 223568899999999988888999999999999999999999985321100 000 00000
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
+..............+..+++ .|+..+|++|| +++++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~li~---~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 217 VKEDQEEYSEKFSEAARSICR---QLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred hhhcccccCcccCHHHHHHHH---HHccCCHHHhcCCCCCCHHHHhc
Confidence 111000000112244555555 99999999999 7777743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.2e-10 Score=108.64 Aligned_cols=110 Identities=27% Similarity=0.358 Sum_probs=74.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... .....++..|++||+......+.++|+||+|++++|+++|+.|++...... ... ....
T Consensus 143 kl~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~--~~~~ 215 (256)
T cd08530 143 KIGDLGISKVLKKNM--AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRY--KVQR 215 (256)
T ss_pred EEeeccchhhhccCC--cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH--HHhc
Confidence 468999998875442 123457889999999998889999999999999999999999975321110 000 0000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..-+.+. ....+++..+++ .|+..+|++||++.|+++
T Consensus 216 ~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 216 GKYPPIP---PIYSQDLQNFIR---SMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCCCc---hhhCHHHHHHHH---HHcCCCcccCCCHHHHhc
Confidence 0001111 112234555555 999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.7e-10 Score=108.80 Aligned_cols=107 Identities=19% Similarity=0.347 Sum_probs=69.0
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccc-cceecccceeeeeceeeeehh-cCCCCCCcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-TMKITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-~~~~s~k~Dvysfgv~llEll-tg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.+|||++...... ....++..|+|||+.. ....+.++|||||||+++||+ +|+.|+........ .
T Consensus 153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---------~ 219 (262)
T cd05077 153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---------E 219 (262)
T ss_pred eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---------H
Confidence 4688887655321 1245778899999876 456888999999999999998 58888642111000 0
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
.......... ....+++..++. .|++.+|++||++.|+++.+
T Consensus 220 ~~~~~~~~~~-~~~~~~~~~li~---~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 RFYEGQCMLV-TPSCKELADLMT---HCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHhcCccCC-CCChHHHHHHHH---HHcCCChhhCcCHHHHHHhc
Confidence 0000111000 011234555555 99999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.7e-10 Score=109.65 Aligned_cols=113 Identities=26% Similarity=0.361 Sum_probs=74.6
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccce-ecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~-~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
....+|||+++...... ......|+..|++||+..... .+.++|+||||++++|++||+.|++...... ... .
T Consensus 140 ~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~---~~~--~ 213 (258)
T cd06632 140 VVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA---AVF--K 213 (258)
T ss_pred CEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---HHH--H
Confidence 34568999887764332 123456788899999987666 8899999999999999999999975322100 000 0
Q ss_pred ccc-ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDE-MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~-~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
... ..-+.++ .....++.++++ .|++.+|++||+|+|+++
T Consensus 214 ~~~~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 214 IGRSKELPPIP---DHLSDEAKDFIL---KCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHhcccCCCcC---CCcCHHHHHHHH---HHhhcCcccCcCHHHHhc
Confidence 000 0001111 112244555665 899999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.3e-10 Score=124.34 Aligned_cols=116 Identities=26% Similarity=0.412 Sum_probs=76.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc--ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.++|||+++.+..... .....||+.|+|||.... ..++.++|||||||+++||+||+.|+...... ..+... +
T Consensus 182 KLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~--~qli~~--l 256 (1021)
T PTZ00266 182 KIGDFGLSKNIGIESM-AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF--SQLISE--L 256 (1021)
T ss_pred EEccCCcccccccccc-ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH--HHHHHH--H
Confidence 4689999987644322 234568999999998743 45789999999999999999999998532110 000000 0
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHH--HHHHhh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS--QQLRIS 497 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~--~~l~~~ 497 (502)
. ..+.++.. ....++..+++ .|++.+|++||++.|++ ..++..
T Consensus 257 k--~~p~lpi~--~~S~eL~dLI~---~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 257 K--RGPDLPIK--GKSKELNILIK---NLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred h--cCCCCCcC--CCCHHHHHHHH---HHhcCChhHCcCHHHHhccHHHhhc
Confidence 0 11222111 12245666666 99999999999999998 445444
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.6e-10 Score=111.01 Aligned_cols=114 Identities=26% Similarity=0.387 Sum_probs=73.8
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccce----ecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK----ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~----~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
+-..+|||+++.+..... .....++.+|+|||+..... .+.++|+||||++++||+||+.|+...... .
T Consensus 153 ~~kL~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~----- 225 (296)
T cd06618 153 NVKLCDFGISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-F----- 225 (296)
T ss_pred CEEECccccchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-H-----
Confidence 345789999876643221 22345778999999986553 788999999999999999999997531110 0
Q ss_pred ccccccccCC---CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 444 DIALDEMLDP---RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 444 ~~~~~~~~d~---~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
.....+.+. ..... ....+++.+++. .|++.+|++||++.++++.
T Consensus 226 -~~~~~~~~~~~~~~~~~-~~~~~~l~~li~---~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 226 -EVLTKILQEEPPSLPPN-EGFSPDFCSFVD---LCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -HHHHHHhcCCCCCCCCC-CCCCHHHHHHHH---HHccCChhhCCCHHHHhcC
Confidence 000011111 11111 112244555555 9999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.94 E-value=9.3e-10 Score=72.88 Aligned_cols=42 Identities=40% Similarity=0.892 Sum_probs=30.9
Q ss_pred HHHHHHHHHHHhhcCcCCCCCCCCCCCCCCCCCCCCCCCccceeeeC
Q 010736 21 NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCN 67 (502)
Q Consensus 21 ~~d~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~C~W~Gv~C~ 67 (502)
++|++||++||+++..+|.+.+.+|+.+. ..+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~-----~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS-----DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT-------S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcC-----CCCCeeeccEEeC
Confidence 57999999999999876778999998751 2589999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.1e-10 Score=111.79 Aligned_cols=119 Identities=25% Similarity=0.381 Sum_probs=70.2
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccc-------cceecccceeeeeceeeeehhc-CCCCCCcccCCCC
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAY-------TMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSS 438 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~-------~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~ 438 (502)
-..+|||+++....... ......++..|+|||+.. ....+.++|||||||+++||+| |+.|+........
T Consensus 139 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (269)
T cd05042 139 VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV 218 (269)
T ss_pred EEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH
Confidence 34689999876433211 112234567799999864 3456789999999999999999 7778643211000
Q ss_pred -CCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 439 -PSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 439 -~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
..... .......++.+.. ...+++..++. .|+ .+|++||+++||.++|.
T Consensus 219 ~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~---~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 219 LKQVVR-EQDIKLPKPQLDL---KYSDRWYEVMQ---FCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHhh-ccCccCCCCcccc---cCCHHHHHHHH---HHh-cCcccccCHHHHHHHhc
Confidence 00000 0001112222211 11233444544 788 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.5e-10 Score=114.15 Aligned_cols=106 Identities=25% Similarity=0.422 Sum_probs=70.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||.......+.++|||||||+++||+||+.|+...... .....
T Consensus 141 kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~ 212 (323)
T cd05615 141 KIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQS 212 (323)
T ss_pred EEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 4689999886543322233456899999999998888999999999999999999999997532110 00111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
+......-+. ....++..+++ .|++.+|.+|++.
T Consensus 213 i~~~~~~~p~-~~~~~~~~li~---~~l~~~p~~R~~~ 246 (323)
T cd05615 213 IMEHNVSYPK-SLSKEAVSICK---GLMTKHPSKRLGC 246 (323)
T ss_pred HHhCCCCCCc-cCCHHHHHHHH---HHcccCHhhCCCC
Confidence 1111111011 11234555555 8999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.3e-10 Score=112.38 Aligned_cols=111 Identities=22% Similarity=0.337 Sum_probs=74.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||++........ .....|+..|+|||.......+.++|||||||+++||++|+.|++....... ......
T Consensus 142 ~l~Dfg~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-----~~~~~~ 215 (285)
T cd05630 142 RISDLGLAVHVPEGQT-IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVER 215 (285)
T ss_pred EEeeccceeecCCCcc-ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-----HHHHHh
Confidence 4689999876643222 2234689999999999888899999999999999999999999853211100 000001
Q ss_pred cc---CCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-----HHHHHH
Q 010736 450 ML---DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-----MKIVSQ 492 (502)
Q Consensus 450 ~~---d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-----m~~v~~ 492 (502)
+. ....+ .....++..+++ .|++.+|++||+ +.|+.+
T Consensus 216 ~~~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 216 LVKEVQEEYS---EKFSPDARSLCK---MLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhhhhhcC---ccCCHHHHHHHH---HHhhcCHHHccCCCCCchHHHHc
Confidence 11 11111 112245566666 899999999999 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.2e-10 Score=110.39 Aligned_cols=64 Identities=23% Similarity=0.236 Sum_probs=48.2
Q ss_pred CccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.-..+|||+++.............++..|+|||...+ ...+.++|||||||+++|++||+.|+.
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 140 VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred CEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 3457899999876543322333456778999998754 456889999999999999999977654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.6e-10 Score=111.43 Aligned_cols=62 Identities=24% Similarity=0.349 Sum_probs=48.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||.+..............++..|++||..... ..+.++|+||+|++++|++||+.|+.
T Consensus 138 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 138 KLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred EEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 368999888775433222234577889999998776 78899999999999999999998874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.3e-10 Score=111.23 Aligned_cols=62 Identities=24% Similarity=0.320 Sum_probs=48.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.........+...++..|++||+..+. ..+.++|||||||+++|++||+.|+.
T Consensus 143 kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 143 KLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred EEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 368999998764433323344578899999987653 57889999999999999999999974
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.2e-10 Score=116.26 Aligned_cols=118 Identities=26% Similarity=0.391 Sum_probs=82.4
Q ss_pred CCCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCC
Q 010736 358 PKLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH 428 (502)
Q Consensus 358 ~~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~ 428 (502)
.++.|.||+--|| ++||||+|-.-.....++++.||+-|+|||......++...|=|+|||+++||++|+.
T Consensus 487 ~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~ 566 (694)
T KOG0694|consen 487 NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGES 566 (694)
T ss_pred cCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCC
Confidence 3455666665554 6999999976533344567999999999999999999999999999999999999999
Q ss_pred CCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 429 p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
|+....+. .....+...++.-|.- ...|.+.+++ .-...+|++|--+
T Consensus 567 PF~gddEe---e~FdsI~~d~~~yP~~------ls~ea~~il~---~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 567 PFPGDDEE---EVFDSIVNDEVRYPRF------LSKEAIAIMR---RLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCHH---HHHHHHhcCCCCCCCc------ccHHHHHHHH---HHhccCcccccCC
Confidence 98522111 1111111223333322 2245556666 6667999999887
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.4e-10 Score=107.28 Aligned_cols=116 Identities=27% Similarity=0.385 Sum_probs=76.7
Q ss_pred CccccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 368 NNITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
.-..+|||.+........ ......++..|.+||+......+.++||||||++++|+++|+.|++...... ......
T Consensus 139 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~ 216 (260)
T cd06606 139 VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKI 216 (260)
T ss_pred CEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhc
Confidence 345689999887754332 1234568889999999988889999999999999999999999975432000 000000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.... ..+.++ .....++.++++ .|++.+|++||++.|+++
T Consensus 217 ~~~~-~~~~~~---~~~~~~l~~~i~---~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 217 GSSG-EPPEIP---EHLSEEAKDFLR---KCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccC-CCcCCC---cccCHHHHHHHH---HhCcCChhhCCCHHHHhh
Confidence 0000 001111 112345555555 999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.1e-10 Score=109.54 Aligned_cols=115 Identities=28% Similarity=0.372 Sum_probs=75.3
Q ss_pred ccccccCcccccCCCC------CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 369 NITGDFGIAKFLKPDS------SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~------~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
-..+|||+++...... .......|+..|+|||+..+...+.++||||||++++|++||+.|+........ ..
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~ 218 (265)
T cd06631 141 IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MF 218 (265)
T ss_pred EEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HH
Confidence 3468999887653211 111235688899999999888889999999999999999999999753211100 00
Q ss_pred cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 443 TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 443 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
. ........+.++. ...+++..+++ .|++.+|++||++.||.+
T Consensus 219 ~-~~~~~~~~~~~~~---~~~~~~~~~i~---~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 219 Y-IGAHRGLMPRLPD---SFSAAAIDFVT---SCLTRDQHERPSALQLLR 261 (265)
T ss_pred H-hhhccCCCCCCCC---CCCHHHHHHHH---HHhcCCcccCCCHHHHhc
Confidence 0 0000011122221 12345666666 999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.8e-10 Score=113.68 Aligned_cols=62 Identities=29% Similarity=0.381 Sum_probs=49.0
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++....... ..+...++..|+|||...+. ..+.++|||||||+++||+||+.|++
T Consensus 143 kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 143 KICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred EeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 4689999987654322 22334578899999998764 47889999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.5e-10 Score=113.87 Aligned_cols=63 Identities=27% Similarity=0.365 Sum_probs=51.5
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-.++|||+++.+..... ......||..|+|||+.....++.++|||||||+++||+||+.|+.
T Consensus 224 ~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 224 AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred EEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 34789999986643221 1224679999999999998889999999999999999999999974
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.6e-10 Score=108.74 Aligned_cols=105 Identities=24% Similarity=0.440 Sum_probs=68.2
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeeh-hcCCCCCCcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEV-IKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llEl-ltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.+|||+++..... ....++..|++||+... ...+.++|||||||+++|+ ++|+.|+........ .
T Consensus 165 l~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---------~ 231 (274)
T cd05076 165 LSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK---------E 231 (274)
T ss_pred ecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---------H
Confidence 4688876543221 12346778999998765 5678999999999999998 478998753211100 0
Q ss_pred cccC--CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 449 EMLD--PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 449 ~~~d--~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
...+ ...+.+ ...++..++ ..|++.+|++||+|.+|++.|
T Consensus 232 ~~~~~~~~~~~~---~~~~~~~li---~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 RFYEKKHRLPEP---SCKELATLI---SQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHhccCCCCC---CChHHHHHH---HHHcccChhhCcCHHHHHHhh
Confidence 0111 111111 112344444 499999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.4e-10 Score=111.92 Aligned_cols=63 Identities=17% Similarity=0.310 Sum_probs=49.1
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.............++..|+|||...+ ...+.++|||||||+++||+||+.|+.
T Consensus 143 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 143 LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred EEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 346899999865433332334467889999998754 457889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.1e-10 Score=110.18 Aligned_cols=64 Identities=27% Similarity=0.298 Sum_probs=49.3
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccce-ecccceeeeeceeeeehhcCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~-~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
+-..+|||+++.............++..|+|||...+.. .+.++|+||||++++||+||+.|+.
T Consensus 144 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 144 ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred cEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 345789999887654322223345778899999886543 6889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.7e-11 Score=112.51 Aligned_cols=233 Identities=16% Similarity=0.218 Sum_probs=135.1
Q ss_pred CCEEEEEecCCCCcee----cCcccCCCCCCCCEEECCCCccccc----CCc-------cCcCCCCCCEEEccCCcCcCC
Q 010736 70 GRVINISLRGVGLKGK----LHAFSFSSFPHLAYLDLRDNKLFGT----IPP-------QISNLTNLSILSLGGNQFSGN 134 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~----l~~~~~~~l~~L~~L~Ls~N~l~g~----~p~-------~l~~l~~L~~L~Ls~N~l~~~ 134 (502)
..++.|+|++|.+.-. +.. .+.+.++|+..++|+- ++|. +|+ .+-.+++|++||||+|.|.-.
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~-~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAK-VLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHH-HHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 4689999999988532 222 3677788999988863 4443 343 345678999999999998755
Q ss_pred CCcc----cCCCCCCcEEEccCCcCcccC-------------CcccCCCCCCcEEEcccCcccccC----CcCCCCCCCC
Q 010736 135 IPHE----VGLMSHLKILYIDSNQLDGSI-------------PLEVGQLSSMVELALFSNNLNGSV----PHSLGNLTQI 193 (502)
Q Consensus 135 ~p~~----l~~l~~L~~L~Ls~N~l~~~~-------------p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L 193 (502)
-+.. +..+..|++|+|.+|.+.-.- ..-.+.-+.|+++...+|++.... ...|...+.|
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~l 187 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTL 187 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcccc
Confidence 4443 456788999999998775211 111233456777777777664221 1223445666
Q ss_pred CeEEccccccccc----CCccCcCCccCCccccccccccCc----ccccccCCCCCcEEEeeCccccccCCCCCcccccc
Q 010736 194 SMLFLHDNSFSGF----IPPDIGNLKSISILSLAINQFSGP----IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLT 265 (502)
Q Consensus 194 ~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~ 265 (502)
+.+.++.|.|... +...+..+++|+.||+..|-|+.. +...+..+++|+.|+++++.+.......+..
T Consensus 188 eevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~---- 263 (382)
T KOG1909|consen 188 EEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD---- 263 (382)
T ss_pred ceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH----
Confidence 6666666665421 122345566666666666666522 2234445556666666666554322111110
Q ss_pred EEECcCCcCcccCCccccCCCCCcEEEccCCccccc----cCcccccCCCCcEEeCCCCcc
Q 010736 266 KLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGT----IPKSLRNCTSLIRVRLDGNNL 322 (502)
Q Consensus 266 ~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~----~~~~l~~l~~L~~L~l~~N~l 322 (502)
..-...++|+.+.+.+|.++.. +...+...+.|..|+|++|.+
T Consensus 264 --------------al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 264 --------------ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred --------------HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 0001235666666666666521 222344466777777777777
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.7e-10 Score=109.51 Aligned_cols=63 Identities=19% Similarity=0.298 Sum_probs=47.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.............++..|+|||...+ ...+.++||||+||+++||++|+.|+.
T Consensus 142 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 142 LKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred EEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 457899998765322222223346788999998765 457889999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.5e-10 Score=126.02 Aligned_cols=90 Identities=22% Similarity=0.255 Sum_probs=61.3
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHH
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISI 469 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 469 (502)
..||..|+|||+.....++.++|||||||+++||++|+.|+..... ..... .....++... .+..+.
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~-~~~~~~~~~~-------~~~~~~ 241 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSL-RHRVLPPQIL-------LNWPKE 241 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHH-HHhhcChhhh-------hcCHHH
Confidence 3578889999999988999999999999999999999888542110 00000 0111222111 111223
Q ss_pred HHHhhccCCcCCCCCCCHHHHHH
Q 010736 470 MEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 470 ~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+...|++++|.+||+|.||++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 34555899999999999999975
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.1e-10 Score=107.53 Aligned_cols=114 Identities=28% Similarity=0.399 Sum_probs=75.8
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
+-..+|||++..............|+..|++||.......+.++|+||+|++++|+++|+.|++..... ..... .
T Consensus 141 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~--~ 215 (258)
T cd08215 141 LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALK--I 215 (258)
T ss_pred cEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHH--H
Confidence 334689998877644321222345788899999998888999999999999999999999997532110 00000 0
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+.++. ...+++..+++ .|+..+|++||++.|+++
T Consensus 216 ~~~~~~~~~~---~~~~~~~~~i~---~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 216 LKGQYPPIPS---QYSSELRNLVS---SLLQKDPEERPSIAQILQ 254 (258)
T ss_pred hcCCCCCCCC---CCCHHHHHHHH---HHcCCChhhCcCHHHHhc
Confidence 0001111211 12345556665 999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=98.90 E-value=5.5e-10 Score=108.02 Aligned_cols=112 Identities=26% Similarity=0.404 Sum_probs=72.9
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccce------ecccceeeeeceeeeehhcCCCCCCcccCCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK------ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSL 441 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~------~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~ 441 (502)
.-..+|||+++.+.... .....++.+|++||...+.. .+.++|+|||||+++|++||+.|++..... ..
T Consensus 141 ~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~ 215 (286)
T cd06622 141 QVKLCDFGVSGNLVASL--AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NI 215 (286)
T ss_pred CEEEeecCCcccccCCc--cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hH
Confidence 34578999987653321 22345788999999975543 478999999999999999999997532111 00
Q ss_pred CcccccccccC---CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 442 NTDIALDEMLD---PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 442 ~~~~~~~~~~d---~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
. .....+.+ +.++. ...+++..+++ .|++.+|++||++++++.
T Consensus 216 ~--~~~~~~~~~~~~~~~~---~~~~~~~~li~---~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 216 F--AQLSAIVDGDPPTLPS---GYSDDAQDFVA---KCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred H--HHHHHHhhcCCCCCCc---ccCHHHHHHHH---HHcccCcccCCCHHHHhc
Confidence 0 00111111 22221 12244555555 999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.6e-10 Score=110.41 Aligned_cols=109 Identities=25% Similarity=0.356 Sum_probs=69.5
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.+|||+++....... .....|+..|+|||+..+...+.++|+|||||+++|++||+.|+........ . ......+
T Consensus 143 l~Dfg~~~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~-~~~~~~~ 217 (285)
T cd05632 143 ISDLGLAVKIPEGES-IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---R-EEVDRRV 217 (285)
T ss_pred EecCCcceecCCCCc-ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---H-HHHHHhh
Confidence 589999876643222 2345789999999999888899999999999999999999999753211000 0 0000011
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~ 488 (502)
........ ....+++.++++ .|++.+|++||++.
T Consensus 218 ~~~~~~~~-~~~~~~~~~li~---~~l~~~P~~R~~~~ 251 (285)
T cd05632 218 LETEEVYS-AKFSEEAKSICK---MLLTKDPKQRLGCQ 251 (285)
T ss_pred hccccccC-ccCCHHHHHHHH---HHccCCHhHcCCCc
Confidence 11110000 011234445554 99999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.9e-10 Score=107.99 Aligned_cols=63 Identities=21% Similarity=0.236 Sum_probs=47.7
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccc-cceecccceeeeeceeeeehhcCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-TMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.-..+|||+++.+..... .+...++..|++||+.. ....+.++|||||||+++||+||+.|+.
T Consensus 137 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 137 ILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred CeEEEecccccccccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 334689999887643221 22345788999999764 4557889999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.3e-09 Score=78.71 Aligned_cols=61 Identities=28% Similarity=0.375 Sum_probs=37.0
Q ss_pred CCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcc
Q 010736 119 TNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNL 179 (502)
Q Consensus 119 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 179 (502)
++|++|++++|+++...+..|.++++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666644445566666666666666666655555566666666666666553
|
... |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.7e-10 Score=115.43 Aligned_cols=60 Identities=30% Similarity=0.453 Sum_probs=48.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
..+|||+++...... ......||..|+|||......++.++|||||||+++||+++..|.
T Consensus 197 kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 197 CIGDLGAAQFPVVAP-AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred EEecCccccccccCc-ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 468999998654322 223567999999999999888999999999999999999976553
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.3e-10 Score=113.11 Aligned_cols=112 Identities=20% Similarity=0.323 Sum_probs=73.0
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccc----eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTM----KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~----~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
-..+|||+++....... ......||..|+|||..... ..+.++|||||||+++||+||+.|+.......
T Consensus 181 ~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------ 254 (370)
T cd05596 181 LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------ 254 (370)
T ss_pred EEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------
Confidence 34789999987643221 22345799999999987643 37789999999999999999999975321100
Q ss_pred ccccccccC----CCCCCCCcchHHHHHHHHHHhhccCCcCCCC--CCCHHHHHH
Q 010736 444 DIALDEMLD----PRLPVPSCSVQEKLISIMEVGFSCLKESPES--RPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d----~~l~~~~~~~~~~~~~~~~val~C~~~~p~~--Rp~m~~v~~ 492 (502)
....+.+ ...+.. .....++..+++ .|...+|++ ||++.|+.+
T Consensus 255 --~~~~i~~~~~~~~~~~~-~~~s~~~~~li~---~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 255 --TYSKIMDHKNSLTFPDD-IEISKQAKDLIC---AFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred --HHHHHHcCCCcCCCCCc-CCCCHHHHHHHH---HHccChhhccCCCCHHHHhc
Confidence 0011111 111111 112345666776 788888887 999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.5e-10 Score=111.09 Aligned_cols=109 Identities=25% Similarity=0.383 Sum_probs=69.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||++..... .....|+..|++||+.. ....+.++|||||||+++||+||+.|+....... ....
T Consensus 161 kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~~~-- 231 (313)
T cd06633 161 KLADFGSASKSSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH-- 231 (313)
T ss_pred EEeecCCCcccCC----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHH--
Confidence 3588988764322 12356888999999974 3567889999999999999999999974321100 0000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+.... ......+..+++ .|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~--~~~~~~l~~li~---~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 232 IAQNDSPTLQS--NEWTDSFRGFVD---YCLQKIPQERPASAELLR 272 (313)
T ss_pred HHhcCCCCCCc--cccCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 00000111111 011234555555 999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.9e-10 Score=108.71 Aligned_cols=61 Identities=28% Similarity=0.443 Sum_probs=49.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.+.... .....|+..|++||...+...+.++|+|||||+++|++||+.|+.
T Consensus 139 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 139 IKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred EEEccCCCcccccccc--cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 3568999987654321 223568889999999888888999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.6e-10 Score=106.24 Aligned_cols=114 Identities=26% Similarity=0.421 Sum_probs=76.7
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.-..+|||+++.............++..|++||+......+.++|||++|++++|+++|+.|+........ . ...
T Consensus 137 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~---~~~ 211 (254)
T cd06627 137 VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--L---FRI 211 (254)
T ss_pred CEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--H---HHH
Confidence 34578999988775543323345688899999998887788999999999999999999999753221000 0 000
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+..+ ....+++..++. .|+..+|++||++.|++.
T Consensus 212 ~~~~~~~~~---~~~~~~~~~~i~---~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 VQDDHPPLP---EGISPELKDFLM---QCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred hccCCCCCC---CCCCHHHHHHHH---HHHhCChhhCcCHHHHhc
Confidence 000111111 112245555555 999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.5e-10 Score=112.30 Aligned_cols=97 Identities=22% Similarity=0.368 Sum_probs=61.9
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHH
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISI 469 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 469 (502)
..||..|+|||.......+.++|||||||+++||+||+.|+........ . .. ..........+... ....+...+
T Consensus 208 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~-~~-i~~~~~~~~~~~~~-~~s~~~~dl 282 (381)
T cd05626 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET--Q-LK-VINWENTLHIPPQV-KLSPEAVDL 282 (381)
T ss_pred ccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHH--H-HH-HHccccccCCCCCC-CCCHHHHHH
Confidence 4689999999999888889999999999999999999999853211000 0 00 00000011111111 112344455
Q ss_pred HHHhhccCCcCCCCCCCHHHHHH
Q 010736 470 MEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 470 ~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
++ .+.|..++|.+||+..|+.+
T Consensus 283 i~-~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 283 IT-KLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HH-HHccCcccccCCCCHHHHhc
Confidence 44 24588888888999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.3e-10 Score=110.04 Aligned_cols=62 Identities=23% Similarity=0.362 Sum_probs=46.7
Q ss_pred cccccCcccccCCCCC-----------CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS-----------NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-----------~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++....... ..+...++..|+|||.... ...+.++|||||||+++||+||+.|++
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 4689998876542211 1223456788999998754 457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.87 E-value=6e-10 Score=107.33 Aligned_cols=62 Identities=27% Similarity=0.360 Sum_probs=48.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.............++..|+|||...+. ..+.++|||||||+++|++||+.|+.
T Consensus 138 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 138 KLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred EEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 468999988765433223334556789999998766 78899999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.4e-09 Score=117.46 Aligned_cols=122 Identities=28% Similarity=0.408 Sum_probs=79.3
Q ss_pred CCCCeeeecCCcc---------ccccCcccccCCCCCC----cccccccccccCccccccceec---ccceeeeeceeee
Q 010736 358 PKLGALNISRNNI---------TGDFGIAKFLKPDSSN----WTGFAGTYGYIAPELAYTMKIT---EKCDVYSFGVLVL 421 (502)
Q Consensus 358 ~~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~----~~~~~gt~gy~aPE~~~~~~~s---~k~Dvysfgv~ll 421 (502)
.++.|-|++.++| -+|||-|+-+...... .....||+.|||||...+.+.. -..||||.|||++
T Consensus 1353 ~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVl 1432 (1509)
T KOG4645|consen 1353 HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVL 1432 (1509)
T ss_pred cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEE
Confidence 4566777777776 4899998876543211 1246799999999998766533 4589999999999
Q ss_pred ehhcCCCCCCccc-CCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHH
Q 010736 422 EVIKGKHPRDFLS-STSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIV 490 (502)
Q Consensus 422 Elltg~~p~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v 490 (502)
||+|||+|..... .+.. ... +...--|.++. ....+-.+.++ .|.+.+|++|-+..|+
T Consensus 1433 EM~tGkrPW~~~dne~aI---My~--V~~gh~Pq~P~---~ls~~g~dFle---~Cl~~dP~~Rw~~~ql 1491 (1509)
T KOG4645|consen 1433 EMATGKRPWAELDNEWAI---MYH--VAAGHKPQIPE---RLSSEGRDFLE---HCLEQDPKMRWTASQL 1491 (1509)
T ss_pred EeecCCCchhhccchhHH---HhH--HhccCCCCCch---hhhHhHHHHHH---HHHhcCchhhhHHHHH
Confidence 9999999953221 1111 000 01111233332 23345567788 9999999999765544
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=98.86 E-value=9.5e-10 Score=106.10 Aligned_cols=115 Identities=28% Similarity=0.406 Sum_probs=74.2
Q ss_pred CccccccCcccccCCCCCCcccccccccccCcccccc----ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT----MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~----~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
+-.++|||+++...... ..+...|+..|+|||.... ...+.++|+||||++++||+||+.|++..... ....
T Consensus 142 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~-- 217 (283)
T cd06617 142 QVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQL-- 217 (283)
T ss_pred CEEEeeccccccccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHH--
Confidence 34478999988664321 1233568889999998754 34578999999999999999999997532110 0000
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
........+.++.. ...+++..+++ .|+..+|++||+++||++
T Consensus 218 -~~~~~~~~~~~~~~--~~~~~l~~li~---~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 218 -KQVVEEPSPQLPAE--KFSPEFQDFVN---KCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -HHHHhcCCCCCCcc--ccCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 00001112222211 12245666666 899999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.2e-10 Score=110.48 Aligned_cols=64 Identities=28% Similarity=0.322 Sum_probs=49.2
Q ss_pred CccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
+-..+|||+++.............++..|+|||.... ...+.++|+|||||+++||++|+.|+.
T Consensus 146 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 146 DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 3446899999876543222233457888999998754 458899999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.5e-10 Score=110.63 Aligned_cols=98 Identities=18% Similarity=0.213 Sum_probs=65.1
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHH
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISI 469 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 469 (502)
..++.+|+|||+......+.++|+||||++++|++||+.|+..... ..+...........+... .....++..+
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 249 (305)
T cd05609 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDDIEWPEGD---EALPADAQDL 249 (305)
T ss_pred CccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcccCCCCcc---ccCCHHHHHH
Confidence 4577899999999888899999999999999999999999742110 011010001111122211 1123456666
Q ss_pred HHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 470 MEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 470 ~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
++ .|++.+|++||++.++.+.|+.
T Consensus 250 i~---~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 250 IS---RLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HH---HHhccChhhccCccCHHHHHhC
Confidence 66 9999999999997766666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.4e-10 Score=108.86 Aligned_cols=115 Identities=22% Similarity=0.324 Sum_probs=75.0
Q ss_pred cccccCcccccCCCCC--------CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS--------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSL 441 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--------~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~ 441 (502)
..+|||++........ ......++..|++||.......+.++||||||++++|++||+.|++......
T Consensus 133 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---- 208 (265)
T cd05579 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---- 208 (265)
T ss_pred EEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 3689998876533211 2233557789999999988888999999999999999999999975321100
Q ss_pred CcccccccccCCCCCC-CCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 442 NTDIALDEMLDPRLPV-PSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 442 ~~~~~~~~~~d~~l~~-~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
....+....... .......++..+++ .|++.+|++||++++|.+.|+
T Consensus 209 ----~~~~~~~~~~~~~~~~~~~~~~~~~i~---~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 209 ----IFQNILNGKIEWPEDVEVSDEAIDLIS---KLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----HHHHHhcCCcCCCccccCCHHHHHHHH---HHhcCCHhhcCCCccHHHHhc
Confidence 000011001100 00111345666666 999999999999977766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.2e-09 Score=109.11 Aligned_cols=63 Identities=29% Similarity=0.340 Sum_probs=51.0
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
+-..+|||+++....... .....++..|+|||...+...+.++|||||||+++||++|+.|+.
T Consensus 156 ~~kL~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 156 TLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred CEEEccCccceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 345689999987643222 223457889999999988889999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.8e-10 Score=111.57 Aligned_cols=59 Identities=32% Similarity=0.533 Sum_probs=48.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++..... .+...|+..|+|||...+ ...+.++||||+||+++||++|+.|+.
T Consensus 158 kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 158 RILDFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred EEcCCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 46899999876432 234568899999999866 468899999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.9e-10 Score=109.55 Aligned_cols=96 Identities=22% Similarity=0.350 Sum_probs=64.4
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCC-cchHHHHHH
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPS-CSVQEKLIS 468 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~ 468 (502)
..|+..|++||+..+...+.++||||||++++|+++|+.|+...... ....++.+....-+. ....+++.+
T Consensus 192 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (316)
T cd05574 192 FVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD--------ETFSNILKKEVTFPGSPPVSSSARD 263 (316)
T ss_pred CcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH--------HHHHHHhcCCccCCCccccCHHHHH
Confidence 45788999999998888999999999999999999999997522111 001111111111010 112355667
Q ss_pred HHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 469 IMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 469 ~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
+++ .|++.+|++||+++..++++..
T Consensus 264 li~---~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 264 LIR---KLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH---HHccCCHhHCCCchhhHHHHHc
Confidence 777 9999999999995555444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.2e-10 Score=108.14 Aligned_cols=62 Identities=19% Similarity=0.268 Sum_probs=47.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.........+...++..|+|||+..+ ...+.++|+||||++++||+||+.|+.
T Consensus 151 kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 151 KIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred EEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 46899998765432222233356788999998764 457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.9e-10 Score=107.90 Aligned_cols=246 Identities=20% Similarity=0.316 Sum_probs=152.6
Q ss_pred ccCcCCCCCCEEEccCCcCcCC----CCcccCCCCCCcEEEccCCcCcc----cCCcc-------cCCCCCCcEEEcccC
Q 010736 113 PQISNLTNLSILSLGGNQFSGN----IPHEVGLMSHLKILYIDSNQLDG----SIPLE-------VGQLSSMVELALFSN 177 (502)
Q Consensus 113 ~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~----~~p~~-------~~~l~~L~~L~L~~N 177 (502)
+.+..+..+++++||+|.|... +-..+.+.++|+..++++- ++| .+|.. +...++|++|+||.|
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDN 102 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDN 102 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeecccc
Confidence 3456678899999999988632 3345667778888888753 333 23322 334557777777777
Q ss_pred cccccCCcCC----CCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccc
Q 010736 178 NLNGSVPHSL----GNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYG 253 (502)
Q Consensus 178 ~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 253 (502)
-|.-..+..| .++..|++|+|.+|.+.-.-...++ ..|..|. .|+ ..++-+.|+.+....|++..
T Consensus 103 A~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 103 AFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNK-------KAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred ccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHh-------ccCCCcceEEEEeecccccc
Confidence 7653333332 3456667777766655421111111 1122221 111 22344567777777777753
Q ss_pred cCCCCC----cc-ccccEEECcCCcCccc----CCccccCCCCCcEEEccCCccccc----cCcccccCCCCcEEeCCCC
Q 010736 254 SIPPSL----DN-LVLTKLSLDDNHFTSY----LPQNICRGGALQIFTVSENRFQGT----IPKSLRNCTSLIRVRLDGN 320 (502)
Q Consensus 254 ~~p~~~----~~-~~L~~L~ls~N~l~~~----~~~~~~~~~~L~~L~ls~n~l~~~----~~~~l~~l~~L~~L~l~~N 320 (502)
.....+ .. ..|+.+.++.|.|... +...+..++.|++||+..|.|+.. +...+..+++|+.++++++
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 221111 11 4677777777766432 223456778999999999988732 3455677889999999999
Q ss_pred ccccccCccc-----CCCCCCcEEEccCcccccc----cCccccCCCCCCeeeecCCcc
Q 010736 321 NLTGNISKAF-----GIYPNLTFIDLSRNNFYGE----ISSNFGECPKLGALNISRNNI 370 (502)
Q Consensus 321 ~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~~~~~~~~~~L~~L~l~~N~l 370 (502)
.+...-..+| ...|+|+.+.+.+|.++.. +...+...|.|..|+|++|.+
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 8875433333 3478999999999998743 223345688999999999998
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.3e-10 Score=109.11 Aligned_cols=216 Identities=19% Similarity=0.222 Sum_probs=106.3
Q ss_pred CCCCCCcEEEccCCcCcccCC--cccCCCCCCcEEEcccCcccccCC--cCCCCCCCCCeEEcccccccccCCcc-CcCC
Q 010736 140 GLMSHLKILYIDSNQLDGSIP--LEVGQLSSMVELALFSNNLNGSVP--HSLGNLTQISMLFLHDNSFSGFIPPD-IGNL 214 (502)
Q Consensus 140 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l 214 (502)
.++.+|+...|.+.... ..+ .....+++++.|+|+.|-|....| .....+++|+.|+++.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45667777777777664 222 234567777777777776653221 22345677777777777765332211 1134
Q ss_pred ccCCccccccccccCc-ccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEE
Q 010736 215 KSISILSLAINQFSGP-IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFT 292 (502)
Q Consensus 215 ~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ 292 (502)
+.|+.|.++.|.++.. +-.....+++|+.|++.+|...+........ ..|+.|+|++|++-....
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~------------- 263 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQ------------- 263 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccc-------------
Confidence 5566666666666521 1222344566666666666411111000000 235555555555433210
Q ss_pred ccCCccccccCcccccCCCCcEEeCCCCccccccC-c-----ccCCCCCCcEEEccCccccccc-CccccCCCCCCeeee
Q 010736 293 VSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNIS-K-----AFGIYPNLTFIDLSRNNFYGEI-SSNFGECPKLGALNI 365 (502)
Q Consensus 293 ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~-~-----~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~~~L~~L~l 365 (502)
-...+.++.|..|+++.+.+...-- . ....+++|++|+++.|++.... -..+..+++|++|.+
T Consensus 264 ----------~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~ 333 (505)
T KOG3207|consen 264 ----------GYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRI 333 (505)
T ss_pred ----------ccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhc
Confidence 0123344444445544444432211 1 1234566666666666664211 122334556666666
Q ss_pred cCCccccccCcccc
Q 010736 366 SRNNITGDFGIAKF 379 (502)
Q Consensus 366 ~~N~l~~dfGl~~l 379 (502)
..|.+.-.=+.+++
T Consensus 334 ~~n~ln~e~~~a~~ 347 (505)
T KOG3207|consen 334 TLNYLNKETDTAKL 347 (505)
T ss_pred ccccccccccceeE
Confidence 66666544444443
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.5e-10 Score=112.90 Aligned_cols=104 Identities=26% Similarity=0.441 Sum_probs=74.9
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCC-CCC----Cccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS-PSL----NTDI 445 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~-~~~----~~~~ 445 (502)
+||.|||.++..... ..+-||+-+||||... -.+.+..||||||+=+|||+|+..|+........ +.. +...
T Consensus 187 IGDLGLAtl~r~s~a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 187 IGDLGLATLLRKSHA--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA 263 (632)
T ss_pred ecchhHHHHhhcccc--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH
Confidence 799999999865332 3478999999999887 6799999999999999999999999864332210 000 0111
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+..|-| .++.++++ .|... ..+||+..|.++
T Consensus 264 sl~kV~d-----------Pevr~fIe---kCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ALSKVKD-----------PEVREFIE---KCLAT-KSERLSAKELLK 295 (632)
T ss_pred HhhccCC-----------HHHHHHHH---HHhcC-chhccCHHHHhh
Confidence 1222222 35667777 99999 999999998764
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.3e-10 Score=107.44 Aligned_cols=63 Identities=27% Similarity=0.368 Sum_probs=48.3
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++....... ..+...++..|++||...+ ...+.++||||||++++|++||+.|++
T Consensus 139 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 139 LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred EEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 34689999887654321 2233456788999997654 457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.2e-09 Score=109.57 Aligned_cols=42 Identities=36% Similarity=0.577 Sum_probs=39.3
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..||..|+|||...+...+.++|||||||+++||+||+.|+.
T Consensus 196 ~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 468999999999988889999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.6e-10 Score=106.67 Aligned_cols=113 Identities=22% Similarity=0.337 Sum_probs=70.7
Q ss_pred ccccccCcccccCCCC---CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDS---SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~---~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
...+|||+++.+.... .......|+..|+|||.......+.++||||||++++|++||+.|+....... . ....
T Consensus 145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~-~~~~ 221 (265)
T cd06652 145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--A-IFKI 221 (265)
T ss_pred EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--H-HHHH
Confidence 3468999888654211 11223568889999999988888999999999999999999999974221100 0 0000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+..+ ......+..++. .|+ .+|++||+++||++
T Consensus 222 -~~~~~~~~~~---~~~~~~~~~~i~---~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 222 -ATQPTNPVLP---PHVSDHCRDFLK---RIF-VEAKLRPSADELLR 260 (265)
T ss_pred -hcCCCCCCCc---hhhCHHHHHHHH---HHh-cChhhCCCHHHHhc
Confidence 0001112221 111233444544 566 48999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.8e-10 Score=112.03 Aligned_cols=63 Identities=29% Similarity=0.381 Sum_probs=48.5
Q ss_pred ccccccCcccccCCCCC-----CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS-----NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-----~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.+..... ......|+..|++||.... ...+.++||||||++++||+||+.|+.
T Consensus 146 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 146 VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 34689999987643221 2234568889999998754 457789999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.1e-09 Score=104.54 Aligned_cols=109 Identities=24% Similarity=0.317 Sum_probs=71.3
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++....... .....++..|++||.......+.++|+||||++++|++||+.|+....... . ....
T Consensus 132 ~~l~df~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~-----~~~~ 204 (262)
T cd05572 132 VKLVDFGFAKKLKSGQK-TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-M-----EIYN 204 (262)
T ss_pred EEEeeCCcccccCcccc-cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-H-----HHHH
Confidence 34689999887754321 123467889999999888888999999999999999999999975322100 0 0011
Q ss_pred cccC-CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 449 EMLD-PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 449 ~~~d-~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
.+.+ +.....+....+++..+++ .|++.+|++||+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~i~---~~l~~~p~~R~~~ 241 (262)
T cd05572 205 DILKGNGKLEFPNYIDKAAKDLIK---QLLRRNPEERLGN 241 (262)
T ss_pred HHhccCCCCCCCcccCHHHHHHHH---HHccCChhhCcCC
Confidence 1111 0000011112345666666 9999999999994
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.84 E-value=6e-10 Score=110.85 Aligned_cols=60 Identities=30% Similarity=0.493 Sum_probs=47.8
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++..... .....++..|+|||.... ...+.++|||||||+++||+||+.|+.
T Consensus 156 ~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 156 LKILDFGLARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred EEEeeCCCCcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 346899998865432 223457788999998765 467889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.8e-10 Score=107.43 Aligned_cols=114 Identities=22% Similarity=0.366 Sum_probs=74.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||++..............|+.+|++||+......+.++|+|||||+++|++||+.|+....... ... ...+
T Consensus 156 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~--~~~~ 230 (292)
T cd06657 156 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK--MIRD 230 (292)
T ss_pred EEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH--HHHh
Confidence 46899988765433222234567889999999888888999999999999999999999974211100 000 0011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+.+... .....++..+++ .|++.+|.+||++.||++
T Consensus 231 ~~~~~~~~~-~~~~~~l~~li~---~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 231 NLPPKLKNL-HKVSPSLKGFLD---RLLVRDPAQRATAAELLK 269 (292)
T ss_pred hCCcccCCc-ccCCHHHHHHHH---HHHhCCcccCcCHHHHhc
Confidence 111111111 112234556666 899999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.4e-09 Score=109.76 Aligned_cols=43 Identities=37% Similarity=0.620 Sum_probs=39.7
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCCc
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~ 432 (502)
..||.+|+|||.......+.++|||||||+++||+||+.|+..
T Consensus 204 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 204 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred cCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCC
Confidence 4689999999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.1e-10 Score=105.47 Aligned_cols=111 Identities=28% Similarity=0.381 Sum_probs=73.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||++....... ......|+..|++||.......+.++|+||||++++|++||+.|++.............. ..
T Consensus 140 ~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~ 216 (258)
T cd05578 140 HITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ET 216 (258)
T ss_pred EEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--cc
Confidence 468999887664432 223456888999999998888999999999999999999999997643221000000000 00
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH--HHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM--KIV 490 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m--~~v 490 (502)
..+..+ .....++.++++ .|+..+|.+||+. +|+
T Consensus 217 -~~~~~~---~~~~~~~~~~i~---~~l~~~p~~R~~~~~~~l 252 (258)
T cd05578 217 -ADVLYP---ATWSTEAIDAIN---KLLERDPQKRLGDNLKDL 252 (258)
T ss_pred -ccccCc---ccCcHHHHHHHH---HHccCChhHcCCccHHHH
Confidence 001111 112345666666 9999999999999 555
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=98.83 E-value=1e-09 Score=105.52 Aligned_cols=118 Identities=23% Similarity=0.345 Sum_probs=73.9
Q ss_pred CccccccCcccccCCCC-CCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 368 NNITGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
+...+|||+++...... .......++..|++||.......+.++||||||++++|+++ |..|+....... .....
T Consensus 155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~ 231 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL 231 (275)
T ss_pred cEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH
Confidence 34468888877543211 12223456778999999888788899999999999999999 777864211100 00000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
.... ...... ....+.+.+++. .|++.+|++||++.|++++|.
T Consensus 232 ~~~~-~~~~~~---~~~~~~l~~~i~---~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGK-LELPVP---EGCPSRLYKLMT---RCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCC-cCCCCC---CCCCHHHHHHHH---HHcCCCcccCCCHHHHHHHhc
Confidence 0000 000000 112244555555 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=1e-09 Score=108.85 Aligned_cols=62 Identities=29% Similarity=0.327 Sum_probs=46.1
Q ss_pred cccccCcccccCC--------------CCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKP--------------DSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~--------------~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.... .........++.+|+|||+..+. ..+.++||||+|++++|++||+.|+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4689998876541 11111223467789999998654 46889999999999999999999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.82 E-value=1e-09 Score=103.64 Aligned_cols=109 Identities=27% Similarity=0.372 Sum_probs=74.1
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||++..............++.+|++||.......+.++|+||||++++|+++|+.|++..... . ...
T Consensus 132 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~-----~~~ 203 (250)
T cd05123 132 IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---E-----IYE 203 (250)
T ss_pred EEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---H-----HHH
Confidence 34689999887654322234467888999999998888899999999999999999999997532110 0 001
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~ 489 (502)
.+......-+ ....+++.++++ .|+..+|++||++++
T Consensus 204 ~~~~~~~~~~-~~~~~~l~~~i~---~~l~~~p~~R~~~~~ 240 (250)
T cd05123 204 KILKDPLRFP-EFLSPEARDLIS---GLLQKDPTKRLGSGG 240 (250)
T ss_pred HHhcCCCCCC-CCCCHHHHHHHH---HHhcCCHhhCCCccc
Confidence 1111111111 112355666666 999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.2e-09 Score=108.33 Aligned_cols=120 Identities=23% Similarity=0.320 Sum_probs=71.9
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
-..+|||+++.+..... ......||..|+|||+.. ....+.++|||||||+++||++|+.|+........ .
T Consensus 141 ~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~---~ 217 (332)
T cd05623 141 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---Y 217 (332)
T ss_pred EEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH---H
Confidence 34689999876543222 222356999999999975 34578899999999999999999999753211000 0
Q ss_pred cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 443 TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 443 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
... .........+........++..+++ .|.|..+++..||++.|+.+.
T Consensus 218 ~~i-~~~~~~~~~p~~~~~~s~~~~~li~-~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 218 GKI-MNHKERFQFPAQVTDVSEDAKDLIR-RLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHH-hCCCccccCCCccccCCHHHHHHHH-HHccChhhhcCCCCHHHHhCC
Confidence 000 0000000111111112345666666 345767777778999888653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.4e-10 Score=110.45 Aligned_cols=94 Identities=19% Similarity=0.301 Sum_probs=59.6
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHH
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISI 469 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 469 (502)
..||..|+|||......++.++|||||||+++||+||+.|+............... .... ..+.. ....+++.++
T Consensus 199 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~-~~~~---~~~~~-~~~s~~~~~l 273 (364)
T cd05599 199 TVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINW-KETL---QFPDE-VPLSPEAKDL 273 (364)
T ss_pred cccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCcc---CCCCC-CCCCHHHHHH
Confidence 45899999999998888999999999999999999999998532110000000000 0000 11110 1122455666
Q ss_pred HHHhhccCCcCCCCCCC---HHHHHH
Q 010736 470 MEVGFSCLKESPESRPT---MKIVSQ 492 (502)
Q Consensus 470 ~~val~C~~~~p~~Rp~---m~~v~~ 492 (502)
++ .|+. +|.+|++ +.|+.+
T Consensus 274 i~---~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 274 IK---RLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HH---HHcc-CHhhcCCCCCHHHHhc
Confidence 66 4554 8999997 888755
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.3e-09 Score=107.86 Aligned_cols=119 Identities=23% Similarity=0.321 Sum_probs=71.2
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCcccccc-----ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYT-----MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~-----~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
-..+|||+++.+..... ......||.+|+|||.... ...+.++|||||||+++||+||+.|+........ ..
T Consensus 141 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--~~ 218 (331)
T cd05597 141 IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG 218 (331)
T ss_pred EEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--HH
Confidence 34689999876543222 1223468999999999863 4567899999999999999999999753211000 00
Q ss_pred cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 443 TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 443 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+.. .++.......+++..+++ .|.|...++..||++.++.+
T Consensus 219 ~i~~~~~~~--~~~~~~~~~~~~~~~li~-~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 219 KIMNHKEHF--QFPPDVTDVSEEAKDLIR-RLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred HHHcCCCcc--cCCCccCCCCHHHHHHHH-HHccCcccccCCCCHHHHhc
Confidence 000000000 011000112345566665 34577777777999988765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-09 Score=107.92 Aligned_cols=62 Identities=31% Similarity=0.430 Sum_probs=50.0
Q ss_pred cccccCcccccCCCC---CCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDS---SNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~---~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++...... .......++..|+|||...+. ..+.++|+||||++++||+||+.|+.
T Consensus 143 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 143 KICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred EEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 468999998775432 122334577889999999877 78999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.2e-09 Score=105.32 Aligned_cols=62 Identities=18% Similarity=0.277 Sum_probs=44.8
Q ss_pred cccccCcccccCCCC-------CCcccccccccccCcccccc--ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDS-------SNWTGFAGTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~-------~~~~~~~gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||.+..+.... .......++..|+|||+... ...+.++|+|||||+++||+||+.|+.
T Consensus 141 kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~ 211 (314)
T cd08216 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211 (314)
T ss_pred EEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 356777765442211 11123456788999999765 347789999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-09 Score=105.50 Aligned_cols=120 Identities=17% Similarity=0.260 Sum_probs=72.2
Q ss_pred cccccCcccccCCCC-CCcccccccccccCccccccce-ecccceeeeeceeeeehhcCCCCCCcccCCC----------
Q 010736 370 ITGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS---------- 437 (502)
Q Consensus 370 l~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~~~~~-~s~k~Dvysfgv~llElltg~~p~~~~~~~~---------- 437 (502)
..+|||+++...... .......|+..|+|||...+.+ .+.++||||+|++++|++||+.|+.......
T Consensus 139 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07832 139 KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG 218 (286)
T ss_pred EEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcC
Confidence 468999988765432 1223456888999999986544 5889999999999999999977764211000
Q ss_pred CC---CC---CcccccccccCCCCCC-----CCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 SP---SL---NTDIALDEMLDPRLPV-----PSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 ~~---~~---~~~~~~~~~~d~~l~~-----~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.. .+ ........+..+.-.. ......+++..+++ .|+..+|++||+++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLK---GLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHH---HHhccChhhCCCHHHHhh
Confidence 00 00 0000000010000000 00012245566666 999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-09 Score=101.80 Aligned_cols=112 Identities=29% Similarity=0.426 Sum_probs=73.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||.+....... ......++..|++||.......+.++|||+||++++|+++|+.|++..... ... ...
T Consensus 127 ~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~-----~~~ 198 (244)
T smart00220 127 KLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LEL-----FKK 198 (244)
T ss_pred EEccccceeeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH-----HHH
Confidence 468999988775432 223456788999999998888899999999999999999999997531110 000 000
Q ss_pred ccCCCCCCCCcc--hHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCS--VQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~--~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+........ ..+++.. +...|+..+|++||++.++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~---~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 199 IGKPKPPFPPPEWKISPEAKD---LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HhccCCCCccccccCCHHHHH---HHHHHccCCchhccCHHHHhh
Confidence 011111000000 1233444 455999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.1e-09 Score=106.49 Aligned_cols=63 Identities=30% Similarity=0.452 Sum_probs=49.8
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCcccccc-----ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYT-----MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~-----~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++....... ......|+.+|+|||.... ...+.++|+|||||+++||+||+.|+.
T Consensus 141 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 141 IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 34689999987654322 2233569999999998765 457789999999999999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-09 Score=116.70 Aligned_cols=122 Identities=26% Similarity=0.404 Sum_probs=78.1
Q ss_pred CCCCeeeecCCcc---------ccccCcccccCC------------------CCCCcccccccccccCccccccce---e
Q 010736 358 PKLGALNISRNNI---------TGDFGIAKFLKP------------------DSSNWTGFAGTYGYIAPELAYTMK---I 407 (502)
Q Consensus 358 ~~L~~L~l~~N~l---------~~dfGl~~ll~~------------------~~~~~~~~~gt~gy~aPE~~~~~~---~ 407 (502)
..+.|.||+..|| +||||+|+.+.. ...+.|+..||.-|+|||...... +
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 3477778877776 799999997310 112346678999999999987654 9
Q ss_pred cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCC---CcchHHHHHHHHHHhhccCCcCCCCC
Q 010736 408 TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVP---SCSVQEKLISIMEVGFSCLKESPESR 484 (502)
Q Consensus 408 s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~---~~~~~~~~~~~~~val~C~~~~p~~R 484 (502)
+.|.|+||.|||++||+.- .++.. .+...+....++.++.+ ......+-.++++ .-++.+|.+|
T Consensus 796 n~KiDmYSLGIVlFEM~yP-F~TsM---------ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~---~Ll~hdP~kR 862 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLYP-FGTSM---------ERASILTNLRKGSIPEPADFFDPEHPEEASLIR---WLLSHDPSKR 862 (1351)
T ss_pred cchhhhHHHHHHHHHHhcc-CCchH---------HHHHHHHhcccCCCCCCcccccccchHHHHHHH---HHhcCCCccC
Confidence 9999999999999999963 22211 01111222223333322 1111112234454 5678999999
Q ss_pred CCHHHHHH
Q 010736 485 PTMKIVSQ 492 (502)
Q Consensus 485 p~m~~v~~ 492 (502)
||..|++.
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99988854
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.8e-10 Score=115.56 Aligned_cols=60 Identities=25% Similarity=0.402 Sum_probs=49.2
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhcCCCC
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p 429 (502)
.++|||+++.+..... ......||..|++||...+..++.++|||||||+++||++|+.|
T Consensus 307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred EEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 3689999987754322 22346789999999999988899999999999999999998754
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.2e-09 Score=105.27 Aligned_cols=111 Identities=22% Similarity=0.362 Sum_probs=72.7
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
.+|||+++...... .....|+..|+|||.... ...+.++|+|||||+++|++||+.|+........... . ....
T Consensus 138 l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~--~~~~ 212 (279)
T cd05633 138 ISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D--RMTL 212 (279)
T ss_pred EccCCcceeccccC--ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-H--HHhh
Confidence 68999987553221 123468899999998764 5578899999999999999999999853221110000 0 0000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
..+..++. ....++.++++ .|+..+|++|| +++|+.+
T Consensus 213 ~~~~~~~~---~~~~~~~~li~---~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 213 TVNVELPD---SFSPELKSLLE---GLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCCcCCcc---ccCHHHHHHHH---HHhcCCHHHhcCCCCCCHHHHHh
Confidence 11222221 12356667776 89999999999 5888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.7e-09 Score=104.29 Aligned_cols=63 Identities=21% Similarity=0.257 Sum_probs=47.5
Q ss_pred ccccccCcccccCCCCC----CcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++....... ......++..|+|||+.... ..+.++||||||++++||+||+.|+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 34689999987643211 12234567889999987654 36789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.2e-09 Score=103.77 Aligned_cols=117 Identities=25% Similarity=0.389 Sum_probs=70.3
Q ss_pred cccccCcccccCCCCC----CcccccccccccCcccc-c-cceecccceeeeeceeeeehhcCCCCCCcccCCCC--CCC
Q 010736 370 ITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELA-Y-TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS--PSL 441 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~-~-~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~--~~~ 441 (502)
-.+|||..-.+...-. .+..+.||+.|||||.. + ..-++.|+|||||||..+|+.+|+.|+........ ..+
T Consensus 166 kLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL 245 (516)
T KOG0582|consen 166 KLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL 245 (516)
T ss_pred EEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 3688888766533111 12457899999999994 3 33589999999999999999999999863221110 000
Q ss_pred Cccc--ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 442 NTDI--ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 442 ~~~~--~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+- -.....|..-... ....+.+++. .|++.+|++||+.++.++
T Consensus 246 qn~pp~~~t~~~~~d~~k~---~~ksf~e~i~---~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 246 QNDPPTLLTSGLDKDEDKK---FSKSFREMIA---LCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCCCCCcccccCChHHhhh---hcHHHHHHHH---HHhhcCcccCCCHHHHhc
Confidence 0000 0000111110000 0123445555 899999999999988753
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-09 Score=106.77 Aligned_cols=62 Identities=23% Similarity=0.352 Sum_probs=48.2
Q ss_pred cccccCcccccCCCCC---CcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.+..... ......++..|+|||...+. ..+.++|||||||+++||+||+.|+.
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 4689999887643221 12345678899999987654 47889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-09 Score=105.28 Aligned_cols=118 Identities=22% Similarity=0.373 Sum_probs=75.9
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccce--ecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMK--ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~--~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
...+|||+++.+..... ......|+..|++||...+.. .+.++||||||++++||+||+.|+......... ...
T Consensus 144 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~ 220 (288)
T cd05583 144 VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ---SEI 220 (288)
T ss_pred EEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH---HHH
Confidence 34689999887543221 112346788999999987655 788999999999999999999997422111000 000
Q ss_pred ccccc--cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 446 ALDEM--LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 446 ~~~~~--~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
...+ .++..+. ....++.+++. .|++.+|++||++++|.+.|+.
T Consensus 221 -~~~~~~~~~~~~~---~~~~~l~~li~---~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 221 -SRRILKSKPPFPK---TMSAEARDFIQ---KLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -HHHHHccCCCCCc---ccCHHHHHHHH---HHhcCCHhhccCcchHHHHhcC
Confidence 0011 1111111 12234555555 8999999999999999877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-09 Score=106.25 Aligned_cols=62 Identities=26% Similarity=0.298 Sum_probs=48.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.........+...++..|+|||...+ ...+.++||||+||+++||++|+.|+.
T Consensus 148 kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 148 KIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred EECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 46899999877543322233345778999998765 457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.78 E-value=7e-10 Score=105.63 Aligned_cols=112 Identities=18% Similarity=0.230 Sum_probs=72.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.... .....++..|++||...+...+.++||||||++++|++||+.|+...... ..........
T Consensus 137 ~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~ 209 (260)
T cd05611 137 KLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFDNILSRR 209 (260)
T ss_pred EEeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcc
Confidence 3689998876533 12346788999999988877899999999999999999999997532110 0000000000
Q ss_pred c-cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 450 M-LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 450 ~-~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
. ..+... .....++..+++ .|++.+|++||+..++.+.|
T Consensus 210 ~~~~~~~~---~~~~~~~~~~i~---~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 210 INWPEEVK---EFCSPEAVDLIN---RLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCCCCccc---ccCCHHHHHHHH---HHccCCHHHccCCCcHHHHH
Confidence 0 000110 012245556666 99999999999876665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-09 Score=104.83 Aligned_cols=111 Identities=24% Similarity=0.292 Sum_probs=70.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... ......++..|++||+..+...+.++|||||||+++|+++|+.|+............... ...
T Consensus 135 ~l~dfg~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~ 212 (277)
T cd05577 135 RISDLGLAVELKGGK-KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-TLE 212 (277)
T ss_pred EEccCcchhhhccCC-ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-ccc
Confidence 468999987764322 222345778999999988888899999999999999999999997532211000000000 000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~ 489 (502)
.....+ .....++..+++ .|++.+|++||+..|
T Consensus 213 -~~~~~~---~~~~~~~~~li~---~~l~~~p~~R~~~~~ 245 (277)
T cd05577 213 -MAVEYP---DKFSPEAKDLCE---ALLQKDPEKRLGCRG 245 (277)
T ss_pred -ccccCC---ccCCHHHHHHHH---HHccCChhHccCCCc
Confidence 011111 112345667777 999999999995555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.7e-09 Score=108.70 Aligned_cols=63 Identities=27% Similarity=0.439 Sum_probs=49.6
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccc----eecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTM----KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~----~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.+..... ......||.+|+|||..... ..+.++|+||+||+++||+||+.|+.
T Consensus 181 ~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 181 LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred EEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 34789999987643221 12346799999999998653 36789999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.1e-09 Score=99.13 Aligned_cols=120 Identities=24% Similarity=0.297 Sum_probs=78.5
Q ss_pred eeecCCccccccCcccccCCCCCCcccccccccccCccccccc--eecccceeeeeceeeeehhcCCCCCCcccCCCCCC
Q 010736 363 LNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM--KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPS 440 (502)
Q Consensus 363 L~l~~N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~--~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~ 440 (502)
||=+++=..||||+.-.+.. +-..|.-+|+..|+|||..... -+..++||||+||.|+|+.||+.|++.+...
T Consensus 201 ldr~G~vKLCDFGIcGqLv~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv---- 275 (361)
T KOG1006|consen 201 LDRHGDVKLCDFGICGQLVD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV---- 275 (361)
T ss_pred EecCCCEeeecccchHhHHH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----
Confidence 44455555799999877653 2234567899999999998654 3788999999999999999999997532110
Q ss_pred CCcccccccccCCCCCCCCc---chHHHHHHHHHHhhccCCcCCCCCCCHHHHH
Q 010736 441 LNTDIALDEMLDPRLPVPSC---SVQEKLISIMEVGFSCLKESPESRPTMKIVS 491 (502)
Q Consensus 441 ~~~~~~~~~~~d~~l~~~~~---~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~ 491 (502)
......--.-||.+..... .....|...+. .|+-.+-..||+-.++.
T Consensus 276 -feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fin---tCl~Kd~~~Rpky~~Lk 325 (361)
T KOG1006|consen 276 -FEQLCQVVIGDPPILLFDKECVHYSFSMVRFIN---TCLIKDRSDRPKYDDLK 325 (361)
T ss_pred -HHHHHHHHcCCCCeecCcccccccCHHHHHHHH---HHhhcccccCcchhhhh
Confidence 0000000112332221110 12234666666 99999999999988764
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.9e-09 Score=103.82 Aligned_cols=62 Identities=27% Similarity=0.361 Sum_probs=47.7
Q ss_pred cccccCcccccCCCCC-CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.+..... ......++..|++||.... ...+.++|||||||+++||++|+.|++
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 4689999987754332 2233456778999997754 356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.1e-09 Score=118.32 Aligned_cols=113 Identities=21% Similarity=0.330 Sum_probs=74.0
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
...+||.++.+..... ....+.||..|+|||...+..++.++|||||||+++||+||+.|++..... ...
T Consensus 518 ~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~--------~~~ 589 (669)
T cd05610 518 IGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQ--------QVF 589 (669)
T ss_pred ccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHH
Confidence 3467888777643211 123457899999999999888999999999999999999999997521110 001
Q ss_pred ccccCCCCCCCC--cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 448 DEMLDPRLPVPS--CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 448 ~~~~d~~l~~~~--~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
..+++.....+. .....++..++. .|+..+|++||++.||++.
T Consensus 590 ~~il~~~~~~p~~~~~~~~~~~~~l~---~lL~~dP~~R~ta~e~l~h 634 (669)
T cd05610 590 QNILNRDIPWPEGEEKLSVNAQNAIE---ILLTMDPTKRAGLKELKQH 634 (669)
T ss_pred HHHHhcCCCCCcccccCCHHHHHHHH---HHcccChhHCcCHHHHHhC
Confidence 112221111000 011123444444 7999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.9e-09 Score=103.32 Aligned_cols=111 Identities=24% Similarity=0.334 Sum_probs=73.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... ...++..|+|||+......+.++|||||||+++|++||+.|+........ . ... ...
T Consensus 150 ~l~dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~--~~~-~~~ 221 (267)
T PHA03390 150 YLCDYGLCKIIGTPS----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-D--LES-LLK 221 (267)
T ss_pred EEecCccceecCCCc----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-h--HHH-HHH
Confidence 468999887664322 24688899999999888889999999999999999999999863221110 0 000 000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-HHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-MKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-m~~v~~ 492 (502)
......... ......+..+++ .|++.+|++||+ ++|+++
T Consensus 222 ~~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 222 RQQKKLPFI-KNVSKNANDFVQ---SMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhcccCCcc-cccCHHHHHHHH---HHhccChhhCCchHHHHhc
Confidence 011111111 112245666666 999999999995 688753
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.5e-09 Score=113.46 Aligned_cols=105 Identities=26% Similarity=0.313 Sum_probs=59.1
Q ss_pred EEEEEecCCCC-ceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 72 VINISLRGVGL-KGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 72 v~~L~L~~~~l-~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
++.|-+.++.. ...++...|..++.|++|||++|.=-+.+|..++++-+|++|+|++..++ .+|..+++++.|.+|++
T Consensus 547 L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl 625 (889)
T KOG4658|consen 547 LRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNL 625 (889)
T ss_pred cceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheecc
Confidence 44555555441 22333333555666666666665544556666666666666666666666 56666666666666666
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccC
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSN 177 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N 177 (502)
..+.-...+|.....+++|++|.+...
T Consensus 626 ~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 626 EVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred ccccccccccchhhhcccccEEEeecc
Confidence 655544444444455666666665443
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.7e-09 Score=102.03 Aligned_cols=116 Identities=25% Similarity=0.433 Sum_probs=73.2
Q ss_pred cccccCcccccCCCCC----CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++.+..... ......|+.+|++||.......+.++||||+|++++|+++|+.|+...............
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (268)
T cd06630 144 RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223 (268)
T ss_pred EEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH
Confidence 4689999877653211 112345788999999988888899999999999999999999997532111100000000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+..+ .....++.+++ ..|+..+|++||++.|+++
T Consensus 224 -~~~~~~~~~~---~~~~~~~~~~i---~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 -ASATTAPSIP---EHLSPGLRDVT---LRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -hccCCCCCCc---hhhCHHHHHHH---HHHcCCCcccCcCHHHHhc
Confidence 0001111111 11123344444 4999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.3e-09 Score=107.87 Aligned_cols=62 Identities=27% Similarity=0.467 Sum_probs=49.4
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccc----eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTM----KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~----~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.+..... ......||..|+|||..... ..+.++|||||||+++||+||+.|+.
T Consensus 182 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 182 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred EEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 4699999987753322 22346799999999998653 37789999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.6e-09 Score=107.10 Aligned_cols=119 Identities=24% Similarity=0.433 Sum_probs=80.6
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCC-----------CCc--ccccccccccCccccccceecccceeeee
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDS-----------SNW--TGFAGTYGYIAPELAYTMKITEKCDVYSF 416 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~-----------~~~--~~~~gt~gy~aPE~~~~~~~s~k~Dvysf 416 (502)
++.|.||+--|| +.|||-||.+++.. ... ..+.||.-|++||.......+..+|+|+|
T Consensus 194 GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAl 273 (604)
T KOG0592|consen 194 GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWAL 273 (604)
T ss_pred CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHH
Confidence 455666665554 68999999986421 112 34789999999999999999999999999
Q ss_pred ceeeeehhcCCCCCCcccCCCCCCCCcccccccc--cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHH
Q 010736 417 GVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM--LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491 (502)
Q Consensus 417 gv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~--~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~ 491 (502)
||+++.|+.|+.|+....+. . ....| +|-..+. .-.+.+..+++ .-...+|.+|++..|+-
T Consensus 274 GCilyQmlaG~PPFra~Ney---l-----iFqkI~~l~y~fp~---~fp~~a~dLv~---KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 274 GCILYQMLAGQPPFRAANEY---L-----IFQKIQALDYEFPE---GFPEDARDLIK---KLLVRDPSDRLTSQQIK 336 (604)
T ss_pred HHHHHHHhcCCCCCccccHH---H-----HHHHHHHhcccCCC---CCCHHHHHHHH---HHHccCccccccHHHHh
Confidence 99999999999998522110 0 01111 2222221 11234444444 44568999999987764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.2e-09 Score=102.35 Aligned_cols=111 Identities=21% Similarity=0.350 Sum_probs=72.9
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
.+|||+++.+.... .....|+..|+|||..... ..+.++|+|||||+++||+||+.|++........... ....
T Consensus 138 l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~ 212 (278)
T cd05606 138 ISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL 212 (278)
T ss_pred EccCcCccccCccC--CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhh
Confidence 68999987654321 1234688999999998744 5789999999999999999999998533211110000 0011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
..++.++.. ...++..+++ .|+..+|++|| ++.|+.+
T Consensus 213 ~~~~~~~~~---~s~~~~~li~---~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 213 TMAVELPDS---FSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ccCCCCCCc---CCHHHHHHHH---HHhhcCHHhccCCCCCCHHHHHh
Confidence 122233211 1244555665 99999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.6e-09 Score=105.83 Aligned_cols=120 Identities=24% Similarity=0.313 Sum_probs=72.9
Q ss_pred cccccCcccccCCCCC----CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCC-------
Q 010736 370 ITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS------- 437 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~------- 437 (502)
..+|||+++....... ..+...|+..|++||.... ...+.++|||||||+++||++|+.|+.......
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (334)
T cd07855 147 RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226 (334)
T ss_pred EecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH
Confidence 4689999876643211 1123467889999998755 457899999999999999999999985321100
Q ss_pred -----CCCCC---cccccccc---cCCCCCCC----CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 -----SPSLN---TDIALDEM---LDPRLPVP----SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 -----~~~~~---~~~~~~~~---~d~~l~~~----~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..... ....+.+. .......+ .....+++..+++ .|++.+|++||+++|+++
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLS---QMLQFDPEERITVEQALQ 293 (334)
T ss_pred HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHH---HHccCChhhCcCHHHHHh
Confidence 00000 00000000 00000000 0011245666666 999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.4e-09 Score=107.42 Aligned_cols=41 Identities=24% Similarity=0.459 Sum_probs=36.0
Q ss_pred cccccccCcccccc--ceecccceeeeeceeeeehhcCCCCCC
Q 010736 391 AGTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 391 ~gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.++..|+|||+... ..++.++|||||||+++|++||+.|++
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 169 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred cceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 45678999999865 457899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.4e-09 Score=107.92 Aligned_cols=109 Identities=27% Similarity=0.412 Sum_probs=77.3
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.||||+||.+....+..+.++||+-|||||...+..++..+|.||.||+++|+++|++|+-... ...++..+ .
T Consensus 141 lcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~I----~ 213 (808)
T KOG0597|consen 141 LCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKSI----L 213 (808)
T ss_pred echhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHHH----h
Confidence 5999999999877777788999999999999999999999999999999999999999973110 00011111 1
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~ 491 (502)
.||-.+.. ....+...+++ .-...+|.+|-+..+..
T Consensus 214 ~d~v~~p~--~~S~~f~nfl~---gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 214 KDPVKPPS--TASSSFVNFLQ---GLLIKDPAQRLTWTDLL 249 (808)
T ss_pred cCCCCCcc--cccHHHHHHHH---HHhhcChhhcccHHHHh
Confidence 22222211 11234455555 45668999998877654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.7e-09 Score=113.34 Aligned_cols=127 Identities=23% Similarity=0.273 Sum_probs=58.7
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEEEccCCc--CcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEE
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQ--FSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~--l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 172 (502)
...+.+.+-+|.+. .++... .+++|++|-+..|. +....+..|..++.|+.|||++|.=-+.+|..++.+-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 34444444444443 222222 22345555555553 221222224445555555555544444555555555555555
Q ss_pred EcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCcccccc
Q 010736 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAI 224 (502)
Q Consensus 173 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 224 (502)
++++..++ .+|..+.++..|.+|++..+.-...+|.....+.+|++|.+..
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeec
Confidence 55555554 4455555555555555554443333344444455555555443
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.6e-09 Score=103.64 Aligned_cols=101 Identities=23% Similarity=0.338 Sum_probs=69.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++..... .....|+..|++||.......+.++|+||||++++||+||+.|+...... .....
T Consensus 141 kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~ 209 (290)
T cd05580 141 KITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--------QIYEK 209 (290)
T ss_pred EEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 36899998876543 22456888999999998888889999999999999999999997532210 00111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP 485 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp 485 (502)
+......-+. .....+..+++ .|++.+|.+||
T Consensus 210 ~~~~~~~~~~-~~~~~l~~li~---~~l~~~p~~R~ 241 (290)
T cd05580 210 ILEGKVRFPS-FFSPDAKDLIR---NLLQVDLTKRL 241 (290)
T ss_pred HhcCCccCCc-cCCHHHHHHHH---HHccCCHHHcc
Confidence 1111111111 12345666776 99999999999
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-09 Score=107.56 Aligned_cols=118 Identities=23% Similarity=0.341 Sum_probs=77.9
Q ss_pred ccccCcccccCC-CCCCcc-cccccccccCccccccceecccceeeeeceeeeehhc--CCCCCCcccCCCCCCCCcccc
Q 010736 371 TGDFGIAKFLKP-DSSNWT-GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK--GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 371 ~~dfGl~~ll~~-~~~~~~-~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt--g~~p~~~~~~~~~~~~~~~~~ 446 (502)
+||||++|-+-. +..... ...-.+.|||+|..-..++|.++|||+|||.+||+++ ..+|+........ +. .
T Consensus 678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ve--n 752 (807)
T KOG1094|consen 678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VE--N 752 (807)
T ss_pred ecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HH--h
Confidence 799999996533 222211 2233578999999999999999999999999999875 7888753322111 00 0
Q ss_pred cccccCCC-----CCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPR-----LPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~-----l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..++++.. +..+ ...+. ++.++.+.||..+.++||++++++.-|.+.
T Consensus 753 ~~~~~~~~~~~~~l~~P-~~cp~---~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 753 AGEFFRDQGRQVVLSRP-PACPQ---GLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhhcCCCCcceeccCC-CcCcH---HHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111110 0111 11223 455667799999999999999999988764
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.1e-09 Score=101.72 Aligned_cols=62 Identities=23% Similarity=0.363 Sum_probs=47.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.............++..|++||...+. ..+.++|+|||||+++|++||+.|+.
T Consensus 140 ~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 140 KLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred EEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 457898887664332222334567889999987553 46889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.9e-09 Score=106.97 Aligned_cols=63 Identities=25% Similarity=0.416 Sum_probs=48.0
Q ss_pred ccccccCcccccCCCCC---CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++....... ......|+..|+|||.... ...+.++|||||||+++||+||+.|+.
T Consensus 145 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 34689999887643221 1123567889999998654 457889999999999999999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.9e-09 Score=99.67 Aligned_cols=62 Identities=39% Similarity=0.612 Sum_probs=52.7
Q ss_pred ccccCcccccCCCCCC-------cccccccccccCccccccc----eecccceeeeeceeeeehhcCCCCCCc
Q 010736 371 TGDFGIAKFLKPDSSN-------WTGFAGTYGYIAPELAYTM----KITEKCDVYSFGVLVLEVIKGKHPRDF 432 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~-------~~~~~gt~gy~aPE~~~~~----~~s~k~Dvysfgv~llElltg~~p~~~ 432 (502)
+.||||+|.+++++.. .+..+||+.|++||.+.-. +++.|.||||.||+.+.++.||+|+..
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 5799999999876533 2356899999999998644 789999999999999999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=98.69 E-value=4e-09 Score=104.45 Aligned_cols=62 Identities=27% Similarity=0.390 Sum_probs=47.8
Q ss_pred cccccCcccccCCCCC----CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.++|||+++.+..... ......|+..|+|||+..+ ...+.++|+||+||+++|+++|+.|+.
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 4689999986543211 1223568889999998765 457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.3e-09 Score=105.54 Aligned_cols=42 Identities=33% Similarity=0.567 Sum_probs=39.0
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..||.+|+|||.......+.++|||||||+++||+||+.|+.
T Consensus 208 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 249 (377)
T cd05629 208 TVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFC 249 (377)
T ss_pred cCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCC
Confidence 458999999999988889999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.7e-09 Score=105.50 Aligned_cols=42 Identities=38% Similarity=0.653 Sum_probs=39.3
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..||..|+|||.......+.++||||+||+++||+||+.|+.
T Consensus 208 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 249 (382)
T cd05625 208 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 249 (382)
T ss_pred cccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCC
Confidence 468999999999988889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=4e-09 Score=104.97 Aligned_cols=114 Identities=24% Similarity=0.254 Sum_probs=80.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.... ......+.||++|+|||......++...|+||.||+++.|++|..|+...........+.... .+
T Consensus 179 k~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~-~~ 256 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD-FD 256 (382)
T ss_pred EEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC-CC
Confidence 3689999999877 444567899999999999999999999999999999999999999985322111000000000 11
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+-++.- ....+.+...+. .+...+|.+|++.+++++
T Consensus 257 f~~~~w----~~is~~akd~i~---~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 257 FTSEPW----DDISESAKDFIR---KLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCc----cccCHHHHHHHH---HhcccCcccCCCHHHHhc
Confidence 122211 122345666666 888999999999999976
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.9e-09 Score=106.01 Aligned_cols=117 Identities=23% Similarity=0.392 Sum_probs=78.4
Q ss_pred eeecCCccccccCcccccCCCCCCcccccccccccCccccccceec-ccceeeeeceeeeehhcCCCCCCcccCCCCCCC
Q 010736 363 LNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKIT-EKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSL 441 (502)
Q Consensus 363 L~l~~N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s-~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~ 441 (502)
||-.+|=-++|||+|-+-.++.-- .+.+|++-|.+||...+.++. .++||||-||+++.|+||+-|||. ++...+
T Consensus 145 Ld~~~nIKIADFGMAsLe~~gklL-eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~L 220 (786)
T KOG0588|consen 145 LDVKNNIKIADFGMASLEVPGKLL-ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVL 220 (786)
T ss_pred hhcccCEeeeccceeecccCCccc-cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHH
Confidence 555666448999999887655432 346899999999999999887 679999999999999999999972 111111
Q ss_pred CcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 442 NTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 442 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..... ..+++ ++. ....+...++. ...+.+|+.|-||.||.+
T Consensus 221 LlKV~-~G~f~--MPs---~Is~eaQdLLr---~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 221 LLKVQ-RGVFE--MPS---NISSEAQDLLR---RMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHHHH-cCccc--CCC---cCCHHHHHHHH---HHhccCccccccHHHHhh
Confidence 10000 11111 111 11223334444 456699999999999965
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=7.9e-09 Score=101.46 Aligned_cols=73 Identities=30% Similarity=0.445 Sum_probs=58.0
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCC-CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGK 427 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~ 427 (502)
++-|.||++.|| ++|||||++...... ..|...-|..|.|||..-+ ..++...|+||.||++.||++||
T Consensus 238 gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk 317 (560)
T KOG0600|consen 238 GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK 317 (560)
T ss_pred CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC
Confidence 344555655554 799999999876543 3566667899999999864 47999999999999999999999
Q ss_pred CCCC
Q 010736 428 HPRD 431 (502)
Q Consensus 428 ~p~~ 431 (502)
..+.
T Consensus 318 PI~~ 321 (560)
T KOG0600|consen 318 PILQ 321 (560)
T ss_pred CCcC
Confidence 8865
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.8e-09 Score=99.60 Aligned_cols=113 Identities=21% Similarity=0.308 Sum_probs=72.9
Q ss_pred ccccccCcccccCCC---CCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPD---SSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~---~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
...+|||+++..... ....+...++..|+|||+..+...+.++|+|||||+++|++||+.|+...... .. ...
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~-~~~- 220 (264)
T cd06653 145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AA-IFK- 220 (264)
T ss_pred EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HH-HHH-
Confidence 356899998865321 11122456888999999998888899999999999999999999997532110 00 000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....-..+.++ ....+++..+++ .|+. .|.+||+..++.+
T Consensus 221 ~~~~~~~~~~p---~~~~~~~~~~i~---~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 IATQPTKPMLP---DGVSDACRDFLK---QIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHcCCCCCCCC---cccCHHHHHHHH---HHhc-CcccCccHHHHhc
Confidence 00001112222 123355666776 8888 5799999887653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.4e-09 Score=95.87 Aligned_cols=59 Identities=29% Similarity=0.508 Sum_probs=50.2
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHP 429 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p 429 (502)
.||||+||.+.......|.-..|-.|.|||...+ .++-...|||+.||++-||+||..=
T Consensus 142 LCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL 201 (396)
T KOG0593|consen 142 LCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPL 201 (396)
T ss_pred eccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcC
Confidence 5999999999754444566667889999999876 7888999999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.8e-09 Score=94.44 Aligned_cols=60 Identities=33% Similarity=0.643 Sum_probs=55.0
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.||||++.-+. +...+-+.+||++|++||....-.++..+|||+-||+|+-++.|+.|+.
T Consensus 154 L~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 154 LADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred ecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 58999999887 5556778999999999999999999999999999999999999999974
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=98.64 E-value=6.5e-09 Score=99.91 Aligned_cols=112 Identities=23% Similarity=0.424 Sum_probs=72.7
Q ss_pred CccccccCcccccCCCC--------------------CCcccccccccccCccccccceecccceeeeeceeeeehhcCC
Q 010736 368 NNITGDFGIAKFLKPDS--------------------SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGK 427 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~--------------------~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~ 427 (502)
+...+|||++....... .......++..|++||.......+.++|+||+|++++|++||+
T Consensus 140 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~ 219 (280)
T cd05581 140 HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219 (280)
T ss_pred CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 34468888887654321 1112345778999999988888999999999999999999999
Q ss_pred CCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH----HHHH
Q 010736 428 HPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM----KIVS 491 (502)
Q Consensus 428 ~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m----~~v~ 491 (502)
.|+....... ....+.+.....+ ....+++.++++ .|++.+|.+||++ +|+.
T Consensus 220 ~p~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 220 PPFRGSNEYL--------TFQKILKLEYSFP-PNFPPDAKDLIE---KLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred CCCCCccHHH--------HHHHHHhcCCCCC-CccCHHHHHHHH---HHhcCCHhhCCCcccCHHHHh
Confidence 9975322100 0011111111000 112245566666 9999999999999 6554
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.7e-09 Score=105.21 Aligned_cols=60 Identities=30% Similarity=0.509 Sum_probs=47.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++..... .....++..|++||.... ...+.++|||||||+++|++||+.|+.
T Consensus 157 ~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 157 LKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred EEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 346899998765432 233467788999998754 367889999999999999999999974
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.4e-08 Score=101.34 Aligned_cols=108 Identities=29% Similarity=0.456 Sum_probs=74.8
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccc---ccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELA---YTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~---~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.+|||-+.++.+.. .+.||+.|||||.. ..++++.|.||||+||...|+.-+|+|.- ..+..+....+.
T Consensus 167 LaDFGSAsi~~PAn----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF---nMNAMSALYHIA- 238 (948)
T KOG0577|consen 167 LADFGSASIMAPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIA- 238 (948)
T ss_pred eccccchhhcCchh----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc---CchHHHHHHHHH-
Confidence 36777776665433 47899999999996 45689999999999999999999999942 222111111111
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.--.|.+..+ .-.+.....++ .|.+.-|.+|||-.+.++
T Consensus 239 -QNesPtLqs~--eWS~~F~~Fvd---~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 239 -QNESPTLQSN--EWSDYFRNFVD---SCLQKIPQERPTSEELLK 277 (948)
T ss_pred -hcCCCCCCCc--hhHHHHHHHHH---HHHhhCcccCCcHHHHhh
Confidence 1123444322 23356677777 999999999999888654
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.2e-08 Score=98.88 Aligned_cols=113 Identities=23% Similarity=0.394 Sum_probs=69.8
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccc--eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTM--KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~--~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
-..+|||+++....... ......|+..|++||+.... ..+.++||||||++++|++||+.|++....... ..+
T Consensus 144 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~- 219 (290)
T cd05613 144 VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAE- 219 (290)
T ss_pred EEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---HHH-
Confidence 34689999887643221 12235688899999998653 467889999999999999999999753211100 000
Q ss_pred ccccc--cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHH
Q 010736 446 ALDEM--LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVS 491 (502)
Q Consensus 446 ~~~~~--~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~ 491 (502)
....+ ..+..+ ......+..+++ .|++.+|++|| +..++.
T Consensus 220 ~~~~~~~~~~~~~---~~~~~~~~~ll~---~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 220 ISRRILKSEPPYP---QEMSALAKDIIQ---RLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred HHHHhhccCCCCC---ccCCHHHHHHHH---HHhcCCHHHhcCCCCCCHHHHH
Confidence 00011 111111 112234555555 99999999997 555553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=98.57 E-value=9.8e-09 Score=102.12 Aligned_cols=62 Identities=27% Similarity=0.415 Sum_probs=46.3
Q ss_pred cccccCcccccCCCCCC---cccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.+...... .....++..|+|||.... ...+.++|||||||+++||+||+.|+.
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 36899998876432111 122356788999997643 457789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=6e-09 Score=109.88 Aligned_cols=119 Identities=18% Similarity=0.157 Sum_probs=68.1
Q ss_pred cccccCcccccCCCC-CCcccccccccccCcccccc----------------------ceecccceeeeeceeeeehhcC
Q 010736 370 ITGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELAYT----------------------MKITEKCDVYSFGVLVLEVIKG 426 (502)
Q Consensus 370 l~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~~~----------------------~~~s~k~Dvysfgv~llElltg 426 (502)
.++|||+++.+.... .......++.+|+|||.... ..+..++|||||||+++||+++
T Consensus 296 KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~ 375 (566)
T PLN03225 296 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFP 375 (566)
T ss_pred EEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhC
Confidence 479999998764322 22334678899999995421 1234567999999999999998
Q ss_pred CCCCCcccC-----CCCCCCCcccccccccCCCCCCC-------CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 427 KHPRDFLSS-----TSSPSLNTDIALDEMLDPRLPVP-------SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 427 ~~p~~~~~~-----~~~~~~~~~~~~~~~~d~~l~~~-------~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..|.+.... ........ ......+++..... ........+++++ .|.+.+|++||+++|+++
T Consensus 376 ~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~---~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 376 NLRSDSNLIQFNRQLKRNDYDL-VAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK---SMMRFKGRQRISAKAALA 449 (566)
T ss_pred cCCCchHHHHHHHHHHhcCCcH-HHHHHhhccccchhhhhhhhhccccchHHHHHHH---HHccCCcccCCCHHHHhC
Confidence 877542100 00000000 00001111110000 0001123445666 899999999999999865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.5e-08 Score=100.13 Aligned_cols=60 Identities=33% Similarity=0.520 Sum_probs=47.0
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++..... .....++..|++||+..+ ...+.++||||||++++|++||+.|+.
T Consensus 147 ~~l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 147 LKICDFGLARIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred EEeCccccccccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 346899988765332 123456788999998765 568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.2e-08 Score=95.91 Aligned_cols=102 Identities=24% Similarity=0.300 Sum_probs=67.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.+... .....++..|++||.......+.++||||+|++++|++||+.|++..... . ..
T Consensus 125 ~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----~------~~ 191 (237)
T cd05576 125 QLTYFSRWSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----I------NT 191 (237)
T ss_pred EEecccchhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----c------cc
Confidence 35788877655332 22344567899999988788899999999999999999999886421110 0 00
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIV 490 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v 490 (502)
.....++. ...+++..+++ .|++.+|++||++.++
T Consensus 192 ~~~~~~~~---~~~~~~~~li~---~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 192 HTTLNIPE---WVSEEARSLLQ---QLLQFNPTERLGAGVA 226 (237)
T ss_pred ccccCCcc---cCCHHHHHHHH---HHccCCHHHhcCCCcc
Confidence 00111111 12245666776 8999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2e-08 Score=96.16 Aligned_cols=75 Identities=31% Similarity=0.442 Sum_probs=61.2
Q ss_pred CCCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCC
Q 010736 358 PKLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH 428 (502)
Q Consensus 358 ~~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~ 428 (502)
..+.+.||+-.|+ ++|||+.|---.+.....++.||+.|+|||......+....|-|+|||+|+||+.|+.
T Consensus 469 kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQp 548 (683)
T KOG0696|consen 469 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 548 (683)
T ss_pred CCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCC
Confidence 4555666655443 6899999865444444456899999999999999999999999999999999999999
Q ss_pred CCCc
Q 010736 429 PRDF 432 (502)
Q Consensus 429 p~~~ 432 (502)
|+|.
T Consensus 549 PFdG 552 (683)
T KOG0696|consen 549 PFDG 552 (683)
T ss_pred CCCC
Confidence 9974
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.2e-08 Score=89.11 Aligned_cols=73 Identities=29% Similarity=0.376 Sum_probs=56.6
Q ss_pred CCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCcccccc----ceecccceeeeeceeeeehhcC
Q 010736 360 LGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT----MKITEKCDVYSFGVLVLEVIKG 426 (502)
Q Consensus 360 L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~----~~~s~k~Dvysfgv~llElltg 426 (502)
+.|.|++-.|+ +||||++-.+.+. -..|..+|+..|+|||.... ..++.|+||||+||.+.||.++
T Consensus 170 vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~l 248 (282)
T KOG0984|consen 170 VIHRDVKPSNILINYDGQVKICDFGISGYLVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAIL 248 (282)
T ss_pred hhhccCCcceEEEccCCcEEEcccccceeehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhc
Confidence 44555655554 7999999888642 22345689999999999753 3688999999999999999999
Q ss_pred CCCCCcc
Q 010736 427 KHPRDFL 433 (502)
Q Consensus 427 ~~p~~~~ 433 (502)
|.|++.+
T Consensus 249 r~PY~~w 255 (282)
T KOG0984|consen 249 RFPYESW 255 (282)
T ss_pred ccccccc
Confidence 9998743
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.5e-08 Score=103.28 Aligned_cols=114 Identities=24% Similarity=0.359 Sum_probs=79.2
Q ss_pred cccccCcccc--cCCCCCC-c------ccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCC
Q 010736 370 ITGDFGIAKF--LKPDSSN-W------TGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS 437 (502)
Q Consensus 370 l~~dfGl~~l--l~~~~~~-~------~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~ 437 (502)
..||||-+.- ..+.++. . ....-|+.|.+||... +..+++|+|||++||+|+-|+.+..||+..+...
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la 265 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA 265 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence 4799998743 2221111 0 0124688999999975 5579999999999999999999999997432211
Q ss_pred CCCCCcccccccccCCCCCCCC-cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 438 SPSLNTDIALDEMLDPRLPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 438 ~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
|++....-+. ....+++..++. .|.+++|.+||++.+|+..+.+++
T Consensus 266 ------------Ilng~Y~~P~~p~ys~~l~~LI~---~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 266 ------------ILNGNYSFPPFPNYSDRLKDLIR---TMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ------------EEeccccCCCCccHHHHHHHHHH---HHhccCcccCCCHHHHHHHHHHHh
Confidence 1222111111 123467777777 999999999999999999988874
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.7e-09 Score=102.64 Aligned_cols=59 Identities=29% Similarity=0.531 Sum_probs=46.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++..... .....++..|+|||.... ...+.++|||||||+++|++||+.|+.
T Consensus 160 kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 160 KILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred EEeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 36799998765332 233567889999998765 457889999999999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.1e-08 Score=93.55 Aligned_cols=68 Identities=28% Similarity=0.456 Sum_probs=55.4
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS 438 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~ 438 (502)
..|+|+.|---......+++.||+.|+|||...+-.+-...|-|++||+++||+.||.|+|.++..+.
T Consensus 392 ltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~ 459 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP 459 (593)
T ss_pred ecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc
Confidence 46889887532222234568999999999999999999999999999999999999999997765443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=7e-08 Score=91.85 Aligned_cols=57 Identities=30% Similarity=0.510 Sum_probs=48.5
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
+-|||-|.+-.... +.+..|-.|.|||..-+...+..+||||+||+|.|+.||..=+
T Consensus 253 vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 253 VIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred EEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 45999998865433 3467888999999999999999999999999999999998643
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.8e-08 Score=98.98 Aligned_cols=113 Identities=23% Similarity=0.413 Sum_probs=73.7
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
.+|||.+.-..........+-||+.|||||..+ ...+..|+|||||||.|.||..+.+|...+... ..-.
T Consensus 171 LADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-----RVll 245 (1187)
T KOG0579|consen 171 LADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLL 245 (1187)
T ss_pred eecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-----HHHH
Confidence 478887532221111112467999999999863 557889999999999999999999996432211 0011
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+...-.|.+..+.. -......+++ .|...+|+.||+.+++++
T Consensus 246 KiaKSePPTLlqPS~-Ws~~F~DfLk---~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 246 KIAKSEPPTLLQPSH-WSRSFSDFLK---RCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHhhcCCCcccCcch-hhhHHHHHHH---HHHhcCCccCCCHHHHhh
Confidence 223334455544332 1234556666 899999999999988754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.3e-07 Score=98.31 Aligned_cols=110 Identities=26% Similarity=0.391 Sum_probs=75.4
Q ss_pred ccccCcccccCCCCCCc---ccccccccccCccccccceecccceeeeeceeeeehhcC-CCCCCcccCCCCCCCCcccc
Q 010736 371 TGDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKG-KHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~---~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg-~~p~~~~~~~~~~~~~~~~~ 446 (502)
++|||++|-+..+.++. .+..||.||+|||.....+-+...|++|+|||++-.+|| ++|+......+. .+.. .
T Consensus 652 iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl~-~- 728 (903)
T KOG1027|consen 652 ISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NILT-G- 728 (903)
T ss_pred ecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhhc-C-
Confidence 68999999887655433 457899999999999998888999999999999999985 999853211100 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~ 491 (502)
..+.+ .+. + ....+...++. ....++|..||+..+|+
T Consensus 729 ~~~L~--~L~-~--~~d~eA~dLI~---~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 729 NYTLV--HLE-P--LPDCEAKDLIS---RMLNPDPQLRPSATDVL 765 (903)
T ss_pred cccee--eec-c--CchHHHHHHHH---HhcCCCcccCCCHHHHh
Confidence 00000 010 0 11114555666 77889999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.5e-08 Score=87.79 Aligned_cols=71 Identities=24% Similarity=0.324 Sum_probs=55.5
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKH 428 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~ 428 (502)
.+-|.|++-||+ ++|||++|+........+...-|--|.|||...+. ++....|+||.||++-||+-|++
T Consensus 121 ~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P 200 (318)
T KOG0659|consen 121 WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP 200 (318)
T ss_pred hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC
Confidence 355667777776 68999999986554444444567789999988754 68899999999999999998764
Q ss_pred C
Q 010736 429 P 429 (502)
Q Consensus 429 p 429 (502)
=
T Consensus 201 ~ 201 (318)
T KOG0659|consen 201 F 201 (318)
T ss_pred C
Confidence 3
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.4e-08 Score=97.32 Aligned_cols=148 Identities=22% Similarity=0.390 Sum_probs=89.7
Q ss_pred ccCccccCCCCCCeeeecCCcc---------ccccCcccccCCCCC--CcccccccccccCccccccce-ec-----ccc
Q 010736 349 EISSNFGECPKLGALNISRNNI---------TGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMK-IT-----EKC 411 (502)
Q Consensus 349 ~~~~~~~~~~~L~~L~l~~N~l---------~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~-~s-----~k~ 411 (502)
.+|..=+..|.+.|.||++-|+ ++|||||..+.+... ...+..||..|||||...+.. +. .+.
T Consensus 326 e~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~ 405 (534)
T KOG3653|consen 326 ELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRI 405 (534)
T ss_pred cCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHH
Confidence 4443334567888999987665 689999988765322 223467999999999987542 22 358
Q ss_pred eeeeeceeeeehhcCCCCCCc--ccCCCC---------CCCC--cccccccccCCCCCCC--CcchHHHHHHHHHHhhcc
Q 010736 412 DVYSFGVLVLEVIKGKHPRDF--LSSTSS---------PSLN--TDIALDEMLDPRLPVP--SCSVQEKLISIMEVGFSC 476 (502)
Q Consensus 412 Dvysfgv~llElltg~~p~~~--~~~~~~---------~~~~--~~~~~~~~~d~~l~~~--~~~~~~~~~~~~~val~C 476 (502)
||||.|.|+||++++-.-.+. ...... +.+. .+....+-.-|.++.. ......-+.+.++ .|
T Consensus 406 DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~E---eC 482 (534)
T KOG3653|consen 406 DVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIE---EC 482 (534)
T ss_pred HHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHH---HH
Confidence 999999999999987544321 110000 0000 0000111122222210 0011223445555 89
Q ss_pred CCcCCCCCCCHHHHHHHHHhhcC
Q 010736 477 LKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 477 ~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
|+.+|+-|-|..=|-+++.++..
T Consensus 483 WDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 483 WDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCCchhhhhhhHHHHHHHHHHhc
Confidence 99999999999888888877643
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=98.46 E-value=7.8e-08 Score=95.06 Aligned_cols=40 Identities=28% Similarity=0.510 Sum_probs=34.6
Q ss_pred ccccccCcccccc--ceecccceeeeeceeeeehhcCCCCCC
Q 010736 392 GTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 392 gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
++..|++||+... ..++.++|||||||+++|+++|+.|+.
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred CccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4567999999865 346889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.8e-08 Score=98.85 Aligned_cols=59 Identities=32% Similarity=0.511 Sum_probs=47.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++..... .....++..|++||.... ...+.++|+||+||+++|+++|+.|+.
T Consensus 158 kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 158 KILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred EEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 46899998866432 223467889999998765 457889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=8.6e-08 Score=92.93 Aligned_cols=142 Identities=21% Similarity=0.346 Sum_probs=85.5
Q ss_pred CCCCCCeeeecCCcc---------ccccCcccccCCCCC----CcccccccccccCccccccce----e--cccceeeee
Q 010736 356 ECPKLGALNISRNNI---------TGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTMK----I--TEKCDVYSF 416 (502)
Q Consensus 356 ~~~~L~~L~l~~N~l---------~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~~----~--s~k~Dvysf 416 (502)
.-|.+.|.||++-|| ++|+|||--.+.+.. ..+...||..|||||...... + -..+|||||
T Consensus 333 gKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYaf 412 (513)
T KOG2052|consen 333 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAF 412 (513)
T ss_pred CCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHH
Confidence 458888899988776 689999865544321 223457999999999986431 1 134999999
Q ss_pred ceeeeehhcC----------CCCCC-cccCCCC-CCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCC
Q 010736 417 GVLVLEVIKG----------KHPRD-FLSSTSS-PSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESR 484 (502)
Q Consensus 417 gv~llElltg----------~~p~~-~~~~~~~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~R 484 (502)
|.|+||+.-+ +.|+. ....+.. +++ .+..-.+-+-|.++.. -...+++..+.++.=.||..+|.-|
T Consensus 413 gLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM-rkVVCv~~~RP~ipnr-W~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 413 GLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM-RKVVCVQKLRPNIPNR-WKSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred HHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH-hcceeecccCCCCCcc-cccCHHHHHHHHHHHHhhcCCchhh
Confidence 9999998742 23332 1111111 000 0000001122222211 1123455555555559999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 010736 485 PTMKIVSQQLRISAP 499 (502)
Q Consensus 485 p~m~~v~~~l~~~~~ 499 (502)
-+.-.+-+.|.++..
T Consensus 491 ltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 491 LTALRIKKTLAKLSN 505 (513)
T ss_pred hHHHHHHHHHHHHhc
Confidence 998888888777643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.1e-08 Score=93.83 Aligned_cols=118 Identities=20% Similarity=0.278 Sum_probs=72.3
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccc-ccceecccceeeeeceeeeehhcCCCCCCcc-------------cCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELA-YTMKITEKCDVYSFGVLVLEVIKGKHPRDFL-------------SST 436 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~-~~~~~s~k~Dvysfgv~llElltg~~p~~~~-------------~~~ 436 (502)
++||||||-+.... ..|.-..|..|.|||.. ...-++.+.|+|+|||++.|+.+=|.=+... +.-
T Consensus 151 iaDFGLARev~Skp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP 229 (538)
T KOG0661|consen 151 IADFGLAREVRSKP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP 229 (538)
T ss_pred ecccccccccccCC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence 69999999875432 24455678899999996 5678999999999999999998866433210 100
Q ss_pred CCCCCCcccccc---cccCCCCCCC-----CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 437 SSPSLNTDIALD---EMLDPRLPVP-----SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 437 ~~~~~~~~~~~~---~~~d~~l~~~-----~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....|.....+. .+--|...+. -.....+..+++. .|.+.+|.+|||.+|.++
T Consensus 230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~---~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIE---RLLAWDPDKRPTASQALQ 290 (538)
T ss_pred ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHH---HHhcCCCccCccHHHHhc
Confidence 011111100000 0111111100 0012245556666 899999999999999865
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=5.5e-08 Score=92.07 Aligned_cols=61 Identities=31% Similarity=0.471 Sum_probs=49.4
Q ss_pred cccccCcccccCCC--CCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCC
Q 010736 370 ITGDFGIAKFLKPD--SSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 370 l~~dfGl~~ll~~~--~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
.+|||||||..... ...+|.-.-|..|.|||..... .+|...||||.||++-||+|||.=+
T Consensus 165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence 37999999998643 2234556678899999998654 6899999999999999999999654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.6e-08 Score=86.93 Aligned_cols=110 Identities=22% Similarity=0.302 Sum_probs=78.4
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
--++|||-+-..+ .....+++||+-|.+||...+...+.+.|+|+.||+.+|++.|.+|++...... ......-.
T Consensus 163 lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI~k~ 237 (281)
T KOG0580|consen 163 LKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRIRKV 237 (281)
T ss_pred eeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHHHHc
Confidence 3478999775543 233456899999999999999999999999999999999999999987533211 11111223
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
++.+|.- ...+...++. .|...+|.+|.+..||+.
T Consensus 238 ~~~~p~~------is~~a~dlI~---~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 DLKFPST------ISGGAADLIS---RLLVKNPIERLALTEVMD 272 (281)
T ss_pred cccCCcc------cChhHHHHHH---HHhccCccccccHHHHhh
Confidence 3444422 2233444444 899999999999999975
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=6.4e-08 Score=89.08 Aligned_cols=113 Identities=23% Similarity=0.372 Sum_probs=77.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
-.+|||.+--+.+.-....++-||+-|||||.....-+..++|+||+||...||.-||+|+........-- .+-.
T Consensus 169 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-----MIPT 243 (502)
T KOG0574|consen 169 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-----MIPT 243 (502)
T ss_pred hhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-----eccC
Confidence 35899998777554444456789999999999999999999999999999999999999974322111100 0101
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~ 491 (502)
--.|..+.+ ..-.++....++ .|.-..|++|-+.-++.
T Consensus 244 ~PPPTF~KP-E~WS~~F~DFi~---~CLiK~PE~R~TA~~L~ 281 (502)
T KOG0574|consen 244 KPPPTFKKP-EEWSSEFNDFIR---SCLIKKPEERKTALRLC 281 (502)
T ss_pred CCCCCCCCh-HhhhhHHHHHHH---HHhcCCHHHHHHHHHHh
Confidence 112222221 112234566677 99999999999866554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.9e-09 Score=85.55 Aligned_cols=111 Identities=23% Similarity=0.317 Sum_probs=61.9
Q ss_pred eCCCCCEEEEEecCCCCceecCcc--cCCCCCCCCEEECCCCcccccCCccC-cCCCCCCEEEccCCcCcCCCCcccCCC
Q 010736 66 CNDAGRVINISLRGVGLKGKLHAF--SFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGLM 142 (502)
Q Consensus 66 C~~~~~v~~L~L~~~~l~g~l~~~--~~~~l~~L~~L~Ls~N~l~g~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~l~~l 142 (502)
|.++...-.++|+++.+- .++.. .+....+|+..+|++|.+.. +|+.| ...+.++.|+|++|.|+ .+|..+..+
T Consensus 23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam 99 (177)
T KOG4579|consen 23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAM 99 (177)
T ss_pred hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence 443333444555555442 12111 13444556666777776663 33333 33446667777777776 566666666
Q ss_pred CCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCccc
Q 010736 143 SHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN 180 (502)
Q Consensus 143 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 180 (502)
+.|+.|+++.|.+. ..|..+..+.++..|+..+|.+.
T Consensus 100 ~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 100 PALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred HHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 66777777766665 45555555666666666666554
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.1e-07 Score=97.16 Aligned_cols=62 Identities=37% Similarity=0.524 Sum_probs=55.3
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccc-cceecccceeeeeceeeeehhcCCCCCCcc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-TMKITEKCDVYSFGVLVLEVIKGKHPRDFL 433 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-~~~~s~k~Dvysfgv~llElltg~~p~~~~ 433 (502)
.+|||.||-+++++ ..+.+.||..|.+||... ...++.-+|.|||||.++|.+||..||...
T Consensus 165 LtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 165 LTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred eecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 58999999998765 566789999999999999 488999999999999999999999998643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.4e-07 Score=85.50 Aligned_cols=114 Identities=27% Similarity=0.368 Sum_probs=74.1
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCC-CCCCCcccc--c
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS-SPSLNTDIA--L 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~-~~~~~~~~~--~ 447 (502)
.+|||+||--.. .....+-.-|+.|+|||.....++...+|.||.||+++-|+.|=.|+=...+.. ++.+...+. .
T Consensus 205 LtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 205 LTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred ecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 589999987542 122234567889999999999999999999999999999999999974332221 122222221 1
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+.-+|+-. ...+....+++ .-...+|++|-++.||..
T Consensus 284 y~FP~pEWs----~VSe~aKdlIR---~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 YEFPEPEWS----CVSEAAKDLIR---KLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCCChhHh----HHHHHHHHHHH---HHhcCCchhheeHHHhhc
Confidence 222222211 12233334444 345688999999999864
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.4e-08 Score=93.16 Aligned_cols=61 Identities=31% Similarity=0.457 Sum_probs=52.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
=++|.|||--+.....+ ++-.||.||||||.....+++...|-|++||+++|||.|+.|+.
T Consensus 327 RISDLGLAvei~~g~~~-~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 327 RISDLGLAVEIPEGKPI-RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred EeeccceEEecCCCCcc-ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchh
Confidence 37899999877654433 34489999999999999999999999999999999999999985
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.7e-09 Score=105.51 Aligned_cols=126 Identities=26% Similarity=0.256 Sum_probs=82.4
Q ss_pred CCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCC
Q 010736 240 NLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318 (502)
Q Consensus 240 ~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~ 318 (502)
.|...+.++|.+. .+..++.. +.++.|+|++|+++.. ..+..++.|++||+++|.+.-...-....+. |..|.++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 3556677777775 33333333 5677788888888775 3677778888888888888732222333444 8888888
Q ss_pred CCccccccCcccCCCCCCcEEEccCcccccccC-ccccCCCCCCeeeecCCccc
Q 010736 319 GNNLTGNISKAFGIYPNLTFIDLSRNNFYGEIS-SNFGECPKLGALNISRNNIT 371 (502)
Q Consensus 319 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~~~L~~L~l~~N~l~ 371 (502)
+|.++.. ..+.++.+|+.|||++|-|.+.-. .-+..+..|+.|+|.+|++-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8887743 245677888888888887764321 12334566777888888773
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.1e-08 Score=88.85 Aligned_cols=58 Identities=31% Similarity=0.476 Sum_probs=52.0
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
+.|||+||-+... .-+.+||+-|+|||...+......+|=|+|||+++||+.|..|+-
T Consensus 185 itDFGFAK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 185 ITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred EEeccceEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 6899999988653 235899999999999999999999999999999999999999974
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.4e-07 Score=85.88 Aligned_cols=114 Identities=21% Similarity=0.301 Sum_probs=72.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc------ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT------MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~------~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
.++|||++.-+++... ....+||+||.|||...- -.++...|.|+.||+++.++.|-.|+..-...-.--++.
T Consensus 163 ~isDFGFa~~l~~Gek-LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im 241 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEK-LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM 241 (411)
T ss_pred EEeccceeeccCCchh-HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence 3789999998876432 346899999999998642 246678999999999999999999975311100000000
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+ ..+.-.|+-. ...+....++. .|.+.+|++|-|.+|+++
T Consensus 242 eG-kyqF~speWa----dis~~~KdLIs---rlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EG-KYQFRSPEWA----DISATVKDLIS---RLLQVDPTKRITAKEALA 282 (411)
T ss_pred hc-ccccCCcchh----hccccHHHHHH---HHHeeCchhcccHHHHhc
Confidence 00 0111111111 11233445555 899999999999998764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.9e-08 Score=82.21 Aligned_cols=132 Identities=23% Similarity=0.341 Sum_probs=84.0
Q ss_pred CCCEEECCCCcccccCCcc---CcCCCCCCEEEccCCcCcCCCCcccC-CCCCCcEEEccCCcCcccCCcccCCCCCCcE
Q 010736 96 HLAYLDLRDNKLFGTIPPQ---ISNLTNLSILSLGGNQFSGNIPHEVG-LMSHLKILYIDSNQLDGSIPLEVGQLSSMVE 171 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~---l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 171 (502)
.+..+||+++++. .+++. +.....|+..+|++|.|. ..|..|. ..+.++.|+|++|.|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4567888888775 34443 445556677788888888 4555554 4457788888888887 67777888888888
Q ss_pred EEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCccc
Q 010736 172 LALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIP 232 (502)
Q Consensus 172 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 232 (502)
|+++.|.+. ..|..+..+.++-.|+..+|.+.. +|-.+-.-+.....++.++.+.+.-+
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~e-id~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAE-IDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCcccc-CcHHHhccccHHHHHhcCCcccccCc
Confidence 888888877 456666667777777777776653 33222222223333444555544433
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.4e-07 Score=86.37 Aligned_cols=60 Identities=28% Similarity=0.423 Sum_probs=52.8
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
+.||||.|---.+......++||+-|.|||......+....|-|..|||++||+.||-|+
T Consensus 309 itDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPF 368 (516)
T KOG0690|consen 309 ITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPF 368 (516)
T ss_pred eeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcc
Confidence 789999986544444456799999999999999999999999999999999999999997
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.2e-07 Score=93.14 Aligned_cols=74 Identities=28% Similarity=0.525 Sum_probs=61.4
Q ss_pred CCCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCC
Q 010736 358 PKLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH 428 (502)
Q Consensus 358 ~~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~ 428 (502)
.++.|.||+.-|+ .-|||+||.+......|| ++||+-|+|||..-..--....|.|++||+++|++||++
T Consensus 539 k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT-FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~p 617 (732)
T KOG0614|consen 539 KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT-FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSP 617 (732)
T ss_pred cCceeccCChhheeeccCCceEEeehhhHHHhccCCceee-ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCC
Confidence 4556666665443 469999999977666664 899999999999988888889999999999999999999
Q ss_pred CCCc
Q 010736 429 PRDF 432 (502)
Q Consensus 429 p~~~ 432 (502)
|+..
T Consensus 618 PFs~ 621 (732)
T KOG0614|consen 618 PFSG 621 (732)
T ss_pred CCCC
Confidence 9853
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.4e-07 Score=93.51 Aligned_cols=124 Identities=22% Similarity=0.426 Sum_probs=74.6
Q ss_pred ccccCcccccCC--CCCCcccccccccccCccccccc-------eecccceeeeeceeeeehhcCCCCCCcccCCCCC-C
Q 010736 371 TGDFGIAKFLKP--DSSNWTGFAGTYGYIAPELAYTM-------KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSP-S 440 (502)
Q Consensus 371 ~~dfGl~~ll~~--~~~~~~~~~gt~gy~aPE~~~~~-------~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~-~ 440 (502)
++|||+..+... +........-..-|.|||..... ..+.++|||||||++.|+++++.|++.......+ .
T Consensus 90 lt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~e 169 (484)
T KOG1023|consen 90 LTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDE 169 (484)
T ss_pred echhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHH
Confidence 689999888753 11111112233468899997653 2578899999999999999999998753222111 0
Q ss_pred CCccc--ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 441 LNTDI--ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 441 ~~~~~--~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.+... .....+-|.+.... ...++ ++.++-.||++.|++||++++|-..++...
T Consensus 170 ii~~~~~~~~~~~rP~i~~~~-e~~~~---l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 170 IILRVKKGGSNPFRPSIELLN-ELPPE---LLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred HHHHHHhcCCCCcCcchhhhh-hcchH---HHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 00000 01112223222110 11123 444444999999999999999988887653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.1e-07 Score=85.27 Aligned_cols=60 Identities=27% Similarity=0.365 Sum_probs=50.2
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
+|||||||.........|...-|..|.|||..-+. .+++..|+||+||++-|++++++=+
T Consensus 218 iaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf 278 (419)
T KOG0663|consen 218 IADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF 278 (419)
T ss_pred ecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence 79999999886544456667789999999998654 5899999999999999999988644
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.7e-07 Score=85.44 Aligned_cols=118 Identities=24% Similarity=0.311 Sum_probs=73.1
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCC----------CC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS----------SP 439 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~----------~~ 439 (502)
+||||-||.+.......+ -..|--|.|||...+. .++.+.||||.|||+-||+-|+.=+....... .+
T Consensus 167 icDFGSAK~L~~~epniS-YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred eccCCcceeeccCCCcee-EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 699999999876554433 2345679999998755 69999999999999999999986543111000 00
Q ss_pred C--CCccc--ccccccCCCCCCCC------cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 440 S--LNTDI--ALDEMLDPRLPVPS------CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 440 ~--~~~~~--~~~~~~d~~l~~~~------~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
. -+... ...+...|.+.... .....+..+++. .+...+|.+|-+..|+++
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~---~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLS---KLLQYSPSKRLSALEALA 305 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHH---HHhccChhhcCCHHHHhc
Confidence 0 00000 11122333332111 112234445555 899999999999888754
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.1e-08 Score=101.22 Aligned_cols=126 Identities=25% Similarity=0.254 Sum_probs=79.0
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCc-ccCCCCCCcEEEc
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPL-EVGQLSSMVELAL 174 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L 174 (502)
.|...+.++|.+. ....++.-++.|+.|||++|+++.. +.+..+++|++|||++|.+. .+|. ....+. |+.|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4566667777766 4455666677777777777777633 25667777777777777776 3332 222233 777777
Q ss_pred ccCcccccCCcCCCCCCCCCeEEcccccccccCC-ccCcCCccCCcccccccccc
Q 010736 175 FSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP-PDIGNLKSISILSLAINQFS 228 (502)
Q Consensus 175 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~ 228 (502)
.+|.++.. ..+.++.+|+.||+++|-+.+.-. ..+..+..|..|.|.+|.+-
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 77777632 235677777777777776664311 12345566777777777653
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.1e-06 Score=88.78 Aligned_cols=68 Identities=29% Similarity=0.472 Sum_probs=55.6
Q ss_pred eecCCccccccCcccccCCCCCCcccccccccccCccccccceec-ccceeeeeceeeeehhcCCCCCCc
Q 010736 364 NISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKIT-EKCDVYSFGVLVLEVIKGKHPRDF 432 (502)
Q Consensus 364 ~l~~N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s-~k~Dvysfgv~llElltg~~p~~~ 432 (502)
+-..|--++|||++.++..... .....|++.|.|||...+.++. .++|+||.||+++-++.|.-|+|.
T Consensus 189 ~~~mnikIaDfgfS~~~~~~~~-lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 189 DENMNIKIADFGFSTFFDYGLM-LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred ccccceeeeccccceeeccccc-ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 3344555899999999875432 2347899999999999988755 789999999999999999999983
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.2e-07 Score=85.07 Aligned_cols=60 Identities=23% Similarity=0.340 Sum_probs=48.5
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
.+|||+|+...-.....+...+|.-|.|||...+. .++...|+||+||++.||++++.=+
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF 221 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF 221 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence 68999999775333334556678889999998766 7999999999999999999977544
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.5e-07 Score=82.26 Aligned_cols=83 Identities=23% Similarity=0.314 Sum_probs=40.3
Q ss_pred CCCCEEECCCCcccc--cCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCc-ccCCCCCCcE
Q 010736 95 PHLAYLDLRDNKLFG--TIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPL-EVGQLSSMVE 171 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g--~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~ 171 (502)
++++.|||.+|.|+. .+-.-+.+++.|++|+|+.|.++..|-..-..+.+|++|-|.+..+.-.-.. .+..++.+++
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 456666666666653 2333445566666666666666533322112344555555555544322111 2233444444
Q ss_pred EEcccC
Q 010736 172 LALFSN 177 (502)
Q Consensus 172 L~L~~N 177 (502)
|.++.|
T Consensus 151 lHmS~N 156 (418)
T KOG2982|consen 151 LHMSDN 156 (418)
T ss_pred hhhccc
Confidence 444444
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=6.2e-07 Score=87.77 Aligned_cols=111 Identities=23% Similarity=0.347 Sum_probs=70.0
Q ss_pred ccccCcccccCCCC-----CCcccccccccccCccccccce----ecccceeeeeceeeeehhcCCCCCCcccCCCCCCC
Q 010736 371 TGDFGIAKFLKPDS-----SNWTGFAGTYGYIAPELAYTMK----ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSL 441 (502)
Q Consensus 371 ~~dfGl~~ll~~~~-----~~~~~~~gt~gy~aPE~~~~~~----~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~ 441 (502)
++|||.+-...... .......||+.++|||...+.. ...+.||||.||.|+=++.|+-|+-......
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~---- 326 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE---- 326 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH----
Confidence 68999987763221 1123468999999999987732 4467999999999999999999974211110
Q ss_pred CcccccccccCCCCCCCCcc-hHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 442 NTDIALDEMLDPRLPVPSCS-VQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 442 ~~~~~~~~~~d~~l~~~~~~-~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....++...+.-+... ..++...+++ .-.+.+|+.|-+..+|..
T Consensus 327 ----l~~KIvn~pL~fP~~pe~~e~~kDli~---~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 327 ----LFDKIVNDPLEFPENPEINEDLKDLIK---RLLEKDPEQRITLPDIKL 371 (576)
T ss_pred ----HHHHHhcCcccCCCcccccHHHHHHHH---HHhhcChhheeehhhhee
Confidence 1122333333212111 2233444444 344589999999998854
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.1e-06 Score=80.00 Aligned_cols=97 Identities=24% Similarity=0.362 Sum_probs=66.7
Q ss_pred cccccccCccccccceec---ccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHH
Q 010736 391 AGTYGYIAPELAYTMKIT---EKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLI 467 (502)
Q Consensus 391 ~gt~gy~aPE~~~~~~~s---~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 467 (502)
.-.+.|++||......-. ..+|.|||.|++||+.|+..|+......+.... .. .|-+-+.++ .+....|.
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---ia-leglrv~ip---pgis~hm~ 419 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---IA-LEGLRVHIP---PGISRHMN 419 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---hh-hccccccCC---CCccHHHH
Confidence 345789999998755432 469999999999999999999854433221110 01 122333333 12334577
Q ss_pred HHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 468 SIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 468 ~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
++++ -|..++|.+||.+..||-.|+..
T Consensus 420 klm~---icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 420 KLMN---ICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHH---HHhcCCCCcCCCcceehhhHHHh
Confidence 7777 79999999999999999888763
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.6e-06 Score=85.59 Aligned_cols=108 Identities=24% Similarity=0.452 Sum_probs=73.5
Q ss_pred cccCcccccCCCCCCcccccccccccCccccccceec-ccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKIT-EKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 372 ~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s-~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.|||++.-+.+..- .++.+|+..|.|||..-+-.+. ...||||+||+|+-++.|+.|++..... ..+.-+
T Consensus 161 TDFGFSNkf~PG~k-L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--------ETLTmI 231 (864)
T KOG4717|consen 161 TDFGFSNKFQPGKK-LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--------ETLTMI 231 (864)
T ss_pred eeccccccCCCcch-hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------hhhhhh
Confidence 69999865554332 3467899999999999877665 6799999999999999999998632111 112223
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.|-....+.. ...+-..+++ .....+|.+|-+..|++.
T Consensus 232 mDCKYtvPsh-vS~eCrdLI~---sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 232 MDCKYTVPSH-VSKECRDLIQ---SMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hcccccCchh-hhHHHHHHHH---HHHhcCchhhccHHHHhc
Confidence 4443333321 1233344555 667799999999988864
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.6e-06 Score=55.71 Aligned_cols=35 Identities=29% Similarity=0.542 Sum_probs=13.6
Q ss_pred CCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCc
Q 010736 121 LSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLD 156 (502)
Q Consensus 121 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 156 (502)
|++|++++|+|+ .+|..++++++|+.|++++|+++
T Consensus 3 L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 3 LEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp -SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred ceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 444444444444 23333444444444444444443
|
... |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=9.6e-07 Score=84.69 Aligned_cols=116 Identities=23% Similarity=0.374 Sum_probs=76.8
Q ss_pred eeecCCccccccCcccccCCCCCCcccccccccccCccccccceec-ccceeeeeceeeeehhcCCCCCCcccCCCCCCC
Q 010736 363 LNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKIT-EKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSL 441 (502)
Q Consensus 363 L~l~~N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s-~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~ 441 (502)
||-.+|--++||||+.+.....- .++++|++-|..||...+..+. ...|.||+||+|+.++.|-.|+|..... -+
T Consensus 186 LD~N~NiKIADFGLSNly~~~kf-LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l 261 (668)
T KOG0611|consen 186 LDQNNNIKIADFGLSNLYADKKF-LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL 261 (668)
T ss_pred ecCCCCeeeeccchhhhhccccH-HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH
Confidence 34445556899999998865433 3568999999999999888776 5699999999999999999999742211 01
Q ss_pred CcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 442 NTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 442 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+..+.-.+...|.-+. ...- ++. .....+|++|-|+.||..
T Consensus 262 vrQIs~GaYrEP~~PS----dA~g---LIR---wmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 262 VRQISRGAYREPETPS----DASG---LIR---WMLMVNPERRATIEDIAS 302 (668)
T ss_pred HHHhhcccccCCCCCc----hHHH---HHH---HHHhcCcccchhHHHHhh
Confidence 1111112233343321 1111 222 234589999999999864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.7e-06 Score=87.44 Aligned_cols=124 Identities=23% Similarity=0.380 Sum_probs=81.8
Q ss_pred CCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhc
Q 010736 360 LGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIK 425 (502)
Q Consensus 360 L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llEllt 425 (502)
..|.|+++||| .+|||++.-+........+..||+.|||||... +..++..+|+||+||.-+||--
T Consensus 144 viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad 223 (953)
T KOG0587|consen 144 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE 223 (953)
T ss_pred eeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC
Confidence 34567888887 479999987765544445678999999999974 3457788999999999999999
Q ss_pred CCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 426 GKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 426 g~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
|..|.-....... +. .+..--.|+++.+. .-.++....+. .|...+-++||+|.+.++
T Consensus 224 G~PPl~DmHPmra--LF---~IpRNPPPkLkrp~-kWs~~FndFIs---~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 224 GAPPLCDMHPMRA--LF---LIPRNPPPKLKRPK-KWSKKFNDFIS---TCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCccCcchhhh--hc---cCCCCCCccccchh-hHHHHHHHHHH---HHHhhccccCcchhhhcc
Confidence 9999632211100 00 00111223333221 11233444444 899999999999887653
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.2e-06 Score=54.96 Aligned_cols=38 Identities=42% Similarity=0.694 Sum_probs=32.3
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcC
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSG 133 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~ 133 (502)
++|++|++++|+|+ .+|+.+++|++|++|++++|+|+.
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence 47999999999999 567779999999999999999983
|
... |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.1e-06 Score=84.21 Aligned_cols=54 Identities=26% Similarity=0.428 Sum_probs=44.0
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGK 427 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~ 427 (502)
+-|||.+-+....-. + --.+.-|.|||..-+.++.++.|+||+||++-||+||.
T Consensus 332 VIDFGSSc~~~q~vy--t-YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~ 385 (586)
T KOG0667|consen 332 VIDFGSSCFESQRVY--T-YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGE 385 (586)
T ss_pred EEecccccccCCcce--e-eeeccccccchhhccCCCCCccceeehhhhHHhHhcCc
Confidence 579999887653221 1 22455799999999999999999999999999999995
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.5e-05 Score=72.90 Aligned_cols=131 Identities=21% Similarity=0.300 Sum_probs=73.9
Q ss_pred CCCCeeeecCCcc-----------ccccCcccccCCCCCCcccccccccccCccccccc-----eecccceeeeeceeee
Q 010736 358 PKLGALNISRNNI-----------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-----KITEKCDVYSFGVLVL 421 (502)
Q Consensus 358 ~~L~~L~l~~N~l-----------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-----~~s~k~Dvysfgv~ll 421 (502)
.+|.|.||+--|| .||||+.+-... ......-+..|.+||..... +.....|+|.|||+++
T Consensus 140 knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f 216 (378)
T KOG1345|consen 140 KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFF 216 (378)
T ss_pred cchhhcccccceEEEecCCccEEEeeecccccccCc---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeee
Confidence 4555566555444 599998764421 11223456678999987543 5667799999999999
Q ss_pred ehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 422 EVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 422 Elltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
.++||+.|.+-........+....+ ..-..++++.....-.+...++.+ .-..+.|++|=.+.++-++.+
T Consensus 217 ~cltG~~PWQka~~~d~~Y~~~~~w-~~rk~~~~P~~F~~fs~~a~r~Fk---k~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 217 YCLTGKFPWQKASIMDKPYWEWEQW-LKRKNPALPKKFNPFSEKALRLFK---KSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred eeecCCCcchhhhccCchHHHHHHH-hcccCccCchhhcccCHHHHHHHH---HhcCCcccccchhHHHHHHHH
Confidence 9999999975211111111100000 111222332211112244555666 666777877766666665543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.4e-06 Score=80.42 Aligned_cols=39 Identities=28% Similarity=0.384 Sum_probs=18.2
Q ss_pred CCCCCEEEccCCcCcC--CCCcccCCCCCCcEEEccCCcCc
Q 010736 118 LTNLSILSLGGNQFSG--NIPHEVGLMSHLKILYIDSNQLD 156 (502)
Q Consensus 118 l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~ 156 (502)
++.++.|||.+|.|+. .+-..+.+++.|++|+|+.|.+.
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~ 110 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLS 110 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCC
Confidence 3445555555555542 12222344455555555555544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.2e-06 Score=87.23 Aligned_cols=42 Identities=33% Similarity=0.562 Sum_probs=40.1
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
+.||+-|||||...+..+...+|-||.||+++||+.|=+|+.
T Consensus 348 tVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~ 389 (550)
T KOG0605|consen 348 TVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFC 389 (550)
T ss_pred ccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 579999999999999999999999999999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=97.84 E-value=4.8e-06 Score=75.58 Aligned_cols=83 Identities=33% Similarity=0.584 Sum_probs=62.3
Q ss_pred CccccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 368 NNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
.-..+|||.+..............+...|.+||..... ..+.+.|+|++|++++|+
T Consensus 131 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------- 187 (215)
T cd00180 131 KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------- 187 (215)
T ss_pred cEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------
Confidence 34467888887665432112235577889999998877 788999999999999998
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
+++.+++. .|++.+|++||++.++++.
T Consensus 188 -----------------~~~~~~l~---~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----------------PELKDLIR---KMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----------------HHHHHHHH---HHhhCCcccCcCHHHHhhC
Confidence 12334444 8999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.79 E-value=4e-05 Score=67.27 Aligned_cols=83 Identities=17% Similarity=0.247 Sum_probs=37.6
Q ss_pred CCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCC-cCCCCCCCCCeEEc
Q 010736 120 NLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFL 198 (502)
Q Consensus 120 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L 198 (502)
+...+||++|.+.. + ..|..++.|++|.|++|+|+.+-|.--..+++|..|.|.+|++..... .-+..+++|++|.+
T Consensus 43 ~~d~iDLtdNdl~~-l-~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltl 120 (233)
T KOG1644|consen 43 QFDAIDLTDNDLRK-L-DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTL 120 (233)
T ss_pred ccceecccccchhh-c-ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeee
Confidence 34445555555531 1 134445555555555555554333333334445555555555431100 11334455555555
Q ss_pred cccccc
Q 010736 199 HDNSFS 204 (502)
Q Consensus 199 ~~N~l~ 204 (502)
-+|..+
T Consensus 121 l~Npv~ 126 (233)
T KOG1644|consen 121 LGNPVE 126 (233)
T ss_pred cCCchh
Confidence 555443
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=9.6e-06 Score=80.50 Aligned_cols=60 Identities=28% Similarity=0.512 Sum_probs=53.0
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.||||+||+....+-. -.+.||+.|.|||.....-+...-|.||.||+++.-++|..|+.
T Consensus 708 lCDFGfARiIgEksFR-rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 708 LCDFGFARIIGEKSFR-RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred eccccceeecchhhhh-hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 6999999999754332 34789999999999999999999999999999999999999985
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.75 E-value=3.7e-06 Score=83.81 Aligned_cols=68 Identities=29% Similarity=0.502 Sum_probs=53.2
Q ss_pred CCCCeeeecCCcc---------ccccCcccccCCCC------CCcccccccccccCccccccceecccceeeeeceeeee
Q 010736 358 PKLGALNISRNNI---------TGDFGIAKFLKPDS------SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLE 422 (502)
Q Consensus 358 ~~L~~L~l~~N~l---------~~dfGl~~ll~~~~------~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llE 422 (502)
+.+.+-|++.-+| ++|||+..-+.... ...|.-.||.-||+||...+..++.|.|+|++|+++.|
T Consensus 375 k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~E 454 (516)
T KOG1033|consen 375 KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAE 454 (516)
T ss_pred ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHH
Confidence 3444556654443 79999987665433 23356679999999999999999999999999999999
Q ss_pred hhc
Q 010736 423 VIK 425 (502)
Q Consensus 423 llt 425 (502)
+++
T Consensus 455 L~~ 457 (516)
T KOG1033|consen 455 LLI 457 (516)
T ss_pred HHH
Confidence 987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=1.6e-05 Score=82.22 Aligned_cols=63 Identities=22% Similarity=0.128 Sum_probs=41.6
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccce----------------------ecccceeeeeceeeeehhc
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMK----------------------ITEKCDVYSFGVLVLEVIK 425 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~----------------------~s~k~Dvysfgv~llEllt 425 (502)
...+|||+++.+..... ......+++.|++||...... ...+.||||+||+++||++
T Consensus 348 ~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~ 427 (507)
T PLN03224 348 VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCV 427 (507)
T ss_pred EEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHh
Confidence 34689999976543221 111123467899999864321 1234799999999999999
Q ss_pred CCC-CCC
Q 010736 426 GKH-PRD 431 (502)
Q Consensus 426 g~~-p~~ 431 (502)
|.. |+.
T Consensus 428 ~~l~p~~ 434 (507)
T PLN03224 428 PELRPVA 434 (507)
T ss_pred CCCCCcc
Confidence 875 553
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.72 E-value=1.9e-06 Score=78.57 Aligned_cols=243 Identities=19% Similarity=0.254 Sum_probs=120.6
Q ss_pred CcCCCCCCEEEccCCcCcCCC----CcccCCCCCCcEEEccCCcCccc----CC-------cccCCCCCCcEEEcccCcc
Q 010736 115 ISNLTNLSILSLGGNQFSGNI----PHEVGLMSHLKILYIDSNQLDGS----IP-------LEVGQLSSMVELALFSNNL 179 (502)
Q Consensus 115 l~~l~~L~~L~Ls~N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~----~p-------~~~~~l~~L~~L~L~~N~l 179 (502)
+.-+..++.++||+|-|...- ...+.+-.+|+..+++.- ++|. ++ ..+.++++|+..+||.|.|
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~-ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAf 104 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDA-FTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAF 104 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhh-hhcccHHHHHHHHHHHHHHHhcCCcceeeecccccc
Confidence 344778888999999886432 334555667777777653 2222 22 2345677777777777777
Q ss_pred cccCCcCC----CCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccC
Q 010736 180 NGSVPHSL----GNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSI 255 (502)
Q Consensus 180 ~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 255 (502)
....|..+ ++-+.|.+|.|++|.+.-.-..-++ +.|. .+..|+ ...+-+.|+......|++. ..
T Consensus 105 g~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rig--kal~--~la~nK-------Kaa~kp~Le~vicgrNRle-ng 172 (388)
T COG5238 105 GSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIG--KALF--HLAYNK-------KAADKPKLEVVICGRNRLE-NG 172 (388)
T ss_pred CcccchHHHHHHhcCCCceeEEeecCCCCccchhHHH--HHHH--HHHHHh-------hhccCCCceEEEeccchhc-cC
Confidence 65555443 3456677777777765421111111 0011 111111 1223345566666666554 11
Q ss_pred CCCC-----cc-ccccEEECcCCcCccc-----CCccccCCCCCcEEEccCCccccc----cCcccccCCCCcEEeCCCC
Q 010736 256 PPSL-----DN-LVLTKLSLDDNHFTSY-----LPQNICRGGALQIFTVSENRFQGT----IPKSLRNCTSLIRVRLDGN 320 (502)
Q Consensus 256 p~~~-----~~-~~L~~L~ls~N~l~~~-----~~~~~~~~~~L~~L~ls~n~l~~~----~~~~l~~l~~L~~L~l~~N 320 (502)
|... .. ..++.+.+.+|.|.-. +-..+....+|+.||+..|-++-. +...+..++.|+.|++..|
T Consensus 173 s~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDC 252 (388)
T COG5238 173 SKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDC 252 (388)
T ss_pred cHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccch
Confidence 1111 00 2455555555544321 001122345666666666666521 2233445555666666666
Q ss_pred ccccccCcc----c--CCCCCCcEEEccCcccccccCcc-------ccCCCCCCeeeecCCcc
Q 010736 321 NLTGNISKA----F--GIYPNLTFIDLSRNNFYGEISSN-------FGECPKLGALNISRNNI 370 (502)
Q Consensus 321 ~l~~~~~~~----~--~~l~~L~~L~Ls~N~l~~~~~~~-------~~~~~~L~~L~l~~N~l 370 (502)
-++..-..+ | ...|+|..|...+|...+.+... -..+|-|..|-+.+|.|
T Consensus 253 lls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~ 315 (388)
T COG5238 253 LLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRI 315 (388)
T ss_pred hhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcc
Confidence 554332211 1 13466666666666554432211 12344455555555555
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.72 E-value=2.7e-06 Score=77.64 Aligned_cols=242 Identities=19% Similarity=0.253 Sum_probs=148.2
Q ss_pred CCCCCCCCEEECCCCccccc----CCccCcCCCCCCEEEccCCcCc---CCCCc-------ccCCCCCCcEEEccCCcCc
Q 010736 91 FSSFPHLAYLDLRDNKLFGT----IPPQISNLTNLSILSLGGNQFS---GNIPH-------EVGLMSHLKILYIDSNQLD 156 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~---~~~p~-------~l~~l~~L~~L~Ls~N~l~ 156 (502)
+..+..++.++||+|.|... +...+.+-.+|+..+++.-... ..+|+ .+.++++|+..+||.|.|.
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg 105 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG 105 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence 44578899999999998653 4445677788999998865322 22332 3567899999999999998
Q ss_pred ccCCcc----cCCCCCCcEEEcccCcccccCCcC-CCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcc
Q 010736 157 GSIPLE----VGQLSSMVELALFSNNLNGSVPHS-LGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI 231 (502)
Q Consensus 157 ~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 231 (502)
...|.. +++-+.|.+|.+++|.+. .+... ++ +.|. .|..|+- ..+-+.|+.+....|++..-.
T Consensus 106 ~~~~e~L~d~is~~t~l~HL~l~NnGlG-p~aG~rig--kal~--~la~nKK-------aa~kp~Le~vicgrNRlengs 173 (388)
T COG5238 106 SEFPEELGDLISSSTDLVHLKLNNNGLG-PIAGGRIG--KALF--HLAYNKK-------AADKPKLEVVICGRNRLENGS 173 (388)
T ss_pred cccchHHHHHHhcCCCceeEEeecCCCC-ccchhHHH--HHHH--HHHHHhh-------hccCCCceEEEeccchhccCc
Confidence 777655 466789999999999874 22211 11 0111 1112211 122344555555555554211
Q ss_pred c----ccccCCCCCcEEEeeCccccccCCCCC---------ccccccEEECcCCcCccc----CCccccCCCCCcEEEcc
Q 010736 232 P----LSLGNLTNLKQFSLVYNNLYGSIPPSL---------DNLVLTKLSLDDNHFTSY----LPQNICRGGALQIFTVS 294 (502)
Q Consensus 232 p----~~~~~l~~L~~L~l~~N~l~~~~p~~~---------~~~~L~~L~ls~N~l~~~----~~~~~~~~~~L~~L~ls 294 (502)
. ..+..-.+|+.+.+.+|.|. |... ...+|+.||+..|-|+-. +...++.++.|+.|.+.
T Consensus 174 ~~~~a~~l~sh~~lk~vki~qNgIr---pegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~ln 250 (388)
T COG5238 174 KELSAALLESHENLKEVKIQQNGIR---PEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLN 250 (388)
T ss_pred HHHHHHHHHhhcCceeEEeeecCcC---cchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhcccc
Confidence 0 11222245666677776554 2221 114677777777776643 23355677778888888
Q ss_pred CCccccccCcc----c--ccCCCCcEEeCCCCccccccCcc-------cCCCCCCcEEEccCcccc
Q 010736 295 ENRFQGTIPKS----L--RNCTSLIRVRLDGNNLTGNISKA-------FGIYPNLTFIDLSRNNFY 347 (502)
Q Consensus 295 ~n~l~~~~~~~----l--~~l~~L~~L~l~~N~l~~~~~~~-------~~~l~~L~~L~Ls~N~l~ 347 (502)
.+-++..-..+ | ...++|..|...+|...+.+... -..+|-|..|.+.+|++.
T Consensus 251 DClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~ 316 (388)
T COG5238 251 DCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK 316 (388)
T ss_pred chhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence 88776332221 1 23567888888888876543222 135677777888888876
|
|
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00022 Score=59.78 Aligned_cols=110 Identities=12% Similarity=0.122 Sum_probs=52.3
Q ss_pred cCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCC
Q 010736 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQ 165 (502)
Q Consensus 86 l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 165 (502)
|+...|.+.++|+.+.+.. .+.......|.++++|+.+.+..+ +...-...|.++++|+.+.+.+ .+.......|..
T Consensus 3 i~~~~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~ 79 (129)
T PF13306_consen 3 IGNNAFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSN 79 (129)
T ss_dssp E-TTTTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT
T ss_pred ECHHHHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccc
Confidence 3444577777777777764 455555566777777777777664 5534444566666677777754 333233445555
Q ss_pred CCCCcEEEcccCcccccCCcCCCCCCCCCeEEccc
Q 010736 166 LSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200 (502)
Q Consensus 166 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 200 (502)
+++|+.+.+..+ +.......|.+. +|+.+.+..
T Consensus 80 ~~~l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~ 112 (129)
T PF13306_consen 80 CTNLKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS 112 (129)
T ss_dssp -TTECEEEETTT--BEEHTTTTTT--T--EEE-TT
T ss_pred cccccccccCcc-ccEEchhhhcCC-CceEEEECC
Confidence 666666666544 433334445554 555555543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=1.9e-05 Score=76.34 Aligned_cols=45 Identities=29% Similarity=0.533 Sum_probs=41.4
Q ss_pred cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 387 WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 387 ~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
+..+.||--|+|||...+.--....|=|+|||+++||+.|+.|+.
T Consensus 292 SnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFK 336 (459)
T KOG0610|consen 292 SNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFK 336 (459)
T ss_pred ccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcC
Confidence 345789999999999999888999999999999999999999985
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.63 E-value=8.4e-05 Score=65.28 Aligned_cols=125 Identities=18% Similarity=0.195 Sum_probs=85.1
Q ss_pred CCEEEccCCcCcCCCCcccC-CCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcc
Q 010736 121 LSILSLGGNQFSGNIPHEVG-LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199 (502)
Q Consensus 121 L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 199 (502)
=+.++|.+.++.. +- .++ .+.+...+||++|.+.. -..|..+++|..|.+.+|+|+.+-|.--.-+++|+.|.|.
T Consensus 21 e~e~~LR~lkip~-ie-nlg~~~d~~d~iDLtdNdl~~--l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~Lt 96 (233)
T KOG1644|consen 21 ERELDLRGLKIPV-IE-NLGATLDQFDAIDLTDNDLRK--LDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILT 96 (233)
T ss_pred ccccccccccccc-hh-hccccccccceecccccchhh--cccCCCccccceEEecCCcceeeccchhhhccccceEEec
Confidence 3455555555541 11 122 24467889999998863 2457788999999999999997666544556789999999
Q ss_pred cccccccC-CccCcCCccCCccccccccccCcc---cccccCCCCCcEEEeeCc
Q 010736 200 DNSFSGFI-PPDIGNLKSISILSLAINQFSGPI---PLSLGNLTNLKQFSLVYN 249 (502)
Q Consensus 200 ~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~---p~~~~~l~~L~~L~l~~N 249 (502)
+|+|.... -+.+..++.|++|.+-+|..+..- -..+..+++|+.||++.-
T Consensus 97 nNsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~kV 150 (233)
T KOG1644|consen 97 NNSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQKV 150 (233)
T ss_pred CcchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhhh
Confidence 99887431 123556788888888888776432 234567788888887643
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.61 E-value=4.9e-07 Score=83.49 Aligned_cols=175 Identities=17% Similarity=0.124 Sum_probs=82.2
Q ss_pred CCCEEEccCCcCcCC-CCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCc-cccc-CCcCCCCCCCCCeE
Q 010736 120 NLSILSLGGNQFSGN-IPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNN-LNGS-VPHSLGNLTQISML 196 (502)
Q Consensus 120 ~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~-~p~~~~~l~~L~~L 196 (502)
.|++||||+..|+.. +-.-++.+.+|+.|.|.++++...+-..+++-.+|+.|+++.+. ++.. .---+.+++.|..|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 355666665555421 11123445556666666666655555555566666666665432 2100 00113455666666
Q ss_pred EcccccccccCCcc-CcC-CccCCccccccccc---cCcccccccCCCCCcEEEeeCcccc-ccCC-CCCccccccEEEC
Q 010736 197 FLHDNSFSGFIPPD-IGN-LKSISILSLAINQF---SGPIPLSLGNLTNLKQFSLVYNNLY-GSIP-PSLDNLVLTKLSL 269 (502)
Q Consensus 197 ~L~~N~l~~~~p~~-~~~-l~~L~~L~ls~N~l---~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p-~~~~~~~L~~L~l 269 (502)
+++.+.+....-.. +.. -.+|..|++++..- ...+..-...+++|..|||+.|..- .... ..+....|++|.+
T Consensus 266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSl 345 (419)
T KOG2120|consen 266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSL 345 (419)
T ss_pred CchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeeh
Confidence 66666544321110 011 13455555555321 1112222345666777777665421 1000 1111245666666
Q ss_pred cCCcCcccCCc---cccCCCCCcEEEccCC
Q 010736 270 DDNHFTSYLPQ---NICRGGALQIFTVSEN 296 (502)
Q Consensus 270 s~N~l~~~~~~---~~~~~~~L~~L~ls~n 296 (502)
+.+.. ++|. .+...+.|.+|++.+.
T Consensus 346 sRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 346 SRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred hhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 65542 2333 3456677888877654
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0003 Score=69.78 Aligned_cols=76 Identities=13% Similarity=0.211 Sum_probs=47.6
Q ss_pred CCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCC-cCcccCCcccCCCCCC
Q 010736 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN-QLDGSIPLEVGQLSSM 169 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L 169 (502)
+..+.+++.|++++|.|+ .+|. + -.+|++|+++++.--..+|..+ .++|++|++++| .+. .+|. +|
T Consensus 48 ~~~~~~l~~L~Is~c~L~-sLP~-L--P~sLtsL~Lsnc~nLtsLP~~L--P~nLe~L~Ls~Cs~L~-sLP~------sL 114 (426)
T PRK15386 48 IEEARASGRLYIKDCDIE-SLPV-L--PNELTEITIENCNNLTTLPGSI--PEGLEKLTVCHCPEIS-GLPE------SV 114 (426)
T ss_pred HHHhcCCCEEEeCCCCCc-ccCC-C--CCCCcEEEccCCCCcccCCchh--hhhhhheEccCccccc-cccc------cc
Confidence 445678889999988877 4452 2 2368888888743323566544 257888888877 443 3443 35
Q ss_pred cEEEcccCcc
Q 010736 170 VELALFSNNL 179 (502)
Q Consensus 170 ~~L~L~~N~l 179 (502)
+.|++..|..
T Consensus 115 e~L~L~~n~~ 124 (426)
T PRK15386 115 RSLEIKGSAT 124 (426)
T ss_pred ceEEeCCCCC
Confidence 5666655543
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00019 Score=71.16 Aligned_cols=129 Identities=17% Similarity=0.307 Sum_probs=78.7
Q ss_pred CEEEEEecCCCCceecCcccCCCC-CCCCEEECCCCcccccCCccCcCCCCCCEEEccCC-cCcCCCCcccCCCCCCcEE
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSF-PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGN-QFSGNIPHEVGLMSHLKIL 148 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l-~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L 148 (502)
..+.|+++++.++ .+| .+ ++|++|.++++.--..+|..+. ++|++|++++| .+. .+|. +|+.|
T Consensus 53 ~l~~L~Is~c~L~-sLP-----~LP~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~-sLP~------sLe~L 117 (426)
T PRK15386 53 ASGRLYIKDCDIE-SLP-----VLPNELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEIS-GLPE------SVRSL 117 (426)
T ss_pred CCCEEEeCCCCCc-ccC-----CCCCCCcEEEccCCCCcccCCchhh--hhhhheEccCccccc-cccc------ccceE
Confidence 4668999988776 333 23 3699999998443346776553 68999999998 555 5554 47788
Q ss_pred EccCCcCcccCCcccCCC-CCCcEEEcccCccc--ccCCcCCCCC-CCCCeEEcccccccccCCccCcCCccCCcccccc
Q 010736 149 YIDSNQLDGSIPLEVGQL-SSMVELALFSNNLN--GSVPHSLGNL-TQISMLFLHDNSFSGFIPPDIGNLKSISILSLAI 224 (502)
Q Consensus 149 ~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~--~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 224 (502)
+++.|.... +..+ ++|+.|.+.+++.. ..+|. .+ ++|++|++++|... ..|+.+. .+|+.|.++.
T Consensus 118 ~L~~n~~~~-----L~~LPssLk~L~I~~~n~~~~~~lp~---~LPsSLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls~ 186 (426)
T PRK15386 118 EIKGSATDS-----IKNVPNGLTSLSINSYNPENQARIDN---LISPSLKTLSLTGCSNI-ILPEKLP--ESLQSITLHI 186 (426)
T ss_pred EeCCCCCcc-----cccCcchHhheecccccccccccccc---ccCCcccEEEecCCCcc-cCccccc--ccCcEEEecc
Confidence 888776531 2222 24667776543311 11111 12 46888888877755 2333332 4677777765
Q ss_pred c
Q 010736 225 N 225 (502)
Q Consensus 225 N 225 (502)
+
T Consensus 187 n 187 (426)
T PRK15386 187 E 187 (426)
T ss_pred c
Confidence 5
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.50 E-value=8.6e-06 Score=74.36 Aligned_cols=60 Identities=30% Similarity=0.349 Sum_probs=48.6
Q ss_pred ccccCcccccCCCC-CCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCC
Q 010736 371 TGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 371 ~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
+|||||+|.-+.+. .++|.-.-|..|.|||..++. .++...||||.||+.-|++-+|.=+
T Consensus 197 ICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF 258 (449)
T KOG0664|consen 197 ICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF 258 (449)
T ss_pred ecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh
Confidence 79999999876543 355555567889999998865 6899999999999999999776543
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.48 E-value=1.1e-06 Score=81.27 Aligned_cols=60 Identities=23% Similarity=0.359 Sum_probs=37.5
Q ss_pred ccCCCCcEEeCCCCc-cccccCcccCCCCCCcEEEccCcccccccCc---cccCCCCCCeeeecCC
Q 010736 307 RNCTSLIRVRLDGNN-LTGNISKAFGIYPNLTFIDLSRNNFYGEISS---NFGECPKLGALNISRN 368 (502)
Q Consensus 307 ~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~~~~L~~L~l~~N 368 (502)
..+++|..|||+.|. ++......|.+++.|++|.|+.+. +.+|. .+...|.|.+||+.+.
T Consensus 310 ~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY--~i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 310 RRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCY--DIIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred HhCCceeeeccccccccCchHHHHHHhcchheeeehhhhc--CCChHHeeeeccCcceEEEEeccc
Confidence 467777777777654 333333455677788888877664 33443 3466777888877553
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=4.8e-05 Score=75.12 Aligned_cols=59 Identities=22% Similarity=0.300 Sum_probs=48.2
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~ 432 (502)
++|||-|=.. ..++|.--.|-.|.+||..-+..+...+|+|||+|+.+||+||-.=|+.
T Consensus 395 IaDlGNACW~---~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFeP 453 (590)
T KOG1290|consen 395 IADLGNACWV---HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEP 453 (590)
T ss_pred Eeeccchhhh---hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecC
Confidence 5788876432 3455555678899999999999999999999999999999999866553
|
|
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0007 Score=56.66 Aligned_cols=124 Identities=14% Similarity=0.131 Sum_probs=63.6
Q ss_pred CccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCC
Q 010736 112 PPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLT 191 (502)
Q Consensus 112 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 191 (502)
...|.++++|+.+.+.. .+...-...|.++++|+.+.+.++ +.......|..+++++.+.+.+ .+.......|..++
T Consensus 5 ~~~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~ 81 (129)
T PF13306_consen 5 NNAFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCT 81 (129)
T ss_dssp TTTTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-T
T ss_pred HHHHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccc
Confidence 34677888888888874 566555667888888888888775 6645555677777888888865 44434455677778
Q ss_pred CCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCC
Q 010736 192 QISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNL 241 (502)
Q Consensus 192 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 241 (502)
+|+.+.+..+ +.......|.+. .|+.+.+.. .+.......|.++++|
T Consensus 82 ~l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 82 NLKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp TECEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred cccccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 8888888665 444444556665 677666654 3333334455555444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00022 Score=75.56 Aligned_cols=61 Identities=28% Similarity=0.502 Sum_probs=49.5
Q ss_pred ccccCcccccC--CCC--CCcccccccccccCccccccceecc-cceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLK--PDS--SNWTGFAGTYGYIAPELAYTMKITE-KCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~--~~~--~~~~~~~gt~gy~aPE~~~~~~~s~-k~Dvysfgv~llElltg~~p~~ 431 (502)
++|||.+.... .+. +...++.|+-+|+|||......+.. -.||||-||++..|++||.|..
T Consensus 461 i~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 461 IIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred EeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 58999887663 222 3445788999999999998887764 4999999999999999999964
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=97.25 E-value=5e-05 Score=69.99 Aligned_cols=63 Identities=32% Similarity=0.506 Sum_probs=48.7
Q ss_pred ccccccCcccccCCCC-CCcccccccccccCcccc-ccceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELA-YTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~-~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||.++...... .......++..|++||.. .....+.+.|+|+||++++|++||+.|++
T Consensus 137 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 137 VKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred EEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 3468899888775432 012234577789999998 66677789999999999999999999974
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.18 E-value=9.2e-05 Score=69.45 Aligned_cols=59 Identities=32% Similarity=0.386 Sum_probs=48.2
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
+.|||+++-...+ -..|-...|--|.|||...+..+.++.|+||.||++-||++|+.=+
T Consensus 159 i~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf 217 (369)
T KOG0665|consen 159 ILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF 217 (369)
T ss_pred eccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence 6899999876544 2234445677899999999999999999999999999999998543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00035 Score=71.31 Aligned_cols=42 Identities=38% Similarity=0.636 Sum_probs=39.6
Q ss_pred ccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 390 FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..||..|+|||.....-++..||-||.||+|+||+.|+.|+-
T Consensus 831 lvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~ 872 (1034)
T KOG0608|consen 831 LVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFL 872 (1034)
T ss_pred hcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCcc
Confidence 469999999999999999999999999999999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.00046 Score=68.91 Aligned_cols=58 Identities=26% Similarity=0.256 Sum_probs=45.1
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
.||||-|-+.........- -+--|.|||..-+..+....|+||.||.|+|+.|||.=|
T Consensus 578 LCDfGSA~~~~eneitPYL--VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 578 LCDFGSASFASENEITPYL--VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred eccCccccccccccccHHH--HHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 6999988776543321111 123599999999999999999999999999999998643
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0005 Score=62.48 Aligned_cols=61 Identities=21% Similarity=0.312 Sum_probs=45.8
Q ss_pred ccccCcccccCCCCC----CcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.+|||++|.+..... ..|...-|..|.+||..-+. .+..+.|+|..||++-||.||.+-++
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 589999987643211 12333458899999998654 58889999999999999999876543
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.00031 Score=75.41 Aligned_cols=15 Identities=13% Similarity=0.206 Sum_probs=7.9
Q ss_pred CCCCcEEEeeCcccc
Q 010736 238 LTNLKQFSLVYNNLY 252 (502)
Q Consensus 238 l~~L~~L~l~~N~l~ 252 (502)
+++|+.||.|+..+.
T Consensus 249 LpeLrfLDcSgTdi~ 263 (699)
T KOG3665|consen 249 LPELRFLDCSGTDIN 263 (699)
T ss_pred CccccEEecCCcchh
Confidence 455555555554443
|
|
| >KOG2123 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=96.84 E-value=2e-05 Score=72.36 Aligned_cols=90 Identities=26% Similarity=0.347 Sum_probs=54.6
Q ss_pred eCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCC-CcccCCCCC
Q 010736 66 CNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNI-PHEVGLMSH 144 (502)
Q Consensus 66 C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~ 144 (502)
|++-..|..|++-|++|.. |+- ...++.|++|.||-|+|+..-| |..|++|+.|+|..|.|...- -..+.++++
T Consensus 15 ~sdl~~vkKLNcwg~~L~D-Isi--c~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlps 89 (388)
T KOG2123|consen 15 CSDLENVKKLNCWGCGLDD-ISI--CEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPS 89 (388)
T ss_pred hhHHHHhhhhcccCCCccH-HHH--HHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCch
Confidence 4333345556666666652 211 4567777777777777774433 667777777777777776321 123566777
Q ss_pred CcEEEccCCcCcccCC
Q 010736 145 LKILYIDSNQLDGSIP 160 (502)
Q Consensus 145 L~~L~Ls~N~l~~~~p 160 (502)
|+.|.|..|.-.|.-+
T Consensus 90 Lr~LWL~ENPCc~~ag 105 (388)
T KOG2123|consen 90 LRTLWLDENPCCGEAG 105 (388)
T ss_pred hhhHhhccCCcccccc
Confidence 7777777776665444
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.00029 Score=66.14 Aligned_cols=43 Identities=26% Similarity=0.529 Sum_probs=37.3
Q ss_pred cccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCC
Q 010736 389 GFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 389 ~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
+..|+.-|||||... ...+..++|.||+||+++-|++|=.|+.
T Consensus 245 tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 245 TPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred CcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 457888999999864 3467889999999999999999999985
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.00097 Score=61.19 Aligned_cols=60 Identities=23% Similarity=0.328 Sum_probs=29.5
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEEEccCC--cCcCCCCcccCCCCCCcEEEccCCcCc
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGN--QFSGNIPHEVGLMSHLKILYIDSNQLD 156 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N--~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 156 (502)
..|+.|++.+..++.. ..|-.+++|++|.+|.| ++++.++.-...+++|++|++++|++.
T Consensus 43 ~~le~ls~~n~gltt~--~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~ 104 (260)
T KOG2739|consen 43 VELELLSVINVGLTTL--TNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIK 104 (260)
T ss_pred cchhhhhhhccceeec--ccCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccc
Confidence 3344444444444311 12344556666666666 444444433444456666666666554
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.00055 Score=74.38 Aligned_cols=60 Identities=30% Similarity=0.531 Sum_probs=46.7
Q ss_pred ccccCcccccCCCCC-CcccccccccccCcccccc-----ceecccceeeeeceeeeehhcCCCCC
Q 010736 371 TGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYT-----MKITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~-----~~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
.+|||-.--+..+.+ ......||+-|++||.... +.+...+|-||.||+++||+.|..||
T Consensus 216 LADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 216 LADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred eccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 578887655543322 3345679999999999753 45677899999999999999999997
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.00031 Score=65.70 Aligned_cols=58 Identities=24% Similarity=0.377 Sum_probs=45.2
Q ss_pred ccccCcccccCCCC---CCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCC
Q 010736 371 TGDFGIAKFLKPDS---SNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKH 428 (502)
Q Consensus 371 ~~dfGl~~ll~~~~---~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~ 428 (502)
++|+|++|+...-- .....+.-|+-|.|||..-+. -+|...|||+.||+.-||+|-++
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~P 238 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEP 238 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCc
Confidence 78999999875311 112345678999999998765 58899999999999999998653
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.0022 Score=58.85 Aligned_cols=64 Identities=17% Similarity=0.269 Sum_probs=32.7
Q ss_pred CcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCC--cCcccCCcccCCCCCCcEEEcccCccc
Q 010736 115 ISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN--QLDGSIPLEVGQLSSMVELALFSNNLN 180 (502)
Q Consensus 115 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~L~~N~l~ 180 (502)
.-.+..|+.|.+.+..++.. ..|-.|++|+.|.++.| ++.+.++.....+++|+++++++|++.
T Consensus 39 ~d~~~~le~ls~~n~gltt~--~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~ 104 (260)
T KOG2739|consen 39 TDEFVELELLSVINVGLTTL--TNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIK 104 (260)
T ss_pred cccccchhhhhhhccceeec--ccCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccc
Confidence 33444555555555555421 13444556666666666 444444444444455555555555554
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.0019 Score=69.42 Aligned_cols=133 Identities=18% Similarity=0.233 Sum_probs=69.9
Q ss_pred CCCCEEECCCCcccc-cCCccCc-CCCCCCEEEccCCcCcCC-CCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcE
Q 010736 95 PHLAYLDLRDNKLFG-TIPPQIS-NLTNLSILSLGGNQFSGN-IPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVE 171 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g-~~p~~l~-~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 171 (502)
.+|++||+++..... .-|..++ -+|.|+.|.+++-.+... .-.-+.++++|..||+|+.+++.. ..++++++|+.
T Consensus 122 ~nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~ 199 (699)
T KOG3665|consen 122 QNLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQV 199 (699)
T ss_pred HhhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHH
Confidence 456666666654321 1122222 256677777666555321 122345566677777777666533 45666666666
Q ss_pred EEcccCcccc-cCCcCCCCCCCCCeEEcccccccccC------CccCcCCccCCccccccccccC
Q 010736 172 LALFSNNLNG-SVPHSLGNLTQISMLFLHDNSFSGFI------PPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 172 L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~------p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
|.+.+=.+.. ..-..+.+|++|+.||+|..+..... -+.-..+++|+.||.|++.+..
T Consensus 200 L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~ 264 (699)
T KOG3665|consen 200 LSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINE 264 (699)
T ss_pred HhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhH
Confidence 6665544431 11113456677777777665433211 0112236677777777666554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.0016 Score=63.49 Aligned_cols=42 Identities=33% Similarity=0.588 Sum_probs=37.3
Q ss_pred cccccccccCccccccc-eecccceeeeeceeeeehhcCCCCC
Q 010736 389 GFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 389 ~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
..+||.||.|||..... .-+.+.||||-||+++-+++++.|+
T Consensus 236 nrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 236 NRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred ccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccccc
Confidence 36899999999998644 5678999999999999999999996
|
|
| >KOG2123 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=96.35 E-value=9.6e-05 Score=68.00 Aligned_cols=87 Identities=24% Similarity=0.227 Sum_probs=58.2
Q ss_pred CCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCC-cccCCCCCCc
Q 010736 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIP-LEVGQLSSMV 170 (502)
Q Consensus 92 ~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~ 170 (502)
+.+.+.++|++.++.|+.+ .....++.|++|.||-|+|+..-| +..+++|+.|+|..|.|...-. .-+.++++|+
T Consensus 16 sdl~~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr 91 (388)
T KOG2123|consen 16 SDLENVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLR 91 (388)
T ss_pred hHHHHhhhhcccCCCccHH--HHHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhh
Confidence 3456778888888888753 235678888899999888885544 6778888888888887763211 1134556666
Q ss_pred EEEcccCccccc
Q 010736 171 ELALFSNNLNGS 182 (502)
Q Consensus 171 ~L~L~~N~l~~~ 182 (502)
.|.|..|.-.|.
T Consensus 92 ~LWL~ENPCc~~ 103 (388)
T KOG2123|consen 92 TLWLDENPCCGE 103 (388)
T ss_pred hHhhccCCcccc
Confidence 666665554443
|
|
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.0022 Score=35.29 Aligned_cols=10 Identities=40% Similarity=0.760 Sum_probs=3.6
Q ss_pred EEEccCCcCc
Q 010736 123 ILSLGGNQFS 132 (502)
Q Consensus 123 ~L~Ls~N~l~ 132 (502)
+|||++|+|+
T Consensus 4 ~Ldls~n~l~ 13 (22)
T PF00560_consen 4 YLDLSGNNLT 13 (22)
T ss_dssp EEEETSSEES
T ss_pred EEECCCCcCE
Confidence 3333333333
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.0033 Score=34.58 Aligned_cols=22 Identities=55% Similarity=0.859 Sum_probs=17.2
Q ss_pred CCCEEECCCCcccccCCccCcCC
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNL 118 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l 118 (502)
+|++|||++|+|+ .+|+.|++|
T Consensus 1 ~L~~Ldls~n~l~-~ip~~~~~l 22 (22)
T PF00560_consen 1 NLEYLDLSGNNLT-SIPSSFSNL 22 (22)
T ss_dssp TESEEEETSSEES-EEGTTTTT-
T ss_pred CccEEECCCCcCE-eCChhhcCC
Confidence 5789999999999 778777653
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.007 Score=62.54 Aligned_cols=94 Identities=24% Similarity=0.363 Sum_probs=57.1
Q ss_pred cccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccC-CCCCCCCcchHH
Q 010736 389 GFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLD-PRLPVPSCSVQE 464 (502)
Q Consensus 389 ~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d-~~l~~~~~~~~~ 464 (502)
.+.||+.|||||.+. .+.+.+++|||+.|+...|+--=+.|.-.......-.+.. ..-++ |++... ..-.+
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT----kS~~qpp~lkDk-~kws~ 245 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT----KSGFQPPTLKDK-TKWSE 245 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh----ccCCCCCcccCC-ccchH
Confidence 467999999999975 4458899999999999998877677742111111000000 11122 233221 11223
Q ss_pred HHHHHHHHhhccCCcCCCCCCCHHHH
Q 010736 465 KLISIMEVGFSCLKESPESRPTMKIV 490 (502)
Q Consensus 465 ~~~~~~~val~C~~~~p~~Rp~m~~v 490 (502)
-.-..++ .|...+|++||+....
T Consensus 246 ~fh~fvK---~altknpKkRptaekl 268 (829)
T KOG0576|consen 246 FFHNFVK---GALTKNPKKRPTAEKL 268 (829)
T ss_pred HHHHHHH---HHhcCCCccCCChhhh
Confidence 3445666 6788999999986653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.0041 Score=67.86 Aligned_cols=91 Identities=21% Similarity=0.272 Sum_probs=57.5
Q ss_pred cccccCccccccc-----------eecccceeeeeceeeeehhc-CCCCCCcccCCCCC---CCCcccccccccCCCCCC
Q 010736 393 TYGYIAPELAYTM-----------KITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSP---SLNTDIALDEMLDPRLPV 457 (502)
Q Consensus 393 t~gy~aPE~~~~~-----------~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~---~~~~~~~~~~~~d~~l~~ 457 (502)
-.+|+|||.+... .++.+-|+||.|||+.|+++ |++|++...-.... ....+.-..++-|+.++
T Consensus 190 RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~~~R- 268 (1431)
T KOG1240|consen 190 RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDVSLR- 268 (1431)
T ss_pred eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCcCccHH-
Confidence 3589999987542 27778999999999999987 78888742111100 00111122334444322
Q ss_pred CCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 458 PSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 458 ~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+-+. ...+.+|.+|-+..++++.=+..
T Consensus 269 ------nlil-------~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 269 ------NLIL-------SMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ------HHHH-------HHHccCchhccCHHHHHHhhhcc
Confidence 2233 45569999999999998875443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.0053 Score=62.35 Aligned_cols=70 Identities=29% Similarity=0.486 Sum_probs=51.0
Q ss_pred CCCeeeecCCccc---------cccCcccccCCCCCCcccccccccccCccccccceeccc-ceeeeeceeeeehhcCCC
Q 010736 359 KLGALNISRNNIT---------GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEK-CDVYSFGVLVLEVIKGKH 428 (502)
Q Consensus 359 ~L~~L~l~~N~l~---------~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k-~Dvysfgv~llElltg~~ 428 (502)
.+.|.|++.-|.+ -|||-+.+... ..+..+.||.+|.|||...+.++--| .|+|+.||+++.++....
T Consensus 690 ~ivhrdikdenvivd~~g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 690 GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred CceecccccccEEEecCCeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 4566677765543 24554444332 22346889999999999998887654 899999999999998888
Q ss_pred CC
Q 010736 429 PR 430 (502)
Q Consensus 429 p~ 430 (502)
|+
T Consensus 768 py 769 (772)
T KOG1152|consen 768 PY 769 (772)
T ss_pred CC
Confidence 75
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.0035 Score=64.40 Aligned_cols=55 Identities=36% Similarity=0.578 Sum_probs=45.8
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..|||+.|..-.... -+||.-|||||... -.....|-|||||+++||+||-.|+.
T Consensus 138 ~tdfglske~v~~~~----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 138 LTDFGLSKEAVKEKI----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred cCCchhhhHhHhhhh----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 579999998754332 28899999999987 35678999999999999999999975
|
|
| >KOG0473 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.00054 Score=61.55 Aligned_cols=85 Identities=21% Similarity=0.203 Sum_probs=44.6
Q ss_pred cCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCC
Q 010736 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSM 169 (502)
Q Consensus 90 ~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 169 (502)
.+....+.+.||++.|++. -.-..|+-++.|..|+++.|++. ..|..++.+..+..+++.+|+.+ ..|.+++..+++
T Consensus 37 ei~~~kr~tvld~~s~r~v-n~~~n~s~~t~~~rl~~sknq~~-~~~~d~~q~~e~~~~~~~~n~~~-~~p~s~~k~~~~ 113 (326)
T KOG0473|consen 37 EIASFKRVTVLDLSSNRLV-NLGKNFSILTRLVRLDLSKNQIK-FLPKDAKQQRETVNAASHKNNHS-QQPKSQKKEPHP 113 (326)
T ss_pred hhhccceeeeehhhhhHHH-hhccchHHHHHHHHHhccHhhHh-hChhhHHHHHHHHHHHhhccchh-hCCccccccCCc
Confidence 3555666666777666654 23334555556666666666655 45555555555555555555444 334444444444
Q ss_pred cEEEcccC
Q 010736 170 VELALFSN 177 (502)
Q Consensus 170 ~~L~L~~N 177 (502)
+.+++-.|
T Consensus 114 k~~e~k~~ 121 (326)
T KOG0473|consen 114 KKNEQKKT 121 (326)
T ss_pred chhhhccC
Confidence 44433333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.0085 Score=58.04 Aligned_cols=120 Identities=23% Similarity=0.351 Sum_probs=73.0
Q ss_pred ccccccCcccccCCCCC------CcccccccccccCcccccc---ceecccceeeeeceeeeehhcCCCCCCcccCC-CC
Q 010736 369 NITGDFGIAKFLKPDSS------NWTGFAGTYGYIAPELAYT---MKITEKCDVYSFGVLVLEVIKGKHPRDFLSST-SS 438 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~------~~~~~~gt~gy~aPE~~~~---~~~s~k~Dvysfgv~llElltg~~p~~~~~~~-~~ 438 (502)
...+|||+++.+..... ......|+..|++||.... .......|+|++|++++++++|+.|+...... ..
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~ 220 (384)
T COG0515 141 VKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT 220 (384)
T ss_pred EEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccH
Confidence 34689999986654322 2345679999999999987 57889999999999999999999995432210 00
Q ss_pred CCCCcccccccccCCCCCCCCcc-----hHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 439 PSLNTDIALDEMLDPRLPVPSCS-----VQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 439 ~~~~~~~~~~~~~d~~l~~~~~~-----~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
... .+ .+.....+........ ....+..++. .|...+|..|.++.+....
T Consensus 221 ~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 221 SQT-LK-IILELPTPSLASPLSPSNPELISKAASDLLK---KLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHH-HH-HHHhcCCcccccccCccccchhhHHHHHHHH---HHHhcCchhcCCHHHHhhc
Confidence 000 00 0000111101000000 0123344444 7888899999999887654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.023 Score=54.04 Aligned_cols=38 Identities=32% Similarity=0.444 Sum_probs=33.1
Q ss_pred cccccccCccccccceecccceeeeeceeeeehhcCCC
Q 010736 391 AGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH 428 (502)
Q Consensus 391 ~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~ 428 (502)
.+-.||.+||+..+.+.+...|+|+||.-.+||.-|..
T Consensus 243 ~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 243 TSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred ccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 45679999999999999999999999988888877653
|
|
| >KOG0473 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.00085 Score=60.34 Aligned_cols=89 Identities=20% Similarity=0.291 Sum_probs=66.1
Q ss_pred ccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCC
Q 010736 113 PQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQ 192 (502)
Q Consensus 113 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 192 (502)
..+......+.||++.|++. ..-..|+.++.|..|+++.|++. ..|..++.+..+..+++..|+.+ ..|.+++..+.
T Consensus 36 ~ei~~~kr~tvld~~s~r~v-n~~~n~s~~t~~~rl~~sknq~~-~~~~d~~q~~e~~~~~~~~n~~~-~~p~s~~k~~~ 112 (326)
T KOG0473|consen 36 REIASFKRVTVLDLSSNRLV-NLGKNFSILTRLVRLDLSKNQIK-FLPKDAKQQRETVNAASHKNNHS-QQPKSQKKEPH 112 (326)
T ss_pred hhhhccceeeeehhhhhHHH-hhccchHHHHHHHHHhccHhhHh-hChhhHHHHHHHHHHHhhccchh-hCCccccccCC
Confidence 44666778888888888876 44456667777888888888876 67777777777777777777776 66777777777
Q ss_pred CCeEEccccccc
Q 010736 193 ISMLFLHDNSFS 204 (502)
Q Consensus 193 L~~L~L~~N~l~ 204 (502)
++++++-.|.+.
T Consensus 113 ~k~~e~k~~~~~ 124 (326)
T KOG0473|consen 113 PKKNEQKKTEFF 124 (326)
T ss_pred cchhhhccCcch
Confidence 777777777654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.45 E-value=0.015 Score=50.23 Aligned_cols=59 Identities=22% Similarity=0.394 Sum_probs=43.8
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccce-ecccceeeeeceeeeehhcCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHP 429 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~-~s~k~Dvysfgv~llElltg~~p 429 (502)
.+|||++|.+..--.-.+.-.-|..|.+|....+.+ +++..|.||.||++-|+....+|
T Consensus 142 ladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 142 LADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred ecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 589999998743211122234577899999887665 78899999999999999875555
|
|
| >PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D | Back alignment and domain information |
|---|
Probab=92.80 E-value=0.064 Score=27.31 Aligned_cols=10 Identities=40% Similarity=0.594 Sum_probs=3.1
Q ss_pred CCEEEccCCc
Q 010736 121 LSILSLGGNQ 130 (502)
Q Consensus 121 L~~L~Ls~N~ 130 (502)
|+.|+|++|+
T Consensus 3 L~~L~l~~n~ 12 (17)
T PF13504_consen 3 LRTLDLSNNR 12 (17)
T ss_dssp -SEEEETSS-
T ss_pred cCEEECCCCC
Confidence 3333333333
|
... |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=92.13 E-value=0.025 Score=51.00 Aligned_cols=59 Identities=24% Similarity=0.353 Sum_probs=45.0
Q ss_pred cccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 372 ~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-|.|||.|..+...-...+ .+-.|..||..... .+...-|+|||||++-+|+..|.|+-
T Consensus 175 IDWGLAEFYHp~~eYnVRV-ASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred eecchHhhcCCCceeeeee-ehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 4899999987654432223 34457789998655 46778899999999999999999974
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.17 E-value=0.19 Score=49.35 Aligned_cols=120 Identities=22% Similarity=0.231 Sum_probs=73.4
Q ss_pred ccccCcccccC---CCC-------CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCC
Q 010736 371 TGDFGIAKFLK---PDS-------SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPS 440 (502)
Q Consensus 371 ~~dfGl~~ll~---~~~-------~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~ 440 (502)
.-|||+++... ... .....+.||.-|.++........+.+.|+||.+-++.|+..|+.|...........
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~ 247 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS 247 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence 35899998321 111 11234669999999999889999999999999999999999998864222110000
Q ss_pred CCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 441 LNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 441 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
............+ .. ...+.++.++.+ .+-+.+-.++|.-..+...++..
T Consensus 248 ~~~~~~~~~~~~~-~~---~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 248 KFEKDPRKLLTDR-FG---DLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHhhhhcccc-cc---CCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHH
Confidence 0000000111111 10 112344555554 56668899999999888887664
|
|
| >TIGR00864 PCC polycystin cation channel protein | Back alignment and domain information |
|---|
Probab=91.06 E-value=0.088 Score=63.38 Aligned_cols=67 Identities=15% Similarity=0.106 Sum_probs=47.8
Q ss_pred EccCcccccccCccccCCCCCCeeeecCCccccccCcccccCCCCCCcccc--cccccccCccccccce
Q 010736 340 DLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFLKPDSSNWTGF--AGTYGYIAPELAYTMK 406 (502)
Q Consensus 340 ~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~~ll~~~~~~~~~~--~gt~gy~aPE~~~~~~ 406 (502)
||++|+|+...+..|..+++|++|+|++|++.|||.+.++..+.......+ ...+-|..|+...+..
T Consensus 1 DLSnN~LstLp~g~F~~L~sL~~LdLsgNPw~CDC~L~WL~~WL~~~~v~v~~~~~i~CasP~~LrG~~ 69 (2740)
T TIGR00864 1 DISNNKISTIEEGICANLCNLSEIDLSGNPFECDCGLARLPRWAEEKGVKVRQPEAALCAGPGALAGQP 69 (2740)
T ss_pred CCCCCcCCccChHHhccCCCceEEEeeCCccccccccHHHHHHHHhcCccccCCcccCCCCChHHCCCC
Confidence 588999998888889999999999999999999999998775532211111 1223455666555443
|
Note: this model has been restricted to the amino half because for technical reasons. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=90.93 E-value=0.25 Score=51.90 Aligned_cols=93 Identities=22% Similarity=0.295 Sum_probs=54.8
Q ss_pred ccccccCccccccceecccceeeeeceeeeehhcCCCCC-CcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHH
Q 010736 392 GTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR-DFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIM 470 (502)
Q Consensus 392 gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~ 470 (502)
....|.|||+......+.++|+||+||+++-+..|.++. +........+... . ..|..........++|+.+-+
T Consensus 171 ~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--~---~~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 171 PHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--N---LLNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred cCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--c---ccccccccccccCcHHHHHHH
Confidence 345799999999999999999999999999998655553 2211111111110 0 011111111112334444444
Q ss_pred HHhhccCCcCCCCCCCHHHHHH
Q 010736 471 EVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 471 ~val~C~~~~p~~Rp~m~~v~~ 492 (502)
. .-+..++.-||+|.++..
T Consensus 246 ~---k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 K---KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred H---HHhcCCcccCcchhhhhc
Confidence 4 456688899998877643
|
|
| >KOG4308 consensus LRR-containing protein [Function unknown] | Back alignment and domain information |
|---|
Probab=90.74 E-value=0.001 Score=68.38 Aligned_cols=83 Identities=25% Similarity=0.280 Sum_probs=44.4
Q ss_pred CCEEECCCCcccccC----CccCcCCCCCCEEEccCCcCcCCCC----cccCCC-CCCcEEEccCCcCccc----CCccc
Q 010736 97 LAYLDLRDNKLFGTI----PPQISNLTNLSILSLGGNQFSGNIP----HEVGLM-SHLKILYIDSNQLDGS----IPLEV 163 (502)
Q Consensus 97 L~~L~Ls~N~l~g~~----p~~l~~l~~L~~L~Ls~N~l~~~~p----~~l~~l-~~L~~L~Ls~N~l~~~----~p~~~ 163 (502)
+..|.|.+|.+.... -..+.....|+.|++++|.+.+.-- ..+... ..|++|++..|.++.. +...+
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~L 168 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAVL 168 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHHH
Confidence 566666666665432 2334556667777777777663211 111222 3455566666666532 23334
Q ss_pred CCCCCCcEEEcccCcc
Q 010736 164 GQLSSMVELALFSNNL 179 (502)
Q Consensus 164 ~~l~~L~~L~L~~N~l 179 (502)
.....++.++++.|.+
T Consensus 169 ~~~~~l~~l~l~~n~l 184 (478)
T KOG4308|consen 169 EKNEHLTELDLSLNGL 184 (478)
T ss_pred hcccchhHHHHHhccc
Confidence 4456666666666665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.30 E-value=0.35 Score=51.67 Aligned_cols=70 Identities=27% Similarity=0.412 Sum_probs=52.0
Q ss_pred eeecC-CccccccCcccccCC-CCC--Ccccccc-cccccCccccccc-eecccceeeeeceeeeehhcCCCCCCc
Q 010736 363 LNISR-NNITGDFGIAKFLKP-DSS--NWTGFAG-TYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDF 432 (502)
Q Consensus 363 L~l~~-N~l~~dfGl~~ll~~-~~~--~~~~~~g-t~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~ 432 (502)
++-++ +--.+|||++..... ... ......| +..|.|||..... -.....|+||-|+++.-+++|..|.+.
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~ 232 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDF 232 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccc
Confidence 44455 455799999987644 221 1223467 8899999999874 445779999999999999999999763
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=89.95 E-value=0.052 Score=51.82 Aligned_cols=76 Identities=21% Similarity=0.385 Sum_probs=44.9
Q ss_pred cccccCcccccc--------ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHH
Q 010736 393 TYGYIAPELAYT--------MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQE 464 (502)
Q Consensus 393 t~gy~aPE~~~~--------~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 464 (502)
+.+|.+||.... ..++.+.|.|++|++++.+-+|+-|++.........+ . +. .+ ...++
T Consensus 205 ~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~----f~-~C----~~~Pe 271 (288)
T PF14531_consen 205 PVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----D----FS-RC----RDMPE 271 (288)
T ss_dssp -TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----G----GT-TS----S---H
T ss_pred CcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----c----ch-hc----CCcCH
Confidence 467888987644 4689999999999999999999999875332211111 0 10 11 12335
Q ss_pred HHHHHHHHhhccCCcCCCCC
Q 010736 465 KLISIMEVGFSCLKESPESR 484 (502)
Q Consensus 465 ~~~~~~~val~C~~~~p~~R 484 (502)
.+..+++ .-.+.+|++|
T Consensus 272 ~v~~LI~---~lL~~~~~~R 288 (288)
T PF14531_consen 272 PVQFLIR---GLLQRNPEDR 288 (288)
T ss_dssp HHHHHHH---HHT-SSGGGS
T ss_pred HHHHHHH---HHccCCcccC
Confidence 5666665 5667888776
|
|
| >smart00370 LRR Leucine-rich repeats, outliers | Back alignment and domain information |
|---|
Probab=89.61 E-value=0.29 Score=27.89 Aligned_cols=14 Identities=50% Similarity=0.596 Sum_probs=6.6
Q ss_pred CCCCEEEccCCcCc
Q 010736 119 TNLSILSLGGNQFS 132 (502)
Q Consensus 119 ~~L~~L~Ls~N~l~ 132 (502)
++|++|+|++|+|+
T Consensus 2 ~~L~~L~L~~N~l~ 15 (26)
T smart00370 2 PNLRELDLSNNQLS 15 (26)
T ss_pred CCCCEEECCCCcCC
Confidence 34444444444444
|
|
| >smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily | Back alignment and domain information |
|---|
Probab=89.61 E-value=0.29 Score=27.89 Aligned_cols=14 Identities=50% Similarity=0.596 Sum_probs=6.6
Q ss_pred CCCCEEEccCCcCc
Q 010736 119 TNLSILSLGGNQFS 132 (502)
Q Consensus 119 ~~L~~L~Ls~N~l~ 132 (502)
++|++|+|++|+|+
T Consensus 2 ~~L~~L~L~~N~l~ 15 (26)
T smart00369 2 PNLRELDLSNNQLS 15 (26)
T ss_pred CCCCEEECCCCcCC
Confidence 34444444444444
|
|
| >KOG4308 consensus LRR-containing protein [Function unknown] | Back alignment and domain information |
|---|
Probab=89.19 E-value=0.0024 Score=65.71 Aligned_cols=181 Identities=22% Similarity=0.230 Sum_probs=104.8
Q ss_pred EEEEEecCCCCceecC---cccCCCCCCCCEEECCCCcccccCC----ccCcCC-CCCCEEEccCCcCcCC----CCccc
Q 010736 72 VINISLRGVGLKGKLH---AFSFSSFPHLAYLDLRDNKLFGTIP----PQISNL-TNLSILSLGGNQFSGN----IPHEV 139 (502)
Q Consensus 72 v~~L~L~~~~l~g~l~---~~~~~~l~~L~~L~Ls~N~l~g~~p----~~l~~l-~~L~~L~Ls~N~l~~~----~p~~l 139 (502)
...+.|.++.+...-. ...+.....|+.|++++|.+.+.-- ..+... ..|++|++..|.+++. +...+
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~L 168 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAVL 168 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHHH
Confidence 5567778887764311 1136778899999999999974321 223333 5678899999988753 45566
Q ss_pred CCCCCCcEEEccCCcCcc----cCCccc----CCCCCCcEEEcccCcccccC----CcCCCCCCC-CCeEEccccccccc
Q 010736 140 GLMSHLKILYIDSNQLDG----SIPLEV----GQLSSMVELALFSNNLNGSV----PHSLGNLTQ-ISMLFLHDNSFSGF 206 (502)
Q Consensus 140 ~~l~~L~~L~Ls~N~l~~----~~p~~~----~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~-L~~L~L~~N~l~~~ 206 (502)
.....++.++++.|.+.. .++..+ ....++++|.+.+|.++... ...+...+. +..|++..|.+.+.
T Consensus 169 ~~~~~l~~l~l~~n~l~~~g~~~l~~~l~~~~~~~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~d~ 248 (478)
T KOG4308|consen 169 EKNEHLTELDLSLNGLIELGLLVLSQALESAASPLSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLGDV 248 (478)
T ss_pred hcccchhHHHHHhcccchhhhHHHhhhhhhhhcccccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcchH
Confidence 678889999999998741 122222 24567777777777765211 111223333 44566666665532
Q ss_pred ----CCccCcCC-ccCCccccccccccCcc----cccccCCCCCcEEEeeCcccc
Q 010736 207 ----IPPDIGNL-KSISILSLAINQFSGPI----PLSLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 207 ----~p~~~~~l-~~L~~L~ls~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~ 252 (502)
....+..+ ..++.++++.|.++..- ...+..++.++.+.++.|.+.
T Consensus 249 g~~~L~~~l~~~~~~l~~l~l~~nsi~~~~~~~L~~~l~~~~~l~~l~l~~n~l~ 303 (478)
T KOG4308|consen 249 GVEKLLPCLSVLSETLRVLDLSRNSITEKGVRDLAEVLVSCRQLEELSLSNNPLT 303 (478)
T ss_pred HHHHHHHHhcccchhhhhhhhhcCCccccchHHHHHHHhhhHHHHHhhcccCccc
Confidence 11223333 44566666666665332 222334445555555555543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=89.17 E-value=0.41 Score=47.08 Aligned_cols=95 Identities=25% Similarity=0.334 Sum_probs=54.4
Q ss_pred ccccccccCccccccce-----e-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchH
Q 010736 390 FAGTYGYIAPELAYTMK-----I-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQ 463 (502)
Q Consensus 390 ~~gt~gy~aPE~~~~~~-----~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 463 (502)
..|-..-||||...... + -+|+|.|+.|-+.+|+++.+.|+=..+.. ......+.|.-=|.++.. ..
T Consensus 411 ~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L~~r~Yqe~qLPalp~~---vp 483 (598)
T KOG4158|consen 411 LGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LLDTRTYQESQLPALPSR---VP 483 (598)
T ss_pred CCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh----eechhhhhhhhCCCCccc---CC
Confidence 34555679999986542 2 36899999999999999999997321111 011111222222333321 11
Q ss_pred HHHHHHHHHhhccCCcCCCCCCCHHHHHHHH
Q 010736 464 EKLISIMEVGFSCLKESPESRPTMKIVSQQL 494 (502)
Q Consensus 464 ~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l 494 (502)
..+.+++- .-.+.+|.+||+-.-....|
T Consensus 484 p~~rqlV~---~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 484 PVARQLVF---DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hHHHHHHH---HHhcCCccccCCccHHHhHH
Confidence 22223322 45679999999865544443
|
|
| >smart00370 LRR Leucine-rich repeats, outliers | Back alignment and domain information |
|---|
Probab=87.67 E-value=0.47 Score=26.99 Aligned_cols=22 Identities=36% Similarity=0.546 Sum_probs=16.7
Q ss_pred CCCCCEEECCCCcccccCCccC
Q 010736 94 FPHLAYLDLRDNKLFGTIPPQI 115 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~g~~p~~l 115 (502)
+++|++|+|++|+|+...+..|
T Consensus 1 L~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00370 1 LPNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCCEEECCCCcCCcCCHHHc
Confidence 5689999999999995444433
|
|
| >smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily | Back alignment and domain information |
|---|
Probab=87.67 E-value=0.47 Score=26.99 Aligned_cols=22 Identities=36% Similarity=0.546 Sum_probs=16.7
Q ss_pred CCCCCEEECCCCcccccCCccC
Q 010736 94 FPHLAYLDLRDNKLFGTIPPQI 115 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~g~~p~~l 115 (502)
+++|++|+|++|+|+...+..|
T Consensus 1 L~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00369 1 LPNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCCEEECCCCcCCcCCHHHc
Confidence 5689999999999995444433
|
|
| >PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A | Back alignment and domain information |
|---|
Probab=82.58 E-value=0.18 Score=28.19 Aligned_cols=13 Identities=38% Similarity=0.613 Sum_probs=5.4
Q ss_pred CCCEEECCCCccc
Q 010736 96 HLAYLDLRDNKLF 108 (502)
Q Consensus 96 ~L~~L~Ls~N~l~ 108 (502)
+|++|+|++|+|+
T Consensus 3 ~L~~L~l~~n~i~ 15 (24)
T PF13516_consen 3 NLETLDLSNNQIT 15 (24)
T ss_dssp T-SEEE-TSSBEH
T ss_pred CCCEEEccCCcCC
Confidence 4445555555444
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 502 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-28 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-28 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 4e-85
Identities = 96/396 (24%), Positives = 159/396 (40%), Gaps = 50/396 (12%)
Query: 12 FLVAVSSETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGR 71
F + S E L+ +K L +++LL W + + PC + G++C D +
Sbjct: 2 FQASPSQSLYREIHQLISFKDVL--PDKNLLPDWSSNKN-------PCTFDGVTCRD-DK 51
Query: 72 VINISLRGVGLKGKLHAFS-------------------------FSSFPHLAYLDLRDNK 106
V +I L L A S F L LDL N
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNS 111
Query: 107 LFGTIPP--QISNLTNLSILSLGGNQFSGNIPHEVGL-MSHLKILYIDSNQLDGSIPLEV 163
L G + + + + L L++ N GL ++ L++L + +N + G+ +
Sbjct: 112 LSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW 171
Query: 164 ---GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISIL 220
+ LA+ N ++G V + + L + N+FS IP +G+ ++ L
Sbjct: 172 VLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHL 228
Query: 221 SLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLP 279
++ N+ SG ++ T LK ++ N G IPP L L LSL +N FT +P
Sbjct: 229 DISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIP 286
Query: 280 QNIC-RGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK-AFGIYPNLT 337
+ L +S N F G +P +C+ L + L NN +G + L
Sbjct: 287 DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 346
Query: 338 FIDLSRNNFYGEISSNFGEC-PKLGALNISRNNITG 372
+DLS N F GE+ + L L++S NN +G
Sbjct: 347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 3e-80
Identities = 94/291 (32%), Positives = 141/291 (48%), Gaps = 8/291 (2%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
L +LD+ NKL G IS T L +L++ NQF G IP + L+ L
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLS 275
Query: 150 IDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+ N+ G IP + G ++ L L N+ G+VP G+ + + L L N+FSG +P
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335
Query: 209 PD-IGNLKSISILSLAINQFSGPIPLSLGNLT-NLKQFSLVYNNLYGSIPPSLDNLV--- 263
D + ++ + +L L+ N+FSG +P SL NL+ +L L NN G I P+L
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 264 LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLT 323
L +L L +N FT +P + L +S N GTIP SL + + L ++L N L
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 324 GNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDF 374
G I + L + L N+ GEI S C L +++S N +TG+
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 4e-80
Identities = 98/319 (30%), Positives = 146/319 (45%), Gaps = 7/319 (2%)
Query: 82 LKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV-G 140
G++ F + L LDL N +G +PP + + L L+L N FSG +P +
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQLS-SMVELALFSNNLNGSVPHSLGN--LTQISMLF 197
M LK+L + N+ G +P + LS S++ L L SNN +G + +L + L+
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 198 LHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP 257
L +N F+G IPP + N + L L+ N SG IP SLG+L+ L+ L N L G IP
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 258 SLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVR 316
L + L L LD N T +P + L ++S NR G IPK + +L ++
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 317 LDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGI 376
L N+ +GNI G +L ++DL+ N F G I + + A N
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKN 580
Query: 377 AKFLK--PDSSNWTGFAGT 393
K + N F G
Sbjct: 581 DGMKKECHGAGNLLEFQGI 599
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 4e-78
Identities = 87/286 (30%), Positives = 133/286 (46%), Gaps = 5/286 (1%)
Query: 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148
+ L L L++N G IPP +SN + L L L N SG IP +G +S L+ L
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+ N L+G IP E+ + ++ L L N+L G +P L N T ++ + L +N +G IP
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLS 268
IG L++++IL L+ N FSG IP LG+ +L L N G+IP ++
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ---SGK 564
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSEN--RFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326
+ N I G + + N FQG + L ++ + G+
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 327 SKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
S F ++ F+D+S N G I G P L LN+ N+I+G
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISG 670
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-73
Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 7/286 (2%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ S+ L L L N L GTIP + +L+ L L L N G IP E+ + L+ L
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
+D N L G IP + +++ ++L +N L G +P +G L +++L L +NSFSG IP
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTK--- 266
++G+ +S+ L L N F+G IP ++ + + N + G + N + K
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECH 588
Query: 267 LSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326
+ + F + + R ++ + G + N S++ + + N L+G I
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648
Query: 327 SKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
K G P L ++L N+ G I G+ L L++S N + G
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDG 694
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 6e-72
Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 9/297 (3%)
Query: 82 LKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISN--LTNLSILSLGGNQFSGNIPHEV 139
G+L + L LDL N G I P + L L L N F+G IP +
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 140 GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
S L L++ N L G+IP +G LS + +L L+ N L G +P L + + L L
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL 259
N +G IP + N +++ +SL+ N+ +G IP +G L NL L N+ G+IP L
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
Query: 260 DNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
+ L L L+ N F +P + + Q ++ N G ++N
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAMFK----QSGKIAANFIAGKRYVYIKNDGMKKECHGA 590
Query: 319 GN--NLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373
GN G S+ +++ + G S F + L++S N ++G
Sbjct: 591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 1e-67
Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 7/286 (2%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
S S L L L N L G IP ++ + L L L N +G IP + ++L +
Sbjct: 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS 496
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
+ +N+L G IP +G+L ++ L L +N+ +G++P LG+ + L L+ N F+G IP
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYN--NLYGSIPPSLDNLV-LTK 266
+ +A N +G + + N K+ N G L+ L
Sbjct: 557 AMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612
Query: 267 LSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326
++ + + G++ +S N G IPK + + L + L N+++G+I
Sbjct: 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672
Query: 327 SKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
G L +DLS N G I L +++S NN++G
Sbjct: 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-59
Identities = 78/264 (29%), Positives = 116/264 (43%), Gaps = 7/264 (2%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
L L L N L G IP +SN TNL+ +SL N+ +G IP +G + +L IL
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
+ +N G+IP E+G S++ L L +N NG++P ++ + + N +G
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYV 576
Query: 210 DIGNLKSISILSLAIN--QFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTK 266
I N A N +F G L L+ ++ G P+ DN +
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
Query: 267 LSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326
L + N + Y+P+ I L I + N G+IP + + L + L N L G I
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696
Query: 327 SKAFGIYPNLTFIDLSRNNFYGEI 350
+A LT IDLS NN G I
Sbjct: 697 PQAMSALTMLTEIDLSNNNLSGPI 720
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-37
Identities = 53/189 (28%), Positives = 78/189 (41%), Gaps = 22/189 (11%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIP--------------------PQISNLTNLSILSLGGN 129
L +LDL N GTIP I N GN
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN 592
Query: 130 --QFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSL 187
+F G ++ +S I S G SM+ L + N L+G +P +
Sbjct: 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
Query: 188 GNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLV 247
G++ + +L L N SG IP ++G+L+ ++IL L+ N+ G IP ++ LT L + L
Sbjct: 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS 712
Query: 248 YNNLYGSIP 256
NNL G IP
Sbjct: 713 NNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-30
Identities = 34/144 (23%), Positives = 63/144 (43%)
Query: 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148
+ + G Q++ L+ + ++ + G+ + L
Sbjct: 578 IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+ N L G IP E+G + + L L N+++GS+P +G+L +++L L N G IP
Sbjct: 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP 697
Query: 209 PDIGNLKSISILSLAINQFSGPIP 232
+ L ++ + L+ N SGPIP
Sbjct: 698 QAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 41/174 (23%), Positives = 68/174 (39%), Gaps = 30/174 (17%)
Query: 212 GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDD 271
+ SI + S +N + SL +LT L+ L +++ GS+ + LT L L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDL-- 107
Query: 272 NHFTSYLPQNICRGGALQIFTVSENRFQGTIP--KSLRNCTSLIRVRLDGNNLTGNISKA 329
S N G + SL +C+ L + + N L +
Sbjct: 108 ----------------------SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVS 145
Query: 330 FGI-YPNLTFIDLSRNNFYGEISSNF---GECPKLGALNISRNNITGDFGIAKF 379
G+ +L +DLS N+ G + C +L L IS N I+GD +++
Sbjct: 146 GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRC 199
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 4e-78
Identities = 78/353 (22%), Positives = 133/353 (37%), Gaps = 59/353 (16%)
Query: 21 NEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGV 80
++ ALL+ K L N + LSSW ++ W G+ C+ +
Sbjct: 5 PQDKQALLQIKKDL--GNPTTLSSW-----LPTTDCCNRTWLGVLCDTDTQTYR------ 51
Query: 81 GLKGKLHAFSFSSFPHLAYLDLRDNKLFGT--IPPQISNLTNLSILSLGG-NQFSGNIPH 137
+ LDL L IP ++NL L+ L +GG N G IP
Sbjct: 52 ----------------VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 138 EVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLF 197
+ ++ L LYI + G+IP + Q+ ++V L N L+G++P S+ +L + +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 198 LHDNSFSGFIPPDIGNLKS-ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIP 256
N SG IP G+ + ++++ N+ +G IP + NL NL L N L G
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDAS 214
Query: 257 PSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVR 316
+ Q +++N + + +L +
Sbjct: 215 VLFGSDK-----------------------NTQKIHLAKNSLAFDLG-KVGLSKNLNGLD 250
Query: 317 LDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNN 369
L N + G + + L +++S NN GEI G + + N
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 5/171 (2%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLS-ILSLGGNQFSGNIPHEVGLMSHLKIL 148
S SS P+L + N++ G IP + + L +++ N+ +G IP ++ L +
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV 202
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+ N L+G + G + ++ L N+L + +G ++ L L +N G +P
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLP 261
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN-LYGSIPPS 258
+ LK + L+++ N G IP GNL + N L GS P+
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 9e-56
Identities = 60/400 (15%), Positives = 127/400 (31%), Gaps = 42/400 (10%)
Query: 12 FLVAVSSETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWS---GISCND 68
++ ++E ++ AL + +L N S + +N + W G+S N
Sbjct: 20 IKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNS 79
Query: 69 AGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFG----TIPPQISNLTNLSIL 124
GRV +SL G G G++ + L L L + P IS +
Sbjct: 80 NGRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 125 SLGGNQFSGNIPHEVGL--MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGS 182
+ S L I+S+ SI ++ SNN+
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TF 197
Query: 183 VPHSLGNLTQISMLFLHDNSFSGF-------------------IPPDIGNLKSISILSLA 223
V ++ LT++ ++ ++ F NLK ++ + +
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257
Query: 224 INQFSGPIPLSLGNLTNLKQFSLVYNNL--------YGSIPPSLDNLV-LTKLSLDDNHF 274
+P L L ++ ++ N + + + N+
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317
Query: 275 TSY-LPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIY 333
++ + ++ + L + N+ +G +P + + L + L N +T + G
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFT 376
Query: 334 PNLTFIDLSRNNFYG-EISSNFGECPKLGALNISRNNITG 372
+ + + N + + A++ S N I
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS 416
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 4e-52
Identities = 40/310 (12%), Positives = 93/310 (30%), Gaps = 35/310 (11%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ L + ++ + N + + L +
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ-----YKTEDLKWDNLKDLTDVE 255
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNL--------NGSVPHSLGNLTQISMLFLHDN 201
+ + +P + L M + + N + +I ++++ N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 202 SF-SGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD 260
+ + + + +K + +L NQ G +P + G+ L +L YN + IP +
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI-TEIPANFC 373
Query: 261 NL--VLTKLSLDDNHFTSYLPQNICRGG--ALQIFTVSENRFQG-------TIPKSLRNC 309
+ LS N +P + S N + +
Sbjct: 374 GFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG 432
Query: 310 TSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNF-------YGEISSNFGECPKLGA 362
++ + L N ++ + F L+ I+L N + + NF L +
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 363 LNISRNNITG 372
+++ N +T
Sbjct: 493 IDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-47
Identities = 53/308 (17%), Positives = 96/308 (31%), Gaps = 31/308 (10%)
Query: 90 SFSSFPHLAYLDLRDNKLF-GTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148
+ + + N L + + + L +L NQ G +P G L L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASL 358
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQISMLFLHDNSFSGF- 206
+ NQ+ G + L+ N L +++ +S + N
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVD 418
Query: 207 ------IPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNL-------YG 253
+ P ++S ++L+ NQ S + L +L+ N L
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
Query: 254 SIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGG--ALQIFTVSENRFQGTIPKSLRNCT 310
+ N LT + L N T L + L +S N F P N +
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS 536
Query: 311 SLIR------VRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALN 364
+L GN + + P+LT + + N+ +++ P + L+
Sbjct: 537 TLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLD 593
Query: 365 ISRNNITG 372
I N
Sbjct: 594 IKDNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-46
Identities = 50/316 (15%), Positives = 92/316 (29%), Gaps = 36/316 (11%)
Query: 90 SFSSFPHLAYLDLRDNKL--------FGTIPPQISNLTNLSILSLGGNQF-SGNIPHEVG 140
+ P + +++ N+ + I+ +G N + + +
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
M L +L NQL+G +P G + L L N + + G Q+ L
Sbjct: 328 KMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAH 386
Query: 201 NSFSGFIPP-DIGNLKSISILSLAINQFSG-------PIPLSLGNLTNLKQFSLVYNNLY 252
N D ++ +S + + N+ P+ + N+ +L N +
Sbjct: 387 NKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446
Query: 253 GSIPPSLDNLV-LTKLSLDDNHFTS-------YLPQNICRGGALQIFTVSENRFQGTIPK 304
L+ ++L N T +N L + N+ +
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSD 505
Query: 305 SLR--NCTSLIRVRLDGNNLTGNISKAFGIYPNLTFI------DLSRNNFYGEISSNFGE 356
R L+ + L N+ + L D N E
Sbjct: 506 DFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL 564
Query: 357 CPKLGALNISRNNITG 372
CP L L I N+I
Sbjct: 565 CPSLTQLQIGSNDIRK 580
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-36
Identities = 43/246 (17%), Positives = 79/246 (32%), Gaps = 31/246 (12%)
Query: 89 FSFSSFPHLAYLDLRDNKL-------FGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGL 141
F S ++ +D N++ F + P N+S ++L NQ S
Sbjct: 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST 455
Query: 142 MSHLKILYIDSNQLDG-------SIPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQI 193
S L + + N L + + L N L S L +
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYL 515
Query: 194 SMLFLHDNSFSGFIPPDIGNLKSISILSL------AINQFSGPIPLSLGNLTNLKQFSLV 247
+ L NSFS P N ++ + N+ P + +L Q +
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 248 YNNLYGSIPPS-LDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSL 306
N++ + N ++ L + DN S +C ++ + ++ Q +
Sbjct: 575 SNDI-RKVNEKITPN--ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-----DI 626
Query: 307 RNCTSL 312
R C +L
Sbjct: 627 RGCDAL 632
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 26/181 (14%), Positives = 53/181 (29%), Gaps = 18/181 (9%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKL-------FGTIPPQISNLTNLSILSLGGNQFSGNIP- 136
K FS+ L+ ++L N L N L+ + L N+ +
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDD 506
Query: 137 HEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELAL------FSNNLNGSVPHSLGNL 190
+ +L + + N P + S++ + N P +
Sbjct: 507 FRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLC 565
Query: 191 TQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250
++ L + N + I +IS+L + N + + L Y+
Sbjct: 566 PSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
Query: 251 L 251
Sbjct: 623 T 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-52
Identities = 63/309 (20%), Positives = 114/309 (36%), Gaps = 8/309 (2%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
KL ++ L+L N+L + + L+ L +G N S P +
Sbjct: 15 KLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM 74
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
LK+L + N+L +++ EL L SN++ + + L L N S
Sbjct: 75 LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134
Query: 205 GFIPPDIGNLKSISILSLAINQFSG--PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNL 262
L+++ L L+ N+ L + ++LK+ L N + P +
Sbjct: 135 STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI 194
Query: 263 V-LTKLSLDDNHFTSYLPQNICRGGA---LQIFTVSENRFQGTIPKSLRNC--TSLIRVR 316
L L L++ L + +C A ++ ++S ++ T + T+L +
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 317 LDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGI 376
L NNL + +F P L + L NN S + + LN+ R+ +
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 377 AKFLKPDSS 385
A K D
Sbjct: 315 ASLPKIDDF 323
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-48
Identities = 57/315 (18%), Positives = 110/315 (34%), Gaps = 20/315 (6%)
Query: 88 AFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGL---MSH 144
+ L L+L N++ P + L L L Q ++ ++ L +
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223
Query: 145 LKILYIDSNQLDGSIPLEVGQL--SSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNS 202
++ L + ++QL + L +++ L L NNLN S L Q+ FL N+
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNN 283
Query: 203 FSGFIPPDIGNLKSISILSLA---------INQFSGPIPLSLGNLTNLKQFSLVYNNLYG 253
+ L ++ L+L + S L L+ ++ N++ G
Sbjct: 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
Query: 254 SIPPSLDNLV-LTKLSLDDNHFT-SYLPQNICRG---GALQIFTVSENRFQGTIPKSLRN 308
L+ L LSL ++ + L L I +++N+ +
Sbjct: 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403
Query: 309 CTSLIRVRLDGNNLTGNIS-KAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISR 367
L + L N + ++ + + N+ I LS N + ++F P L L + R
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463
Query: 368 NNITGDFGIAKFLKP 382
+ +P
Sbjct: 464 VALKNVDSSPSPFQP 478
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-46
Identities = 66/337 (19%), Positives = 111/337 (32%), Gaps = 26/337 (7%)
Query: 62 SGISCNDAGRVINISLRGVGLKG----KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQIS- 116
+ + N SL+ + L + F + L L L + +L ++ ++
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
Query: 117 --NLTNLSILSLGGNQFSGNIPHEVGLM--SHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172
T++ LSL +Q S + ++L +L + N L+ L +
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDN---------SFSGFIPPDIGNLKSISILSLA 223
L NN+ HSL L + L L + S LK + L++
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME 337
Query: 224 INQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-----SLDNLVLTKLSLDDNHFTSYL 278
N G L NLK SL + SL + L L+L N +
Sbjct: 338 DNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE 397
Query: 279 PQNICRGGALQIFTVSENRFQGTIPKS-LRNCTSLIRVRLDGNNLTGNISKAFGIYPNLT 337
G L++ + N + R ++ + L N +F + P+L
Sbjct: 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 338 FIDLSRNNFYG--EISSNFGECPKLGALNISRNNITG 372
+ L R S F L L++S NNI
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-44
Identities = 66/307 (21%), Positives = 102/307 (33%), Gaps = 19/307 (6%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGL--- 141
K+ FSF L +L++ DN + G + L NL LSL + S
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 142 -MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLH 199
S L IL + N++ L + L L N + + L I ++L
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFSG--PIPLSLGNLTNLKQFSLVYNNLYGSIPP 257
N + + S+ L L P L NL L NN+
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 258 SLDNLV-LTKLSLDDNHFTSYLPQNICRGG---------ALQIFTVSENRFQGTIPKSLR 307
L+ L L L L N+ L ++ GG L I + N F + +
Sbjct: 499 MLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK 557
Query: 308 NCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPK-LGALNIS 366
+ L + L NNL + F +L ++L +N FG + L L++
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMR 617
Query: 367 RNNITGD 373
N
Sbjct: 618 FNPFDCT 624
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-38
Identities = 62/284 (21%), Positives = 105/284 (36%), Gaps = 17/284 (5%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQIS----NLTNLSILSLGGNQFSGNIPHEVGL 141
+ + F+ +L YL L ++ + + L IL+L N+ S
Sbjct: 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403
Query: 142 MSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
+ HL++L + N++ + + L ++ E+ L N +S + + L L
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463
Query: 201 NSFSGF--IPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNL------- 251
+ P L++++IL L+ N + L L L+ L +NNL
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHA 523
Query: 252 -YGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNC 309
G L L L L+L+ N F + L+I + N N
Sbjct: 524 NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQ 583
Query: 310 TSLIRVRLDGNNLTGNISKAFG-IYPNLTFIDLSRNNFYGEISS 352
SL + L N +T K FG + NLT +D+ N F S
Sbjct: 584 VSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 39/206 (18%), Positives = 70/206 (33%), Gaps = 12/206 (5%)
Query: 82 LKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSG--NIPHEV 139
+ +L + ++ + L NK + + +L L L + P
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
Query: 140 GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN--------GSVPHSLGNLT 191
+ +L IL + +N + + L + L L NNL G + L L+
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536
Query: 192 QISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNL 251
+ +L L N F +L + I+ L +N + N +LK +L N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 252 YGSIPPSLDNLV--LTKLSLDDNHFT 275
LT+L + N F
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFD 622
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-49
Identities = 53/363 (14%), Positives = 107/363 (29%), Gaps = 30/363 (8%)
Query: 28 LKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVGLKGKLH 87
L + + + ++ ++ +
Sbjct: 359 ETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418
Query: 88 AFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKI 147
S S + N++ I I LT L I+ + F+ + ++
Sbjct: 419 KDSRISLKDT-QIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-- 474
Query: 148 LYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF- 206
D + + L L + ++ L++ +P L +L ++ L + N
Sbjct: 475 ---DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531
Query: 207 --------IPPDIGNLKSISILSLAINQFSG-PIPLSLGNLTNLKQFSLVYNNLYGSIPP 257
+ D I I + N P SL + L V+N +
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLE 589
Query: 258 SLDNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPK--SLRNCTSLI 313
+ V LT L LD N +P++ C ++ S N+ + IP + ++ +
Sbjct: 590 AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMG 647
Query: 314 RVRLDGNNLTGNISKAFGIYP-----NLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368
V N + N + + LS N + F + + +S N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 369 NIT 371
+T
Sbjct: 708 LMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-43
Identities = 51/311 (16%), Positives = 102/311 (32%), Gaps = 32/311 (10%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSG---------NIPHEVG 140
S+S+ L ++L + +P + +L L L++ N+ + +
Sbjct: 486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545
Query: 141 LMSHLKILYIDSNQLDGSIPLEV--GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFL 198
++I Y+ N L+ P ++ + L N + + G +++ L L
Sbjct: 546 TGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKL 602
Query: 199 HDNSFSGFIPPDIG-NLKSISILSLAINQFSG-PIPLSLGNLTNLKQFSLVYNNLYG--- 253
N IP D + L + N+ P + ++ + YN +
Sbjct: 603 DYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGR 661
Query: 254 SIPPSLDNLV---LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQ-------GTIP 303
+I S+D+ + ++L N + + G + +S N
Sbjct: 662 NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKD 721
Query: 304 KSLRNCTSLIRVRLDGNNLTGNI-SKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGA 362
+ +N L + L N LT P L+ +D+S N F + +L A
Sbjct: 722 GNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKA 780
Query: 363 LNISRNNITGD 373
I
Sbjct: 781 FGIRHQRDAEG 791
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-40
Identities = 65/379 (17%), Positives = 111/379 (29%), Gaps = 56/379 (14%)
Query: 17 SSETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSS---KISPCAWS---GISCNDAG 70
++E ++ AL +L N S I +T + + W G+ ++ G
Sbjct: 264 TAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG 323
Query: 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQ 130
RV L L G +P I LT L +LS G +
Sbjct: 324 RVT-------------------------GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHS 358
Query: 131 FSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNL 190
+ + + +++ + L+ + P + +
Sbjct: 359 ETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP-EMKPI 417
Query: 191 TQISMLFLHDNSFSG------FIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQF 244
+ S + L D FI I L + I+ A + F+ N
Sbjct: 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-- 475
Query: 245 SLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQG--- 300
Y Y + S NL LT + L + + LP + LQ ++ NR
Sbjct: 476 ---YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 301 ------TIPKSLRNCTSLIRVRLDGNNLTG-NISKAFGIYPNLTFIDLSRNNFYGEISSN 353
+ + + NNL S + L +D N + +
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV-RHLEA- 590
Query: 354 FGECPKLGALNISRNNITG 372
FG KL L + N I
Sbjct: 591 FGTNVKLTDLKLDYNQIEE 609
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-39
Identities = 58/306 (18%), Positives = 98/306 (32%), Gaps = 33/306 (10%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG-LMSHLKIL 148
S L LD NK+ L+ L L NQ IP + ++ L
Sbjct: 568 SLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624
Query: 149 YIDSNQLDGSIP--LEVGQLSSMVELALFSNNL-----NGSVPHSLGNLTQISMLFLHDN 201
N+L IP + M + N + N S S + L N
Sbjct: 625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683
Query: 202 SFSGFIPPDIGNLKSISILSLAINQFS-------GPIPLSLGNLTNLKQFSLVYNNLYGS 254
F IS + L+ N + P + N L L +N L S
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TS 742
Query: 255 IPPSL--DNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSE------NRFQGTIPKS 305
+ L L+ + + N F+S P L+ F + NR P
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801
Query: 306 LRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNI 365
+ C SLI++++ N++ + + + P L +D++ N ++ + G +
Sbjct: 802 ITTCPSLIQLQIGSNDIR-KVDE--KLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVL 858
Query: 366 SRNNIT 371
+
Sbjct: 859 LYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-38
Identities = 48/319 (15%), Positives = 90/319 (28%), Gaps = 44/319 (13%)
Query: 90 SFSSFPHLAYLDLRDNKL---------FGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG 140
P L L++ N+ + + + I +G N P
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASAS 568
Query: 141 L--MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLG-NLTQISMLF 197
L M L +L N++ G + +L L N + +P Q+ L
Sbjct: 569 LQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG 625
Query: 198 LHDNSFSGFIPPD--IGNLKSISILSLAINQFSG-----PIPLSLGNLTNLKQFSLVYNN 250
N IP ++ + + + N+ + N +L YN
Sbjct: 626 FSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684
Query: 251 LYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGG--------ALQIFTVSENRFQGT 301
+ ++ + L +N TS +P+N + L + N+ +
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTS-IPENSLKPKDGNYKNTYLLTTIDLRFNKLT-S 742
Query: 302 IPKSLR--NCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSR------NNFYGEISSN 353
+ R L + + N + L + N + +
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801
Query: 354 FGECPKLGALNISRNNITG 372
CP L L I N+I
Sbjct: 802 ITTCPSLIQLQIGSNDIRK 820
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-28
Identities = 41/245 (16%), Positives = 78/245 (31%), Gaps = 29/245 (11%)
Query: 88 AFSFSSFPHLAYLDLRDNKLFGTIPPQIS------NLTNLSILSLGGNQFSGNIPHEVGL 141
F+ S + +D NK+ G+ IS N S ++L N+
Sbjct: 637 IFNAKSVYVMGSVDFSYNKI-GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695
Query: 142 MSHLKILYIDSNQLD-------GSIPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQI 193
S + + + +N + + + L N L S L +
Sbjct: 696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYL 755
Query: 194 SMLFLHDNSFSGFIPPDIGNLKSISILSL------AINQFSGPIPLSLGNLTNLKQFSLV 247
S + + N FS P N + + N+ P + +L Q +
Sbjct: 756 SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 248 YNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLR 307
N++ + L L L + DN S ++C ++ + ++ Q +R
Sbjct: 815 SNDI-RKVDEKLTPQ-LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ-----DIR 867
Query: 308 NCTSL 312
C +L
Sbjct: 868 GCDAL 872
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 4e-20
Identities = 30/264 (11%), Positives = 72/264 (27%), Gaps = 14/264 (5%)
Query: 118 LTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177
LT + + + + + I L + + L + + + +
Sbjct: 251 LTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKEL-D 309
Query: 178 NLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGN 237
L N +++ L L G +P IG L + +LS + + L
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 238 LTNLK-------QFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQI 290
+ + Y ++ L+ L + +++ N + ++
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ 429
Query: 291 FTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEI 350
NR I K+++ T L + + T + + Y
Sbjct: 430 IGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENE 483
Query: 351 SSNFGECPKLGALNISRNNITGDF 374
++ L + +
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQL 507
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 12/97 (12%), Positives = 23/97 (23%)
Query: 291 FTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEI 350
F + + L N + + L G G + A G L + ++
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 351 SSNFGECPKLGALNISRNNITGDFGIAKFLKPDSSNW 387
E ++ I + N
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-44
Identities = 53/294 (18%), Positives = 92/294 (31%), Gaps = 17/294 (5%)
Query: 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN 153
LDL N L + L +L L + +SHL L + N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 154 QLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF-IPPDIG 212
+ LSS+ +L NL +G+L + L + N F +P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 213 NLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLV----YNNLYGSIPPSLDNLVLTKLS 268
NL ++ L L+ N+ L L + +L N + P + + L KL+
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206
Query: 269 LDDNHFTSYLPQNICRG-GALQIFTVSENRFQGT------IPKSLRNCTSLIRVRLDGNN 321
L +N + + + +G L++ + F+ +L +L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 322 L---TGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
L +I F N++ L E +F L +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQ 318
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-42
Identities = 52/316 (16%), Positives = 99/316 (31%), Gaps = 14/316 (4%)
Query: 72 VINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQF 131
+ L + F+ +++ L + S L L +F
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKF 316
Query: 132 SGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN--GSVPHSLGN 189
++ + L G L S+ L L N L+ G S
Sbjct: 317 GQFPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 190 LTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLS-LGNLTNLKQFSLVY 248
T + L L N + + L+ + L + S +L NL + +
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 249 NNLYGSIPPSLDNLV-LTKLSLDDNHFT-SYLPQNICRGGALQIFTVSENRFQGTIPKSL 306
+ + + L L L + N F ++LP L +S+ + + P +
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 307 RNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPK-LGALNI 365
+ +SL + + NN + + +L +D S N+ P L LN+
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550
Query: 366 SRNNITGDFGIAKFLK 381
++N+ FL+
Sbjct: 551 TQNDFACTCEHQSFLQ 566
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-34
Identities = 45/232 (19%), Positives = 73/232 (31%), Gaps = 13/232 (5%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV-GLMSH 144
+ S L YLDL N + T+ L L L + V + +
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSV-PHSLGNLTQISMLFLHDNSF 203
L L I + LSS+ L + N+ + P L ++ L L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 204 SGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV 263
P +L S+ +L+++ N F L +L+ N++ S L +
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542
Query: 264 --LTKLSLDDNHFT-----SYLPQNICRGGALQIFTVSENRFQGTIPKSLRN 308
L L+L N F Q I + V R + P +
Sbjct: 543 SSLAFLNLTQNDFACTCEHQSFLQWIKD---QRQLLVEVERMECATPSDKQG 591
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-29
Identities = 38/200 (19%), Positives = 74/200 (37%), Gaps = 4/200 (2%)
Query: 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGN 134
+ + LK F S +L YLD+ + L++L +L + GN F N
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 135 IPHEV-GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQI 193
++ + +L L + QL+ P LSS+ L + NN L +
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520
Query: 194 SMLFLHDNSFSGFIPPDIGNL-KSISILSLAINQFSGPIPLS--LGNLTNLKQFSLVYNN 250
+L N ++ + S++ L+L N F+ L + + +Q +
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVER 580
Query: 251 LYGSIPPSLDNLVLTKLSLD 270
+ + P + + L++
Sbjct: 581 MECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-27
Identities = 38/212 (17%), Positives = 67/212 (31%), Gaps = 29/212 (13%)
Query: 167 SSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQ 226
S L L N L +S + ++ +L L +L +S L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 227 FSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRG 285
+ L++L++ V NL + +L L +L++ N S
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS--------- 138
Query: 286 GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTF----IDL 341
+P+ N T+L + L N + + + +DL
Sbjct: 139 --------------FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 342 SRNNFYGEISSNFGECPKLGALNISRNNITGD 373
S N F E +L L + N + +
Sbjct: 185 SLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLN 215
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-42
Identities = 66/304 (21%), Positives = 109/304 (35%), Gaps = 10/304 (3%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHL 145
+ + +F F L LDL L +P + L+ L L L N+F L
Sbjct: 269 ISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327
Query: 146 KILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGS--VPHSLGNLTQISMLFLHDNS 202
L I N + L ++ EL L +++ S L NL+ + L L N
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 203 FSGFIPPDIGNLKSISILSLAINQFSGPIPLS-LGNLTNLKQFSLVYNNLYGSIPPSLDN 261
+ +L LA + S NL LK +L ++ L S D
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
Query: 262 LV-LTKLSLDDNHFTSYLPQ---NICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRL 317
L L L+L NHF Q ++ G L+I +S + + + V L
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDL 507
Query: 318 DGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIA 377
N LT + +A + ++L+ N+ + S + +N+ +N +
Sbjct: 508 SHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566
Query: 378 KFLK 381
FL+
Sbjct: 567 YFLE 570
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-41
Identities = 46/295 (15%), Positives = 96/295 (32%), Gaps = 7/295 (2%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
+ +FS +L +LDL +++ + L L L N +
Sbjct: 47 TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
LK L+ + + + ++ L L SN+++ ++ +L +N+
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166
Query: 205 GFIPPDIGNLKSISILSLAINQ-FSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV 263
D+ +L+ + LSL +N I + + + I L N
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 264 LTKL---SLDDNHFTSYLPQNICRGGALQIFTV--SENRFQGTIPKSLRNCTSLIRVRLD 318
+ L + +D P + + ++ ++ F + + L + L
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 319 GNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373
+L+ + L + LS N F + P L L+I N +
Sbjct: 287 ATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 52/297 (17%), Positives = 104/297 (35%), Gaps = 11/297 (3%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSI--LSLGGNQFSGNIPHEVGLMS 143
S+ L D P L +S+ ++L + F + S
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278
Query: 144 HLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSF 203
L+ L + + L +P + LS++ +L L +N S N ++ L + N+
Sbjct: 279 GLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337
Query: 204 SGFIPPD-IGNLKSISILSLAINQ--FSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD 260
+ + NL+++ L L+ + S L L NL++L+ +L YN +
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 261 NLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
L L L Q+ + L++ +S + + + +L + L
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 319 GNNLTGNI---SKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
GN+ + + L + LS + F + +++S N +T
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 56/298 (18%), Positives = 99/298 (33%), Gaps = 13/298 (4%)
Query: 86 LHAFSFSSFPHLA--YLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGL-- 141
L SS L+L N + I P + L+ GG Q I +
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 142 MSHLKILYIDSNQLDGSIPLEVGQLS--SMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
+ L + + + P L S+ + L + ++ + + L L
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-S 258
S +P + L ++ L L+ N+F +S N +L S+ N +
Sbjct: 287 ATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 259 LDNLV-LTKLSLDDNHFTS--YLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRV 315
L+NL L +L L + + + LQ +S N ++ + C L +
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 316 RLDGNNLTGNISK-AFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
L L ++ F L ++LS + F P L LN+ N+
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 53/303 (17%), Positives = 96/303 (31%), Gaps = 34/303 (11%)
Query: 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKL--FGTIPPQISNLTNLSILSLGGNQFS 132
+S++G + +L + +L LDL + + Q+ NL++L L+L N+
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 133 GNIPHEVGLMSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLT 191
L++L + +L L + L L + L+ S L
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
Query: 192 QISMLFLHDNSFSGFI---PPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVY 248
+ L L N F + L + IL L+ S + +L + L +
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 249 NNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRN 308
N L S +L +L L+L NH + +P L
Sbjct: 510 NRLTSSSIEALSHLKGIYLNLASNHISI------------------------ILPSLLPI 545
Query: 309 CTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368
+ + L N L S L + + + P L + +S
Sbjct: 546 LSQQRTINLRQNPLDCTCS----NIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDV 601
Query: 369 NIT 371
++
Sbjct: 602 TLS 604
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-40
Identities = 47/258 (18%), Positives = 95/258 (36%), Gaps = 15/258 (5%)
Query: 76 SLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNI 135
+ G LK ++ P L+LR L P Q L++L +++ +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 136 PHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGN------ 189
P + + L+ L + N L ++P + L+ + EL++ + +P L +
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 190 ---LTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSL 246
L + L L +P I NL+++ L + + S + ++ +L L++ L
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236
Query: 247 VYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKS 305
+ PP L +L L D LP +I R L+ + +P
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296
Query: 306 LRNCTSLIRVRLDGNNLT 323
+ + + + +
Sbjct: 297 IAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 41/285 (14%), Positives = 85/285 (29%), Gaps = 22/285 (7%)
Query: 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLD 156
L + + +S + + ++ +I L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRTGRAL- 68
Query: 157 GSIPLEVGQLSSM--VELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNL 214
+ + + V L L S L P L+ + + + +P +
Sbjct: 69 KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQF 126
Query: 215 KSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV----------L 264
+ L+LA N +P S+ +L L++ S+ +P L + L
Sbjct: 127 AGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 265 TKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324
L L+ S LP +I L+ + + + ++ + L + L G
Sbjct: 186 QSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 325 NISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNN 369
N FG L + L + + + +L L++
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 47/227 (20%), Positives = 82/227 (36%), Gaps = 15/227 (6%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
HL ++ + L +P + L L+L N +P + ++ L+ L
Sbjct: 99 QAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156
Query: 150 IDSNQLDGSIPLEVGQ---------LSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
I + +P + L ++ L L + S+P S+ NL + L + +
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD 260
+ S + P I +L + L L P G LK+ L + ++P +
Sbjct: 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH 274
Query: 261 NLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSL 306
L L KL L S LP I + A I V + Q + +
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 25/203 (12%), Positives = 49/203 (24%), Gaps = 20/203 (9%)
Query: 181 GSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTN 240
GS H + + L+ ++ + + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 241 LKQFSLVYNNLYGSIPPSLDNLV---LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENR 297
+ + L + L++ L L P R LQ T+
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAG 115
Query: 298 FQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGEC 357
+P +++ L + L N L + + L + + E+
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 358 PKLGA---------LNISRNNIT 371
G L + I
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR 196
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-38
Identities = 60/282 (21%), Positives = 111/282 (39%), Gaps = 20/282 (7%)
Query: 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150
S+ L L + NK+ T + NLTNL L L + S P + ++ + L +
Sbjct: 84 LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNL 139
Query: 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPD 210
+N + + ++ + L + + + P + NLT + L L+ N P
Sbjct: 140 GANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP-- 194
Query: 211 IGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSL 269
+ +L S+ + +NQ + P+ N+T L + N + + L NL LT L +
Sbjct: 195 LASLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKI--TDLSPLANLSQLTWLEI 250
Query: 270 DDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKA 329
N + + L++ V N+ + L N + L + L+ N L +
Sbjct: 251 GTNQISD--INAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEV 306
Query: 330 FGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
G NLT + LS+N+ K+ + + + I
Sbjct: 307 IGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 67/284 (23%), Positives = 118/284 (41%), Gaps = 20/284 (7%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+L YL+L N++ P +SNL L+ L +G N+ + + +++L+ LY
Sbjct: 61 GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELY 116
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
++ + + PL L+ M L L N N S L N+T ++ L + ++ P
Sbjct: 117 LNEDNISDISPL--ANLTKMYSLNL-GANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP- 172
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLS 268
I NL + LSL NQ PL +LT+L F+ N + P + N+ L L
Sbjct: 173 -IANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328
+ +N T + L + N+ + ++++ T L + + N ++
Sbjct: 228 IGNNKITD--LSPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--IS 281
Query: 329 AFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
L + L+ N E G L L +S+N+IT
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 22/284 (7%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ + L + K+ I LTNL L+L GNQ + P + + L LY
Sbjct: 39 TQEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLY 94
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
I +N++ + + L+++ EL L +N++ P L NLT++ L L N + P
Sbjct: 95 IGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLS 268
+ N+ ++ L++ ++ P + NLT+L SL YN + P L +L L +
Sbjct: 151 -LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFT 205
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328
N T + L + N+ P L N + L + + N ++ +I+
Sbjct: 206 AYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN- 259
Query: 329 AFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
A L +++ N S +L +L ++ N +
Sbjct: 260 AVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGN 301
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 59/285 (20%), Positives = 117/285 (41%), Gaps = 22/285 (7%)
Query: 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148
F + L+ + + L +++ L + G + + +I + +++L+ L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYL 71
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
++ NQ+ PL L + L + +N + + +L NLT + L+L++++ S P
Sbjct: 72 NLNGNQITDISPL--SNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP 127
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKL 267
+ NL + L+L N + L N+T L ++ + + P + NL L L
Sbjct: 128 --LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 268 SLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNIS 327
SL+ N + +L FT N+ P + N T L +++ N +T
Sbjct: 183 SLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--L 236
Query: 328 KAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
LT++++ N + + KL LN+ N I+
Sbjct: 237 SPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 34/161 (21%), Positives = 61/161 (37%), Gaps = 16/161 (9%)
Query: 214 LKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDN 272
+++ L INQ +L + L ++ + + + L +TKL +
Sbjct: 2 AATLATLPAPINQIF-----PDADLAEGIRAVLQKASV--TDVVTQEELESITKLVVAGE 54
Query: 273 HFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGI 332
S Q I L+ ++ N+ P L N L + + N +T +IS A
Sbjct: 55 KVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS-ALQN 108
Query: 333 YPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373
NL + L+ +N S K+ +LN+ N+ D
Sbjct: 109 LTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSD 147
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 3e-10
Identities = 19/90 (21%), Positives = 38/90 (42%), Gaps = 4/90 (4%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ L L++ N++ + ++NL+ L+ L L NQ +G +++L L+
Sbjct: 260 AVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNL 179
+ N + PL LS M + +
Sbjct: 318 LSQNHITDIRPL--ASLSKMDSADFANQVI 345
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-36
Identities = 53/301 (17%), Positives = 93/301 (30%), Gaps = 13/301 (4%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHL 145
F +++ + L + + LS+ Q + + L
Sbjct: 276 DDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLD---LPFL 330
Query: 146 KILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNL--TQISMLFLHDNSF 203
K L + N+ SI + L S+ L L N L+ S S +L + L L N
Sbjct: 331 KSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388
Query: 204 SGFIPPDIGNLKSISILSLAINQFSGPIPLS-LGNLTNLKQFSLVYNNLYGSIPPSLDNL 262
+ + L+ + L + S +L L + Y N L
Sbjct: 389 II-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447
Query: 263 V-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGN 320
L L + N F N+ L +S+ + + L + + N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 321 NLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFL 380
NL S + +L+ +D S N L N++ N++ KFL
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFL 567
Query: 381 K 381
+
Sbjct: 568 Q 568
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 51/294 (17%), Positives = 96/294 (32%), Gaps = 18/294 (6%)
Query: 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN 153
+DL N L SN + L L L + + HL L + N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 154 QLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPD-IG 212
+ P L+S+ L L +G L + L + N P
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 213 NLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLV----YNNLYGSIPPSLDNLVLTKLS 268
NL ++ + L+ N L L Q +L N + + + L +L+
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELT 210
Query: 269 LDDNHFTSYLPQNICRG-GALQIFTVSENRFQG---------TIPKSLRNCTSLIRVRLD 318
L N +S + + + L + + F+ +I + L + ++ RL
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV-TIDEFRLT 269
Query: 319 GNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
N + F N++ + L+ + + + + K +L+I R +
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-31
Identities = 43/265 (16%), Positives = 77/265 (29%), Gaps = 28/265 (10%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
+L F P L L L NK +I + L +LS L L N S + +
Sbjct: 318 QLKQFPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
+ ++D S N + + L ++ L ++
Sbjct: 376 NSLRHLD-----------------------LSFNGAIIMSANFMGLEELQHLDFQHSTLK 412
Query: 205 GFIPPD-IGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS-LDNL 262
+L+ + L ++ LT+L + N+ + + N
Sbjct: 413 RVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT 472
Query: 263 V-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNN 321
LT L L LQ+ +S N SL + N
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 322 LTGNISKAFGIYPNLTFIDLSRNNF 346
+ + +L F +L+ N+
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-22
Identities = 47/270 (17%), Positives = 79/270 (29%), Gaps = 57/270 (21%)
Query: 109 GTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSS 168
G++ P I + N++ + S +P + S K + + N L +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPD--DIPSSTKNIDLSFNPLK-ILK-------- 48
Query: 169 MVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFS 228
+S N +++ L L L +S L L N
Sbjct: 49 ---------------SYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 229 GPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGA 287
P S LT+L+ V L + L+ L KL++ N S
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS----------- 142
Query: 288 LQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTF----IDLSR 343
+P N T+L+ V L N + +D+S
Sbjct: 143 ------------CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 344 NNFYGEISSNFGECPKLGALNISRNNITGD 373
N I + KL L + N + +
Sbjct: 191 NPI-DFIQDQAFQGIKLHELTLRGNFNSSN 219
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 19/105 (18%), Positives = 38/105 (36%)
Query: 76 SLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNI 135
+ G K + F++ +L +LDL +L L L +L++ N
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLD 513
Query: 136 PHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN 180
+ L L N+++ S + S+ L +N++
Sbjct: 514 SSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-34
Identities = 62/286 (21%), Positives = 97/286 (33%), Gaps = 38/286 (13%)
Query: 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGL---------- 141
+ P L L++ N+L ++P L LSI S L
Sbjct: 78 ALPPELRTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSL 136
Query: 142 ---MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFL 198
L+ L + NQL S+P +L L ++N L S+P L + L +
Sbjct: 137 PVLPPGLQELSVSDNQLA-SLPALPSELCK---LWAYNNQLT-SLPMLPSGLQE---LSV 188
Query: 199 HDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS 258
DN + +P L + + + +P L L V N S+P
Sbjct: 189 SDNQLA-SLPTLPSELYKLWAYNNRLTS----LPALPSGLKELI----VSGNRLTSLPVL 239
Query: 259 LDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
L +L + N TS LP L +V N+ +P+SL + +S V L+
Sbjct: 240 PSE--LKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 319 GNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALN 364
GN L+ +A + F +S E L
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA 338
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 61/287 (21%), Positives = 100/287 (34%), Gaps = 40/287 (13%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
L H+ L + DN L ++P L L + GNQ + ++P +
Sbjct: 51 GLTTLPDCLPAHITTLVIPDNNL-TSLPALPPELRT---LEVSGNQLT-SLPVLPPGLLE 105
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L I L S + +L +F N L S+P L + L + DN +
Sbjct: 106 LSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPGLQE---LSVSDNQLA 154
Query: 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVL 264
+P L + + + +P+ L L S+ N L S+P L
Sbjct: 155 S-LPALPSELCKLWAYNNQLTS----LPMLPSGLQEL---SVSDNQL-ASLPTLPSE--L 203
Query: 265 TKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324
KL +N TS LP L+ VS NR ++P L + GN LT
Sbjct: 204 YKLWAYNNRLTS-LPALP---SGLKELIVSGNRLT-SLPVLPSELKEL---MVSGNRLT- 254
Query: 325 NISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
++ L + + RN + + +N+ N ++
Sbjct: 255 SLPMLPS---GLLSLSVYRNQL-TRLPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 26/228 (11%)
Query: 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID 151
P L L + DN+L ++P S L L NQ + ++P S L+ L +
Sbjct: 138 VLPPGLQELSVSDNQL-ASLPALPSELCKLWAY---NNQLT-SLPML---PSGLQELSVS 189
Query: 152 SNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI 211
NQL S+P +L L ++N L S+P L + L + N + +P
Sbjct: 190 DNQL-ASLPTLPSELYK---LWAYNNRLT-SLPALPSGLKE---LIVSGNRLTS-LPVLP 240
Query: 212 GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLD 270
LK L ++ N+ + +P+ L +L S+ N L +P SL +L T ++L+
Sbjct: 241 SELKE---LMVSGNRLTS-LPMLPSGLLSL---SVYRNQL-TRLPESLIHLSSETTVNLE 292
Query: 271 DNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
N + Q + + ++ RF + R +L D
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAAD 340
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 37/174 (21%), Positives = 65/174 (37%), Gaps = 27/174 (15%)
Query: 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSI-----------------LSLGGNQFSGN 134
L L + DN+L ++P S L L L + GN+ + +
Sbjct: 178 MLPSGLQELSVSDNQL-ASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-S 235
Query: 135 IPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQIS 194
+P S LK L + N+L S+P+ L + L+++ N L +P SL +L+ +
Sbjct: 236 LPVL---PSELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSET 287
Query: 195 MLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVY 248
+ L N S + + S S I +F + L + +
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 24/284 (8%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
S + + L + + L NL+ ++ NQ + P + ++ L +
Sbjct: 41 SQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 96
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
+++NQ+ PL L+++ L LF+N + P L NLT ++ L L N+ S
Sbjct: 97 MNNNQIADITPL--ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--IS 150
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLS 268
+ L S+ LS NQ + P L NLT L++ + N + S L L L L
Sbjct: 151 ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLI 205
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328
+N + P I L +++ N+ +L + T+L + L N ++
Sbjct: 206 ATNNQISDITPLGILT--NLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLA-- 259
Query: 329 AFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
LT + L N S L L ++ N +
Sbjct: 260 PLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED 301
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-32
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 24/284 (8%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
++ +L L L +N++ T + NLTNL+ L L N S + ++ L+ L
Sbjct: 107 PLANLTNLTGLTLFNNQI--TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS 162
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
NQ+ PL L+++ L + SN + S L LT + L +N S P
Sbjct: 163 F-GNQVTDLKPL--ANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP- 216
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLS 268
+G L ++ LSL NQ L+ +LTNL L N + P L L LT+L
Sbjct: 217 -LGILTNLDELSLNGNQLKDIGTLA--SLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328
L N ++ P AL ++EN+ + P + N +L + L NN++
Sbjct: 272 LGANQISNISPLAGLT--ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD--IS 325
Query: 329 AFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
L + N S+ + L+ N I+
Sbjct: 326 PVSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISD 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-32
Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 24/290 (8%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+L ++ +N+L P + NLT L + + NQ + P + +++L L
Sbjct: 63 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
+ +NQ+ PL L+++ L L SN ++ +L LT + L N + P
Sbjct: 119 LFNNQITDIDPL--KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP- 172
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLS 268
+ NL ++ L ++ N+ S L LTNL+ N + P L L L +LS
Sbjct: 173 -LANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITP--LGILTNLDELS 227
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328
L+ N + L ++ N+ P L T L ++L N ++
Sbjct: 228 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--IS 281
Query: 329 AFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAK 378
LT ++L+ N S L L + NNI+ ++
Sbjct: 282 PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVSS 329
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 64/284 (22%), Positives = 120/284 (42%), Gaps = 23/284 (8%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
++ L LD+ NK+ + ++ LTNL L NQ S P +G++++L L
Sbjct: 172 PLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELS 227
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
++ NQL L L+++ +L L +N ++ P L LT+++ L L N S P
Sbjct: 228 LNGNQLKDIGTL--ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP- 282
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLS 268
+ L +++ L L NQ P + NL NL +L +NN+ P + +L L +L
Sbjct: 283 -LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328
+N + ++ + + N+ P L N T + ++ L+ T
Sbjct: 338 FYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVN 393
Query: 329 AFGIYPNLTFIDLSRNNFYGEIS-SNFGECPKLGALNISRNNIT 371
N++ + +N I+ + + +I+ N +
Sbjct: 394 YK---ANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 68/282 (24%), Positives = 114/282 (40%), Gaps = 25/282 (8%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ S L L N++ P ++NLT L L + N+ S + +++L+ L
Sbjct: 151 ALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLI 205
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
+NQ+ PL G L+++ EL+L N L +L +LT ++ L L +N S P
Sbjct: 206 ATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP- 260
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLS 268
+ L ++ L L NQ S PL+ LT L L N L P + NL LT L+
Sbjct: 261 -LSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQLEDISP--ISNLKNLTYLT 315
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328
L N+ + P + LQ N+ + SL N T++ + N ++
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP- 370
Query: 329 AFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNI 370
+T + L+ + + + N +N
Sbjct: 371 -LANLTRITQLGLNDQAWTNAPVNYK---ANVSIPNTVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 67/297 (22%), Positives = 113/297 (38%), Gaps = 41/297 (13%)
Query: 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIP-------------------- 136
L + + I + L LG + +
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI 61
Query: 137 HEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISML 196
V +++L + +NQL PL L+ +V++ + +N + P L NLT ++ L
Sbjct: 62 DGVEYLNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP--LANLTNLTGL 117
Query: 197 FLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIP 256
L +N + P + NL +++ L L+ N S LS LT+L+Q S N + P
Sbjct: 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS--GLTSLQQLSF-GNQVTDLKP 172
Query: 257 PSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRV 315
L NL L +L + N + + + L+ + N+ P L T+L +
Sbjct: 173 --LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 226
Query: 316 RLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
L+GN L +I NLT +DL+ N + KL L + N I+
Sbjct: 227 SLNGNQLK-DIG-TLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 58/237 (24%), Positives = 102/237 (43%), Gaps = 14/237 (5%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ +S +L LDL +N++ P +S LT L+ L LG NQ S P + ++ L L
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
++ NQL+ P+ L ++ L L+ NN++ P + +LT++ LF ++N S
Sbjct: 294 LNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VS 347
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSL 269
+ NL +I+ LS NQ S PL+ NLT + Q L + N+ +
Sbjct: 348 SLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405
Query: 270 DDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326
+ P I GG+ ++ N + + + + +G +
Sbjct: 406 NVTGALI-APATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTV 460
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 41/239 (17%), Positives = 76/239 (31%), Gaps = 42/239 (17%)
Query: 142 MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
++ + + ++ L + L + + L ++ + +N
Sbjct: 23 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 78
Query: 202 SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN 261
+ P + NL + + + NQ + PL NLTNL +L N + + L N
Sbjct: 79 QLTDITP--LKNLTKLVDILMNNNQIADITPL--ANLTNLTGLTLFNNQI--TDIDPLKN 132
Query: 262 LV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGN 320
L L +L L N + +L TSL ++ GN
Sbjct: 133 LTNLNRLELSSNTISD--------------------------ISALSGLTSLQQLSF-GN 165
Query: 321 NLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKF 379
+T L +D+S N S + L +L + N I+ +
Sbjct: 166 QVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGIL 220
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 20/119 (16%), Positives = 44/119 (36%), Gaps = 5/119 (4%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
S ++ ++ +L N++ P ++NLT ++ L L ++ + +S +
Sbjct: 348 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+ L P + S E + + NL +Q + +FSG +
Sbjct: 406 NVTGAL--IAPATISDGGSYTEPDI-TWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 51/282 (18%), Positives = 95/282 (33%), Gaps = 15/282 (5%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
+ A S ++ LDL N L ++ T L +L+L N ++ +S
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L+ L +++N + E+ S+ L +NN++ ++L +N +
Sbjct: 82 LRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKN---IYLANNKIT 133
Query: 205 GFIPPDIGNLKSISILSLAINQFSG-PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV 263
D G + L L +N+ + L+ +L YN +Y + +
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK 192
Query: 264 LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLT 323
L L L N + + ++ N+ I K+LR +L L GN
Sbjct: 193 LKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
Query: 324 -GNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALN 364
G + F + + + P LG
Sbjct: 251 CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 52/260 (20%), Positives = 94/260 (36%), Gaps = 20/260 (7%)
Query: 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150
+ + D+ L + + N+ L L GN S ++ + L++L +
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPD 210
SN L L++ LS++ L L +N + L I L +N+ S +
Sbjct: 66 SSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS 117
Query: 211 IGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNL----YGSIPPSLDNLVLTK 266
+ + LA N+ + L G + ++ L N + + + S D L
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT--LEH 173
Query: 267 LSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326
L+L N + + L+ +S N+ + ++ + + L N L I
Sbjct: 174 LNLQYNFIYD-VKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LI 229
Query: 327 SKAFGIYPNLTFIDLSRNNF 346
KA NL DL N F
Sbjct: 230 EKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 44/266 (16%), Positives = 76/266 (28%), Gaps = 18/266 (6%)
Query: 111 IPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170
I N I + + + ++K L + N L ++ + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 171 ELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP 230
L L SN L L +L+ + L L++N ++ SI L A N S
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR- 113
Query: 231 IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGG--A 287
+S K L N + + L L N + +
Sbjct: 114 --VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSDT 170
Query: 288 LQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFY 347
L+ + N + + L + L N L + F +T+I L N
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL- 226
Query: 348 GEISSNFGECPKLGALNISRNNITGD 373
I L ++ N
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFHCG 252
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 31/215 (14%), Positives = 75/215 (34%), Gaps = 12/215 (5%)
Query: 158 SIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSI 217
+I + + ++L ++ + + L L N S D+ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 218 SILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSY 277
+L+L+ N + L +L+ L+ L N + + + L +N+ +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-QELLVGPS---IETLHAANNNISR- 113
Query: 278 LPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG-NISKAFGIYPNL 336
+ + +G + ++ N+ + + + L N + N ++ L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 337 TFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
++L N Y ++ KL L++S N +
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA 204
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 39/281 (13%)
Query: 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID 151
PHL L N L +P +L +L + + S P L+ L +
Sbjct: 88 ELPPHLESLVASCNSL-TELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVS 139
Query: 152 SNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI 211
+NQL+ +P E+ S + + + +N+L +P +L + +N P++
Sbjct: 140 NNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEF---IAAGNNQLEEL--PEL 191
Query: 212 GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLD 270
NL ++ + N +P +L ++ N L P L NL LT + D
Sbjct: 192 QNLPFLTAIYADNNSLKK-LPDLPLSLESI---VAGNNIL--EELPELQNLPFLTTIYAD 245
Query: 271 DNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF 330
+N + LP L+ V +N +P+ ++ T L + L+
Sbjct: 246 NNLLKT-LPDLPPS---LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELP---- 296
Query: 331 GIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
PNL +++ S N I S P L LN+S N +
Sbjct: 297 ---PNLYYLNASSNE----IRSLCDLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 51/300 (17%), Positives = 98/300 (32%), Gaps = 56/300 (18%)
Query: 90 SFSSFPHLAYLDLRDNKLFG------------------TIPPQISNLTNLSILSLGGNQF 131
+ L +D+ +N L P++ NL L+ + N
Sbjct: 148 ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 207
Query: 132 SGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLT 191
+P L L+ + +N L E+ L + + +N L ++P +L
Sbjct: 208 K-KLP---DLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE 260
Query: 192 QISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNL 251
L + DN + +P +L + + + + NL L +N
Sbjct: 261 A---LNVRDNYLTD-LPELPQSLTFLDVSENIFSG----LSELPPNLYYLN----ASSNE 308
Query: 252 YGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTS 311
S+ + L +L++ +N LP R L+ S N +P+ +N
Sbjct: 309 IRSLCDLPPS--LEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPELPQNLKQ 361
Query: 312 LIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
L ++ N L ++ DL N+ E+ L L++ N +
Sbjct: 362 L---HVEYNPLR-EFPDIPE---SVE--DLRMNSHLAEVPE---LPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 46/309 (14%), Positives = 98/309 (31%), Gaps = 54/309 (17%)
Query: 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID 151
P L ++ +N+L P++ NL L+ + N +P L L+ +
Sbjct: 170 DLPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLP---DLPLSLESIVAG 223
Query: 152 SNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI 211
+N L E+ L + + +N L ++P +L L + DN + +P
Sbjct: 224 NNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA---LNVRDNYLTD-LPELP 276
Query: 212 GNLKSISILSLAINQFSGPIP----LSLGN---------LTNLKQFSLVYNNLYGSIPPS 258
+L + + + S P L+ + +L++ ++ N L +P
Sbjct: 277 QSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL 335
Query: 259 LDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCT-------- 310
L +L NH +P+ L+ V N + P +
Sbjct: 336 PPRL--ERLIASFNHLAE-VPELP---QNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHL 388
Query: 311 --------SLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGA 362
+L ++ ++ N L ++ + ++ KL
Sbjct: 389 AEVPELPQNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLED 444
Query: 363 LNISRNNIT 371
++
Sbjct: 445 DVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 54/309 (17%), Positives = 98/309 (31%), Gaps = 55/309 (17%)
Query: 93 SFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG------------ 140
S L + L +P + N+ + + +++ N P G
Sbjct: 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 141 -LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
L L +++ L S+P L L N+L +P +L + + +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 200 DNSFSGFIP---------------PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQF 244
+ S P P++ N + I+ + N +P +L +
Sbjct: 123 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFI--- 178
Query: 245 SLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIP 303
+ N L P L NL LT + D+N LP L+ N
Sbjct: 179 AAGNNQL--EELPELQNLPFLTAIYADNNSLKK-LPDLPLS---LESIVAGNNIL--EEL 230
Query: 304 KSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGAL 363
L+N L + D N L + +L +++ N ++ L L
Sbjct: 231 PELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNY----LTDLPELPQSLTFL 282
Query: 364 NISRNNITG 372
++S N +G
Sbjct: 283 DVSENIFSG 291
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 53/288 (18%), Positives = 91/288 (31%), Gaps = 47/288 (16%)
Query: 111 IPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170
I P+ + T L + + +P E + Y ++ + + P G+ M
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 171 ELALFSNNLNG------------SVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSIS 218
L S+P +L L NS + +P +LKS+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHLES---LVASCNSLT-ELPELPQSLKSLL 117
Query: 219 ILSLAINQFSGPIPL---------------SLGNLTNLKQFSLVYNNLYGSIPPSLDNLV 263
+ + + S PL L N + LK + N+L +P +
Sbjct: 118 VDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL-KKLPDLPPS-- 174
Query: 264 LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLT 323
L ++ +N LP + L N + +P + S++ N L
Sbjct: 175 LEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE 228
Query: 324 GNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
P LT I N + + P L ALN+ N +T
Sbjct: 229 --ELPELQNLPFLTTIYADNNL----LKTLPDLPPSLEALNVRDNYLT 270
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 44/282 (15%), Positives = 92/282 (32%), Gaps = 42/282 (14%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ P L + +N L +P +L ++ G N E+ + L +Y
Sbjct: 190 ELQNLPFLTAIYADNNSL-KKLPDLPLSLESIV---AGNNILE--ELPELQNLPFLTTIY 243
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
D+N L ++P L + L + N L +P +LT + + + +
Sbjct: 244 ADNNLL-KTLPDLPPSLEA---LNVRDNYLT-DLPELPQSLTFLDVSENIFSG----LSE 294
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSL 269
NL ++ S I +L++ ++ N L +P L +L
Sbjct: 295 LPPNLYYLNASSNEIRSLC-------DLPPSLEELNVSNNKLI-ELPALPPR--LERLIA 344
Query: 270 DDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKA 329
NH +P+ L+ V N + P + L + ++++
Sbjct: 345 SFNHLAE-VPELP---QNLKQLHVEYNPLR-EFPDIPESVEDL--------RMNSHLAEV 391
Query: 330 FGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
+ NL + + N + + L ++ +
Sbjct: 392 PELPQNLKQLHVETNP----LREFPDIPESVEDLRMNSERVV 429
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 14/130 (10%), Positives = 39/130 (30%), Gaps = 19/130 (14%)
Query: 256 PPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRN------- 308
P ++ N L + ++ T +P + + + + ++ P
Sbjct: 5 PRNVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 309 ------CTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGA 362
+ L+ L+ ++ + +L + S N+ E+ L
Sbjct: 64 RLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSL-TELPELPQSLKSLLV 118
Query: 363 LNISRNNITG 372
N + ++
Sbjct: 119 DNNNLKALSD 128
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 51/287 (17%), Positives = 95/287 (33%), Gaps = 15/287 (5%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHL 145
A S ++ LDL N L ++ T L +L+L N ++ +S L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTL 82
Query: 146 KILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSG 205
+ L +++N + E+ S+ L +NN++ ++L +N +
Sbjct: 83 RTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKN---IYLANNKITM 134
Query: 206 FIPPDIGNLKSISILSLAINQFSG-PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVL 264
D G + L L +N+ + L+ +L YN +Y + + L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKL 193
Query: 265 TKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324
L L N + + ++ N+ I K+LR +L L GN
Sbjct: 194 KTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251
Query: 325 NISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
+ F N +++ N EC +
Sbjct: 252 GTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 39/287 (13%), Positives = 83/287 (28%), Gaps = 12/287 (4%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
P + L +N + + S + L N+ + + G S ++ L
Sbjct: 94 ELLVGPSIETLHAANNNI-SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 150 IDSNQLDG-SIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+ N++D + ++ L L N + V + ++ L L N + F+
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMG 207
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLS 268
P+ + ++ +SL N+ I +L NL+ F L N + + +
Sbjct: 208 PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGN--- 325
+ QN + + +L R + G+
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE 326
Query: 326 -ISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
+ ID + + I L + +
Sbjct: 327 RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 36/292 (12%), Positives = 77/292 (26%), Gaps = 13/292 (4%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSG-NIPHEVGLMS 143
+ S S + L +NK+ + + L L N+ N
Sbjct: 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 144 HLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSF 203
L+ L + N + + +V + + L L SN L + + ++ + L +N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 204 SGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIP--PSLDN 261
I + +++ L N F + ++ V + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEEC 283
Query: 262 LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQG----TIPKSLRNCTSLIRVRL 317
V T R AL+ + QG + N +
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDA 343
Query: 318 DGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNN 369
I + ++ + ++S+ +L
Sbjct: 344 LKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 8e-22
Identities = 38/238 (15%), Positives = 77/238 (32%), Gaps = 13/238 (5%)
Query: 135 IPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQIS 194
I + KI + + L ++ ++ EL L N L+ L T++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 195 MLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGS 254
+L L N D+ +L ++ L L N L +++ NN+
Sbjct: 62 LLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SR 113
Query: 255 IPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQG-TIPKSLRNCTSLI 313
+ S + L +N T + +Q + N + + +L
Sbjct: 114 VSCSRGQG-KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 314 RVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
+ L N + ++ L +DLS N + F + +++ N +
Sbjct: 173 HLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 5e-19
Identities = 33/192 (17%), Positives = 65/192 (33%), Gaps = 12/192 (6%)
Query: 182 SVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNL 241
++ N + + + D+S + + ++ L L+ N S L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 242 KQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQG 300
+ +L N L L++L L L L++N+ + G +++ + N
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR 113
Query: 301 TIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYG-EISSNFGECPK 359
+ ++ L N +T G + ++DL N +
Sbjct: 114 VSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 360 LGALNISRNNIT 371
L LN+ N I
Sbjct: 171 LEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 6e-19
Identities = 31/215 (14%), Positives = 75/215 (34%), Gaps = 12/215 (5%)
Query: 158 SIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSI 217
+I + + ++L ++ + + L L N S D+ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 218 SILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSY 277
+L+L+ N + L +L+ L+ L N + + + L +N+ +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-QELLVGPS---IETLHAANNNISR- 113
Query: 278 LPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG-NISKAFGIYPNL 336
+ + +G + ++ N+ + + + L N + N ++ L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 337 TFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
++L N Y ++ KL L++S N +
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 26/214 (12%), Positives = 49/214 (22%), Gaps = 6/214 (2%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
F S + ++ LR+NKL I + NL L GN F + ++
Sbjct: 209 EFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQT 266
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSG---- 205
+ + + + + L + S G
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE 326
Query: 206 FIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLT 265
+ + N + Q+ I L +
Sbjct: 327 RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386
Query: 266 KLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQ 299
+L L LQ+ R++
Sbjct: 387 DGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 14/71 (19%), Positives = 29/71 (40%)
Query: 302 IPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLG 361
I + +N ++ ++L ++ N+ +DLS N +++ KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 362 ALNISRNNITG 372
LN+S N +
Sbjct: 62 LLNLSSNVLYE 72
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 59/290 (20%), Positives = 112/290 (38%), Gaps = 20/290 (6%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGL-M 142
KL A SF + L+L D ++ I + + L +G N +P V +
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNV 116
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
L +L ++ N L S+P + + L++ +NNL + T + L L N
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175
Query: 202 SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN 261
+ D+ + S+ +++ N S +L +++ +N++ + + N
Sbjct: 176 RLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV-N 225
Query: 262 LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNN 321
+ LT L L N+ T + L +S N + + L R+ + N
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 322 LTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
L ++ P L +DLS N+ + N + +L L + N+I
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 55/317 (17%), Positives = 114/317 (35%), Gaps = 25/317 (7%)
Query: 63 GISCNDAGRVINISLRGVGL----KGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SN 117
C D+ + V + + F + + + +++ + +P + +
Sbjct: 9 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDS 67
Query: 118 LTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDGSIPLEVGQ-LSSMVELALF 175
+ +L+L Q I ++ LY+ N + +P V Q + + L L
Sbjct: 68 FRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLE 125
Query: 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI-GNLKSISILSLAINQFSGPIPLS 234
N+L+ N +++ L + +N+ I D S+ L L+ N+ + +
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VD 181
Query: 235 LGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVS 294
L + +L ++ YN L ++ + + +L N + + L I +
Sbjct: 182 LSLIPSLFHANVSYNLL-STLAI---PIAVEELDASHNSINV-VRGPVNVE--LTILKLQ 234
Query: 295 ENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNF 354
N T L N L+ V L N L + F L + +S N ++
Sbjct: 235 HNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYG 291
Query: 355 GECPKLGALNISRNNIT 371
P L L++S N++
Sbjct: 292 QPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 56/265 (21%), Positives = 99/265 (37%), Gaps = 25/265 (9%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV-GLMS 143
L F + P L L L N L ++P I N L+ LS+ N I + +
Sbjct: 108 LPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATT 165
Query: 144 HLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSF 203
L+ L + SN+L + L + S+ + N L+ +L + L NS
Sbjct: 166 SLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 217
Query: 204 SGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNL 262
+ + + ++IL L N + L N L + L YN L I +
Sbjct: 218 N-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNEL-EKIMYHPFVKM 271
Query: 263 V-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNN 321
L +L + +N + L L++ +S N + ++ L + LD N+
Sbjct: 272 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329
Query: 322 LTGNISKAFGIYPNLTFIDLSRNNF 346
+ + + L + LS N++
Sbjct: 330 IV---TLKLSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 44/272 (16%), Positives = 90/272 (33%), Gaps = 20/272 (7%)
Query: 104 DNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEV 163
+ I + + + E +++ KI+ ++ + +P +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64
Query: 164 -GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI-GNLKSISILS 221
+ L L + ++ I L++ N+ ++PP + N+ +++L
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 123
Query: 222 LAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS-LDNLV-LTKLSLDDNHFTSYLP 279
L N S N L S+ NNL I L L L N T +
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTH-VD 181
Query: 280 QNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFI 339
++ L VS N +L ++ + N++ + + LT +
Sbjct: 182 LSLIPS--LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTIL 231
Query: 340 DLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
L NN ++ P L +++S N +
Sbjct: 232 KLQHNNL--TDTAWLLNYPGLVEVDLSYNELE 261
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 32/177 (18%), Positives = 60/177 (33%), Gaps = 7/177 (3%)
Query: 199 HDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS 258
I ++ + + + L N K + + + +P +
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAA 63
Query: 259 -LDNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRV 315
LD+ + L+L+D + +Q + N + P +N L +
Sbjct: 64 LLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122
Query: 316 RLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN-FGECPKLGALNISRNNIT 371
L+ N+L+ F P LT + +S NN I + F L L +S N +T
Sbjct: 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 18/100 (18%), Positives = 32/100 (32%), Gaps = 6/100 (6%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
P L LDL N L + L L L N + + LK L
Sbjct: 290 YGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLT 345
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGN 189
+ N D + + ++ A+ + + + + L +
Sbjct: 346 LSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 60/312 (19%), Positives = 106/312 (33%), Gaps = 15/312 (4%)
Query: 65 SCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSIL 124
C+ R + + A LDL N++ + ++ +L L
Sbjct: 8 ECSAQDRAVLCHRKR------FVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61
Query: 125 SLGGNQFSGNIPHEV--GLMSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNG 181
L N S + L +L+ L + SN+L IPL V LS++ +L + N +
Sbjct: 62 ELNENIVS-AVEPGAFNNL-FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVI 118
Query: 182 SVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNL 241
+ + +L + L + DN L S+ L+L + +L +L L
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGL 178
Query: 242 KQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQG 300
L + N+ S L L L + + + N G L +++
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238
Query: 301 TIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN-FGECPK 359
++R+ L + L N ++ L I L + F
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNY 297
Query: 360 LGALNISRNNIT 371
L LN+S N +T
Sbjct: 298 LRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 59/268 (22%), Positives = 111/268 (41%), Gaps = 13/268 (4%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV-GLMS 143
+ +F++ +L L LR N+L IP + + L+NL+ L + N+ + + +
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLY 128
Query: 144 HLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNS 202
+LK L + N L I L+S+ +L L NL +L +L + +L L +
Sbjct: 129 NLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187
Query: 203 FSGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLD 260
+ I L + +L ++ + + + NL S+ + NL ++P ++
Sbjct: 188 IN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVR 245
Query: 261 NLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
+LV L L+L N ++ + ++ LQ + + P + R L + +
Sbjct: 246 HLVYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304
Query: 319 GNNLTGNISKAFGIYPNLTFIDLSRNNF 346
GN LT F NL + L N
Sbjct: 305 GNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 13/245 (5%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV-GLM 142
+ F+ +L LD+ +NK+ + + +L NL L +G N I H +
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKI-VILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGL 151
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
+ L+ L ++ L SIP E L ++ L L N+N +S L ++ +L +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 202 SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLD 260
+ + P+ +++ LS+ + L++ +L L+ +L YN + +I L
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI-STIEGSMLH 269
Query: 261 NLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSL-RNCTSLIRVRL 317
L+ L ++ L + RG L++ VS N+ T+ +S+ + +L + L
Sbjct: 270 ELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLIL 327
Query: 318 DGNNL 322
D N L
Sbjct: 328 DSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 23/154 (14%), Positives = 50/154 (32%), Gaps = 12/154 (7%)
Query: 54 SKISPCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPP 113
+ I ++ + R+ + + + +L L + L +P
Sbjct: 189 NAIRDYSFKRLY-----RLKVLEISHWPYLDTMTPNCLYG-LNLTSLSITHCNL-TAVPY 241
Query: 114 Q-ISNLTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDGSIPLEV-GQLSSMV 170
+ +L L L+L N S I + + L+ + + QL + L+ +
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLR 299
Query: 171 ELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L + N L ++ + L L N +
Sbjct: 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-28
Identities = 62/325 (19%), Positives = 110/325 (33%), Gaps = 30/325 (9%)
Query: 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSG 133
+ L + +F + P+L LDL +K+ + P L +L L L S
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI-YFLHPDAFQGLFHLFELRLYFCGLSD 111
Query: 134 NIPHEVGL--MSHLKILYIDSNQLDG-SIPLEVGQLSSMVELALFSNNLNGSVPHSLGNL 190
+ + + L L + NQ+ + G+L+S+ + SN + H L L
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171
Query: 191 TQIS--MLFLHDNSFSGFIPPDI------------------GNLKSISILSLAINQFSGP 230
+ L NS + D GN ++ I N S
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 231 IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV---LTKLSLDDNHFTSYLPQNICRG-G 286
SL ++ ++N+ + L + L L S L +
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVFETLK 290
Query: 287 ALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNF 346
L++ ++ N+ ++ +L + L N L S F P + +IDL +N+
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 347 YGEISSNFGECPKLGALNISRNNIT 371
F KL L++ N +T
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 66/323 (20%), Positives = 105/323 (32%), Gaps = 36/323 (11%)
Query: 65 SCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSIL 124
SC+ GR+ L L L N + L L +L
Sbjct: 1 SCSFDGRIAFYRFCN------LTQV-PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 125 SLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGS 182
LG I E + +L+IL + S+++ + + L + EL L+ L+ +
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 183 V--PHSLGNLTQISMLFLHDNSFSGFIPPD-IGNLKSISILSLAINQFSGPIPLSLGNLT 239
V NL ++ L L N G L S+ + + NQ L L
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172
Query: 240 --NLKQFSLVYNNLYGSIPP-------SLDNLVLTKLSLDDNHFTSYLPQNICRGGALQI 290
L FSL N+LY + N+VL L + N +T + N
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS------- 225
Query: 291 FTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFG--IYPNLTFIDLSRNNFYG 348
N + SL ++ +N+ F ++ +DLS +
Sbjct: 226 -----NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS 280
Query: 349 EISSNFGECPKLGALNISRNNIT 371
S F L LN++ N I
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 59/292 (20%), Positives = 111/292 (38%), Gaps = 19/292 (6%)
Query: 88 AFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGLMSHLK 146
F+ + + +LDL +F ++ ++ L +L +L+L N+ + + +L+
Sbjct: 259 TFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317
Query: 147 ILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF 206
+L + N L L + + L N++ + L ++ L L DN+ +
Sbjct: 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-- 375
Query: 207 IPPDIGNLKSISILSLAINQFSGPIPLSL-GNLTNLKQFSLVYNNLYGSIPPSLDNLVLT 265
I + SI + L+ N+ ++L NL +L + L N + +L
Sbjct: 376 ---TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLE-NLDILYFLLRVPHL--Q 429
Query: 266 KLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSL-----RNCTSLIRVRLDG 319
L L+ N F+S +L+ + EN Q L + L + L+
Sbjct: 430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489
Query: 320 NNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
N L F L + L+ N + S+ L L+ISRN +
Sbjct: 490 NYLNSLPPGVFSHLTALRGLSLNSNRL--TVLSHNDLPANLEILDISRNQLL 539
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 50/230 (21%), Positives = 81/230 (35%), Gaps = 18/230 (7%)
Query: 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQ--ISNLTNLSILSLGGNQFS 132
I L L+ + PHL L L N+ + S +L L LG N
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRF-SSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 133 GNIPHEVGL-----MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSL 187
E+ +SHL++LY++ N L+ P L+++ L+L SN L + L
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL 524
Query: 188 GNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLS-LGNLTNLKQFSL 246
+ +L + N P +L + I N+F LS N N ++
Sbjct: 525 --PANLEILDISRNQLLAPNPDVFVSLSVLDITH---NKFICECELSTFINWLNHTNVTI 579
Query: 247 VYN--NLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVS 294
++Y P S + L SL + + TV+
Sbjct: 580 AGPPADIYCVYPDSFSGVSL--FSLSTEGCDEEEVLKSLKFSLFIVCTVT 627
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 47/310 (15%), Positives = 107/310 (34%), Gaps = 25/310 (8%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV-GLM 142
+ + +L L L+ +++ TI +L +L L L N S ++ G +
Sbjct: 40 YIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPL 97
Query: 143 SHLKILYIDSNQLDG-SIPLEVGQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLHD 200
S LK L + N + L+++ L + + + LT ++ L +
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYG------- 253
S + + +++ I L+L +++ + + + L++++ L NL
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLP 217
Query: 254 --SIPPSLDNLVLTKLSLDDNHFT--SYLPQNICRGGALQIFTVSENRFQGTIPKSLR-- 307
+ + L L D F L + I ++ + N P
Sbjct: 218 VDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVV 277
Query: 308 ------NCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLG 361
++ R+ + L ++S + + + I + + + S L
Sbjct: 278 SELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLE 337
Query: 362 ALNISRNNIT 371
L++S N +
Sbjct: 338 FLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 39/294 (13%), Positives = 101/294 (34%), Gaps = 15/294 (5%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
++ F+ L L+++ L + ++ ++ L+L ++ + + ++S
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
++ L + L + + + + S L ++ L +
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
Query: 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV- 263
+ + ++ L +++ + L+ + L
Sbjct: 258 ------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 264 LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKS---LRNCTSLIRVRLDG 319
+ +++++++ +P + + +L+ +SEN K+ SL + L
Sbjct: 312 VKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 320 NNLT--GNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
N+L + NLT +D+SRN F + + K+ LN+S I
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 47/319 (14%), Positives = 93/319 (29%), Gaps = 45/319 (14%)
Query: 40 SLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVG-----LKGKLHAFSFSSF 94
L+ ++ S I + +L G+G +
Sbjct: 226 KKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET 285
Query: 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG-LMSHLKILYIDSN 153
+ L + LF + S L + +++ ++ +P + L+ L + N
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSEN 344
Query: 154 QL---DGSIPLEVGQLSSMVELALFSNNLN--GSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+ G S+ L L N+L L L ++ L + N+F +P
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP 403
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLS 268
+ + L+L+ + L+ + NNL S L L +L
Sbjct: 404 DSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNL-DSFSLFLPRL--QELY 457
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328
+ N + +P + L+ +++ N L
Sbjct: 458 ISRNKLKT-------------------------LPDAS-LFPVLLVMKISRNQLKSVPDG 491
Query: 329 AFGIYPNLTFIDLSRNNFY 347
F +L I L N +
Sbjct: 492 IFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-19
Identities = 50/322 (15%), Positives = 93/322 (28%), Gaps = 25/322 (7%)
Query: 74 NISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSG 133
+ + +F D N+L + I L+ + N
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGD 268
Query: 134 NIPHEVGLMSH--------LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPH 185
P E ++S ++ L+I L + L + + + ++ +
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 186 SLGNLTQISMLFLHDNSFSGFIPPD---IGNLKSISILSLAINQFS--GPIPLSLGNLTN 240
+L + L L +N + G S+ L L+ N L L N
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 241 LKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQ 299
L + N +P S + L+L + I + L++ VS N
Sbjct: 389 LTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRV-VKTCIPQT--LEVLDVSNNNLD 444
Query: 300 GTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPK 359
+ L L + + N L + +P L + +SRN F
Sbjct: 445 -SFSLFL---PRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTS 498
Query: 360 LGALNISRNNITGDFGIAKFLK 381
L + + N +L
Sbjct: 499 LQKIWLHTNPWDCSCPRIDYLS 520
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 44/254 (17%), Positives = 88/254 (34%), Gaps = 6/254 (2%)
Query: 121 LSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN 180
+ F+ +IP GL + +K L + N++ ++ +++ L L S+ +N
Sbjct: 7 SGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 181 GSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG-PIPLSLGNLT 239
+ +L + L L DN S G L S+ L+L N + + NLT
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 240 NLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENR 297
NL+ + + I L L +L + +Y Q++ + T+ +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 298 FQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGEC 357
+ +S+ + L NL + + + +F E
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 358 PKLGALNISRNNIT 371
KL + + +
Sbjct: 244 LKLLRYILELSEVE 257
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 39/129 (30%), Positives = 63/129 (48%), Gaps = 12/129 (9%)
Query: 372 GDFGIAKFLKPDSSN-WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430
GDFG+AK + ++ T GT G+IAPE T K +EK DV+ +GV++LE+I G+
Sbjct: 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
Query: 431 DFLSSTSSPSLN---------TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESP 481
D + + + L+ ++D L E++ +++V C + SP
Sbjct: 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSP 293
Query: 482 ESRPTMKIV 490
RP M V
Sbjct: 294 MERPKMSEV 302
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 55/317 (17%), Positives = 114/317 (35%), Gaps = 25/317 (7%)
Query: 63 GISCNDAGRVINISLRGVGL----KGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SN 117
C D+ + V + + F + + + +++ + +P + +
Sbjct: 15 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDS 73
Query: 118 LTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDGSIPLEVGQ-LSSMVELALF 175
+ +L+L Q I ++ LY+ N + +P V Q + + L L
Sbjct: 74 FRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLE 131
Query: 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI-GNLKSISILSLAINQFSGPIPLS 234
N+L+ N +++ L + +N+ I D S+ L L+ N+ + +
Sbjct: 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VD 187
Query: 235 LGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVS 294
L + +L ++ YN L ++ + + +L N + + L I +
Sbjct: 188 LSLIPSLFHANVSYNLL-STLAI---PIAVEELDASHNSINV-VRGPVNVE--LTILKLQ 240
Query: 295 ENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNF 354
N T L N L+ V L N L + F L + +S N ++
Sbjct: 241 HNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYG 297
Query: 355 GECPKLGALNISRNNIT 371
P L L++S N++
Sbjct: 298 QPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 60/311 (19%), Positives = 113/311 (36%), Gaps = 37/311 (11%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGL-M 142
KL A SF + L+L D ++ I + + L +G N +P V +
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNV 122
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
L +L ++ N L S+P + + L++ +NNL + T + L L N
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181
Query: 202 SFSGFIPPDIGNLKSISILSLAINQFSG-PIPLSL---------------GNLTNLKQFS 245
+ D+ + S+ +++ N S IP+++ L
Sbjct: 182 RLTHV---DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILK 238
Query: 246 LVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIP 303
L +NNL + L N L ++ L N + + L+ +S NR +
Sbjct: 239 LQHNNL--TDTAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLV-ALN 294
Query: 304 KSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISS-NFGECPKLGA 362
+ +L + L N+L ++ + + L + L N+ I + L
Sbjct: 295 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS----IVTLKLSTHHTLKN 349
Query: 363 LNISRNNITGD 373
L +S N+ +
Sbjct: 350 LTLSHNDWDCN 360
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 18/100 (18%), Positives = 32/100 (32%), Gaps = 6/100 (6%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
P L LDL N L + L L L N + + LK L
Sbjct: 296 YGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLT 351
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGN 189
+ N D + + ++ A+ + + + + L +
Sbjct: 352 LSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 389
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 55/292 (18%), Positives = 92/292 (31%), Gaps = 17/292 (5%)
Query: 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN 153
LDL N L + L +L L + +SHL L + N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 154 QLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI-G 212
+ LSS+ +L NL +G+L + L + N F P+
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 213 NLKSISILSLAINQFSGPIPLSLGNLTNLKQF----SLVYNNLYGSIPPSLDNLVLTKLS 268
NL ++ L L+ N+ L L + L N + P + + L KL+
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206
Query: 269 LDDNHFTSYLPQNICRG-GALQIFTVSENRFQG-----TIPKS-LRNCTSLIRVRLDGNN 321
L +N + + + +G L++ + F+ KS L +L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 322 LTG---NISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNI 370
L +I F N++ L E +F L +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKF 316
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 65/324 (20%), Positives = 107/324 (33%), Gaps = 40/324 (12%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
+ ++ S HL+ L L N + S L++L L + +G +
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 145 LKILYIDSNQL-DGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLF----LH 199
LK L + N + +P L+++ L L SN + L L Q+ +L L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGPIP-LSLGNLTNLKQFSLVYNNLYG----- 253
N + FI P + L+L N S + + L L+ LV
Sbjct: 186 LNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 254 ----SIPPSLDNLVLTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLR- 307
S L NL + + L + ++ + F++ + S
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 308 ------------------NCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRN--NFY 347
SL R+ N S P+L F+DLSRN +F
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFK 362
Query: 348 GEISSNFGECPKLGALNISRNNIT 371
G S + L L++S N +
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 61/324 (18%), Positives = 106/324 (32%), Gaps = 42/324 (12%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
L ++SF SFP L LDL ++ +L++LS L L GN +S
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN-GSVPHSLGNLTQISMLFLHDNSF 203
L+ L L +G L ++ EL + N + +P NLT + L L N
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 204 SGFIPPDIGNLKSISI----LSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-- 257
D+ L + + L L++N + I L + +L N ++
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
Query: 258 -----SLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENR------FQGTIPKSL 306
L+ L + ++ G L T+ E R + I
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG--LCNLTIEEFRLAYLDYYLDDIIDLF 278
Query: 307 RNCTSLIRVRLDGNNLTGNISKAF-------------------GIYPNLTFIDLSRNNFY 347
T++ L + ++ +L + + N
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 348 GEISSNFGECPKLGALNISRNNIT 371
S + P L L++SRN ++
Sbjct: 339 NAFS--EVDLPSLEFLDLSRNGLS 360
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 59/323 (18%), Positives = 102/323 (31%), Gaps = 23/323 (7%)
Query: 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKL------FGTIPPQISNLTNLSIL 124
V + L +G L F S+ L L + + +L I + LTN+S
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 125 SLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVP 184
SL + + L + + + +L S+ L SN +
Sbjct: 288 SLVSVTIE-RVKDFSYNFG-WQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNA-- 340
Query: 185 HSLGNLTQISMLFLHDN--SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLK 242
S +L + L L N SF G S+ L L+ N + + L L+
Sbjct: 341 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLE 399
Query: 243 QFSLVYNNLYGSIPPS--LDNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRF 298
++NL + +L L L + H I G +L++ ++ N F
Sbjct: 400 HLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSF 457
Query: 299 QGTIPK-SLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGEC 357
Q +L + L L AF +L ++++ N F
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRL 517
Query: 358 PKLGALNISRNNITGDFGIAKFL 380
L + + N +L
Sbjct: 518 TSLQKIWLHTNPWDCSCPRIDYL 540
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 8e-22
Identities = 49/287 (17%), Positives = 90/287 (31%), Gaps = 20/287 (6%)
Query: 101 DLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIP 160
+ + IP + + L L N + L++L + ++
Sbjct: 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 161 LEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISIL 220
LS + L L N + + L+ + L + + + IG+LK++ L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 221 SLAINQF-SGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNL-----VLTKLSLDDNHF 274
++A N S +P NLTNL+ L N + L L + L L N
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 275 TSYLPQNICRGGALQIFTVSENRFQGTIPK-------SLRNCTSLIRVRLDGNNLTGNIS 327
+ + L T+ N + K L ++ + NL
Sbjct: 190 NF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 328 KAFGIYPNLTFIDLSRN---NFYGEISSNFGECPKLGALNISRNNIT 371
A NLT + + +I F + + ++ I
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 56/298 (18%), Positives = 101/298 (33%), Gaps = 48/298 (16%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGLMS 143
++ F + +L L L +NK+ I P + L L L L NQ +P +
Sbjct: 66 EIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQLK-ELP--EKMPK 121
Query: 144 HLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSF 203
L+ L + N++ + L Q+ ++ L N
Sbjct: 122 TLQELRVHENEI-TKVR-----------------------KSVFNGLNQMIVVELGTNPL 157
Query: 204 -SGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLD 260
S I +K +S + +A + + G +L + L N + + SL
Sbjct: 158 KSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKI-TKVDAASLK 213
Query: 261 NL-VLTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
L L KL L N ++ + L+ ++ N+ +P L + + V L
Sbjct: 214 GLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271
Query: 319 GNNLTGNISKAFGI------YPNLTFIDLSRNNF-YGEISSN-FGECPKLGALNISRN 368
NN++ S F + + + L N Y EI + F A+ +
Sbjct: 272 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 58/282 (20%), Positives = 101/282 (35%), Gaps = 60/282 (21%)
Query: 94 FPHLAYLDLRDNKLFGTIPP-QISNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKILYI 150
P A LDL++NK+ I NL NL L L N+ S I L L+ LY+
Sbjct: 51 PPDTALLDLQNNKI-TEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPL-VKLERLYL 107
Query: 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPD 210
NQL +P ++ ++ EL + N + L Q+ ++ L N
Sbjct: 108 SKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-------- 156
Query: 211 IGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL-DNLVLTKLSL 269
+ + F G + L + N+ +IP L +L T+L L
Sbjct: 157 ------LKSSGIENGAFQG--------MKKLSYIRIADTNI-TTIPQGLPPSL--TELHL 199
Query: 270 DDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKA 329
D N T V +G +L ++ L N+++ + +
Sbjct: 200 DGNKITK----------------VDAASLKG--------LNNLAKLGLSFNSISAVDNGS 235
Query: 330 FGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
P+L + L+ N ++ + + + + NNI+
Sbjct: 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 49/234 (20%), Positives = 90/234 (38%), Gaps = 18/234 (7%)
Query: 144 HLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSF 203
HL+++ L+ +P ++ L L +N + NL + L L +N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 204 SGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDN 261
S I P L + L L+ NQ +P + L++ + N + + +
Sbjct: 89 S-KISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNG 143
Query: 262 LV-LTKLSLDDNHFTS-YLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
L + + L N S + +G L +++ TIP+ L SL + LD
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLD 200
Query: 319 GNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN-FGECPKLGALNISRNNIT 371
GN +T + + NL + LS N+ + + P L L+++ N +
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNKLV 253
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 43/268 (16%), Positives = 87/268 (32%), Gaps = 24/268 (8%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GL 141
+ +L L L N + TI S+L +L L L N S N+ L
Sbjct: 66 YISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPL 123
Query: 142 MSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPH-SLGNLTQISMLFLH 199
S L L + N + L+ + L + + + + LT + L +
Sbjct: 124 -SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL 259
+ + P + +++++S L L + Q + + + ++++ L +L L
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242
Query: 260 DNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDG 319
L + + +++ + K L + L+ +
Sbjct: 243 STGETNSLI---------------KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286
Query: 320 NNLTGNISKAFGIYPNLTFIDLSRNNFY 347
N L F +L I L N +
Sbjct: 287 NQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 49/287 (17%), Positives = 85/287 (29%), Gaps = 54/287 (18%)
Query: 94 FPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKILYI 150
+ LDL +N++ I NL L L N + I + L L+ L +
Sbjct: 51 TEAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSL-GSLEHLDL 107
Query: 151 DSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSL-GNLTQISMLFLHDNSFSGFIP 208
N L ++ LSS+ L L N SL +LT++ +L + + I
Sbjct: 108 SYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 209 PDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV-LT 265
L + L + + P SL ++ N+ L + +D +
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVE 225
Query: 266 KLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGN 325
L L D + T + SL + V++ +L
Sbjct: 226 CLELRDTD----------------LDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-- 267
Query: 326 ISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
++ + L L SRN +
Sbjct: 268 -----------------------QVMKLLNQISGLLELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 42/242 (17%), Positives = 87/242 (35%), Gaps = 18/242 (7%)
Query: 143 SHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNS 202
I S L+ SIP G ++ L L +N + L + L L N
Sbjct: 31 DRNGICKGSSGSLN-SIP--SGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87
Query: 203 FSGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS--L 259
+ I D +L S+ L L+ N S L++L +L N Y ++ +
Sbjct: 88 IN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL-LGNPYKTLGETSLF 145
Query: 260 DNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRL 317
+L L L + + + + + G L+ + + Q PKSL++ ++ + L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 318 DGNNLTGNISKAFGIYPNLTFIDLSRNNFYG----EISS----NFGECPKLGALNISRNN 369
+ + ++ ++L + E+S+ + + + I+ +
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265
Query: 370 IT 371
+
Sbjct: 266 LF 267
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 59/306 (19%), Positives = 104/306 (33%), Gaps = 32/306 (10%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GL 141
+L+ SFS L +L + I L++L IL L NQF + GL
Sbjct: 44 ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGL 102
Query: 142 MSHLKILYIDSNQLDGSIPLEVG---QLSSMVELALFSNNLNGSVPHSL-GNLTQISMLF 197
++L++L + LD L L+S+ L L NN+ P S N+ + +L
Sbjct: 103 -ANLEVLTLTQCNLD-GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160
Query: 198 LHDNSFSGFIPPDI-----------GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSL 246
L N I + L SI++ + + T++ L
Sbjct: 161 LTFNKVKS-ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDL 219
Query: 247 VYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSL 306
N S+ + + SY + + F+G
Sbjct: 220 SGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK--DPDNFTFKGL----- 272
Query: 307 RNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN-FGECPKLGALNI 365
+ + L + + + F + +L + L++N +I N F L LN+
Sbjct: 273 -EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNL 330
Query: 366 SRNNIT 371
S+N +
Sbjct: 331 SQNFLG 336
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 53/329 (16%), Positives = 105/329 (31%), Gaps = 35/329 (10%)
Query: 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQF-S 132
+ + + +F L L L N+ + + L NL +L+L
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDG 117
Query: 133 GNIPHEV-GLMSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNL 190
+ ++ L++L + N + P + L L N + L N
Sbjct: 118 AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNF 177
Query: 191 T----------QISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTN 240
I++ +++ + SI+ L L+ N F + +
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIA 237
Query: 241 LKQF-SLVYNNLYGSIP---------------PSLDNLVLTKLSLDDNHFTSYLPQNICR 284
+ SL+ +N Y L+ + L + + L +++
Sbjct: 238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFS 296
Query: 285 G-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSR 343
L+ T+++N + T L+++ L N L S+ F L +DLS
Sbjct: 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY 356
Query: 344 NNFYGEISSN-FGECPKLGALNISRNNIT 371
N+ + F P L L + N +
Sbjct: 357 NHI-RALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 9e-19
Identities = 62/292 (21%), Positives = 100/292 (34%), Gaps = 35/292 (11%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI--SNLTNLSILSLGGNQFSGNIPHEV---G 140
L F L L LRDN + I P N+ +L L N+ +I E
Sbjct: 120 LSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNF 177
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQ--------LSSMVELALFSNNLNGSVP---HSLGN 189
H +L + S L +G +S+ L L N S+
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIA 237
Query: 190 LTQISMLFLHDN-------SFSGFIPPDIGNLK-----SISILSLAINQFSGPIPLSLGN 237
T+I L L ++ + F PD K + L+ ++ + +
Sbjct: 238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSH 297
Query: 238 LTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVS 294
T+L+Q +L N + I + L L KL+L N S + + L++ +S
Sbjct: 298 FTDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLS 355
Query: 295 ENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNF 346
N + +S +L + LD N L F +L I L N +
Sbjct: 356 YNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 40/212 (18%), Positives = 70/212 (33%), Gaps = 23/212 (10%)
Query: 167 SSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI-GNLKSISILSLAIN 225
+ + + L N++ S L + L + + I + L S+ IL L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 226 QFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP--SLDNLV-LTKLSLDDNHFTSYLPQNI 282
QF + L NL+ +L NL G++ L L L L DN+ P +
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 283 CRG-GALQIFTVSENRFQGTIPKSLRNCTS--LIRVRLDGNNLTGNISKAFGIYPNLTFI 339
+ ++ N+ + + L N +RL L
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ---------------- 193
Query: 340 DLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
D++ E N + + L++S N
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 40/188 (21%), Positives = 71/188 (37%), Gaps = 14/188 (7%)
Query: 25 DALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVGLKG 84
+ + I + S + ++ N+ S + + ++ L
Sbjct: 225 KESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSK 284
Query: 85 K----LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV 139
L FS F L L L N++ I LT+L L+L N +I +
Sbjct: 285 SKIFALLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRM 342
Query: 140 --GLMSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHS-LGNLTQISM 195
L L++L + N + ++ + L ++ ELAL +N L SVP LT +
Sbjct: 343 FENL-DKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQK 399
Query: 196 LFLHDNSF 203
++LH N +
Sbjct: 400 IWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 29/146 (19%), Positives = 52/146 (35%), Gaps = 13/146 (8%)
Query: 207 IPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV-L 264
+P + + + L++N + S L +L+ + I + L L
Sbjct: 28 LPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 265 TKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTI--PKSLRNCTSLIRVRLDGNN 321
L LD N F L G L++ T+++ G + + TSL + L NN
Sbjct: 82 IILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 322 LTG-NISKAFGIYPNLTFIDLSRNNF 346
+ + F +DL+ N
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKV 166
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 37/132 (28%), Positives = 59/132 (44%), Gaps = 14/132 (10%)
Query: 372 GDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH 428
DFG+A+ + + GT Y+APE A +IT K D+YSFGV++LE+I G
Sbjct: 175 SDFGLAR-ASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP 232
Query: 429 PRDF------LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPE 482
D L + + +++ +D ++ + ++ V CL E
Sbjct: 233 AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTS-VEAMYSVASQCLHEKKN 289
Query: 483 SRPTMKIVSQQL 494
RP +K V Q L
Sbjct: 290 KRPDIKKVQQLL 301
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 47/256 (18%), Positives = 82/256 (32%), Gaps = 55/256 (21%)
Query: 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN 153
+ L L L ++P + + +L I N
Sbjct: 58 INQFSELQLNRLNL-SSLPDNLP--------------------------PQITVLEITQN 90
Query: 154 QLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGN 213
L S+P L L N L+ ++P +L L + +N + +P
Sbjct: 91 ALI-SLPELPASLE---YLDACDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELPAL 141
Query: 214 LKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNH 273
L+ ++ NQ + +P +L L S+ N L +P ++ L L + N
Sbjct: 142 LEY---INADNNQLTM-LPELPTSLEVL---SVRNNQL-TFLPELPES--LEALDVSTNL 191
Query: 274 FTSYLPQNICRGGALQ----IFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKA 329
S LP R + F ENR IP+++ + + L+ N L+ S+
Sbjct: 192 LES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS---SRI 246
Query: 330 FGIYPNLTFIDLSRNN 345
T
Sbjct: 247 RESLSQQTAQPDYHGP 262
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 3e-22
Identities = 47/275 (17%), Positives = 83/275 (30%), Gaps = 49/275 (17%)
Query: 100 LDLRDNKLFGT---IPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLD 156
+ N + GT ++ N+ + L++ L ++ L
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS 72
Query: 157 GSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKS 216
S+P + + L + N L S+P +L L DN S +P +LK
Sbjct: 73 -SLPDNLPP--QITVLEITQNAL-ISLPELPASLEY---LDACDNRLS-TLPELPASLKH 124
Query: 217 ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTS 276
L + NQ + +P L + NN +P +L LS+ +N T
Sbjct: 125 ---LDVDNNQLTM-LPELPALLEYIN----ADNNQLTMLPELPTSL--EVLSVRNNQLTF 174
Query: 277 YLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNL 336
LP+ +L+ VS N + ++P
Sbjct: 175 -LPELP---ESLEALDVSTNLLE-SLPAVPVRNHHSEET--------------------E 209
Query: 337 TFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
F N I N + + N ++
Sbjct: 210 IFFRCRENRI-THIPENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 4e-22
Identities = 45/233 (19%), Positives = 91/233 (39%), Gaps = 27/233 (11%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
L + + P + L++ N L ++P ++L L N+ S +P L +
Sbjct: 70 NLSSLPDNLPPQITVLEITQNAL-ISLPELPASLEY---LDACDNRLS-TLP---ELPAS 121
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
LK L +D+NQL +P L + +N L +P +L L + +N +
Sbjct: 122 LKHLDVDNNQLT-MLPELPALLE---YINADNNQLT-MLPELPTSLEV---LSVRNNQLT 173
Query: 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQ----FSLVYNNLYGSIPPSLD 260
F+P +L+ L ++ N +P + ++ F N + IP ++
Sbjct: 174 -FLPELPESLE---ALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI-THIPENIL 227
Query: 261 NLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSL 312
+L + L+DN +S + +++ + A + F + + L
Sbjct: 228 SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPL 280
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 31/174 (17%), Positives = 61/174 (35%), Gaps = 14/174 (8%)
Query: 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID 151
L Y++ +N+L +P ++L +LS+ NQ + +P L L+ L +
Sbjct: 137 ELPALLEYINADNNQL-TMLPELPTSLE---VLSVRNNQLTF-LPE---LPESLEALDVS 188
Query: 152 SNQLDGSIPLEVGQLSSMVELALF---SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+N L+ S+P + E +F N +P ++ +L + L DN S I
Sbjct: 189 TNLLE-SLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIR 247
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNL 262
+ + F + N + V + + +
Sbjct: 248 ESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 40/132 (30%), Positives = 59/132 (44%), Gaps = 13/132 (9%)
Query: 373 DFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFGI+K + T GT GYI PE ++TEK DVYSFGV++ EV+ +
Sbjct: 182 DFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 430 RDFLSSTSSPSL-------NTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPE 482
+L + + L++++DP L + L + CL S E
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL-ADKIRPES-LRKFGDTAVKCLALSSE 298
Query: 483 SRPTMKIVSQQL 494
RP+M V +L
Sbjct: 299 DRPSMGDVLWKL 310
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 59/290 (20%), Positives = 97/290 (33%), Gaps = 27/290 (9%)
Query: 94 FPHLAYLDLRDNKLFGTIPP-QISNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKILYI 150
P LDL++N + + L +L L L N+ S I + L L+ LYI
Sbjct: 53 SPDTTLLDLQNNDI-SELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPL-RKLQKLYI 109
Query: 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSF-SGFIPP 209
N L IP SS+VEL + N + L ++ + + N + P
Sbjct: 110 SKNHLV-EIP--PNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKL 267
+ ++ L ++ + +G + L + L +N + +I L L +L
Sbjct: 167 GAFDGLKLNYLRISEAKLTG---IPKDLPETLNELHLDHNKI-QAIELEDLLRYSKLYRL 222
Query: 268 SLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326
L N + L+ + N+ +P L + L V L NN+T
Sbjct: 223 GLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVG 280
Query: 327 SKAF------GIYPNLTFIDLSRNNF-YGEISSN-FGECPKLGALNISRN 368
F I L N Y E+ F A+
Sbjct: 281 VNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 52/287 (18%), Positives = 102/287 (35%), Gaps = 19/287 (6%)
Query: 88 AFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKI 147
A + S P L L + P +L ++ +P E+ +
Sbjct: 7 AETTSGIPDLDSLPPTYSA---MCPFGCHC--HLRVVQCSDLGLK-AVPKEIS--PDTTL 58
Query: 148 LYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF 206
L + +N + + + L + L L +N ++ + L ++ L++ N
Sbjct: 59 LDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE- 116
Query: 207 IPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY-GSIPP-SLDNLVL 264
IPP++ S+ L + N+ L N+ + N L P + D L L
Sbjct: 117 IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKL 174
Query: 265 TKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324
L + + T +P+++ L + N+ Q + L + L R+ L N +
Sbjct: 175 NYLRISEAKLTG-IPKDLPE--TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231
Query: 325 NISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
+ + P L + L N + + + L + + NNIT
Sbjct: 232 IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 21/127 (16%), Positives = 47/127 (37%), Gaps = 13/127 (10%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGLMS 143
+ + L L L N++ I S L L L L N+ S +P + +
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264
Query: 144 HLKILYIDSNQLDGSIPLEV-------GQLSSMVELALFSNNLNGSV--PHSLGNLTQIS 194
L+++Y+ +N + + + + + ++LF+N + P + +T
Sbjct: 265 LLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323
Query: 195 MLFLHDN 201
+ +
Sbjct: 324 AIQFGNY 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 53/287 (18%), Positives = 91/287 (31%), Gaps = 30/287 (10%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
+ S +L YL NKL + ++ LT L+ L+ N+ + +V
Sbjct: 75 NITTLDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L L N L ++V + + EL N + + TQ++ L N +
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVL 264
D+ K ++ L+ N + L L L N L I + L
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EIDVT-PLTQL 235
Query: 265 TKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324
T N T L + L + I + + T LI + +G
Sbjct: 236 TYFDCSVNPLTE-LDVSTL--SKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKIK 289
Query: 325 NISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
+ L +D + + PKL L ++ +T
Sbjct: 290 ELD--VTHNTQLYLLDCQAAGI---TELDLSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 48/288 (16%), Positives = 92/288 (31%), Gaps = 32/288 (11%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
KL + L YL+ NKL + +S L+ L+ N + +V +
Sbjct: 96 KLTNLDVTPLTKLTYLNCDTNKL-TKLD--VSQNPLLTYLNCARNTLT---EIDVSHNTQ 149
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L L N+ L+V + + L N + + ++ L N+ +
Sbjct: 150 LTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT 204
Query: 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVL 264
D+ ++ L + N+ + + + LT L F N L + S L
Sbjct: 205 KL---DLNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPL-TELDVS-TLSKL 256
Query: 265 TKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324
T L ++ L F R + + + T L + +T
Sbjct: 257 TTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT- 310
Query: 325 NISKAFGIYPNLTFIDLSRNNFYGEISS-NFGECPKLGALNISRNNIT 371
P L ++ L+ ++ + KL +L+ +I
Sbjct: 311 --ELDLSQNPKLVYLYLNNTE----LTELDVSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 52/299 (17%), Positives = 96/299 (32%), Gaps = 42/299 (14%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
S L LD ++ + T I LT L+ L N + + + ++L L
Sbjct: 37 SEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLA 91
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISM-------------- 195
DSN+L L+V L+ + L +N L LT ++
Sbjct: 92 CDSNKLTN---LDVTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLTEIDVSHNT 148
Query: 196 --LFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYG 253
L + D+ ++ L + N+ + L + L + + NN+
Sbjct: 149 QLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT- 204
Query: 254 SIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLI 313
+ + N+ LT L N T ++ L F S N + S + L
Sbjct: 205 KLDLN-QNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLT 257
Query: 314 RVRLDGNNLTG-NISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
+ +L +++ L + E+ + +L L+ IT
Sbjct: 258 TLHCIQTDLLEIDLTHN----TQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-21
Identities = 51/287 (17%), Positives = 94/287 (32%), Gaps = 29/287 (10%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
KL S P L YL+ N L I +S+ T L+ L N+ + V +
Sbjct: 117 KLTKLDVSQNPLLTYLNCARNTL-TEID--VSHNTQLTELDCHLNKKITKLD--VTPQTQ 171
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L L N++ L+V Q + L +NN+ + L Q++ L N +
Sbjct: 172 LTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT 225
Query: 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVL 264
D+ L ++ ++N + L + L+ L + +L I + N L
Sbjct: 226 EI---DVTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EIDLT-HNTQL 277
Query: 265 TKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324
+ L ++ L + + L L+ + L+ LT
Sbjct: 278 IYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT- 331
Query: 325 NISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
+ L + + + S+ G+ P L +
Sbjct: 332 ELD--VSHNTKLKSLSCVNAHI--QDFSSVGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 48/277 (17%), Positives = 91/277 (32%), Gaps = 27/277 (9%)
Query: 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQ 154
+ A ++ T L L+ L + + ++ + ++ L L SN
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 155 LDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNL 214
+ L++ Q +++ LA SN L + LT+++ L N + D+
Sbjct: 76 ITT---LDLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKL---DVSQN 126
Query: 215 KSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHF 274
++ L+ A N + + + + T L + N + LT L N
Sbjct: 127 PLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK-ITKLDVTPQTQLTTLDCSFNKI 182
Query: 275 TSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYP 334
T ++ + L N + L L + N LT I
Sbjct: 183 TEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLT 233
Query: 335 NLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
LT+ D S N + KL L+ + ++
Sbjct: 234 QLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 29/201 (14%), Positives = 60/201 (29%), Gaps = 35/201 (17%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
+ + L +LD NKL I ++ LT L+ N + + V +S
Sbjct: 202 NITKLDLNQNIQLTFLDCSSNKL-TEID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSK 255
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L L+ L +++ + ++ + + + TQ+ +L +
Sbjct: 256 LTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT 310
Query: 205 GFIPPDIGNLKSISILSLAINQFSGPIPLS--------------------LGNLTNLKQF 244
D+ + L L + + + +S +G + L
Sbjct: 311 EL---DLSQNPKLVYLYLNNTELTE-LDVSHNTKLKSLSCVNAHIQDFSSVGKIPALNNN 366
Query: 245 SLVYNNLYGSIPPSLDNLVLT 265
+L N LT
Sbjct: 367 FEAEGQTITMPKETLTNNSLT 387
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 29/195 (14%), Positives = 61/195 (31%), Gaps = 13/195 (6%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
L S+ L L L I +++ T L G + + +V +
Sbjct: 244 PLTELDVSTLSKLTTLHCIQTDL-LEID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQ 298
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L +L + + L++ Q +V L L + L + + + T++ L +
Sbjct: 299 LYLLDCQAAGI---TELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
Query: 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVL 264
F +G + +++ A Q +L N + S + +G+
Sbjct: 353 DF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGG 410
Query: 265 TKLSLDDNHFTSYLP 279
+ L
Sbjct: 411 VYDQATNTITWENLS 425
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 31/184 (16%), Positives = 60/184 (32%), Gaps = 20/184 (10%)
Query: 199 HDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS 258
SF+ + P D N S + + +S L L +++ +
Sbjct: 7 QTQSFNDWFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSI-TDMTGI 60
Query: 259 LDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
LTKL N+ T+ ++ + L N+ + + T L + D
Sbjct: 61 EKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCD 114
Query: 319 GNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISS-NFGECPKLGALNISRNNITGDFGIA 377
N LT P LT+++ +RN ++ + +L L+ N +
Sbjct: 115 TNKLT---KLDVSQNPLLTYLNCARNT----LTEIDVSHNTQLTELDCHLNKKITKLDVT 167
Query: 378 KFLK 381
+
Sbjct: 168 PQTQ 171
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 11/223 (4%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKL-FGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGLM 142
L F L L L N L F Q T+L L L N + +
Sbjct: 42 SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 100
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
L+ L + L V L +++ L + + + L+ + +L + N
Sbjct: 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 202 SFSGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS-L 259
SF PDI L++++ L L+ Q P + +L++L+ ++ +NN S+
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF-FSLDTFPY 219
Query: 260 DNLV-LTKLSLDDNHFTSYLPQNICRG--GALQIFTVSENRFQ 299
L L L NH + + + +L +++N F
Sbjct: 220 KCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 47/258 (18%), Positives = 95/258 (36%), Gaps = 12/258 (4%)
Query: 120 NLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNL 179
+ + + + ++P G+ S L ++SN+L +L+ + +L+L SN L
Sbjct: 8 SGTEIRCNSKGLT-SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 180 N--GSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSL-G 236
+ G S T + L L N + + L+ + L + S+
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 237 NLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTV 293
+L NL + + + + L L L + N F +I L +
Sbjct: 124 SLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 294 SENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN 353
S+ + + P + + +SL + + NN + + +L +D S N+
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242
Query: 354 FGECPK-LGALNISRNNI 370
P L LN+++N+
Sbjct: 243 LQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 54/234 (23%), Positives = 86/234 (36%), Gaps = 15/234 (6%)
Query: 146 KILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN--SF 203
+ +S L S+P + SS L L SN L LTQ++ L L N SF
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 204 SGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS--LDN 261
G S+ L L+ N + + L L+ ++NL + +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLS 124
Query: 262 LV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTI-PKSLRNCTSLIRVRLD 318
L L L + H I G +L++ ++ N FQ P +L + L
Sbjct: 125 LRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 319 GNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN-FGECPKLGALNISRNNIT 371
L AF +L +++S NNF + + + L L+ S N+I
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 56/258 (21%), Positives = 96/258 (37%), Gaps = 13/258 (5%)
Query: 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN 153
+ + L +P I +N L+L N + HL++L + N
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 154 QLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI- 211
+ I + L+S+ L LF N L + L+++ L+L +N IP
Sbjct: 110 SI-RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167
Query: 212 GNLKSISILSLA-INQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSL 269
+ S+ L L + + + L NLK +L N+ P+L LV L +L +
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEM 225
Query: 270 DDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328
NHF + G +L+ V ++ + SL+ + L NNL+
Sbjct: 226 SGNHFPE-IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD 284
Query: 329 AFGIYPNLTFIDLSRNNF 346
F L + L N +
Sbjct: 285 LFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 51/222 (22%), Positives = 92/222 (41%), Gaps = 16/222 (7%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GLM 142
+ A +F HL L L N + I + L +L+ L L N + IP L
Sbjct: 90 IQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYL- 146
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLHD 200
S L+ L++ +N + SIP ++ S++ L L + + L + L L
Sbjct: 147 SKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SL 259
+ P++ L + L ++ N F P S L++LK+ ++ + + I +
Sbjct: 206 CNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAF 262
Query: 260 DNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQ 299
D L L +L+L N+ +S LP ++ L + N +
Sbjct: 263 DGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 49/194 (25%), Positives = 78/194 (40%), Gaps = 12/194 (6%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV-GLM 142
++ +F+ L L+L DN L IP L+ L L L N +IP +
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRV 170
Query: 143 SHLKILYI-DSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
L L + + +L+ I L ++ L L N+ +P+ L L + L +
Sbjct: 171 PSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSG 227
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS-L 259
N F P L S+ L + +Q S + L +L + +L +NNL S+P
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL-SSLPHDLF 286
Query: 260 DNLV-LTKLSLDDN 272
L L +L L N
Sbjct: 287 TPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 38/201 (18%), Positives = 71/201 (35%), Gaps = 13/201 (6%)
Query: 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSL 235
L+ VP + + L L +N+ +L + +L L N +
Sbjct: 63 RRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF 119
Query: 236 GNLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFT 292
L +L L N L IP + + L L +L L +N S +P +L
Sbjct: 120 NGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLD 177
Query: 293 VSE-NRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEIS 351
+ E + + + +L + L N+ ++ L +++S N+F EI
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHF-PEIR 234
Query: 352 SN-FGECPKLGALNISRNNIT 371
F L L + + ++
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVS 255
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-21
Identities = 56/244 (22%), Positives = 95/244 (38%), Gaps = 38/244 (15%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GLM 142
+ SF HL L L N + TI + L NL+ L L N+ + IP+ L
Sbjct: 79 IKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYL- 135
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLHD 200
S LK L++ +N ++ SIP ++ S+ L L + + L+ + L L
Sbjct: 136 SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM 194
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SL 259
+ P++ L + L L+ N S P S L +L++ ++ + + I +
Sbjct: 195 CNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAF 251
Query: 260 DNL-VLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
DNL L +++L N+ T LP ++ L R+ L
Sbjct: 252 DNLQSLVEINLAHNNLTL-LPHDL-----------------------FTPLHHLERIHLH 287
Query: 319 GNNL 322
N
Sbjct: 288 HNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 52/283 (18%), Positives = 89/283 (31%), Gaps = 33/283 (11%)
Query: 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN 153
+ + L +P IS TN +L+L NQ I I N
Sbjct: 42 SNQFSKVICVRKNL-REVPDGIS--TNTRLLNLHENQ----------------IQIIKVN 82
Query: 154 QLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI-G 212
L + L L N++ + L ++ L L DN + IP
Sbjct: 83 SFKH--------LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFV 133
Query: 213 NLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLD 270
L + L L N + + +L++ L I + + L L L+L
Sbjct: 134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193
Query: 271 DNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF 330
+ N+ L +S N P S + L ++ + + + AF
Sbjct: 194 MCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251
Query: 331 GIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373
+L I+L+ NN F L +++ N +
Sbjct: 252 DNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 12/194 (6%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV-GLM 142
+ +F+ +L L+L DN+L TIP L+ L L L N +IP +
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRI 159
Query: 143 SHLKILYI-DSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
L+ L + + +L I LS++ L L NL +P+ L L ++ L L
Sbjct: 160 PSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSG 216
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS-L 259
N S P L + L + +Q + NL +L + +L +NNL +P
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL-TLLPHDLF 275
Query: 260 DNLV-LTKLSLDDN 272
L L ++ L N
Sbjct: 276 TPLHHLERIHLHHN 289
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 28/144 (19%), Positives = 51/144 (35%), Gaps = 24/144 (16%)
Query: 372 GDFGIAKFLKPDSSNW--TGFAGTYGYIAPELA-----YTMKITEKCDVYSFGVLVLEVI 424
DFG+A + S G GT Y+APE+ + + D+Y+ G+++ E+
Sbjct: 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232
Query: 425 KGKHPRDFLSST----------SSPSLN--TDIALDEMLDPRLP--VPSCSVQEKLISIM 470
D PSL ++ + + P L + L +
Sbjct: 233 SRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETI 292
Query: 471 EVGFSCLKESPESRPTMKIVSQQL 494
E C E+R + V +++
Sbjct: 293 E---ECWDHDAEARLSAGCVGERI 313
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 23/285 (8%)
Query: 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148
F + + + + + T+ ++L ++ LS G + I V +++L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGL 68
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+ NQ+ PL+ L+ + EL L N L ++ L I L L + P
Sbjct: 69 ELKDNQITDLAPLK--NLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKL 267
+ L ++ +L L +NQ + PL+ LTNL+ S+ + + P L NL LT L
Sbjct: 125 --LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVS-DLTP-LANLSKLTTL 178
Query: 268 SLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNIS 327
DDN + + L + N+ P L N ++L V L +T +
Sbjct: 179 KADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT---N 231
Query: 328 KAFGIYPNLTFIDLSRNNFYGEIS-SNFGECPKLGALNISRNNIT 371
+ NL ++ + I+ + + + N++ N +
Sbjct: 232 QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 48/216 (22%), Positives = 86/216 (39%), Gaps = 16/216 (7%)
Query: 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148
+ + + LDL ++ T ++ L+NL +L L NQ + NI + +++L+ L
Sbjct: 101 SAIAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYL 156
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
I + Q+ PL LS + L N ++ P L +L + + L +N S P
Sbjct: 157 SIGNAQVSDLTPLA--NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS--LDNLVLTK 266
+ N ++ I++L + NL ++V I P+ DN
Sbjct: 213 --LANTSNLFIVTLTNQTITNQPVFYNNNLVVP---NVVKGPSGAPIAPATISDNGTYAS 267
Query: 267 LSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTI 302
+L N TS++ F + F GT+
Sbjct: 268 PNLTWN-LTSFINNVSYTFNQSVTFKNTTVPFSGTV 302
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 31/124 (25%), Positives = 60/124 (48%), Gaps = 12/124 (9%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG A ++ ++ T G+ ++APE+ +EKCDV+S+G+++ EVI + P D
Sbjct: 148 CDFGTACDIQ---THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491
+ + I R P+ ++ + + S+M C + P RP+M+ +
Sbjct: 205 EIGGPAF-----RIMWAVHNGTRPPLIK-NLPKPIESLMT---RCWSKDPSQRPSMEEIV 255
Query: 492 QQLR 495
+ +
Sbjct: 256 KIMT 259
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 57/307 (18%), Positives = 92/307 (29%), Gaps = 24/307 (7%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPH--EVGLM 142
L F L YLDL NKL I NL L L N F +P E G M
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKL-VKISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNM 114
Query: 143 SHLKILYIDSNQLDGSIPLEVGQLSSM-VELALFSNNLNGSVPHSLGNL--TQISMLFLH 199
S LK L + + L+ S L + L+ V L L P L + + ++F
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFSG------PIPLSLGNLTNLKQFSLVYNNLYG 253
+ F + + + ++ + ++ I L L +L
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234
Query: 254 SIPPSLDNLV----LTKLSLDDNHFTSYLPQNICRGG-----ALQIFTVSENRFQGTIPK 304
+ + LV + S+ + L AL I V + F
Sbjct: 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSY 294
Query: 305 SLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALN 364
+++ + +D S N + N G +L L
Sbjct: 295 IYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLI 354
Query: 365 ISRNNIT 371
+ N +
Sbjct: 355 LQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 8e-19
Identities = 51/312 (16%), Positives = 105/312 (33%), Gaps = 34/312 (10%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGLMS 143
+L S L L + N++ + + L L L N+ I
Sbjct: 35 ELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSHNKLV-KISC--HPTV 90
Query: 144 HLKILYIDSNQLDGSIPL--EVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
+LK L + N D ++P+ E G +S + L L + +L S + +L +L +
Sbjct: 91 NLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE 149
Query: 202 SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD- 260
++ P L+ + SL I + + +++ +L +N+ + +
Sbjct: 150 TYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207
Query: 261 ----------------NLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQG---- 300
NL L + N F L + + F++S + QG
Sbjct: 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDF 265
Query: 301 -TIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPK 359
S + +L ++ + S + I+ N+ + + + +
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325
Query: 360 LGALNISRNNIT 371
L+ S N +T
Sbjct: 326 FLHLDFSNNLLT 337
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 43/271 (15%), Positives = 87/271 (32%), Gaps = 14/271 (5%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
KL S L ++ N Q+ T + S+ + G + S
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 145 -----LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
L I + S+ S+M + ++ L
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFS--GPIPLSLGNLTNLKQFSLVYNNLYGSIPP 257
+N + + + G+L + L L +NQ I + +L+Q + N++
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
Query: 258 SL-DNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRV 315
L L++ N T + + + +++ + N+ + +IPK + +L +
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQEL 449
Query: 316 RLDGNNLTGNISKAFGIYPNLTFIDLSRNNF 346
+ N L F +L I L N +
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 8e-16
Identities = 48/334 (14%), Positives = 105/334 (31%), Gaps = 48/334 (14%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQ--ISNLTNLSILSLGGNQFSGNIPHEVGLM 142
KL S +L +LDL N +P N++ L L L + + +
Sbjct: 80 KLVKISCHPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 143 SH-------------------LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNG-- 181
+ L+ +S + E + + + + L+
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198
Query: 182 ------------SVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNL---KSISILSLAINQ 226
S+ L ++S L L++ + I L ++ S++ +
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258
Query: 227 FSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV------LTKLSLDDNHFTSYLPQ 280
G + + + +L + + + + + + + +
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318
Query: 281 NICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLT--GNISKAFGIYPNLTF 338
+ S N T+ ++ + T L + L N L I++ +L
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378
Query: 339 IDLSRNNF-YGEISSNFGECPKLGALNISRNNIT 371
+D+S+N+ Y E + L +LN+S N +T
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 38/232 (16%), Positives = 72/232 (31%), Gaps = 9/232 (3%)
Query: 140 GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
L IL I N + ++ LS + L + N + ++ L L
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQF-SGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS 258
N I ++ L L+ N F + PI GN++ LK L +L S
Sbjct: 78 HNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLP 134
Query: 259 LDNL--VLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVR 316
+ +L L L + + P+ + ++ + + +
Sbjct: 135 IAHLNISKVLLVLGETYGEKEDPEGLQD---FNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 317 LDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368
L+ +N+ + Y L N ++ N E + I +
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQL 243
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 37/201 (18%), Positives = 59/201 (29%), Gaps = 12/201 (5%)
Query: 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSL 235
N L VP L T I L + N S DI +L + IL ++ N+
Sbjct: 9 KNGLI-HVPKDLSQKTTI--LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF 65
Query: 236 GNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGG--ALQIFT 292
L+ L +N L I V L L L N F + LP G L+
Sbjct: 66 KFNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDLSFNAFDA-LPICKEFGNMSQLKFLG 121
Query: 293 VSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISS 352
+S + + + + + + G + L +
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFH 179
Query: 353 NFGECPKLGALNISRNNITGD 373
+ N+ +NI
Sbjct: 180 FILDVSVKTVANLELSNIKCV 200
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 48/216 (22%), Positives = 86/216 (39%), Gaps = 8/216 (3%)
Query: 135 IPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQIS 194
+P G+ + + +++ N++ ++ L L SN L + L +
Sbjct: 26 VPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 195 MLFLHDNSFSGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYG 253
L L DN+ + P L + L L P L L+ L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-Q 142
Query: 254 SIPP-SLDNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCT 310
++P + +L LT L L N +S +P+ RG +L + +NR P + R+
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 311 SLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNF 346
L+ + L NNL+ ++A L ++ L+ N +
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 53/195 (27%), Positives = 79/195 (40%), Gaps = 12/195 (6%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GL 141
+ A SF + +L L L N L I + L L L L N ++ GL
Sbjct: 46 HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL 104
Query: 142 MSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
L L++D L + + L+++ L L N L + +L ++ LFLH
Sbjct: 105 -GRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162
Query: 201 NSFSGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS- 258
N S +P L S+ L L N+ + P + +L L L NNL ++P
Sbjct: 163 NRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL-SALPTEA 220
Query: 259 LDNLV-LTKLSLDDN 272
L L L L L+DN
Sbjct: 221 LAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 41/171 (23%), Positives = 66/171 (38%), Gaps = 9/171 (5%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GLM 142
+ A +F+ L LDL DN ++ P L L L L + + GL
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGL- 128
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
+ L+ LY+ N L ++P + L ++ L L N ++ + L + L LH N
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 202 SFSGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNL 251
+ + P +L + L L N S +L L L+ L N
Sbjct: 188 RVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 47/224 (20%), Positives = 78/224 (34%), Gaps = 13/224 (5%)
Query: 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPD 210
L ++P+ + ++ + L N ++ S +++L+LH N + I
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA 74
Query: 211 I-GNLKSISILSLAINQFSGPIPLS-LGNLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTK 266
L + L L+ N + + L L L L + P L L
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQY 133
Query: 267 LSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGN 325
L L DN + LP + R G L + NR ++ R SL R+ L N +
Sbjct: 134 LYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 326 ISKAFGIYPNLTFIDLSRNNFYGEISSN-FGECPKLGALNISRN 368
AF L + L NN + + L L ++ N
Sbjct: 193 HPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 11/201 (5%)
Query: 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSL 235
L +VP + +Q +FLH N S ++++IL L N + +
Sbjct: 20 QQGLQ-AVPVGIPAASQR--IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 236 GNLTNLKQFSLVYNNLYGSIPPS-LDNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFT 292
L L+Q L N S+ P+ L L L LD L + RG ALQ
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLY 135
Query: 293 VSENRFQGTIPK-SLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEIS 351
+ +N Q +P + R+ +L + L GN ++ +AF +L + L +N +
Sbjct: 136 LQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV-AHVH 193
Query: 352 SN-FGECPKLGALNISRNNIT 371
+ F + +L L + NN++
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 17/194 (8%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GLM 142
+ +F L L L L + P + L L L L N +P + L
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL- 152
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
+L L++ N++ S+P L S+ L L N + PH+ +L ++ L+L N
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 202 SFSGFIPPDI-GNLKSISILSLAINQFS---GPIPLSLGNLTNLKQFSLVYNNLYGSIPP 257
+ S +P + L+++ L L N + PL L++F + + S+P
Sbjct: 212 NLS-ALPTEALAPLRALQYLRLNDNPWVCDCRARPLW----AWLQKFRGSSSEVPCSLPQ 266
Query: 258 SLDNLVLTKLSLDD 271
L L +L+ +D
Sbjct: 267 RLAGRDLKRLAAND 280
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 35/125 (28%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+A+ + AG Y ++APE+ ++ DV+S+GVL+ E++ G+ P
Sbjct: 158 TDFGLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 432 FLSSTSSPSLNTDIALD-EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIV 490
+ +A M LP+PS + E +ME C P SRP+ +
Sbjct: 216 GID-------GLAVAYGVAMNKLALPIPS-TCPEPFAKLME---DCWNPDPHSRPSFTNI 264
Query: 491 SQQLR 495
QL
Sbjct: 265 LDQLT 269
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 32/125 (25%), Positives = 54/125 (43%), Gaps = 12/125 (9%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+++ + AGT ++APE+ EK DVYSFGV++ E+ + P
Sbjct: 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 432 FLSSTSSPSLNTDIALD-EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIV 490
L+ + RL +P ++ ++ +I+E C P RP+ +
Sbjct: 241 NLN-------PAQVVAAVGFKCKRLEIPR-NLNPQVAAIIE---GCWTNEPWKRPSFATI 289
Query: 491 SQQLR 495
LR
Sbjct: 290 MDLLR 294
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 6e-18
Identities = 48/294 (16%), Positives = 94/294 (31%), Gaps = 15/294 (5%)
Query: 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148
F +F +L+ + + + L ++ + + ++ + + ++ L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 70
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+++ N+L PL L ++ L L N + L +L ++ L L N S I
Sbjct: 71 FLNGNKLTDIKPLT--NLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISD-IN 125
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLS 268
+ +L + L L N+ + LS LT L SL N + I P L L
Sbjct: 126 G-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLY 181
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328
L NH + + + L + + N V+ +L
Sbjct: 182 LSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 239
Query: 329 AFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFLKP 382
+ + F E+S F + +G + +
Sbjct: 240 SDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVS 293
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 76.3 bits (187), Expect = 7e-15
Identities = 44/276 (15%), Positives = 88/276 (31%), Gaps = 21/276 (7%)
Query: 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLD 156
+ + I P +L + + ++ + + +++ +
Sbjct: 1 MGETITVSTPI-KQIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 157 GSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKS 216
++ L ++ +L L N L P L NL + LFL +N + +LK
Sbjct: 57 SVQGIQ--YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKK 110
Query: 217 ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFT 275
+ LSL N S L +L L+ L N + + L L L LSL+DN +
Sbjct: 111 LKSLSLEHNGISDINGLV--HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS 166
Query: 276 SYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPN 335
+ LQ +S+N + ++L +L + L
Sbjct: 167 DI--VPLAGLTKLQNLYLSKN--HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 336 LTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371
+ + + + + N+ +
Sbjct: 223 PNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLPE 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 55/280 (19%), Positives = 99/280 (35%), Gaps = 19/280 (6%)
Query: 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148
FS +F +L+ + + + L ++ + + ++ + + ++ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 73
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+++ N+L PL L ++ L L N + L +L ++ L L N S
Sbjct: 74 FLNGNKLTDIKPLA--NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDING 129
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKL 267
+ +L + L L N+ + LS LT L SL N + I P L L L L
Sbjct: 130 --LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 183
Query: 268 SLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVR-LDGNNLTGNI 326
L NH + + + L + + N V+ DG+ +T I
Sbjct: 184 YLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 241
Query: 327 SKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNIS 366
G Y + F E+S F + +G
Sbjct: 242 ISDDGDYEKPN-VKWHLPEFTNEVSFIFYQPVTIGKAKAR 280
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 41/227 (18%), Positives = 77/227 (33%), Gaps = 23/227 (10%)
Query: 148 LYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFI 207
+ + + ++ L ++ +V L I + +++
Sbjct: 7 TITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV- 61
Query: 208 PPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTK 266
I L +++ L L N+ + PL+ NL NL L N + + L +L L
Sbjct: 62 -QGIQYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKV-KDLSS-LKDLKKLKS 116
Query: 267 LSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326
LSL+ N + + L+ + N + T L T L + L+ N ++ +I
Sbjct: 117 LSLEHNGISDI--NGLVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQIS-DI 171
Query: 327 SKAFGIYPNLTFIDLSRNNFYGEIS--SNFGECPKLGALNISRNNIT 371
L + LS+N+ IS L L +
Sbjct: 172 V-PLAGLTKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECL 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 39/162 (24%), Positives = 65/162 (40%), Gaps = 31/162 (19%)
Query: 340 DL-SRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIA 398
DL S N F + N C K+ DFG+++ S +G G + ++A
Sbjct: 149 DLRSPNIFLQSLDENAPVCAKVA-----------DFGLSQQ-SVHSV--SGLLGNFQWMA 194
Query: 399 PELAYTMKI--TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEML---DP 453
PE + TEK D YSF +++ ++ G+ P D S I M+
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-------YGKIKFINMIREEGL 247
Query: 454 RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495
R +P +L +++E C P+ RP + ++L
Sbjct: 248 RPTIPE-DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 3e-17
Identities = 48/330 (14%), Positives = 102/330 (30%), Gaps = 48/330 (14%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGLMS 143
+L S L L L N++ ++ + +L L + N+ NI M+
Sbjct: 66 ELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMA 121
Query: 144 HLKILYIDSNQLDGSIPL--EVGQLSSMVELALFSNNLNGSVPHSLGNL-TQISMLFLHD 200
L+ L + N D +P+ E G L+ + L L + + +L +L L
Sbjct: 122 SLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVS 180
Query: 201 NSFSGFIPPDI--GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYG----- 253
G + N + ++ + FS + +S+ L +L+ ++ N+
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 254 ---------------------------SIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGG 286
+ + L++ + T + +
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS 300
Query: 287 -----ALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDL 341
+L I V F + + L ++ + TF++
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNF 360
Query: 342 SRNNFYGEISSNFGECPKLGALNISRNNIT 371
++N F + +L L + RN +
Sbjct: 361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 47/273 (17%), Positives = 87/273 (31%), Gaps = 36/273 (13%)
Query: 83 KGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-----SNLTNLSILSLGGNQFSGNIPH 137
K + F F + YL++ + + I + + L +L I + F +
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323
Query: 138 EVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLF 197
+ + + I + + + SS L N SV L ++ L
Sbjct: 324 LYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383
Query: 198 LHDNSFSGFIPPDIGNLKSISILSLAINQF----SGPIPLSLGNLTNLKQFSLVYNNLYG 253
L N K++S L S + ++ +L N L G
Sbjct: 384 LQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442
Query: 254 SIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLI 313
S+ L + L L +N S +P+++ ALQ V+ N+ + ++P
Sbjct: 443 SVFRCLPPK-VKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDG-------- 491
Query: 314 RVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNF 346
F +L +I L N +
Sbjct: 492 ---------------VFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 47/332 (14%), Positives = 96/332 (28%), Gaps = 46/332 (13%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPP--QISNLTNLSILSLGGNQF-SGNIPHEVGL 141
+L S L +LDL N +P + NLT L+ L L +F ++ L
Sbjct: 111 RLQNISCCPMASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL 169
Query: 142 MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLT----QISMLF 197
+L + S + G + ++ V +F N SV ++ Q+S +
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 198 LHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIP-----LSLGNLTNLKQFSLVYNNLY 252
L+D + + + ++L++ + ++ ++ +
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 253 GSI---PPSLDNLVLTKLSLDD---NHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSL 306
I + L L ++ F + I +S +
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 307 RNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNF-------------------- 346
+ +S + N T ++ + L + L RN
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409
Query: 347 -------YGEISSNFGECPKLGALNISRNNIT 371
+ LN+S N +T
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 43/246 (17%), Positives = 77/246 (31%), Gaps = 17/246 (6%)
Query: 140 GLMSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFL 198
L K L + N + + + LS + L L N + H + L +
Sbjct: 49 DLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV 107
Query: 199 HDNSFSGFIPPDIGNLKSISILSLAINQF-SGPIPLSLGNLTNLKQFSLVYNNLYGSIPP 257
N I + S+ L L+ N F P+ GNLT L L
Sbjct: 108 SHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLL 164
Query: 258 SLDNLVLTK--LSLDDNHFTSYLPQNICRGGA--LQIFTVSENRFQGTIPKSLRNCTSL- 312
+ +L L+ L L H +++ L + + F + S+ L
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQ 224
Query: 313 -IRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISS-----NFGECPKLGALNIS 366
++L+ N ++ + T ++++ + F + LNI
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284
Query: 367 RNNITG 372
IT
Sbjct: 285 NLTITE 290
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 53/319 (16%), Positives = 98/319 (30%), Gaps = 33/319 (10%)
Query: 65 SCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSIL 124
SCN + + S L L D + I +L L
Sbjct: 14 SCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRL 73
Query: 125 SLGGNQFSGNIPH---EVGLMSHLKILYIDSNQLDGSIPLEVGQLS--SMVELALFSNNL 179
++ + I V +S L+ L +++ ++ G+ P + + + + L L N
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL-RNVS 132
Query: 180 NGSVPHSLGNL-----TQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLS 234
+ L L + +L + F + ++S L L+ N G L
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192
Query: 235 LGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVS 294
+ L P+L L L + + LQ +S
Sbjct: 193 --------------SALCPLKFPTLQVLALRNAGM--ETPSGVCSALAAARVQLQGLDLS 236
Query: 295 ENRFQGTIPKSL-RNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN 353
N + + L + L L G+ L+ +DLS N + + +
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLK---QVPKGLPAKLSVLDLSYNRL--DRNPS 291
Query: 354 FGECPKLGALNISRNNITG 372
E P++G L++ N
Sbjct: 292 PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 43/211 (20%), Positives = 65/211 (30%), Gaps = 14/211 (6%)
Query: 28 LKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVGLKGKLH 87
+ A + + I + NVS + + + +S+
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS-LNFS 165
Query: 88 AFSFSSFPHLAYLDLRDNKLFGTI-------PPQISNLTNLSILSLGGNQFSGNIPHEVG 140
FP L+ LDL DN G P + L L++ + G SG
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQ-LSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
L+ L + N L + S + L L L VP L ++S+L L
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLS 282
Query: 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGP 230
N P L + LSL N F
Sbjct: 283 YNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 35/214 (16%), Positives = 72/214 (33%), Gaps = 17/214 (7%)
Query: 188 GNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIP---LSLGNLTNLKQF 244
G + +L D DI S+ L++ + I L + ++ L++
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 245 SLVYNNLYGSIPPSLDNLV---LTKLSLDDNHFTSYLPQ----NICRGGALQIFTVSENR 297
+L + G+ PP L L L+L + + + L++ ++++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 298 FQGTIPKSLRNCTSLIRVRLDGNNLTGNI----SKAFGIYPNLTFIDLSRNNF---YGEI 350
+ +R +L + L N G + +P L + L G
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 351 SSNFGECPKLGALNISRNNITGDFGIAKFLKPDS 384
S+ +L L++S N++ G P
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 29/161 (18%), Positives = 54/161 (33%), Gaps = 11/161 (6%)
Query: 235 LGNLTNLKQFSLVYNNLYGSIPPS--LDNLVLTKLSLDDNHFTSYLPQNICRGGA---LQ 289
G +L+ + + + +L L +L++ S + R LQ
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 290 IFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF------GIYPNLTFIDLSR 343
T+ GT P L T L+ N++ A+ + P L + +++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 344 NNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFLKPDS 384
+ P L L++S N G+ G+ L P
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 47/182 (25%), Positives = 71/182 (39%), Gaps = 9/182 (4%)
Query: 94 FPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDS 152
L L +N L T T L+ L+L + + + + L L L +
Sbjct: 30 PKDTTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTL-PVLGTLDLSH 86
Query: 153 NQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI- 211
NQL S+PL L ++ L + N L +L L ++ L+L N +PP +
Sbjct: 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLL 144
Query: 212 GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL-DNLVLTKLSLD 270
+ LSLA N + L L NL L N+LY +IP + +L L
Sbjct: 145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 271 DN 272
N
Sbjct: 204 GN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 18/211 (8%)
Query: 116 SNLTNLSILSLGGNQFS---GNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172
S + + ++ + ++P IL++ N L + + + +L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIP 232
L L + G L + L L N +P L ++++L ++ N+ +
Sbjct: 61 NLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 233 LSLGNLTNLKQFSLVYNNLYGSIPPSL-DNLV-LTKLSLDDNHFTSYLPQNICRG-GALQ 289
+L L L++ L N L ++PP L L KLSL +N+ T LP + G L
Sbjct: 118 GALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLD 175
Query: 290 IFTVSENRFQGTIPKSLRNCTSLIRVRLDGN 320
+ EN TIPK L L GN
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKIL 148
+ P L LDL N+L ++P L L++L + N+ + ++P GL L+ L
Sbjct: 73 DGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL-GELQEL 129
Query: 149 YIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSL-GNLTQISMLFLHDNSFSGF 206
Y+ N+L ++P + + +L+L +NNL +P L L + L L +NS
Sbjct: 130 YLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT- 186
Query: 207 IPPDIGNLKSISILSLAIN 225
IP + L N
Sbjct: 187 IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 44/177 (24%), Positives = 64/177 (36%), Gaps = 7/177 (3%)
Query: 196 LFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSI 255
+ + + +PPD+ K +IL L+ N +L T L Q +L L +
Sbjct: 15 VNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKL 70
Query: 256 PPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRV 315
VL L L N S LP AL + VS NR +LR L +
Sbjct: 71 QVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129
Query: 316 RLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN-FGECPKLGALNISRNNIT 371
L GN L P L + L+ NN E+ + L L + N++
Sbjct: 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 25/96 (26%), Positives = 38/96 (39%), Gaps = 7/96 (7%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GL 141
L + L L L+ N+L T+PP + + L LSL N + +P + GL
Sbjct: 114 SLPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGL 171
Query: 142 MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177
+L L + N L +IP + L N
Sbjct: 172 -ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 24/162 (14%), Positives = 59/162 (36%), Gaps = 7/162 (4%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ + L Y+ L + + + I N+ L++ + P + +S+L+ L
Sbjct: 39 TEAQMNSLTYITLANINV-TDLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
I + + L+S+ L + + + S+ + L +++ + L N I P
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNL 251
+ L + L++ + + + L Q +
Sbjct: 155 -LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 25/162 (15%), Positives = 58/162 (35%), Gaps = 9/162 (5%)
Query: 116 SNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALF 175
S LG + + + M+ L + + + + +E ++ +L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVTDLTGIE--YAHNIKDLTIN 74
Query: 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSL 235
+ + P + L+ + L + + P++ L S+++L ++ + I +
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 236 GNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTS 276
L + L YN I P L L L L++ +
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD 173
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 28/187 (14%), Positives = 63/187 (33%), Gaps = 15/187 (8%)
Query: 189 NLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVY 248
L +S + + +L I++ ++ + +G + N+K ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 249 NNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLR 307
+ + P + L L +L + TS N+ +L + +S + +I +
Sbjct: 76 IHA-TNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 308 NCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEIS--SNFGECPKLGALNI 365
+ + L N +I P L +++ + + + PKL L
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG----VHDYRGIEDFPKLNQLYA 188
Query: 366 SRNNITG 372
I G
Sbjct: 189 FSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 16/115 (13%), Positives = 45/115 (39%), Gaps = 3/115 (2%)
Query: 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150
S +L L + + P +S LT+L++L + + +I ++ + + + +
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSG 205
N I + L + L + + ++ + + +++ L+ + G
Sbjct: 144 SYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 19/92 (20%), Positives = 37/92 (40%), Gaps = 3/92 (3%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ S L LD+ + +I +I+ L ++ + L N +I + + LK L
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNG 181
I + + +E + +L FS + G
Sbjct: 166 IQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 30/138 (21%), Positives = 46/138 (33%), Gaps = 23/138 (16%)
Query: 372 GDFGIAKFL--------------KPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFG 417
DFG+A+ + KPD G ++APE+ EK DV+SFG
Sbjct: 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209
Query: 418 VLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCL 477
+++ E+I + D L+ P + I C
Sbjct: 210 IVLCEIIGRVNADPDYL-----PRTMDFGLNVRGFLDRYCPP-NCPPSFFPIT---VRCC 260
Query: 478 KESPESRPTMKIVSQQLR 495
PE RP+ + L
Sbjct: 261 DLDPEKRPSFVKLEHWLE 278
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 57/257 (22%), Positives = 76/257 (29%), Gaps = 65/257 (25%)
Query: 99 YLDLRDNKLFGTIPP-QISNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKILYIDSNQL 155
LDL N L + + L +L L + I L SHL L + N +
Sbjct: 32 NLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSL-SHLSTLILTGNPI 88
Query: 156 DGSIPLEV-GQLSSMVELALFSNNLNGSVPHSL-GNLTQISMLFLHDNSFSGFIPPDIGN 213
S+ L LSS+ +L NL S+ + G+L + L + N F P+
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY-- 144
Query: 214 LKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV-----LTKL 267
FS NLTNL+ L N + SI L L L
Sbjct: 145 -------------FS--------NLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSL 182
Query: 268 SLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNIS 327
L N I L + LD N L
Sbjct: 183 DLSLNPMNF-------------------------IQPGAFKEIRLKELALDTNQLKSVPD 217
Query: 328 KAFGIYPNLTFIDLSRN 344
F +L I L N
Sbjct: 218 GIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 34/174 (19%), Positives = 58/174 (33%), Gaps = 14/174 (8%)
Query: 207 IPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL-DNLV-L 264
IP ++ S L L+ N S + L+ L + +I +L L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHL 78
Query: 265 TKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLT 323
+ L L N S L G +LQ E + + +L + + N +
Sbjct: 79 STLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 324 GNIS-KAFGIYPNLTFIDLSRNNFYGEISSN-FGECPKL----GALNISRNNIT 371
+ F NL +DLS N I ++ +L++S N +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 29/133 (21%), Positives = 61/133 (45%), Gaps = 19/133 (14%)
Query: 372 GDFGIAKFLK--PDSSNWTGFAGTYGYIAPEL---AYTMKITEKCDVYSFGVLVLEVIKG 426
GDFG+A S + +G+ ++APE+ + + + DVY+FG+++ E++ G
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221
Query: 427 KHPRDFLSSTSSPSLNTDIALD----EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPE 482
+ P ++ N D ++ L P L + +++ +M CLK+ +
Sbjct: 222 QLPYSNIN-------NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMA---ECLKKKRD 271
Query: 483 SRPTMKIVSQQLR 495
RP+ + ++
Sbjct: 272 ERPSFPRILAEIE 284
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-15
Identities = 34/200 (17%), Positives = 74/200 (37%), Gaps = 20/200 (10%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GLM 142
+ + +FS+ P+++ + + + + NL+ ++ + + + I + L
Sbjct: 46 IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKEL- 104
Query: 143 SHLKILYIDSNQLDGSIP--LEVGQLSSMVELALFSNNLNGSVPH----SLGNLTQISML 196
LK L I + L P +V L + N S+P L N T L
Sbjct: 105 PLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT--L 161
Query: 197 FLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSL--GNLTNLKQFSLVYNNLYGS 254
L++N F+ + N + + L N++ I G + + ++ +
Sbjct: 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV-TA 219
Query: 255 IPP-SLDNLVLTKLSLDDNH 273
+P L++ L +L +
Sbjct: 220 LPSKGLEH--LKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 46/232 (19%), Positives = 80/232 (34%), Gaps = 17/232 (7%)
Query: 143 SHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNS 202
+ + + IP S L L +L H+ NL IS +++ +
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 203 FSGFIPPDI-GNLKSISILSLAINQFSGPIPLS-LGNLTNLKQFSLVYNNLYGSIPPSL- 259
+ NL ++ + + + I L L LK + L P
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTK 125
Query: 260 --DNLVLTKLSLDDNHFTSYLPQNICRG--GALQIFTVSENRFQGTIPKSLRNCTSLIRV 315
+ L + DN + + +P N +G + N F ++ N T L V
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 316 RLDGNNLTGNISK-AF-GIYPNLTFIDLSRNNFYGEISSN-FGECPKLGALN 364
L+ N I K AF G+Y + +D+S+ + + S +L A N
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV-TALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 20/120 (16%), Positives = 38/120 (31%), Gaps = 31/120 (25%)
Query: 254 SIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLI 313
S+PPS L L + H + +P + + N ++
Sbjct: 28 SLPPST-----QTLKLIETHLRT-IPSH-----------------------AFSNLPNIS 58
Query: 314 RVRLDGNNLTGNI-SKAFGIYPNLTFIDLSRNNFYGEISSN-FGECPKLGALNISRNNIT 371
R+ + + + S +F +T I++ I + E P L L I +
Sbjct: 59 RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 20/138 (14%), Positives = 40/138 (28%), Gaps = 24/138 (17%)
Query: 372 GDFGIAK-----FLKPDSSNWTGFAGTYGYIAPELAYTMKI---------TEKCDVYSFG 417
DFG+ G ++APE+ + ++ DV++ G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
Query: 418 VLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCL 477
+ E+ + P I + + + +++ I+ C
Sbjct: 231 TIWYELHAREWPFKTQP-------AEAIIWQMGTGMKPNLSQIGMGKEISDILL---FCW 280
Query: 478 KESPESRPTMKIVSQQLR 495
E RPT + L
Sbjct: 281 AFEQEERPTFTKLMDMLE 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 24/127 (18%), Positives = 46/127 (36%), Gaps = 18/127 (14%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPEL---AYTMKITEKCDVYSFGVLVLEVIKGKH 428
+ + G ++APE D++SF VL+ E++ +
Sbjct: 155 SMADVKFSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
P LS+ +AL+ + R +P + + +M+ C+ E P RP
Sbjct: 210 PFADLSNMEIGM---KVALEGL---RPTIPP-GISPHVSKLMK---ICMNEDPAKRPKFD 259
Query: 489 IVSQQLR 495
++ L
Sbjct: 260 MIVPILE 266
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 52/174 (29%), Positives = 73/174 (41%), Gaps = 18/174 (10%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GL 141
L + +F L L L DNKL T+P I L NL L + N+ +P V L
Sbjct: 51 SLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQL 108
Query: 142 MSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPH----SLGNLTQISML 196
+L L +D NQL S+P V L+ + L+L N L S+P L +L + L
Sbjct: 109 -VNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE---L 162
Query: 197 FLHDNSFSGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYN 249
L++N +P L + L L NQ + +L LK L N
Sbjct: 163 RLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 59/246 (23%), Positives = 93/246 (37%), Gaps = 61/246 (24%)
Query: 105 NKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKILYIDSNQLDGSIPLE 162
+K IP I + L L N+ S ++P + L + L++LY++ N+L ++P
Sbjct: 25 SKKLTAIPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRL-TKLRLLYLNDNKLQ-TLPAG 79
Query: 163 V-GQLSSMVELALFSNNLNGSVPHSL-GNLTQISMLFLHDNSFSGFIPPDIGNLKSISIL 220
+ +L ++ L + N L ++P + L ++ L L N +PP +
Sbjct: 80 IFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRV--------- 128
Query: 221 SLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL-DNLV-LTKLSLDDNHFTSYL 278
F LT L SL YN L S+P + D L L +L L +N
Sbjct: 129 ------FDS--------LTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNN------ 167
Query: 279 PQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTF 338
Q+ V E F T L ++LD N L AF L
Sbjct: 168 ----------QLKRVPEGAF--------DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209
Query: 339 IDLSRN 344
+ L N
Sbjct: 210 LQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 49/179 (27%), Positives = 70/179 (39%), Gaps = 11/179 (6%)
Query: 196 LFLHDNSFSGFIPPDI-GNLKSISILSLAINQFSGPIPLSL-GNLTNLKQFSLVYNNLYG 253
L L N S +P L + +L L N+ +P + L NL+ + N L
Sbjct: 42 LDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKL-Q 98
Query: 254 SIPPSL-DNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSL-RNC 309
++P + D LV L +L LD N S LP + L ++ N Q ++PK +
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL 156
Query: 310 TSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368
TSL +RL N L AF L + L N F KL L + N
Sbjct: 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 27/146 (18%), Positives = 54/146 (36%), Gaps = 26/146 (17%)
Query: 372 GDFGIAKFLKPDSS----NWTGFAGTYGYIAPEL------AYTMKITEKCDVYSFGVLVL 421
D G+A ++ GT Y+APE+ ++ D+++FG+++
Sbjct: 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214
Query: 422 EVIKGKHPRDFLSSTSSP---SLNTDIALDEMLDP------RLPVP----SCSVQEKLIS 468
EV + + P + D + ++M R +P S L
Sbjct: 215 EVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK 274
Query: 469 IMEVGFSCLKESPESRPTMKIVSQQL 494
+M+ C ++P +R T + + L
Sbjct: 275 LMK---ECWYQNPSARLTALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 32/148 (21%), Positives = 54/148 (36%), Gaps = 28/148 (18%)
Query: 372 GDFGIAKFLKPDSSNW----TGFAGTYGYIAPE-LAYTMKI-----TEKCDVYSFGVLVL 421
D G+A D++ GT Y+ PE L ++ D+YSFG L+L
Sbjct: 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG-LIL 242
Query: 422 -EVIKGKHPRDFLSSTSSPS---LNTDIALDEMLDP------RLPVPSC----SVQEKLI 467
EV + + P + +D + ++M + R P+ ++
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302
Query: 468 SIMEVGFSCLKESPESRPTMKIVSQQLR 495
+M C +P SR T V + L
Sbjct: 303 KLMT---ECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 27/147 (18%), Positives = 51/147 (34%), Gaps = 26/147 (17%)
Query: 372 GDFGIAKFLKPDSS----NWTGFAGTYGYIAPEL------AYTMKITEKCDVYSFGVLVL 421
D G+A + GT Y+APE+ + ++ D+Y+ G++
Sbjct: 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248
Query: 422 EVIKGKHPRDFLSSTSSP---SLNTDIALDEMLDP------RLPVP----SCSVQEKLIS 468
E+ + P + +D +++EM R +P SC +
Sbjct: 249 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 308
Query: 469 IMEVGFSCLKESPESRPTMKIVSQQLR 495
IM C + +R T + + L
Sbjct: 309 IMR---ECWYANGAARLTALRIKKTLS 332
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 30/124 (24%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GL 141
+ +FS + L +DL +N++ + P L +L+ L L GN+ + +P + GL
Sbjct: 46 VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGL 103
Query: 142 MSHLKILYIDSNQLDGSIPLEVGQ-LSSMVELALFSNNLNGSVPH-SLGNLTQISMLFLH 199
L++L +++N++ + ++ Q L ++ L+L+ N L ++ + L I + L
Sbjct: 104 -FSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLA 160
Query: 200 DNSF 203
N F
Sbjct: 161 QNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 29/144 (20%), Positives = 56/144 (38%), Gaps = 13/144 (9%)
Query: 207 IPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV-L 264
+P I + + L N P + L++ L N + + P + L L
Sbjct: 30 LPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSL 82
Query: 265 TKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPK-SLRNCTSLIRVRLDGNNL 322
L L N T LP+++ G +LQ+ ++ N+ + + ++ +L + L N L
Sbjct: 83 NSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
Query: 323 TGNISKAFGIYPNLTFIDLSRNNF 346
F + + L++N F
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 29/157 (18%), Positives = 55/157 (35%), Gaps = 29/157 (18%)
Query: 167 SSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQ 226
++ E+ L N + P + ++ + L +N S + PD
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA--------------- 75
Query: 227 FSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL-DNLV-LTKLSLDDNHFTSYLPQNICR 284
F G L +L L N + +P SL + L L L L+ N L + +
Sbjct: 76 FQG--------LRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQ 125
Query: 285 G-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGN 320
L + ++ +N+ Q + ++ + L N
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 15/167 (8%)
Query: 94 FPHLAYLDLRDNKLFGTIPPQI--SNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKILY 149
+ A LDL N L + + + LTNL L L N + I E + +L+ L
Sbjct: 38 PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV-PNLRYLD 94
Query: 150 IDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
+ SN L ++ + L ++ L L++N++ ++ ++ Q+ L+L N S P
Sbjct: 95 LSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFP 152
Query: 209 PDI----GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSL-VYNN 250
++ L + +L L+ N+ L L + L ++NN
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 35/128 (27%), Positives = 56/128 (43%), Gaps = 13/128 (10%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GL 141
+ + +F P+L YLDL N L T+ + S+L L +L L N + +
Sbjct: 78 FISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDM 135
Query: 142 MSHLKILYIDSNQLDGSIPLEV----GQLSSMVELALFSNNLNGSVPHSLGNLTQISM-- 195
+ L+ LY+ NQ+ P+E+ +L ++ L L SN L L L
Sbjct: 136 -AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 196 LFLHDNSF 203
L+LH+N
Sbjct: 194 LYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 33/170 (19%), Positives = 63/170 (37%), Gaps = 11/170 (6%)
Query: 207 IPPDIGNLKSISILSLAINQFSG-PIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV- 263
+P + + ++L L+ N S + LTNL L +N+L I + +
Sbjct: 33 VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPN 89
Query: 264 LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNL 322
L L L NH + L + + AL++ + N + + L ++ L N +
Sbjct: 90 LRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI 148
Query: 323 TGNISKAFGIY---PNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNN 369
+ + P L +DLS N ++ + P + +N
Sbjct: 149 SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 30/119 (25%), Positives = 54/119 (45%), Gaps = 10/119 (8%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GLMSHLK 146
F P L ++ +NK+ I + ++ + L N+ N+ H++ GL LK
Sbjct: 52 IFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGL-ESLK 108
Query: 147 ILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPH-SLGNLTQISMLFLHDNSF 203
L + SN++ + + LSS+ L+L+ N + +V + L +S L L N F
Sbjct: 109 TLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 8e-08
Identities = 20/97 (20%), Positives = 43/97 (44%), Gaps = 8/97 (8%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GL 141
+ +F + + L N+L + ++ L +L L L N+ + + ++ GL
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGL 128
Query: 142 MSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSN 177
S +++L + NQ+ ++ L S+ L L +N
Sbjct: 129 -SSVRLLSLYDNQI-TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 28/144 (19%), Positives = 56/144 (38%), Gaps = 8/144 (5%)
Query: 207 IPPDIGNLKSISILSLAINQFSG-PIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV- 263
IP I + + L L N+F+ L L++ + N + I + +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASG 82
Query: 264 LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNL 322
+ ++ L N + + + +G +L+ + NR S +S+ + L N +
Sbjct: 83 VNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
Query: 323 TGNISKAFGIYPNLTFIDLSRNNF 346
T AF +L+ ++L N F
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 23/110 (20%), Positives = 38/110 (34%), Gaps = 6/110 (5%)
Query: 171 ELALFSNNLNGSVPHSL-GNLTQISMLFLHDNSFSGFIPPDI-GNLKSISILSLAINQFS 228
EL L +N + L Q+ + +N + I ++ + L N+
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLE 94
Query: 229 GPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLDDNHFTS 276
L +LK L N + + S L + LSL DN T+
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQITT 143
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 17/74 (22%), Positives = 30/74 (40%), Gaps = 6/74 (8%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GLM 142
+ F L L LR N++ + L+++ +LSL NQ + + L
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153
Query: 143 SHLKILYIDSNQLD 156
S L L + +N +
Sbjct: 154 S-LSTLNLLANPFN 166
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 48/244 (19%), Positives = 83/244 (34%), Gaps = 20/244 (8%)
Query: 105 NKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSI---PL 161
+ L L + S + E+ L+ L ++ +I
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEK-STVLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 162 EVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILS 221
+ L E + + L P L + FL +NS D+ +L
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV------RVLH 447
Query: 222 LAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQ 280
LA + L L + L +N L ++PP+L L L L DN + +
Sbjct: 448 LAHKDLTVLC--HLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALEN-VD- 502
Query: 281 NICRGGALQIFTVSENRFQG-TIPKSLRNCTSLIRVRLDGNNLT---GNISKAFGIYPNL 336
+ LQ + NR Q + L +C L+ + L GN+L G + + P++
Sbjct: 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562
Query: 337 TFID 340
+ I
Sbjct: 563 SSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 8e-10
Identities = 34/301 (11%), Positives = 78/301 (25%), Gaps = 22/301 (7%)
Query: 82 LKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIP----- 136
+ L ++ + L ++ + + L L ++ ++
Sbjct: 232 HRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPD 291
Query: 137 ----HEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQ 192
+ L ++ + + S E L + Q
Sbjct: 292 GRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQ 350
Query: 193 ISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY 252
+ L S + ++ + K + L I L + L L
Sbjct: 351 LFRCELSVEK-STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF- 408
Query: 253 GSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSL 312
S ++D + L + F +++ ++ T+ L +
Sbjct: 409 -STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLV 465
Query: 313 IRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISS--NFGECPKLGALNISRNNI 370
+ L N L + A L + S N + + P+L L + N +
Sbjct: 466 THLDLSHNRLR-ALPPALAALRCLEVLQASDN----ALENVDGVANLPRLQELLLCNNRL 520
Query: 371 T 371
Sbjct: 521 Q 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 4e-08
Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ +LDL N+L +PP ++ L L +L N N+ V + L+ L
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELL 514
Query: 150 IDSNQLDG-SIPLEVGQLSSMVELALFSNNL 179
+ +N+L + + +V L L N+L
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 46/245 (18%), Positives = 75/245 (30%), Gaps = 41/245 (16%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSL-GGNQFSGNIPHEV--G 140
+ +FS F L +++ N + I + SNL L + + N I E
Sbjct: 44 VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQN 102
Query: 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200
L +L+ L I + + +P + Q +L + D
Sbjct: 103 L-PNLQYLLISNTGI-KHLP-----------------------DVHKIHSLQKVLLDIQD 137
Query: 201 NSFSGFIPPDI--GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP- 257
N I + G IL L N I S N T L + +L NN +P
Sbjct: 138 NINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPND 196
Query: 258 SLDNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRV 315
L + S LP L+ + + +P +L +L+
Sbjct: 197 VFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEA 251
Query: 316 RLDGN 320
L
Sbjct: 252 SLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 36/276 (13%), Positives = 74/276 (26%), Gaps = 40/276 (14%)
Query: 100 LDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKILYIDSNQLDG 157
+++K+ IP + N L + I G L+ + I N +
Sbjct: 14 FLCQESKV-TEIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGF-GDLEKIEISQNDVLE 68
Query: 158 SIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI-GNLKS 216
I +V FSN L L +I + N+ +I P+ NL +
Sbjct: 69 VIEADV-----------FSN---------LPKLHEIRIE--KANNLL-YINPEAFQNLPN 105
Query: 217 ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV--LTKLSLDDNH 273
+ L ++ + + + N +I S L L L+ N
Sbjct: 106 LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165
Query: 274 FTSYLPQNICRG-GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGI 332
+ + G ++ N + + + + + + S
Sbjct: 166 IQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224
Query: 333 YPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368
L + L +++
Sbjct: 225 LKKLRARSTYNLKKLP----TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 23/147 (15%), Positives = 45/147 (30%), Gaps = 9/147 (6%)
Query: 231 IPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLDDNHFTSYLPQNICRG-GA 287
IP L N + V L I + L K+ + N + ++
Sbjct: 24 IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 288 LQIFTVSE-NRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNF 346
L + + N P++ +N +L + + + +D+ N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 347 YGEISSN--FGECPKLGALNISRNNIT 371
I N G + L +++N I
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQ 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 19/109 (17%), Positives = 35/109 (32%), Gaps = 5/109 (4%)
Query: 265 TKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324
++ T +P ++ R + + + L ++ + N++
Sbjct: 12 RVFLCQESKVTE-IPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 325 NISK-AFGIYPNLTFIDLSRNNFYGEISSN-FGECPKLGALNISRNNIT 371
I F P L I + + N I+ F P L L IS I
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 117
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 26/119 (21%), Positives = 46/119 (38%), Gaps = 21/119 (17%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPR 430
GDFG+ LK D GT Y++PE + ++ D+Y+ G+++ E++
Sbjct: 164 GDFGLVTSLKNDGKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222
Query: 431 DFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEK-LISIMEVGFSCLKESPESRPTMK 488
+ T ++ D + +EK L+ L + PE RP
Sbjct: 223 E-----------TSKFFTDLRDGIIS-DIFDKKEKTLLQ------KLLSKKPEDRPNTS 263
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 33/188 (17%), Positives = 70/188 (37%), Gaps = 14/188 (7%)
Query: 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148
F + +L + T L+ + + + ++ + ++LK L
Sbjct: 13 FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208
++ NQ+ PL+ L+ + EL++ N L L++ LFL +N
Sbjct: 69 HLSHNQISDLSPLK--DLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNELRDTDS 123
Query: 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLS 268
+ +LK++ ILS+ N+ + L L+ L+ L N + + + +
Sbjct: 124 --LIHLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEIT-NTGGLTRLKKVNWID 178
Query: 269 LDDNHFTS 276
L +
Sbjct: 179 LTGQKCVN 186
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 32/188 (17%), Positives = 60/188 (31%), Gaps = 20/188 (10%)
Query: 187 LGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSL 246
L L S + + L + + + + TNLK+ L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAGMQ--FFTNLKELHL 70
Query: 247 VYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKS 305
+N + + P L +L L +LS++ N + L + N S
Sbjct: 71 SHNQI-SDLSP-LKDLTKLEELSVNRNRLKNLNGIPSA---CLSRLFLDNNEL--RDTDS 123
Query: 306 LRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEIS--SNFGECPKLGAL 363
L + +L + + N L +I G L +DL N I+ K+ +
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNE----ITNTGGLTRLKKVNWI 177
Query: 364 NISRNNIT 371
+++
Sbjct: 178 DLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 44/220 (20%), Positives = 85/220 (38%), Gaps = 17/220 (7%)
Query: 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150
F +L L L N++ + P + +LT L LS+ N+ N+ L L++
Sbjct: 59 MQFFTNLKELHLSHNQI-SDLSP-LKDLTKLEELSVNRNRLK-NLNGIPSA--CLSRLFL 113
Query: 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPD 210
D+N+L + L L ++ L++ +N L V LG L+++ +L LH N +
Sbjct: 114 DNNELRDTDSLI--HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGG-- 167
Query: 211 IGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL--DNLVLTKLS 268
+ LK ++ + L + + L + V + I P +
Sbjct: 168 LTRLKKVNWIDLTGQKCV---NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC 224
Query: 269 LDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRN 308
+ Y + + +E F GT+ + ++N
Sbjct: 225 VLWE-LPVYTDEVSYKFSEYINVGETEAIFDGTVTQPIKN 263
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 28/142 (19%), Positives = 53/142 (37%), Gaps = 8/142 (5%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144
+L + L+ L L +N+L + +L NL ILS+ N+ +I +G +S
Sbjct: 96 RLKNLNGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSK 151
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L++L + N++ + L +L + + L L + + D +
Sbjct: 152 LEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW- 208
Query: 205 GFIPPDIGNLKSISILSLAINQ 226
P I N S +
Sbjct: 209 -ISPYYISNGGSYVDGCVLWEL 229
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 33/124 (26%), Positives = 47/124 (37%), Gaps = 18/124 (14%)
Query: 373 DFGIAKFLKPDSS---NWTGFAGTYGYIAPEL---AYTMKITEKCDVYSFGVLVLEVI-K 425
DFG+ K L +G GT G+IAPE+ T D++S G + VI +
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEK-LISIMEVGFSCLKESPESR 484
G HP + L + LD P V + LI + P+ R
Sbjct: 226 GSHPFGKSLQRQANILLGACS----LDCLHPEKHEDVIARELIE------KMIAMDPQKR 275
Query: 485 PTMK 488
P+ K
Sbjct: 276 PSAK 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-12
Identities = 33/117 (28%), Positives = 49/117 (41%), Gaps = 15/117 (12%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
GDFG+A+ L D+S F GT Y++PE M EK D++S G L+ E+ P
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-- 215
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQE--KLISIMEVGFSCLKESPESRPT 486
F ++ S L I +P E ++I+ L RP+
Sbjct: 216 F-TAFSQKELAGKI----REGKFRRIPYRYSDELNEIIT------RMLNLKDYHRPS 261
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 31/118 (26%), Positives = 50/118 (42%), Gaps = 10/118 (8%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
GD G+ +F ++ GT Y++PE + K D++S G L+ E+ + P
Sbjct: 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP-- 235
Query: 432 FLSSTSS-PSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
F + SL I + P LP S E+L ++ C+ PE RP +
Sbjct: 236 FYGDKMNLYSLCKKIEQCDY--PPLPSDHYS--EELRQLVN---MCINPDPEKRPDVT 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 24/155 (15%), Positives = 48/155 (30%), Gaps = 35/155 (22%)
Query: 372 GDFGIAKFLKPDSSNW--------TGFAGTYGYIAPE-------LAYTMKITEKCDVYSF 416
DFG++ L + GT Y+APE L ++ D+Y+
Sbjct: 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221
Query: 417 GVLVLEVIKGKHPR--------------DFLSSTSSPSLNTDIALDEMLDPRLP---VPS 459
G++ E+ + + + + E P+ P +
Sbjct: 222 GLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN 281
Query: 460 CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
L +E C + E+R T + +++
Sbjct: 282 SLAVRSLKETIE---DCWDQDAEARLTAQXAEERM 313
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 28/129 (21%), Positives = 49/129 (37%), Gaps = 25/129 (19%)
Query: 372 GDFGIAKFLK------------PDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
GDFG+ + P + TG GT Y++PE + + K D++S G++
Sbjct: 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLI 219
Query: 420 VLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKE 479
+ E++ +P F + TD+ + P L + ++ L
Sbjct: 220 LFELL---YP--FSTQMERVRTLTDVRNLKF--PPLFTQKYPCEYVMVQ------DMLSP 266
Query: 480 SPESRPTMK 488
SP RP
Sbjct: 267 SPMERPEAI 275
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 30/115 (26%), Positives = 47/115 (40%), Gaps = 11/115 (9%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
GDFGIA+ L GT Y++PE+ K D+++ G ++ E+ KH
Sbjct: 167 GDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA-- 224
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
F + S +L I + PV L S++ K +P RP+
Sbjct: 225 F-EAGSMKNLVLKI----ISGSFPPVSLH-YSYDLRSLVS---QLFKRNPRDRPS 270
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-11
Identities = 42/123 (34%), Positives = 63/123 (51%), Gaps = 13/123 (10%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV-GLM 142
KL F S +L L L N+L G +P + +LT L++L LG NQ + +P V +
Sbjct: 54 KLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRL 111
Query: 143 SHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPH----SLGNLTQISMLFL 198
HLK L++ N+L +P + +L+ + LAL N L S+PH L +LT +L
Sbjct: 112 VHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHA---YL 166
Query: 199 HDN 201
N
Sbjct: 167 FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 37/130 (28%), Positives = 56/130 (43%), Gaps = 5/130 (3%)
Query: 99 YLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDG 157
L L DN++ P +L NL L LG NQ +P V ++ L +L + +NQL
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 158 SIPLEV-GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKS 216
+P V +L + EL + N L +P + LT ++ L L N L S
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 217 ISILSLAINQ 226
++ L N
Sbjct: 161 LTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 41/129 (31%), Positives = 57/129 (44%), Gaps = 6/129 (4%)
Query: 219 ILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL-DNLV-LTKLSLDDNHFTS 276
IL L NQ + P +L NLK+ L N L G++P + D+L LT L L N T
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 277 YLPQNIC-RGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPN 335
LP + R L+ + N+ +P+ + T L + LD N L AF +
Sbjct: 103 -LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 336 LTFIDLSRN 344
LT L N
Sbjct: 161 LTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 14/152 (9%)
Query: 104 DNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEV 163
+K ++P I TN IL L NQ + P + +LK LY+ SNQL ++P+ V
Sbjct: 27 RSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGV 83
Query: 164 -GQLSSMVELALFSNNLNGSVPH----SLGNLTQISMLFLHDNSFSGFIPPDIGNLKSIS 218
L+ + L L +N L +P L +L + LF+ N + +P I L ++
Sbjct: 84 FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKE---LFMCCNKLTE-LPRGIERLTHLT 138
Query: 219 ILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250
L+L NQ + L++L L + N
Sbjct: 139 HLALDQNQLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 27/129 (20%), Positives = 48/129 (37%), Gaps = 25/129 (19%)
Query: 372 GDFGIAKFLKPDSS------------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
GDFG+ + D TG GT Y++PE + + K D++S G++
Sbjct: 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLI 265
Query: 420 VLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKE 479
+ E++ + F + + TD+ + P L + ++ L
Sbjct: 266 LFELL---YS--FSTQMERVRIITDVRNLKF--PLLFTQKYPQEHMMVQ------DMLSP 312
Query: 480 SPESRPTMK 488
SP RP
Sbjct: 313 SPTERPEAT 321
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 27/128 (21%), Positives = 52/128 (40%), Gaps = 17/128 (13%)
Query: 364 NISRNNITG-----DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGV 418
NI TG D G+A + + GT ++APE+ Y K E DVY+FG+
Sbjct: 161 NIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-YEEKYDESVDVYAFGM 217
Query: 419 LVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLK 478
+LE+ ++P S + + + + +++I C++
Sbjct: 218 CMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE------GCIR 268
Query: 479 ESPESRPT 486
++ + R +
Sbjct: 269 QNKDERYS 276
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 37/129 (28%), Positives = 53/129 (41%), Gaps = 21/129 (16%)
Query: 373 DFGIAKFLKPDSSNWT----GFAGTYGYIAPEL-------AYTMKITEKCDVYSFGVLVL 421
DFG+ K L S++ +GT G+ APEL ++T D++S G +
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 422 EVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEK-LISIMEVGFSCLKE 479
++ KGKHP S S + +LDEM L S + LIS +
Sbjct: 231 YILSKGKHPFGDKYSRESNIIRGIFSLDEM--KCLHDRSLIAEATDLIS------QMIDH 282
Query: 480 SPESRPTMK 488
P RPT
Sbjct: 283 DPLKRPTAM 291
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 8/147 (5%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV-GLM 142
L +F L +L+L N+L T+ + +LT L L L NQ + ++P V +
Sbjct: 49 TLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHL 106
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPHSL-GNLTQISMLFLHD 200
+ L LY+ NQL S+P V +L+ + EL L +N L S+P LT + L L
Sbjct: 107 TQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLST 164
Query: 201 NSFSGFIPPDIGNLKSISILSLAINQF 227
N L + ++L NQF
Sbjct: 165 NQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 42/155 (27%), Positives = 58/155 (37%), Gaps = 7/155 (4%)
Query: 196 LFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSI 255
L L + L ++ L+L NQ +LT L L N L S+
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL-ASL 98
Query: 256 PPSL-DNLV-LTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQGTIPKSL-RNCTS 311
P + D+L L KL L N S LP + L+ ++ N+ Q +IP T+
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156
Query: 312 LIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNF 346
L + L N L AF L I L N F
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 48/177 (27%), Positives = 73/177 (41%), Gaps = 13/177 (7%)
Query: 104 DNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEV 163
K ++P I + L L + ++ L L +D NQL ++ V
Sbjct: 22 QGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGV 78
Query: 164 -GQLSSMVELALFSNNLNGSVPHSL-GNLTQISMLFLHDNSFSGFIPPDI-GNLKSISIL 220
L+ + L L +N L S+P + +LTQ+ L+L N +P + L + L
Sbjct: 79 FDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKEL 136
Query: 221 SLAINQFSGPIPLSL-GNLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLDDNHF 274
L NQ IP LTNL+ SL N S+P + D L L ++L N F
Sbjct: 137 RLNTNQLQS-IPAGAFDKLTNLQTLSL-STNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 100 LDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDGS 158
LDL+ L LT L+ L+L NQ + V ++ L L + +NQL S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 159 IPLEV-GQLSSMVELALFSNNLNGSVPHSL-GNLTQISMLFLHDNSFSGFIPPDI-GNLK 215
+PL V L+ + +L L N L S+P + LT++ L L+ N IP L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLT 155
Query: 216 SISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250
++ LSL+ NQ + L L+ +L + N
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITL-FGN 189
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 42/121 (34%), Positives = 65/121 (53%), Gaps = 8/121 (6%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISN-LTNLSILSLGGNQFSGNIPHEV-GLM 142
L F L L L NKL ++P + N LT+L+ L+L NQ ++P+ V +
Sbjct: 42 SLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKL 99
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSNNLNGSVPH-SLGNLTQISMLFLHD 200
+ LK L +++NQL S+P V +L+ + +L L+ N L SVP LT + ++LHD
Sbjct: 100 TQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHD 157
Query: 201 N 201
N
Sbjct: 158 N 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 44/133 (33%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 99 YLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDG 157
YLDL N L LT+L+ L LGGN+ ++P+ V ++ L L + +NQL
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 158 SIPLEV-GQLSSMVELALFSNNLNGSVPHSL-GNLTQISMLFLHDNSFSGFIPPDI-GNL 214
S+P V +L+ + ELAL +N L S+P + LTQ+ L L+ N +P + L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRL 147
Query: 215 KSISILSLAINQF 227
S+ + L N +
Sbjct: 148 TSLQYIWLHDNPW 160
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 42/175 (24%), Positives = 59/175 (33%), Gaps = 37/175 (21%)
Query: 104 DNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEV 163
++ ++P I + L L N ++ L LY+ N+L L
Sbjct: 15 YSQGRTSVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS---LPN 69
Query: 164 GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI-GNLKSISILSL 222
G V + L +LT L L N +P + L + L+L
Sbjct: 70 G------------------VFNKLTSLTY---LNLSTNQLQS-LPNGVFDKLTQLKELAL 107
Query: 223 AINQFSGPIPLSLG---NLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLDDN 272
NQ L G LT LK L Y N S+P D L L + L DN
Sbjct: 108 NTNQLQS---LPDGVFDKLTQLKDLRL-YQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 33/137 (24%), Positives = 55/137 (40%), Gaps = 22/137 (16%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGT---YGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGK 427
GDFG+ + L + ++ + + APE T + D + FGV + E+ G+
Sbjct: 163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222
Query: 428 HPRDFLSSTSSPSLNTDIALDEMLDP---RLPVP-SCSVQEKLISIMEVGFSCLKESPES 483
P L+ + I +D RLP P C + + ++M C PE
Sbjct: 223 EPWIGLN-------GSQIL--HKIDKEGERLPRPEDCP--QDIYNVMV---QCWAHKPED 268
Query: 484 RPTMKIVSQQLRISAPS 500
RPT + L + P+
Sbjct: 269 RPTFVALRDFLLEAQPT 285
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 37/133 (27%), Positives = 58/133 (43%), Gaps = 25/133 (18%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI-----APELAYTMKITEKCDVYSFGVLVLEVI-K 425
DFG++K L+ D + + A T+G APE K + K DV+SFGVL+ E
Sbjct: 159 SDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 216
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCSVQEKLISIMEVGFSCLKESPE 482
G+ P + +++ ML+ R+ P C ++ +M C E
Sbjct: 217 GQKPYRGMK-------GSEVT--AMLEKGERMGCPAGCP--REMYDLM---NLCWTYDVE 262
Query: 483 SRPTMKIVSQQLR 495
+RP V +LR
Sbjct: 263 NRPGFAAVELRLR 275
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 41/182 (22%), Positives = 68/182 (37%), Gaps = 20/182 (10%)
Query: 104 DNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEV 163
+ P +L + + + L S + + +++ + ++
Sbjct: 6 STPIKQIFPDDAF--AETIKANLKKKSVT-DAVTQNELNS-IDQIIANNSDIKSVQGIQ- 60
Query: 164 GQLSSMVELALFSNNLNGSVPHSLG---NLTQISMLFLHDNSFSGFIPPDI-GNLKSISI 219
L ++ LAL N L H + LT ++ L L N +P + L ++
Sbjct: 61 -YLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKE 113
Query: 220 LSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL-DNLV-LTKLSLDDNHFTSY 277
L L NQ LTNL +L +N L S+P + D L LT+L L N S
Sbjct: 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQS- 171
Query: 278 LP 279
LP
Sbjct: 172 LP 173
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 62 SGISCNDAGRVINISLRGVGLKGKLHAF--SFSSFPHLAYLDLRDNKLFGTIPPQISNLT 119
LK K + + + + ++ + I L
Sbjct: 15 DDAFA---------ETIKANLKKKSVTDAVTQNELNSIDQIIANNSDI--KSVQGIQYLP 63
Query: 120 NLSILSLGGNQFSGNIPHEVGL---MSHLKILYIDSNQLDGSIPLEV-GQLSSMVELALF 175
N+ L+LGGN+ ++ +++L L + NQL S+P V +L+++ EL L
Sbjct: 64 NVRYLALGGNKLH-----DISALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLV 117
Query: 176 SNNLNGSVPHSLGN-LTQISMLFLHDNSFSGFIPPDI-GNLKSISILSLAINQFSGPIPL 233
N L S+P + + LT ++ L L N +P + L +++ L L+ NQ L
Sbjct: 118 ENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQS---L 172
Query: 234 SLG---NLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLDDN 272
G LT LK L N L S+P D L L + L DN
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 215
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 28/105 (26%), Positives = 53/105 (50%), Gaps = 7/105 (6%)
Query: 100 LDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDGS 158
L L N+ +P ++SN +L+++ L N+ S + ++ M+ L L + N+L
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL-RC 92
Query: 159 IPLEV-GQLSSMVELALFSNNLNGSVPH-SLGNLTQISMLFLHDN 201
IP L S+ L+L N+++ VP + +L+ +S L + N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 91 FSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKI 147
S++ HL +DL +N++ T+ Q SN+T L L L N+ IP GL S L++
Sbjct: 50 LSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKS-LRL 106
Query: 148 LYIDSNQLDGSIPLEV-GQLSSMVELALFSN 177
L + N + +P LS++ LA+ +N
Sbjct: 107 LSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 28/83 (33%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 196 LFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSI 255
L+L N F+ +P ++ N K ++++ L+ N+ S S N+T L L YN L I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RCI 93
Query: 256 PPSL-DNLV-LTKLSLDDNHFTS 276
PP D L L LSL N +
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISV 116
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 27/75 (36%), Positives = 35/75 (46%), Gaps = 6/75 (8%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GL 141
L SFS+ L L L N+L IPP+ L +L +LSL GN S +P L
Sbjct: 68 TLSNQSFSNMTQLLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL 125
Query: 142 MSHLKILYIDSNQLD 156
+ L L I +N L
Sbjct: 126 SA-LSHLAIGANPLY 139
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 33/136 (24%), Positives = 48/136 (35%), Gaps = 34/136 (25%)
Query: 372 GDFGIAKFLKPDSSN-----------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLV 420
DFG+++ WT APE + + + DV+SFG+L+
Sbjct: 255 SDFGMSREEADGVYAASGGLRQVPVKWT---------APEALNYGRYSSESDVWSFGILL 305
Query: 421 LEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLK 478
E G P LS N RLP P C + + +ME C
Sbjct: 306 WETFSLGASPYPNLS-------NQQTREFVEKGGRLPCPELCP--DAVFRLME---QCWA 353
Query: 479 ESPESRPTMKIVSQQL 494
P RP+ + Q+L
Sbjct: 354 YEPGQRPSFSTIYQEL 369
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 33/138 (23%), Positives = 52/138 (37%), Gaps = 38/138 (27%)
Query: 372 GDFGIAKFLKPDSS-----------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLV 420
DFG+AK L + W A E T + DV+S+GV V
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWM---------ALESILHRIYTHQSDVWSYGVTV 209
Query: 421 LEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSC 476
E++ G P D + ++I+ +L+ RLP P C+ + IM C
Sbjct: 210 WELMTFGSKPYDGIP-------ASEIS--SILEKGERLPQPPICT--IDVYMIM---RKC 255
Query: 477 LKESPESRPTMKIVSQQL 494
+SRP + + +
Sbjct: 256 WMIDADSRPKFRELIIEF 273
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 9e-09
Identities = 34/133 (25%), Positives = 56/133 (42%), Gaps = 25/133 (18%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI-----APELAYTMKITEKCDVYSFGVLVLEVI-K 425
DFG++K L D S +T A + G APE K + + DV+S+GV + E +
Sbjct: 152 SDFGLSKALGADDSYYT--ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 209
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCSVQEKLISIMEVGFSCLKESPE 482
G+ P + ++ ++ R+ P C +L ++M C E
Sbjct: 210 GQKPYKKMK-------GPEVM--AFIEQGKRMECPPECP--PELYALM---SDCWIYKWE 255
Query: 483 SRPTMKIVSQQLR 495
RP V Q++R
Sbjct: 256 DRPDFLTVEQRMR 268
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 34/138 (24%), Positives = 52/138 (37%), Gaps = 21/138 (15%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI-----APELAYTMKITEKCDVYSFGVLVLEVI-K 425
DFG+AK L D + G APE + + DV+SFGV++ E+
Sbjct: 169 ADFGLAKLLPLDKDYYV--VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 226
Query: 426 GKHPRDFLSSTSSPSLNT--DIALDEMLDP-----RLPVPS-CSVQEKLISIMEVGFSCL 477
+ AL +L+ RLP P C ++ +M+ C
Sbjct: 227 CDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACP--AEVHELMK---LCW 281
Query: 478 KESPESRPTMKIVSQQLR 495
SP+ RP+ + QL
Sbjct: 282 APSPQDRPSFSALGPQLD 299
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 27/119 (22%), Positives = 40/119 (33%), Gaps = 23/119 (19%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPEL---AYTMKITEKCDVYSFGVLVLEVIKGKH 428
GDFG+ L + G Y+APEL +Y DV+S G+ +LEV
Sbjct: 199 GDFGLLVELGTAGAGEV-QEGDPRYMAPELLQGSYG----TAADVFSLGLTILEVACNME 253
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEK-LISIMEVGFSCLKESPESRPT 486
L L P S + + ++ L+ P+ R T
Sbjct: 254 L--PHGGEGWQQLRQGY-----LPPEFT-AGLSSELRSVLV------MMLEPDPKLRAT 298
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 27/146 (18%)
Query: 360 LGALNI--SRNNI--TGDFGIAKFLKPDSSNWTGFAGTYGYI---APELAYTMKITEKCD 412
L A NI S + + DFG+A+ ++ + +T G I APE T K D
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 413 VYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLIS 468
V+SFG+L++E++ G+ P +S N ++ L+ R+P P C E+L +
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMS-------NPEVI--RALERGYRMPRPENCP--EELYN 416
Query: 469 IMEVGFSCLKESPESRPTMKIVSQQL 494
IM C K PE RPT + + L
Sbjct: 417 IM---MRCWKNRPEERPTFEYIQSVL 439
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 32/131 (24%), Positives = 55/131 (41%), Gaps = 21/131 (16%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI---APELAYTMKITEKCDVYSFGVLVLEVI-KGK 427
DFG++K L D S +T + + APE K + + DV+S+GV + E + G+
Sbjct: 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 537
Query: 428 HPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCSVQEKLISIMEVGFSCLKESPESR 484
P + ++ ++ R+ P C +L ++M C E R
Sbjct: 538 KPYKKMK-------GPEVM--AFIEQGKRMECPPECP--PELYALM---SDCWIYKWEDR 583
Query: 485 PTMKIVSQQLR 495
P V Q++R
Sbjct: 584 PDFLTVEQRMR 594
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 41/153 (26%)
Query: 360 LGALNI--SRNNIT--GDFGIAKFLKPDSSN----------WTGFAGTYGYIAPELAYTM 405
L A NI N + DFG+A+ ++ + WT APE A
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---------APEAALYG 356
Query: 406 KITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCS 461
+ T K DV+SFG+L+ E+ KG+ P + N ++ + ++ R+P P C
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVL--DQVERGYRMPCPPECP 407
Query: 462 VQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
E L +M C ++ PE RPT + + L
Sbjct: 408 --ESLHDLM---CQCWRKEPEERPTFEYLQAFL 435
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 18/50 (36%), Positives = 29/50 (58%), Gaps = 8/50 (16%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPEL----AYTMKITEKCDVYSFGV 418
DFG+A ++ + W GFAGT GY++PE+ Y + D+++ GV
Sbjct: 156 DFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY----GKPVDLWACGV 201
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 28/137 (20%), Positives = 53/137 (38%), Gaps = 21/137 (15%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI-----APELAYTMKITEKCDVYSFGVLVLEVI-K 425
GDFG+ K ++ D +T APE K DV+SFGV + E++
Sbjct: 168 GDFGLTKAIETDKEYYT--VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225
Query: 426 GKHPRDFLSSTSSPSLNT--DIALDEMLDP-----RLPVPS-CSVQEKLISIMEVGFSCL 477
++ T + + +++ RLP P C +++ +M C
Sbjct: 226 CDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCP--DEVYQLMR---KCW 280
Query: 478 KESPESRPTMKIVSQQL 494
+ P +R + + + +
Sbjct: 281 EFQPSNRTSFQNLIEGF 297
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 18/58 (31%), Positives = 26/58 (44%), Gaps = 1/58 (1%)
Query: 373 DFGIAKFLKPDSSNWTGFA-GTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFGIA + G GT Y+APE T + D+Y+ ++ E + G P
Sbjct: 177 DFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 23/58 (39%), Positives = 31/58 (53%), Gaps = 1/58 (1%)
Query: 373 DFGIAKFLKPDSSNWTGFA-GTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFGIAK L S T GT Y +PE A E D+YS G+++ E++ G+ P
Sbjct: 154 DFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 30/133 (22%), Positives = 47/133 (35%), Gaps = 27/133 (20%)
Query: 372 GDFGIAKFLKPDSSNW--------------TGFAGTYGYIAPE-LAYTMKITEKCDVYSF 416
GDFG+AK + T GT Y+A E L T EK D+YS
Sbjct: 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217
Query: 417 GVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM-LDPRLPVPSCSVQEKLISIMEVGFS 475
G++ E+I F + ++ + + P V++K+I
Sbjct: 218 GIIFFEMIYP-----FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR------L 266
Query: 476 CLKESPESRPTMK 488
+ P RP +
Sbjct: 267 LIDHDPNKRPGAR 279
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 32/127 (25%), Positives = 51/127 (40%), Gaps = 32/127 (25%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE--------LAYTMKITEKCDVYSFGVLVLEVI 424
DFGI+ +L D AG Y+APE Y++K D++S G+ ++E+
Sbjct: 153 DFGISGYLV-DDVAKDIDAGCKPYMAPERINPELNQKGYSVK----SDIWSLGITMIELA 207
Query: 425 KGKHPRDFLSSTSSPSLNTDIALDEML----DPRLPVPSCSVQ-EKLISIMEVGFSCLKE 479
+ P S T + + P+LP S + S CLK+
Sbjct: 208 ILRFPY--------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS------QCLKK 253
Query: 480 SPESRPT 486
+ + RPT
Sbjct: 254 NSKERPT 260
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 23/134 (17%), Positives = 45/134 (33%), Gaps = 35/134 (26%)
Query: 372 GDFGIAKFLKPDSS-----NWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVLVLEVI- 424
D GI+ + P W PE + + D +SFG + E+
Sbjct: 163 SDPGISITVLPKDILQERIPWV---------PPECIENPKNLNLATDKWSFGTTLWEICS 213
Query: 425 KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCSVQEKLISIMEVGFSCLKESP 481
G P L + + + +LP P + + ++ +C+ P
Sbjct: 214 GGDKPLSALD-------SQRKL--QFYEDRHQLPAPKAAELAN----LIN---NCMDYEP 257
Query: 482 ESRPTMKIVSQQLR 495
+ RP+ + + + L
Sbjct: 258 DHRPSFRAIIRDLN 271
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 41/153 (26%)
Query: 360 LGALNI--SRNNIT--GDFGIAKFLKPDSSN----------WTGFAGTYGYIAPELAYTM 405
L A NI N + DFG+A+ ++ + WT APE A
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---------APEAALYG 439
Query: 406 KITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCS 461
+ T K DV+SFG+L+ E+ KG+ P + N ++ + ++ R+P P C
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVL--DQVERGYRMPCPPECP 490
Query: 462 VQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
E L +M C ++ PE RPT + + L
Sbjct: 491 --ESLHDLM---CQCWRKEPEERPTFEYLQAFL 518
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 27/146 (18%)
Query: 360 LGALNI--SRNNIT--GDFGIAKFLKPDSSNWTGFAGT---YGYIAPELAYTMKITEKCD 412
L A N N++ DFG+++ + D+ +T AG + APE K + K D
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 413 VYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCSVQEKLIS 468
V++FGVL+ E+ G P + + + E+L+ R+ P C EK+
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGID-------LSQVY--ELLEKDYRMERPEGCP--EKVYE 450
Query: 469 IMEVGFSCLKESPESRPTMKIVSQQL 494
+M +C + +P RP+ + Q
Sbjct: 451 LM---RACWQWNPSDRPSFAEIHQAF 473
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 43/153 (28%), Positives = 64/153 (41%), Gaps = 41/153 (26%)
Query: 360 LGALNI--SRNNIT--GDFGIAKFLKPD----SSN------WTGFAGTYGYIAPELAYTM 405
L A N N + DFG+ +F+ D S+ W +PE+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---------SPEVFSFS 180
Query: 406 KITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCS 461
+ + K DV+SFGVL+ EV +GK P + S N+++ E + RL P S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVV--EDISTGFRLYKPRLAS 231
Query: 462 VQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
+ IM C +E PE RP + +QL
Sbjct: 232 --THVYQIMN---HCWRERPEDRPAFSRLLRQL 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 52/365 (14%), Positives = 98/365 (26%), Gaps = 98/365 (26%)
Query: 74 NISLRGVGLKG--------KLHAFSFSSFPHLAYLDLRDNKL----FGTIPPQISNLTNL 121
S+ G LK K + + L N + + I++ +L
Sbjct: 3 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62
Query: 122 SILSLGGNQFSGNIPHEVGL-----------MSHLKILYIDSNQL--DGSIPLEVG--QL 166
I F+G + E+ L + + N PL +
Sbjct: 63 EIAEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121
Query: 167 SSMVELALFSNNL-------------NGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGN 213
+ + L L +N L +V N + + N + N
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN--------RLEN 173
Query: 214 LKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY-----GSIPPSL-DNLVLTKL 267
S+ + + L +V N + + L L L
Sbjct: 174 -GSMKEWAKT-----------FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVL 221
Query: 268 SLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGN-- 325
L DN FT G+ + +L++ +L + L+ L+
Sbjct: 222 DLQDNTFTH--------LGSSALA------------IALKSWPNLRELGLNDCLLSARGA 261
Query: 326 --ISKAFGIYPN--LTFIDLSRNNFYGEISSNFGE-----CPKLGALNISRNNITGDFGI 376
+ AF N L + L N + P L L ++ N + + +
Sbjct: 262 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 321
Query: 377 AKFLK 381
++
Sbjct: 322 VDEIR 326
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 24/141 (17%), Positives = 40/141 (28%), Gaps = 40/141 (28%)
Query: 259 LDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
+ + SL + I +F L S+ + L
Sbjct: 1 MARFSIEGKSLKLD--------AITTEDEKSVF------------AVLLEDDSVKEIVLS 40
Query: 319 GNNLTGN----ISKAFGIYPNLTFIDLSRNNFYGEISSNFGE-----------CPKLGAL 363
GN + +S+ +L + S + F G + E CPKL +
Sbjct: 41 GNTIGTEAARWLSENIASKKDLEIAEFS-DIFTGRVKDEIPEALRLLLQALLKCPKLHTV 99
Query: 364 NISRNNITGDFG---IAKFLK 381
+S N G + FL
Sbjct: 100 RLSDNAF-GPTAQEPLIDFLS 119
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 8e-08
Identities = 71/458 (15%), Positives = 134/458 (29%), Gaps = 144/458 (31%)
Query: 19 ETNEEADALLKWKASLQIHNRSLL------SSWIKDTSNVSSKISPCAWSGISCNDAG-- 70
E LLK K + LL ++ + N+S KI ++
Sbjct: 229 SIQAELRRLLKSKP----YENCLLVLLNVQNAKAWNAFNLSCKIL------LTTRFKQVT 278
Query: 71 -RVINISLRGVGLKGKLHAFS-------FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLS 122
+ + + L + YLD R L P ++ TN
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLK-----YLDCRPQDL----PREVLT-TNPR 328
Query: 123 ILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGS 182
LS+ + +I + + K +++ ++L I + L +F
Sbjct: 329 RLSI----IAESIRDGLATWDNWK--HVNCDKLTTIIESSLNVLEPAEYRKMF------- 375
Query: 183 VPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLK 242
L +F PP IP L
Sbjct: 376 --DRLS-------VF----------PPSA------------------HIPTIL------- 391
Query: 243 QFSLVYNNLYGSIPPSLDNLVLTKLSL---DDNHFTSYLPQNICRGGALQIFTVSENRFQ 299
SL++ ++ S + N L K SL T +P + + + +
Sbjct: 392 -LSLIWFDVIKSDVMVVVNK-LHKYSLVEKQPKESTISIPS-------IYLELKVKLENE 442
Query: 300 GTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPK 359
+ +S+ + ++ + D ++L ++D FY I +
Sbjct: 443 YALHRSIVDHYNIPK-TFDSDDLI------------PPYLD---QYFYSHIGHHLKNIEH 486
Query: 360 LGALNISRNNITGDFG-IAKFLKPDSSNWTGFAGTYGYIAPELA----YTMKITEKCDVY 414
+ + R + DF + + ++ DS+ W G I L Y I + Y
Sbjct: 487 PERMTLFR-MVFLDFRFLEQKIRHDSTAWNA----SGSILNTLQQLKFYKPYICDNDPKY 541
Query: 415 SFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLD 452
LV ++ DFL P + ++ + D
Sbjct: 542 E--RLVNAIL------DFL-----PKIEENLICSKYTD 566
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 2e-07
Identities = 68/488 (13%), Positives = 149/488 (30%), Gaps = 124/488 (25%)
Query: 74 NISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSG 133
N+ + GV GK + +A K+ + +I L
Sbjct: 152 NVLIDGVLGSGK------TW---VALDVCLSYKVQCKMDFKIFWLN------------LK 190
Query: 134 NIPHEVGLMSHLKILY--IDSN---QLDGS--IPLEVGQLSSMVELALFSNNLNGSVPHS 186
N ++ L+ L ID N + D S I L + + + + L S +
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY----ENC 246
Query: 187 LGNLTQISMLFLHD----NSFSGFIPPDIGNLKS-ISILSLAINQFSGPIPLSLGNLTNL 241
L L L + +++ F NL I L +F + L T
Sbjct: 247 L--------LVLLNVQNAKAWNAF------NLSCKI----LLTTRFKQ-VTDFLSAATT- 286
Query: 242 KQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSE------ 295
SL ++ P + +L+L L LP+ + ++ ++E
Sbjct: 287 THISLD-HHSMTLTPDEVKSLLLKYLDCR----PQDLPREVLTTNPRRLSIIAESIRDGL 341
Query: 296 NRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK----AFGIYP---NLTFIDLSR---NN 345
+ + T++I L N L + ++P ++ I LS +
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSL--NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 346 FYGEISSNFGECPKLGALNISRNNIT---------------GDFG-----IAKFLKPDSS 385
++ + K + T ++ + + P +
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 386 NWTGFAGTY--GYIAPELAYTMKITEKCDVYS-FGVLVLEV--IKGKHPRDFLSSTSSPS 440
+ Y Y + + +K E + + F ++ L+ ++ K + S+
Sbjct: 460 DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK-----IRHDSTAW 514
Query: 441 LNTDIALDEMLDPRL----PVPSCSVQEKLI-SIMEVGFSC---LKESPESRPTMKIVSQ 492
+ L+ + + + E+L+ +I++ L S + ++
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTD----LL-- 568
Query: 493 QLRISAPS 500
++ + A
Sbjct: 569 RIALMAED 576
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 20/122 (16%), Positives = 30/122 (24%), Gaps = 18/122 (14%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPEL--AYTMKITEKCDVYSFGVLVLEVIKGKHP 429
GD + + Y E A T T + + G+ + V P
Sbjct: 236 GDVSALW---KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
Query: 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCS-----VQEKLISIMEVGFSCLKESPESR 484
L + +L L SC+ V+ LI L R
Sbjct: 293 FG-LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-LIG------RFLNFDRRRR 344
Query: 485 PT 486
Sbjct: 345 LL 346
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 373 DFGIAKFLKPDSSNWTGFA---GTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFGIA+ + ++ T A GT Y++PE A + + DVYS G ++ EV+ G+ P
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 29/138 (21%), Positives = 51/138 (36%), Gaps = 21/138 (15%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI-----APELAYTMKITEKCDVYSFGVLVLEVI-K 425
GDFG+AK + + G APE K DV+SFGV + E++
Sbjct: 176 GDFGLAKAVPEGHEYYR--VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233
Query: 426 GKHPRDFLSSTSSPSLNT--DIALDEMLDP-----RLPVP-SCSVQEKLISIMEVGFSCL 477
+ + + + + + RLP P C ++ +M+ +C
Sbjct: 234 CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCP--AEVYHLMK---NCW 288
Query: 478 KESPESRPTMKIVSQQLR 495
+ RPT + + L+
Sbjct: 289 ETEASFRPTFENLIPILK 306
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 35/149 (23%), Positives = 57/149 (38%), Gaps = 37/149 (24%)
Query: 360 LGALNI--SRNNIT--GDFGIAKFLKPDSSN------WTGFAGTYGYIAPELAYTMKITE 409
L A N+ S +N+ DFG+ K WT APE K +
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALREKKFST 365
Query: 410 KCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEK 465
K DV+SFG+L+ E+ G+ P + D+ ++ ++ P C
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVV--PRVEKGYKMDAPDGCP--PA 414
Query: 466 LISIMEVGFSCLKESPESRPTMKIVSQQL 494
+ +M +C +RPT + +QL
Sbjct: 415 VYDVM---KNCWHLDAATRPTFLQLREQL 440
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 33/138 (23%), Positives = 51/138 (36%), Gaps = 38/138 (27%)
Query: 372 GDFGIAKFLKPDSS-----------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLV 420
DFG+A L PD W A E + K T + DV+S+GV V
Sbjct: 157 ADFGVADLLPPDDKQLLYSEAKTPIKWM---------ALESIHFGKYTHQSDVWSYGVTV 207
Query: 421 LEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSC 476
E++ G P L ++ ++L+ RL P C+ + +M C
Sbjct: 208 WELMTFGAEPYAGLR-------LAEVP--DLLEKGERLAQPQICT--IDVYMVM---VKC 253
Query: 477 LKESPESRPTMKIVSQQL 494
RPT K ++ +
Sbjct: 254 WMIDENIRPTFKELANEF 271
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 33/127 (25%), Positives = 47/127 (37%), Gaps = 29/127 (22%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE----LAYTMKITEKCDVYSFGVLVLEVIKGKH 428
DFGI+ L DS T AG Y+APE A + DV+S G+ + E+ G+
Sbjct: 169 DFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFS---------CLKE 479
P P N+ + + P +L + E FS CL +
Sbjct: 228 PY--------PKWNSVFDQLTQV-VKGDPP------QLSNSEEREFSPSFINFVNLCLTK 272
Query: 480 SPESRPT 486
RP
Sbjct: 273 DESKRPK 279
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 8/91 (8%)
Query: 91 FSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKI 147
F PHL L+L+ N+L I P +++ L LG N+ I +++ GL LK
Sbjct: 50 FGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGL-HQLKT 106
Query: 148 LYIDSNQLDGSIPLEV-GQLSSMVELALFSN 177
L + NQ+ + L+S+ L L SN
Sbjct: 107 LNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 34/127 (26%), Positives = 53/127 (41%), Gaps = 9/127 (7%)
Query: 105 NKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDGSIPLEV 163
+ IP I + + L L N+ + G + HL L + NQL I
Sbjct: 17 GRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNA 73
Query: 164 -GQLSSMVELALFSNNLNGSVPHSL-GNLTQISMLFLHDNSFSGFIPPDI-GNLKSISIL 220
S + EL L N + + + + L Q+ L L+DN S + P +L S++ L
Sbjct: 74 FEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSL 131
Query: 221 SLAINQF 227
+LA N F
Sbjct: 132 NLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 23/98 (23%), Positives = 39/98 (39%), Gaps = 6/98 (6%)
Query: 182 SVPHSLGNLTQISMLFLHDNSFSGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTN 240
+P + T L L+DN + G L + L L NQ +G P + ++
Sbjct: 22 EIPRDIPLHTTE--LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 241 LKQFSLVYNNLYGSIPPSL-DNLV-LTKLSLDDNHFTS 276
+++ L N + I + L L L+L DN +
Sbjct: 80 IQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQISC 116
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 33/138 (23%), Positives = 52/138 (37%), Gaps = 38/138 (27%)
Query: 372 GDFGIAKFLKPDSS-----------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLV 420
DFG+AK L + W A E T + DV+S+GV V
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWM---------ALESILHRIYTHQSDVWSYGVTV 209
Query: 421 LEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSC 476
E++ G P D + ++I+ +L+ RLP P C+ + IM C
Sbjct: 210 WELMTFGSKPYDGIP-------ASEIS--SILEKGERLPQPPICT--IDVYMIM---VKC 255
Query: 477 LKESPESRPTMKIVSQQL 494
+SRP + + +
Sbjct: 256 WMIDADSRPKFRELIIEF 273
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 42/153 (27%), Positives = 64/153 (41%), Gaps = 41/153 (26%)
Query: 360 LGALNI--SRNNI--TGDFGIAKFLKPD----SSN------WTGFAGTYGYIAPELAYTM 405
L A NI S DFG+A+ ++ + WT APE
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---------APEAINYG 185
Query: 406 KITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCS 461
T K DV+SFG+L+ E++ G+ P ++ N ++ + L+ R+ P +C
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVI--QNLERGYRMVRPDNCP 236
Query: 462 VQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
E+L +M C KE PE RPT + L
Sbjct: 237 --EELYQLM---RLCWKERPEDRPTFDYLRSVL 264
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 37/153 (24%), Positives = 62/153 (40%), Gaps = 41/153 (26%)
Query: 360 LGALNI--SRNNIT--GDFGIAKFLKPD----SSN------WTGFAGTYGYIAPELAYTM 405
L A N N++ DFG+++ + D + WT APE
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------APESLAYN 187
Query: 406 KITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCS 461
K + K DV++FGVL+ E+ G P + + + E+L+ R+ P C
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVY--ELLEKDYRMERPEGCP 238
Query: 462 VQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
EK+ +M +C + +P RP+ + Q
Sbjct: 239 --EKVYELMR---ACWQWNPSDRPSFAEIHQAF 266
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 34/149 (22%), Positives = 57/149 (38%), Gaps = 37/149 (24%)
Query: 360 LGALNI--SRNNIT--GDFGIAKFLKPDSSN------WTGFAGTYGYIAPELAYTMKITE 409
L A N+ S +N+ DFG+ K WT APE K +
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALREKKFST 193
Query: 410 KCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEK 465
K DV+SFG+L+ E+ G+ P + D+ ++ ++ P C
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVV--PRVEKGYKMDAPDGCP--PA 242
Query: 466 LISIMEVGFSCLKESPESRPTMKIVSQQL 494
+ +M+ +C RP+ + +QL
Sbjct: 243 VYEVMK---NCWHLDAAMRPSFLQLREQL 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 33/130 (25%), Positives = 55/130 (42%), Gaps = 24/130 (18%)
Query: 373 DFGIAKFLKPDSSNW--TGFAGTYGYIAPEL-----------AYTMKITEKCDVYSFGVL 419
DFGIA ++PD+++ GT Y+ PE KI+ K DV+S G +
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 420 VLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPS-CSVQEKLISIMEVGFSCLK 478
+ + GK P F N L ++DP + ++ L +++ CLK
Sbjct: 229 LYYMTYGKTP--FQQII-----NQISKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLK 278
Query: 479 ESPESRPTMK 488
P+ R ++
Sbjct: 279 RDPKQRISIP 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 33/130 (25%), Positives = 55/130 (42%), Gaps = 24/130 (18%)
Query: 373 DFGIAKFLKPDSSNW--TGFAGTYGYIAPEL-----------AYTMKITEKCDVYSFGVL 419
DFGIA ++PD+++ GT Y+ PE KI+ K DV+S G +
Sbjct: 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209
Query: 420 VLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLK 478
+ + GK P F N L ++DP + ++ L +++ CLK
Sbjct: 210 LYYMTYGKTP--FQQII-----NQISKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLK 259
Query: 479 ESPESRPTMK 488
P+ R ++
Sbjct: 260 RDPKQRISIP 269
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 11/59 (18%), Positives = 22/59 (37%), Gaps = 2/59 (3%)
Query: 373 DFGIAKFLK--PDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G + +K P + +T T G+ E+ + D + V ++ G +
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 16/101 (15%), Positives = 29/101 (28%), Gaps = 4/101 (3%)
Query: 105 NKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDGSIPLEV 163
+ NL+ L + Q ++ + L+ L I + L + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 164 GQ-LSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSF 203
+ L L N L S+ + L L N
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 3e-07
Identities = 17/93 (18%), Positives = 35/93 (37%), Gaps = 4/93 (4%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQ-ISNLTNLSILSLGGNQFSGNIPHEV-GLMSHLKI 147
+L L + + + + + + L L L++ + + + L
Sbjct: 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSR 84
Query: 148 LYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN 180
L + N L+ S+ + Q S+ EL L N L+
Sbjct: 85 LNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 6e-06
Identities = 16/101 (15%), Positives = 36/101 (35%), Gaps = 1/101 (0%)
Query: 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP-DIGNLKSISILSLAINQFSGPIPLS 234
+ + H L ++ L++ + + D+ L + L++ + P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 235 LGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFT 275
L + +L +N L ++ L L +L L N
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 14/73 (19%), Positives = 23/73 (31%), Gaps = 3/73 (4%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEVGLMS 143
L L L + + L + P LS L+L N ++ +
Sbjct: 46 HLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGL 103
Query: 144 HLKILYIDSNQLD 156
L+ L + N L
Sbjct: 104 SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 10/73 (13%), Positives = 27/73 (36%), Gaps = 3/73 (4%)
Query: 301 TIPKSLRNCTSLIRVRLDGNNLTGNI-SKAFGIYPNLTFIDLSRNNFYGEISSN-FGECP 358
L +L + ++ ++ + L + + ++ ++ + F P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTP 80
Query: 359 KLGALNISRNNIT 371
+L LN+S N +
Sbjct: 81 RLSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 20/118 (16%), Positives = 32/118 (27%), Gaps = 27/118 (22%)
Query: 231 IPLSLGNLTNLKQFSLVYNNLYGSIPP-SLDNLV-LTKLSLDDNHFTSYLPQNICRGGAL 288
L NL + + + L L L L++ +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS---------------- 66
Query: 289 QIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNF 346
+ V+ + F T L R+ L N L K +L + LS N
Sbjct: 67 GLRFVAPDAFHFT--------PRLSRLNLSFNALESLSWKTV-QGLSLQELVLSGNPL 115
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 41/153 (26%), Positives = 66/153 (43%), Gaps = 41/153 (26%)
Query: 360 LGALNI--SRNNIT--GDFGIAKFLKPD----SSN------WTGFAGTYGYIAPELAYTM 405
L A N + + DFG+++++ D S W+ PE+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS---------PPEVLMYS 196
Query: 406 KITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCS 461
K + K D+++FGVL+ E+ GK P + + N++ A E + RL P S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETA--EHIAQGLRLYRPHLAS 247
Query: 462 VQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
EK+ +IM SC E + RPT KI+ +
Sbjct: 248 --EKVYTIMY---SCWHEKADERPTFKILLSNI 275
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 27/138 (19%), Positives = 51/138 (36%), Gaps = 23/138 (16%)
Query: 372 GDFGIAKFLKPDSSN---------WTGFAGTYGYIAPEL----AYTMKITEKCDVYSFGV 418
D G W T Y APEL ++ + I E+ DV+S G
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGC 234
Query: 419 LVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLK 478
++ ++ G+ P + +++ P+ P S ++ + L++ M +
Sbjct: 235 VLYAMMFGEGP--YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ-LLNSM------MT 285
Query: 479 ESPESRPTMKIVSQQLRI 496
P RP + ++ QL
Sbjct: 286 VDPHQRPHIPLLLSQLEA 303
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 41/153 (26%), Positives = 64/153 (41%), Gaps = 41/153 (26%)
Query: 360 LGALNI--SRNNIT--GDFGIAKFLKPD----SSN------WTGFAGTYGYIAPELAYTM 405
L A N R+ DFG+ +++ D S W+ APE+ +
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS---------APEVFHYF 180
Query: 406 KITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCS 461
K + K DV++FG+L+ EV GK P D + N+++ + RL P S
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYT-------NSEVV--LKVSQGHRLYRPHLAS 231
Query: 462 VQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
+ + IM SC E PE RPT + + +
Sbjct: 232 --DTIYQIMY---SCWHELPEKRPTFQQLLSSI 259
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 29/145 (20%), Positives = 52/145 (35%), Gaps = 36/145 (24%)
Query: 372 GDFGIAKFLKPDSSN------------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
GDFG+ K L D W APE K + DV+SFGV+
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWY---------APESLTESKFSVASDVWSFGVV 206
Query: 420 VLEVIKGKHPRDFLSSTSSPSLNT----DIALDEMLDP-----RLPVPS-CSVQEKLISI 469
+ E+ + + + + +++ RLP P C +++ I
Sbjct: 207 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCP--DEIYMI 264
Query: 470 MEVGFSCLKESPESRPTMKIVSQQL 494
M C + RP+ + ++ ++
Sbjct: 265 MT---ECWNNNVNQRPSFRDLALRV 286
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 50/342 (14%), Positives = 110/342 (32%), Gaps = 61/342 (17%)
Query: 88 AFSFSSFPHLAYLDLRDNKL----FGTIPPQI-SNLTNLSILSLGGNQFS----GNIPHE 138
+ + P LA L+LR N+L + + + + LSL + G +
Sbjct: 49 SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108
Query: 139 VGLMSHLKILYIDSNQL--DGSIPLEVGQLS---SMVELALFSNNLN----GSVPHSLGN 189
+ + L+ L++ N L G L G L + +L L +L+ + L
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 190 LTQISMLFLHDNSFSGFIPPDIG----------NLKSISILSLAINQFS----GPIPLSL 235
L + +N + + G + + L L + + +
Sbjct: 169 KPDFKELTVSNNDIN-----EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 236 GNLTNLKQFSLVYNNLYGS----IPPSLD--NLVLTKLSLDDNHFT----SYLPQNICRG 285
+ +L++ +L N L + P L + L L + + T L + +
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283
Query: 286 GALQIFTVSENRFQGT----IPKSLRNC-TSLIRVRLDGNNLTG----NISKAFGIYPNL 336
+L+ +++ N + ++L L + + + T + S L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 337 TFIDLSRNNFYGEISSNFGE-----CPKLGALNISRNNITGD 373
+ +S N + L L ++ +++
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 56/341 (16%), Positives = 107/341 (31%), Gaps = 61/341 (17%)
Query: 96 HLAYLDLRDNKL----FGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLM--------- 142
+ L L++ L G + + L L L L N + GL
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG-----DAGLQLLCEGLLDP 140
Query: 143 -SHLKILYIDSNQLD----GSIPLEVGQLSSMVELALFSNNLNGSVPHSLG-----NLTQ 192
L+ L ++ L + + EL + +N++N + L + Q
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQ 200
Query: 193 ISMLFLHDNSFS----GFIPPDIGNLKSISILSLAINQF--SGPIPLSLGNL---TNLKQ 243
+ L L + + + + S+ L+L N+ G L G L + L+
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260
Query: 244 FSLVYNNL----YGSIPPSL-DNLVLTKLSLDDNHFTSYLPQNICRG-----GALQIFTV 293
+ + G + L L +LSL N + +C L+ V
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320
Query: 294 SENRFQGT----IPKSLRNCTSLIRVRLDGNNLTGNISKAFG-----IYPNLTFIDLSRN 344
F L L+ +++ N L + L + L+
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380
Query: 345 NF----YGEISSNFGECPKLGALNISRNNITGDFGIAKFLK 381
+ +++ L L++S N + GD GI + ++
Sbjct: 381 DVSDSSCSSLAATLLANHSLRELDLSNNCL-GDAGILQLVE 420
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 30/188 (15%), Positives = 61/188 (32%), Gaps = 28/188 (14%)
Query: 214 LKSISILSLAINQFS----GPIPLSLGNLTNLKQFSLVYNNLYGSIPPSL------DNLV 263
L+ ++ L + I +L L + +L N L + +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 264 LTKLSLDDNHFT----SYLPQNICRGGALQIFTVSENRFQGTIPKSL-----RNCTSLIR 314
+ KLSL + T L + LQ +S+N + L L +
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 315 VRLDGNNLT----GNISKAFGIYPNLTFIDLSRNNFYGEISSNFGEC-----PKLGALNI 365
++L+ +L+ ++ P+ + +S N+ + +L AL +
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206
Query: 366 SRNNITGD 373
+T D
Sbjct: 207 ESCGVTSD 214
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 16/47 (34%), Positives = 24/47 (51%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
DFG AK L+ ++ T ++APE+ CD++S GVL
Sbjct: 163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 34/139 (24%), Positives = 54/139 (38%), Gaps = 39/139 (28%)
Query: 372 GDFGIAKFLKPDSSN------------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
DFG+++ L+ D WT APE K T DV+SFG++
Sbjct: 189 SDFGLSRVLEDDPEATYTTSGGKIPIRWT---------APEAISYRKFTSASDVWSFGIV 239
Query: 420 VLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCSVQEKLISIMEVGFS 475
+ EV+ G+ P LS N ++ + ++ RLP P C + +M
Sbjct: 240 MWEVMTYGERPYWELS-------NHEVM--KAINDGFRLPTPMDCP--SAIYQLMM---Q 285
Query: 476 CLKESPESRPTMKIVSQQL 494
C ++ RP + L
Sbjct: 286 CWQQERARRPKFADIVSIL 304
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 33/139 (23%), Positives = 51/139 (36%), Gaps = 39/139 (28%)
Query: 372 GDFGIAKFLKPDSSN------------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
DFG+++ L+ D WT APE + DV+SFGV+
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWT---------APEAIAFRTFSSASDVWSFGVV 243
Query: 420 VLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCSVQEKLISIMEVGFS 475
+ EV+ G+ P ++ N D+ ++ RLP P C L +M
Sbjct: 244 MWEVLAYGERPYWNMT-------NRDVI--SSVEEGYRLPAPMGCP--HALHQLM---LD 289
Query: 476 CLKESPESRPTMKIVSQQL 494
C + RP + L
Sbjct: 290 CWHKDRAQRPRFSQIVSVL 308
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 18/47 (38%), Positives = 23/47 (48%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
DFG A+ PD+ T Y APEL E CD++S GV+
Sbjct: 152 DFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVI 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 14/46 (30%), Positives = 23/46 (50%), Gaps = 1/46 (2%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGV 418
DFG++K ++ GT GY APE+ + D++S G+
Sbjct: 194 DFGLSKIVEHQVL-MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 21/47 (44%), Positives = 25/47 (53%), Gaps = 2/47 (4%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
DFG++ F D GT YIAPE K EKCDV+S GV+
Sbjct: 192 DFGLSSFFSKDYK-LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVI 236
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 29/138 (21%), Positives = 53/138 (38%), Gaps = 22/138 (15%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI-----APELAYTMKITEKCDVYSFGVLVLEVIKG 426
GDFG+ K L D + G APE K + DV+SFGV++ E+
Sbjct: 187 GDFGLTKVLPQDKEYYK--VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244
Query: 427 KHPRDFLSSTSSPSLNT----DIALDEMLDP-----RLPVPS-CSVQEKLISIMEVGFSC 476
+ + + + +++ RLP P C +++ IM C
Sbjct: 245 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCP--DEIYMIMT---EC 299
Query: 477 LKESPESRPTMKIVSQQL 494
+ RP+ + ++ ++
Sbjct: 300 WNNNVNQRPSFRDLALRV 317
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 32/138 (23%), Positives = 52/138 (37%), Gaps = 37/138 (26%)
Query: 372 GDFGIAKFLKPDSSN----------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVL 421
GDFG++++++ + W +PE + T DV+ F V +
Sbjct: 155 GDFGLSRYIEDEDYYKASVTRLPIKWM---------SPESINFRRFTTASDVWMFAVCMW 205
Query: 422 EVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCSVQEKLISIMEVGFSCL 477
E++ GK P +L N D+ +L+ RLP P C L ++M C
Sbjct: 206 EILSFGKQPFFWLE-------NKDVI--GVLEKGDRLPKPDLCP--PVLYTLMT---RCW 251
Query: 478 KESPESRPTMKIVSQQLR 495
P RP + L
Sbjct: 252 DYDPSDRPRFTELVCSLS 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 32/130 (24%), Positives = 54/130 (41%), Gaps = 24/130 (18%)
Query: 373 DFGIAKFLKPDSSNW--TGFAGTYGYIAPEL-----------AYTMKITEKCDVYSFGVL 419
DFGIA ++PD+++ G Y+ PE KI+ K DV+S G +
Sbjct: 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256
Query: 420 VLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLK 478
+ + GK P F N L ++DP + ++ L +++ CLK
Sbjct: 257 LYYMTYGKTP--FQQII-----NQISKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLK 306
Query: 479 ESPESRPTMK 488
P+ R ++
Sbjct: 307 RDPKQRISIP 316
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 33/125 (26%), Positives = 47/125 (37%), Gaps = 26/125 (20%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITE-----KCDVYSFGVLVLEVIKGK 427
DFGI+ L D AG Y+APE T+ + DV+S G+ ++E+ G+
Sbjct: 168 DFGISGRLV-DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
Query: 428 HPRDFLSSTSSPSLNTDI-ALDEMLD---PRLPVPSCSVQEKLISIMEVGF--SCLKESP 481
P + TD L ++L P LP S F CL +
Sbjct: 227 FPY--------KNCKTDFEVLTKVLQEEPPLLP------GHMGFSGDFQSFVKDCLTKDH 272
Query: 482 ESRPT 486
RP
Sbjct: 273 RKRPK 277
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 34/139 (24%), Positives = 55/139 (39%), Gaps = 39/139 (28%)
Query: 372 GDFGIAKFLKPDSSN------------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
DFG+ + L+ D WT +PE K T DV+S+G++
Sbjct: 189 SDFGLGRVLEDDPEAAYTTRGGKIPIRWT---------SPEAIAYRKFTSASDVWSYGIV 239
Query: 420 VLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCSVQEKLISIMEVGFS 475
+ EV+ G+ P +S N D+ + +D RLP P C L +M
Sbjct: 240 LWEVMSYGERPYWEMS-------NQDVI--KAVDEGYRLPPPMDCP--AALYQLM---LD 285
Query: 476 CLKESPESRPTMKIVSQQL 494
C ++ +RP + + L
Sbjct: 286 CWQKDRNNRPKFEQIVSIL 304
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 5/99 (5%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI---TEKCDVYSFGVLVLEVIKGKHP 429
DF IA L ++ T AGT Y+APE+ + K + D +S GV E+++G+ P
Sbjct: 158 DFNIAAMLPRETQITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
Query: 430 RDFLSSTSSPSLNTDIALDEMLDPR-LPVPSCSVQEKLI 467
SSTSS + + P S+ +KL+
Sbjct: 217 YHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLL 255
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 17/46 (36%), Positives = 28/46 (60%), Gaps = 1/46 (2%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGV 418
DFG+A + + W GFAGT GY++PE+ ++ D+++ GV
Sbjct: 151 DFGLAIEVNDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 21/57 (36%), Positives = 30/57 (52%), Gaps = 2/57 (3%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG++ + GT YIAPE+ K EKCDV+S GV++ ++ G P
Sbjct: 182 DFGLSAVFENQKK-MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 15/48 (31%), Positives = 25/48 (52%), Gaps = 3/48 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVL 419
DFG+++ + GT Y+APE L Y IT D+++ G++
Sbjct: 177 DFGMSRKIGHACE-LREIMGTPEYLAPEILNYD-PITTATDMWNIGII 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 24/57 (42%), Positives = 26/57 (45%), Gaps = 1/57 (1%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G AK L F GT Y+APEL K T D +SFG L E I G P
Sbjct: 167 DLGYAKELDQGELCTE-FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 18/51 (35%), Positives = 29/51 (56%), Gaps = 9/51 (17%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPEL----AYTMKITEKCDVYSFGV 418
DFG+A + + W GFAGT GY++PE+ Y ++ D+++ GV
Sbjct: 173 ADFGLAIEVNDSEA-WHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGV 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 19/49 (38%), Positives = 26/49 (53%), Gaps = 8/49 (16%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPEL---AYTMKITEKCDVYSFGV 418
DFG++ + ++ GT YIAPE+ Y EKCDV+S GV
Sbjct: 167 DFGLSTCFQQNTK-MKDRIGTAYYIAPEVLRGTY----DEKCDVWSAGV 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 14/48 (29%), Positives = 26/48 (54%), Gaps = 3/48 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVL 419
DFG+A ++ + GT ++APE + Y + + D++S GV+
Sbjct: 162 DFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 18/46 (39%), Positives = 25/46 (54%), Gaps = 2/46 (4%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGV 418
DFG++ + ++ GT YIAPE+ EKCDV+S GV
Sbjct: 167 DFGLSTCFQQNTK-MKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGV 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 15/46 (32%), Positives = 24/46 (52%), Gaps = 2/46 (4%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGV 418
DFG++K + + GT GY+APE+ ++ D +S GV
Sbjct: 152 DFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 3/48 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVL 419
DFGIA ++ + + GT ++APE + Y + + D++S GV+
Sbjct: 155 DFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 200
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 28/161 (17%), Positives = 53/161 (32%), Gaps = 33/161 (20%)
Query: 100 LDLRDNKLFGTIPPQISNLTNLSILSLGGNQFS--GNIPHEVGLMSHLKILYIDSNQLDG 157
L + + +S L L+L N ++ M +L+IL + N +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLSG----MENLRILSLGRNLIKK 84
Query: 158 SIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSI 217
L+ ++ EL + N + + + L + +L++ +N I N I
Sbjct: 85 IENLD-AVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNK--------ITNWGEI 133
Query: 218 SILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS 258
L+ L L+ L N LY +
Sbjct: 134 DKLA---------------ALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 31/117 (26%), Positives = 52/117 (44%), Gaps = 14/117 (11%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNL---TNLSILSLGGNQFSGNIPHEVGLMSHLK 146
+ S+ +L L N + +IS+L NL ILSLG N I + + L+
Sbjct: 43 TLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 147 ILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN--GSVPHSLGNLTQISMLFLHDN 201
L+I NQ+ +E +L ++ L + +N + G + L L ++ L L N
Sbjct: 97 ELWISYNQIASLSGIE--KLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGN 150
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 24/117 (20%), Positives = 40/117 (34%), Gaps = 6/117 (5%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP--- 429
DFG++ L S F GT Y++PE + + D++S G+ ++E+ G++P
Sbjct: 175 DFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232
Query: 430 -RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP 485
A + PR P + F L P
Sbjct: 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 15/48 (31%), Positives = 22/48 (45%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
G FG+A L G GT ++APE+ + DV+ GV+
Sbjct: 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 34/138 (24%), Positives = 54/138 (39%), Gaps = 37/138 (26%)
Query: 372 GDFGIAKFLKPD----SSN------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVL 421
GDFG++++++ +S W APE + T DV+ FGV +
Sbjct: 158 GDFGLSRYMEDSTYYKASKGKLPIKWM---------APESINFRRFTSASDVWMFGVCMW 208
Query: 422 EVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVP-SCSVQEKLISIMEVGFSCL 477
E++ G P + N D+ ++ RLP+P +C L S+M C
Sbjct: 209 EILMHGVKPFQGVK-------NNDVI--GRIENGERLPMPPNCP--PTLYSLMT---KCW 254
Query: 478 KESPESRPTMKIVSQQLR 495
P RP + QL
Sbjct: 255 AYDPSRRPRFTELKAQLS 272
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 14/124 (11%), Positives = 30/124 (24%), Gaps = 26/124 (20%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYG---YIAPELAY-----TMKITEKCDVYSFGVLVLEV 423
F + +S + + A + +T D ++ G+ + +
Sbjct: 253 TGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
Query: 424 IKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPES 483
P + +P P V+ L+ L+ E
Sbjct: 311 WCADLP--NTDDAALGGSEWIFR----SCKNIPQP---VRA-LLE------GFLRYPKED 354
Query: 484 RPTM 487
R
Sbjct: 355 RLLP 358
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 16/58 (27%), Positives = 28/58 (48%), Gaps = 3/58 (5%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G+A + GT+GY+APE L + D +S G ++ ++++G P
Sbjct: 335 DLGLACDFSKKKPH--ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 26/124 (20%), Positives = 38/124 (30%), Gaps = 24/124 (19%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
D G + GT G+ APE+ T T D+Y+ G + + R+
Sbjct: 224 DLGAVSRINSFGY----LYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRN- 277
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-TMKIVS 491
L D DP L S + + P R T + +S
Sbjct: 278 --GRYVDGLPED-------DPVLKTYD--------SYGRLLRRAIDPDPRQRFTTAEEMS 320
Query: 492 QQLR 495
QL
Sbjct: 321 AQLT 324
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 18/57 (31%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G+A + + GT GY+APE+ + T D ++ G L+ E+I G+ P
Sbjct: 329 DLGLAVHVPEGQTIKG-RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 20/57 (35%), Positives = 31/57 (54%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
D G+A LK + G+AGT G++APEL + D ++ GV + E+I + P
Sbjct: 332 DLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 14/48 (29%), Positives = 26/48 (54%), Gaps = 3/48 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVL 419
DFG+A + + + GT ++APE + Y + + D++S GV+
Sbjct: 161 DFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 20/57 (35%), Positives = 29/57 (50%), Gaps = 2/57 (3%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG++ + GT YIAPE+ EKCDV+S GV++ ++ G P
Sbjct: 172 DFGLSTHFEASKK-MKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 14/48 (29%), Positives = 26/48 (54%), Gaps = 3/48 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVL 419
DFG+A ++ + GT ++APE + Y + + D++S GV+
Sbjct: 162 DFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 18/47 (38%), Positives = 25/47 (53%), Gaps = 1/47 (2%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
DFG AK +S T T Y+APE+ K + CD++S GV+
Sbjct: 207 DFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 15/48 (31%), Positives = 22/48 (45%), Gaps = 3/48 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVL 419
DFG+A L PD T + APE + + D+++ GVL
Sbjct: 194 DFGLATKLNPDEIVKVTT-ATAEFAAPEIVDREP-VGFYTDMWAIGVL 239
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 29/119 (24%), Positives = 49/119 (41%), Gaps = 14/119 (11%)
Query: 373 DFGIAKFLKPDSSNWTG-----FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGK 427
DFG A L+PD + GT ++APE+ K D++S ++L ++ G
Sbjct: 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
Query: 428 HPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
HP + L IA + +P PSC+ ++ L++ P R +
Sbjct: 254 HP---WTQYFRGPLCLKIASEPPPIREIP-PSCA--PLTAQAIQ---EGLRKEPVHRAS 303
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 21/47 (44%), Positives = 27/47 (57%), Gaps = 4/47 (8%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGV 418
DFG+A+ K D T AGT Y+APE +T KCD++S GV
Sbjct: 170 DFGLAELFKSDEH-STNAAGTALYMAPEVFKR--DVTFKCDIWSAGV 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 17/49 (34%), Positives = 20/49 (40%), Gaps = 4/49 (8%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKI--TEKCDVYSFGV 418
DFG +K L S GT Y+APE L D +S GV
Sbjct: 160 DFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 22/73 (30%), Positives = 34/73 (46%), Gaps = 7/73 (9%)
Query: 364 NISRNNITG-----DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI--TEKCDVYSF 416
N+ N +G DFG +K L + F GT Y+APE+ + D++S
Sbjct: 152 NVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSL 211
Query: 417 GVLVLEVIKGKHP 429
G ++E+ GK P
Sbjct: 212 GCTIIEMATGKPP 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 16/49 (32%), Positives = 23/49 (46%), Gaps = 8/49 (16%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPEL---AYTMKITEKCDVYSFGV 418
DFG+A KP GT Y++P++ Y +CD +S GV
Sbjct: 152 DFGLAARFKPGK-MMRTKVGTPYYVSPQVLEGLY----GPECDEWSAGV 195
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 17/52 (32%), Positives = 24/52 (46%), Gaps = 6/52 (11%)
Query: 373 DFGIAKFLKP----DSSNWTGFAGTYGYIAPEL--AYTMKITEKCDVYSFGV 418
DFG++K + T AGT ++APE+ KCD +S GV
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 33/138 (23%), Positives = 52/138 (37%), Gaps = 37/138 (26%)
Query: 372 GDFGIAKFLKPDS----------SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVL 421
GDFG++++++ + W APE + T DV+ FGV +
Sbjct: 533 GDFGLSRYMEDSTYYKASKGKLPIKWM---------APESINFRRFTSASDVWMFGVCMW 583
Query: 422 EVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSCL 477
E++ G P + N D+ ++ RLP+P C L S+M C
Sbjct: 584 EILMHGVKPFQGVK-------NNDVI--GRIENGERLPMPPNCP--PTLYSLMT---KCW 629
Query: 478 KESPESRPTMKIVSQQLR 495
P RP + QL
Sbjct: 630 AYDPSRRPRFTELKAQLS 647
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 3/48 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVL 419
DFG+A+ KP F GT ++APE + Y ++ D++S GV+
Sbjct: 232 DFGLARRYKPREKLKVNF-GTPEFLAPEVVNYD-FVSFPTDMWSVGVI 277
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 16/52 (30%), Positives = 24/52 (46%), Gaps = 7/52 (13%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKI-----TEKCDVYSFGV 418
DFG + L P GT Y+APE + +M ++ D++S GV
Sbjct: 167 DFGFSCQLDPGEK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 16/47 (34%), Positives = 24/47 (51%), Gaps = 2/47 (4%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
DFG AK ++ T Y+APE+ K + CD++S GV+
Sbjct: 174 DFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 35/132 (26%), Positives = 53/132 (40%), Gaps = 24/132 (18%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI-----APELAYTMKITEKCDVYSFGVLVLEVI-K 425
DFG+A+ + D + T + A E T K T K DV+SFGVL+ E++ +
Sbjct: 234 ADFGLARDMY-DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 292
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSCLKESPE 482
G P ++ DI L RL P C + L +M C E
Sbjct: 293 GAPPYPDVN-------TFDIT--VYLLQGRRLLQPEYCP--DPLYEVML---KCWHPKAE 338
Query: 483 SRPTMKIVSQQL 494
RP+ + ++
Sbjct: 339 MRPSFSELVSRI 350
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 15/48 (31%), Positives = 24/48 (50%), Gaps = 3/48 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVL 419
+FG A+ LKP + F Y APE + + ++ D++S G L
Sbjct: 147 EFGQARQLKPGDNFRLLF-TAPEYYAPEVHQHDV-VSTATDMWSLGTL 192
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 34/132 (25%), Positives = 58/132 (43%), Gaps = 24/132 (18%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI-----APELAYTMKITEKCDVYSFGVLVLEVI-K 425
DFG+A+ + D ++ + + A E T + T K DV+SFGVL+ E++ +
Sbjct: 166 ADFGLARDIL-DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSCLKESPE 482
G P + D+ L RLP P C + L +M+ C + P
Sbjct: 225 GAPPYRHID-------PFDLT--HFLAQGRRLPQPEYCP--DSLYQVMQ---QCWEADPA 270
Query: 483 SRPTMKIVSQQL 494
RPT +++ ++
Sbjct: 271 VRPTFRVLVGEV 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 18/52 (34%), Positives = 25/52 (48%), Gaps = 7/52 (13%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEK-----CDVYSFGV 418
DFG + L+P GT GY+APE L +M T D+++ GV
Sbjct: 243 DFGFSCHLEPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 85 KLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV-GLM 142
L F L L L N++ ++P + LT L+IL L N+ ++P+ V +
Sbjct: 42 SLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKL 99
Query: 143 SHLKILYIDSNQLDGSIPLEV-GQLSSMVELALFSN 177
+ LK L +D+NQL S+P + +L+S+ ++ L +N
Sbjct: 100 TQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 17/51 (33%), Positives = 22/51 (43%), Gaps = 4/51 (7%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKI--TEKCDVYSFGVLV 420
DFG +K L S GT Y+APE L D +S GV++
Sbjct: 285 DFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 28/138 (20%), Positives = 44/138 (31%), Gaps = 29/138 (21%)
Query: 372 GDFGIAKFLKPDSSN------------WTGFAGTYGYIAPELAYTMK---ITEKCDVYSF 416
DFG A + T Y PE+ I EK D+++
Sbjct: 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239
Query: 417 GVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSC 476
G ++ + +HP F +N ++ P LI M
Sbjct: 240 GCILYLLCFRQHP--FEDGAKLRIVNGKYSI-----PPHDTQYTVFH-SLIRAM------ 285
Query: 477 LKESPESRPTMKIVSQQL 494
L+ +PE R ++ V QL
Sbjct: 286 LQVNPEERLSIAEVVHQL 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 30/123 (24%), Positives = 48/123 (39%), Gaps = 27/123 (21%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGK---- 427
DFG+A L F GT ++APE+ K D++S G+ +E+ +G+
Sbjct: 161 ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220
Query: 428 --HPRD--FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPES 483
HP FL ++P P L ++ + +CL + P
Sbjct: 221 ELHPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVE------ACLNKEPSF 261
Query: 484 RPT 486
RPT
Sbjct: 262 RPT 264
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 17/48 (35%), Positives = 23/48 (47%), Gaps = 1/48 (2%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLV 420
DFG+ L P S GT + APE+A + D++S GVL
Sbjct: 300 DFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 17/65 (26%), Positives = 26/65 (40%), Gaps = 9/65 (13%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPEL--------AYTMKITEKCDVYSFGVLVLEVI 424
DFG A+ L+ D + GT Y+ P++ + K D++S GV
Sbjct: 159 DFGAARELEDDEQFVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
Query: 425 KGKHP 429
G P
Sbjct: 218 TGSLP 222
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 25/131 (19%), Positives = 47/131 (35%), Gaps = 13/131 (9%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPEL--------AYTMKITEKCDVYSFGVLVLEVI 424
DFG A+ L+ D + GT Y+ P++ + K D++S GV
Sbjct: 159 DFGAARELEDDEQFVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
Query: 425 KGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESR 484
G P F P N ++ + +++ + VQ+ ++ SR
Sbjct: 218 TGSLP--FRPF-EGPRRNKEV-MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 485 PTMKIVSQQLR 495
+++ L
Sbjct: 274 GLQVLLTPVLA 284
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 35/132 (26%), Positives = 54/132 (40%), Gaps = 24/132 (18%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI-----APELAYTMKITEKCDVYSFGVLVLEVI-K 425
DFG+A+ + D ++ T + A E T K T K DV+SFGVL+ E++ +
Sbjct: 170 ADFGLARDMY-DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 228
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSCLKESPE 482
G P ++ DI L RL P C + L +M C E
Sbjct: 229 GAPPYPDVN-------TFDIT--VYLLQGRRLLQPEYCP--DPLYEVML---KCWHPKAE 274
Query: 483 SRPTMKIVSQQL 494
RP+ + ++
Sbjct: 275 MRPSFSELVSRI 286
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 20/123 (16%), Positives = 37/123 (30%), Gaps = 33/123 (26%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430
GD G + G ++A E L K D+++ + V+ +
Sbjct: 176 GDLGHVTRISSPQV----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231
Query: 431 DFLSSTSSPSLNTDIALDEMLD------PRLPVPSCSVQ-EKLISIMEVGFSCLKESPES 483
D+ + PR+P S + +L+ + PE
Sbjct: 232 R--------------NGDQWHEIRQGRLPRIP-QVLSQEFTELLK------VMIHPDPER 270
Query: 484 RPT 486
RP+
Sbjct: 271 RPS 273
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 25/101 (24%), Positives = 42/101 (41%), Gaps = 17/101 (16%)
Query: 398 APELAYTMKITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--R 454
APE + T + DV+S+G+ + E+ G P P + D +M+ R
Sbjct: 215 APESIFNCVYTFESDVWSYGIFLWELFSLGSSP--------YPGMPVDSKFYKMIKEGFR 266
Query: 455 LPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
+ P ++ IM+ +C P RPT K + Q +
Sbjct: 267 MLSPEHAP--AEMYDIMK---TCWDADPLKRPTFKQIVQLI 302
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 32/138 (23%), Positives = 47/138 (34%), Gaps = 37/138 (26%)
Query: 372 GDFGIAKFLKPDSSN-----------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLV 420
DFG+A+ + D W APE + T + DV+SFGVL+
Sbjct: 235 CDFGLARDIYKDPDYVRKGDARLPLKWM---------APETIFDRVYTIQSDVWSFGVLL 285
Query: 421 LEVIK-GKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSC 476
E+ G P P + D L R+ P + ++ M C
Sbjct: 286 WEIFSLGASP--------YPGVKIDEEFCRRLKEGTRMRAPDYTT--PEMYQTML---DC 332
Query: 477 LKESPESRPTMKIVSQQL 494
P RPT + + L
Sbjct: 333 WHGEPSQRPTFSELVEHL 350
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 20/63 (31%), Positives = 31/63 (49%), Gaps = 6/63 (9%)
Query: 373 DFGIAKFLKPDSSNWTG-FAGTYGYIAPELAYTMKITEK-----CDVYSFGVLVLEVIKG 426
DFG L D + + GT YI+PE+ M+ + CD +S GV + E++ G
Sbjct: 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
Query: 427 KHP 429
+ P
Sbjct: 278 ETP 280
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 24/101 (23%), Positives = 44/101 (43%), Gaps = 17/101 (16%)
Query: 398 APELAYTMKITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--R 454
APE + T K DV+S+G+L+ E+ G +P P + D +++ +
Sbjct: 242 APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--------YPGIPVDANFYKLIQNGFK 293
Query: 455 LPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
+ P + E++ IM+ SC RP+ ++ L
Sbjct: 294 MDQPFYAT--EEIYIIMQ---SCWAFDSRKRPSFPNLTSFL 329
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 27/122 (22%), Positives = 43/122 (35%), Gaps = 25/122 (20%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGK----- 427
DFG + D GT ++APE+ + D++S G++V+E++ G+
Sbjct: 184 DFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243
Query: 428 -HPRD--FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESR 484
P S P P+L V L +E L P+ R
Sbjct: 244 DSPVQAMKRLRDSPP-------------PKLKNSH-KVSPVLRDFLER---MLVRDPQER 286
Query: 485 PT 486
T
Sbjct: 287 AT 288
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 20/137 (14%), Positives = 41/137 (29%), Gaps = 26/137 (18%)
Query: 113 PQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172
Q +N L L G + I + + + N++ L + L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 69
Query: 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIP 232
+ +N + L ++ L L +NS + L + L+
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNS--------LVELGDLDPLA----------- 110
Query: 233 LSLGNLTNLKQFSLVYN 249
+L +L ++ N
Sbjct: 111 ----SLKSLTYLCILRN 123
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 27/122 (22%), Positives = 49/122 (40%), Gaps = 25/122 (20%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGK----- 427
DFG + P+ S + GT ++APE+ K D++S G++ +E+I+G+
Sbjct: 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
Query: 428 -HPRD--FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESR 484
+P +L +T+ P L P + + CL+ E R
Sbjct: 219 ENPLRALYLIATNGT-------------PELQNPE-KLSAIFRDFLNR---CLEMDVEKR 261
Query: 485 PT 486
+
Sbjct: 262 GS 263
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 32/138 (23%), Positives = 57/138 (41%), Gaps = 37/138 (26%)
Query: 372 GDFGIAKFLKPDS-----SN------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLV 420
GDFG+A+ + DS N W APE + T + DV+S+G+L+
Sbjct: 206 GDFGLARDIMNDSNYIVKGNARLPVKWM---------APESIFDCVYTVQSDVWSYGILL 256
Query: 421 LEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSC 476
E+ G +P P + + +++ ++ P+ + + SIM+ +C
Sbjct: 257 WEIFSLGLNP--------YPGILVNSKFYKLVKDGYQMAQPAFAP--KNIYSIMQ---AC 303
Query: 477 LKESPESRPTMKIVSQQL 494
P RPT + + L
Sbjct: 304 WALEPTHRPTFQQICSFL 321
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 21/63 (33%), Positives = 34/63 (53%), Gaps = 5/63 (7%)
Query: 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKG 426
IT DFG AK L P+S + F GT Y++PEL + D+++ G ++ +++ G
Sbjct: 171 IT-DFGTAKVLSPESKQARANS-FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
Query: 427 KHP 429
P
Sbjct: 229 LPP 231
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 2e-04
Identities = 20/163 (12%), Positives = 45/163 (27%), Gaps = 20/163 (12%)
Query: 229 GPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGA- 287
+ L + L + N NL L + + ++I
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL--KSLEIISGGLPDSVVEDILGSDLP 219
Query: 288 ----LQIFTVSENRFQGTIPKSL------RNCTSLIRVRLDGNNLTGNISKAFG---IYP 334
L ++ E+ +L + + + + F I P
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 335 NLTFIDLSRNNFYGE----ISSNFGECPKLGALNISRNNITGD 373
L +D+S E + + + L +N+ N ++ +
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 20/103 (19%)
Query: 398 APE-LAYTMKITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP-- 453
PE + Y K T + DV+SFGV++ E+ GK P LS NT++ E +
Sbjct: 203 PPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NTEVI--ECITQGR 252
Query: 454 RLPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495
L P C +++ +M C + P+ R +K + + L
Sbjct: 253 VLERPRVCP--KEVYDVML---GCWQREPQQRLNIKEIYKILH 290
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 21/57 (36%), Positives = 27/57 (47%), Gaps = 2/57 (3%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG + P S GT Y+ PE+ EK D++S GVL E + GK P
Sbjct: 152 DFGWSVHA-PSSRRTD-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 26/101 (25%), Positives = 38/101 (37%), Gaps = 17/101 (16%)
Query: 398 APELAYTMKITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--R 454
APE + T + DV+SFGVL+ E+ G P P + D L R
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------YPGVKIDEEFCRRLKEGTR 269
Query: 455 LPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
+ P + ++ M C P RPT + + L
Sbjct: 270 MRAPDYTT--PEMYQTML---DCWHGEPSQRPTFSELVEHL 305
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 15/64 (23%), Positives = 28/64 (43%), Gaps = 1/64 (1%)
Query: 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSG-NIPHEVGLMSHLKILY 149
L L+L DN++ G + NL+ L+L GN+ + + + +LK L
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119
Query: 150 IDSN 153
+ +
Sbjct: 120 LFNC 123
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 25/101 (24%), Positives = 41/101 (40%), Gaps = 18/101 (17%)
Query: 398 APELAYTMKITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--R 454
A E T DV++FGV + E++ +G+ P + N +I L R
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-------NAEIY--NYLIGGNR 257
Query: 455 LPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
L P C E++ +M C P+ RP+ + +L
Sbjct: 258 LKQPPECM--EEVYDLMY---QCWSADPKQRPSFTCLRMEL 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 16/128 (12%), Positives = 33/128 (25%), Gaps = 31/128 (24%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPEL-----------AYTMKITEKCDVYSFGVLV 420
F D + + + G+ PEL +T D ++ G+++
Sbjct: 248 TGFEHLV---RDGARVV-SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 421 LEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKES 480
+ P + + +P V+ L+ L+
Sbjct: 304 YWIWCADLP--ITKD------AALGGSEWIFRSCKNIPQ-PVRA-LLE------GFLRYP 347
Query: 481 PESRPTMK 488
E R
Sbjct: 348 KEDRLLPL 355
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 29/101 (28%), Positives = 43/101 (42%), Gaps = 18/101 (17%)
Query: 398 APELAYTMKITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--R 454
A E T K DV++FGV + E+ +G P + N ++ + L R
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-------NHEMY--DYLLHGHR 267
Query: 455 LPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
L P C ++L IM SC + P RPT ++ QL
Sbjct: 268 LKQPEDCL--DELYEIMY---SCWRTDPLDRPTFSVLRLQL 303
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 17/65 (26%), Positives = 28/65 (43%), Gaps = 8/65 (12%)
Query: 373 DFGIAKFLKPDSSNWTG-FAGTYGYIAPELAYTMKITEK-------CDVYSFGVLVLEVI 424
DFG L+ D + + GT Y++PE+ + CD ++ GV E+
Sbjct: 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 425 KGKHP 429
G+ P
Sbjct: 265 YGQTP 269
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 17/62 (27%), Positives = 26/62 (41%), Gaps = 5/62 (8%)
Query: 373 DFGIAKFLKPDSSNWTG-FAGTYGYIAPEL----AYTMKITEKCDVYSFGVLVLEVIKGK 427
DFG + + GT YI+PE+ +CD +S GV + E++ G
Sbjct: 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
Query: 428 HP 429
P
Sbjct: 271 TP 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 31/130 (23%), Positives = 50/130 (38%), Gaps = 31/130 (23%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITE-----KCDVYSFGVLVLEVIKG 426
DFG++ L F GT ++APE+ + + K D++S G+ +E+ +G
Sbjct: 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 427 K------HPRD--FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLK 478
HP FL + PRL S +K S +E CL
Sbjct: 231 APPLCDMHPMRALFLIPRNPA-------------PRLKSKKWS--KKFQSFIES---CLV 272
Query: 479 ESPESRPTMK 488
++ RP +
Sbjct: 273 KNHSQRPATE 282
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 23/102 (22%), Positives = 40/102 (39%), Gaps = 18/102 (17%)
Query: 398 APELAYTMKITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP--R 454
+PE T DV+SFGV++ E+ + P LS N + +
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVL--RFVMEGGL 258
Query: 455 LPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495
L P C + L +M C + +P+ RP+ + ++
Sbjct: 259 LDKPDNCP--DMLFELMR---MCWQYNPKMRPSFLEIISSIK 295
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 30/122 (24%), Positives = 48/122 (39%), Gaps = 25/122 (20%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGK----- 427
DFG+A L + GT ++APE+ + D++S G+ +E+ +GK
Sbjct: 168 DFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227
Query: 428 -HPRD--FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESR 484
HP F+ T+ P P P + ++ CL +SPE R
Sbjct: 228 IHPMRAIFMIPTNPP-------------PTFRKPE-LWSDNFTDFVKQ---CLVKSPEQR 270
Query: 485 PT 486
T
Sbjct: 271 AT 272
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 34/142 (23%), Positives = 50/142 (35%), Gaps = 50/142 (35%)
Query: 372 GDFGIAKFLKPDSSNWTG-----FAGTYGYIAPEL-----AYTMKITEKCDVYSFGVLVL 421
DFG++ FL F GT ++APE+ Y K D++SFG+ +
Sbjct: 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD----FKADIWSFGITAI 218
Query: 422 EVIKGKHPRD--------FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQE--------- 464
E+ G P L+ + P P L +
Sbjct: 219 ELATGAAPYHKYPPMKVLMLTLQNDP-------------PSLETGVQDKEMLKKYGKSFR 265
Query: 465 KLISIMEVGFSCLKESPESRPT 486
K+IS CL++ PE RPT
Sbjct: 266 KMIS------LCLQKDPEKRPT 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 33/126 (26%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITE---KCDVYSFGVLVLEVIKGK- 427
GDFG A + P +S F GT ++APE+ M + K DV+S G+ +E+ + K
Sbjct: 196 GDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
Query: 428 -----HPRD--FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKES 480
+ + + + P L S E + ++ CL++
Sbjct: 252 PLFNMNAMSALYHIAQNES-------------PALQSGHWS--EYFRNFVDS---CLQKI 293
Query: 481 PESRPT 486
P+ RPT
Sbjct: 294 PQDRPT 299
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 13/59 (22%), Positives = 23/59 (38%), Gaps = 12/59 (20%)
Query: 373 DFGIAKFLKPDSS-------NWTGFAGTYGYIAPE-----LAYTMKITEKCDVYSFGVL 419
DF + +K + G+ Y+APE ++CD++S GV+
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 5e-04
Identities = 26/106 (24%), Positives = 40/106 (37%), Gaps = 8/106 (7%)
Query: 99 YLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFS--GNIPHEVGLMSHLKILYIDSNQLD 156
LD + G I + NL LSL N+P + LK L + N++
Sbjct: 30 VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLELSENRIF 84
Query: 157 GSIPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQISMLFLHDN 201
G + + +L ++ L L N L S L L + L L +
Sbjct: 85 GGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 23/112 (20%), Positives = 41/112 (36%), Gaps = 9/112 (8%)
Query: 166 LSSMVELALFSNNLN-GSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAI 224
+++ EL L + N G + + L L + ++ L + L L+
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80
Query: 225 NQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV----LTKLSLDDN 272
N+ G + + L NL +L N L +L+ L L L L +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKL--KDISTLEPLKKLECLKSLDLFNC 130
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 33/133 (24%), Positives = 53/133 (39%), Gaps = 28/133 (21%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYI-----APE-LAYTMKITEKCDVYSFGVLVLEVI- 424
GDFG+A+ + +++ G + PE T K D +SFGVL+ E+
Sbjct: 185 GDFGMARDIY--RASYYR-KGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFS 240
Query: 425 KGKHPRDFLSSTSSPSLNTDIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSCLKESP 481
G P S N ++ E + R+ P C + IM C + P
Sbjct: 241 LGYMPYPSKS-------NQEVL--EFVTSGGRMDPPKNCP--GPVYRIMT---QCWQHQP 286
Query: 482 ESRPTMKIVSQQL 494
E RP I+ +++
Sbjct: 287 EDRPNFAIILERI 299
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 26/105 (24%)
Query: 398 APE-LAYTMKITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP-- 453
A E L Y+ T DV+S+GVL+ E++ G P + E+ +
Sbjct: 209 AIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP--------YC----GMTCAELYEKLP 255
Query: 454 ---RLPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQL 494
RL P C +++ +M C +E P RP+ + L
Sbjct: 256 QGYRLEKPLNCD--DEVYDLM---RQCWREKPYERPSFAQILVSL 295
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 7e-04
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 6/82 (7%)
Query: 99 YLDLRDNKLFGTIPPQI-SNLTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLD 156
L L DN++ + P + LT L+ L L NQ + +P V ++ L L ++ NQL
Sbjct: 34 VLYLYDNQI-TKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK 91
Query: 157 GSIPLEV-GQLSSMVELALFSN 177
SIP L S+ + L +N
Sbjct: 92 -SIPRGAFDNLKSLTHIWLLNN 112
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 20/103 (19%)
Query: 398 APE-LAYTMKITEKCDVYSFGVLVLEVI-KGKHPRDFLSSTSSPSLNTDIALDEMLDP-- 453
PE + Y K T + DV+SFGV++ E+ GK P LS NT+ + +
Sbjct: 228 PPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLS-------NTEAI--DCITQGR 277
Query: 454 RLPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495
L P C ++ +IM C + P+ R ++K V +L+
Sbjct: 278 ELERPRACP--PEVYAIMR---GCWQREPQQRHSIKDVHARLQ 315
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 26/175 (14%), Positives = 48/175 (27%), Gaps = 29/175 (16%)
Query: 237 NLTNLKQFSLVYNNL--YGSIPPSLDNLVLTKLSLDDNHFT--------SYLPQNICRGG 286
L + +L L G L KL L N L + C+
Sbjct: 99 GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQ-- 156
Query: 287 ALQIFTVSENRFQGT----IPKSLRNCTSLIRVRLDGNNLTGN----ISKAFGIYPNLTF 338
+ +S N + + L TS+ + L L ++ L
Sbjct: 157 -ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQE 215
Query: 339 IDLSRNNFYGE----ISSNFGECPKLGALNISRNNITGDFG---IAKFLKPDSSN 386
++++ N ++ E P L L++ N + G +
Sbjct: 216 LNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL-SSEGRQVLRDLGGAAEGG 269
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 502 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.98 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.98 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.98 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.94 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.94 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.86 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.85 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.84 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.79 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.77 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.75 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.72 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.61 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.6 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.56 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.52 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.51 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.5 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.49 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.47 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.47 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.47 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.45 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.44 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.43 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.42 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.41 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.41 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.41 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.4 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.39 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.39 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.39 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.38 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.38 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.37 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.37 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.37 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.37 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.37 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.37 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.37 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.36 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.36 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.36 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.36 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.36 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.35 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.35 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.35 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.35 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.34 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.34 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.34 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.34 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.34 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.34 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.34 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.34 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.34 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.33 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.33 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.33 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.33 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.33 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.33 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.33 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.33 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.32 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.32 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.32 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.31 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.31 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.31 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.3 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.3 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.3 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.3 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.3 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.3 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.3 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.29 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.29 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.29 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.29 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.29 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.28 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.28 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.28 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.28 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.28 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.28 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.28 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.28 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.27 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.27 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.27 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.27 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.27 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.27 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.26 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.26 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.26 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.25 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.25 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.25 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.25 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.24 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.24 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.24 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.24 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.24 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.24 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.24 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.23 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.23 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.23 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.23 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.23 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.23 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.23 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.23 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.23 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.22 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.22 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.22 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.22 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.22 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.22 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.21 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.21 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.21 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.21 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.2 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.2 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.2 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.2 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.2 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.2 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.2 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.2 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.19 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.19 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.19 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.19 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.18 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.18 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.18 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.18 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.18 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.17 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.17 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.17 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.17 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.17 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.16 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.16 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.16 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.16 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.16 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.16 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.16 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.16 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.16 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.15 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.15 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.15 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.15 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.15 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.15 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.14 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.14 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.14 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.14 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.14 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.13 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.13 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.13 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.13 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.13 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.13 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.13 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.12 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.12 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.12 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.12 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.12 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.11 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.11 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.1 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.1 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.1 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.1 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.1 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.1 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.09 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.09 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.09 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.09 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.09 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.09 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.09 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.08 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.08 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.08 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.08 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.08 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.08 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.08 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.08 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.07 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.07 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.07 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.07 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.06 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.06 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.06 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.06 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.05 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.05 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.05 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.04 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.04 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.03 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.03 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.03 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.02 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.02 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.02 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.01 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.01 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.01 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.01 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.01 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 98.99 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 98.98 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 98.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 98.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 98.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 98.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 98.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 98.96 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.9 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 98.87 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 98.8 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.76 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.7 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.6 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 98.6 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 98.59 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.51 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.5 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.39 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.97 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.78 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.71 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 97.07 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.05 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 96.94 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.53 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 88.17 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=423.35 Aligned_cols=346 Identities=26% Similarity=0.430 Sum_probs=281.7
Q ss_pred HHhhccCCCHHHHHHHHHHHhhcCcCCCCCCCCCCCCCCCCCCCCCCCccceeeeCCCCCEEEEEecCCCCcee---cCc
Q 010736 12 FLVAVSSETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVGLKGK---LHA 88 (502)
Q Consensus 12 ~~~~~~~~~~~d~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~C~W~Gv~C~~~~~v~~L~L~~~~l~g~---l~~ 88 (502)
|+.+++++.++|++||++||+++. ||. .+++|..+ .+||.|.||+|+ .++|+.|+|+++++.|. +++
T Consensus 2 ~~~~~~~~~~~~~~all~~k~~~~-~~~-~l~~W~~~-------~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~ 71 (768)
T 3rgz_A 2 FQASPSQSLYREIHQLISFKDVLP-DKN-LLPDWSSN-------KNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSS 71 (768)
T ss_dssp ------CCHHHHHHHHHHHHTTCS-CTT-SSTTCCTT-------SCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHH
T ss_pred CcCccccCCHHHHHHHHHHHhhCC-Ccc-cccCCCCC-------CCCcCCcceEEC-CCcEEEEECCCCCcCCccCccCh
Confidence 444556667889999999999997 566 89999744 689999999998 68999999999999997 553
Q ss_pred ----------------------ccCCCCCCCCEEECCCCcccccCCc--cCcCCCCCCEEEccCCcCcCCCCccc-CCCC
Q 010736 89 ----------------------FSFSSFPHLAYLDLRDNKLFGTIPP--QISNLTNLSILSLGGNQFSGNIPHEV-GLMS 143 (502)
Q Consensus 89 ----------------------~~~~~l~~L~~L~Ls~N~l~g~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~ 143 (502)
..|+.+++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .+++
T Consensus 72 ~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~ 151 (768)
T 3rgz_A 72 SLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN 151 (768)
T ss_dssp HTTTCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCT
T ss_pred hHhccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCC
Confidence 3488889999999999999998888 89999999999999999998888776 7899
Q ss_pred CCcEEEccCCcCcccCCcc---cCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCcc
Q 010736 144 HLKILYIDSNQLDGSIPLE---VGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISIL 220 (502)
Q Consensus 144 ~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 220 (502)
+|++|++++|++++..|.. +.++++|++|++++|++++.+|. ..+++|++|++++|.+++.+|. ++++++|++|
T Consensus 152 ~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L 228 (768)
T 3rgz_A 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHL 228 (768)
T ss_dssp TCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEE
T ss_pred CCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEE
Confidence 9999999999999888776 78888888888888888876653 7788888888988888887776 8888889999
Q ss_pred ccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCC-CCCcEEEccCCccc
Q 010736 221 SLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRG-GALQIFTVSENRFQ 299 (502)
Q Consensus 221 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~-~~L~~L~ls~n~l~ 299 (502)
++++|++++.+|..++++++|++|++++|.+.+.+|.. ....|++|++++|++++.+|..+... ++|+.|++++|.++
T Consensus 229 ~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~ 307 (768)
T 3rgz_A 229 DISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307 (768)
T ss_dssp ECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEE
T ss_pred ECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCC
Confidence 99998888888888888888888888888888777665 44678888888888887777777665 78888888888888
Q ss_pred cccCcccccCCCCcEEeCCCCccccccCcc-cCCCCCCcEEEccCcccccccCccccCCC-CCCeeeecCCccc
Q 010736 300 GTIPKSLRNCTSLIRVRLDGNNLTGNISKA-FGIYPNLTFIDLSRNNFYGEISSNFGECP-KLGALNISRNNIT 371 (502)
Q Consensus 300 ~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~-~L~~L~l~~N~l~ 371 (502)
+.+|..+..+++|++|++++|++++.+|.. +..+++|++|++++|++.+.+|..+..++ +|++|++++|++.
T Consensus 308 ~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~ 381 (768)
T 3rgz_A 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381 (768)
T ss_dssp ECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEE
T ss_pred CccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcC
Confidence 778888888888888888888887776654 77777888888888877777777776665 6777777666654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=399.47 Aligned_cols=337 Identities=20% Similarity=0.332 Sum_probs=254.4
Q ss_pred HHHHHHHHHHHhhcCcCCCCCC-------CCCCCCCCCCCCCCCCCcc---ceeeeCCCCCEEEEEecCCCCceecCccc
Q 010736 21 NEEADALLKWKASLQIHNRSLL-------SSWIKDTSNVSSKISPCAW---SGISCNDAGRVINISLRGVGLKGKLHAFS 90 (502)
Q Consensus 21 ~~d~~aLl~~k~~~~~~~~~~l-------~~W~~~~~~~~~~~~~C~W---~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~ 90 (502)
..|+.||.++|.+++.+++... .+|..+ .++|.| .||+|+..++|+.|+|+++++.|.+|+.
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-------~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~- 100 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-------KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA- 100 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-------SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGG-
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-------CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChH-
Confidence 4699999999999875443322 267644 689999 9999988799999999999999999985
Q ss_pred CCCCCCCCEEECCCC-----------------------------------------------------------------
Q 010736 91 FSSFPHLAYLDLRDN----------------------------------------------------------------- 105 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N----------------------------------------------------------------- 105 (502)
++++++|++|+|++|
T Consensus 101 l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~ 180 (636)
T 4eco_A 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180 (636)
T ss_dssp GGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCC
T ss_pred HhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccc
Confidence 999999999999988
Q ss_pred -------------cccccCCccCcCCCCCCEEEccCCcCcCC-----------------CCcccC--CCCCCcEEEccCC
Q 010736 106 -------------KLFGTIPPQISNLTNLSILSLGGNQFSGN-----------------IPHEVG--LMSHLKILYIDSN 153 (502)
Q Consensus 106 -------------~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~-----------------~p~~l~--~l~~L~~L~Ls~N 153 (502)
+++| +|..|+++++|++|+|++|.++|. +|..++ ++++|++|+|++|
T Consensus 181 ~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp CCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred cchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence 4456 889999999999999999999986 999999 9999999999999
Q ss_pred cCcccCCcccCCCCCCcEEEcccCc-ccc-cCCcCCCCC------CCCCeEEcccccccccCCc--cCcCCccCCccccc
Q 010736 154 QLDGSIPLEVGQLSSMVELALFSNN-LNG-SVPHSLGNL------TQISMLFLHDNSFSGFIPP--DIGNLKSISILSLA 223 (502)
Q Consensus 154 ~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~ls 223 (502)
++.+.+|..|+++++|++|++++|+ ++| .+|..++.+ ++|++|++++|+++ .+|. .++.+++|++|+++
T Consensus 260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~ 338 (636)
T 4eco_A 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECL 338 (636)
T ss_dssp TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECC
T ss_pred cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCc
Confidence 9999999999999999999999998 988 788777665 78888888888888 6777 77888888888888
Q ss_pred cccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-cc-ccEEECcCCcCcccCCccccCCC--CCcEEEccCCccc
Q 010736 224 INQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LV-LTKLSLDDNHFTSYLPQNICRGG--ALQIFTVSENRFQ 299 (502)
Q Consensus 224 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~-L~~L~ls~N~l~~~~~~~~~~~~--~L~~L~ls~n~l~ 299 (502)
+|+++|.+| .++.+++|+.|++++|+++ .+|..+.. .. |++|++++|+++ .+|..+.... +|+.|++++|.++
T Consensus 339 ~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~ 415 (636)
T 4eco_A 339 YNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIG 415 (636)
T ss_dssp SCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTT
T ss_pred CCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCC
Confidence 888887777 7777777777777777776 66665555 45 777777777766 4555555443 6666666666666
Q ss_pred cccCcccc-------cCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCc-cccCC-------CCCCeee
Q 010736 300 GTIPKSLR-------NCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISS-NFGEC-------PKLGALN 364 (502)
Q Consensus 300 ~~~~~~l~-------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~-------~~L~~L~ 364 (502)
+..|..+. .+++|+.|++++|++++..+..+..+++|++|+|++|+++ .+|. .+... ++|++|+
T Consensus 416 ~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~ 494 (636)
T 4eco_A 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSID 494 (636)
T ss_dssp TTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEE
T ss_pred CcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEE
Confidence 66665555 5556666666666666333333344555666666666555 3332 22211 1555555
Q ss_pred ecCCccc
Q 010736 365 ISRNNIT 371 (502)
Q Consensus 365 l~~N~l~ 371 (502)
+++|++.
T Consensus 495 Ls~N~l~ 501 (636)
T 4eco_A 495 LRFNKLT 501 (636)
T ss_dssp CCSSCCC
T ss_pred CcCCcCC
Confidence 5555554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=356.45 Aligned_cols=292 Identities=27% Similarity=0.486 Sum_probs=242.9
Q ss_pred CCCHHHHHHHHHHHhhcCcCCCCCCCCCCCCCCCCCCCCCCCc--cceeeeCCC---CCEEEEEecCCCCce--ecCccc
Q 010736 18 SETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCA--WSGISCNDA---GRVINISLRGVGLKG--KLHAFS 90 (502)
Q Consensus 18 ~~~~~d~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~C~--W~Gv~C~~~---~~v~~L~L~~~~l~g--~l~~~~ 90 (502)
.+.++|++||++||+++.+ |. .+++|..+ .+||. |.||+|+.. ++|+.|+|+++++.| .+|..
T Consensus 2 ~c~~~~~~aL~~~k~~~~~-~~-~l~~W~~~-------~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~- 71 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGN-PT-TLSSWLPT-------TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS- 71 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTC-CG-GGTTCCTT-------SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGG-
T ss_pred CCCHHHHHHHHHHHHhcCC-cc-cccCCCCC-------CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChh-
Confidence 4678899999999999964 44 78899654 57998 999999864 799999999999999 88875
Q ss_pred CCCCCCCCEEECCC-CcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCC
Q 010736 91 FSSFPHLAYLDLRD-NKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSM 169 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~-N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 169 (502)
|+++++|++|+|++ |.+.+.+|..|+++++|++|+|++|.+++.+|..|+++++|++|++++|++++.+|..+..+++|
T Consensus 72 l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 151 (313)
T 1ogq_A 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151 (313)
T ss_dssp GGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC
T ss_pred HhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCC
Confidence 99999999999995 99999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cEEEcccCcccccCCcCCCCCC-CCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeC
Q 010736 170 VELALFSNNLNGSVPHSLGNLT-QISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVY 248 (502)
Q Consensus 170 ~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 248 (502)
++|++++|++++.+|..++.++ +|++|++++|++++.+|..+..++ |+.|++++|++++..|..+..+++|+.|++++
T Consensus 152 ~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 230 (313)
T 1ogq_A 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230 (313)
T ss_dssp CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCS
T ss_pred CeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCC
Confidence 9999999999999999999998 999999999999999999999887 99999999999988899999999999999999
Q ss_pred ccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCc
Q 010736 249 NNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK 328 (502)
Q Consensus 249 N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 328 (502)
|.+++.+|. +..+++|+.|++++|++++.+|..+..+++|+.|++++|++++.+|.
T Consensus 231 N~l~~~~~~------------------------~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 231 NSLAFDLGK------------------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp SEECCBGGG------------------------CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred CceeeecCc------------------------ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence 988765443 22334455555555555555555555555555555555555555544
Q ss_pred ccCCCCCCcEEEccCcc
Q 010736 329 AFGIYPNLTFIDLSRNN 345 (502)
Q Consensus 329 ~~~~l~~L~~L~Ls~N~ 345 (502)
. ..+++|+.+++++|.
T Consensus 287 ~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 287 G-GNLQRFDVSAYANNK 302 (313)
T ss_dssp S-TTGGGSCGGGTCSSS
T ss_pred C-ccccccChHHhcCCC
Confidence 3 455555555555554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=390.04 Aligned_cols=338 Identities=20% Similarity=0.309 Sum_probs=250.8
Q ss_pred CCCHHHHHHHHHHHhhcCcCCCCCCCCCCCCCCCCCCCCCC--Ccc------------ceeeeCCCCCEEEEEecCCCCc
Q 010736 18 SETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISP--CAW------------SGISCNDAGRVINISLRGVGLK 83 (502)
Q Consensus 18 ~~~~~d~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~--C~W------------~Gv~C~~~~~v~~L~L~~~~l~ 83 (502)
++...|+.||++||+++.+ | +|+.+..+ ...+| |.| .||+|+..++|+.|+|+++++.
T Consensus 265 ~~~~~d~~ALl~~k~~l~~-~-----~W~~~~~~--~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~ 336 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDG-K-----NWRYYSGT--INNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAK 336 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTG-G-----GCCCCCSS--CSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCE
T ss_pred ccchHHHHHHHHHHHHcCC-C-----CCCcCCCc--ccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCC
Confidence 3445799999999999964 3 78765211 01356 999 9999997799999999999999
Q ss_pred eecCcccCCCCCCCCEEEC-CCCccccc----------------------------------------------------
Q 010736 84 GKLHAFSFSSFPHLAYLDL-RDNKLFGT---------------------------------------------------- 110 (502)
Q Consensus 84 g~l~~~~~~~l~~L~~L~L-s~N~l~g~---------------------------------------------------- 110 (502)
|.+|+. |+++++|++|+| ++|.++|.
T Consensus 337 G~ip~~-l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~ 415 (876)
T 4ecn_A 337 GRVPDA-IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMK 415 (876)
T ss_dssp EEECGG-GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSC
T ss_pred CcCchH-HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccc
Confidence 999986 999999999999 77766554
Q ss_pred ------------------------CCccCcCCCCCCEEEccCCcCcC-----------------CCCcccC--CCCCCcE
Q 010736 111 ------------------------IPPQISNLTNLSILSLGGNQFSG-----------------NIPHEVG--LMSHLKI 147 (502)
Q Consensus 111 ------------------------~p~~l~~l~~L~~L~Ls~N~l~~-----------------~~p~~l~--~l~~L~~ 147 (502)
+|..|+++++|++|+|++|+|+| .+|..++ ++++|++
T Consensus 416 ~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~ 495 (876)
T 4ecn_A 416 PIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495 (876)
T ss_dssp CCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred ccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence 88899999999999999999998 3899988 9999999
Q ss_pred EEccCCcCcccCCcccCCCCCCcEEEcccCc-ccc-cCCcCCCCCC-------CCCeEEcccccccccCCc--cCcCCcc
Q 010736 148 LYIDSNQLDGSIPLEVGQLSSMVELALFSNN-LNG-SVPHSLGNLT-------QISMLFLHDNSFSGFIPP--DIGNLKS 216 (502)
Q Consensus 148 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~~~~l~~ 216 (502)
|+|++|++.+.+|..|+++++|+.|++++|+ ++| .+|..++.++ +|++|++++|+++ .+|. .++++++
T Consensus 496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~ 574 (876)
T 4ecn_A 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK 574 (876)
T ss_dssp EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence 9999999999999999999999999999998 888 7776555444 8888888888888 6777 7888888
Q ss_pred CCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-cc-ccEEECcCCcCcccCCccccCCCC--CcEEE
Q 010736 217 ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LV-LTKLSLDDNHFTSYLPQNICRGGA--LQIFT 292 (502)
Q Consensus 217 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~-L~~L~ls~N~l~~~~~~~~~~~~~--L~~L~ 292 (502)
|+.|++++|+++ .+| .++.+++|+.|++++|+++ .+|..+.. .. |+.|++++|+++ .+|..+..... |+.|+
T Consensus 575 L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~ 650 (876)
T 4ecn_A 575 LGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVD 650 (876)
T ss_dssp CCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEE
T ss_pred CCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEE
Confidence 888888888888 677 7788888888888888887 67766655 45 777777777777 45655554433 66666
Q ss_pred ccCCccccccC----------------------------ccc-ccCCCCcEEeCCCCccccccCccc-CCC-------CC
Q 010736 293 VSENRFQGTIP----------------------------KSL-RNCTSLIRVRLDGNNLTGNISKAF-GIY-------PN 335 (502)
Q Consensus 293 ls~n~l~~~~~----------------------------~~l-~~l~~L~~L~l~~N~l~~~~~~~~-~~l-------~~ 335 (502)
+++|++++.+| ..+ ..+++|+.|+|++|+++ .+|..+ ... ++
T Consensus 651 Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~ 729 (876)
T 4ecn_A 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYL 729 (876)
T ss_dssp CCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGG
T ss_pred CcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCC
Confidence 66666655433 221 23445555555555555 222222 111 15
Q ss_pred CcEEEccCcccccccCcccc--CCCCCCeeeecCCccc
Q 010736 336 LTFIDLSRNNFYGEISSNFG--ECPKLGALNISRNNIT 371 (502)
Q Consensus 336 L~~L~Ls~N~l~~~~~~~~~--~~~~L~~L~l~~N~l~ 371 (502)
|+.|+|++|+++ .+|..+. .+++|++|++++|++.
T Consensus 730 L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~ 766 (876)
T 4ecn_A 730 LTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS 766 (876)
T ss_dssp CCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCS
T ss_pred ccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCC
Confidence 555555555555 4444444 5555555555555554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.94 Aligned_cols=319 Identities=21% Similarity=0.229 Sum_probs=272.8
Q ss_pred CCCccce--eeeCCC---------CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccC-CccCcCCCCCCEE
Q 010736 57 SPCAWSG--ISCNDA---------GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTI-PPQISNLTNLSIL 124 (502)
Q Consensus 57 ~~C~W~G--v~C~~~---------~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~-p~~l~~l~~L~~L 124 (502)
+.|.|.+ |.|+.. .+++.|+|+++.+++..+.. |+++++|++|+|++|.+.+.+ |..|.++++|++|
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~-~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETS-FSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTT-TSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhH-hccCccccEEECcCCcccceECcccccccccCCEE
Confidence 4566666 888742 36899999999999766654 999999999999999998655 5679999999999
Q ss_pred EccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcc--cCCCCCCcEEEcccCcccccCCcC-CCCCCCCCeEEcccc
Q 010736 125 SLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLE--VGQLSSMVELALFSNNLNGSVPHS-LGNLTQISMLFLHDN 201 (502)
Q Consensus 125 ~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N 201 (502)
+|++|++++..|..|+++++|++|++++|++++..|.. +..+++|++|++++|++++..|.. +.++++|++|++++|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence 99999999999999999999999999999999866655 999999999999999999888876 889999999999999
Q ss_pred cccccCCccCcCC----------------------------------ccCCccccccccccCcccccccC----------
Q 010736 202 SFSGFIPPDIGNL----------------------------------KSISILSLAINQFSGPIPLSLGN---------- 237 (502)
Q Consensus 202 ~l~~~~p~~~~~l----------------------------------~~L~~L~ls~N~l~~~~p~~~~~---------- 237 (502)
++++..+..+..+ ++|++|++++|++++..|..+..
T Consensus 165 ~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L 244 (455)
T 3v47_A 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244 (455)
T ss_dssp CBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEE
T ss_pred cccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeE
Confidence 9998888776554 56888888888776655443321
Q ss_pred -----------------------------CCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCC
Q 010736 238 -----------------------------LTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGA 287 (502)
Q Consensus 238 -----------------------------l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~ 287 (502)
.++|+.|++++|.+++..|..+.. ..|++|++++|++++..|..+..+++
T Consensus 245 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 324 (455)
T 3v47_A 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324 (455)
T ss_dssp ECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred eeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCccc
Confidence 257888888888888877877766 68999999999999888888888999
Q ss_pred CcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecC
Q 010736 288 LQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISR 367 (502)
Q Consensus 288 L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~ 367 (502)
|+.|++++|.+++..+..+..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++
T Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 404 (455)
T 3v47_A 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404 (455)
T ss_dssp CCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccC
Confidence 99999999999888788888899999999999999888888899999999999999999877777788899999999999
Q ss_pred CccccccCc
Q 010736 368 NNITGDFGI 376 (502)
Q Consensus 368 N~l~~dfGl 376 (502)
|++.|++..
T Consensus 405 N~l~~~~~~ 413 (455)
T 3v47_A 405 NPWDCSCPR 413 (455)
T ss_dssp SCBCCCTTT
T ss_pred CCcccCCCc
Confidence 999999873
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=367.79 Aligned_cols=234 Identities=33% Similarity=0.503 Sum_probs=142.5
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCC-CCCEEEccCCcCcCCCCcccCC--CCCCc
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLT-NLSILSLGGNQFSGNIPHEVGL--MSHLK 146 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~--l~~L~ 146 (502)
..++.|++++|.+.|.+|...|..+++|++|++++|.++|.+|..+.+++ +|++|++++|.+++.+|..+.. +++|+
T Consensus 318 ~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~ 397 (768)
T 3rgz_A 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 397 (768)
T ss_dssp TTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCC
T ss_pred CCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCcc
Confidence 45778888888888888776678888888888888888777777776665 6666666666666655555544 55555
Q ss_pred EEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCcccccccc
Q 010736 147 ILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQ 226 (502)
Q Consensus 147 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 226 (502)
+|++++|++++.+|..+..+++|++|++++|++++.+|..++.+++|++|++++|.+++.+|..+..+++|++|++++|+
T Consensus 398 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 477 (768)
T 3rgz_A 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477 (768)
T ss_dssp EEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred EEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCc
Confidence 55555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred ccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccC
Q 010736 227 FSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIP 303 (502)
Q Consensus 227 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~ 303 (502)
+++.+|..+.++++|+.|++++|++++.+|..+.. ..|++|++++|++++.+|..++.+++|+.|++++|+++|.+|
T Consensus 478 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip 555 (768)
T 3rgz_A 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555 (768)
T ss_dssp CCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCC
T ss_pred ccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCC
Confidence 55555555555555555555555555555554444 445555555555555555555555555555555555544444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=338.68 Aligned_cols=322 Identities=20% Similarity=0.197 Sum_probs=295.3
Q ss_pred ccceeeeCCC----------CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCC
Q 010736 60 AWSGISCNDA----------GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGN 129 (502)
Q Consensus 60 ~W~Gv~C~~~----------~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N 129 (502)
.|..|.|... ..++.|+|+++++++..+. .|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQD-EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHh-HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 4788999742 3688999999999976555 4999999999999999999999999999999999999999
Q ss_pred cCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCc
Q 010736 130 QFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209 (502)
Q Consensus 130 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 209 (502)
++++..+..|.++++|++|+|++|++++..|..|..+++|++|++++|.+++..|..|..+++|++|++++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 99977667789999999999999999999999999999999999999999999899999999999999999999987777
Q ss_pred cCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCC
Q 010736 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGAL 288 (502)
Q Consensus 210 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L 288 (502)
.+..+++|+.|++++|.+++..+..|..+++|+.|++++|.+.+.+|..... ..|+.|++++|++++..+..+..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 8999999999999999999888889999999999999999887777665444 689999999999998666788999999
Q ss_pred cEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCC
Q 010736 289 QIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368 (502)
Q Consensus 289 ~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N 368 (502)
+.|++++|.+++..+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+..+..+++|++|++++|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 99999999999888888999999999999999999999999999999999999999999888888899999999999999
Q ss_pred ccccccCcccccCC
Q 010736 369 NITGDFGIAKFLKP 382 (502)
Q Consensus 369 ~l~~dfGl~~ll~~ 382 (502)
++.|||.+.++...
T Consensus 331 ~l~c~c~~~~~~~~ 344 (477)
T 2id5_A 331 PLACDCRLLWVFRR 344 (477)
T ss_dssp CEECSGGGHHHHTT
T ss_pred CccCccchHhHHhh
Confidence 99999998877643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.67 Aligned_cols=150 Identities=26% Similarity=0.308 Sum_probs=119.1
Q ss_pred CCCCccc----eeeeCC----------CCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCC
Q 010736 56 ISPCAWS----GISCND----------AGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNL 121 (502)
Q Consensus 56 ~~~C~W~----Gv~C~~----------~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L 121 (502)
.+||.|. .+.|.. ..+++.|+|+++.+++..+. .|.++++|++|+|++|++++..|..|.++++|
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L 82 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSY-SFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECTTCCCCEECTTTTTTCTTC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChh-hccCCccCcEEeCCCCcccccCHHHhhchhhc
Confidence 3567553 467753 14688999999999876554 48999999999999999998888889999999
Q ss_pred CEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccc-cCCcCCCCCCCCCeEEccc
Q 010736 122 SILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQISMLFLHD 200 (502)
Q Consensus 122 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~ 200 (502)
++|+|++|.+++..|..|+++++|++|++++|++++..+..++++++|++|++++|.+++ .+|..++++++|++|++++
T Consensus 83 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~ 162 (606)
T 3vq2_A 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162 (606)
T ss_dssp CEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCS
T ss_pred CEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccC
Confidence 999999999988888888888899999998888887776778888888888888888875 5677777777777777777
Q ss_pred cccccc
Q 010736 201 NSFSGF 206 (502)
Q Consensus 201 N~l~~~ 206 (502)
|++++.
T Consensus 163 n~l~~~ 168 (606)
T 3vq2_A 163 NYIQTI 168 (606)
T ss_dssp SCCCEE
T ss_pred Ccceec
Confidence 766544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.82 Aligned_cols=334 Identities=21% Similarity=0.218 Sum_probs=293.8
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
.++.++++++.+++..+ ..|+.+++|++|++++|+++ .+|..+.++++|++|++++|.+++..|..++.+++|++|++
T Consensus 255 ~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 332 (606)
T 3t6q_A 255 SVESINLQKHYFFNISS-NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332 (606)
T ss_dssp EEEEEECTTCCCSSCCT-TTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEEC
T ss_pred ceeEEEeecCccCccCH-HHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEEC
Confidence 68999999999986544 45999999999999999999 78889999999999999999999888989999999999999
Q ss_pred cCCcCcccCCcc-cCCCCCCcEEEcccCcccccC--CcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccc
Q 010736 151 DSNQLDGSIPLE-VGQLSSMVELALFSNNLNGSV--PHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQF 227 (502)
Q Consensus 151 s~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 227 (502)
++|.+.+.+|.. +..+++|++|++++|++++.. |..+..+++|++|++++|++.+..|..+..+++|+.|++++|++
T Consensus 333 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 412 (606)
T 3t6q_A 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412 (606)
T ss_dssp CSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCE
T ss_pred CCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcC
Confidence 999999777765 899999999999999999776 78899999999999999999999999999999999999999999
Q ss_pred cCccccc-ccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCccc---CCccccCCCCCcEEEccCCcccccc
Q 010736 228 SGPIPLS-LGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSY---LPQNICRGGALQIFTVSENRFQGTI 302 (502)
Q Consensus 228 ~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~---~~~~~~~~~~L~~L~ls~n~l~~~~ 302 (502)
++..|.. +..+++|+.|++++|.+.+..|..+.. ..|++|++++|++++. .+..+..+++|+.|++++|++++..
T Consensus 413 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 492 (606)
T 3t6q_A 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492 (606)
T ss_dssp ECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEEC
T ss_pred CCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccC
Confidence 9876654 899999999999999999888887776 7899999999999873 3356888999999999999999998
Q ss_pred CcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCcccccCC
Q 010736 303 PKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFLKP 382 (502)
Q Consensus 303 ~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~~ll~~ 382 (502)
|..+..+++|+.|++++|++++..+..+..++.| +|++++|++++..|..+..+++|+++++++|++.|||...++..+
T Consensus 493 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~w 571 (606)
T 3t6q_A 493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEW 571 (606)
T ss_dssp TTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHHHHHH
T ss_pred hhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHHHHHH
Confidence 9999999999999999999999999999999999 999999999999898899999999999999999999998776543
Q ss_pred CCCCcccc--cccccccCcccccccee
Q 010736 383 DSSNWTGF--AGTYGYIAPELAYTMKI 407 (502)
Q Consensus 383 ~~~~~~~~--~gt~gy~aPE~~~~~~~ 407 (502)
.......+ .....|..|+...+.++
T Consensus 572 ~~~~~~~~~~~~~~~C~~p~~~~g~~l 598 (606)
T 3t6q_A 572 YKENMQKLEDTEDTLCENPPLLRGVRL 598 (606)
T ss_dssp HHHCGGGEECGGGCBEEESGGGTTCBG
T ss_pred HHhCcccccCCCCCeeCCchHhCCCee
Confidence 21111111 12234455666655544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.31 Aligned_cols=350 Identities=21% Similarity=0.260 Sum_probs=263.5
Q ss_pred CCCccc----eeeeCCC----------CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCC
Q 010736 57 SPCAWS----GISCNDA----------GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLS 122 (502)
Q Consensus 57 ~~C~W~----Gv~C~~~----------~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~ 122 (502)
+||.+. .|.|... ..++.|||++|++++ +++.+|.++++|++|+|++|+|++..|.+|.++++|+
T Consensus 25 ~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~ 103 (635)
T 4g8a_A 25 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 103 (635)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCC
Confidence 467543 4678642 368999999999985 5555699999999999999999998888999999999
Q ss_pred EEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccc-cCCcCCCCCCCCCeEEcccc
Q 010736 123 ILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQISMLFLHDN 201 (502)
Q Consensus 123 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N 201 (502)
+|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|++++|++++ .+|..++.+++|++|++++|
T Consensus 104 ~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N 183 (635)
T 4g8a_A 104 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 183 (635)
T ss_dssp EEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred EEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCc
Confidence 99999999998777889999999999999999998877889999999999999999976 46788899999999999999
Q ss_pred cccccCCccCcCCcc-----------------------------------------------------------------
Q 010736 202 SFSGFIPPDIGNLKS----------------------------------------------------------------- 216 (502)
Q Consensus 202 ~l~~~~p~~~~~l~~----------------------------------------------------------------- 216 (502)
++++..+..+..+.+
T Consensus 184 ~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~ 263 (635)
T 4g8a_A 184 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 263 (635)
T ss_dssp CCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred cccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccc
Confidence 887654443322111
Q ss_pred ------------------------------------------------------------------CCccccccccccCc
Q 010736 217 ------------------------------------------------------------------ISILSLAINQFSGP 230 (502)
Q Consensus 217 ------------------------------------------------------------------L~~L~ls~N~l~~~ 230 (502)
++.|++.+|.+.+.
T Consensus 264 ~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~ 343 (635)
T 4g8a_A 264 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 343 (635)
T ss_dssp SCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSC
T ss_pred ccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCc
Confidence 11112222211110
Q ss_pred cc-------------------ccccCCCCCcEEEeeCcccc---------------------------------------
Q 010736 231 IP-------------------LSLGNLTNLKQFSLVYNNLY--------------------------------------- 252 (502)
Q Consensus 231 ~p-------------------~~~~~l~~L~~L~l~~N~l~--------------------------------------- 252 (502)
.+ .....+++|+.|+++.|.+.
T Consensus 344 ~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~ 423 (635)
T 4g8a_A 344 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLE 423 (635)
T ss_dssp CCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCC
T ss_pred CcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhcccccccccccccccccccc
Confidence 00 01112344555555554432
Q ss_pred -----------------------------------ccCCCCCcc-ccccEEECcCCcC-cccCCccccCCCCCcEEEccC
Q 010736 253 -----------------------------------GSIPPSLDN-LVLTKLSLDDNHF-TSYLPQNICRGGALQIFTVSE 295 (502)
Q Consensus 253 -----------------------------------~~~p~~~~~-~~L~~L~ls~N~l-~~~~~~~~~~~~~L~~L~ls~ 295 (502)
+..+..+.. ..++.|++++|.+ .+..|..+..+++|+.|++++
T Consensus 424 ~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~ 503 (635)
T 4g8a_A 424 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 503 (635)
T ss_dssp EEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred chhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCC
Confidence 111111111 3466777777764 344677788899999999999
Q ss_pred CccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCC-CCCCeeeecCCcccccc
Q 010736 296 NRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGEC-PKLGALNISRNNITGDF 374 (502)
Q Consensus 296 n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~~L~~L~l~~N~l~~df 374 (502)
|++++..|..|.++++|++|+|++|++++..+..|..+++|++|||++|+|++..|..+..+ ++|++|++++|++.|||
T Consensus 504 N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 504 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred CccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 99999999999999999999999999999988899999999999999999999999999888 68999999999999999
Q ss_pred CcccccCCCCCCcc--cccccccccCcccccccee
Q 010736 375 GIAKFLKPDSSNWT--GFAGTYGYIAPELAYTMKI 407 (502)
Q Consensus 375 Gl~~ll~~~~~~~~--~~~gt~gy~aPE~~~~~~~ 407 (502)
.+.++..+...... .....+.|..|+...+..+
T Consensus 584 ~~~~~~~wl~~~~~~~~~~~~~~C~~P~~~~g~~l 618 (635)
T 4g8a_A 584 EHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPV 618 (635)
T ss_dssp GGHHHHHHHHHTTTTBSCGGGCBBCSSTTTTTCBG
T ss_pred CcHHHHHHHHhCCCccCCCCCceeCCchHHCCCEe
Confidence 99887653211111 1112334556766665544
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=314.32 Aligned_cols=306 Identities=23% Similarity=0.266 Sum_probs=242.6
Q ss_pred CCCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCC-
Q 010736 57 SPCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNI- 135 (502)
Q Consensus 57 ~~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~- 135 (502)
+||. .+-.|. + ..++.++++++ .+|. + .++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+
T Consensus 2 ~p~~-~~c~~~--~--~~~~c~~~~l~-~lp~--l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~ 71 (455)
T 3v47_A 2 DPGT-SECSVI--G--YNAICINRGLH-QVPE--L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71 (455)
T ss_dssp ------CCEEE--T--TEEECCSSCCS-SCCC--C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEEC
T ss_pred CCcc-ceeEEE--c--cccCcCCCCcc-cCCC--C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceEC
Confidence 5776 233343 2 24778888876 4443 2 278999999999999999999999999999999999998666
Q ss_pred CcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcC--CCCCCCCCeEEcccccccccCCcc-Cc
Q 010736 136 PHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHS--LGNLTQISMLFLHDNSFSGFIPPD-IG 212 (502)
Q Consensus 136 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~ 212 (502)
|..|.++++|++|+|++|++++..|..|+++++|++|++++|++++.+|.. +..+++|++|++++|.+++..|.. +.
T Consensus 72 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 151 (455)
T 3v47_A 72 NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151 (455)
T ss_dssp TTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGG
T ss_pred cccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccC
Confidence 567999999999999999999999999999999999999999999866554 899999999999999999887876 88
Q ss_pred CCccCCccccccccccCcccccccCC----------------------------------CCCcEEEeeCccccccCCCC
Q 010736 213 NLKSISILSLAINQFSGPIPLSLGNL----------------------------------TNLKQFSLVYNNLYGSIPPS 258 (502)
Q Consensus 213 ~l~~L~~L~ls~N~l~~~~p~~~~~l----------------------------------~~L~~L~l~~N~l~~~~p~~ 258 (502)
.+++|++|++++|++++..|..+..+ ++|+.|++++|++++..|..
T Consensus 152 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~ 231 (455)
T 3v47_A 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKR 231 (455)
T ss_dssp GCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHH
T ss_pred CCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhh
Confidence 99999999999999998888766554 46777777777665433221
Q ss_pred Cc----------------------------------------cccccEEECcCCcCcccCCccccCCCCCcEEEccCCcc
Q 010736 259 LD----------------------------------------NLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRF 298 (502)
Q Consensus 259 ~~----------------------------------------~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l 298 (502)
+. ...++.|++++|++++..|..+..+++|+.|++++|++
T Consensus 232 ~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 311 (455)
T 3v47_A 232 FFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI 311 (455)
T ss_dssp HHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred hhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcc
Confidence 10 03577777777777777777777778888888888888
Q ss_pred ccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCcccc
Q 010736 299 QGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 299 ~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
++..+..+..+++|+.|++++|.+++..+..+..+++|++|+|++|++++..|..+..+++|++|++++|++.+
T Consensus 312 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 312 NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred cccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcccc
Confidence 77777777778888888888888877777777778888888888888877777777788888888888887754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.73 Aligned_cols=164 Identities=17% Similarity=0.197 Sum_probs=98.7
Q ss_pred CCccCCccccccccccCcccccccCCCCCcEEEeeCccccc--cCCCCCcc-ccccEEECcCCcCcccCCc-cccCCCCC
Q 010736 213 NLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYG--SIPPSLDN-LVLTKLSLDDNHFTSYLPQ-NICRGGAL 288 (502)
Q Consensus 213 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~-~~L~~L~ls~N~l~~~~~~-~~~~~~~L 288 (502)
.+++|++|++++|++++.+|..++.+++|+.|++++|++++ .+|..+.. ..|++|++++|++++.+|. .+..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 34445555555555555455555555555555555555543 22222222 4455555555555553332 24455555
Q ss_pred cEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCC
Q 010736 289 QIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368 (502)
Q Consensus 289 ~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N 368 (502)
+.|++++|++++..|..+. ++|+.|++++|+++ .+|..+..+++|++|++++|+++...+..+..+++|++|++++|
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N 478 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCC
Confidence 6666666655555444332 56777777777776 55665667888888888888887433334778888888888888
Q ss_pred ccccccCcccc
Q 010736 369 NITGDFGIAKF 379 (502)
Q Consensus 369 ~l~~dfGl~~l 379 (502)
++.|||.+.++
T Consensus 479 ~~~c~c~~~~~ 489 (520)
T 2z7x_B 479 PWDCSCPRIDY 489 (520)
T ss_dssp CBCCCHHHHHH
T ss_pred CCcccCCchHH
Confidence 88888887766
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=327.37 Aligned_cols=313 Identities=20% Similarity=0.218 Sum_probs=279.7
Q ss_pred CCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccC-CccCcCCCCCCEEEccCCcCcCCCC
Q 010736 58 PCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTI-PPQISNLTNLSILSLGGNQFSGNIP 136 (502)
Q Consensus 58 ~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~-p~~l~~l~~L~~L~Ls~N~l~~~~p 136 (502)
.|.|..|.+ -..+++.|+|++|.+++..+. .|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|
T Consensus 13 ~~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~-~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p 90 (844)
T 3j0a_A 13 FCNLTQVPQ-VLNTTERLLLSFNYIRTVTAS-SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90 (844)
T ss_dssp CCCSSCCCS-SCTTCCEEEEESCCCCEECSS-SCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred CCCCCCCCC-CCCCcCEEECCCCcCCccChh-HCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence 457888887 557899999999999976665 4999999999999999776666 7889999999999999999999999
Q ss_pred cccCCCCCCcEEEccCCcCcccCCcc--cCCCCCCcEEEcccCcccccCC-cCCCCCCCCCeEEcccccccccCCccCcC
Q 010736 137 HEVGLMSHLKILYIDSNQLDGSIPLE--VGQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLHDNSFSGFIPPDIGN 213 (502)
Q Consensus 137 ~~l~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 213 (502)
..|+++++|++|+|++|++++.+|.. |.++++|++|++++|.+++..+ ..|+++++|++|++++|.+++..+..+..
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 99999999999999999999877765 9999999999999999987765 57899999999999999999998988888
Q ss_pred C--ccCCccccccccccCcccccccCCCC------CcEEEeeCccccccCCCCCc-------------------------
Q 010736 214 L--KSISILSLAINQFSGPIPLSLGNLTN------LKQFSLVYNNLYGSIPPSLD------------------------- 260 (502)
Q Consensus 214 l--~~L~~L~ls~N~l~~~~p~~~~~l~~------L~~L~l~~N~l~~~~p~~~~------------------------- 260 (502)
+ ++|+.|+++.|.+.+..|..++.+.+ |+.|++++|.+++..+..+.
T Consensus 171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~ 250 (844)
T 3j0a_A 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250 (844)
T ss_dssp HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence 7 89999999999999988888777765 99999999988766554322
Q ss_pred --------------cccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCcccccc
Q 010736 261 --------------NLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326 (502)
Q Consensus 261 --------------~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 326 (502)
...++.|++++|.+.+..+..+..+++|+.|++++|++++..+..|..+++|++|++++|.+++..
T Consensus 251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 330 (844)
T 3j0a_A 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330 (844)
T ss_dssp SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence 136889999999999988899999999999999999999888889999999999999999999888
Q ss_pred CcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCcccc
Q 010736 327 SKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 327 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
+..|..+++|++|++++|++.+..+..+..+++|++|++++|.+.+
T Consensus 331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376 (844)
T ss_dssp SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence 8999999999999999999988888889999999999999998764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=322.33 Aligned_cols=292 Identities=20% Similarity=0.354 Sum_probs=258.8
Q ss_pred CCEEEEEecCCCCcee-----------------cCcccCC--CCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCc
Q 010736 70 GRVINISLRGVGLKGK-----------------LHAFSFS--SFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQ 130 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~-----------------l~~~~~~--~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~ 130 (502)
.+++.|+|++|.++|. +|.. ++ ++++|++|+|++|++.|.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 5789999999999996 8876 88 99999999999999999999999999999999999998
Q ss_pred -CcC-CCCcccCCC------CCCcEEEccCCcCcccCCc--ccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEccc
Q 010736 131 -FSG-NIPHEVGLM------SHLKILYIDSNQLDGSIPL--EVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD 200 (502)
Q Consensus 131 -l~~-~~p~~l~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 200 (502)
++| .+|..++.+ ++|++|++++|+++ .+|. .++.+++|++|++++|+++|.+| .++.+++|++|++++
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 998 899988876 99999999999999 8888 89999999999999999999999 899999999999999
Q ss_pred ccccccCCccCcCCcc-CCccccccccccCcccccccCCC--CCcEEEeeCccccccCCCCCc-------c-ccccEEEC
Q 010736 201 NSFSGFIPPDIGNLKS-ISILSLAINQFSGPIPLSLGNLT--NLKQFSLVYNNLYGSIPPSLD-------N-LVLTKLSL 269 (502)
Q Consensus 201 N~l~~~~p~~~~~l~~-L~~L~ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~~~~-------~-~~L~~L~l 269 (502)
|+++ .+|..+..+++ |++|++++|+++ .+|..+..++ +|+.|++++|.+++.+|..+. . ..|+.|++
T Consensus 363 N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~L 440 (636)
T 4eco_A 363 NQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440 (636)
T ss_dssp SEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEEC
T ss_pred Cccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEEC
Confidence 9999 78888999999 999999999999 7888887765 899999999999998888776 3 57999999
Q ss_pred cCCcCcccCCccccCCCCCcEEEccCCccccccCcc-cccC-------CCCcEEeCCCCccccccCcccC--CCCCCcEE
Q 010736 270 DDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKS-LRNC-------TSLIRVRLDGNNLTGNISKAFG--IYPNLTFI 339 (502)
Q Consensus 270 s~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~-l~~l-------~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L 339 (502)
++|++++..+..+..+++|+.|++++|+++ .+|.. +... ++|+.|++++|+++ .+|..+. .+++|+.|
T Consensus 441 s~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L 518 (636)
T 4eco_A 441 SNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGI 518 (636)
T ss_dssp CSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEE
T ss_pred cCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEE
Confidence 999999654445566899999999999998 55543 3322 28999999999998 6677776 88999999
Q ss_pred EccCcccccccCccccCCCCCCeeeecCCc
Q 010736 340 DLSRNNFYGEISSNFGECPKLGALNISRNN 369 (502)
Q Consensus 340 ~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~ 369 (502)
+|++|++++ +|..+..+++|++|++++|+
T Consensus 519 ~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~ 547 (636)
T 4eco_A 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547 (636)
T ss_dssp ECCSSCCSS-CCCGGGGCSSCCEEECCSCB
T ss_pred ECCCCCCCC-cChhhhcCCCCCEEECCCCc
Confidence 999999987 88888899999999996654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=315.09 Aligned_cols=154 Identities=18% Similarity=0.227 Sum_probs=130.2
Q ss_pred CCccceeeeCCC------------CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEE
Q 010736 58 PCAWSGISCNDA------------GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILS 125 (502)
Q Consensus 58 ~C~W~Gv~C~~~------------~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ 125 (502)
+|.|.|+ |+.. .+++.|+|+++++++..+. .|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 80 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHG-DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSS-TTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChh-hhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence 5899998 8532 3699999999999977665 499999999999999999999999999999999999
Q ss_pred ccCCcCcCCCCcccCCCCCCcEEEccCCcCcc-cCCcccCCCCCCcEEEcccCcccccCC-cCCCCCCCCCeEEcccccc
Q 010736 126 LGGNQFSGNIPHEVGLMSHLKILYIDSNQLDG-SIPLEVGQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLHDNSF 203 (502)
Q Consensus 126 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l 203 (502)
|++|++++..|..|+++++|++|++++|++++ ..|..++++++|++|++++|++.+.+| ..+.++++|++|++++|++
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 99999998877779999999999999999986 356788899999999999998544554 5788888888888888888
Q ss_pred cccCCccCcC
Q 010736 204 SGFIPPDIGN 213 (502)
Q Consensus 204 ~~~~p~~~~~ 213 (502)
++..|..++.
T Consensus 161 ~~~~~~~l~~ 170 (549)
T 2z81_A 161 RNYQSQSLKS 170 (549)
T ss_dssp CEECTTTTTT
T ss_pred cccChhhhhc
Confidence 8766665543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=312.13 Aligned_cols=301 Identities=18% Similarity=0.199 Sum_probs=230.0
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
..++.|+|++|.+++..+. .|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNT-TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp TTCCEEECTTCCCSEECTT-TSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CcCcEEEccCCccCcCChh-HhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence 3689999999999976555 599999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCC--ccccccccc
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSIS--ILSLAINQF 227 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~--~L~ls~N~l 227 (502)
+++|++++..|..++.+++|++|++++|++++..+..+..+++|++|++++|.+++..|..++.+++|+ .|++++|.+
T Consensus 112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred ccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 999999987788899999999999999999975444555689999999999988877777677776666 566666655
Q ss_pred cCcc---------------------------------------------------------------------------c
Q 010736 228 SGPI---------------------------------------------------------------------------P 232 (502)
Q Consensus 228 ~~~~---------------------------------------------------------------------------p 232 (502)
++.. +
T Consensus 192 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~ 271 (606)
T 3t6q_A 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271 (606)
T ss_dssp CEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred CccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence 5433 3
Q ss_pred ccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCc-ccccCC
Q 010736 233 LSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPK-SLRNCT 310 (502)
Q Consensus 233 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~-~l~~l~ 310 (502)
..|..+++|+.|++++|.++ .+|..+.. ..|++|++++|++++..|..+..+++|+.|++++|.+.+.++. .+..++
T Consensus 272 ~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 350 (606)
T 3t6q_A 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350 (606)
T ss_dssp TTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred HHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence 33555666777777777666 55555544 5677777777777666666666666666777666666655443 366666
Q ss_pred CCcEEeCCCCcccccc--CcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCcccc
Q 010736 311 SLIRVRLDGNNLTGNI--SKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 311 ~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
+|++|++++|.+++.. +..+..+++|++|++++|++.+..+..+..+++|++|++++|.+.+
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 414 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEEC
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCC
Confidence 6777777777666554 5566666777777777777766666666667777777777776643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.81 Aligned_cols=301 Identities=19% Similarity=0.206 Sum_probs=202.3
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|+|++|.+++..+. .|.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMP-DISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCGG-GTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCccccChh-hhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 5788999999999865444 5999999999999999999888999999999999999999998 56665 789999999
Q ss_pred ccCCcCcc-cCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCC--CeEEcccccc-----------------------
Q 010736 150 IDSNQLDG-SIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQI--SMLFLHDNSF----------------------- 203 (502)
Q Consensus 150 Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l----------------------- 203 (502)
+++|++++ .+|..|+++++|++|++++|++++. .+..+++| ++|++++|.+
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 204 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEEC
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEec
Confidence 99999987 3467889999999999998887642 23333333 5555554444
Q ss_pred --------------------------------------------------------------------------------
Q 010736 204 -------------------------------------------------------------------------------- 203 (502)
Q Consensus 204 -------------------------------------------------------------------------------- 203 (502)
T Consensus 205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~ 284 (562)
T 3a79_B 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284 (562)
T ss_dssp SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEE
T ss_pred CccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEe
Confidence
Q ss_pred ----cccCCccC-----------------------------------------------------cCCccCCcccccccc
Q 010736 204 ----SGFIPPDI-----------------------------------------------------GNLKSISILSLAINQ 226 (502)
Q Consensus 204 ----~~~~p~~~-----------------------------------------------------~~l~~L~~L~ls~N~ 226 (502)
+|.+|..+ ..+++|++|++++|+
T Consensus 285 ~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~ 364 (562)
T 3a79_B 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364 (562)
T ss_dssp EEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSC
T ss_pred ccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCc
Confidence 33333332 334455555555555
Q ss_pred ccCcccccccCCCCCcEEEeeCcccccc--CCCCCcc-ccccEEECcCCcCcccCCc-cccCCCCCcEEEccCCcccccc
Q 010736 227 FSGPIPLSLGNLTNLKQFSLVYNNLYGS--IPPSLDN-LVLTKLSLDDNHFTSYLPQ-NICRGGALQIFTVSENRFQGTI 302 (502)
Q Consensus 227 l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~-~~L~~L~ls~N~l~~~~~~-~~~~~~~L~~L~ls~n~l~~~~ 302 (502)
+++.+|..+.++++|+.|++++|++++. +|..+.. ..|+.|++++|++++.+|. .+..+++|+.|++++|++++..
T Consensus 365 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 444 (562)
T 3a79_B 365 FTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444 (562)
T ss_dssp CCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGG
T ss_pred cccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcch
Confidence 5555555555555555555555555531 1222222 4555555555555553332 3445555666666666665544
Q ss_pred CcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCccccc
Q 010736 303 PKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFL 380 (502)
Q Consensus 303 ~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~~ll 380 (502)
|..+. ++|+.|++++|+++ .+|..+..+++|++|+|++|++++..+..+..+++|++|++++|++.|||.+.+++
T Consensus 445 ~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~ 519 (562)
T 3a79_B 445 FRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYL 519 (562)
T ss_dssp GSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHHHH
T ss_pred hhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHHHH
Confidence 44332 56777777777776 45555557788888888888887433334777888888888888888888776654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=315.93 Aligned_cols=311 Identities=19% Similarity=0.191 Sum_probs=204.1
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCC-------------------------------
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLT------------------------------- 119 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~------------------------------- 119 (502)
.++.|+++++.+++..+.. |+.+++|++|++++|++++..|..|.+++
T Consensus 249 ~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~ 327 (680)
T 1ziw_A 249 NLTMLDLSYNNLNVVGNDS-FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327 (680)
T ss_dssp CCCEEECTTSCCCEECTTT-TTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTT
T ss_pred CCCEEECCCCCcCccCccc-ccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhccc
Confidence 3677777777776655443 77777777777777777766655444444
Q ss_pred --CCCEEEccCCcCcCCCCcccCCCCCCcEEEccCC----------------------------cCcccCCcccCCCCCC
Q 010736 120 --NLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN----------------------------QLDGSIPLEVGQLSSM 169 (502)
Q Consensus 120 --~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N----------------------------~l~~~~p~~~~~l~~L 169 (502)
+|++|++++|.+++..|..|.++++|++|++++| ++++..|..|..+++|
T Consensus 328 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 407 (680)
T 1ziw_A 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407 (680)
T ss_dssp CTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCC
Confidence 4444444445555444444444444444444333 2333333444444444
Q ss_pred cEEEcccCcccccCC-cCCCCCCCCCeEEcccccccccCCccCcCCccCCcccccccccc--CcccccccCCCCCcEEEe
Q 010736 170 VELALFSNNLNGSVP-HSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFS--GPIPLSLGNLTNLKQFSL 246 (502)
Q Consensus 170 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~--~~~p~~~~~l~~L~~L~l 246 (502)
+.|++++|.+++.+| ..+..+++|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..+..+++|+.|++
T Consensus 408 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~L 487 (680)
T 1ziw_A 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487 (680)
T ss_dssp CEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEEC
T ss_pred CEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEEC
Confidence 444444444444333 33444444555555555544444445555555555555555554 456677778888888888
Q ss_pred eCccccccCCCCCcc-ccccEEECcCCcCcccCC--------ccccCCCCCcEEEccCCccccccCcccccCCCCcEEeC
Q 010736 247 VYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLP--------QNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRL 317 (502)
Q Consensus 247 ~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~--------~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l 317 (502)
++|++++..+..+.. ..|++|++++|++++..+ ..+..+++|+.|++++|+++...+..|.++++|+.|++
T Consensus 488 s~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 567 (680)
T 1ziw_A 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeEC
Confidence 888888666655555 678888888888876422 23677788888888888888544456888889999999
Q ss_pred CCCccccccCcccCCCCCCcEEEccCcccccccCcccc-CCCCCCeeeecCCccccccCc-ccccCC
Q 010736 318 DGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFG-ECPKLGALNISRNNITGDFGI-AKFLKP 382 (502)
Q Consensus 318 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~~L~~L~l~~N~l~~dfGl-~~ll~~ 382 (502)
++|++++..+..|..+++|+.|+|++|++++..+..+. .+++|+++++++|++.|||.+ .++..+
T Consensus 568 s~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~ 634 (680)
T 1ziw_A 568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNW 634 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECC
T ss_pred CCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHH
Confidence 99999877777788889999999999999887777776 788999999999999999985 666654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=304.93 Aligned_cols=302 Identities=18% Similarity=0.133 Sum_probs=274.6
Q ss_pred eeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCC
Q 010736 65 SCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144 (502)
Q Consensus 65 ~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 144 (502)
.|.... ..++.++++++ .+|.. + .+++++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++
T Consensus 8 ~C~~~~--~~v~c~~~~l~-~ip~~-~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 81 (477)
T 2id5_A 8 ECSAQD--RAVLCHRKRFV-AVPEG-I--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81 (477)
T ss_dssp EEETTT--TEEECCSCCCS-SCCSC-C--CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred eECCCC--CEEEeCCCCcC-cCCCC-C--CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCcc
Confidence 475433 35788888887 45543 3 368999999999999999999999999999999999999988999999999
Q ss_pred CcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCcccccc
Q 010736 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAI 224 (502)
Q Consensus 145 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 224 (502)
|++|+|++|++++..+..|.++++|++|++++|++++..|..|..+++|++|++++|.+++..+..|..+++|+.|++++
T Consensus 82 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 161 (477)
T 2id5_A 82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEK 161 (477)
T ss_dssp CCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEES
T ss_pred CCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCC
Confidence 99999999999977777789999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccC
Q 010736 225 NQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIP 303 (502)
Q Consensus 225 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~ 303 (502)
|++++..+..+.++++|+.|++++|.+.+..+..+.. ..|+.|++++|.+.+.++.......+|+.|++++|++++..+
T Consensus 162 n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 241 (477)
T 2id5_A 162 CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241 (477)
T ss_dssp CCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCH
T ss_pred CcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCH
Confidence 9999877788999999999999999999877777766 789999999999888888877777899999999999996555
Q ss_pred cccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCcccc
Q 010736 304 KSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 304 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
..+..+++|+.|++++|.+++..+..|..+++|+.|+|++|++.+..+..+..+++|++|++++|.+.+
T Consensus 242 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 310 (477)
T 2id5_A 242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT 310 (477)
T ss_dssp HHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSC
T ss_pred HHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCce
Confidence 678999999999999999998888899999999999999999999999999999999999999999864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.54 Aligned_cols=145 Identities=16% Similarity=0.184 Sum_probs=98.4
Q ss_pred cCCCCCcEEEeeCccccccCC-CCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccc-cccCcccccCCCC
Q 010736 236 GNLTNLKQFSLVYNNLYGSIP-PSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQ-GTIPKSLRNCTSL 312 (502)
Q Consensus 236 ~~l~~L~~L~l~~N~l~~~~p-~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~-~~~~~~l~~l~~L 312 (502)
..+++|+.|++++|.+.+..| ..+.. ..|++|++++|.+++..|..+..+++|+.|++++|.++ +.+|..+..+++|
T Consensus 393 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L 472 (570)
T 2z63_A 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472 (570)
T ss_dssp ETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred cccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCC
Confidence 334444444444444444333 12222 56777777777777766767777777777777777776 4667777777777
Q ss_pred cEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCccccc
Q 010736 313 IRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFL 380 (502)
Q Consensus 313 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~~ll 380 (502)
+.|++++|++++..|..+..+++|++|++++|++++..+..+..+++|++|++++|++.|++...+++
T Consensus 473 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 540 (570)
T 2z63_A 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 540 (570)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred CEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHH
Confidence 77777777777776777777777777777777777776677777777777788777777777654443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=297.64 Aligned_cols=273 Identities=18% Similarity=0.269 Sum_probs=172.5
Q ss_pred CCCHHHHHHHHHHHhhcCcCCCCCCCCCCCCCCCCCCCCCCCccceeeeCC---------CCCEEEEEecCCCCceecCc
Q 010736 18 SETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCND---------AGRVINISLRGVGLKGKLHA 88 (502)
Q Consensus 18 ~~~~~d~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~C~W~Gv~C~~---------~~~v~~L~L~~~~l~g~l~~ 88 (502)
++..+|++||++||+++..++.+++.+|.... ....++|.|.|+.|+. ..+|+.|+|++++++ .+|+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~---~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQAN---SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHT---TTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccc---cccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 35568999999999999767777788884210 0135789999999952 246777777777766 5555
Q ss_pred ccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCC---
Q 010736 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQ--- 165 (502)
Q Consensus 89 ~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~--- 165 (502)
. +..+++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++++++|++|++++|++.+.+|..+..
T Consensus 99 ~-l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~ 175 (328)
T 4fcg_A 99 Q-AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175 (328)
T ss_dssp C-GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-
T ss_pred h-hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccc
Confidence 4 666777777777777766 66666677777777777777766 56666666777777777776666666665543
Q ss_pred ------CCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCC
Q 010736 166 ------LSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLT 239 (502)
Q Consensus 166 ------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 239 (502)
+++|++|++++|+++ .+|..++.+++|++|++++|++++ +|..++.++
T Consensus 176 ~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-------------------------l~~~l~~l~ 229 (328)
T 4fcg_A 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-------------------------LGPAIHHLP 229 (328)
T ss_dssp CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-------------------------CCGGGGGCT
T ss_pred hhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-------------------------CchhhccCC
Confidence 445555555555544 444444444555555555554443 333344445
Q ss_pred CCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCC
Q 010736 240 NLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318 (502)
Q Consensus 240 ~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~ 318 (502)
+|+.|++++|.+.+.+|..+.. ..|++|++++|++.+.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.+++.
T Consensus 230 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~ 309 (328)
T 4fcg_A 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309 (328)
T ss_dssp TCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECC
T ss_pred CCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCC
Confidence 5555555555444444444433 445555555555555566666667777777777777777777777777777777776
Q ss_pred CCccc
Q 010736 319 GNNLT 323 (502)
Q Consensus 319 ~N~l~ 323 (502)
.+.+.
T Consensus 310 ~~~~~ 314 (328)
T 4fcg_A 310 PHLQA 314 (328)
T ss_dssp GGGSC
T ss_pred HHHHH
Confidence 65544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=311.39 Aligned_cols=291 Identities=18% Similarity=0.174 Sum_probs=213.4
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
.+..++++++.+. .+|+..|..+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 52 ~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 52 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 4577888888776 466666889999999999999999998889999999999999999999988888999999999999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCc
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP 230 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 230 (502)
++|.+++..+..|+.+++|++|++++|.+++..|..|+.+++|++|++++|.+++.. ++.+++|+.|++++|.+++.
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l 207 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL 207 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc
Confidence 999999766666899999999999999999998989999999999999999998753 44556666666666666531
Q ss_pred c------------------cccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEE
Q 010736 231 I------------------PLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIF 291 (502)
Q Consensus 231 ~------------------p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L 291 (502)
. +.. ..++|+.|++++|.+++. ..+.. ..|+.|++++|.+++..|..+..+++|+.|
T Consensus 208 ~~~~~L~~L~ls~n~l~~~~~~--~~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 283 (597)
T 3oja_B 208 AIPIAVEELDASHNSINVVRGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283 (597)
T ss_dssp ECCTTCSEEECCSSCCCEEECS--CCSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred cCCchhheeeccCCcccccccc--cCCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEE
Confidence 1 111 113455555555555532 22222 456666666666666666666666666666
Q ss_pred EccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccc
Q 010736 292 TVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371 (502)
Q Consensus 292 ~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~ 371 (502)
++++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|++|+|++|.+.+.. +..+++|++|++++|++.
T Consensus 284 ~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~ 358 (597)
T 3oja_B 284 YISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWD 358 (597)
T ss_dssp ECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEE
T ss_pred ECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCC
Confidence 666666664 3444555666666666666666 34445556666666666666665432 555677777777777777
Q ss_pred ccc
Q 010736 372 GDF 374 (502)
Q Consensus 372 ~df 374 (502)
|++
T Consensus 359 ~~~ 361 (597)
T 3oja_B 359 CNS 361 (597)
T ss_dssp HHH
T ss_pred Chh
Confidence 765
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=294.40 Aligned_cols=291 Identities=17% Similarity=0.162 Sum_probs=194.6
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
..++.++++++.++ .+|+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 35778889888876 56666688999999999999999988888999999999999999999988888899999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
+++|+++...+..|..+++|++|++++|++++..|..+..+++|++|++++|++++.. +..+++|+.|++++|.+++
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccc
Confidence 9999999555555789999999999999999888888999999999999999998652 4556677777777776653
Q ss_pred cccccccCCCCCcEEEeeCccccccCC-------------------CCCcc-ccccEEECcCCcCcccCCccccCCCCCc
Q 010736 230 PIPLSLGNLTNLKQFSLVYNNLYGSIP-------------------PSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQ 289 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L~l~~N~l~~~~p-------------------~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~ 289 (502)
. ...++|+.|++++|.+..... ..+.. ..|++|++++|.+++..|..+..+++|+
T Consensus 201 ~-----~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 275 (390)
T 3o6n_A 201 L-----AIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 275 (390)
T ss_dssp E-----ECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred c-----CCCCcceEEECCCCeeeeccccccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHccccccCC
Confidence 2 222345555555555442211 11211 3444555555554444444444445555
Q ss_pred EEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCc
Q 010736 290 IFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNN 369 (502)
Q Consensus 290 ~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~ 369 (502)
.|++++|++++ ++..+..+++|+.|++++|++++ +|..+..+++|+.|++++|+++.. .+..+++|++|++++|+
T Consensus 276 ~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~---~~~~~~~L~~L~l~~N~ 350 (390)
T 3o6n_A 276 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHND 350 (390)
T ss_dssp EEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC---CCCTTCCCSEEECCSSC
T ss_pred EEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCcccee---CchhhccCCEEEcCCCC
Confidence 55555554442 23333444445555555554442 233334444555555555554422 13444555555555555
Q ss_pred ccccc
Q 010736 370 ITGDF 374 (502)
Q Consensus 370 l~~df 374 (502)
+.|++
T Consensus 351 ~~~~~ 355 (390)
T 3o6n_A 351 WDCNS 355 (390)
T ss_dssp EEHHH
T ss_pred ccchh
Confidence 55554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=291.07 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=209.0
Q ss_pred CCCCEEECCCCcccc--cCCccCcCCCCCCEEEccC-CcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcE
Q 010736 95 PHLAYLDLRDNKLFG--TIPPQISNLTNLSILSLGG-NQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVE 171 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g--~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 171 (502)
.++++|+|++|.++| .+|..|+++++|++|+|++ |.+.+.+|..|+++++|++|++++|++++.+|..|..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 478889999999988 8888899999999999984 8888888888888888888888888888888888888888888
Q ss_pred EEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCc-cCCccccccccccCcccccccCCCCCcEEEeeCcc
Q 010736 172 LALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLK-SISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250 (502)
Q Consensus 172 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 250 (502)
|++++|++++.+|..+..+++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..++ |
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L--------- 199 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-L--------- 199 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-C---------
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-c---------
Confidence 88888888888888788888888888888887777777766665 666666666666655555555443 4
Q ss_pred ccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCccc
Q 010736 251 LYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF 330 (502)
Q Consensus 251 l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 330 (502)
+.|++++|++++..|..+..+++|+.|++++|++++.++. +..+++|++|++++|++++.+|..+
T Consensus 200 --------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 200 --------------AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp --------------SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred --------------cEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence 4555555555555666777888999999999999877665 7889999999999999999999999
Q ss_pred CCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCcccccc
Q 010736 331 GIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDF 374 (502)
Q Consensus 331 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~df 374 (502)
..+++|++|+|++|++++.+|.. ..+++|+.+++++|+..|+.
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred hcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCC
Confidence 99999999999999999999886 88999999999999977654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=317.56 Aligned_cols=290 Identities=19% Similarity=0.293 Sum_probs=248.1
Q ss_pred CCEEEEEecCCCCce-----------------ecCcccCC--CCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCc
Q 010736 70 GRVINISLRGVGLKG-----------------KLHAFSFS--SFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQ 130 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g-----------------~l~~~~~~--~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~ 130 (502)
.+++.|+|++|.++| .+|.. ++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 578999999999999 48875 77 99999999999999999999999999999999999998
Q ss_pred -CcC-CCCcccCCCC-------CCcEEEccCCcCcccCCc--ccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcc
Q 010736 131 -FSG-NIPHEVGLMS-------HLKILYIDSNQLDGSIPL--EVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199 (502)
Q Consensus 131 -l~~-~~p~~l~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 199 (502)
++| .+|..++.++ +|++|+|++|+++ .+|. .++++++|+.|++++|+++ .+| .|+.+++|+.|+++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLD 603 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECC
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECc
Confidence 998 8888666555 9999999999999 8888 8999999999999999999 888 89999999999999
Q ss_pred cccccccCCccCcCCcc-CCccccccccccCcccccccCCCC--CcEEEeeCccccccCCCCC------ccccccEEECc
Q 010736 200 DNSFSGFIPPDIGNLKS-ISILSLAINQFSGPIPLSLGNLTN--LKQFSLVYNNLYGSIPPSL------DNLVLTKLSLD 270 (502)
Q Consensus 200 ~N~l~~~~p~~~~~l~~-L~~L~ls~N~l~~~~p~~~~~l~~--L~~L~l~~N~l~~~~p~~~------~~~~L~~L~ls 270 (502)
+|+++ .+|..+..+++ |+.|++++|+++ .+|..+..++. |+.|++++|++.+.+|... ....|+.|+++
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls 681 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECC
T ss_pred CCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEcc
Confidence 99999 88888999999 999999999999 78888877754 9999999999998766432 12478899999
Q ss_pred CCcCcccCCccc-cCCCCCcEEEccCCccccccCccccc--------CCCCcEEeCCCCccccccCcccC--CCCCCcEE
Q 010736 271 DNHFTSYLPQNI-CRGGALQIFTVSENRFQGTIPKSLRN--------CTSLIRVRLDGNNLTGNISKAFG--IYPNLTFI 339 (502)
Q Consensus 271 ~N~l~~~~~~~~-~~~~~L~~L~ls~n~l~~~~~~~l~~--------l~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L 339 (502)
+|+++. +|..+ ..+++|+.|++++|+++ .+|..+.. +++|+.|+|++|+++ .+|..+. .+++|+.|
T Consensus 682 ~N~L~~-lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L 758 (876)
T 4ecn_A 682 YNEIQK-FPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758 (876)
T ss_dssp SSCCCS-CCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEE
T ss_pred CCcCCc-cCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEE
Confidence 999985 45444 47888899999998888 55544332 238888888888888 5667776 88888888
Q ss_pred EccCcccccccCccccCCCCCCeeeecCCc
Q 010736 340 DLSRNNFYGEISSNFGECPKLGALNISRNN 369 (502)
Q Consensus 340 ~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~ 369 (502)
+|++|++++ +|..+..+++|+.|++++|+
T Consensus 759 ~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~ 787 (876)
T 4ecn_A 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQR 787 (876)
T ss_dssp ECCSSCCSS-CCCGGGGCTTCCEEECCCCB
T ss_pred EeCCCCCCc-cchhhhcCCCCCEEECCCCC
Confidence 888888886 67788888888888887744
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=307.99 Aligned_cols=300 Identities=19% Similarity=0.207 Sum_probs=257.1
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|+|+++++++.. +..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLP-AANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCCCC-GGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCCcC-HHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 47999999999999754 44599999999999999999999999999999999999999999966666799999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCc--CCccCCccccccccc
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIG--NLKSISILSLAINQF 227 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~ls~N~l 227 (502)
+++|++++..|..|+++++|++|++++|.+++..|..++++++|++|++++|.+++..+..+. .+++|+.|++++|++
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 999999988888999999999999999999999999999999999999999999987776654 458999999999999
Q ss_pred cCcccccccCC---------------------------CCCcEEEeeCccccccCCCCCcc---ccccEEECcCCcCccc
Q 010736 228 SGPIPLSLGNL---------------------------TNLKQFSLVYNNLYGSIPPSLDN---LVLTKLSLDDNHFTSY 277 (502)
Q Consensus 228 ~~~~p~~~~~l---------------------------~~L~~L~l~~N~l~~~~p~~~~~---~~L~~L~ls~N~l~~~ 277 (502)
++..|..+..+ ++|+.|++++|.+++..|..+.. ..|+.|++++|++++.
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence 98888766554 45778888888888888877765 3499999999999998
Q ss_pred CCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccc-----cC----cccCCCCCCcEEEccCccccc
Q 010736 278 LPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGN-----IS----KAFGIYPNLTFIDLSRNNFYG 348 (502)
Q Consensus 278 ~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~-----~~----~~~~~l~~L~~L~Ls~N~l~~ 348 (502)
.|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|...+. +| ..|..+++|++|++++|++.+
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 888899999999999999999988888888888888888887654431 22 266778888888888888888
Q ss_pred ccCccccCCCCCCeeeecCCcc
Q 010736 349 EISSNFGECPKLGALNISRNNI 370 (502)
Q Consensus 349 ~~~~~~~~~~~L~~L~l~~N~l 370 (502)
..+..+..+++|++|++++|.+
T Consensus 344 ~~~~~~~~l~~L~~L~Ls~n~~ 365 (680)
T 1ziw_A 344 IKSNMFTGLINLKYLSLSNSFT 365 (680)
T ss_dssp CCTTTTTTCTTCCEEECTTCBS
T ss_pred CChhHhccccCCcEEECCCCch
Confidence 7777788888888888777653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=298.21 Aligned_cols=296 Identities=21% Similarity=0.207 Sum_probs=248.1
Q ss_pred EEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccC
Q 010736 73 INISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDS 152 (502)
Q Consensus 73 ~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 152 (502)
..++.++++++ .+|.. +. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~-~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~ 89 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDD-IP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG 89 (606)
T ss_dssp TEEECTTSCCS-SCCTT-SC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CceEccCCCcc-cCCCC-CC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCC
Confidence 46899999987 56653 43 7899999999999999998999999999999999999988899999999999999999
Q ss_pred CcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccc-cCCccCcCCccCCccccccccccCcc
Q 010736 153 NQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSG-FIPPDIGNLKSISILSLAINQFSGPI 231 (502)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~ 231 (502)
|++++..|..|+++++|++|++++|++++..+..++++++|++|++++|.+++ .+|..++++++|++|++++|++++..
T Consensus 90 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~ 169 (606)
T 3vq2_A 90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169 (606)
T ss_dssp CCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred CcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence 99999889999999999999999999998887889999999999999999986 56999999999999999988776543
Q ss_pred ccccc---------------------------------------------------------------------------
Q 010736 232 PLSLG--------------------------------------------------------------------------- 236 (502)
Q Consensus 232 p~~~~--------------------------------------------------------------------------- 236 (502)
|..++
T Consensus 170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~ 249 (606)
T 3vq2_A 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249 (606)
T ss_dssp TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred hhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence 32111
Q ss_pred --------------------------------------------------------------------------------
Q 010736 237 -------------------------------------------------------------------------------- 236 (502)
Q Consensus 237 -------------------------------------------------------------------------------- 236 (502)
T Consensus 250 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~ 329 (606)
T 3vq2_A 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF 329 (606)
T ss_dssp CCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSS
T ss_pred cChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCc
Confidence
Q ss_pred ------------------CCCCCcEEEeeCcccccc-------------------------CCCCCcc-ccccEEECcCC
Q 010736 237 ------------------NLTNLKQFSLVYNNLYGS-------------------------IPPSLDN-LVLTKLSLDDN 272 (502)
Q Consensus 237 ------------------~l~~L~~L~l~~N~l~~~-------------------------~p~~~~~-~~L~~L~ls~N 272 (502)
.+++|+.|++++|.+++. +|..+.. ..|+.|++++|
T Consensus 330 L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n 409 (606)
T 3vq2_A 330 LKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHS 409 (606)
T ss_dssp CCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTS
T ss_pred cceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCC
Confidence 122333344444433322 1112222 46788888889
Q ss_pred cCcccCC-ccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCcccc-ccCcccCCCCCCcEEEccCccccccc
Q 010736 273 HFTSYLP-QNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG-NISKAFGIYPNLTFIDLSRNNFYGEI 350 (502)
Q Consensus 273 ~l~~~~~-~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~ 350 (502)
++++..| ..+..+++|+.|++++|.+++..|..+..+++|++|++++|.+++ .+|..+..+++|+.|++++|++++..
T Consensus 410 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 489 (606)
T 3vq2_A 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489 (606)
T ss_dssp EEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEEC
T ss_pred ccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccC
Confidence 8888777 678889999999999999998888889999999999999999987 47888899999999999999999888
Q ss_pred CccccCCCCCCeeeecCCcccc
Q 010736 351 SSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 351 ~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
|..+..+++|++|++++|++.+
T Consensus 490 ~~~~~~l~~L~~L~Ls~N~l~~ 511 (606)
T 3vq2_A 490 WGVFDTLHRLQLLNMSHNNLLF 511 (606)
T ss_dssp TTTTTTCTTCCEEECCSSCCSC
T ss_pred hhhhcccccCCEEECCCCcCCC
Confidence 8889999999999999998865
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.42 Aligned_cols=293 Identities=18% Similarity=0.178 Sum_probs=200.1
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|+|+++.+++..+. .|..+++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|.. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTS-DILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCCCCCHH-HHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred ccccEEECCCCcccccChh-hccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 5788999999999865544 4899999999999999999888889999999999999999998 56665 789999999
Q ss_pred ccCCcCcc-cCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCC--CeEEcccccc--cccCCccCcC-----------
Q 010736 150 IDSNQLDG-SIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQI--SMLFLHDNSF--SGFIPPDIGN----------- 213 (502)
Q Consensus 150 Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~----------- 213 (502)
+++|++++ .+|..|+.+++|++|++++|++++ ..+..+++| ++|++++|.+ .+..|..+..
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 173 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence 99999987 478889999999999999999886 346777777 9999999988 6666665554
Q ss_pred ---------------CccCCcccccccc-------ccCcccccccCC---------------------------CCCcEE
Q 010736 214 ---------------LKSISILSLAINQ-------FSGPIPLSLGNL---------------------------TNLKQF 244 (502)
Q Consensus 214 ---------------l~~L~~L~ls~N~-------l~~~~p~~~~~l---------------------------~~L~~L 244 (502)
+++|+.+++++|. +.+.+| .++.+ ++|+.|
T Consensus 174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L 252 (520)
T 2z7x_B 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252 (520)
T ss_dssp SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred cCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence 3333444443332 111111 11111 134444
Q ss_pred EeeCccccccCCCCC-----cc---------------------------ccccEEECcCCcCcccCCccccCCCCCcEEE
Q 010736 245 SLVYNNLYGSIPPSL-----DN---------------------------LVLTKLSLDDNHFTSYLPQNICRGGALQIFT 292 (502)
Q Consensus 245 ~l~~N~l~~~~p~~~-----~~---------------------------~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ 292 (502)
++++|+++|.+|..+ .. ..++.|++++|.+.... ....+++|+.|+
T Consensus 253 ~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~ 330 (520)
T 2z7x_B 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLD 330 (520)
T ss_dssp EEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEE
T ss_pred EeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEE
Confidence 444444444444433 11 12444444444443321 114566777777
Q ss_pred ccCCccccccCcccccCCCCcEEeCCCCcccc--ccCcccCCCCCCcEEEccCcccccccCc-cccCCCCCCeeeecCCc
Q 010736 293 VSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG--NISKAFGIYPNLTFIDLSRNNFYGEISS-NFGECPKLGALNISRNN 369 (502)
Q Consensus 293 ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~~L~~L~l~~N~ 369 (502)
+++|++++..|..+..+++|+.|++++|++++ .+|..+..+++|++|++++|++.+.+|. .+..+++|++|++++|.
T Consensus 331 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~ 410 (520)
T 2z7x_B 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410 (520)
T ss_dssp CCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSC
T ss_pred eECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCC
Confidence 77777776667677777777777777777765 3445566777777777777777764443 36666777777777777
Q ss_pred ccc
Q 010736 370 ITG 372 (502)
Q Consensus 370 l~~ 372 (502)
+.+
T Consensus 411 l~~ 413 (520)
T 2z7x_B 411 LTD 413 (520)
T ss_dssp CCG
T ss_pred CCc
Confidence 654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=294.72 Aligned_cols=156 Identities=24% Similarity=0.277 Sum_probs=135.8
Q ss_pred EEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEcc
Q 010736 72 VINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID 151 (502)
Q Consensus 72 v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 151 (502)
.+.++++++++++ +|.. +. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 33 ~~~l~ls~~~L~~-ip~~-~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 108 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKD-LP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108 (562)
T ss_dssp CCEEECTTSCCCS-CCTT-SC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred CcEEEcCCCCCcc-CCCC-CC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence 3789999999995 7764 43 899999999999999888999999999999999999999889999999999999999
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcccc-cCCcCCCCCCCCCeEEcccccccccCCccCcCCccC--Cccccccccc-
Q 010736 152 SNQLDGSIPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSI--SILSLAINQF- 227 (502)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~ls~N~l- 227 (502)
+|+++ .+|.. .+++|++|++++|++++ .+|..|+++++|++|++++|++++. .+..+++| +.|++++|++
T Consensus 109 ~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~ 182 (562)
T 3a79_B 109 HNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH 182 (562)
T ss_dssp TSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred CCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence 99999 56666 89999999999999997 4568899999999999999999863 45556666 9999999988
Q ss_pred -cCcccccccC
Q 010736 228 -SGPIPLSLGN 237 (502)
Q Consensus 228 -~~~~p~~~~~ 237 (502)
++..|..+..
T Consensus 183 ~~~~~~~~l~~ 193 (562)
T 3a79_B 183 IKGGETESLQI 193 (562)
T ss_dssp CCSSSCCEEEE
T ss_pred ccccCcccccc
Confidence 6666665554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=270.83 Aligned_cols=283 Identities=22% Similarity=0.273 Sum_probs=241.6
Q ss_pred EEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCc
Q 010736 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQ 154 (502)
Q Consensus 75 L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 154 (502)
+++++++++ .+|.. + .++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|++++|+
T Consensus 38 l~~~~~~l~-~ip~~-~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 113 (332)
T 2ft3_A 38 VQCSDLGLK-AVPKE-I--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113 (332)
T ss_dssp EECCSSCCS-SCCSC-C--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSC
T ss_pred EECCCCCcc-ccCCC-C--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCc
Confidence 444455554 45543 3 3689999999999998888899999999999999999998889999999999999999999
Q ss_pred CcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEccccccc--ccCCccCcCCccCCccccccccccCccc
Q 010736 155 LDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS--GFIPPDIGNLKSISILSLAINQFSGPIP 232 (502)
Q Consensus 155 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~ls~N~l~~~~p 232 (502)
++ .+|..+. ++|++|++++|++++..+..|..+++|++|++++|.++ +..+..+..+ +|+.|++++|++++ +|
T Consensus 114 l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~ 188 (332)
T 2ft3_A 114 LV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IP 188 (332)
T ss_dssp CC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CC
T ss_pred CC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cC
Confidence 98 5666655 79999999999999777777899999999999999996 4677888888 99999999999986 55
Q ss_pred ccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCC
Q 010736 233 LSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTS 311 (502)
Q Consensus 233 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~ 311 (502)
..+. ++|+.|++++|.+++..+..+.. ..|+.|++++|++++..+..+..+++|+.|++++|+++ .+|..+..+++
T Consensus 189 ~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~ 265 (332)
T 2ft3_A 189 KDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265 (332)
T ss_dssp SSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTT
T ss_pred cccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCcc
Confidence 5544 78999999999999877777766 78999999999999988888999999999999999998 78888999999
Q ss_pred CcEEeCCCCccccccCcccCC------CCCCcEEEccCcccc--cccCccccCCCCCCeeeecCCc
Q 010736 312 LIRVRLDGNNLTGNISKAFGI------YPNLTFIDLSRNNFY--GEISSNFGECPKLGALNISRNN 369 (502)
Q Consensus 312 L~~L~l~~N~l~~~~~~~~~~------l~~L~~L~Ls~N~l~--~~~~~~~~~~~~L~~L~l~~N~ 369 (502)
|+.|++++|++++..+..|.. .+.|+.+++++|.+. +..+..+..+++|+.+++++|+
T Consensus 266 L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 266 LQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 999999999999877777654 477999999999987 5677889999999999999885
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=307.63 Aligned_cols=296 Identities=19% Similarity=0.219 Sum_probs=256.8
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcc--cCCCCCCcE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHE--VGLMSHLKI 147 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~--l~~l~~L~~ 147 (502)
..++.|+|+++...+.+++..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++.+|.. |+++++|++
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 468899999999999998778999999999999999999999999999999999999999999877765 999999999
Q ss_pred EEccCCcCcccCC-cccCCCCCCcEEEcccCcccccCCcCCCCC--CCCCeEEcccccccccCCccCcCCcc------CC
Q 010736 148 LYIDSNQLDGSIP-LEVGQLSSMVELALFSNNLNGSVPHSLGNL--TQISMLFLHDNSFSGFIPPDIGNLKS------IS 218 (502)
Q Consensus 148 L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~------L~ 218 (502)
|+|++|.+++..+ ..|+++++|++|++++|.+++..|..+..+ ++|+.|++++|.+.+..|..++.+.+ |+
T Consensus 128 L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~ 207 (844)
T 3j0a_A 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207 (844)
T ss_dssp EEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBS
T ss_pred EECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCcee
Confidence 9999999998765 579999999999999999999999888877 89999999999999888877776665 99
Q ss_pred ccccccccccCcccccccC--------------------------------------CCCCcEEEeeCccccccCCCCCc
Q 010736 219 ILSLAINQFSGPIPLSLGN--------------------------------------LTNLKQFSLVYNNLYGSIPPSLD 260 (502)
Q Consensus 219 ~L~ls~N~l~~~~p~~~~~--------------------------------------l~~L~~L~l~~N~l~~~~p~~~~ 260 (502)
.|++++|.+++..+..+.. .++|+.|++++|.+.+..|..+.
T Consensus 208 ~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~ 287 (844)
T 3j0a_A 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE 287 (844)
T ss_dssp EEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSS
T ss_pred EEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhh
Confidence 9999999887665544322 25789999999999888777776
Q ss_pred c-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEE
Q 010736 261 N-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFI 339 (502)
Q Consensus 261 ~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 339 (502)
. ..|+.|++++|++++..|..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+++..+..|..+++|++|
T Consensus 288 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 367 (844)
T 3j0a_A 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL 367 (844)
T ss_dssp SCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEE
T ss_pred cCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEE
Confidence 6 789999999999999888889999999999999999998888899999999999999999988888889999999999
Q ss_pred EccCcccccccCccccCCCCCCeeeecCCcc
Q 010736 340 DLSRNNFYGEISSNFGECPKLGALNISRNNI 370 (502)
Q Consensus 340 ~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l 370 (502)
+|++|.+++.. .+++|+.|++++|++
T Consensus 368 ~Ls~N~l~~i~-----~~~~L~~L~l~~N~l 393 (844)
T 3j0a_A 368 DLRDNALTTIH-----FIPSIPDIFLSGNKL 393 (844)
T ss_dssp EEETCCSCCCS-----SCCSCSEEEEESCCC
T ss_pred ECCCCCCCccc-----CCCCcchhccCCCCc
Confidence 99999887422 245555555555544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-32 Score=268.15 Aligned_cols=268 Identities=23% Similarity=0.272 Sum_probs=224.8
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEc
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELAL 174 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 174 (502)
++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|+.+++|++|++++|+++ .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 68999999999999888888999999999999999999888999999999999999999998 5666554 78999999
Q ss_pred ccCcccccCCcCCCCCCCCCeEEcccccccc--cCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccc
Q 010736 175 FSNNLNGSVPHSLGNLTQISMLFLHDNSFSG--FIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 175 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 252 (502)
++|++++..+..+.++++|++|++++|.+.. ..+..+..+++|++|++++|+++. +|..+. ++|+.|++++|.++
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKIT 205 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCC
Confidence 9999998777778899999999999999864 667788889999999999999884 555443 78999999999998
Q ss_pred ccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccC
Q 010736 253 GSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFG 331 (502)
Q Consensus 253 ~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 331 (502)
+..|..+.. ..|+.|++++|++++..+..+..+++|+.|++++|+++ .+|..+..+++|++|++++|++++..+..|.
T Consensus 206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~ 284 (330)
T 1xku_A 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284 (330)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred ccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcC
Confidence 777776666 68899999999998887778888899999999999998 7788888899999999999999877766664
Q ss_pred C------CCCCcEEEccCccccc--ccCccccCCCCCCeeeecCCc
Q 010736 332 I------YPNLTFIDLSRNNFYG--EISSNFGECPKLGALNISRNN 369 (502)
Q Consensus 332 ~------l~~L~~L~Ls~N~l~~--~~~~~~~~~~~L~~L~l~~N~ 369 (502)
. .+.++.+++++|.+.. ..|..+..++.++.+++++|+
T Consensus 285 ~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 3 3778899999998863 456778888999999998874
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-32 Score=266.25 Aligned_cols=279 Identities=20% Similarity=0.238 Sum_probs=241.9
Q ss_pred CCccceeeeCCC----------CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEcc
Q 010736 58 PCAWSGISCNDA----------GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLG 127 (502)
Q Consensus 58 ~C~W~Gv~C~~~----------~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls 127 (502)
.|.|..+.|+.. ..++.|+++++++++..+. .|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKD-DFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHh-HhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 378999999742 2689999999999865544 59999999999999999999999999999999999999
Q ss_pred CCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCccc--ccCCcCCCCCCCCCeEEcccccccc
Q 010736 128 GNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN--GSVPHSLGNLTQISMLFLHDNSFSG 205 (502)
Q Consensus 128 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~ 205 (502)
+|.++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|.++ +..|..+..+ +|++|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 99999 6776665 89999999999999777778999999999999999996 4778888888 99999999999996
Q ss_pred cCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccC
Q 010736 206 FIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICR 284 (502)
Q Consensus 206 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~ 284 (502)
+|..+. ++|+.|++++|++++..+..+..+++|+.|++++|++++..+..+.. ..|+.|++++|+++. +|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCB-CCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCee-cChhhhc
Confidence 555544 78999999999999988899999999999999999999877766666 789999999999994 7788999
Q ss_pred CCCCcEEEccCCccccccCccccc------CCCCcEEeCCCCccc--cccCcccCCCCCCcEEEccCcc
Q 010736 285 GGALQIFTVSENRFQGTIPKSLRN------CTSLIRVRLDGNNLT--GNISKAFGIYPNLTFIDLSRNN 345 (502)
Q Consensus 285 ~~~L~~L~ls~n~l~~~~~~~l~~------l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~ 345 (502)
+++|+.|++++|++++..+..|.. ...|+.+++++|.+. +..+..|..+++|+.+++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 999999999999999776666654 367899999999987 5677889999999999999884
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-32 Score=288.64 Aligned_cols=181 Identities=19% Similarity=0.192 Sum_probs=144.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCC
Q 010736 40 SLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLT 119 (502)
Q Consensus 40 ~~l~~W~~~~~~~~~~~~~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~ 119 (502)
..++.|+.. -|..|..-.|.... +.++.++.+|+ .+|.. +. +++++|||++|+|++..|..|.+++
T Consensus 11 ~~~~~~~~~--------~p~~~~~c~~~~~~--~~~~c~~~~l~-~vP~~-lp--~~~~~LdLs~N~i~~l~~~~f~~l~ 76 (635)
T 4g8a_A 11 DKLAAANSS--------IPESWEPCVEVVPN--ITYQCMELNFY-KIPDN-LP--FSTKNLDLSFNPLRHLGSYSFFSFP 76 (635)
T ss_dssp ----------------------CCSEEEETT--TEEECTTSCCS-SCCSS-SC--TTCCEEECTTSCCCEECTTTTTTCT
T ss_pred chhhcccCC--------CCCCCCCccccCCC--CEEECCCCCcC-ccCCC-CC--cCCCEEEeeCCCCCCCCHHHHhCCC
Confidence 345666543 47788876664333 34678888887 56653 32 4799999999999988888999999
Q ss_pred CCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcc
Q 010736 120 NLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199 (502)
Q Consensus 120 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 199 (502)
+|++|+|++|+|++..|.+|.++++|++|+|++|++++..+..|.++++|++|++++|++++..+..|+++++|++|+++
T Consensus 77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls 156 (635)
T 4g8a_A 77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 156 (635)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccc
Confidence 99999999999998888899999999999999999998888889999999999999999998877889999999999999
Q ss_pred ccccccc-CCccCcCCccCCccccccccccCccccc
Q 010736 200 DNSFSGF-IPPDIGNLKSISILSLAINQFSGPIPLS 234 (502)
Q Consensus 200 ~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 234 (502)
+|.+++. .|..++.+++|++|++++|++++..+..
T Consensus 157 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 192 (635)
T 4g8a_A 157 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 192 (635)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred cCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence 9999864 5788899999999999999887655443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-31 Score=260.57 Aligned_cols=267 Identities=19% Similarity=0.260 Sum_probs=237.2
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALF 175 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 175 (502)
+++.++++++.++ .+|..+. +.|++|+|++|++++..+..|+++++|++|++++|++++..|..|..+++|++|+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 5677777777777 4666554 689999999999998888889999999999999999998889999999999999999
Q ss_pred cCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC--cccccccCCCCCcEEEeeCccccc
Q 010736 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG--PIPLSLGNLTNLKQFSLVYNNLYG 253 (502)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~ 253 (502)
+|+++ .+|..+. ++|++|++++|++++..+..+..+++|+.|++++|.++. ..+..+.++++|+.|++++|.++
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~- 184 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 184 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-
Confidence 99998 5666554 799999999999998888889999999999999999964 67788999999999999999998
Q ss_pred cCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCC
Q 010736 254 SIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIY 333 (502)
Q Consensus 254 ~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 333 (502)
.+|..+. ..|++|++++|++++..+..+..+++|+.|++++|.+++..+..+..+++|++|++++|+++ .+|..+..+
T Consensus 185 ~l~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 262 (330)
T 1xku_A 185 TIPQGLP-PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262 (330)
T ss_dssp SCCSSCC-TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred cCCcccc-ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccC
Confidence 4665544 78999999999999988999999999999999999999888888999999999999999998 677889999
Q ss_pred CCCcEEEccCcccccccCccccC------CCCCCeeeecCCccc
Q 010736 334 PNLTFIDLSRNNFYGEISSNFGE------CPKLGALNISRNNIT 371 (502)
Q Consensus 334 ~~L~~L~Ls~N~l~~~~~~~~~~------~~~L~~L~l~~N~l~ 371 (502)
++|++|++++|++++..+..|.. .+.++.+++++|++.
T Consensus 263 ~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccc
Confidence 99999999999999877766643 478899999999985
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.06 Aligned_cols=171 Identities=21% Similarity=0.216 Sum_probs=148.8
Q ss_pred eeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCC
Q 010736 64 ISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMS 143 (502)
Q Consensus 64 v~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 143 (502)
..|... .+ .++++++++ .+|.. +. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|++++
T Consensus 2 ~~C~~~-~~--c~~~~~~l~-~ip~~-~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 74 (549)
T 2z81_A 2 LSCDAS-GV--CDGRSRSFT-SIPSG-LT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLG 74 (549)
T ss_dssp CEECTT-SE--EECTTSCCS-SCCSC-CC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred ccCCCC-ce--EECCCCccc-ccccc-CC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccc
Confidence 368653 34 789999988 56664 43 7999999999999999999999999999999999999998889999999
Q ss_pred CCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccc-cCCcCCCCCCCCCeEEcccccccccC-CccCcCCccCCccc
Q 010736 144 HLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQISMLFLHDNSFSGFI-PPDIGNLKSISILS 221 (502)
Q Consensus 144 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 221 (502)
+|++|++++|++++..|..|+.+++|++|++++|++++ ..|..++++++|++|++++|.+.+.+ +..+..+++|++|+
T Consensus 75 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~ 154 (549)
T 2z81_A 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE 154 (549)
T ss_dssp TCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred cCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeee
Confidence 99999999999998888889999999999999999986 46778999999999999999854444 46899999999999
Q ss_pred cccccccCcccccccCCCCC
Q 010736 222 LAINQFSGPIPLSLGNLTNL 241 (502)
Q Consensus 222 ls~N~l~~~~p~~~~~l~~L 241 (502)
+++|++++..|..++.+++|
T Consensus 155 L~~n~l~~~~~~~l~~l~~L 174 (549)
T 2z81_A 155 IKALSLRNYQSQSLKSIRDI 174 (549)
T ss_dssp EEETTCCEECTTTTTTCSEE
T ss_pred ccCCcccccChhhhhccccC
Confidence 99999998888777654433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-31 Score=268.56 Aligned_cols=266 Identities=17% Similarity=0.212 Sum_probs=192.6
Q ss_pred CCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcE
Q 010736 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVE 171 (502)
Q Consensus 92 ~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 171 (502)
..++++++|++++|.++...+..|.++++|++|+|++|.+++..|..|+.+++|++|++++|++++..|..|+.+++|++
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 34689999999999999766666899999999999999999888889999999999999999999888888999999999
Q ss_pred EEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccc
Q 010736 172 LALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNL 251 (502)
Q Consensus 172 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 251 (502)
|++++|+++...+..|..+++|++|++++|++++..|..+..+++|++|++++|++++. .+..+++|+.|++++|.+
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence 99999999965555579999999999999999998888999999999999999999864 356788999999999998
Q ss_pred cccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccC
Q 010736 252 YGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFG 331 (502)
Q Consensus 252 ~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 331 (502)
++.... ..++.|++++|.++... .. ..++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+..+.
T Consensus 199 ~~~~~~----~~L~~L~l~~n~l~~~~-~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (390)
T 3o6n_A 199 STLAIP----IAVEELDASHNSINVVR-GP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV 269 (390)
T ss_dssp SEEECC----SSCSEEECCSSCCCEEE-CC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred cccCCC----CcceEEECCCCeeeecc-cc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence 753211 24555555555554431 11 123445555555544432 2344444555555555555444444444
Q ss_pred CCCCCcEEEccCcccccccCccccCCCCCCeeeecCCcc
Q 010736 332 IYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNI 370 (502)
Q Consensus 332 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l 370 (502)
.+++|+.|++++|++++ ++..+..+++|++|++++|++
T Consensus 270 ~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l 307 (390)
T 3o6n_A 270 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 307 (390)
T ss_dssp TCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCC
T ss_pred ccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcc
Confidence 44555555555554443 233334444455555554444
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-31 Score=283.61 Aligned_cols=273 Identities=18% Similarity=0.215 Sum_probs=233.8
Q ss_pred CCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEE
Q 010736 93 SFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172 (502)
Q Consensus 93 ~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 172 (502)
.+++++.|++++|.++...+..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+.+++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46789999999999998777778999999999999999999888899999999999999999999888889999999999
Q ss_pred EcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccc
Q 010736 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 173 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 252 (502)
+|++|.+++..+..|+.+++|++|++++|.+++..|..|+.+++|++|++++|.+++.. +..+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence 99999999766666899999999999999999999999999999999999999998753 344556666666666554
Q ss_pred cc-CCCCC----------------ccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEE
Q 010736 253 GS-IPPSL----------------DNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRV 315 (502)
Q Consensus 253 ~~-~p~~~----------------~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L 315 (502)
+. .|..+ ....|+.|++++|.+++. ..+..+++|+.|++++|.+++..|..|..+++|+.|
T Consensus 206 ~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 283 (597)
T 3oja_B 206 TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283 (597)
T ss_dssp EEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred cccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEE
Confidence 31 11111 114688888888888873 678888999999999999998889999999999999
Q ss_pred eCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCcccc
Q 010736 316 RLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 316 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
+|++|.+++. +..+..+++|+.|+|++|.+. .+|..+..+++|++|++++|++++
T Consensus 284 ~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~ 338 (597)
T 3oja_B 284 YISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT 338 (597)
T ss_dssp ECTTSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC
T ss_pred ECCCCCCCCC-CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCC
Confidence 9999999864 566677899999999999998 567778889999999999999864
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=269.71 Aligned_cols=284 Identities=17% Similarity=0.201 Sum_probs=213.9
Q ss_pred CCCCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCC
Q 010736 56 ISPCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNI 135 (502)
Q Consensus 56 ~~~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~ 135 (502)
..+|.|.|+ |+ +++++++ .+|.. +. ++|++|++++|++++..+..|.++++|++|+|++|++++..
T Consensus 27 ~~~C~~~~~-c~---------~~~~~l~-~iP~~-~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 92 (353)
T 2z80_A 27 SLSCDRNGI-CK---------GSSGSLN-SIPSG-LT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE 92 (353)
T ss_dssp CCEECTTSE-EE---------CCSTTCS-SCCTT-CC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred CCCCCCCeE-ee---------CCCCCcc-ccccc-cc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence 457899887 64 3445555 45543 33 58999999999999877778999999999999999999888
Q ss_pred CcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCC-cCCCCCCCCCeEEcccc-cccccCCccCcC
Q 010736 136 PHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLHDN-SFSGFIPPDIGN 213 (502)
Q Consensus 136 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~ 213 (502)
|..|+++++|++|++++|++++..+..|..+++|++|++++|++++..+ ..+..+++|++|++++| .+.+..+..+..
T Consensus 93 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 172 (353)
T 2z80_A 93 EDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172 (353)
T ss_dssp TTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTT
T ss_pred HhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccC
Confidence 8889999999999999999996655568999999999999999985433 47889999999999998 577777788888
Q ss_pred CccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCc--cccccEEECcCCcCcccCCccccCCCCCcEE
Q 010736 214 LKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLD--NLVLTKLSLDDNHFTSYLPQNICRGGALQIF 291 (502)
Q Consensus 214 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L 291 (502)
+++|++|++++|++++..|..+..+++|++|++++|.++ .+|..+. ...|+.|++++|++++..+..+..
T Consensus 173 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~------- 244 (353)
T 2z80_A 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELST------- 244 (353)
T ss_dssp CCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC-----------
T ss_pred CCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCcccccccccccc-------
Confidence 999999999999998888888888899999999888875 3332221 145666666666665543322211
Q ss_pred EccCCccccccCcccccCCCCcEEeCCCCcccc----ccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecC
Q 010736 292 TVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG----NISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISR 367 (502)
Q Consensus 292 ~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~ 367 (502)
......++.++++++.+.+ .+|..+..+++|+.|++++|+++...+..+..+++|++|++++
T Consensus 245 --------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 310 (353)
T 2z80_A 245 --------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHT 310 (353)
T ss_dssp ----------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred --------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeC
Confidence 1123345555555555544 2455677788888888888888844444468889999999999
Q ss_pred CccccccC
Q 010736 368 NNITGDFG 375 (502)
Q Consensus 368 N~l~~dfG 375 (502)
|++.||+-
T Consensus 311 N~~~~~~~ 318 (353)
T 2z80_A 311 NPWDCSCP 318 (353)
T ss_dssp SCBCCCHH
T ss_pred CCccCcCC
Confidence 99999884
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-31 Score=261.85 Aligned_cols=284 Identities=24% Similarity=0.386 Sum_probs=188.0
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.++++++++.. ++. +..+++|++|++++|++++. |. +.++++|++|++++|.++. +| .+..+++|++|+
T Consensus 44 ~~L~~L~l~~~~i~~-~~~--~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~ 116 (347)
T 4fmz_A 44 ESITKLVVAGEKVAS-IQG--IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELY 116 (347)
T ss_dssp TTCSEEECCSSCCCC-CTT--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred ccccEEEEeCCcccc-chh--hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEE
Confidence 356677777777653 332 66677777777777777643 33 7777777777777777764 33 577777777777
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
+++|++++..+ +..+++|+.|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|.+++
T Consensus 117 l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (347)
T 4fmz_A 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191 (347)
T ss_dssp CTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC
T ss_pred CcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc
Confidence 77777764332 6677777777777775554433 36677777777777777765433 6667777777777777765
Q ss_pred cccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCccccc
Q 010736 230 PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRN 308 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~ 308 (502)
..+ +..+++|+.|++++|.+++..+ +.. ..|++|++++|++++..+ +..+++|+.|++++|.+++. ..+..
T Consensus 192 ~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~ 263 (347)
T 4fmz_A 192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKD 263 (347)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTT
T ss_pred ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhc
Confidence 433 6667777777777777664332 222 567777777777766433 66677777777777777643 34666
Q ss_pred CCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccC
Q 010736 309 CTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFG 375 (502)
Q Consensus 309 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfG 375 (502)
+++|++|++++|++++. ..+..+++|+.|++++|++.+..+..+..+++|++|++++|++.+...
T Consensus 264 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 264 LTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 77777777777777653 346666777777777777776666667777777777777777665433
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=259.18 Aligned_cols=280 Identities=22% Similarity=0.321 Sum_probs=243.5
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|+++++.+++ +++ +..+++|++|++++|.+++ +| .+.++++|++|++++|.+++. |. +..+++|++|+
T Consensus 66 ~~L~~L~l~~n~i~~-~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~ 138 (347)
T 4fmz_A 66 TNLEYLNLNGNQITD-ISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISDI-SP-LANLTKMYSLN 138 (347)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCCC-GG-GTTCTTCCEEE
T ss_pred CCccEEEccCCcccc-chh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccCc-hh-hccCCceeEEE
Confidence 479999999999985 333 8999999999999999986 34 699999999999999999954 43 89999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
+++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|.+.+..+ +..+++|+.|++++|.+++
T Consensus 139 l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 213 (347)
T 4fmz_A 139 LGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213 (347)
T ss_dssp CTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCC
Confidence 99997665544 48999999999999999986544 8899999999999999986543 8889999999999999997
Q ss_pred cccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCccccc
Q 010736 230 PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRN 308 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~ 308 (502)
..+ +..+++|+.|++++|.+++..+ +.. ..|++|++++|.+++. ..+..+++|+.|++++|++++. ..+..
T Consensus 214 ~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~ 285 (347)
T 4fmz_A 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNN 285 (347)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGG
T ss_pred Cch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcC
Confidence 655 8889999999999999985443 333 7899999999999885 5688999999999999999864 46889
Q ss_pred CCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccc
Q 010736 309 CTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371 (502)
Q Consensus 309 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~ 371 (502)
+++|+.|++++|.+++..+..+..+++|++|++++|++++..| +..+++|++|++++|+|.
T Consensus 286 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 9999999999999998888889999999999999999997766 888999999999999975
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=269.91 Aligned_cols=282 Identities=23% Similarity=0.334 Sum_probs=169.7
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|+|+++.+++.. + +..+++|++|++++|.+++..| ++++++|++|++++|.+++..+ +..+++|++|+
T Consensus 68 ~~L~~L~Ls~n~l~~~~-~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 140 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDIT-P--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 140 (466)
T ss_dssp TTCCEEECCSSCCCCCG-G--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred cCCCEEECCCCccCCch-h--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEE
Confidence 46888889888887643 2 7888888888888888886554 8888888888888888875432 77788888888
Q ss_pred ccCCcCcccCC-------------------cccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCcc
Q 010736 150 IDSNQLDGSIP-------------------LEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPD 210 (502)
Q Consensus 150 Ls~N~l~~~~p-------------------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 210 (502)
+++|++++... ..+..+++|++|++++|.+++. + .+..+++|++|++++|.+++..|
T Consensus 141 l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~-- 216 (466)
T 1o6v_A 141 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI-S-VLAKLTNLESLIATNNQISDITP-- 216 (466)
T ss_dssp EEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCCCGG--
T ss_pred CCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC-h-hhccCCCCCEEEecCCccccccc--
Confidence 88877764211 1255667777777777777643 2 36667777777777777765544
Q ss_pred CcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCC----------
Q 010736 211 IGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLP---------- 279 (502)
Q Consensus 211 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~---------- 279 (502)
++.+++|+.|++++|++++. ..+..+++|+.|++++|.+++..+ +.. ..|+.|++++|++++..+
T Consensus 217 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L 292 (466)
T 1o6v_A 217 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL 292 (466)
T ss_dssp GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEE
T ss_pred ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccCeE
Confidence 45556666666666665532 234555555555555555553322 211 345555555555544322
Q ss_pred ----------ccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccc
Q 010736 280 ----------QNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGE 349 (502)
Q Consensus 280 ----------~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 349 (502)
..+..+++|+.|++++|++++..| +..+++|+.|++++|.+++. ..+..+++|+.|++++|++++.
T Consensus 293 ~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~ 368 (466)
T 1o6v_A 293 ELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDL 368 (466)
T ss_dssp ECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBC
T ss_pred EcCCCcccCchhhcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCcc
Confidence 013444445555555555544333 44455555555555555443 2445555555555555555554
Q ss_pred cCccccCCCCCCeeeecCCcccc
Q 010736 350 ISSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 350 ~~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
.| +..+++|++|++++|++++
T Consensus 369 ~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 369 TP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp GG--GTTCTTCCEEECCCEEEEC
T ss_pred ch--hhcCCCCCEEeccCCcccC
Confidence 44 5555566666666665543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-31 Score=268.08 Aligned_cols=254 Identities=19% Similarity=0.170 Sum_probs=181.3
Q ss_pred EEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCc
Q 010736 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQ 154 (502)
Q Consensus 75 L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 154 (502)
++.++.+++ .+|.. +. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|+
T Consensus 48 v~c~~~~l~-~iP~~-~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 48 VICVRKNLR-EVPDG-IS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp EECCSCCCS-SCCSC-CC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred EEeCCCCcC-cCCCC-CC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 444444554 44443 32 577788888888887777778888888888888888776666777777777777777777
Q ss_pred CcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCccccc
Q 010736 155 LDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLS 234 (502)
Q Consensus 155 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 234 (502)
+++..+..|..+++|++|++++|+++...+..|..+++|++|++++|+..+. ..+..
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~-----------------------i~~~~ 180 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY-----------------------ISEGA 180 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCE-----------------------ECTTT
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcce-----------------------eCcch
Confidence 7755555667777777777777776655555566666666666665322211 12224
Q ss_pred ccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcE
Q 010736 235 LGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIR 314 (502)
Q Consensus 235 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~ 314 (502)
|.++++|+.|++++|+++ .+| .+..+++|+.|++++|++++..+..|.++++|+.
T Consensus 181 ~~~l~~L~~L~L~~n~l~-~~~------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 235 (440)
T 3zyj_A 181 FEGLSNLRYLNLAMCNLR-EIP------------------------NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK 235 (440)
T ss_dssp TTTCSSCCEEECTTSCCS-SCC------------------------CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred hhcccccCeecCCCCcCc-ccc------------------------ccCCCcccCEEECCCCccCccChhhhccCccCCE
Confidence 455555666666665554 222 1334556777777777777666777888888888
Q ss_pred EeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCccccc
Q 010736 315 VRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFL 380 (502)
Q Consensus 315 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~~ll 380 (502)
|++++|++++..+..|..+++|+.|+|++|++++..+..+..+++|++|++++|++.|||.+.++.
T Consensus 236 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l~ 301 (440)
T 3zyj_A 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLS 301 (440)
T ss_dssp EECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHHH
T ss_pred EECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHHH
Confidence 888888888888888889999999999999999888888899999999999999999999988764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=267.22 Aligned_cols=238 Identities=21% Similarity=0.190 Sum_probs=176.4
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEc
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELAL 174 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 174 (502)
+++++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|++
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 57788888888888777777888888888888888887777777777778888888877777665566777777777777
Q ss_pred ccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccccc
Q 010736 175 FSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGS 254 (502)
Q Consensus 175 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 254 (502)
++|+++...+..|.++++|++|++++|...+. ..+..|.++++|+.|++++|++++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~-----------------------i~~~~~~~l~~L~~L~L~~n~l~~- 210 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEY-----------------------ISEGAFEGLFNLKYLNLGMCNIKD- 210 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCE-----------------------ECTTTTTTCTTCCEEECTTSCCSS-
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccc-----------------------cChhhccCCCCCCEEECCCCcccc-
Confidence 77777655555666666666666665322211 112234455556666666665542
Q ss_pred CCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCC
Q 010736 255 IPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYP 334 (502)
Q Consensus 255 ~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 334 (502)
+| .+..+++|+.|++++|.+++..|..|.++++|+.|++++|++++..+..|..++
T Consensus 211 ~~------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 266 (452)
T 3zyi_A 211 MP------------------------NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA 266 (452)
T ss_dssp CC------------------------CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred cc------------------------cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCC
Confidence 11 133456677777777777777777788888888888888988888888888999
Q ss_pred CCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCccccc
Q 010736 335 NLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFL 380 (502)
Q Consensus 335 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~~ll 380 (502)
+|+.|+|++|++++..+..+..+++|++|++++|++.|||.+.++.
T Consensus 267 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~~l~ 312 (452)
T 3zyi_A 267 SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLA 312 (452)
T ss_dssp TCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTHHHH
T ss_pred CCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCchHHH
Confidence 9999999999999877888889999999999999999999987653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=279.35 Aligned_cols=299 Identities=23% Similarity=0.229 Sum_probs=218.4
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|+|+++++++..+. .|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSY-SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp SSCCEEECCSCCCCEECTT-TTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ccccEEEccCCccCccChh-HhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 4689999999999976554 599999999999999999998899999999999999999999988889999999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccc-cCCcCCCCCCCCCeEEcccccccccCCccCcCCccC----Ccccccc
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSI----SILSLAI 224 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~ls~ 224 (502)
+++|++++..+..++.+++|++|++++|.+++ .+|..++++++|++|++++|++++..+..++.+++| ..+++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 99999997766679999999999999999987 479999999999999999999999888889888888 8899999
Q ss_pred ccccCcccc-----------------------------------------------------------------------
Q 010736 225 NQFSGPIPL----------------------------------------------------------------------- 233 (502)
Q Consensus 225 N~l~~~~p~----------------------------------------------------------------------- 233 (502)
|.+++..|.
T Consensus 187 n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 877654332
Q ss_pred ----------cccCCCCCcEEEeeCccccccCCCCCcc------------------------------------------
Q 010736 234 ----------SLGNLTNLKQFSLVYNNLYGSIPPSLDN------------------------------------------ 261 (502)
Q Consensus 234 ----------~~~~l~~L~~L~l~~N~l~~~~p~~~~~------------------------------------------ 261 (502)
.+..+++|+.|++++|.++ .+|..+..
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~ 345 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCB
T ss_pred chhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccccc
Confidence 2344566777777777665 34433322
Q ss_pred -ccccEEECcCCcCcccC--CccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccC-cccCCCCCCc
Q 010736 262 -LVLTKLSLDDNHFTSYL--PQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNIS-KAFGIYPNLT 337 (502)
Q Consensus 262 -~~L~~L~ls~N~l~~~~--~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~ 337 (502)
..|+.|++++|++++.. +..+..+++|+.|++++|.+++..+. +..+++|+.|++++|.+.+..+ ..+..+++|+
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 23344444444443321 23344444555555555554433222 5555555555665555554443 3455566666
Q ss_pred EEEccCcccccccCccccCCCCCCeeeecCCccc
Q 010736 338 FIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371 (502)
Q Consensus 338 ~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~ 371 (502)
+|++++|++.+..+..+..+++|++|++++|.+.
T Consensus 425 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 458 (570)
T 2z63_A 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458 (570)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEG
T ss_pred EEeCcCCcccccchhhhhcCCcCcEEECcCCcCc
Confidence 6666666666555556666666666666666554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=258.13 Aligned_cols=283 Identities=20% Similarity=0.185 Sum_probs=219.7
Q ss_pred CCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcC--CC
Q 010736 58 PCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSG--NI 135 (502)
Q Consensus 58 ~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~--~~ 135 (502)
.|.|.+|.|+.. +++ .+|.. + .++|++|+|++|+++...+..|.++++|++|+|++|.++. ..
T Consensus 6 ~C~~~~l~c~~~-----------~l~-~ip~~-~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 70 (306)
T 2z66_A 6 SCSGTEIRCNSK-----------GLT-SVPTG-I--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70 (306)
T ss_dssp EEETTEEECCSS-----------CCS-SCCSC-C--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEE
T ss_pred eeCCCEEEcCCC-----------Ccc-cCCCC-C--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCc
Confidence 378999999752 122 23332 2 3678899999999886555567889999999999998873 33
Q ss_pred CcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCC-cCCCCCCCCCeEEcccccccccCCccCcCC
Q 010736 136 PHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLHDNSFSGFIPPDIGNL 214 (502)
Q Consensus 136 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 214 (502)
|..+..+++|++|++++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..+..+..+
T Consensus 71 ~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 149 (306)
T 2z66_A 71 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 149 (306)
T ss_dssp EHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTC
T ss_pred ccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccC
Confidence 666777889999999999887 466778889999999999999886554 578888999999999999988888888888
Q ss_pred ccCCccccccccccC-cccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEE
Q 010736 215 KSISILSLAINQFSG-PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFT 292 (502)
Q Consensus 215 ~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ 292 (502)
++|++|++++|.+++ .+|..+..+++|+.|++++|.+++..|..+.. ..|+.|++++|++++..+..+..+++|+.|+
T Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 229 (306)
T 2z66_A 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229 (306)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEE
T ss_pred cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeE
Confidence 999999999998886 57888888999999999999998877777766 6899999999999887777888889999999
Q ss_pred ccCCccccccCcccccC-CCCcEEeCCCCccccccCc-c-cCCCCCCcEEEccCcccccccCccccC
Q 010736 293 VSENRFQGTIPKSLRNC-TSLIRVRLDGNNLTGNISK-A-FGIYPNLTFIDLSRNNFYGEISSNFGE 356 (502)
Q Consensus 293 ls~n~l~~~~~~~l~~l-~~L~~L~l~~N~l~~~~~~-~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 356 (502)
+++|++++..+..+..+ ++|++|++++|.+++.... . ...+...+.+.+..+.+....|..+..
T Consensus 230 L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp CTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred CCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence 99999998888888887 4899999999998764321 1 111223333445556666666665544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-30 Score=262.35 Aligned_cols=276 Identities=18% Similarity=0.192 Sum_probs=148.0
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
+++.|+++++++++. | .++.+++|++|+|++|++++. | ++++++|++|++++|++++. | ++.+++|++|++
T Consensus 43 ~L~~L~Ls~n~l~~~-~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 43 TLTSLDCHNSSITDM-T--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TCCEEECCSSCCCCC-T--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCEEEccCCCcccC-h--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 455566666665542 2 255556666666666665543 2 55556666666666665542 2 555556666666
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCc
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP 230 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 230 (502)
++|++++ +| ++.+++|++|++++|++++. + ++.+++|++|++++|+..+.+ .+..+++|+.|++++|++++
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~- 184 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE- 184 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-
Confidence 6665554 22 55555555555555555542 2 444455555555555333332 23444444444444444443
Q ss_pred cc-------------------ccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCC----
Q 010736 231 IP-------------------LSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGG---- 286 (502)
Q Consensus 231 ~p-------------------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~---- 286 (502)
+| ..++.+++|+.|++++|++++ +| +.. ..|+.|++++|++++..+..+..+.
T Consensus 185 l~l~~l~~L~~L~l~~N~l~~~~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l 261 (457)
T 3bz5_A 185 LDVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHC 261 (457)
T ss_dssp CCCTTCTTCCEEECCSSCCSCCCCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEEC
T ss_pred eccccCCCCCEEECcCCcCCeeccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEec
Confidence 22 024444555555555555543 23 222 4455555555555543322222221
Q ss_pred ---CCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCc--------ccCCCCCCcEEEccCcccccccCcccc
Q 010736 287 ---ALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISK--------AFGIYPNLTFIDLSRNNFYGEISSNFG 355 (502)
Q Consensus 287 ---~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~--------~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 355 (502)
+|+.|++++|.+.+.+| +..+++|+.|++++|...+.+|. .+...++|++|++++|++++. .++
T Consensus 262 ~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l---~l~ 336 (457)
T 3bz5_A 262 IQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL---DVS 336 (457)
T ss_dssp TTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC---CCT
T ss_pred cCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc---ccc
Confidence 22333333333333333 34556777777777765554432 245567888888888888874 377
Q ss_pred CCCCCCeeeecCCcccc
Q 010736 356 ECPKLGALNISRNNITG 372 (502)
Q Consensus 356 ~~~~L~~L~l~~N~l~~ 372 (502)
.+++|+.|++++|++.+
T Consensus 337 ~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 337 HNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp TCTTCSEEECCSSCCCB
T ss_pred cCCcCcEEECCCCCCCC
Confidence 88888888888888864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-30 Score=261.58 Aligned_cols=271 Identities=18% Similarity=0.206 Sum_probs=193.1
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|+++++++++. + ++.+++|++|++++|++++. | ++++++|++|++++|++++ +| ++.+++|++|+
T Consensus 64 ~~L~~L~Ls~n~l~~~-~---~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~ 133 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D---LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLN 133 (457)
T ss_dssp TTCSEEECCSSCCSCC-C---CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCeE-c---cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEE
Confidence 3566667776666652 1 66666666666666666653 2 6666666666666666664 33 55666666666
Q ss_pred ccCCcCcccCC--------------------cccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCc
Q 010736 150 IDSNQLDGSIP--------------------LEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209 (502)
Q Consensus 150 Ls~N~l~~~~p--------------------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 209 (502)
+++|++++. + ..+..+++|++|++++|++++ +| +..+++|+.|++++|++++.
T Consensus 134 l~~N~l~~l-~l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--- 206 (457)
T 3bz5_A 134 CARNTLTEI-DVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--- 206 (457)
T ss_dssp CTTSCCSCC-CCTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---
T ss_pred CCCCcccee-ccccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---
Confidence 666666542 1 025556667777777777765 34 66777888888888888765
Q ss_pred cCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc--------ccccEEECcCCcCcccCCcc
Q 010736 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN--------LVLTKLSLDDNHFTSYLPQN 281 (502)
Q Consensus 210 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--------~~L~~L~ls~N~l~~~~~~~ 281 (502)
.++.+++|+.|++++|++++ +| ++.+++|+.|++++|++++..+..+.. ..++.+++++|.+.+.+|
T Consensus 207 ~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~-- 281 (457)
T 3bz5_A 207 DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ-- 281 (457)
T ss_dssp CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--
T ss_pred ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--
Confidence 37788999999999999997 55 889999999999999999765544432 145667777777666655
Q ss_pred ccCCCCCcEEEccCCccccccCc--------ccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCcc
Q 010736 282 ICRGGALQIFTVSENRFQGTIPK--------SLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN 353 (502)
Q Consensus 282 ~~~~~~L~~L~ls~n~l~~~~~~--------~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 353 (502)
+..+++|+.|++++|...+.+|. .+..+++|+.|++++|++++. .+..+++|+.|++++|++++.
T Consensus 282 ~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~l---- 354 (457)
T 3bz5_A 282 AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQDF---- 354 (457)
T ss_dssp CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCBC----
T ss_pred ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCCc----
Confidence 46779999999999988776654 256778999999999999984 388999999999999999862
Q ss_pred ccCCCCCCeeeecCCccccc
Q 010736 354 FGECPKLGALNISRNNITGD 373 (502)
Q Consensus 354 ~~~~~~L~~L~l~~N~l~~d 373 (502)
+.|..|+++.|.+.|.
T Consensus 355 ----~~L~~L~l~~n~l~g~ 370 (457)
T 3bz5_A 355 ----SSVGKIPALNNNFEAE 370 (457)
T ss_dssp ----TTGGGSSGGGTSEEEE
T ss_pred ----cccccccccCCcEEec
Confidence 3444555555555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=263.11 Aligned_cols=249 Identities=15% Similarity=0.142 Sum_probs=182.6
Q ss_pred CCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEccc
Q 010736 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFS 176 (502)
Q Consensus 97 L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 176 (502)
....++++|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|++++..|..|.++++|++|++++
T Consensus 33 ~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 33 NGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp TSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 345788889888 5676554 5899999999999977666889999999999999999988788888899999999999
Q ss_pred CcccccCCcCCCCCCCCCeEEcccccccccCC-ccCcCCccCCccccccc-cccCcccccccCCCCCcEEEeeCcccccc
Q 010736 177 NNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP-PDIGNLKSISILSLAIN-QFSGPIPLSLGNLTNLKQFSLVYNNLYGS 254 (502)
Q Consensus 177 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 254 (502)
|++++..+..+.++++|++|++++|++++..+ ..+..+++|++|++++| .++...+..+.++++|+.|++++|.+++.
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 189 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCcc
Confidence 99886555557888888888888888885443 46777788888888877 35555556677777777777777766654
Q ss_pred CCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCccc---C
Q 010736 255 IPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF---G 331 (502)
Q Consensus 255 ~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~---~ 331 (502)
.|. .+..+++|+.|++++|.++......+..+++|+.|++++|.+++..+..+ .
T Consensus 190 ~~~-----------------------~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~ 246 (353)
T 2z80_A 190 EPK-----------------------SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE 246 (353)
T ss_dssp CTT-----------------------TTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------
T ss_pred CHH-----------------------HHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccccc
Confidence 444 44445556666666666543322233446667777777777665443332 2
Q ss_pred CCCCCcEEEccCccccc----ccCccccCCCCCCeeeecCCccc
Q 010736 332 IYPNLTFIDLSRNNFYG----EISSNFGECPKLGALNISRNNIT 371 (502)
Q Consensus 332 ~l~~L~~L~Ls~N~l~~----~~~~~~~~~~~L~~L~l~~N~l~ 371 (502)
..+.++.++++++.+.+ .+|..+..+++|++|++++|++.
T Consensus 247 ~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~ 290 (353)
T 2z80_A 247 TNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK 290 (353)
T ss_dssp CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC
T ss_pred ccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC
Confidence 45678899999988876 36777889999999999999987
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-30 Score=263.70 Aligned_cols=279 Identities=27% Similarity=0.365 Sum_probs=203.0
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|++.++++.. ++. +..+++|++|+|++|.+++..| +.++++|++|++++|.+++..| ++++++|++|+
T Consensus 46 ~~l~~L~l~~~~i~~-l~~--~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-IDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HTCCEEECCSSCCCC-CTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred ccccEEecCCCCCcc-Ccc--hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 468899999998874 553 8889999999999999997654 9999999999999999996655 99999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCc--------------------CCCCCCCCCeEEcccccccccCCc
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPH--------------------SLGNLTQISMLFLHDNSFSGFIPP 209 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--------------------~~~~l~~L~~L~L~~N~l~~~~p~ 209 (502)
+++|++++..+ +..+++|++|++++|.+++. +. .+.++++|++|++++|.+++. .
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~ 193 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--S 193 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-GGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--G
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-hhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--h
Confidence 99999996543 89999999999999998853 22 134555666666666666543 2
Q ss_pred cCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCC
Q 010736 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGAL 288 (502)
Q Consensus 210 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L 288 (502)
.+..+++|++|++++|.+++..| ++.+++|+.|++++|.+++ ++ .+.. ..|+.|++++|.+++..+ +..+++|
T Consensus 194 ~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L 267 (466)
T 1o6v_A 194 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP--LSGLTKL 267 (466)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-ch-hhhcCCCCCEEECCCCccccchh--hhcCCCC
Confidence 35666677777777777665544 5566777777777777663 22 2222 567777888877776543 6677777
Q ss_pred cEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCC
Q 010736 289 QIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368 (502)
Q Consensus 289 ~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N 368 (502)
+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++.+..+ +..+++|++|++++|
T Consensus 268 ~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n 341 (466)
T 1o6v_A 268 TELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341 (466)
T ss_dssp SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSS
T ss_pred CEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCC
Confidence 777777777775433 6667777777777777765443 5666777777777777765544 556666666666666
Q ss_pred cccc
Q 010736 369 NITG 372 (502)
Q Consensus 369 ~l~~ 372 (502)
++.+
T Consensus 342 ~l~~ 345 (466)
T 1o6v_A 342 KVSD 345 (466)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 6544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=253.13 Aligned_cols=258 Identities=17% Similarity=0.214 Sum_probs=205.0
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCccc--CCcccCCCCCCcEEEcc
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGS--IPLEVGQLSSMVELALF 175 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~ 175 (502)
+.++.+++.++ .+|..+. ++|++|+|++|+++...+..|.++++|++|++++|+++.. .|..+..+++|++|+++
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 57888888887 5666543 6899999999999855445578899999999999988733 35667778888888888
Q ss_pred cCcccccCCcCCCCCCCCCeEEcccccccccCC-ccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccccc
Q 010736 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP-PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGS 254 (502)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 254 (502)
+|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..+..+++|+.|++++|.+++.
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 88887 456667788888888888888876554 4677777777777777777766666677777777777776666531
Q ss_pred CCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCC
Q 010736 255 IPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYP 334 (502)
Q Consensus 255 ~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 334 (502)
..|..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++..+..+..++
T Consensus 166 ----------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 223 (306)
T 2z66_A 166 ----------------------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223 (306)
T ss_dssp ----------------------EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCT
T ss_pred ----------------------cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcc
Confidence 2445566677888888888888877788888889999999999999887777888899
Q ss_pred CCcEEEccCcccccccCccccCCC-CCCeeeecCCccccccCcccccC
Q 010736 335 NLTFIDLSRNNFYGEISSNFGECP-KLGALNISRNNITGDFGIAKFLK 381 (502)
Q Consensus 335 ~L~~L~Ls~N~l~~~~~~~~~~~~-~L~~L~l~~N~l~~dfGl~~ll~ 381 (502)
+|++|++++|++.+..+..+..++ +|++|++++|++.||+.+.++..
T Consensus 224 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~ 271 (306)
T 2z66_A 224 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQ 271 (306)
T ss_dssp TCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHH
T ss_pred cCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHH
Confidence 999999999999999998898885 99999999999999999876654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-29 Score=258.03 Aligned_cols=236 Identities=18% Similarity=0.220 Sum_probs=191.8
Q ss_pred cceeeeCCC----------CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCc
Q 010736 61 WSGISCNDA----------GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQ 130 (502)
Q Consensus 61 W~Gv~C~~~----------~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~ 130 (502)
|..|.|... ..++.|+|++|++++..+. .|.++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQAD-TFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHH-HcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 678889742 3689999999999976655 49999999999999999999999999999999999999999
Q ss_pred CcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccC-cccccCCcCCCCCCCCCeEEcccccccccCCc
Q 010736 131 FSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN-NLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209 (502)
Q Consensus 131 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 209 (502)
+++..+..|..+++|++|+|++|+++...+..|..+++|+.|++++| .+....+..|..+++|++|++++|++++. |
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~- 212 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P- 212 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-
Confidence 99777778999999999999999999877778999999999999995 45544445689999999999999999865 3
Q ss_pred cCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCC
Q 010736 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGAL 288 (502)
Q Consensus 210 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L 288 (502)
.+..+++|+.|++++|++++..|..|.++++|+.|++++|++++..+..+.. ..|+.|++++|++++..+..+..+++|
T Consensus 213 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 292 (452)
T 3zyi_A 213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL 292 (452)
T ss_dssp CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTC
T ss_pred cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCC
Confidence 5778888999999999888888888888888888888888887666655544 456666666666665554555555555
Q ss_pred cEEEccCCccc
Q 010736 289 QIFTVSENRFQ 299 (502)
Q Consensus 289 ~~L~ls~n~l~ 299 (502)
+.|++++|.+.
T Consensus 293 ~~L~L~~Np~~ 303 (452)
T 3zyi_A 293 VELHLHHNPWN 303 (452)
T ss_dssp CEEECCSSCEE
T ss_pred CEEEccCCCcC
Confidence 55555555543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-30 Score=250.34 Aligned_cols=235 Identities=19% Similarity=0.263 Sum_probs=206.0
Q ss_pred CCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEE
Q 010736 93 SFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172 (502)
Q Consensus 93 ~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 172 (502)
..+++++|+|++|+++ .+|..++++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++.+++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3478899999999988 77888888999999999999998 88888888999999999999988 778888888889999
Q ss_pred EcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccc
Q 010736 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 173 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 252 (502)
++++|++.+.+|..+... ..+..+.++++|++|++++|+++ .+|..++++++|+.|++++|.++
T Consensus 156 ~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 156 SIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred ECCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 998888888888765431 12234667889999999999998 78888999999999999999999
Q ss_pred ccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccC
Q 010736 253 GSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFG 331 (502)
Q Consensus 253 ~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 331 (502)
+ +|..+.. ..|++|++++|++.+.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++.+.+|..+.
T Consensus 220 ~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~ 298 (328)
T 4fcg_A 220 A-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298 (328)
T ss_dssp C-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGG
T ss_pred c-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHh
Confidence 5 5555655 7899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcEEEccCcccc
Q 010736 332 IYPNLTFIDLSRNNFY 347 (502)
Q Consensus 332 ~l~~L~~L~Ls~N~l~ 347 (502)
.+++|+.+++..|.+.
T Consensus 299 ~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 299 QLPANCIILVPPHLQA 314 (328)
T ss_dssp GSCTTCEEECCGGGSC
T ss_pred hccCceEEeCCHHHHH
Confidence 9999999999987665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=241.81 Aligned_cols=223 Identities=20% Similarity=0.203 Sum_probs=176.9
Q ss_pred EEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccC
Q 010736 73 INISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDS 152 (502)
Q Consensus 73 ~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 152 (502)
+.++.++++++ .+|. .-.++|++|++++|.+++..+..|.++++|++|+|++|.+++..|..|+.+++|++|++++
T Consensus 14 ~~~~c~~~~l~-~ip~---~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPV---GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCT---TCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCc---CCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 55677777776 3443 2357899999999999988888899999999999999999988888999999999999999
Q ss_pred Cc-CcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcc
Q 010736 153 NQ-LDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI 231 (502)
Q Consensus 153 N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 231 (502)
|+ ++...|..|..+++|++|++++|++++..|..+..+++|++|++++|++++..+..+..+++|++|++++|++++..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 97 77666888999999999999999999888888889999999999999998777777888888888999888888666
Q ss_pred cccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccc
Q 010736 232 PLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQ 299 (502)
Q Consensus 232 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~ 299 (502)
+..+..+++|+.|++++|.+++..|..+.. ..|+.|++++|++++..+..+..+++|+.|++++|.+.
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence 666888888888888888877666655544 45666666666665544444555555566666555554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=252.01 Aligned_cols=237 Identities=19% Similarity=0.223 Sum_probs=189.5
Q ss_pred ccceeeeCCC----------CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCC
Q 010736 60 AWSGISCNDA----------GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGN 129 (502)
Q Consensus 60 ~W~Gv~C~~~----------~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N 129 (502)
.|..|.|... ..++.|+|++|++++..+. .|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVN-SFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTT-TTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHH-HhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 3678888642 3578999999999976555 5999999999999999999988899999999999999999
Q ss_pred cCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCc-ccccCCcCCCCCCCCCeEEcccccccccCC
Q 010736 130 QFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNN-LNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208 (502)
Q Consensus 130 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 208 (502)
++++..+..|..+++|++|+|++|+++...+..|..+++|++|++++|+ +....+..|.++++|++|++++|+++.. |
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-P 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-C
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-c
Confidence 9997777789999999999999999998888889999999999999954 5544445789999999999999999843 4
Q ss_pred ccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCC
Q 010736 209 PDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGA 287 (502)
Q Consensus 209 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~ 287 (502)
.+..+++|+.|++++|++++..|..|.++++|+.|++++|++++..+..+.. .+|+.|++++|++++..+..+..+++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 4777888888888888888777888888888888888888777665555544 45666666666665555555555555
Q ss_pred CcEEEccCCccc
Q 010736 288 LQIFTVSENRFQ 299 (502)
Q Consensus 288 L~~L~ls~n~l~ 299 (502)
|+.|++++|.+.
T Consensus 281 L~~L~L~~Np~~ 292 (440)
T 3zyj_A 281 LERIHLHHNPWN 292 (440)
T ss_dssp CCEEECCSSCEE
T ss_pred CCEEEcCCCCcc
Confidence 555555555543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-28 Score=247.39 Aligned_cols=263 Identities=24% Similarity=0.267 Sum_probs=140.2
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|+++++.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .++++++|++|+
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~ 159 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID 159 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence 356666777666665 4432 2455555555555553 2211 1455555555555553 44 355555555555
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
+++|++++ +|..+ .+|++|++++|++++ +| .++.+++|++|++++|++++ +|... ++|++|++++|+++
T Consensus 160 l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~- 228 (454)
T 1jl5_A 160 VDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE- 228 (454)
T ss_dssp CCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-
T ss_pred CCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-
Confidence 55555553 33322 355555555555554 34 35555555555555555553 22211 34555555555554
Q ss_pred cccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccc-----------------cCCCCCcEEE
Q 010736 230 PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNI-----------------CRGGALQIFT 292 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~-----------------~~~~~L~~L~ 292 (502)
.+| .++.+++|+.|++++|++++ +|... ..|+.|++++|++++ +|... ...++|+.|+
T Consensus 229 ~lp-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~N~l~~-l~~~~~~L~~L~ls~N~l~~l~~~~~~L~~L~ 303 (454)
T 1jl5_A 229 ELP-ELQNLPFLTTIYADNNLLKT-LPDLP--PSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLN 303 (454)
T ss_dssp SCC-CCTTCTTCCEEECCSSCCSS-CCSCC--TTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSEESCCCTTCCEEE
T ss_pred ccc-ccCCCCCCCEEECCCCcCCc-ccccc--cccCEEECCCCcccc-cCcccCcCCEEECcCCccCcccCcCCcCCEEE
Confidence 334 24455555555555555542 22211 334444444444443 22111 0013444555
Q ss_pred ccCCccccccCcccccC-CCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccc
Q 010736 293 VSENRFQGTIPKSLRNC-TSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371 (502)
Q Consensus 293 ls~n~l~~~~~~~l~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~ 371 (502)
+++|++++ + ..+ ++|+.|++++|++++ +|.. +++|++|++++|++++ +|. .+++|++|++++|++.
T Consensus 304 l~~N~l~~-i----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~ 370 (454)
T 1jl5_A 304 ASSNEIRS-L----CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLR 370 (454)
T ss_dssp CCSSCCSE-E----CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred CcCCcCCc-c----cCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCC
Confidence 55554443 1 122 478888888888875 4433 5788888888888874 454 4678888888888887
Q ss_pred c
Q 010736 372 G 372 (502)
Q Consensus 372 ~ 372 (502)
+
T Consensus 371 ~ 371 (454)
T 1jl5_A 371 E 371 (454)
T ss_dssp S
T ss_pred c
Confidence 6
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=240.00 Aligned_cols=224 Identities=20% Similarity=0.204 Sum_probs=175.6
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 177 (502)
++++.+++.++ .+|..+ .++|++|+|++|.+++..+..|..+++|++|++++|++++..|..|..+++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 67899999988 556544 479999999999999887788999999999999999999888889999999999999999
Q ss_pred c-ccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCC
Q 010736 178 N-LNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIP 256 (502)
Q Consensus 178 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 256 (502)
. +....|..+..+++|++|++++|.+++..|..+..+++|++|++++|++++..+..+..+++|+.|++++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 7 776668889999999999999999998888888889999999999999987777778888888888888888875544
Q ss_pred CCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCcccc
Q 010736 257 PSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324 (502)
Q Consensus 257 ~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~ 324 (502)
..+.. ..|+.|++++|++++..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|.+..
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 44443 456666666666666556666666666666666666665444445556666666666665543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=259.78 Aligned_cols=272 Identities=25% Similarity=0.333 Sum_probs=226.1
Q ss_pred CCCCccceee--------eCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEcc
Q 010736 56 ISPCAWSGIS--------CNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLG 127 (502)
Q Consensus 56 ~~~C~W~Gv~--------C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls 127 (502)
.++|.|.|.. |.. ..++.|++++++++ .+|.. +. ++|++|+|++|+|+ .+|. .+++|++|+|+
T Consensus 19 ~~~~~~~~r~~~~~~~~~c~~-~~l~~L~ls~n~L~-~lp~~-l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls 89 (622)
T 3g06_A 19 APAEESRGRAAVVQKMRACLN-NGNAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVS 89 (622)
T ss_dssp CCGGGHHHHHHHHHHHHHHHH-HCCCEEECCSSCCS-CCCSC-CC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcchhccccccCcccccccC-CCCcEEEecCCCcC-ccChh-hC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcC
Confidence 5688997643 322 35889999999998 77764 44 89999999999999 4665 57999999999
Q ss_pred CCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccC
Q 010736 128 GNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFI 207 (502)
Q Consensus 128 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 207 (502)
+|+|+ .+|. .+++|++|++++|++++ +|. .+++|+.|++++|++++ +|.. +++|++|++++|++++.
T Consensus 90 ~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l- 156 (622)
T 3g06_A 90 GNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL- 156 (622)
T ss_dssp SCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-
T ss_pred CCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-
Confidence 99999 5665 67999999999999995 444 67899999999999985 6654 48999999999999864
Q ss_pred CccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCC
Q 010736 208 PPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGA 287 (502)
Q Consensus 208 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~ 287 (502)
|. .+++|+.|++++|++++ +| ..+++|+.|++++|.+++ +|..+ ..|+.|++++|.++.. |.. .++
T Consensus 157 ~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~~--~~L~~L~L~~N~l~~l-~~~---~~~ 222 (622)
T 3g06_A 157 PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTLP--SELYKLWAYNNRLTSL-PAL---PSG 222 (622)
T ss_dssp CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSSC-CCC---CTT
T ss_pred CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCcc--chhhEEECcCCccccc-CCC---CCC
Confidence 43 34689999999999996 55 457899999999999985 55433 6899999999999864 432 478
Q ss_pred CcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecC
Q 010736 288 LQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISR 367 (502)
Q Consensus 288 L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~ 367 (502)
|+.|++++|++++ +| ..+++|+.|++++|+++. +|. .+++|+.|+|++|+|+ .+|..+..+++|+.|++++
T Consensus 223 L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~ 293 (622)
T 3g06_A 223 LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293 (622)
T ss_dssp CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred CCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence 9999999999996 55 456899999999999985 444 6789999999999999 7788899999999999999
Q ss_pred Ccccc
Q 010736 368 NNITG 372 (502)
Q Consensus 368 N~l~~ 372 (502)
|++.+
T Consensus 294 N~l~~ 298 (622)
T 3g06_A 294 NPLSE 298 (622)
T ss_dssp CCCCH
T ss_pred CCCCC
Confidence 99875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=252.08 Aligned_cols=249 Identities=22% Similarity=0.248 Sum_probs=145.6
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCC-------------CEEEccCCcCcCC--
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNL-------------SILSLGGNQFSGN-- 134 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L-------------~~L~Ls~N~l~~~-- 134 (502)
.+++.++++++++ |.+|.. ++++++|++|++++|.++|.+|..++++++| ++|++++|.+++.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~-i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS
T ss_pred ccchhhhcccCch-hhCChh-HhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC
Confidence 3567777777777 677765 7777777777777777777777777665543 5555555555531
Q ss_pred -----------------CCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEE
Q 010736 135 -----------------IPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLF 197 (502)
Q Consensus 135 -----------------~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 197 (502)
+|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .++++++|++|+
T Consensus 89 ~~~~L~~L~l~~n~l~~lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~ 159 (454)
T 1jl5_A 89 LPPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID 159 (454)
T ss_dssp CCTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred CcCCCCEEEccCCcCCccccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence 3321 2344555555555442 1111 1567777777777775 56 477777888888
Q ss_pred cccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCccc
Q 010736 198 LHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSY 277 (502)
Q Consensus 198 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~ 277 (502)
+++|++++ +|..+ .+|++|++++|++++ +| .++++++|+.|++++|++++ +|... ..|++|++++|+++.
T Consensus 160 l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~l~~- 229 (454)
T 1jl5_A 160 VDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNILEE- 229 (454)
T ss_dssp CCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSCCSS-
T ss_pred CCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCcCCc-
Confidence 88887775 44432 467777888887776 45 57778888888888888774 44332 467888888888774
Q ss_pred CCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCccccc
Q 010736 278 LPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYG 348 (502)
Q Consensus 278 ~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 348 (502)
+| .+..+++|+.|++++|++++ +|.. .++|+.|++++|++++ +|.. .++|++|++++|++++
T Consensus 230 lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 230 LP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG 291 (454)
T ss_dssp CC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE
T ss_pred cc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc
Confidence 55 37778888888888888774 3432 3567777777777765 3322 2566677777776665
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-28 Score=230.54 Aligned_cols=215 Identities=24% Similarity=0.258 Sum_probs=170.0
Q ss_pred CCCCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCC
Q 010736 56 ISPCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNI 135 (502)
Q Consensus 56 ~~~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~ 135 (502)
.+.|.|.|+.|...+.++.+++++++++. +|.. +. +++++|+|++|++++..+..|.++++|++|+|++|.++...
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~-ip~~-~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSN-IP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCSS-CCSC-CC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCCc-cCCC-CC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 46899999999765667789999999884 6553 33 67999999999999877778999999999999999998666
Q ss_pred CcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCc
Q 010736 136 PHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLK 215 (502)
Q Consensus 136 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 215 (502)
+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 66678899999999999999877777788899999999999999887777788889999999999988877666788888
Q ss_pred cCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcC
Q 010736 216 SISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHF 274 (502)
Q Consensus 216 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l 274 (502)
+|+.|++++|++++..+..|..+++|+.|++++|++++..+..+.. ..|+.|++++|.+
T Consensus 158 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred ccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence 8888888888888766667777888888888877776433333322 3344444444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-31 Score=255.78 Aligned_cols=250 Identities=20% Similarity=0.199 Sum_probs=122.9
Q ss_pred CCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcC-cCCCCcccC-------CCCCCcEEEccCCcCcccCCccc
Q 010736 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQF-SGNIPHEVG-------LMSHLKILYIDSNQLDGSIPLEV 163 (502)
Q Consensus 92 ~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l-~~~~p~~l~-------~l~~L~~L~Ls~N~l~~~~p~~~ 163 (502)
+..++|++|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|++++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3344555566666665 455544433 55566666665 334444443 45556666666666655555554
Q ss_pred --CCCCCCcEEEcccCcccccCCcCCCCC-----CCCCeEEcccccccccCCccCcCCccCCccccccccccCc--cccc
Q 010736 164 --GQLSSMVELALFSNNLNGSVPHSLGNL-----TQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP--IPLS 234 (502)
Q Consensus 164 --~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~p~~ 234 (502)
..+++|++|++++|++++. |..++.+ ++|++|++++|++++..|..++.+++|++|++++|++.+. .|..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 5555666666666665544 4444444 5555666666655555555555555555555555555443 1222
Q ss_pred c--cCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccC-cccccCCC
Q 010736 235 L--GNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIP-KSLRNCTS 311 (502)
Q Consensus 235 ~--~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~-~~l~~l~~ 311 (502)
+ ..+++|++|++++|++++. + ......+..+++|+.|++++|++++..| ..+..+++
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~-~-------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 254 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETP-S-------------------GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCH-H-------------------HHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred HHhccCCCCCEEECCCCcCcch-H-------------------HHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence 2 4555555555555555411 0 0000112233444444444444443332 22333444
Q ss_pred CcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccc
Q 010736 312 LIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371 (502)
Q Consensus 312 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~ 371 (502)
|++|++++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|++|++++|++.
T Consensus 255 L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 255 LNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred CCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 555555555544 3333333 4455555555555443 22 444555555555555543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=253.67 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=165.4
Q ss_pred EEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEcc
Q 010736 72 VINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID 151 (502)
Q Consensus 72 v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 151 (502)
....+++.+.+...+.. .+..+++|++|+|++|++++..|..|.++++|++|+|++|.+++..| +..+++|++|+++
T Consensus 12 l~i~~ls~~~l~~~~~~-~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 12 YKIEKVTDSSLKQALAS-LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEESCCTTTHHHHHHH-HHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred eeEeeccccchhhhHHH-HhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 34444555555433322 25555667777777777776666667777777777777777765443 6666777777777
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcc
Q 010736 152 SNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI 231 (502)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 231 (502)
+|++++.. ..++|++|++++|++++..+.. +++|++|++++|++++..+..+..+++|++|++++|++++..
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 77666422 2256666666666666544332 455666666666666655555666666666666666666544
Q ss_pred ccccc-CCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCC
Q 010736 232 PLSLG-NLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCT 310 (502)
Q Consensus 232 p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~ 310 (502)
+..+. .+++|+.|++++|.++ +. .....+++|+.|++++|++++. |..+..++
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~-----------------------~~--~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~ 214 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIY-----------------------DV--KGQVVFAKLKTLDLSSNKLAFM-GPEFQSAA 214 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCC-----------------------EE--ECCCCCTTCCEEECCSSCCCEE-CGGGGGGT
T ss_pred HHHHhhccCcCCEEECCCCcCc-----------------------cc--ccccccccCCEEECCCCcCCcc-hhhhcccC
Confidence 44442 4555555555555554 32 1122356777788888877743 44577788
Q ss_pred CCcEEeCCCCccccccCcccCCCCCCcEEEccCcccc-cccCccccCCCCCCeeeecCCc
Q 010736 311 SLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFY-GEISSNFGECPKLGALNISRNN 369 (502)
Q Consensus 311 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~~~~L~~L~l~~N~ 369 (502)
+|+.|++++|++++ +|..+..+++|+.|++++|.+. +.++..+..++.|+.+++++++
T Consensus 215 ~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~ 273 (317)
T 3o53_A 215 GVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273 (317)
T ss_dssp TCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred cccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCch
Confidence 88888888888874 5667778888888888888887 6677777778888888887443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=253.16 Aligned_cols=244 Identities=18% Similarity=0.194 Sum_probs=182.9
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcc-cccCCccCc-------CCCCCCEEEccCCcCcCCCCccc--C
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKL-FGTIPPQIS-------NLTNLSILSLGGNQFSGNIPHEV--G 140 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l-~g~~p~~l~-------~l~~L~~L~Ls~N~l~~~~p~~l--~ 140 (502)
+++.++++++.+ .+|.. +... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+ +
T Consensus 44 ~L~~l~l~~n~l--~~p~~-~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 118 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQ-FTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA 118 (312)
T ss_dssp ECTTHHHHCCTT--CCCHH-HHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSC
T ss_pred CceeEeeccccc--ccHHH-HHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHh
Confidence 466677888888 66654 4433 89999999999 467787776 89999999999999999999987 8
Q ss_pred CCCCCcEEEccCCcCcccCCcccCCC-----CCCcEEEcccCcccccCCcCCCCCCCCCeEEccccccccc--CCccC--
Q 010736 141 LMSHLKILYIDSNQLDGSIPLEVGQL-----SSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF--IPPDI-- 211 (502)
Q Consensus 141 ~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~-- 211 (502)
.+++|++|+|++|++++. |..++.+ ++|++|++++|++++..|..|+.+++|++|++++|++.+. .+..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 999999999999999987 8777776 9999999999999998889999999999999999998765 23344
Q ss_pred cCCccCCccccccccccCc--cc-ccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCC
Q 010736 212 GNLKSISILSLAINQFSGP--IP-LSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGAL 288 (502)
Q Consensus 212 ~~l~~L~~L~ls~N~l~~~--~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L 288 (502)
..+++|++|++++|++++. ++ ..+..+++|+.|++++|++++..|... +..+++|
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----------------------~~~l~~L 255 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS----------------------CDWPSQL 255 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSC----------------------CCCCTTC
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhh----------------------hhhcCCC
Confidence 8899999999999999842 22 344677889999999998886654221 1123344
Q ss_pred cEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccc
Q 010736 289 QIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFY 347 (502)
Q Consensus 289 ~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 347 (502)
+.|++++|+++ .+|..+. ++|++|++++|++++. |. +..+++|++|++++|+++
T Consensus 256 ~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred CEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 55555555554 3444333 4555666666666544 33 555566666666666554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-29 Score=248.78 Aligned_cols=242 Identities=18% Similarity=0.175 Sum_probs=188.7
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALF 175 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 175 (502)
.++.++++.+.+...++..+..+++|++|+|++|++++..|..|+.+++|++|+|++|++++..+ +..+++|++|+++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 34566788888876666667778899999999999998777889999999999999999987654 8888899999999
Q ss_pred cCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccC
Q 010736 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSI 255 (502)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 255 (502)
+|++++.. ..++|++|++++|++++..+.. +++|+.|++++|++++..+..+..+++|+.|++++|.++
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--- 157 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID--- 157 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCC---
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCC---
Confidence 99887533 2377888888888887654433 456777777777777666656666666666666655554
Q ss_pred CCCCccccccEEECcCCcCcccCCccc-cCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCC
Q 010736 256 PPSLDNLVLTKLSLDDNHFTSYLPQNI-CRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYP 334 (502)
Q Consensus 256 p~~~~~~~L~~L~ls~N~l~~~~~~~~-~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 334 (502)
+..+..+ ..+++|+.|++++|.+++. + ....+++|++|++++|++++. +..+..++
T Consensus 158 --------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~ 214 (317)
T 3o53_A 158 --------------------TVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAA 214 (317)
T ss_dssp --------------------EEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGT
T ss_pred --------------------cccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccC
Confidence 3333444 3568899999999999865 3 234589999999999999965 45588999
Q ss_pred CCcEEEccCcccccccCccccCCCCCCeeeecCCcccccc
Q 010736 335 NLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDF 374 (502)
Q Consensus 335 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~df 374 (502)
+|++|++++|+++ .+|..+..+++|++|++++|++.|+.
T Consensus 215 ~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~ 253 (317)
T 3o53_A 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253 (317)
T ss_dssp TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHH
T ss_pred cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcC
Confidence 9999999999998 56778999999999999999999763
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=253.86 Aligned_cols=237 Identities=21% Similarity=0.263 Sum_probs=165.7
Q ss_pred CCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEE
Q 010736 93 SFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172 (502)
Q Consensus 93 ~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 172 (502)
.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..| ++.+++|++|+|++|.+++..+ .++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34477888888888877777777788888888888888776555 7777778888888777774332 2677777
Q ss_pred EcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCccccccc-CCCCCcEEEeeCccc
Q 010736 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLG-NLTNLKQFSLVYNNL 251 (502)
Q Consensus 173 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l 251 (502)
++++|.+++..+. .+++|+.|++++|.+++..|..++.+++|+.|++++|.+++.+|..+. .+++|+.|++++|.+
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 7777777765543 345677777777777766666666677777777777777666665554 566666666666665
Q ss_pred cccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccC
Q 010736 252 YGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFG 331 (502)
Q Consensus 252 ~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 331 (502)
++. | ....+++|+.|++++|.+++. |..+..+++|+.|++++|.+++ +|..+.
T Consensus 182 ~~~-~------------------------~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~ 234 (487)
T 3oja_A 182 YDV-K------------------------GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALR 234 (487)
T ss_dssp CEE-E------------------------CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCC
T ss_pred ccc-c------------------------ccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhc
Confidence 532 1 122356777777777777754 3447778888888888888885 566677
Q ss_pred CCCCCcEEEccCcccc-cccCccccCCCCCCeeeec
Q 010736 332 IYPNLTFIDLSRNNFY-GEISSNFGECPKLGALNIS 366 (502)
Q Consensus 332 ~l~~L~~L~Ls~N~l~-~~~~~~~~~~~~L~~L~l~ 366 (502)
.+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus 235 ~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred cCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 7888888888888887 5666667777777777775
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=222.20 Aligned_cols=206 Identities=22% Similarity=0.226 Sum_probs=167.6
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEc
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELAL 174 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 174 (502)
++|++|++++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 57999999999999888888999999999999999999877788999999999999999999888888999999999999
Q ss_pred ccCcccccCCcCCCCCCCCCeEEccccccccc-CCccCcCCccCCccccccccccCcccccccCCCCCc----EEEeeCc
Q 010736 175 FSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF-IPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLK----QFSLVYN 249 (502)
Q Consensus 175 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~----~L~l~~N 249 (502)
++|++++..+..+..+++|++|++++|.+++. +|..+..+++|++|++++|++++..+..+..+++|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999987777789999999999999999874 588888899999999999999877777777666666 7778888
Q ss_pred cccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCcccc
Q 010736 250 NLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQG 300 (502)
Q Consensus 250 ~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~ 300 (502)
.+++..+..+....|+.|++++|++++..+..+..+++|+.|++++|.+++
T Consensus 188 ~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 188 PMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred cccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 777655555544566666666666666544445556666666666666553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=253.89 Aligned_cols=228 Identities=19% Similarity=0.213 Sum_probs=174.7
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
+++.|+|++|++++..|. .|+.+++|++|+|++|.+++..| |+.+++|++|+|++|.|++..+ .++|++|++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAA-DLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GCCEEECCSSCCCCCCGG-GGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CccEEEeeCCcCCCCCHH-HHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 799999999999975544 59999999999999999998776 9999999999999999985432 389999999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCc-CCccCCccccccccccC
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIG-NLKSISILSLAINQFSG 229 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~ 229 (502)
++|.+++..+. .+++|+.|++++|.+++..|..++.+++|++|+|++|.+++..|..+. .+++|+.|++++|.+++
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 99999976664 457899999999999999999999999999999999999998888876 79999999999999997
Q ss_pred cccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccc-cccCcccc
Q 010736 230 PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQ-GTIPKSLR 307 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~-~~~~~~l~ 307 (502)
..+ +..+++|+.|++++|.+++..|. +.. ..|+.|++++|.+++ +|..+..+++|+.|++++|.+. +.+|..+.
T Consensus 184 ~~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 184 VKG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp EEC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred ccc--cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 633 34578888888888888754333 322 445555555555554 3333444444444444444444 33333333
Q ss_pred cCCCCc
Q 010736 308 NCTSLI 313 (502)
Q Consensus 308 ~l~~L~ 313 (502)
.++.|+
T Consensus 260 ~l~~L~ 265 (487)
T 3oja_A 260 KNQRVQ 265 (487)
T ss_dssp TCHHHH
T ss_pred hCCCCc
Confidence 333333
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=220.29 Aligned_cols=227 Identities=18% Similarity=0.168 Sum_probs=145.8
Q ss_pred EEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCc
Q 010736 99 YLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNN 178 (502)
Q Consensus 99 ~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 178 (502)
.++.++.+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4555555555 4555443 467777777777776666667777777777777777776655666667777777777776
Q ss_pred ccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCc-ccccccCCCCCcEEEeeCccccccCCC
Q 010736 179 LNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP-IPLSLGNLTNLKQFSLVYNNLYGSIPP 257 (502)
Q Consensus 179 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~ 257 (502)
+++..+..|.++++|++|++++|.+++..+..+..+++|++|++++|++++. +|..+..+
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l------------------- 148 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL------------------- 148 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGC-------------------
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccC-------------------
Confidence 6666556666666666666666666554444455555555555555544432 23344444
Q ss_pred CCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCc----EEeCCCCccccccCcccCCC
Q 010736 258 SLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLI----RVRLDGNNLTGNISKAFGIY 333 (502)
Q Consensus 258 ~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~----~L~l~~N~l~~~~~~~~~~l 333 (502)
++|+.|++++|++++..+..+..+.+|+ .+++++|.+++..+..+. .
T Consensus 149 ----------------------------~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~ 199 (276)
T 2z62_A 149 ----------------------------TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-E 199 (276)
T ss_dssp ----------------------------TTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-S
T ss_pred ----------------------------CCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-C
Confidence 4444444444444443333444444444 678888888766555444 3
Q ss_pred CCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCc
Q 010736 334 PNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGI 376 (502)
Q Consensus 334 ~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl 376 (502)
.+|+.|++++|++++..+..+..+++|++|++++|++.|||..
T Consensus 200 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 200 IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 4889999999998877777778899999999999999999863
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-30 Score=264.57 Aligned_cols=302 Identities=17% Similarity=0.176 Sum_probs=174.9
Q ss_pred CCEEEEEecCCCCceecCcccCCCCC----CCCEEECCCCcccc----cCCccCcCCCCCCEEEccCCcCcCCCCccc--
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFP----HLAYLDLRDNKLFG----TIPPQISNLTNLSILSLGGNQFSGNIPHEV-- 139 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~----~L~~L~Ls~N~l~g----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l-- 139 (502)
.+++.|+|+++.+.+..+..-+..++ +|++|+|++|.++. .+|..+.++++|++|+|++|.+++..+..+
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 135 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE 135 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH
Confidence 34666666666665432221122233 56666666666663 446666666666677776666654333222
Q ss_pred ---CCCCCCcEEEccCCcCcccC----CcccCCCCCCcEEEcccCcccccCCcCCC-----CCCCCCeEEccccccccc-
Q 010736 140 ---GLMSHLKILYIDSNQLDGSI----PLEVGQLSSMVELALFSNNLNGSVPHSLG-----NLTQISMLFLHDNSFSGF- 206 (502)
Q Consensus 140 ---~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~- 206 (502)
...++|++|++++|++++.. +..+..+++|++|++++|.++...+..+. ..++|++|++++|.+++.
T Consensus 136 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 215 (461)
T 1z7x_W 136 GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred HHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence 12445666667666666532 34445566677777776666543333222 244666777777766642
Q ss_pred ---CCccCcCCccCCccccccccccCcc-----cccccCCCCCcEEEeeCcccccc----CCCCCcc-ccccEEECcCCc
Q 010736 207 ---IPPDIGNLKSISILSLAINQFSGPI-----PLSLGNLTNLKQFSLVYNNLYGS----IPPSLDN-LVLTKLSLDDNH 273 (502)
Q Consensus 207 ---~p~~~~~l~~L~~L~ls~N~l~~~~-----p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~-~~L~~L~ls~N~ 273 (502)
++..+..+++|++|++++|+++... +..+..+++|+.|++++|.+++. ++..+.. ..|++|++++|.
T Consensus 216 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 295 (461)
T 1z7x_W 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCC
T ss_pred HHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCC
Confidence 3445556666777777777665432 22223466677777777766543 2332222 457777777777
Q ss_pred CcccCCccccC-----CCCCcEEEccCCccccc----cCcccccCCCCcEEeCCCCccccccCcccC-----CCCCCcEE
Q 010736 274 FTSYLPQNICR-----GGALQIFTVSENRFQGT----IPKSLRNCTSLIRVRLDGNNLTGNISKAFG-----IYPNLTFI 339 (502)
Q Consensus 274 l~~~~~~~~~~-----~~~L~~L~ls~n~l~~~----~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~L 339 (502)
+++..+..+.. .++|+.|++++|.+++. ++..+..+++|+.|++++|.+++..+..+. ..++|++|
T Consensus 296 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L 375 (461)
T 1z7x_W 296 LGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375 (461)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred CchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEE
Confidence 65443322222 24677777777777654 345556667777777777777654333332 15677777
Q ss_pred EccCccccc----ccCccccCCCCCCeeeecCCccc
Q 010736 340 DLSRNNFYG----EISSNFGECPKLGALNISRNNIT 371 (502)
Q Consensus 340 ~Ls~N~l~~----~~~~~~~~~~~L~~L~l~~N~l~ 371 (502)
++++|++++ .++..+..+++|++|++++|++.
T Consensus 376 ~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp ECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred ECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 777777765 55666666777777777777764
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=216.61 Aligned_cols=192 Identities=22% Similarity=0.226 Sum_probs=172.4
Q ss_pred CCCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCC
Q 010736 57 SPCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIP 136 (502)
Q Consensus 57 ~~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p 136 (502)
+||.|.|.+|.. ..+.+++++++++ .+|.. +. +++++|+|++|++++..+..|.++++|++|+|++|.+++..|
T Consensus 3 ~Cp~~~gC~C~~--~~~~l~~~~~~l~-~~p~~-~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNE--GKKEVDCQGKSLD-SVPSG-IP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEG--GGTEEECTTCCCS-SCCSC-CC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCC--CCeEEecCCCCcc-ccCCC-CC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 466899999963 2456899999988 55553 43 689999999999999999999999999999999999999888
Q ss_pred cccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCcc
Q 010736 137 HEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKS 216 (502)
Q Consensus 137 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 216 (502)
..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 156 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence 88999999999999999999888888999999999999999999877777899999999999999999888878999999
Q ss_pred CCccccccccccCcccccccCCCCCcEEEeeCcccccc
Q 010736 217 ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGS 254 (502)
Q Consensus 217 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 254 (502)
|++|++++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 157 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999999999988888899999999999999999865
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-29 Score=258.86 Aligned_cols=300 Identities=18% Similarity=0.156 Sum_probs=151.9
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccc----cCCccCcCCCCCCEEEccCCcCcCCCCccc-CCCC--
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFG----TIPPQISNLTNLSILSLGGNQFSGNIPHEV-GLMS-- 143 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~-- 143 (502)
+++.|+|++++++.......+..+++|++|+|++|++++ .++..+..+++|++|+|++|.++...+..+ ..++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 355666666665433222224555666666666666553 234455556666666666666654322222 1233
Q ss_pred --CCcEEEccCCcCcc----cCCcccCCCCCCcEEEcccCcccccCCcCC-----CCCCCCCeEEcccccccccC----C
Q 010736 144 --HLKILYIDSNQLDG----SIPLEVGQLSSMVELALFSNNLNGSVPHSL-----GNLTQISMLFLHDNSFSGFI----P 208 (502)
Q Consensus 144 --~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~----p 208 (502)
+|++|++++|+++. .++..+..+++|++|++++|.+++..+..+ ...++|++|++++|++++.. +
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 46666666666652 345555666666666666666553322221 12345666666666655422 3
Q ss_pred ccCcCCccCCccccccccccCccccccc-----CCCCCcEEEeeCcccccc----CCCCCcc-ccccEEECcCCcCcccC
Q 010736 209 PDIGNLKSISILSLAINQFSGPIPLSLG-----NLTNLKQFSLVYNNLYGS----IPPSLDN-LVLTKLSLDDNHFTSYL 278 (502)
Q Consensus 209 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~~----~p~~~~~-~~L~~L~ls~N~l~~~~ 278 (502)
..+..+++|++|++++|.++...+..+. ..++|+.|++++|.+++. ++..+.. ..|++|++++|.+++..
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 3344455666666666665543322222 234566666666655532 1222222 45666666666555431
Q ss_pred -----CccccCCCCCcEEEccCCccccc----cCcccccCCCCcEEeCCCCccccccCcccC-----CCCCCcEEEccCc
Q 010736 279 -----PQNICRGGALQIFTVSENRFQGT----IPKSLRNCTSLIRVRLDGNNLTGNISKAFG-----IYPNLTFIDLSRN 344 (502)
Q Consensus 279 -----~~~~~~~~~L~~L~ls~n~l~~~----~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N 344 (502)
+..+...++|+.|++++|.+++. ++..+..+++|+.|++++|.+++..+..+. ..++|++|++++|
T Consensus 244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 323 (461)
T 1z7x_W 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCC
Confidence 11122345566666666665542 344455556666666666655433222221 2245666666666
Q ss_pred ccccc----cCccccCCCCCCeeeecCCcc
Q 010736 345 NFYGE----ISSNFGECPKLGALNISRNNI 370 (502)
Q Consensus 345 ~l~~~----~~~~~~~~~~L~~L~l~~N~l 370 (502)
.+++. ++..+..+++|++|++++|.+
T Consensus 324 ~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 353 (461)
T 1z7x_W 324 SFTAACCSHFSSVLAQNRFLLELQISNNRL 353 (461)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBC
T ss_pred CCchHHHHHHHHHHhhCCCccEEEccCCcc
Confidence 65543 233444455666666666654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-24 Score=204.79 Aligned_cols=203 Identities=20% Similarity=0.256 Sum_probs=150.6
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEc
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELAL 174 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 174 (502)
.+.+.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|++++|+++...+..|..+++|++|++
T Consensus 16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 35788999999988 4676554 67899999999998777778888999999999999988666666788889999999
Q ss_pred ccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccccc
Q 010736 175 FSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGS 254 (502)
Q Consensus 175 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 254 (502)
++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|++++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 99988877677778888888888888888877777778888888888888888866666677777777777777777644
Q ss_pred CCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccc
Q 010736 255 IPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLT 323 (502)
Q Consensus 255 ~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~ 323 (502)
.+. .+..+++|+.|++++|++++..+..+..+++|+.|++++|.+.
T Consensus 173 ~~~-----------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 173 PEG-----------------------AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CTT-----------------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred Chh-----------------------HhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 333 3344455555555555555444444555566666666666554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=210.10 Aligned_cols=206 Identities=23% Similarity=0.271 Sum_probs=101.9
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
.++.|+++++++.. ++ .+..+++|++|++++|.+++. +.+.++++|++|+|++|.+++..+..|+.+++|++|++
T Consensus 42 ~L~~L~l~~~~i~~-~~--~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 42 SIDQIIANNSDIKS-VQ--GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TCCEEECTTSCCCC-CT--TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ceeeeeeCCCCccc-cc--ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 34445555544431 11 144455555555555555431 24455555555555555555444444455555555555
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCc
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP 230 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 230 (502)
++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|+.|++++|++++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSV 196 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCcc
Confidence 55555544444445555555555555555544444444555555555555555544444444445555555555555544
Q ss_pred ccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCC
Q 010736 231 IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCT 310 (502)
Q Consensus 231 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~ 310 (502)
.+..+..+++|+. |++++|.+.+. +++++.++++.|.++|.+|.+++.+.
T Consensus 197 ~~~~~~~l~~L~~-----------------------L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 197 PDGVFDRLTSLQY-----------------------IWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp CTTTTTTCTTCCE-----------------------EECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred CHHHHhCCcCCCE-----------------------EEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccC
Confidence 4444444444444 44544444332 23455566666666666666555444
Q ss_pred C
Q 010736 311 S 311 (502)
Q Consensus 311 ~ 311 (502)
.
T Consensus 247 ~ 247 (272)
T 3rfs_A 247 P 247 (272)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=208.59 Aligned_cols=212 Identities=23% Similarity=0.217 Sum_probs=155.0
Q ss_pred cCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCC
Q 010736 139 VGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSIS 218 (502)
Q Consensus 139 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 218 (502)
++++++++++++++|+++ .+|..+. ++++.|++++|++++..|..|..+++|++|++++|.+++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 556677777777777776 4554443 4677777777777766666677777777777777776654322 4555566
Q ss_pred ccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCcc
Q 010736 219 ILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRF 298 (502)
Q Consensus 219 ~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l 298 (502)
+|++++|+++ .+|..+..+++|+. |++++|++++..+..|..+++|+.|++++|++
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~-----------------------L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l 136 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTV-----------------------LDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCE-----------------------EECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred EEECCCCcCC-cCchhhccCCCCCE-----------------------EECCCCcCcccCHHHHcCCCCCCEEECCCCCC
Confidence 6666666555 34444444444544 45555555554556677778888888888888
Q ss_pred ccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCccc
Q 010736 299 QGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAK 378 (502)
Q Consensus 299 ~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~~ 378 (502)
++..+..|..+++|+.|++++|++++..+..|..+++|++|+|++|+++ .+|..+...+.|+++++++|++.|||++.+
T Consensus 137 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~~~~ 215 (290)
T 1p9a_G 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILY 215 (290)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGHH
T ss_pred CccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCccHH
Confidence 8776777888899999999999999777777888999999999999998 677777788899999999999999999876
Q ss_pred cc
Q 010736 379 FL 380 (502)
Q Consensus 379 ll 380 (502)
+.
T Consensus 216 l~ 217 (290)
T 1p9a_G 216 FR 217 (290)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-24 Score=207.04 Aligned_cols=156 Identities=22% Similarity=0.228 Sum_probs=90.0
Q ss_pred CCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCc
Q 010736 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 170 (502)
+.++++++++++++|+++ .+|..+. +++++|+|++|.+++..|..|..+++|++|+|++|++++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 455556666666666665 3444332 4566666666666655555666666666666666666543221 4556666
Q ss_pred EEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcc
Q 010736 171 ELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250 (502)
Q Consensus 171 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 250 (502)
+|++++|+++ .+|..+..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 6666666665 455555566666666666666665555555556666666666666555444445555555555555555
Q ss_pred cc
Q 010736 251 LY 252 (502)
Q Consensus 251 l~ 252 (502)
++
T Consensus 160 l~ 161 (290)
T 1p9a_G 160 LT 161 (290)
T ss_dssp CS
T ss_pred CC
Confidence 54
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-24 Score=225.58 Aligned_cols=247 Identities=25% Similarity=0.329 Sum_probs=207.4
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
..++.|+|++|+++ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|++|.+++ +|. .+++|+.|+
T Consensus 61 ~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~ 127 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLW 127 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEE
T ss_pred CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEE
Confidence 46899999999998 4654 57899999999999984 665 78999999999999995 554 578999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
+++|++++ +|.. +++|++|++++|++++ +|. .+.+|+.|++++|.+++ +| ..+++|+.|++++|++++
T Consensus 128 L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 128 IFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS 195 (622)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC
T ss_pred CCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC
Confidence 99999985 5653 4899999999999985 454 34789999999999996 45 456899999999999996
Q ss_pred cccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccC
Q 010736 230 PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNC 309 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l 309 (502)
+|.. +++|+.|++++|.++ .+|..+ .+|+.|++++|++++ +| ..+++|+.|++++|+++ .+|. .+
T Consensus 196 -l~~~---~~~L~~L~L~~N~l~-~l~~~~--~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~ 260 (622)
T 3g06_A 196 -LPTL---PSELYKLWAYNNRLT-SLPALP--SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LP 260 (622)
T ss_dssp -CCCC---CTTCCEEECCSSCCS-SCCCCC--TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CC
T ss_pred -CCCc---cchhhEEECcCCccc-ccCCCC--CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---cc
Confidence 4443 478999999999998 555433 679999999999998 44 45589999999999998 4565 57
Q ss_pred CCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCC
Q 010736 310 TSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGEC 357 (502)
Q Consensus 310 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 357 (502)
++|+.|++++|+++ .+|..+..+++|+.|+|++|.+++..+..+..+
T Consensus 261 ~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred ccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 89999999999999 678889999999999999999998887766544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=207.95 Aligned_cols=211 Identities=21% Similarity=0.262 Sum_probs=144.7
Q ss_pred CCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCc
Q 010736 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 170 (502)
+..+++|+.|++++|.++. + +.+..+++|++|+|++|.+++. ..++.+++|++|++++|++++..+..|..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 4456677777777777663 2 2466777777777777777642 3566777777777777777766666666777777
Q ss_pred EEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcc
Q 010736 171 ELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250 (502)
Q Consensus 171 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 250 (502)
+|++++|++++..+..+..+++|++|++++|++++..+..+..+++|+.|++++|++++..+..++.+++|+.|++++|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 77777777766655556666677777777776665555555666666666666666665555445555555555555554
Q ss_pred ccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCccc
Q 010736 251 LYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF 330 (502)
Q Consensus 251 l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 330 (502)
+++..+..+..+++|+.|++++|.+.+. +++|+.+++..|.++|.+|..+
T Consensus 193 -----------------------l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 193 -----------------------LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp -----------------------CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTT
T ss_pred -----------------------CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcc
Confidence 4444555667788999999999998754 5578899999999999999888
Q ss_pred CCCCC
Q 010736 331 GIYPN 335 (502)
Q Consensus 331 ~~l~~ 335 (502)
+.++.
T Consensus 243 ~~~~~ 247 (272)
T 3rfs_A 243 GSVAP 247 (272)
T ss_dssp SCBCG
T ss_pred cccCC
Confidence 76554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=208.31 Aligned_cols=227 Identities=16% Similarity=0.146 Sum_probs=156.9
Q ss_pred CCCCEEECCCCcccccCCc---cCcCCCCCCEEEccCCcCcCCCCccc--CCCCCCcEEEccCCcCcccCC----cccCC
Q 010736 95 PHLAYLDLRDNKLFGTIPP---QISNLTNLSILSLGGNQFSGNIPHEV--GLMSHLKILYIDSNQLDGSIP----LEVGQ 165 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~---~l~~l~~L~~L~Ls~N~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 165 (502)
..++.+.+.++.++...-. .+..+++|++|++++|.+++..|..+ +.+++|++|+|++|++++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3578888888877532111 12235679999999999999999888 889999999999999987655 34567
Q ss_pred CCCCcEEEcccCcccccCCcCCCCCCCCCeEEccccccccc---C-CccCcCCccCCccccccccccCcccc----cccC
Q 010736 166 LSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF---I-PPDIGNLKSISILSLAINQFSGPIPL----SLGN 237 (502)
Q Consensus 166 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~-p~~~~~l~~L~~L~ls~N~l~~~~p~----~~~~ 237 (502)
+++|++|++++|++++..|..++.+++|++|++++|++.+. . +..+..+++|++|++++|+++. ++. .++.
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence 89999999999999988888899999999999999987652 1 2334678899999999999873 222 2467
Q ss_pred CCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeC
Q 010736 238 LTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRL 317 (502)
Q Consensus 238 l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l 317 (502)
+++|++|++++|++++..|..+... ...++|+.|++++|+++ .+|..+. ++|+.|++
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~--------------------~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~L 279 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRC--------------------MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDL 279 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSC--------------------CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEEC
T ss_pred CCCCCEEECCCCCCCccchhhHHhc--------------------cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEEC
Confidence 7888888888888887666554331 01134444445555444 3333332 45555555
Q ss_pred CCCccccccCcccCCCCCCcEEEccCcccc
Q 010736 318 DGNNLTGNISKAFGIYPNLTFIDLSRNNFY 347 (502)
Q Consensus 318 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 347 (502)
++|++++. |. +..+++|+.|+|++|+++
T Consensus 280 s~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 280 SSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred CCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 55555543 11 445566666666666554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=208.72 Aligned_cols=225 Identities=21% Similarity=0.218 Sum_probs=169.7
Q ss_pred CEEEEEecCCCCceecCc--ccCCCCCCCCEEECCCCcccccCCccC--cCCCCCCEEEccCCcCcCCCC----cccCCC
Q 010736 71 RVINISLRGVGLKGKLHA--FSFSSFPHLAYLDLRDNKLFGTIPPQI--SNLTNLSILSLGGNQFSGNIP----HEVGLM 142 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~--~~~~~l~~L~~L~Ls~N~l~g~~p~~l--~~l~~L~~L~Ls~N~l~~~~p----~~l~~l 142 (502)
++..+.+.+..+...--. ..+..+++|++|++++|.+++..|..+ .++++|++|+|++|.+++..| ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 456666666665421100 012234679999999999999999998 999999999999999998766 345679
Q ss_pred CCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCccccc--C--CcCCCCCCCCCeEEcccccccccC--Cc-cCcCCc
Q 010736 143 SHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGS--V--PHSLGNLTQISMLFLHDNSFSGFI--PP-DIGNLK 215 (502)
Q Consensus 143 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~--p~-~~~~l~ 215 (502)
++|++|+|++|++++..|..|..+++|++|++++|++.+. + +..+..+++|++|++++|+++... +. .+..++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV 224 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC
Confidence 9999999999999988889999999999999999998752 2 233478999999999999997431 11 256789
Q ss_pred cCCccccccccccCcccccccCC---CCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEE
Q 010736 216 SISILSLAINQFSGPIPLSLGNL---TNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFT 292 (502)
Q Consensus 216 ~L~~L~ls~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ 292 (502)
+|++|++++|++++..|..+..+ ++|++|++++|+++ .+|..+. ..|+.|++++|++++. |. +..+++|+.|+
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~ 300 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLT 300 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-SCCSCEECCSCCCCSC-CC-TTSCCCCSCEE
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-CCCCEEECCCCcCCCC-ch-hhhCCCccEEE
Confidence 99999999999998888887776 58999999999888 5665543 4566666666666653 21 34445555555
Q ss_pred ccCCccc
Q 010736 293 VSENRFQ 299 (502)
Q Consensus 293 ls~n~l~ 299 (502)
+++|+++
T Consensus 301 L~~N~l~ 307 (310)
T 4glp_A 301 LDGNPFL 307 (310)
T ss_dssp CSSTTTS
T ss_pred CcCCCCC
Confidence 5555544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.6e-26 Score=223.96 Aligned_cols=266 Identities=13% Similarity=0.139 Sum_probs=182.3
Q ss_pred CCccceeeeCCCCCEEEEEecCCCCceecCcccCCCC--CCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCC-
Q 010736 58 PCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSF--PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGN- 134 (502)
Q Consensus 58 ~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~- 134 (502)
+..|.++.|+. ..++.++++++.+.+ ..+..+ ++++.|++++|.+.+..+. +.++++|++|+|++|.+++.
T Consensus 36 c~~W~~~~~~~-~~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~ 109 (336)
T 2ast_B 36 CKRWYRLASDE-SLWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST 109 (336)
T ss_dssp CHHHHHHHTCS-TTSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred HHHHHHHhcCc-hhheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence 34799998863 457889999887763 235666 7899999999999877665 56789999999999988765
Q ss_pred CCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccC-ccccc-CCcCCCCCCCCCeEEcccc-ccccc-CCcc
Q 010736 135 IPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN-NLNGS-VPHSLGNLTQISMLFLHDN-SFSGF-IPPD 210 (502)
Q Consensus 135 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~ 210 (502)
+|..+..+++|++|++++|++++..+..++.+++|++|++++| .+++. ++..+..+++|++|++++| .+++. ++..
T Consensus 110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~ 189 (336)
T 2ast_B 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 189 (336)
T ss_dssp HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH
T ss_pred HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH
Confidence 7777888889999999999888878888888888888888888 57652 5555677788888888888 77753 4555
Q ss_pred CcCCc-cCCccccccc--ccc-CcccccccCCCCCcEEEeeCcc-ccccCCCCCccccccEEECcCCcCcccCCccccCC
Q 010736 211 IGNLK-SISILSLAIN--QFS-GPIPLSLGNLTNLKQFSLVYNN-LYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRG 285 (502)
Q Consensus 211 ~~~l~-~L~~L~ls~N--~l~-~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~ 285 (502)
+..++ +|++|++++| .++ +.+|..+..+++|+.|++++|. +++. .+..+..+
T Consensus 190 ~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~-----------------------~~~~l~~l 246 (336)
T 2ast_B 190 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND-----------------------CFQEFFQL 246 (336)
T ss_dssp HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGG-----------------------GGGGGGGC
T ss_pred HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHH-----------------------HHHHHhCC
Confidence 66677 7777777777 344 3445555666667777666666 4433 33344555
Q ss_pred CCCcEEEccCCc-cccccCcccccCCCCcEEeCCCCccccccCcccCCC-CCCcEEEccCcccccccCccccC
Q 010736 286 GALQIFTVSENR-FQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIY-PNLTFIDLSRNNFYGEISSNFGE 356 (502)
Q Consensus 286 ~~L~~L~ls~n~-l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~ 356 (502)
++|+.|++++|. +.......+..+++|+.|++++| ++.. .+..+ .++..|++++|++++..|..++.
T Consensus 247 ~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 247 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp TTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCcccc
Confidence 666666666663 22221224566777777777766 3321 22222 22445556777777766665543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-23 Score=194.55 Aligned_cols=195 Identities=18% Similarity=0.133 Sum_probs=156.4
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCc-CcCCCCcccCCCCCCcEEEccC-CcCcccCCcccCCCCCCcEEE
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQ-FSGNIPHEVGLMSHLKILYIDS-NQLDGSIPLEVGQLSSMVELA 173 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 173 (502)
+|++|++++|++++..+..|.++++|++|++++|+ +++..+..|.++++|++|++++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 78889999999887777788889999999999996 8766666888888999999988 888877777888888999999
Q ss_pred cccCcccccCCcCCCCCCCCC---eEEcccc-cccccCCccCcCCccCC-ccccccccccCcccccccCCCCCcEEEeeC
Q 010736 174 LFSNNLNGSVPHSLGNLTQIS---MLFLHDN-SFSGFIPPDIGNLKSIS-ILSLAINQFSGPIPLSLGNLTNLKQFSLVY 248 (502)
Q Consensus 174 L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 248 (502)
+++|++++ +|. +..+++|+ +|++++| .+++..+..|..+++|+ .|++++|+++ .+|......++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 99998886 665 77888887 8999998 88877777788888898 9999999888 4544433347889999999
Q ss_pred cc-ccccCCCCCcc--ccccEEECcCCcCcccCCccccCCCCCcEEEccCC
Q 010736 249 NN-LYGSIPPSLDN--LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSEN 296 (502)
Q Consensus 249 N~-l~~~~p~~~~~--~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n 296 (502)
|+ +++..+..+.. ..|+.|++++|++++..+. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 94 87665665654 4788999999998874433 5678888888765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-23 Score=193.82 Aligned_cols=179 Identities=16% Similarity=0.180 Sum_probs=131.4
Q ss_pred CCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCc-CcccCCcccCCCCCCcEEEccc-CcccccCCcCCCCCCCCCeE
Q 010736 119 TNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQ-LDGSIPLEVGQLSSMVELALFS-NNLNGSVPHSLGNLTQISML 196 (502)
Q Consensus 119 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 196 (502)
++|++|++++|++++..+..|+++++|++|++++|+ +++..+..|..+++|++|++++ |++++..+..|..+++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 389999999999998777789999999999999997 8877777899999999999998 99997777788899999999
Q ss_pred EcccccccccCCccCcCCccCC---ccccccc-cccCcccccccCCCCCc-EEEeeCccccccCCCCCccccccEEECcC
Q 010736 197 FLHDNSFSGFIPPDIGNLKSIS---ILSLAIN-QFSGPIPLSLGNLTNLK-QFSLVYNNLYGSIPPSLDNLVLTKLSLDD 271 (502)
Q Consensus 197 ~L~~N~l~~~~p~~~~~l~~L~---~L~ls~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~~~L~~L~ls~ 271 (502)
++++|++++ +|. +..+++|+ .|++++| ++++..+..|.++++|+ .|++++|+++...+..+....|+.|++++
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCC
Confidence 999999986 555 77777777 8888888 88766666677888888 88888887763222222223455555555
Q ss_pred Cc-CcccCCccccCC-CCCcEEEccCCccc
Q 010736 272 NH-FTSYLPQNICRG-GALQIFTVSENRFQ 299 (502)
Q Consensus 272 N~-l~~~~~~~~~~~-~~L~~L~ls~n~l~ 299 (502)
|+ +++..+..+..+ ++|+.|++++|+++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 52 444333333333 44444444444443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-25 Score=222.53 Aligned_cols=86 Identities=13% Similarity=0.091 Sum_probs=45.0
Q ss_pred CCcEEEccCCccccc----cCccccc-CCCCcEEeCCCCccccccC----cccCCCCCCcEEEccCcccccc-------c
Q 010736 287 ALQIFTVSENRFQGT----IPKSLRN-CTSLIRVRLDGNNLTGNIS----KAFGIYPNLTFIDLSRNNFYGE-------I 350 (502)
Q Consensus 287 ~L~~L~ls~n~l~~~----~~~~l~~-l~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~-------~ 350 (502)
+|+.|++++|.+++. ++..+.. .++|+.|++++|.+++..+ ..+..+++|+.|+|++|.+.+. +
T Consensus 197 ~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l 276 (362)
T 3goz_A 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKAL 276 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHH
T ss_pred CCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHH
Confidence 455555555555431 2333333 2356666666666654322 2334556666666666663322 2
Q ss_pred CccccCCCCCCeeeecCCcccc
Q 010736 351 SSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 351 ~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
+..+..+++|++||+++|++..
T Consensus 277 ~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 277 GAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HTTSTTCCEEEEECTTSCBCCG
T ss_pred HHHhccCCceEEEecCCCcCCC
Confidence 2345556666677777776643
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-22 Score=190.76 Aligned_cols=176 Identities=23% Similarity=0.250 Sum_probs=137.4
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALF 175 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 175 (502)
..++++++++.++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|++|+++
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4678999999888 5666665 689999999999998888888999999999999999988888788889999999999
Q ss_pred cCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccC
Q 010736 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSI 255 (502)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 255 (502)
+|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 99998777777888888889999888888777767788888888888888888766667777778888877777776444
Q ss_pred CCCCcc-ccccEEECcCCcC
Q 010736 256 PPSLDN-LVLTKLSLDDNHF 274 (502)
Q Consensus 256 p~~~~~-~~L~~L~ls~N~l 274 (502)
+..+.. ..|+.|++++|.+
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~ 191 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQF 191 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCB
T ss_pred HHHHhCCCCCCEEEeeCCce
Confidence 433332 3344444444443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-25 Score=226.26 Aligned_cols=94 Identities=17% Similarity=0.258 Sum_probs=70.3
Q ss_pred cccCCCCCcEEEccCCccc----cccCcccccCCCCcEEeCCCCccccc----cCccc--CCCCCCcEEEccCccccc--
Q 010736 281 NICRGGALQIFTVSENRFQ----GTIPKSLRNCTSLIRVRLDGNNLTGN----ISKAF--GIYPNLTFIDLSRNNFYG-- 348 (502)
Q Consensus 281 ~~~~~~~L~~L~ls~n~l~----~~~~~~l~~l~~L~~L~l~~N~l~~~----~~~~~--~~l~~L~~L~Ls~N~l~~-- 348 (502)
.+..+++|+.|++++|.++ +.+|..+..+++|+.|+|++|.+++. ++..+ +.+++|++|+|++|.+++
T Consensus 211 ~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g 290 (386)
T 2ca6_A 211 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 290 (386)
T ss_dssp TGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHH
T ss_pred HhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHH
Confidence 5556677777777777775 45667777888888888888888765 34444 347888899999888887
Q ss_pred --ccCccc-cCCCCCCeeeecCCcccccc
Q 010736 349 --EISSNF-GECPKLGALNISRNNITGDF 374 (502)
Q Consensus 349 --~~~~~~-~~~~~L~~L~l~~N~l~~df 374 (502)
.+|..+ ..+++|++|++++|++.++.
T Consensus 291 ~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 291 VRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 366666 56789999999999887654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-23 Score=187.53 Aligned_cols=182 Identities=24% Similarity=0.276 Sum_probs=131.0
Q ss_pred CCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCc
Q 010736 58 PCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPH 137 (502)
Q Consensus 58 ~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 137 (502)
.|.|.+|.|+..+ ++ .+|. .-.++|++|++++|++++..+..|.++++|++|++++|++++..+.
T Consensus 6 ~C~~~~v~c~~~~-----------l~-~~p~---~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (208)
T 2o6s_A 6 SCSGTTVECYSQG-----------RT-SVPT---GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG 70 (208)
T ss_dssp EEETTEEECCSSC-----------CS-SCCS---CCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred EECCCEEEecCCC-----------cc-CCCC---CCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence 4799999997532 11 2222 2245777888888887766666677778888888888888766555
Q ss_pred ccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccC
Q 010736 138 EVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSI 217 (502)
Q Consensus 138 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 217 (502)
.|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|
T Consensus 71 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 150 (208)
T 2o6s_A 71 VFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL 150 (208)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred hcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCc
Confidence 67777788888888888776666667777888888888888776666667777788888888888776666667777788
Q ss_pred CccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc
Q 010736 218 SILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN 261 (502)
Q Consensus 218 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 261 (502)
+.|++++|.+.+ .+++|+.|+++.|+++|.+|..++.
T Consensus 151 ~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~ 187 (208)
T 2o6s_A 151 QYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGS 187 (208)
T ss_dssp CEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred cEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcc
Confidence 888888776664 3456777777778887777776654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-25 Score=221.82 Aligned_cols=256 Identities=17% Similarity=0.142 Sum_probs=148.4
Q ss_pred EEecCCCCceecCcccCCCCCCCCEEECCCCcccccCC----ccCcCCC-CCCEEEccCCcCcCCCCcccCCC-----CC
Q 010736 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIP----PQISNLT-NLSILSLGGNQFSGNIPHEVGLM-----SH 144 (502)
Q Consensus 75 L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p----~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~ 144 (502)
.+++.++++|.+|.. +...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|.+++..+..+..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~-~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEF-TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHH-HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHH-HhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 456777777776653 5555557777777777776655 5666777 77777777777776666666554 77
Q ss_pred CcEEEccCCcCcccCCccc----CCC-CCCcEEEcccCcccccCCcCC----CC-CCCCCeEEcccccccccCC----cc
Q 010736 145 LKILYIDSNQLDGSIPLEV----GQL-SSMVELALFSNNLNGSVPHSL----GN-LTQISMLFLHDNSFSGFIP----PD 210 (502)
Q Consensus 145 L~~L~Ls~N~l~~~~p~~~----~~l-~~L~~L~L~~N~l~~~~p~~~----~~-l~~L~~L~L~~N~l~~~~p----~~ 210 (502)
|++|+|++|++++..+..+ ..+ ++|++|++++|++++..+..+ .. .++|++|++++|.+++..+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 7777777777776555533 333 677777777777765544332 22 2467777777777664322 22
Q ss_pred CcCCc-cCCccccccccccCccccccc----CC-CCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccC
Q 010736 211 IGNLK-SISILSLAINQFSGPIPLSLG----NL-TNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICR 284 (502)
Q Consensus 211 ~~~l~-~L~~L~ls~N~l~~~~p~~~~----~l-~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~ 284 (502)
+..++ +|++|++++|++++..+..+. .+ ++|+.|++++|.+++..... ++..+..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~-------------------l~~~l~~ 222 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAE-------------------LAYIFSS 222 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHH-------------------HHHHHHH
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHH-------------------HHHHHhc
Confidence 23333 566666666666554443322 22 35666666666555321110 1222222
Q ss_pred -CCCCcEEEccCCccccccC----cccccCCCCcEEeCCCCccccc-------cCcccCCCCCCcEEEccCccccccc
Q 010736 285 -GGALQIFTVSENRFQGTIP----KSLRNCTSLIRVRLDGNNLTGN-------ISKAFGIYPNLTFIDLSRNNFYGEI 350 (502)
Q Consensus 285 -~~~L~~L~ls~n~l~~~~~----~~l~~l~~L~~L~l~~N~l~~~-------~~~~~~~l~~L~~L~Ls~N~l~~~~ 350 (502)
.++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+. ++..+..+++|+.||+++|++....
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~ 300 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH 300 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGG
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcc
Confidence 2355566666665554322 2234556666666666663322 2235566677777777777776543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-25 Score=222.76 Aligned_cols=238 Identities=17% Similarity=0.227 Sum_probs=146.0
Q ss_pred CCCCCCCCEEECCCCcccccC----CccCcCCCCCCEEEccCC---cCcCCCCccc-------CCCCCCcEEEccCCcCc
Q 010736 91 FSSFPHLAYLDLRDNKLFGTI----PPQISNLTNLSILSLGGN---QFSGNIPHEV-------GLMSHLKILYIDSNQLD 156 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~----p~~l~~l~~L~~L~Ls~N---~l~~~~p~~l-------~~l~~L~~L~Ls~N~l~ 156 (502)
+..+++|++|+|++|.+++.. +..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|+++
T Consensus 28 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 107 (386)
T 2ca6_A 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107 (386)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCC
Confidence 556677777777777776553 334667777777777774 4445555544 56677777777777766
Q ss_pred c----cCCcccCCCCCCcEEEcccCcccccCCcCCC----CC---------CCCCeEEccccccc-ccCC---ccCcCCc
Q 010736 157 G----SIPLEVGQLSSMVELALFSNNLNGSVPHSLG----NL---------TQISMLFLHDNSFS-GFIP---PDIGNLK 215 (502)
Q Consensus 157 ~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~ 215 (502)
+ .+|..+..+++|++|+|++|.++...+..+. .+ ++|++|++++|+++ +.++ ..+..++
T Consensus 108 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~ 187 (386)
T 2ca6_A 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 187 (386)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCC
Confidence 5 3555566666666666666666533322222 22 55555555555554 2222 2333444
Q ss_pred cCCcccccccccc--C---cccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCc----ccCCccccCCC
Q 010736 216 SISILSLAINQFS--G---PIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFT----SYLPQNICRGG 286 (502)
Q Consensus 216 ~L~~L~ls~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~----~~~~~~~~~~~ 286 (502)
+|+.|++++|+++ | ..|..+..++ .|+.|++++|.++ ..+|..+..++
T Consensus 188 ~L~~L~L~~n~l~~~g~~~l~~~~l~~~~-----------------------~L~~L~Ls~n~l~~~g~~~l~~~l~~~~ 244 (386)
T 2ca6_A 188 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQ-----------------------ELKVLDLQDNTFTHLGSSALAIALKSWP 244 (386)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCT-----------------------TCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred CcCEEECcCCCCCHhHHHHHHHHHhhcCC-----------------------CccEEECcCCCCCcHHHHHHHHHHccCC
Confidence 4444444444443 1 1222333444 4555555555553 33556667778
Q ss_pred CCcEEEccCCccccc----cCccccc--CCCCcEEeCCCCcccc----ccCccc-CCCCCCcEEEccCcccccccC
Q 010736 287 ALQIFTVSENRFQGT----IPKSLRN--CTSLIRVRLDGNNLTG----NISKAF-GIYPNLTFIDLSRNNFYGEIS 351 (502)
Q Consensus 287 ~L~~L~ls~n~l~~~----~~~~l~~--l~~L~~L~l~~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l~~~~~ 351 (502)
+|+.|++++|.+++. ++..+.. +++|+.|++++|.+++ .++..+ ..+++|++|++++|++++..+
T Consensus 245 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 888888888888765 4555533 8889999999999987 366655 567999999999999886653
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=216.04 Aligned_cols=209 Identities=22% Similarity=0.303 Sum_probs=143.1
Q ss_pred CCCC-----cccee-eeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCC
Q 010736 56 ISPC-----AWSGI-SCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGN 129 (502)
Q Consensus 56 ~~~C-----~W~Gv-~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N 129 (502)
.+|| .|.|+ .|.. ++++.|+|+++++++ +|.. + +++|++|+|++|+|+ .+| ..+++|++|+|++|
T Consensus 40 ~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N 110 (571)
T 3cvr_A 40 ALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALI-SLP---ELPASLEYLDACDN 110 (571)
T ss_dssp CCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSS
T ss_pred CCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCC
Confidence 5678 79999 7864 578888888888886 6664 3 377888888888888 566 45678888888888
Q ss_pred cCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCc
Q 010736 130 QFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209 (502)
Q Consensus 130 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 209 (502)
+|++ +|. +.. +|++|+|++|++++ +|. .+++|+.|++++|++++ +|. .+++|++|++++|++++ +|.
T Consensus 111 ~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~ 177 (571)
T 3cvr_A 111 RLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE 177 (571)
T ss_dssp CCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC
T ss_pred CCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch
Confidence 8886 666 554 78888888888876 554 56777777887777775 554 45677777777777765 444
Q ss_pred cCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCc
Q 010736 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQ 289 (502)
Q Consensus 210 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~ 289 (502)
+. ++|+.|++++|+|+ .+|. +.. +| . .....++.|++++|+|+. +|..+..+++|+
T Consensus 178 -l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L----------~------~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~ 233 (571)
T 3cvr_A 178 -LP--ESLEALDVSTNLLE-SLPA-VPV--RN----------H------HSEETEIFFRCRENRITH-IPENILSLDPTC 233 (571)
T ss_dssp -CC--TTCCEEECCSSCCS-SCCC-CC--------------------------CCEEEECCSSCCCC-CCGGGGGSCTTE
T ss_pred -hh--CCCCEEECcCCCCC-chhh-HHH--hh----------h------cccccceEEecCCCccee-cCHHHhcCCCCC
Confidence 44 56666666666665 3333 322 22 0 000123677777777765 566677788888
Q ss_pred EEEccCCccccccCcccccCC
Q 010736 290 IFTVSENRFQGTIPKSLRNCT 310 (502)
Q Consensus 290 ~L~ls~n~l~~~~~~~l~~l~ 310 (502)
.|++++|.+++.+|..+..+.
T Consensus 234 ~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 234 TIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp EEECCSSSCCHHHHHHHHHHH
T ss_pred EEEeeCCcCCCcCHHHHHHhh
Confidence 888888888887777766543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.9e-25 Score=215.75 Aligned_cols=249 Identities=15% Similarity=0.161 Sum_probs=189.6
Q ss_pred CCCEEECCCCcccccCCccCcCC--CCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCccc-CCcccCCCCCCcEE
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNL--TNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGS-IPLEVGQLSSMVEL 172 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 172 (502)
.++.+++++|.+. |..+..+ ++++.|++++|.+++..+. +..+++|++|++++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4789999999876 4566677 8899999999999877665 56788999999999998865 77778888999999
Q ss_pred EcccCcccccCCcCCCCCCCCCeEEcccc-ccccc-CCccCcCCccCCccccccc-cccCc-ccccccCCC-CCcEEEee
Q 010736 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDN-SFSGF-IPPDIGNLKSISILSLAIN-QFSGP-IPLSLGNLT-NLKQFSLV 247 (502)
Q Consensus 173 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~ls~N-~l~~~-~p~~~~~l~-~L~~L~l~ 247 (502)
++++|.+++..+..++.+++|++|++++| .+++. ++..+..+++|++|++++| .+++. ++..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999888777777888888899998888 56652 4555667778888888888 77653 455566677 77777777
Q ss_pred CccccccCCCCCccccccEEECcCCcCc-ccCCccccCCCCCcEEEccCCc-cccccCcccccCCCCcEEeCCCCc-ccc
Q 010736 248 YNNLYGSIPPSLDNLVLTKLSLDDNHFT-SYLPQNICRGGALQIFTVSENR-FQGTIPKSLRNCTSLIRVRLDGNN-LTG 324 (502)
Q Consensus 248 ~N~l~~~~p~~~~~~~L~~L~ls~N~l~-~~~~~~~~~~~~L~~L~ls~n~-l~~~~~~~l~~l~~L~~L~l~~N~-l~~ 324 (502)
+|.+ .++ +.++..+..+++|+.|++++|. +++..+..+..+++|+.|++++|. +..
T Consensus 204 ~~~~---------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~ 262 (336)
T 2ast_B 204 GYRK---------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 262 (336)
T ss_dssp SCGG---------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred CCcc---------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCH
Confidence 6632 121 2234456677899999999999 777778889999999999999995 433
Q ss_pred ccCcccCCCCCCcEEEccCcccccccCccccCC-CCCCeeeecCCccccc
Q 010736 325 NISKAFGIYPNLTFIDLSRNNFYGEISSNFGEC-PKLGALNISRNNITGD 373 (502)
Q Consensus 325 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~~L~~L~l~~N~l~~d 373 (502)
.....+..+++|+.|++++| +.. ..+..+ ..+..|++++|++++.
T Consensus 263 ~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~ 308 (336)
T 2ast_B 263 ETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTI 308 (336)
T ss_dssp GGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCT
T ss_pred HHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccc
Confidence 32336788999999999998 432 233333 3477788999998754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-22 Score=195.41 Aligned_cols=195 Identities=23% Similarity=0.317 Sum_probs=130.1
Q ss_pred CCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCc
Q 010736 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 170 (502)
+..+++|++|++++|.++. +| .+..+++|++|+|++|.+++..+ +..+++|++|++++|++++. + .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence 4456777888888887774 44 57778888888888888875433 77788888888888887753 3 577777888
Q ss_pred EEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcc
Q 010736 171 ELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250 (502)
Q Consensus 171 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 250 (502)
+|++++|++++. +. +..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|+
T Consensus 111 ~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence 888888877753 32 6777777777777777775433 6667777777777777765333 6666677777776666
Q ss_pred ccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCcccc
Q 010736 251 LYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324 (502)
Q Consensus 251 l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~ 324 (502)
+++..+ +..+++|+.|++++|++++.. .+..+++|+.|++++|.+++
T Consensus 185 l~~~~~-------------------------l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 185 ISDISP-------------------------LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCCGG-------------------------GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred cCcChh-------------------------hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 653211 344455666666666665433 25566666666666666653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-21 Score=194.02 Aligned_cols=244 Identities=14% Similarity=0.087 Sum_probs=133.4
Q ss_pred CccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCC-c
Q 010736 59 CAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIP-H 137 (502)
Q Consensus 59 C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~ 137 (502)
|.|..|.|+ +++++ .+|.. + .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| .
T Consensus 9 C~~~~v~C~-----------~~~Lt-~iP~~-l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~ 73 (350)
T 4ay9_X 9 CSNRVFLCQ-----------ESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73 (350)
T ss_dssp EETTEEEEE-----------STTCC-SCCTT-C--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred eeCCEEEec-----------CCCCC-ccCcC-c--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence 466666664 33444 44543 3 2568888888888886655678888888888888888766555 3
Q ss_pred ccCCCCCCcE-EEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEccc-ccccccCCccCcCCc
Q 010736 138 EVGLMSHLKI-LYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHD-NSFSGFIPPDIGNLK 215 (502)
Q Consensus 138 ~l~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~ 215 (502)
.|.++++|+. +.+++|+++...|..|..+++|++|++++|++++..+..+....++..+++.+ |++....+..|..+.
T Consensus 74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~ 153 (350)
T 4ay9_X 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153 (350)
T ss_dssp SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence 5677777654 55566777766677777777777777777777755555555555666666643 344433333333322
Q ss_pred cCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcC-CcCcccCCccccCCCCCcEEEcc
Q 010736 216 SISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDD-NHFTSYLPQNICRGGALQIFTVS 294 (502)
Q Consensus 216 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~-N~l~~~~~~~~~~~~~L~~L~ls 294 (502)
..++.|++++|+++...+..+....++.+++++ |.++.+.+..|..+++|+.|+++
T Consensus 154 -----------------------~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs 210 (350)
T 4ay9_X 154 -----------------------FESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210 (350)
T ss_dssp -----------------------SSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECT
T ss_pred -----------------------hhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcC
Confidence 134445555555543322333334445555543 33333333344555556666666
Q ss_pred CCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCc
Q 010736 295 ENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRN 344 (502)
Q Consensus 295 ~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 344 (502)
+|+++...+..+ .+|+.|++.++.--..+| .+..+++|+.+++.++
T Consensus 211 ~N~l~~lp~~~~---~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 211 RTRIHSLPSYGL---ENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp TSCCCCCCSSSC---TTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCH
T ss_pred CCCcCccChhhh---ccchHhhhccCCCcCcCC-CchhCcChhhCcCCCC
Confidence 665553222222 233333332222112233 2444555555555443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=5.6e-22 Score=192.87 Aligned_cols=209 Identities=22% Similarity=0.352 Sum_probs=158.5
Q ss_pred EEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCc
Q 010736 99 YLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNN 178 (502)
Q Consensus 99 ~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 178 (502)
.+.+..+.+++.++ +..+++|++|++++|.++. +| .+..+++|++|++++|++++..+ +..+++|++|++++|+
T Consensus 23 ~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 23 KIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (308)
T ss_dssp HHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCceec--HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence 34455666654433 4568889999999999884 55 57888999999999999885444 8888889999998888
Q ss_pred ccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCC
Q 010736 179 LNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS 258 (502)
Q Consensus 179 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 258 (502)
+++. + .+..+++|++|++++|++++. + .+..+++|+.|++++|++++..+ +..+++|+.|++++|.++
T Consensus 97 l~~~-~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~------ 164 (308)
T 1h6u_A 97 LKNV-S-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS------ 164 (308)
T ss_dssp CSCC-G-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC------
T ss_pred CCCc-h-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCC------
Confidence 8753 3 577888888888888888764 2 26677777777777777765433 555666666666655554
Q ss_pred CccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcE
Q 010736 259 LDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTF 338 (502)
Q Consensus 259 ~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 338 (502)
+..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++.. .+..+++|+.
T Consensus 165 -----------------~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~ 221 (308)
T 1h6u_A 165 -----------------DLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFI 221 (308)
T ss_dssp -----------------CCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCE
T ss_pred -----------------CChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCE
Confidence 3222 6677889999999999986543 889999999999999999765 3889999999
Q ss_pred EEccCccccc
Q 010736 339 IDLSRNNFYG 348 (502)
Q Consensus 339 L~Ls~N~l~~ 348 (502)
|++++|.+++
T Consensus 222 L~l~~N~i~~ 231 (308)
T 1h6u_A 222 VTLTNQTITN 231 (308)
T ss_dssp EEEEEEEEEC
T ss_pred EEccCCeeec
Confidence 9999999975
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-21 Score=204.18 Aligned_cols=193 Identities=22% Similarity=0.327 Sum_probs=134.9
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALF 175 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 175 (502)
+|+.|+|++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|++++|+|++ +|. +.. +|+.|+++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78888888888876 666553 77888888888888 566 446788888888888876 665 554 78888888
Q ss_pred cCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccC
Q 010736 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSI 255 (502)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 255 (502)
+|++++ +|. .+++|++|++++|.+++ +|. .+++|+.|++++|++++ +|. +. ++|+.|++++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 888776 555 56777777777777775 443 35666666666666665 444 43 55666666666655 33
Q ss_pred CCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCC
Q 010736 256 PPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGI 332 (502)
Q Consensus 256 p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 332 (502)
|. +.. .| ......|+.|++++|+++ .+|..+..+++|+.|++++|.+++.+|..+..
T Consensus 196 p~-~~~-~L-----------------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 196 PA-VPV-RN-----------------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp CC-CC--------------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred hh-HHH-hh-----------------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 32 211 00 011233499999999999 68888888999999999999999988776654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-21 Score=178.65 Aligned_cols=179 Identities=20% Similarity=0.162 Sum_probs=143.2
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 177 (502)
+.++.+++.++ .+|..+ .++|++|++++|++++..+..|+.+++|++|++++|++++..+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 56788888887 456544 468999999999999777777899999999999999999776677889999999999999
Q ss_pred cccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCC
Q 010736 178 NLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP 257 (502)
Q Consensus 178 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 257 (502)
++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|+.|++++|.+.+..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~- 165 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP- 165 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT-
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC-
Confidence 9997777778899999999999999998777778888999999999999987777678888888888888887764332
Q ss_pred CCccccccEEECcCCcCcccCCccccCC
Q 010736 258 SLDNLVLTKLSLDDNHFTSYLPQNICRG 285 (502)
Q Consensus 258 ~~~~~~L~~L~ls~N~l~~~~~~~~~~~ 285 (502)
.++.|+++.|++++.+|..++.+
T Consensus 166 -----~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 166 -----GIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp -----TTHHHHHHHHHCTTTBBCTTSSB
T ss_pred -----CHHHHHHHHHhCCceeeccCccc
Confidence 34555555666665555554433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.4e-21 Score=189.46 Aligned_cols=242 Identities=12% Similarity=0.079 Sum_probs=145.6
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCc-ccCCCCCCcEEEccc
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPL-EVGQLSSMVELALFS 176 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~ 176 (502)
++++.++++++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|.+++++++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~----- 83 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE----- 83 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCE-----
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhh-----
Confidence 34555555555 445443 23555555555555533333455555555555555555433332 3444444332
Q ss_pred CcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeC-ccccccC
Q 010736 177 NNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVY-NNLYGSI 255 (502)
Q Consensus 177 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~ 255 (502)
.+.++.|+++...|..|..+++|++|++++|+++...+..+....++..+++.+ +++....
T Consensus 84 ------------------~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 84 ------------------IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp ------------------EEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred ------------------hhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 233344455544445555555555555555555544444444555566677654 4555433
Q ss_pred CCCCcc--ccccEEECcCCcCcccCCccccCCCCCcEEEccC-CccccccCcccccCCCCcEEeCCCCccccccCcccCC
Q 010736 256 PPSLDN--LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSE-NRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGI 332 (502)
Q Consensus 256 p~~~~~--~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~-n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 332 (502)
+..+.. ..++.|++++|+++.+ +.......+|+.+++++ |.++...+..|..+++|++|++++|+++...+..+
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~-- 222 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL-- 222 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC--
T ss_pred ccchhhcchhhhhhccccccccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh--
Confidence 344443 4688999999999975 44455667899999975 66664444678999999999999999996655444
Q ss_pred CCCCcEEEccCcccccccCccccCCCCCCeeeecCCcc
Q 010736 333 YPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNI 370 (502)
Q Consensus 333 l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l 370 (502)
.+|+.|.+.++.-...+| .+..+++|+.+++.++..
T Consensus 223 -~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 223 -ENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp -TTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHHH
T ss_pred -ccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCcc
Confidence 556666655544344566 478899999999975543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.3e-21 Score=177.68 Aligned_cols=160 Identities=23% Similarity=0.289 Sum_probs=133.6
Q ss_pred CCCCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCC
Q 010736 56 ISPCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNI 135 (502)
Q Consensus 56 ~~~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~ 135 (502)
...|.|.+|.|+.. ++ +.+|.. + .++|++|+|++|++++..|..|.++++|++|+|++|+|+...
T Consensus 16 ~~~Cs~~~v~c~~~-~l-----------~~ip~~-~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 80 (229)
T 3e6j_A 16 QCSCSGTTVDCRSK-RH-----------ASVPAG-I--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP 80 (229)
T ss_dssp TCEEETTEEECTTS-CC-----------SSCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCEEeCCEeEccCC-Cc-----------CccCCC-C--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcC
Confidence 46899999999752 22 234442 3 378999999999999988999999999999999999998666
Q ss_pred CcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCc
Q 010736 136 PHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLK 215 (502)
Q Consensus 136 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 215 (502)
+..|..+++|++|+|++|++++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..+..+..++
T Consensus 81 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 159 (229)
T 3e6j_A 81 VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159 (229)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCC
Confidence 677899999999999999999777777889999999999999998 6788888889999999999998877777788888
Q ss_pred cCCccccccccccCcc
Q 010736 216 SISILSLAINQFSGPI 231 (502)
Q Consensus 216 ~L~~L~ls~N~l~~~~ 231 (502)
+|+.|++++|.+.+..
T Consensus 160 ~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 160 SLTHAYLFGNPWDCEC 175 (229)
T ss_dssp TCCEEECTTSCBCTTB
T ss_pred CCCEEEeeCCCccCCc
Confidence 8888888888887544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.3e-23 Score=220.86 Aligned_cols=257 Identities=18% Similarity=0.164 Sum_probs=135.9
Q ss_pred CHHHHHHHHHHHhhcCcCCCCCCCCCCCCCCCCCCCCCCCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCE
Q 010736 20 TNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAY 99 (502)
Q Consensus 20 ~~~d~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~ 99 (502)
...+.++|+++..+.....+..-..|... ....+.|.+++++. ++++.++|.++++... +.. .|+.
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~-~~~------~l~~ 195 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGD------STPSGTATNSAVST-PLTPKIELFANGKDEA-NQA------LLQH 195 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCC------CCccccCCCceecC-CccceEEeeCCCCCcc-hhh------Hhhc
Confidence 34577889999887743222223345332 23456899999875 7899999999888753 222 2334
Q ss_pred EECCCCcccc---------cCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCc
Q 010736 100 LDLRDNKLFG---------TIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170 (502)
Q Consensus 100 L~Ls~N~l~g---------~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 170 (502)
++|++|.|.+ ..|..+..++.|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|+.+++|+
T Consensus 196 l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~ 273 (727)
T 4b8c_D 196 KKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLR 273 (727)
T ss_dssp --------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCC
T ss_pred CccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCC
Confidence 4444444433 45778899999999999999998 78888889999999999999999 8888899999999
Q ss_pred EEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCC-CcEEEeeCc
Q 010736 171 ELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTN-LKQFSLVYN 249 (502)
Q Consensus 171 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~-L~~L~l~~N 249 (502)
+|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.+++.+|..+..+.. +..+++++|
T Consensus 274 ~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N 351 (727)
T 4b8c_D 274 VLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDN 351 (727)
T ss_dssp EEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHC
T ss_pred EEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccC
Confidence 9999999999 77999999999999999999997 67888999999999999999999988887765432 234778899
Q ss_pred cccccCCCCCccccccEEECcCC--------cCcccCCccccCCCCCcEEEccCCccc
Q 010736 250 NLYGSIPPSLDNLVLTKLSLDDN--------HFTSYLPQNICRGGALQIFTVSENRFQ 299 (502)
Q Consensus 250 ~l~~~~p~~~~~~~L~~L~ls~N--------~l~~~~~~~~~~~~~L~~L~ls~n~l~ 299 (502)
.+++.+|..+ ..|+++.| .+.+..+..+..+..+....++.|.+.
T Consensus 352 ~l~~~~p~~l-----~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 352 RPEIPLPHER-----RFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp CCCCCCCCC----------------------------------------------CCC
T ss_pred cccCcCcccc-----ceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 9998888654 44555555 333333334445555566666777664
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.6e-23 Score=219.78 Aligned_cols=306 Identities=12% Similarity=0.062 Sum_probs=171.3
Q ss_pred CCEEEEEecCCCCcee----cCcccCCCCCCCCEEECCCCccc----ccCCccCcCCCCCCEEEccCCcCcCCCCcccCC
Q 010736 70 GRVINISLRGVGLKGK----LHAFSFSSFPHLAYLDLRDNKLF----GTIPPQISNLTNLSILSLGGNQFSGNIPHEVGL 141 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~----l~~~~~~~l~~L~~L~Ls~N~l~----g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 141 (502)
..++.|+|+++.+++. ++.. +..+++|++|++++|.++ +.++..+.++++|++|+|++|.+.+ +|..+..
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~-~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHEL-AQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHH-HHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCEEECccccccCcchhHHHHH-HhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence 4678888888877654 3322 556788888888888886 3445556678888888888888774 5566666
Q ss_pred CCCCcEEEccCCcCc---ccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEccccccccc------------
Q 010736 142 MSHLKILYIDSNQLD---GSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF------------ 206 (502)
Q Consensus 142 l~~L~~L~Ls~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~------------ 206 (502)
+++|++|+++.+... +..+..+..+++|+.|+++++.. +.+|..+..+++|++|++++|.+++.
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L 320 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence 777777777643222 12223344445555555544322 23444444445555555555544322
Q ss_pred -------------CCccCcCCccCCccccc-----------cccccCc-ccccccCCCCCcEEEeeCccccccCCCCCcc
Q 010736 207 -------------IPPDIGNLKSISILSLA-----------INQFSGP-IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN 261 (502)
Q Consensus 207 -------------~p~~~~~l~~L~~L~ls-----------~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 261 (502)
++..+..+++|++|+++ .|.+++. ++.....+++|++|+++.|.+++..+..+..
T Consensus 321 ~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~ 400 (592)
T 3ogk_B 321 EVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400 (592)
T ss_dssp CEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHH
T ss_pred CEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHh
Confidence 12222334445555555 2333322 1111233555566666555555433322221
Q ss_pred --ccccEEECc----CCcCccc-----CCccccCCCCCcEEEccCC--ccccccCcccc-cCCCCcEEeCCCCccccc-c
Q 010736 262 --LVLTKLSLD----DNHFTSY-----LPQNICRGGALQIFTVSEN--RFQGTIPKSLR-NCTSLIRVRLDGNNLTGN-I 326 (502)
Q Consensus 262 --~~L~~L~ls----~N~l~~~-----~~~~~~~~~~L~~L~ls~n--~l~~~~~~~l~-~l~~L~~L~l~~N~l~~~-~ 326 (502)
..|+.|+++ .|.+++. ++..+..+++|+.|+++.+ .+++.....+. .+++|+.|++++|.+++. +
T Consensus 401 ~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~ 480 (592)
T 3ogk_B 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGL 480 (592)
T ss_dssp HCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHH
T ss_pred hCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHH
Confidence 356666664 5555542 2222445666777777543 24443333333 367788888887777653 2
Q ss_pred CcccCCCCCCcEEEccCcccccc-cCccccCCCCCCeeeecCCccccccCcccc
Q 010736 327 SKAFGIYPNLTFIDLSRNNFYGE-ISSNFGECPKLGALNISRNNITGDFGIAKF 379 (502)
Q Consensus 327 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~~~L~~L~l~~N~l~~dfGl~~l 379 (502)
+..+..+++|++|++++|.+++. ++..+..+++|++|++++|++ .+.|+..+
T Consensus 481 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i-t~~~~~~l 533 (592)
T 3ogk_B 481 MEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA-SMTGQDLM 533 (592)
T ss_dssp HHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC-CTTCTTGG
T ss_pred HHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC-CHHHHHHH
Confidence 33345677888888888877644 233345677888888888884 44454433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-23 Score=219.67 Aligned_cols=301 Identities=14% Similarity=0.066 Sum_probs=192.9
Q ss_pred CEEEEEecCCC-Cce-ecCcccCCCCCCCCEEECCCCccccc----CCccCcCCCCCCEEEccCCcCcC----CCCcccC
Q 010736 71 RVINISLRGVG-LKG-KLHAFSFSSFPHLAYLDLRDNKLFGT----IPPQISNLTNLSILSLGGNQFSG----NIPHEVG 140 (502)
Q Consensus 71 ~v~~L~L~~~~-l~g-~l~~~~~~~l~~L~~L~Ls~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~~----~~p~~l~ 140 (502)
+++.|+|+++. ++. .++. ....+++|++|+|++|.+++. ++..+.++++|++|++++|.+++ .++..+.
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~ 217 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLS-IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHH-HHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHH-HHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence 48999998876 221 1211 134789999999999998766 44456788999999999999983 3445567
Q ss_pred CCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCccc---ccCCcCCCCCCCCCeEEcccccccccCCccCcCCccC
Q 010736 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN---GSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSI 217 (502)
Q Consensus 141 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 217 (502)
++++|++|++++|.+.+ +|..+..+++|++|+++..... +..+..+..+++|+.|+++++.. +.+|..+..+++|
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L 295 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQI 295 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGC
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCC
Confidence 88999999999999985 6788899999999999864333 34445678889999999988643 4567778889999
Q ss_pred CccccccccccCccc-ccccCCCCCcEEEeeCccccccCCCCC-cc-ccccEEECc-----------CCcCcccC-Cccc
Q 010736 218 SILSLAINQFSGPIP-LSLGNLTNLKQFSLVYNNLYGSIPPSL-DN-LVLTKLSLD-----------DNHFTSYL-PQNI 282 (502)
Q Consensus 218 ~~L~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~-~~L~~L~ls-----------~N~l~~~~-~~~~ 282 (502)
++|++++|.+++... ..+..+++|+.|+++ +.+.......+ .. ..|++|+++ .|.++... +...
T Consensus 296 ~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~ 374 (592)
T 3ogk_B 296 RKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALA 374 (592)
T ss_dssp CEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHH
T ss_pred cEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHH
Confidence 999999999765433 335677788888877 33322111111 11 345556655 23443221 1111
Q ss_pred cCCCCCcEEEccCCccccccCcc----------------------------------cccCCCCcEEeCCCCc--ccccc
Q 010736 283 CRGGALQIFTVSENRFQGTIPKS----------------------------------LRNCTSLIRVRLDGNN--LTGNI 326 (502)
Q Consensus 283 ~~~~~L~~L~ls~n~l~~~~~~~----------------------------------l~~l~~L~~L~l~~N~--l~~~~ 326 (502)
..+++|+.|+++.|.+++..+.. +.++++|++|+++++. +++..
T Consensus 375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 22344444444444444333322 3445555555554322 33322
Q ss_pred CcccC-CCCCCcEEEccCcccccc-cCccccCCCCCCeeeecCCccccccCc
Q 010736 327 SKAFG-IYPNLTFIDLSRNNFYGE-ISSNFGECPKLGALNISRNNITGDFGI 376 (502)
Q Consensus 327 ~~~~~-~l~~L~~L~Ls~N~l~~~-~~~~~~~~~~L~~L~l~~N~l~~dfGl 376 (502)
...+. .+++|++|++++|++++. ++..+..+++|++|++++|++ +|-|+
T Consensus 455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l-~~~~~ 505 (592)
T 3ogk_B 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF-SERAI 505 (592)
T ss_dssp HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC-BHHHH
T ss_pred HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC-cHHHH
Confidence 22222 367777777777777652 333446677888888888875 44333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-20 Score=170.83 Aligned_cols=156 Identities=22% Similarity=0.293 Sum_probs=125.6
Q ss_pred CccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcc
Q 010736 59 CAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHE 138 (502)
Q Consensus 59 C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 138 (502)
|.|..|.|. +++++ .+|.. +. ++|+.|+|++|+|++..+..|.++++|++|+|++|++++..|..
T Consensus 11 C~~~~v~c~-----------~~~l~-~iP~~-l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~ 75 (220)
T 2v9t_B 11 CSNNIVDCR-----------GKGLT-EIPTN-LP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA 75 (220)
T ss_dssp EETTEEECT-----------TSCCS-SCCSS-CC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTT
T ss_pred ECCCEEEcC-----------CCCcC-cCCCc-cC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHH
Confidence 466666665 34444 34443 32 68899999999999888888999999999999999999888889
Q ss_pred cCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCC
Q 010736 139 VGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSIS 218 (502)
Q Consensus 139 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 218 (502)
|.++++|++|+|++|+++...+..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+
T Consensus 76 ~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 155 (220)
T 2v9t_B 76 FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155 (220)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred hhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCC
Confidence 99999999999999999866666678888899999999988888888888888888888888888877777777777788
Q ss_pred ccccccccccC
Q 010736 219 ILSLAINQFSG 229 (502)
Q Consensus 219 ~L~ls~N~l~~ 229 (502)
.|++++|.+..
T Consensus 156 ~L~L~~N~~~c 166 (220)
T 2v9t_B 156 TMHLAQNPFIC 166 (220)
T ss_dssp EEECCSSCEEC
T ss_pred EEEeCCCCcCC
Confidence 88888777764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.7e-20 Score=170.13 Aligned_cols=153 Identities=19% Similarity=0.273 Sum_probs=139.6
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 177 (502)
+.+++++++++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46889999998 5676664 78999999999999888889999999999999999999988999999999999999999
Q ss_pred cccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccc
Q 010736 178 NLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYG 253 (502)
Q Consensus 178 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 253 (502)
+++...+..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..|..+++|+.|++++|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 9997766778999999999999999999989999999999999999999998888889999999999999999864
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.5e-20 Score=170.97 Aligned_cols=154 Identities=21% Similarity=0.216 Sum_probs=123.9
Q ss_pred EEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCC-ccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccC
Q 010736 74 NISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIP-PQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDS 152 (502)
Q Consensus 74 ~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 152 (502)
.+++++++++ .+|.. + ...+++|+|++|++++..| ..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 15 ~l~~s~n~l~-~iP~~-~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEH-I--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCSC-C--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc-cCccC-C--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 4555566665 35543 3 2456899999999987755 4578899999999999999887777888999999999999
Q ss_pred CcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcc
Q 010736 153 NQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI 231 (502)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 231 (502)
|++++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|.+++..
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 9998877777888888889998888888888888888888888888888888877888888888888888888777543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.5e-20 Score=170.95 Aligned_cols=148 Identities=19% Similarity=0.247 Sum_probs=137.0
Q ss_pred CccceeeeCCC----------CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccC
Q 010736 59 CAWSGISCNDA----------GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGG 128 (502)
Q Consensus 59 C~W~Gv~C~~~----------~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~ 128 (502)
|.|..+.|+.. ..++.|+|++|++++..+...|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 68999999742 24789999999999887766689999999999999999998888999999999999999
Q ss_pred CcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEccccccccc
Q 010736 129 NQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF 206 (502)
Q Consensus 129 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 206 (502)
|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|++++|.+.+.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 999988888899999999999999999999999999999999999999999998899999999999999999999864
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.3e-20 Score=184.56 Aligned_cols=175 Identities=23% Similarity=0.222 Sum_probs=141.6
Q ss_pred EEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCc-CCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccC
Q 010736 74 NISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQIS-NLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDS 152 (502)
Q Consensus 74 ~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 152 (502)
.+++++++++. +|.. +. +.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 22 ~l~c~~~~l~~-iP~~-~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQS-LP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EEECCSSCCSS-CCSS-CC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEEeCCCCcCc-cCcc-CC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 35666666663 5543 32 4689999999999988888887 999999999999999988888899999999999999
Q ss_pred CcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccC---cCCccCCccccccccccC
Q 010736 153 NQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDI---GNLKSISILSLAINQFSG 229 (502)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~ls~N~l~~ 229 (502)
|++++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..| ..+++|+.|++++|++++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99998777789999999999999999998888889999999999999999987555555 567888888888888886
Q ss_pred cccccccCCCC--CcEEEeeCcccc
Q 010736 230 PIPLSLGNLTN--LKQFSLVYNNLY 252 (502)
Q Consensus 230 ~~p~~~~~l~~--L~~L~l~~N~l~ 252 (502)
..+..+..++. ++.|++++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 65566666665 366777777665
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-19 Score=166.85 Aligned_cols=153 Identities=26% Similarity=0.286 Sum_probs=136.1
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 177 (502)
+.++.+++.++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+++...+..|..+++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 56788888887 6676554 89999999999999988999999999999999999998766677899999999999999
Q ss_pred cccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccccc
Q 010736 178 NLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGS 254 (502)
Q Consensus 178 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 254 (502)
++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999877777899999999999999999 6788889999999999999999987777888999999999999988754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=180.80 Aligned_cols=175 Identities=20% Similarity=0.193 Sum_probs=143.2
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccC-CCCCCcEEEccCCcCcccCCcccCCCCCCcEEEccc
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG-LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFS 176 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 176 (502)
+.+++++++++ .+|..+. +.+++|+|++|+|++..+..+. .+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57999999998 4676654 4689999999999988888887 999999999999999988888899999999999999
Q ss_pred CcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccc---cCCCCCcEEEeeCccccc
Q 010736 177 NNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSL---GNLTNLKQFSLVYNNLYG 253 (502)
Q Consensus 177 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~ 253 (502)
|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..| ..+++|+.|++++|++++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99998878889999999999999999998888999999999999999999997555555 568888888888888874
Q ss_pred cCCCCCcc-c--cccEEECcCCcCc
Q 010736 254 SIPPSLDN-L--VLTKLSLDDNHFT 275 (502)
Q Consensus 254 ~~p~~~~~-~--~L~~L~ls~N~l~ 275 (502)
..+..+.. . .++.|++++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 33222222 1 1355666666654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=174.59 Aligned_cols=173 Identities=21% Similarity=0.351 Sum_probs=103.1
Q ss_pred CCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCc
Q 010736 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 170 (502)
+..+++|++|++++|.++.. + .+..+++|++|+|++|++++..| +..+++|++|++++|++++ +| .+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 34556667777777766643 3 36666777777777777764433 6666777777777776664 22 366666666
Q ss_pred EEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcc
Q 010736 171 ELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250 (502)
Q Consensus 171 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 250 (502)
+|++++|++++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|++++..+ +..+++|+.|++++|.
T Consensus 116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence 666666666642 3455666666666666666643 345555666666666666554433 5555555555555554
Q ss_pred ccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCcccc
Q 010736 251 LYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQG 300 (502)
Q Consensus 251 l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~ 300 (502)
++ +. + .+..+++|+.|++++|+++.
T Consensus 190 i~-----------------------~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 190 IS-----------------------DL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CC-----------------------BC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred CC-----------------------CC-h-hhccCCCCCEEECcCCcccC
Confidence 43 21 1 25556667777777776653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4e-19 Score=171.16 Aligned_cols=169 Identities=25% Similarity=0.351 Sum_probs=149.3
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|+++++++... + .+..+++|++|+|++|++++..+ +.++++|++|+|++|.+++ +| .+..+++|++|+
T Consensus 46 ~~L~~L~l~~~~i~~~-~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~ 118 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (291)
T ss_dssp HTCCEEECTTSCCCCC-T--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred CcccEEEccCCCcccC-h--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEE
Confidence 4688999999998743 3 38899999999999999997655 9999999999999999986 34 499999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
+++|++++. ..+..+++|+.|++++|++++. ..+..+++|++|++++|++++..+ +..+++|+.|++++|++++
T Consensus 119 L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 999999864 4688999999999999999965 568999999999999999997655 8899999999999999986
Q ss_pred cccccccCCCCCcEEEeeCccccc
Q 010736 230 PIPLSLGNLTNLKQFSLVYNNLYG 253 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L~l~~N~l~~ 253 (502)
. + .+..+++|+.|++++|.++.
T Consensus 193 l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 193 L-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp C-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred C-h-hhccCCCCCEEECcCCcccC
Confidence 4 4 48899999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=6e-21 Score=183.84 Aligned_cols=137 Identities=22% Similarity=0.359 Sum_probs=88.3
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCC--CCcccccccccccCcccccc---ceecccceeeeeceeeeehh
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYT---MKITEKCDVYSFGVLVLEVI 424 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~---~~~s~k~Dvysfgv~llEll 424 (502)
++.|.||+..|| ++|||+++...... ...+...||+.|+|||.... ..++.|+|||||||++|||+
T Consensus 152 ~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ell 231 (307)
T 3omv_A 152 NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM 231 (307)
T ss_dssp TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHH
Confidence 445555555444 79999999875432 22345789999999999853 46899999999999999999
Q ss_pred cCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCCC
Q 010736 425 KGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPSL 501 (502)
Q Consensus 425 tg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~~ 501 (502)
||+.|+...... .............|.+........+++.+++. .||+.+|++||+|+||++.|+.++.++
T Consensus 232 tg~~Pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~---~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 232 TGELPYSHINNR---DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVA---DCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HSSCTTTTCCCH---HHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHH---HHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HCCCCCCCCChH---HHHHHHHhcCCCCCCcccccccchHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 999998532110 00000011122333332211222345555555 999999999999999999999887665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.1e-19 Score=188.41 Aligned_cols=186 Identities=22% Similarity=0.320 Sum_probs=124.6
Q ss_pred EEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCc
Q 010736 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQ 154 (502)
Q Consensus 75 L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 154 (502)
+.+..+.+.+.++ +..+++|+.|++++|.+.. +| .+..+++|+.|+|++|.|++..| +..+++|+.|+|++|+
T Consensus 26 l~l~~~~i~~~~~---~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 98 (605)
T 1m9s_A 26 DNLKKKSVTDAVT---QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK 98 (605)
T ss_dssp HHTTCSCTTSEEC---HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred HhccCCCcccccc---hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCC
Confidence 3444444444332 4567778888888888774 33 47788888888888888876544 7778888888888888
Q ss_pred CcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCccccc
Q 010736 155 LDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLS 234 (502)
Q Consensus 155 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 234 (502)
+++ +| .+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++..|
T Consensus 99 l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-- 170 (605)
T 1m9s_A 99 IKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 170 (605)
T ss_dssp CCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--
T ss_pred CCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--
Confidence 874 33 677788888888888887753 3467777888888888877764 456777777777777777776555
Q ss_pred ccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcc
Q 010736 235 LGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTS 276 (502)
Q Consensus 235 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~ 276 (502)
+..+++|+.|+|++|.+++. |.......|+.|++++|++.+
T Consensus 171 l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 171 LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEEC
T ss_pred hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcC
Confidence 66777777777777766632 221111345555555554443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3e-19 Score=188.55 Aligned_cols=171 Identities=25% Similarity=0.351 Sum_probs=150.7
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
..++.|+++++++.. ++ .+..+++|+.|+|++|.+++..| +..+++|+.|+|++|.+++ +| .+..+++|+.|+
T Consensus 43 ~~L~~L~l~~n~i~~-l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~ 115 (605)
T 1m9s_A 43 NSIDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS 115 (605)
T ss_dssp TTCCCCBCTTCCCCC-CT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred CCCCEEECcCCCCCC-Ch--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence 468889999999874 44 38999999999999999997655 8999999999999999985 44 789999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
|++|++++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++
T Consensus 116 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 116 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp CTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred ecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence 999999863 4688999999999999999965 568999999999999999998766 8899999999999999996
Q ss_pred cccccccCCCCCcEEEeeCccccccC
Q 010736 230 PIPLSLGNLTNLKQFSLVYNNLYGSI 255 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L~l~~N~l~~~~ 255 (502)
. | .+..+++|+.|++++|.+.+..
T Consensus 190 l-~-~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 190 L-R-ALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp C-G-GGTTCTTCSEEECCSEEEECCC
T ss_pred C-h-HHccCCCCCEEEccCCcCcCCc
Confidence 4 3 6889999999999999998643
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.2e-19 Score=161.59 Aligned_cols=153 Identities=14% Similarity=0.210 Sum_probs=98.2
Q ss_pred CCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcE
Q 010736 92 SSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVE 171 (502)
Q Consensus 92 ~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 171 (502)
..+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44556667777777666 444 4666677777777777554 2235666677777777777776666666667777777
Q ss_pred EEcccCcccccCCcCCCCCCCCCeEEccccc-ccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcc
Q 010736 172 LALFSNNLNGSVPHSLGNLTQISMLFLHDNS-FSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250 (502)
Q Consensus 172 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 250 (502)
|++++|++++..|..+..+++|++|++++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 7777777766566666667777777777776 43 333 46666777777777777764 22 56667777777777776
Q ss_pred cc
Q 010736 251 LY 252 (502)
Q Consensus 251 l~ 252 (502)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 64
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-21 Score=206.68 Aligned_cols=303 Identities=16% Similarity=0.147 Sum_probs=157.2
Q ss_pred CCEEEEEecCCCCceecCcccCC-CCCCCCEEECCCC-ccccc-CCccCcCCCCCCEEEccCCcCcCCCCccc----CCC
Q 010736 70 GRVINISLRGVGLKGKLHAFSFS-SFPHLAYLDLRDN-KLFGT-IPPQISNLTNLSILSLGGNQFSGNIPHEV----GLM 142 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~-~l~~L~~L~Ls~N-~l~g~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l----~~l 142 (502)
.+++.|+|+++.+++..... +. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..+
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~-l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLEL-IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHH-HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCeEEeeCcEEcHHHHHH-HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 46888889888887655443 43 5788888888888 45432 44445578888888888888776544433 356
Q ss_pred CCCcEEEccCCc--Cccc-CCcccCCCCCCcEEEcccC-cccccCCcCCCCCCCCCeEEccccc----------------
Q 010736 143 SHLKILYIDSNQ--LDGS-IPLEVGQLSSMVELALFSN-NLNGSVPHSLGNLTQISMLFLHDNS---------------- 202 (502)
Q Consensus 143 ~~L~~L~Ls~N~--l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~---------------- 202 (502)
++|++|++++|. ++.. ++..+..+++|+.|++++| .+.+ +|..+..+++|+.|+++.+.
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~ 262 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence 688888888876 2211 1111234577788887776 2222 33333334444444432221
Q ss_pred ----------cc----ccCCccCcCCccCCccccccccccCcc-cccccCCCCCcEEEeeCc------------------
Q 010736 203 ----------FS----GFIPPDIGNLKSISILSLAINQFSGPI-PLSLGNLTNLKQFSLVYN------------------ 249 (502)
Q Consensus 203 ----------l~----~~~p~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~L~l~~N------------------ 249 (502)
+. +.++..+..+++|+.|++++|.+++.. +..+..+++|+.|++++|
T Consensus 263 ~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~~~~l~~l~~~~~~L~~ 342 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRE 342 (594)
T ss_dssp TCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCE
T ss_pred cCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCccCHHHHHHHHHhCCCCCE
Confidence 00 011111223445555555555543221 111234444444444444
Q ss_pred ---------------cccccCCCCCc--cccccEEECcCCcCcccCCcccc-CCCCCcEEEcc--C----Cccccc----
Q 010736 250 ---------------NLYGSIPPSLD--NLVLTKLSLDDNHFTSYLPQNIC-RGGALQIFTVS--E----NRFQGT---- 301 (502)
Q Consensus 250 ---------------~l~~~~p~~~~--~~~L~~L~ls~N~l~~~~~~~~~-~~~~L~~L~ls--~----n~l~~~---- 301 (502)
.+++.....+. ...|+.|.+..|.+++.....+. .+++|+.|+++ + +.+++.
T Consensus 343 L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~ 422 (594)
T 2p1m_B 343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI 422 (594)
T ss_dssp EEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHH
T ss_pred EEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhh
Confidence 12111000000 13455555555555443333332 35666666666 2 344311
Q ss_pred -cCcccccCCCCcEEeCCCCccccccCcccCC-CCCCcEEEccCcccccccCccc-cCCCCCCeeeecCCccccccCc
Q 010736 302 -IPKSLRNCTSLIRVRLDGNNLTGNISKAFGI-YPNLTFIDLSRNNFYGEISSNF-GECPKLGALNISRNNITGDFGI 376 (502)
Q Consensus 302 -~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~~~~L~~L~l~~N~l~~dfGl 376 (502)
++..+..+++|+.|++++ .+++.....+.. +++|+.|+|++|.+++.....+ ..+++|++|++++|++ ++-|+
T Consensus 423 ~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~-~~~~~ 498 (594)
T 2p1m_B 423 GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF-GDKAL 498 (594)
T ss_dssp HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC-CHHHH
T ss_pred HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC-cHHHH
Confidence 112244556666666655 444433333333 5677777777777655444333 4567777777777776 44444
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.6e-20 Score=178.31 Aligned_cols=128 Identities=20% Similarity=0.299 Sum_probs=88.3
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCC--CCcccccccccccCccccccceecccceeeeeceeeeehhc-C
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-G 426 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g 426 (502)
++.|.||+..|+ ++|||+++.+.... ...+...||+.|+|||...+..++.|+|||||||++|||+| |
T Consensus 165 ~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g 244 (308)
T 4gt4_A 165 HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 244 (308)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCC
Confidence 344555555443 79999999875422 22345679999999999999999999999999999999999 8
Q ss_pred CCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 427 ~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+.|+...... . ....+.+...+..+....+++.+++. .||+.+|++||+|+||+++|++.
T Consensus 245 ~~Pf~~~~~~---~-----~~~~i~~~~~~~~p~~~~~~~~~li~---~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 245 LQPYCGYSNQ---D-----VVEMIRNRQVLPCPDDCPAWVYALMI---ECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CCTTTTCCHH---H-----HHHHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCHH---H-----HHHHHHcCCCCCCcccchHHHHHHHH---HHcCCChhHCcCHHHHHHHHHhc
Confidence 9997532110 0 01111111111111122345555544 99999999999999999999864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=157.17 Aligned_cols=152 Identities=17% Similarity=0.232 Sum_probs=132.6
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.++++++++. .++ .+..+++|++|++++|.++ .++.+..+++|++|++++|.+++..|..++.+++|++|+
T Consensus 44 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HTCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred CCccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 46889999999998 566 3899999999999999775 345799999999999999999988889999999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
+++|++++..|..+..+++|++|++++|++.+.+| .+..+++|++|++++|++++. + .+..+++|+.|++++|++.+
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC----
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcccCC
Confidence 99999998888999999999999999998333566 689999999999999999974 3 78899999999999999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=5.9e-18 Score=152.56 Aligned_cols=129 Identities=26% Similarity=0.308 Sum_probs=105.2
Q ss_pred EEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCc-cCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCC
Q 010736 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPP-QISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN 153 (502)
Q Consensus 75 L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 153 (502)
+++++++++ .+|.. +. .+|++|+|++|++++..+. .|+++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 l~~s~~~l~-~ip~~-~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 13 VDCTGRGLK-EIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EECTTSCCS-SCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEcCCCCcC-cCccC-CC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 444455553 56653 33 3889999999999877664 4888999999999999999888888999999999999999
Q ss_pred cCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccC
Q 010736 154 QLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFI 207 (502)
Q Consensus 154 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 207 (502)
++++..+..|..+++|++|++++|++++..|..+..+++|++|++++|.+++..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 999888888888899999999999998888888888888888888888887643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-21 Score=204.50 Aligned_cols=120 Identities=24% Similarity=0.361 Sum_probs=68.2
Q ss_pred CCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccC
Q 010736 217 ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSE 295 (502)
Q Consensus 217 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~ 295 (502)
|+.|++++|++++ +|. ++.+++|+.|++++|.++ .+|..+.. ..|+.|++++|++++ +| .+..+++|+.|++++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 4444444444443 333 444444444444444444 34443333 345555555555554 34 566667777777777
Q ss_pred Ccccccc-CcccccCCCCcEEeCCCCccccccCcc---cCCCCCCcEEEc
Q 010736 296 NRFQGTI-PKSLRNCTSLIRVRLDGNNLTGNISKA---FGIYPNLTFIDL 341 (502)
Q Consensus 296 n~l~~~~-~~~l~~l~~L~~L~l~~N~l~~~~~~~---~~~l~~L~~L~L 341 (502)
|++++.. |..+..+++|+.|++++|.+++.++.. +..+|+|+.|++
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 7777665 777777777777777777777654422 223677777754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-19 Score=195.67 Aligned_cols=217 Identities=18% Similarity=0.175 Sum_probs=123.9
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEE-----EccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCC
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSIL-----SLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSM 169 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L-----~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 169 (502)
+.++.|+|.+|.+.. +|..+.....|+.+ +++.|.+. ..|..+..+++|+.|+|++|++. .+|..+..+++|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 568899999999885 34433333333322 23334444 45778999999999999999998 788888899999
Q ss_pred cEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCc
Q 010736 170 VELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYN 249 (502)
Q Consensus 170 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 249 (502)
++|+|++|.|+ .+|..|+.+++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+++++|+.|+|++|
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 99999999999 88999999999999999999999 77999999999999999999997 67888999999999999999
Q ss_pred cccccCCCCCccc--cccEEECcCCcCcccCCccccCCCCCcEEEccCC--------ccccccCcccccCCCCcEEeCCC
Q 010736 250 NLYGSIPPSLDNL--VLTKLSLDDNHFTSYLPQNICRGGALQIFTVSEN--------RFQGTIPKSLRNCTSLIRVRLDG 319 (502)
Q Consensus 250 ~l~~~~p~~~~~~--~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n--------~l~~~~~~~l~~l~~L~~L~l~~ 319 (502)
.+++.+|..+... ....+++++|.+++.+|.. |..|+++.| .+.+..+..+..+..+....+++
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~ 400 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSY 400 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------------------------------------------
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeec
Confidence 9998888776542 2334678999998887764 455566655 22333333344455555556666
Q ss_pred Cccc
Q 010736 320 NNLT 323 (502)
Q Consensus 320 N~l~ 323 (502)
|-+.
T Consensus 401 Nil~ 404 (727)
T 4b8c_D 401 NTLC 404 (727)
T ss_dssp -CCC
T ss_pred cccc
Confidence 6554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.75 E-value=6.9e-21 Score=202.20 Aligned_cols=305 Identities=12% Similarity=0.078 Sum_probs=191.8
Q ss_pred CCEEEEEecCC-CCcee-cCcccCCCCCCCCEEECCCCcccccCCccC----cCCCCCCEEEccCCc--CcCC-CCcccC
Q 010736 70 GRVINISLRGV-GLKGK-LHAFSFSSFPHLAYLDLRDNKLFGTIPPQI----SNLTNLSILSLGGNQ--FSGN-IPHEVG 140 (502)
Q Consensus 70 ~~v~~L~L~~~-~l~g~-l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l----~~l~~L~~L~Ls~N~--l~~~-~p~~l~ 140 (502)
.+++.|+|+++ .++.. ++. .+..+++|++|+|++|.+++..+..+ ..+++|++|++++|. ++.. ++..+.
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAA-IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHH-HHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHH-HHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHH
Confidence 46888999888 44432 332 24578999999999999876554443 367799999999887 2211 111224
Q ss_pred CCCCCcEEEccCC-cCcccCCcccCC------------------------------------------------------
Q 010736 141 LMSHLKILYIDSN-QLDGSIPLEVGQ------------------------------------------------------ 165 (502)
Q Consensus 141 ~l~~L~~L~Ls~N-~l~~~~p~~~~~------------------------------------------------------ 165 (502)
.+++|++|++++| .+++ +|..+..
T Consensus 209 ~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~ 287 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSV 287 (594)
T ss_dssp HCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHH
T ss_pred hCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHh
Confidence 4688888888887 2221 3333333
Q ss_pred CCCCcEEEcccCcccccCC-cCCCCCCCCCeEEccccccccc-CCccCcCCccCCccccc---------cccccCccccc
Q 010736 166 LSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLHDNSFSGF-IPPDIGNLKSISILSLA---------INQFSGPIPLS 234 (502)
Q Consensus 166 l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls---------~N~l~~~~p~~ 234 (502)
+++|++|++++|.+++... ..+..+++|++|++++| ++.. ++.....+++|+.|+++ .+.+++.....
T Consensus 288 ~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~ 366 (594)
T 2p1m_B 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366 (594)
T ss_dssp HTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHH
T ss_pred hCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHH
Confidence 3455555555555432211 11234455555555555 2211 11112235666666662 23443322222
Q ss_pred c-cCCCCCcEEEeeCccccccCCCCCcc--ccccEEECc--C----CcCccc-----CCccccCCCCCcEEEccCCcccc
Q 010736 235 L-GNLTNLKQFSLVYNNLYGSIPPSLDN--LVLTKLSLD--D----NHFTSY-----LPQNICRGGALQIFTVSENRFQG 300 (502)
Q Consensus 235 ~-~~l~~L~~L~l~~N~l~~~~p~~~~~--~~L~~L~ls--~----N~l~~~-----~~~~~~~~~~L~~L~ls~n~l~~ 300 (502)
+ ..+++|+.|.+..|.+++..+..+.. ..|+.|+++ + +.++.. ++..+..+++|+.|++++ .+++
T Consensus 367 l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 2 24788999988888887654443332 679999998 4 566532 122256678999999987 6666
Q ss_pred ccCccccc-CCCCcEEeCCCCccccccCccc-CCCCCCcEEEccCcccccccCc-cccCCCCCCeeeecCCccccccCcc
Q 010736 301 TIPKSLRN-CTSLIRVRLDGNNLTGNISKAF-GIYPNLTFIDLSRNNFYGEISS-NFGECPKLGALNISRNNITGDFGIA 377 (502)
Q Consensus 301 ~~~~~l~~-l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~~L~~L~l~~N~l~~dfGl~ 377 (502)
.....+.. +++|+.|++++|.+++.....+ ..+++|+.|+|++|.+++.... ....+++|++|++++|++ .+-|+.
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~-~~~~~~ 524 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV-SFGACK 524 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC-BHHHHH
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC-CHHHHH
Confidence 55555555 8999999999999976654444 5689999999999999654443 345689999999999998 455554
Q ss_pred cc
Q 010736 378 KF 379 (502)
Q Consensus 378 ~l 379 (502)
.+
T Consensus 525 ~l 526 (594)
T 2p1m_B 525 LL 526 (594)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=162.60 Aligned_cols=167 Identities=19% Similarity=0.256 Sum_probs=124.9
Q ss_pred EEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEcc
Q 010736 72 VINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID 151 (502)
Q Consensus 72 v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 151 (502)
++.++++++++++.. .+..+++|++|++++|+++. +| .+..+++|++|+|++|++++..| +..+++|++|+++
T Consensus 21 l~~l~l~~~~i~~~~---~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV---SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHTCSCTTSEE---CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHhcCCCccccc---chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 334455566665432 26777888888888888874 45 67888888888888888885444 8888888888888
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcc
Q 010736 152 SNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI 231 (502)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 231 (502)
+|++++ +|.. .. ++|+.|++++|++++. + .+..+++|++|++++|++++. + .+..+++|+.|++++|++++.
T Consensus 94 ~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 94 RNRLKN-LNGI-PS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp SSCCSC-CTTC-CC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred CCccCC-cCcc-cc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence 888875 3332 22 7888888888888853 3 477888888888888888865 3 577788888888888888865
Q ss_pred cccccCCCCCcEEEeeCcccccc
Q 010736 232 PLSLGNLTNLKQFSLVYNNLYGS 254 (502)
Q Consensus 232 p~~~~~l~~L~~L~l~~N~l~~~ 254 (502)
..+..+++|+.|++++|.+++.
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHhccCCCCCEEeCCCCcccCC
Confidence 5677788888888888887744
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=9.7e-20 Score=177.71 Aligned_cols=129 Identities=25% Similarity=0.383 Sum_probs=82.1
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-C
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-G 426 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g 426 (502)
++.|.||+..|+ ++|||+++.+..... ..+...||+.|+|||...+..++.++|||||||++|||+| |
T Consensus 178 ~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G 257 (329)
T 4aoj_A 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257 (329)
T ss_dssp TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCC
Confidence 455556655444 799999998754322 2335679999999999999999999999999999999999 8
Q ss_pred CCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 427 ~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
+.|+...... .... .+.+-..+..+ ....+++.++++ .||+.+|++||+|+||+++|+.+.
T Consensus 258 ~~Pf~~~~~~---~~~~--~i~~g~~~~~p---~~~~~~~~~li~---~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 258 KQPWYQLSNT---EAID--CITQGRELERP---RACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp CCTTCSSCHH---HHHH--HHHHTCCCCCC---TTCCHHHHHHHH---HHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHH---HHHH--HHHcCCCCCCc---ccccHHHHHHHH---HHcCcChhHCcCHHHHHHHHHHHh
Confidence 9997532110 0000 01111111222 122345555555 999999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.8e-19 Score=174.35 Aligned_cols=128 Identities=20% Similarity=0.263 Sum_probs=83.7
Q ss_pred cccccCcccccCCCCC----CcccccccccccCccccccc------eecccceeeeeceeeeehhcCCCCCCcccCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTM------KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSP 439 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~------~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~ 439 (502)
.++|||+++....... ......||+.|+|||+..+. .++.|+|||||||++|||+||+.|+........+
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 3799999998754332 12245799999999998653 5788999999999999999999886532221111
Q ss_pred --CCCc-c----c----ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 440 --SLNT-D----I----ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 440 --~~~~-~----~----~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.+.. . . ...+..+|.++... ...+....+.+++..||+.+|++||||.||+++|+.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1000 0 0 01223344443211 11234445566777999999999999999999999874
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-17 Score=150.09 Aligned_cols=132 Identities=28% Similarity=0.309 Sum_probs=118.0
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCc-ccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEccc
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPH-EVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFS 176 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 176 (502)
+++++++|+++ .+|..+.. +|++|+|++|+|++..+. .|+.+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 68999999996 67776654 899999999999977664 488999999999999999988899999999999999999
Q ss_pred CcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCccc
Q 010736 177 NNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIP 232 (502)
Q Consensus 177 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 232 (502)
|++++..|..|..+++|++|+|++|++++..|..+..+++|++|++++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99998888889999999999999999999999999999999999999999987654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-20 Score=197.83 Aligned_cols=202 Identities=15% Similarity=0.167 Sum_probs=120.0
Q ss_pred CCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCc-------------ccccCCcCCCCCCCCCeEE-ccccccccc
Q 010736 141 LMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNN-------------LNGSVPHSLGNLTQISMLF-LHDNSFSGF 206 (502)
Q Consensus 141 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~~ 206 (502)
.+++|+.|+|++|+++ .+|..++.+++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--- 422 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--- 422 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH---
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc---
Confidence 3444444445544443 344444444444444443332 2334444444445555444 333322
Q ss_pred CCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCC
Q 010736 207 IPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRG 285 (502)
Q Consensus 207 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~ 285 (502)
..|..+.+++|.++...+ ..|+.|++++|.+++ +|. +.. ..|+.|++++|+++ .+|..++.+
T Consensus 423 --------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 485 (567)
T 1dce_A 423 --------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485 (567)
T ss_dssp --------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred --------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcC
Confidence 233444455555543221 236777888887774 554 444 56777777777777 466777777
Q ss_pred CCCcEEEccCCccccccCcccccCCCCcEEeCCCCcccccc-CcccCCCCCCcEEEccCcccccccCcc---ccCCCCCC
Q 010736 286 GALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI-SKAFGIYPNLTFIDLSRNNFYGEISSN---FGECPKLG 361 (502)
Q Consensus 286 ~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~~~~L~ 361 (502)
++|+.|++++|++++ +| .+..+++|+.|+|++|++++.. |..+..+++|+.|+|++|.+++.++.. +..+++|+
T Consensus 486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~ 563 (567)
T 1dce_A 486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 563 (567)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCS
T ss_pred CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccC
Confidence 777777777777775 45 6777777777777777777665 777777777777777777777654432 23367777
Q ss_pred eeee
Q 010736 362 ALNI 365 (502)
Q Consensus 362 ~L~l 365 (502)
.||+
T Consensus 564 ~L~l 567 (567)
T 1dce_A 564 SILT 567 (567)
T ss_dssp EEEC
T ss_pred ccCC
Confidence 7653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=7.6e-20 Score=176.02 Aligned_cols=129 Identities=22% Similarity=0.342 Sum_probs=88.5
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-C
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-G 426 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g 426 (502)
++.|.||+..|+ ++|||+++........ .....||+.|+|||...+..++.|+|||||||++|||+| |
T Consensus 148 ~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G 227 (299)
T 4asz_A 148 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYG 227 (299)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCC
Confidence 445555554443 7999999987543221 223568999999999999999999999999999999999 8
Q ss_pred CCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 427 ~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
+.|+...... . ....+.....+..+....+++.+++. .||+.+|++||+|+||++.|+.+.
T Consensus 228 ~~Pf~~~~~~---~-----~~~~i~~~~~~~~p~~~~~~~~~li~---~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 228 KQPWYQLSNN---E-----VIECITQGRVLQRPRTCPQEVYELML---GCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp CCTTTTSCHH---H-----HHHHHHHTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHH---H-----HHHHHHcCCCCCCCccchHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHH
Confidence 9997532110 0 01111111111111122345555555 999999999999999999998763
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.5e-18 Score=163.05 Aligned_cols=171 Identities=18% Similarity=0.292 Sum_probs=126.4
Q ss_pred CCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEE
Q 010736 93 SFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172 (502)
Q Consensus 93 ~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 172 (502)
.+.+++.+++++|.+++.. .+..+++|++|++++|.++ .+| .+..+++|++|++++|++++..+ +..+++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 4556777888888888543 5788899999999999988 455 68888999999999999986544 8888999999
Q ss_pred EcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccc
Q 010736 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 173 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 252 (502)
++++|++++ +|. +.. ++|++|++++|++++. ..+..+++|+.|++++|++++. + .+..+++|+.|++++|+++
T Consensus 91 ~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 999998885 443 223 7888888888888764 3477777788888888877754 3 4666677777777666665
Q ss_pred ccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccc
Q 010736 253 GSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGT 301 (502)
Q Consensus 253 ~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~ 301 (502)
+. ..+..+++|+.|++++|.+++.
T Consensus 164 ~~-------------------------~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT-------------------------GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC-------------------------TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch-------------------------HHhccCCCCCEEeCCCCcccCC
Confidence 32 2345566777777777777643
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.73 E-value=9.7e-18 Score=147.68 Aligned_cols=133 Identities=20% Similarity=0.172 Sum_probs=90.7
Q ss_pred CCCCCEEECCCCccc-ccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEE
Q 010736 94 FPHLAYLDLRDNKLF-GTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~-g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 172 (502)
.++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 366777777777776 66777777777777777777777754 567777777777777777776666666667777777
Q ss_pred EcccCcccccC-CcCCCCCCCCCeEEcccccccccCC---ccCcCCccCCcccccccccc
Q 010736 173 ALFSNNLNGSV-PHSLGNLTQISMLFLHDNSFSGFIP---PDIGNLKSISILSLAINQFS 228 (502)
Q Consensus 173 ~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~ls~N~l~ 228 (502)
++++|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 77777776432 2456666777777777776665433 34555666666666666554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=5.9e-19 Score=173.64 Aligned_cols=129 Identities=26% Similarity=0.349 Sum_probs=88.8
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-C
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-G 426 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g 426 (502)
++.|.||+..|| +||||++|.+..+... .+...||+.|+|||...+..++.|+|||||||++|||+| |
T Consensus 205 ~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 345555554443 7999999987554332 234678999999999999999999999999999999999 8
Q ss_pred CCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 427 ~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+.|+....... .+.. .+.+-..+..+ ....+++.+++. .||+.+|++||+|.||++.|+.+
T Consensus 285 ~~Pf~~~~~~~--~~~~--~i~~g~~~~~p---~~~~~~~~~li~---~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 285 ASPYPGVKIDE--EFCR--RLKEGTRMRAP---DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSSTTCCCSH--HHHH--HHHHTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHH--HHHH--HHHcCCCCCCC---ccCCHHHHHHHH---HHcCcChhHCcCHHHHHHHHHHH
Confidence 99985321110 0000 01111112222 122345555555 99999999999999999999875
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=7.6e-17 Score=143.22 Aligned_cols=135 Identities=27% Similarity=0.357 Sum_probs=109.3
Q ss_pred CCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCc
Q 010736 58 PCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPH 137 (502)
Q Consensus 58 ~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 137 (502)
.|.|.++.|+.. +++ .+|. ...++|++|++++|++++..+..|.++++|++|+|++|++++..+.
T Consensus 6 ~C~~~~l~~~~~-----------~l~-~~p~---~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (177)
T 2o6r_A 6 SCSGTEIRCNSK-----------GLT-SVPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG 70 (177)
T ss_dssp EEETTEEECCSS-----------CCS-SCCT---TCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred EeCCCEEEecCC-----------CCc-cCCC---CCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh
Confidence 368999888742 222 2332 2236899999999999987777789999999999999999977777
Q ss_pred ccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccC
Q 010736 138 EVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFI 207 (502)
Q Consensus 138 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 207 (502)
.|+.+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|.+.+..
T Consensus 71 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 71 VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred HccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 7889999999999999999777777888999999999999998766666788889999999999887643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.71 E-value=9.4e-18 Score=144.64 Aligned_cols=128 Identities=16% Similarity=0.182 Sum_probs=95.5
Q ss_pred CCCCCEEECCCCccc-ccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEE
Q 010736 94 FPHLAYLDLRDNKLF-GTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~-g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 172 (502)
.++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|++++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 467888888888887 67777778888888888888888755 567778888888888888887677777777888888
Q ss_pred EcccCccccc-CCcCCCCCCCCCeEEcccccccccCC---ccCcCCccCCccccc
Q 010736 173 ALFSNNLNGS-VPHSLGNLTQISMLFLHDNSFSGFIP---PDIGNLKSISILSLA 223 (502)
Q Consensus 173 ~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~ls 223 (502)
++++|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 8888887753 33567777777777777777776544 356666667766664
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.3e-17 Score=145.25 Aligned_cols=138 Identities=16% Similarity=0.133 Sum_probs=121.1
Q ss_pred CCCCCCEEEccCCcCc-CCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCe
Q 010736 117 NLTNLSILSLGGNQFS-GNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISM 195 (502)
Q Consensus 117 ~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 195 (502)
..++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3478999999999998 78898899999999999999999866 78899999999999999999878887878999999
Q ss_pred EEcccccccccC-CccCcCCccCCccccccccccCccc---ccccCCCCCcEEEeeCccccccCCC
Q 010736 196 LFLHDNSFSGFI-PPDIGNLKSISILSLAINQFSGPIP---LSLGNLTNLKQFSLVYNNLYGSIPP 257 (502)
Q Consensus 196 L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~~p~ 257 (502)
|++++|.+++.. +..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+. .+|.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 999999998753 2678899999999999999997655 47889999999999999886 4444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-16 Score=144.28 Aligned_cols=126 Identities=23% Similarity=0.289 Sum_probs=99.2
Q ss_pred EEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCc
Q 010736 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQ 154 (502)
Q Consensus 75 L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 154 (502)
+++++++++ .+|.. + .++|++|+|++|+++ .+|..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+
T Consensus 15 l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EECTTSCCS-SCCSC-C--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 444555555 45543 3 257888888888887 677888888888888888888887777788888888888888888
Q ss_pred CcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccc
Q 010736 155 LDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSG 205 (502)
Q Consensus 155 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 205 (502)
+++..|..|..+++|+.|+|++|++++..+..|..+++|++|++++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 887777788888888888888888886666667788888888888887764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.1e-17 Score=145.48 Aligned_cols=137 Identities=23% Similarity=0.289 Sum_probs=118.3
Q ss_pred cEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCc
Q 010736 242 KQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNN 321 (502)
Q Consensus 242 ~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~ 321 (502)
+.+++++|.++ .+|..+. ..++.|++++|+++. +|..+..+++|+.|++++|.+++..+..|.++++|++|+|++|+
T Consensus 13 ~~l~~~~~~l~-~ip~~~~-~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP-RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC-TTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCC-cCCCCCC-CCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 45667777766 4555443 467888888888874 56788899999999999999998888889999999999999999
Q ss_pred cccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCcccccC
Q 010736 322 LTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFLK 381 (502)
Q Consensus 322 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~~ll~ 381 (502)
+++..+..|..+++|++|+|++|++++..+..+..+++|++|++++|++.|||.+.++..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~ 149 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSD 149 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHH
Confidence 999888899999999999999999998777789999999999999999999999887754
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.3e-16 Score=140.03 Aligned_cols=133 Identities=20% Similarity=0.207 Sum_probs=104.7
Q ss_pred CCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEccc
Q 010736 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFS 176 (502)
Q Consensus 97 L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 176 (502)
.+.+++++|+++ .+|..+ .++|++|++++|++++..+..|+.+++|++|++++|++++..+..|..+++|++|++++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 467888888887 455444 36889999999998876666778888899999999988876666678888888888888
Q ss_pred CcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCccc
Q 010736 177 NNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIP 232 (502)
Q Consensus 177 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 232 (502)
|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|.+++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 88887766667888888888888888886666666777788888888887776544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-17 Score=140.99 Aligned_cols=128 Identities=15% Similarity=0.156 Sum_probs=111.8
Q ss_pred CCCCCEEEccCCcCc-CCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeE
Q 010736 118 LTNLSILSLGGNQFS-GNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISML 196 (502)
Q Consensus 118 l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 196 (502)
.++|++|++++|.++ +.+|..+..+++|++|++++|++++. ..+..+++|++|++++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 478999999999998 88898899999999999999999866 778899999999999999998788877789999999
Q ss_pred Eccccccccc-CCccCcCCccCCccccccccccCccc---ccccCCCCCcEEEee
Q 010736 197 FLHDNSFSGF-IPPDIGNLKSISILSLAINQFSGPIP---LSLGNLTNLKQFSLV 247 (502)
Q Consensus 197 ~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~L~l~ 247 (502)
++++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 9999999874 34778889999999999999987655 468888899988875
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-16 Score=154.66 Aligned_cols=217 Identities=10% Similarity=0.056 Sum_probs=132.3
Q ss_pred CCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccc----cccCCccCcCCccC
Q 010736 142 MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSF----SGFIPPDIGNLKSI 217 (502)
Q Consensus 142 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~p~~~~~l~~L 217 (502)
+++|+.|+|.+ +++...+.+|..+++|+.+++.+|.+....+.+|..+.++..+.+..+.. .......|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 56666666665 55544445566666666666666655545555555555444444433211 11112223333333
Q ss_pred C-ccccccccccCcccccc----cCCCCCcEEEeeCccccccCCCCCc--cccccEEECcCCcCcccCCccccCCCCCcE
Q 010736 218 S-ILSLAINQFSGPIPLSL----GNLTNLKQFSLVYNNLYGSIPPSLD--NLVLTKLSLDDNHFTSYLPQNICRGGALQI 290 (502)
Q Consensus 218 ~-~L~ls~N~l~~~~p~~~----~~l~~L~~L~l~~N~l~~~~p~~~~--~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~ 290 (502)
+ .+.+... +.++..+ ....++..+.+.++-.. .....+. ...|+.+++++|+++.+.+..|..+.+|+.
T Consensus 179 ~~~i~~~~~---~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~ 254 (329)
T 3sb4_A 179 ETTIQVGAM---GKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLK 254 (329)
T ss_dssp EEEEEECTT---CCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCE
T ss_pred ceeEEecCC---CcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCE
Confidence 3 1211110 0111110 12234444544433111 0000000 247889999998888887788888999999
Q ss_pred EEccCCccccccCcccccCCCCc-EEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeee
Q 010736 291 FTVSENRFQGTIPKSLRNCTSLI-RVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNI 365 (502)
Q Consensus 291 L~ls~n~l~~~~~~~l~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l 365 (502)
+++.+| ++...+..|.++.+|+ .+++.+ +++...+.+|..+++|+.+++++|++....+.+|..+++|+.++.
T Consensus 255 l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 255 IKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 999887 7766677889999998 999987 777777788999999999999999998888888999999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.61 E-value=8.4e-14 Score=139.72 Aligned_cols=261 Identities=9% Similarity=0.026 Sum_probs=147.3
Q ss_pred CCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEE
Q 010736 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELA 173 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 173 (502)
...++.+.+.+ .++.+-...|.++ +|+.+.+..| ++..-..+|.+. +|+.+.+.+ .++...+.+|..+++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 46667777764 3555556667664 6777777766 554555566663 577777775 56655566777777888888
Q ss_pred cccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccc
Q 010736 174 LFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYG 253 (502)
Q Consensus 174 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 253 (502)
+.+|+++......|. ..+|+.+.+..+ ++.....+|.++++|+.+++..| ++..-..+|.+ .+|+.+.+. +.++.
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~ 261 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN 261 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE
Confidence 877777754444554 577777777644 66566667777777887777764 44344445555 567777763 33332
Q ss_pred cCCCCCcc-ccccEEECcCCcCc-----ccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccC
Q 010736 254 SIPPSLDN-LVLTKLSLDDNHFT-----SYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNIS 327 (502)
Q Consensus 254 ~~p~~~~~-~~L~~L~ls~N~l~-----~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 327 (502)
.....|.. ..|+.+.+.+|.+. .+.+..|..+.+|+.+.+. +.++..-...|.+|.+|+.+.+..| ++....
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~ 339 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINF 339 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence 22333333 34555555444433 2333444555555555555 2244333444555555555555332 444444
Q ss_pred cccCCCCCCcEEEccCcccccccCccccCCC-CCCeeeecC
Q 010736 328 KAFGIYPNLTFIDLSRNNFYGEISSNFGECP-KLGALNISR 367 (502)
Q Consensus 328 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~-~L~~L~l~~ 367 (502)
.+|..+ +|+.+++++|.+.......|..++ .+..|++..
T Consensus 340 ~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~ 379 (401)
T 4fdw_A 340 SAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPA 379 (401)
T ss_dssp TSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECG
T ss_pred HhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCH
Confidence 455555 555555555554433334444442 344444433
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=7.1e-16 Score=136.81 Aligned_cols=131 Identities=18% Similarity=0.227 Sum_probs=80.9
Q ss_pred CCCCCCCCEEECCCCcccccCCccCcCCC-CCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCC
Q 010736 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLT-NLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSM 169 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 169 (502)
+..+++|++|++++|+++. +|. +..+. +|++|+|++|.+++. ..++.+++|++|++++|++++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 5556677777777777763 343 33433 777777777777754 456677777777777777765443444666777
Q ss_pred cEEEcccCcccccCCc--CCCCCCCCCeEEcccccccccCCcc----CcCCccCCccccccccc
Q 010736 170 VELALFSNNLNGSVPH--SLGNLTQISMLFLHDNSFSGFIPPD----IGNLKSISILSLAINQF 227 (502)
Q Consensus 170 ~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~ls~N~l 227 (502)
++|++++|+++ .+|. .+..+++|++|++++|.++. +|.. +..+++|+.|+++.|.+
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCH
Confidence 77777777764 3443 55666666666666666653 2332 45555555555555544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.60 E-value=6.9e-17 Score=154.29 Aligned_cols=110 Identities=22% Similarity=0.387 Sum_probs=74.0
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
++|||++++.... ......||+.|+|||...+ +++.++|||||||+++||+||+.|+...... ..+... .....
T Consensus 173 l~DFGla~~~~~~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~-i~~~~ 246 (290)
T 3fpq_A 173 IGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRR-VTSGV 246 (290)
T ss_dssp ECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHH-HTTTC
T ss_pred EEeCcCCEeCCCC--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHH-HHcCC
Confidence 7999999976432 2345789999999998764 6999999999999999999999998521110 000000 00000
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+..+ .....++..+++ .|++.+|++|||++|+++
T Consensus 247 ~~~~~~---~~~~~~~~~li~---~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 KPASFD---KVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGGG---GCCCHHHHHHHH---HHSCSSGGGSCCHHHHHT
T ss_pred CCCCCC---ccCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 111111 011235666666 999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=7.3e-17 Score=156.91 Aligned_cols=118 Identities=23% Similarity=0.283 Sum_probs=80.3
Q ss_pred ccccCcccccCCCCCC-----cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 371 TGDFGIAKFLKPDSSN-----WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~-----~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
++|||+++.+..+... ...+.||+.|+|||...+..++.++||||+||+++||+||+.|+...... ......
T Consensus 192 l~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i 268 (336)
T 4g3f_A 192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCLKI 268 (336)
T ss_dssp ECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHHHH
T ss_pred EeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHH
Confidence 7999999988653221 12467999999999999999999999999999999999999998532211 111100
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.....--+.++ ....+++.++++ .|++.+|++||++.|+++.|...
T Consensus 269 ~~~~~~~~~~~---~~~s~~~~~li~---~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 269 ASEPPPIREIP---PSCAPLTAQAIQ---EGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp HHSCCGGGGSC---TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCchhcC---ccCCHHHHHHHH---HHccCCHhHCcCHHHHHHHHHHH
Confidence 00000001121 112355667776 99999999999999999887654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.9e-18 Score=156.66 Aligned_cols=147 Identities=22% Similarity=0.324 Sum_probs=84.5
Q ss_pred CCCCCEEECCCCcccccCCc------cCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCC
Q 010736 94 FPHLAYLDLRDNKLFGTIPP------QISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLS 167 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~g~~p~------~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 167 (502)
...++.++++.+.++|.+|. .+.++++|++|+|++|.+++ +| .+..+++|++|++++|+++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34445555555555555544 56666666666666666664 45 5566666666666666665 4455555556
Q ss_pred CCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCC-ccCcCCccCCccccccccccCccccc----------cc
Q 010736 168 SMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP-PDIGNLKSISILSLAINQFSGPIPLS----------LG 236 (502)
Q Consensus 168 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~----------~~ 236 (502)
+|++|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++.+|.. +.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 66666666666654 33 35555666666666666654321 34555666666666666665544432 55
Q ss_pred CCCCCcEEE
Q 010736 237 NLTNLKQFS 245 (502)
Q Consensus 237 ~l~~L~~L~ 245 (502)
.+++|+.|+
T Consensus 172 ~l~~L~~Ld 180 (198)
T 1ds9_A 172 RLPNLKKLD 180 (198)
T ss_dssp HCSSCSEEC
T ss_pred hCCCcEEEC
Confidence 666666665
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-17 Score=160.12 Aligned_cols=111 Identities=24% Similarity=0.383 Sum_probs=79.1
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
++|||+++.+.......+...||+.|+|||...+..++.++||||+||+++||+||+.|+...... .....+
T Consensus 166 l~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i 237 (350)
T 4b9d_A 166 LGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--------NLVLKI 237 (350)
T ss_dssp ECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHH
T ss_pred EcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHH
Confidence 799999998754322234567999999999999999999999999999999999999998531100 001111
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+....+.......+++..+++ .|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~s~~~~~li~---~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 238 ISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHTCCCCCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred HcCCCCCCCccCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 111111111122356677777 999999999999999865
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=1.7e-14 Score=127.01 Aligned_cols=86 Identities=24% Similarity=0.257 Sum_probs=46.2
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEc
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELAL 174 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 174 (502)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 45555555555555555555555555555555555555444444555555555555555555444444445555555555
Q ss_pred ccCccc
Q 010736 175 FSNNLN 180 (502)
Q Consensus 175 ~~N~l~ 180 (502)
++|.+.
T Consensus 110 ~~N~~~ 115 (170)
T 3g39_A 110 LNNPWD 115 (170)
T ss_dssp CSSCBC
T ss_pred CCCCCC
Confidence 555444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-15 Score=133.85 Aligned_cols=134 Identities=16% Similarity=0.182 Sum_probs=110.2
Q ss_pred ccCcCCCCCCEEEccCCcCcCCCCcccCCCC-CCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCC
Q 010736 113 PQISNLTNLSILSLGGNQFSGNIPHEVGLMS-HLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLT 191 (502)
Q Consensus 113 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 191 (502)
..+.++++|++|++++|+++ .+|. +..+. +|++|++++|++++. ..+..+++|++|++++|++++..+..+..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 34678899999999999999 4564 44444 999999999999975 6789999999999999999965545458899
Q ss_pred CCCeEEcccccccccCCc--cCcCCccCCccccccccccCcccc----cccCCCCCcEEEeeCcccc
Q 010736 192 QISMLFLHDNSFSGFIPP--DIGNLKSISILSLAINQFSGPIPL----SLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 192 ~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~ls~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~ 252 (502)
+|++|++++|+++. +|. .+..+++|+.|++++|.++. +|. .+..+++|+.|+++.|.+.
T Consensus 89 ~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 89 DLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999999999964 454 78888999999999999984 455 3788899999999888765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.6e-16 Score=155.09 Aligned_cols=113 Identities=23% Similarity=0.375 Sum_probs=81.7
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
++|||+++.+.......+...||+.|+|||......++.++||||+||+++||+||+.|+...... ... ..+.+.
T Consensus 211 l~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~--~~i~~~ 285 (346)
T 4fih_A 211 LSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM--KMIRDN 285 (346)
T ss_dssp ECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH--HHHHHS
T ss_pred EecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH--HHHHcC
Confidence 799999998866554455688999999999999889999999999999999999999998521100 000 011111
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+.+... ....+++..+++ .|++.+|++||++.|+++
T Consensus 286 ~~~~~~~~-~~~s~~~~dli~---~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 286 LPPRLKNL-HKVSPSLKGFLD---RLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCCCCSCG-GGSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCcc-ccCCHHHHHHHH---HHcCCChhHCcCHHHHhc
Confidence 22222211 122356677777 999999999999999865
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-14 Score=142.48 Aligned_cols=245 Identities=16% Similarity=0.109 Sum_probs=167.5
Q ss_pred CCCCCEEECCCCccc--------------------ccCCccCcC--------CCCCCEEEccCCcCcCCCCcccCCCCCC
Q 010736 94 FPHLAYLDLRDNKLF--------------------GTIPPQISN--------LTNLSILSLGGNQFSGNIPHEVGLMSHL 145 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~--------------------g~~p~~l~~--------l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 145 (502)
+++|+.|||++|++. ...+..|.+ +++|+.|+|.+ .++..-+.+|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 566777777777766 223446777 99999999999 8886777789999999
Q ss_pred cEEEccCCcCcccCCcccCCCCCCcEEEcccCc----ccccCCcCCCCCCCCC-eEEccccc-ccccCCccCcCCccCCc
Q 010736 146 KILYIDSNQLDGSIPLEVGQLSSMVELALFSNN----LNGSVPHSLGNLTQIS-MLFLHDNS-FSGFIPPDIGNLKSISI 219 (502)
Q Consensus 146 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~----l~~~~p~~~~~l~~L~-~L~L~~N~-l~~~~p~~~~~l~~L~~ 219 (502)
+.|++++|.++...+..|..+.++..+.+..+. ........|.++..|+ .+.+.... +...+...-....++..
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~ 206 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF 206 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence 999999999987778889888888877766532 2223334455566665 44443221 11000001112334444
Q ss_pred cccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCc-EEEccCCc
Q 010736 220 LSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQ-IFTVSENR 297 (502)
Q Consensus 220 L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~-~L~ls~n~ 297 (502)
+.+.++-...........+++|+.+++++|+++...+..|.. ..|+.+++.+| ++.+.+..|..+.+|+ .+++.+ .
T Consensus 207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~ 284 (329)
T 3sb4_A 207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-S 284 (329)
T ss_dssp EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-T
T ss_pred EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-c
Confidence 444433111111111123678888888888887555555555 57888888887 7777777888899999 999988 6
Q ss_pred cccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEc
Q 010736 298 FQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDL 341 (502)
Q Consensus 298 l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 341 (502)
++..-+..|.+|++|+.+++++|+++...+.+|..+++|+.++.
T Consensus 285 l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 285 VTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 77666788999999999999999999888889999999998864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=4.7e-18 Score=154.04 Aligned_cols=152 Identities=22% Similarity=0.296 Sum_probs=127.6
Q ss_pred CCEEEEEecCCCCceecCc-----ccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCC
Q 010736 70 GRVINISLRGVGLKGKLHA-----FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSH 144 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~-----~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 144 (502)
.+++.++++.+.+.|.+|. ..|..+++|++|+|++|.+++ +| .+.++++|++|++++|.++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3566667777777777665 138899999999999999997 67 8999999999999999999 67888888899
Q ss_pred CcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCC-cCCCCCCCCCeEEcccccccccCCcc----------CcC
Q 010736 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLHDNSFSGFIPPD----------IGN 213 (502)
Q Consensus 145 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~ 213 (502)
|++|++++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+++..|.. +..
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~ 172 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence 9999999999996 45 68889999999999999985332 46889999999999999998876653 778
Q ss_pred CccCCcccccccccc
Q 010736 214 LKSISILSLAINQFS 228 (502)
Q Consensus 214 l~~L~~L~ls~N~l~ 228 (502)
+++|+.|+ +|.++
T Consensus 173 l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 173 LPNLKKLD--GMPVD 185 (198)
T ss_dssp CSSCSEEC--CGGGT
T ss_pred CCCcEEEC--CcccC
Confidence 89999887 56555
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.6e-14 Score=125.44 Aligned_cols=103 Identities=18% Similarity=0.228 Sum_probs=55.5
Q ss_pred EEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCC
Q 010736 74 NISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN 153 (502)
Q Consensus 74 ~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 153 (502)
.+++++++++ .+|.. +. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 16 ~l~~~~n~l~-~iP~~-~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAG-IP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp EEECCSSCCS-SCCSC-CC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCCC-ccCCC-cC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 4566666653 44442 22 55666666666666555555566666666666666665444444455555555555555
Q ss_pred cCcccCCcccCCCCCCcEEEcccCccc
Q 010736 154 QLDGSIPLEVGQLSSMVELALFSNNLN 180 (502)
Q Consensus 154 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 180 (502)
+|++..+..|..+++|+.|++++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555433333555555555555555444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=5.3e-14 Score=123.86 Aligned_cols=107 Identities=23% Similarity=0.293 Sum_probs=90.8
Q ss_pred CCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEccc
Q 010736 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFS 176 (502)
Q Consensus 97 L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 176 (502)
.+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 468999999998 4676663 7899999999999988888899999999999999999977777788899999999999
Q ss_pred CcccccCCcCCCCCCCCCeEEccccccccc
Q 010736 177 NNLNGSVPHSLGNLTQISMLFLHDNSFSGF 206 (502)
Q Consensus 177 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 206 (502)
|++++..+..|..+++|++|+|++|.+...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 999877777788888999999998888754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=6.3e-16 Score=148.42 Aligned_cols=109 Identities=26% Similarity=0.417 Sum_probs=74.9
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
++|||+++.............||+.|+|||......++.++||||+||+++||+||+.|+...... . ....+
T Consensus 167 l~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~-----~~~~i 238 (304)
T 3ubd_A 167 LTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---E-----TMTMI 238 (304)
T ss_dssp EESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H-----HHHHH
T ss_pred ecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---H-----HHHHH
Confidence 689999997755444445678999999999999999999999999999999999999998521110 0 01111
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-----HHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-----MKIVS 491 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-----m~~v~ 491 (502)
......-+ ....+++..+++ .|++.+|++||+ ++|+.
T Consensus 239 ~~~~~~~p-~~~s~~~~~li~---~~L~~dP~~R~ta~~~~~~eil 280 (304)
T 3ubd_A 239 LKAKLGMP-QFLSPEAQSLLR---MLFKRNPANRLGAGPDGVEEIK 280 (304)
T ss_dssp HHCCCCCC-TTSCHHHHHHHH---HHTCSSGGGSTTCSTTTHHHHH
T ss_pred HcCCCCCC-CcCCHHHHHHHH---HHcccCHHHCCCCCcCCHHHHH
Confidence 11111111 122356677777 999999999998 56665
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=6.2e-16 Score=154.66 Aligned_cols=125 Identities=22% Similarity=0.356 Sum_probs=88.3
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p 429 (502)
++.|.||+..|| ++|||+++.+.......+...||+.|+|||......++.++||||+||+++||+||+.|
T Consensus 267 ~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~P 346 (423)
T 4fie_A 267 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346 (423)
T ss_dssp TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 445556655554 79999999886655555667899999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+...... ... ..+.+...+.+... ....+++..+++ .|++.+|++||++.|+++
T Consensus 347 F~~~~~~---~~~--~~i~~~~~~~~~~~-~~~s~~~~dli~---~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 347 YFNEPPL---KAM--KMIRDNLPPRLKNL-HKVSPSLKGFLD---RLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTTSCHH---HHH--HHHHHSCCCCCSCT-TSSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred CCCcCHH---HHH--HHHHcCCCCCCccc-ccCCHHHHHHHH---HHcCCChhHCcCHHHHhc
Confidence 8521100 000 01111122222211 122356777777 999999999999999865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=3.5e-15 Score=145.89 Aligned_cols=126 Identities=33% Similarity=0.517 Sum_probs=90.4
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCC---------C
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS---------P 439 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~---------~ 439 (502)
..+|||+++....... ......||.+|+|||.......+.++||||||++++||+||+.|++....... .
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 4689999998754332 23345699999999999888999999999999999999999999863211100 0
Q ss_pred CCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 440 SLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 440 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..........+.++.+... ...++...+.+++..|++.+|++||++.||+++|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGN--YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTS--CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHhhchhhhhhcChhhccc--cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 0111122334455554432 2334556677777799999999999999999999864
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.2e-13 Score=121.97 Aligned_cols=105 Identities=23% Similarity=0.356 Sum_probs=89.5
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 177 (502)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999986 6777664 88999999999999888888999999999999999999766666788999999999999
Q ss_pred cccccCCcCCCCCCCCCeEEcccccccc
Q 010736 178 NLNGSVPHSLGNLTQISMLFLHDNSFSG 205 (502)
Q Consensus 178 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 205 (502)
+|++..+..|..+++|++|+|++|.+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 9987666668888889999999888774
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.8e-12 Score=129.93 Aligned_cols=245 Identities=12% Similarity=0.079 Sum_probs=199.3
Q ss_pred cCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCe
Q 010736 116 SNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISM 195 (502)
Q Consensus 116 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 195 (502)
..+..++.+.+.+ .++..-..+|.+. +|+.+.+..| ++..-..+|.+ .+|+.+.+.+ .++...+.+|.++++|+.
T Consensus 110 ~~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 110 EILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKK 184 (401)
T ss_dssp EECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred EecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCe
Confidence 3457788888865 4664556778875 7999999877 77666677877 4799999986 677677788999999999
Q ss_pred EEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCc
Q 010736 196 LFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFT 275 (502)
Q Consensus 196 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~ 275 (502)
+++.+|+++......|. ..+|+.+.+..+ ++......|.++++|+.+++..| ++......|....|+.+.+ .+.++
T Consensus 185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~~~L~~i~l-p~~i~ 260 (401)
T 4fdw_A 185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRESGITTVKL-PNGVT 260 (401)
T ss_dssp EECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTTCCCSEEEE-ETTCC
T ss_pred eecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccccccccCCccEEEe-CCCcc
Confidence 99999999977666776 589999999854 76666778999999999999875 5545556666678999999 56677
Q ss_pred ccCCccccCCCCCcEEEccCCccc-----cccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCccccccc
Q 010736 276 SYLPQNICRGGALQIFTVSENRFQ-----GTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEI 350 (502)
Q Consensus 276 ~~~~~~~~~~~~L~~L~ls~n~l~-----~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 350 (502)
.+....|..+.+|+.+.+.+|.+. ...+..|.+|++|+.+.+. +.++.....+|..+.+|+.++|..| +....
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~ 338 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQIN 338 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence 777888999999999999988765 3556789999999999998 5588777889999999999999665 77667
Q ss_pred CccccCCCCCCeeeecCCcccc
Q 010736 351 SSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 351 ~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
..+|..+ +|+.+++++|.+..
T Consensus 339 ~~aF~~~-~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 339 FSAFNNT-GIKEVKVEGTTPPQ 359 (401)
T ss_dssp TTSSSSS-CCCEEEECCSSCCB
T ss_pred HHhCCCC-CCCEEEEcCCCCcc
Confidence 7889999 99999999997643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.49 E-value=1.8e-15 Score=143.23 Aligned_cols=109 Identities=21% Similarity=0.325 Sum_probs=67.3
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
.+|||+++....... .+...||+.|+|||...+..+ +.++||||+||+++||+||+.|++.... ..+ ...
T Consensus 153 l~DFGla~~~~~~~~-~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~-----~~~ 223 (275)
T 3hyh_A 153 IADFGLSNIMTDGNF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVL-----FKN 223 (275)
T ss_dssp ECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH-----HHH
T ss_pred EeecCCCeecCCCCc-cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHH-----HHH
Confidence 699999998754332 335689999999999987775 5799999999999999999999853110 000 011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+......-+ ....+++..+++ .|++.+|++|||++|+++
T Consensus 224 i~~~~~~~p-~~~s~~~~~li~---~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 224 ISNGVYTLP-KFLSPGAAGLIK---RMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHTCCCCC-TTSCHHHHHHHH---HHSCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCC-CCCCHHHHHHHH---HHccCChhHCcCHHHHHc
Confidence 111111111 112355667777 999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-14 Score=141.50 Aligned_cols=126 Identities=33% Similarity=0.414 Sum_probs=88.8
Q ss_pred cccccCcccccCCCC--CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCC------
Q 010736 370 ITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSL------ 441 (502)
Q Consensus 370 l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~------ 441 (502)
..+|||+++...... .......||..|+|||......++.++||||||++++||+||+.|+...........
T Consensus 179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 258 (321)
T 2qkw_B 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258 (321)
T ss_dssp EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH
T ss_pred EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh
Confidence 478999998764321 222345689999999999888999999999999999999999999863222111100
Q ss_pred -CcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 442 -NTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 442 -~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.......+++++.+.... ..+....+.++...|++.+|++||+|.||++.|+.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 259 SHNNGQLEQIVDPNLADKI--RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HHTTTCCCSSSSSSCTTCS--CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccHHHhcChhhcccc--CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 001123345566554321 234445566666699999999999999999999976
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=4.2e-15 Score=144.32 Aligned_cols=120 Identities=25% Similarity=0.393 Sum_probs=73.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||.......+.++|||||||+++||+||+.|++..... ...... ...
T Consensus 179 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~-~~~ 254 (309)
T 3p86_A 179 KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAV-GFK 254 (309)
T ss_dssp EECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHH-HHS
T ss_pred EECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-Hhc
Confidence 3689999987654433334567999999999999888999999999999999999999997532110 000000 000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
.....++ .....++..+++ .|++.+|++||++.||++.|+.+..
T Consensus 255 ~~~~~~~---~~~~~~l~~li~---~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 255 CKRLEIP---RNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCCCCCC---TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCC---ccCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111111 112345666666 9999999999999999999998743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.44 E-value=3.6e-15 Score=143.22 Aligned_cols=106 Identities=23% Similarity=0.394 Sum_probs=77.1
Q ss_pred ccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
++|||+++.+..... ......||+.|+|||...+..++.++|+||+||+++||+||+.|+..... ... ..
T Consensus 173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~-----~~ 244 (311)
T 4aw0_A 173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLI-----FA 244 (311)
T ss_dssp ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH-----HH
T ss_pred EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHH-----HH
Confidence 799999998864322 23457899999999999998999999999999999999999999852110 000 11
Q ss_pred ccc--CCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHH
Q 010736 449 EML--DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIV 490 (502)
Q Consensus 449 ~~~--d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v 490 (502)
.+. +..++. ...+++..+++ .|++.+|++||+.+|+
T Consensus 245 ~i~~~~~~~p~---~~s~~~~dli~---~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 245 KIIKLEYDFPE---KFFPKARDLVE---KLLVLDATKRLGCEEM 282 (311)
T ss_dssp HHHHTCCCCCT---TCCHHHHHHHH---HHSCSSGGGSTTSGGG
T ss_pred HHHcCCCCCCc---ccCHHHHHHHH---HHccCCHhHCcChHHH
Confidence 111 112221 12245667777 9999999999999886
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=1.4e-14 Score=141.50 Aligned_cols=128 Identities=19% Similarity=0.222 Sum_probs=81.8
Q ss_pred cccccCcccccCCCCC--CcccccccccccCcccccc-----ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYT-----MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~-----~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
..+|||+++....... ......||..|+|||...+ ...+.++|||||||+++||+||+.|++.........+.
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 4799999987754322 2234679999999999876 46778999999999999999999998632221111000
Q ss_pred c-------ccc-----cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 443 T-------DIA-----LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 443 ~-------~~~-----~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
. ... ......|.+... .....+...+.++...|++.+|++||++.||+++|+.++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDY-WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGG-GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCcccc-ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 000 011111221110 001112223444445999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=4.8e-14 Score=136.50 Aligned_cols=127 Identities=28% Similarity=0.458 Sum_probs=85.1
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCC-CCC----
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSP-SLN---- 442 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~-~~~---- 442 (502)
..+|||+++........ .....|+.+|+|||...+ ..+.++||||||++++||+||+.|++........ .+.
T Consensus 173 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (307)
T 2nru_A 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251 (307)
T ss_dssp EECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHH
T ss_pred EEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhh
Confidence 46899999876543221 224578999999998764 5889999999999999999999998643221110 000
Q ss_pred -cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCC
Q 010736 443 -TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPS 500 (502)
Q Consensus 443 -~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~ 500 (502)
....+.+.+++.+.... ......+.++...|++.+|++||+++||++.|+++..|
T Consensus 252 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 252 DEEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp TTSCCHHHHSCSSCSCCC---HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred hhhhhhhhhccccccccc---hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 00112334555543222 22233444555599999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=1.5e-14 Score=139.63 Aligned_cols=128 Identities=20% Similarity=0.282 Sum_probs=78.5
Q ss_pred ccccccCcccccCCCCCC----cccccccccccCccccccc------eecccceeeeeceeeeehhcC----------CC
Q 010736 369 NITGDFGIAKFLKPDSSN----WTGFAGTYGYIAPELAYTM------KITEKCDVYSFGVLVLEVIKG----------KH 428 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~----~~~~~gt~gy~aPE~~~~~------~~s~k~Dvysfgv~llElltg----------~~ 428 (502)
-..+|||+++........ .....||..|+|||..... ..+.++|||||||+++||+|| +.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 347899999876543221 1234799999999998776 667899999999999999999 55
Q ss_pred CCCcccCCCCCC-CCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 429 PRDFLSSTSSPS-LNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 429 p~~~~~~~~~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
|+.......... ........+...+.++.. .........+.++...|++.+|++||++.||+++|+++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR-WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChh-hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 543211110000 000000011112222210 00112223344444599999999999999999999876
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=5.2e-13 Score=131.64 Aligned_cols=109 Identities=25% Similarity=0.298 Sum_probs=83.1
Q ss_pred CCccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCC-CcccccCCccCcCCCCCCEEEccCCcCcCCCC
Q 010736 58 PCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRD-NKLFGTIPPQISNLTNLSILSLGGNQFSGNIP 136 (502)
Q Consensus 58 ~C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~-N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p 136 (502)
.|.|..|.|+..+ +|+ .+|. +..+++|++|+|++ |.|++..|..|+++++|++|+|++|+|++..|
T Consensus 7 ~C~~~~v~~~~~n----------~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 7 PHGSSGLRCTRDG----------ALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp CSSSSCEECCSSC----------CCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred cccCCEEEcCCCC----------CCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 3778777775421 444 3565 78888888888885 88888777888888888888888888888888
Q ss_pred cccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCccc
Q 010736 137 HEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLN 180 (502)
Q Consensus 137 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 180 (502)
..|+++++|++|+|++|+|++..+..|..++ |+.|+|.+|.+.
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred HHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 8888888888888888888865555555555 777777777776
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.41 E-value=3.1e-14 Score=139.26 Aligned_cols=115 Identities=27% Similarity=0.434 Sum_probs=78.7
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......+|.+|+|||...+..++.++|||||||+++||+| |+.|++......
T Consensus 157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------- 227 (327)
T 3poz_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------- 227 (327)
T ss_dssp EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------
T ss_pred EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---------
Confidence 4789999998754332 2234456889999999999999999999999999999999 999985321110
Q ss_pred cccccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..+.+.. ....+ .....++..++ ..|++.+|++||+|.||+++|+.+
T Consensus 228 ~~~~~~~~~~~~~~-~~~~~~~~~li---~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 228 ISSILEKGERLPQP-PICTIDVYMIM---VKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp HHHHHHTTCCCCCC-TTBCHHHHHHH---HHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCC-ccCCHHHHHHH---HHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111110 11111 11223444444 499999999999999999999876
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=5.4e-15 Score=142.29 Aligned_cols=121 Identities=23% Similarity=0.361 Sum_probs=70.7
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCC------------CcccccccccccCccccccceecccceeeeec
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSS------------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFG 417 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~------------~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfg 417 (502)
++.|.||+..|| ++|||+++.+..... ..+...||+.|+|||...+..++.++||||+|
T Consensus 138 ~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlG 217 (299)
T 4g31_A 138 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLG 217 (299)
T ss_dssp TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHH
T ss_pred cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHH
Confidence 445555555443 699999998754321 12345799999999999999999999999999
Q ss_pred eeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 418 VLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 418 v~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
|+++||++ |+..... .......+.+...+........+...+++ .|++.+|++||++.|+++
T Consensus 218 vilyell~---Pf~~~~~-------~~~~~~~~~~~~~p~~~~~~~~~~~~li~---~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 218 LILFELLY---PFSTQME-------RVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHS---CCSSHHH-------HHHHHHHHHTTCCCHHHHHHCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcc---CCCCccH-------HHHHHHHHhcCCCCCCCcccCHHHHHHHH---HHcCCChhHCcCHHHHhc
Confidence 99999997 6531100 00011111222221000001123344555 899999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.39 E-value=3.8e-14 Score=136.36 Aligned_cols=122 Identities=18% Similarity=0.243 Sum_probs=82.9
Q ss_pred cccccCcccccCCCCCC-------cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSN-------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~-------~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
..+|||+++........ .....||..|+|||...+...+.++|||||||+++||+||+.|+............
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 3uzp_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh
Confidence 36899999887543221 23467999999999999989999999999999999999999998643221111100
Q ss_pred cccccccccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 443 TDIALDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 443 ~~~~~~~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..........+ .+. ....+++..+++ .|++.+|++||++.||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~---~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 228 ERISEKKMSTPIEVLC---KGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHHHHHSCHHHHT---TTSCHHHHHHHH---HHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhcccccCCchHHHH---hhCCHHHHHHHH---HHHhcCcCcCCCHHHHHHHHHHH
Confidence 00000000000 000 011245666666 99999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=3.7e-14 Score=137.59 Aligned_cols=121 Identities=22% Similarity=0.394 Sum_probs=81.4
Q ss_pred ccccccCcccccCCCCCC--------------cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSN--------------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLS 434 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~--------------~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~ 434 (502)
-..+|||+++........ .....||..|+|||...+...+.++||||||++++||+||+.|+....
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 147 VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp EEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred EEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 347899999877432211 114579999999999999999999999999999999999999875322
Q ss_pred CCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 435 STSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 435 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..... . ........++..+.. ..+++.++++ .|++.+|++||++.|+++.|+.++
T Consensus 227 ~~~~~-~--~~~~~~~~~~~~~~~---~~~~l~~li~---~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 227 PRTMD-F--GLNVRGFLDRYCPPN---CPPSFFPITV---RCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp CBCTT-S--SBCHHHHHHHTCCTT---CCTTHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHH-H--hhhhhccccccCCCC---CCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHH
Confidence 11110 0 011111122222111 1134555555 999999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.39 E-value=5.7e-14 Score=139.87 Aligned_cols=117 Identities=27% Similarity=0.391 Sum_probs=81.4
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......++..|+|||...+..++.++|||||||+++||+| |+.|+...... .... .
T Consensus 243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~~~~--~ 317 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---ELFK--L 317 (370)
T ss_dssp EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH--H
T ss_pred EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH--H
Confidence 4789999997654322 2233557789999999998899999999999999999999 99997532110 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+..-..+..+ ....+++..+++ .|++.+|++||++.|+++.|+.+
T Consensus 318 ~~~~~~~~~~---~~~~~~l~~li~---~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 318 LKEGHRMDKP---ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHTTCCCCCC---TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCCC---CCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHH
Confidence 0000111111 122345666666 99999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.3e-14 Score=136.35 Aligned_cols=118 Identities=26% Similarity=0.435 Sum_probs=75.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++..... .....||..|+|||...+...+.++||||||++++||+||+.|++....... ........
T Consensus 146 kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~ 219 (307)
T 2eva_A 146 KICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---RIMWAVHN 219 (307)
T ss_dssp EECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---HHHHHHHT
T ss_pred EEcccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---HHHHHHhc
Confidence 36899998765432 2335689999999999988999999999999999999999999863221100 00000000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
...+... ....+++.++++ .|++.+|++||++.||+++|+.+..
T Consensus 220 ~~~~~~~---~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 220 GTRPPLI---KNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp TCCCCCB---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CCCCCcc---cccCHHHHHHHH---HHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 112245666665 9999999999999999999998743
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.38 E-value=2e-14 Score=138.22 Aligned_cols=124 Identities=18% Similarity=0.251 Sum_probs=83.0
Q ss_pred cccccCcccccCCCCC-------CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS-------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-------~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
..+|||+++....... ......||..|+|||...+...+.++|||||||+++||+||+.|+............
T Consensus 148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 4hgt_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence 3689999988754322 122467899999999999989999999999999999999999998643222111110
Q ss_pred cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 443 TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 443 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..........+ .........+++.++++ .|++.+|++||++.||++.|+.+
T Consensus 228 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~---~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 228 ERISEKKMSTP-IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHHHHHSC-HHHHTTTSCHHHHHHHH---HHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhhcccccch-hhhhhccCCHHHHHHHH---HHHhcCCCCCCCHHHHHHHHHHH
Confidence 00000000000 00000011245666666 99999999999999999999886
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.9e-14 Score=139.59 Aligned_cols=119 Identities=25% Similarity=0.349 Sum_probs=81.0
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+..... ......||..|+|||...+..++.++|||||||+++||+| |+.|+....... .. . ..
T Consensus 233 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~-~-~~ 308 (359)
T 3vhe_A 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF-C-RR 308 (359)
T ss_dssp EECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HH-H-HH
T ss_pred EEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HH-H-HH
Confidence 3689999987644322 2234568889999999999999999999999999999999 999975321100 00 0 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..+-..+..+ ....+++.+++. .|++.+|++||+|+||++.|+++.
T Consensus 309 ~~~~~~~~~~---~~~~~~l~~li~---~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 309 LKEGTRMRAP---DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCC---CCCCHHHHHHHH---HHccCChhhCCCHHHHHHHHHHHH
Confidence 0111111111 112245555555 999999999999999999999864
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.3e-12 Score=128.75 Aligned_cols=105 Identities=17% Similarity=0.138 Sum_probs=92.1
Q ss_pred CEEECCCC-cccccCCccCcCCCCCCEEEccC-CcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 010736 98 AYLDLRDN-KLFGTIPPQISNLTNLSILSLGG-NQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALF 175 (502)
Q Consensus 98 ~~L~Ls~N-~l~g~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 175 (502)
..++++++ +|+ .+|. |..+++|++|+|++ |.|++..|..|+++++|+.|+|++|+|++..|..|..+++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35688888 888 4787 99999999999996 99998888899999999999999999999999999999999999999
Q ss_pred cCcccccCCcCCCCCCCCCeEEcccccccc
Q 010736 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSG 205 (502)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 205 (502)
+|+|++..+..|..++ |+.|+|.+|.+..
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 9999976666666655 9999999998874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.37 E-value=1.4e-14 Score=144.06 Aligned_cols=123 Identities=13% Similarity=0.161 Sum_probs=84.4
Q ss_pred cccccCcccccCCCCC-------CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCC-C
Q 010736 370 ITGDFGIAKFLKPDSS-------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPS-L 441 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-------~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~-~ 441 (502)
.++|||+++.+..... ......||..|+|||...+..++.++|||||||+++||+||+.|++......... .
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~ 273 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD 273 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH
Confidence 3689999987753211 1123559999999999999899999999999999999999999986321110000 0
Q ss_pred C---cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 442 N---TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 442 ~---~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
. ....+.+++++.+... ...+++..+++ .|++.+|++||++.+|++.|+.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~---~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 274 SKIRYRENIASLMDKCFPAA--NAPGEIAKYME---TVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHCHHHHHHHHSCTT--CCCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhhhhHHHHHHHhcccc--cCHHHHHHHHH---HHhcCCCCCCCCHHHHHHHHHHH
Confidence 0 0001223333333211 12355666666 99999999999999999999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.37 E-value=5.4e-14 Score=137.94 Aligned_cols=131 Identities=25% Similarity=0.326 Sum_probs=78.2
Q ss_pred cccccCcccccCCCCCC----cccccccccccCccccccceeccc------ceeeeeceeeeehhcCCCCCCcccCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSN----WTGFAGTYGYIAPELAYTMKITEK------CDVYSFGVLVLEVIKGKHPRDFLSSTSSP 439 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~----~~~~~gt~gy~aPE~~~~~~~s~k------~Dvysfgv~llElltg~~p~~~~~~~~~~ 439 (502)
..+|||+++........ .....||..|+|||.........+ +|||||||+++||+||+.|.........+
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 46899999876543221 124578999999999876655544 99999999999999995554321111000
Q ss_pred --CCC-cc---ccc-----ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCCC
Q 010736 440 --SLN-TD---IAL-----DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPSL 501 (502)
Q Consensus 440 --~~~-~~---~~~-----~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~~ 501 (502)
... .. ... .....+..+.. ....+....+.++...|++.+|++||++.||++.|+.+..+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNR-WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhcCCCCchhhhHHHHhhhccCcccccc-chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 000 00 000 11112222110 001122333444555999999999999999999999986543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=5.5e-14 Score=137.89 Aligned_cols=126 Identities=19% Similarity=0.261 Sum_probs=79.2
Q ss_pred cccccCcccccCCCC--------CCcccccccccccCcccccc-------ceecccceeeeeceeeeehhcCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDS--------SNWTGFAGTYGYIAPELAYT-------MKITEKCDVYSFGVLVLEVIKGKHPRDFLS 434 (502)
Q Consensus 370 l~~dfGl~~ll~~~~--------~~~~~~~gt~gy~aPE~~~~-------~~~s~k~Dvysfgv~llElltg~~p~~~~~ 434 (502)
..+|||+++.+.... .......||..|+|||...+ ...+.++|||||||+++||+||+.|+....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 468999998775321 11224569999999999876 567789999999999999999987753221
Q ss_pred CCCCCCCCcc---------c-----ccccccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 435 STSSPSLNTD---------I-----ALDEMLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 435 ~~~~~~~~~~---------~-----~~~~~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.......... . ...+...+.++... ....+++.++++ .|++.+|++||+++||+++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE---DCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHH---HHSCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHH---HHhcCChhhCcchHHHHHHHHHH
Confidence 1110000000 0 00011112222111 112234555555 99999999999999999999987
Q ss_pred c
Q 010736 498 A 498 (502)
Q Consensus 498 ~ 498 (502)
.
T Consensus 317 l 317 (336)
T 3g2f_A 317 M 317 (336)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.37 E-value=4.3e-14 Score=135.73 Aligned_cols=123 Identities=23% Similarity=0.452 Sum_probs=72.9
Q ss_pred cccccCcccccCCC--CCCcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPD--SSNWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~--~~~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++..... ........||..|+|||... ....+.++||||+|++++||+||+.|++...... .. ..
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~-~~ 236 (289)
T 3og7_A 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QI-IE 236 (289)
T ss_dssp EECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HH-HH
T ss_pred EEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HH-HH
Confidence 36899999876432 12223467899999999886 5567889999999999999999999985321100 00 00
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
........+.+........+++..+++ .|++.+|++||++.||+++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 237 MVGRGSLSPDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHTSCCCCTTSSCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HhcccccCcchhhccccCCHHHHHHHH---HHccCChhhCCCHHHHHHHHHHHh
Confidence 000111112111111122355666666 999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.37 E-value=3.9e-14 Score=136.36 Aligned_cols=127 Identities=21% Similarity=0.311 Sum_probs=79.0
Q ss_pred cccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccC--------CCC
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSS--------TSS 438 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~--------~~~ 438 (502)
..+|||+++........ .....++..|+|||.......+.++||||||++++||+||+.|...... ...
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~ 233 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCC
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccc
Confidence 36899999987543221 1234567789999999988999999999999999999999998753110 000
Q ss_pred CCCCccccccccc-CCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCC
Q 010736 439 PSLNTDIALDEML-DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPS 500 (502)
Q Consensus 439 ~~~~~~~~~~~~~-d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~ 500 (502)
...........+. ..+.+.+ ....+++.++++ .|++.+|++||+++||+++|+++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~---~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 234 GQMIVFHLIELLKNNGRLPRP-DGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp THHHHHHHHHHHHTTCCCCCC-TTCCHHHHHHHH---HHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchhHHHHHHHHhccCcCCCC-cCcCHHHHHHHH---HHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0000000000011 1111111 122356666666 99999999999999999999987643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=8.4e-14 Score=136.07 Aligned_cols=118 Identities=25% Similarity=0.351 Sum_probs=78.5
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......|+.+|+|||......++.++||||||++++|++| |+.|+....... ... .
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~--~ 229 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD--L 229 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH--H
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH--H
Confidence 3689999998754332 2334667889999999998899999999999999999999 999985322110 000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
+.....+..+ .....++..++. .|++.+|++||++.||++.|+.+.
T Consensus 230 ~~~~~~~~~~---~~~~~~~~~li~---~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 230 LEKGERLAQP---QICTIDVYMVMV---KCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HHTTCBCCCC---TTBCTTTTHHHH---HHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHcCCCCCCC---CcCcHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHH
Confidence 0000000111 011123444444 999999999999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=3.5e-14 Score=136.76 Aligned_cols=124 Identities=15% Similarity=0.234 Sum_probs=82.4
Q ss_pred cccccCcccccCCCCC-------CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS-------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-------~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
..+|||+++....... ......||..|+|||...+...+.++||||||++++||+||+.|+............
T Consensus 151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 230 (298)
T 1csn_A 151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230 (298)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence 4689999998754322 123467999999999999888999999999999999999999998642211100000
Q ss_pred cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 443 TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 443 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.... .....+..........+++.++++ .|++.+|++||++++|++.|+++
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 231 ERIG-EKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHH-HHHHHSCHHHHTTTSCHHHHHHHH---HHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHH-hhccCccHHHHHhhCcHHHHHHHH---HHhcCCcccCCCHHHHHHHHHHH
Confidence 0000 000000000000012245666666 99999999999999999999886
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.3e-14 Score=141.33 Aligned_cols=128 Identities=16% Similarity=0.214 Sum_probs=83.1
Q ss_pred ccccccCcccccCCCC-------CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCC
Q 010736 369 NITGDFGIAKFLKPDS-------SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSL 441 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~-------~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~ 441 (502)
-..+|||+++.+.... .......||..|+|||...+..++.++|||||||+++||+||+.|++..........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 3479999998774321 112345799999999999988899999999999999999999999853111100000
Q ss_pred CcccccccccCCCCC--CCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 442 NTDIALDEMLDPRLP--VPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 442 ~~~~~~~~~~d~~l~--~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
.........+.+.+. .+.....+++.++++ .|++.+|++||++.+|++.|+....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLV---CAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHH---HHhhcCcccCCCHHHHHHHHhccCC
Confidence 000000000000000 000012245666666 9999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=4.9e-14 Score=133.75 Aligned_cols=119 Identities=29% Similarity=0.456 Sum_probs=81.7
Q ss_pred cccccCcccccCCCC-CCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++...... .......++..|+|||.......+.++||||+|++++||+| |+.|++..... .... .+
T Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~--~~ 220 (269)
T 4hcu_A 146 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE--DI 220 (269)
T ss_dssp EECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH--HH
T ss_pred EeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHH--HH
Confidence 368999998764321 11233556788999999998899999999999999999999 89997532110 0000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
.....+..+ ....+++.++++ .|++.+|++||+++|+++.|+++..
T Consensus 221 ~~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 221 STGFRLYKP---RLASTHVYQIMN---HCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HTTCCCCCC---TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCccCCCC---CcCCHHHHHHHH---HHccCCcccCcCHHHHHHHHHHHHH
Confidence 000111111 112345666666 9999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.36 E-value=5.6e-14 Score=143.89 Aligned_cols=129 Identities=30% Similarity=0.476 Sum_probs=87.1
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GK 427 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~ 427 (502)
++.|.||+..|| ++|||+++....... ......++..|+|||......++.++|||||||+++||+| |+
T Consensus 304 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~ 383 (454)
T 1qcf_A 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383 (454)
T ss_dssp TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCC
Confidence 455566655443 689999998753211 1223456788999999998899999999999999999999 99
Q ss_pred CCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 428 HPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 428 ~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.|+...... .... .+.. ..+++.+ ....+++..+++ .|++.+|++||+|.+|+++|+...
T Consensus 384 ~P~~~~~~~---~~~~--~i~~--~~~~~~~-~~~~~~l~~li~---~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 384 IPYPGMSNP---EVIR--ALER--GYRMPRP-ENCPEELYNIMM---RCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CSSTTCCHH---HHHH--HHHH--TCCCCCC-TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHH---HHHH--HHHc--CCCCCCC-CCCCHHHHHHHH---HHccCChhHCcCHHHHHHHHHHHH
Confidence 997532110 0000 0000 0111111 122345666655 999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=8.4e-14 Score=132.00 Aligned_cols=119 Identities=26% Similarity=0.427 Sum_probs=81.8
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++....... ......++..|+|||.......+.++||||+|++++||+| |+.|++...... ..
T Consensus 144 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~ 215 (268)
T 3sxs_A 144 KVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--------VV 215 (268)
T ss_dssp EECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HH
T ss_pred EEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--------HH
Confidence 4689999987754322 1223456778999999998899999999999999999999 999975321100 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
..+.............+++.++++ .|++.+|++||+++||++.|+.+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 216 LKVSQGHRLYRPHLASDTIYQIMY---SCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHcCCCCCCCCcChHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHhhh
Confidence 000000000001112245666666 9999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-13 Score=137.87 Aligned_cols=117 Identities=27% Similarity=0.391 Sum_probs=81.4
Q ss_pred cccccCcccccCCCC--CCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++...... .......+|.+|+|||...+...+.++|||||||+++||+| |+.|+...... .... .
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---~~~~--~ 305 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELFK--L 305 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH--H
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--H
Confidence 368999998775432 12234567889999999999999999999999999999999 99997522110 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+.+...+..+ ....+++.++++ .|++.+|++||+++||++.|+.+
T Consensus 306 ~~~~~~~~~~---~~~~~~l~~li~---~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 306 LKEGHRMDKP---SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHTTCCCCCC---SSCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCC---ccCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHH
Confidence 0011111111 112345666666 99999999999999999999886
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=7.7e-14 Score=137.24 Aligned_cols=118 Identities=19% Similarity=0.323 Sum_probs=81.0
Q ss_pred ccccCcccccCCCC--CCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.+|||+++...... .......++..|+|||......++.++||||||++++||+| |+.|+..... ....
T Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~ 286 (343)
T 1luf_A 215 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--------EEVI 286 (343)
T ss_dssp ECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHH
T ss_pred EeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh--------HHHH
Confidence 68999998764322 11224567889999999988889999999999999999999 9999752111 0001
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
..+.+............++..+++ .|++.+|++||++.||++.|+.+..
T Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 287 YYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHhCCCcCCCCCCCCHHHHHHHH---HHcccCcccCCCHHHHHHHHHHHHh
Confidence 111111111111122345666666 9999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.6e-13 Score=145.49 Aligned_cols=128 Identities=25% Similarity=0.422 Sum_probs=84.2
Q ss_pred CCCCeeeecCCcc---------ccccCcccccCCCCCCc---ccccccccccCccccccceecccceeeeeceeeeehhc
Q 010736 358 PKLGALNISRNNI---------TGDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK 425 (502)
Q Consensus 358 ~~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~---~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt 425 (502)
.++.|.||+..|| ++|||+++.+....... ....++..|+|||......++.++|||||||+++||+|
T Consensus 455 ~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 534 (613)
T 2ozo_A 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534 (613)
T ss_dssp TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 3566666666554 68999999875432211 12345678999999998999999999999999999998
Q ss_pred -CCCCCCcccCCCCCCCCcccccccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 426 -GKHPRDFLSSTSSPSLNTDIALDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 426 -g~~p~~~~~~~~~~~~~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
|+.|+....... . ...+... ++..+ ....+++.+++. .||+.+|++||+|.+|+++|+..
T Consensus 535 ~G~~Pf~~~~~~~---~-----~~~i~~~~~~~~p-~~~~~~l~~li~---~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 535 YGQKPYKKMKGPE---V-----MAFIEQGKRMECP-PECPPELYALMS---DCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp TSCCTTTTCCSHH---H-----HHHHHTTCCCCCC-TTCCHHHHHHHH---HTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH---H-----HHHHHcCCCCCCC-CcCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHH
Confidence 999985322110 0 0001110 11111 112345666655 99999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-13 Score=137.84 Aligned_cols=118 Identities=26% Similarity=0.355 Sum_probs=70.9
Q ss_pred cccccCcccccCCCCC----CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++.+..... ..+...++..|+|||......++.++|||||||+++||+| |+.|+....... ..
T Consensus 232 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~-- 306 (373)
T 3c1x_A 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT-- 306 (373)
T ss_dssp EECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HH--
T ss_pred EEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HH--
Confidence 4789999987643221 1234567788999999999999999999999999999999 566654321110 00
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..+........+....+++..+++ .|++.+|++||++.||++.|+++.
T Consensus 307 ---~~~~~~~~~~~p~~~~~~l~~li~---~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 307 ---VYLLQGRRLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp ---HHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHcCCCCCCCCCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHH
Confidence 001111100011112345666666 999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.35 E-value=6.9e-14 Score=139.39 Aligned_cols=115 Identities=26% Similarity=0.443 Sum_probs=67.9
Q ss_pred cccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++........ .....++.+|+|||......++.++|||||||+++|++| |+.|+......
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------- 257 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------- 257 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---------
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence 37899999987543221 112345678999999999999999999999999999998 99997422110
Q ss_pred ccccccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
...+.++. +.+.+ ....+++.+++. .|++.+|++||+|.||+++|+.+
T Consensus 258 ~~~~~i~~~~~~~~~-~~~~~~l~~li~---~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 258 DVIKAVDEGYRLPPP-MDCPAALYQLML---DCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HHHHHHHTTEECCCC-TTCBHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCC-ccccHHHHHHHH---HHhCcChhhCcCHHHHHHHHHHH
Confidence 00001111 11111 112244555554 99999999999999999999876
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.34 E-value=9.7e-11 Score=117.46 Aligned_cols=271 Identities=10% Similarity=0.038 Sum_probs=131.3
Q ss_pred cCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCC------------
Q 010736 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN------------ 153 (502)
Q Consensus 86 l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N------------ 153 (502)
|...+|.++.+|+.+.|.. .++.+-..+|.++++|+.++|..+ ++..-...|.++.+|+.+.+..+
T Consensus 62 Ig~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~ 139 (394)
T 4fs7_A 62 IGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGC 139 (394)
T ss_dssp ECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTC
T ss_pred hHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecc
Confidence 3344466666666666653 255444555666666666666543 33233344555555555444322
Q ss_pred ---------cCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCcccccc
Q 010736 154 ---------QLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAI 224 (502)
Q Consensus 154 ---------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 224 (502)
........+|..+++|+.+.+.++. .......|.++.+|+.+.+..| ++......|.++..|+.+.+..
T Consensus 140 ~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 140 DFKEITIPEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp CCSEEECCTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred cccccccCccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence 1111122345566666666665443 2234445666666666666554 3333344555556666555544
Q ss_pred ccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCC---------------------ccc
Q 010736 225 NQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLP---------------------QNI 282 (502)
Q Consensus 225 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~---------------------~~~ 282 (502)
+... +........+|+.+.+..+. +......+.. ..++.+.+..+.. .... ..+
T Consensus 218 ~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~~i~~~~F 293 (394)
T 4fs7_A 218 SLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSVIVPEKTF 293 (394)
T ss_dssp TCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEECSSEECTTTT
T ss_pred CceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcc-eeeccccccccccceeccCceeeccccc
Confidence 3221 11122223344444433211 1011111111 2344444433221 1112 234
Q ss_pred cCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCe
Q 010736 283 CRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGA 362 (502)
Q Consensus 283 ~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 362 (502)
....+|+.+.+..+ ++..-...|.++.+|+.+++.. .++.....+|..+.+|+.+++..| +...-..+|..|++|+.
T Consensus 294 ~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~-~v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~ 370 (394)
T 4fs7_A 294 YGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPY-LVEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKK 370 (394)
T ss_dssp TTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCE
T ss_pred cccccccccccccc-cceechhhhcCCCCCCEEEeCC-cccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCE
Confidence 44555666665433 3333344566666666666643 355444556666666776666554 54444556666666776
Q ss_pred eeecC
Q 010736 363 LNISR 367 (502)
Q Consensus 363 L~l~~ 367 (502)
+++..
T Consensus 371 i~lp~ 375 (394)
T 4fs7_A 371 VELPK 375 (394)
T ss_dssp EEEEG
T ss_pred EEECC
Confidence 66654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=7.8e-14 Score=139.27 Aligned_cols=116 Identities=26% Similarity=0.402 Sum_probs=79.5
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
.++|||+++........ .....++..|+|||......++.++|||||||+++||+| |+.|+...... .
T Consensus 253 kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---------~ 323 (377)
T 3cbl_A 253 KISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---------Q 323 (377)
T ss_dssp EECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---------H
T ss_pred EECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------H
Confidence 36899999875432111 111235678999999998999999999999999999999 99997532110 0
Q ss_pred cccccC--CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLD--PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d--~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..+.+. .+++.+ ....+++.++++ .|++.+|++||++.||+++|+.++
T Consensus 324 ~~~~~~~~~~~~~~-~~~~~~l~~li~---~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 324 TREFVEKGGRLPCP-ELCPDAVFRLME---QCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HHHHHHTTCCCCCC-TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCC-CCCCHHHHHHHH---HHcCCCchhCcCHHHHHHHHHHHH
Confidence 000010 111111 112345666666 999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=8.7e-14 Score=136.01 Aligned_cols=117 Identities=26% Similarity=0.422 Sum_probs=78.4
Q ss_pred cccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++........ .....+|..|+|||......++.++||||||++++||+| |+.|+...... .
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~ 262 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------D 262 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------H
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------H
Confidence 46899999987543221 123446778999999998999999999999999999999 99997421110 0
Q ss_pred ccccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 446 ALDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 446 ~~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
....+... ..+.+ ....+++.++++ .|++.+|++||+|.||+++|+.+.
T Consensus 263 ~~~~~~~~~~~~~~-~~~~~~l~~li~---~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 263 VISSVEEGYRLPAP-MGCPHALHQLML---DCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp HHHHHHTTCCCCCC-TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCC-CCcCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHH
Confidence 00111110 11111 112345666665 999999999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-13 Score=140.67 Aligned_cols=128 Identities=29% Similarity=0.458 Sum_probs=81.8
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GK 427 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~ 427 (502)
++.|.||+..|+ ++|||+++....... ......++..|+|||......++.++|||||||+++||+| |+
T Consensus 300 ~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 379 (452)
T 1fmk_A 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379 (452)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCC
Confidence 455556655443 689999988754321 1224457789999999998899999999999999999999 99
Q ss_pred CCCCcccCCCCCCCCcccccccccC-CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 428 HPRDFLSSTSSPSLNTDIALDEMLD-PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 428 ~p~~~~~~~~~~~~~~~~~~~~~~d-~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.|+...... .....+.. .+.+.+ ....+++.++++ .|++.+|++||++.+|+++|+...
T Consensus 380 ~P~~~~~~~--------~~~~~i~~~~~~~~~-~~~~~~l~~li~---~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 380 VPYPGMVNR--------EVLDQVERGYRMPCP-PECPESLHDLMC---QCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CSSTTCCHH--------HHHHHHHTTCCCCCC-TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCHH--------HHHHHHHcCCCCCCC-CCCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHh
Confidence 997522110 00001100 011111 122345666665 999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-13 Score=131.27 Aligned_cols=117 Identities=21% Similarity=0.353 Sum_probs=70.3
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++....... ......++..|+|||.......+.++||||||++++||+| |+.|++..... . ..
T Consensus 156 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~-----~~ 227 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---D-----VI 227 (281)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---G-----HH
T ss_pred EECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---H-----HH
Confidence 3689999987754322 1223456788999999988889999999999999999997 99997532111 0 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..+.............+++..+++ .|++.+|++||++.||++.|+.+
T Consensus 228 ~~i~~~~~~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 228 GRIENGERLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHH
Confidence 111111100001112345666666 99999999999999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.8e-13 Score=130.75 Aligned_cols=118 Identities=21% Similarity=0.340 Sum_probs=78.7
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++....... ......++.+|+|||.......+.++||||||++++||+| |+.|+....... ... .+
T Consensus 153 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~--~~ 227 (281)
T 3cc6_A 153 KLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIG--VL 227 (281)
T ss_dssp EECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHH--HH
T ss_pred EeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHH--HH
Confidence 4789999987754322 2233557889999999988889999999999999999999 999975321110 000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.....+..+ ....+++..+++ .|++.+|++||++.||++.|+.+.
T Consensus 228 ~~~~~~~~~---~~~~~~l~~li~---~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 228 EKGDRLPKP---DLCPPVLYTLMT---RCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp HHTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCCC---CCCCHHHHHHHH---HHccCCchhCcCHHHHHHHHHHHH
Confidence 000001111 112345666666 999999999999999999998763
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-13 Score=136.98 Aligned_cols=117 Identities=11% Similarity=0.055 Sum_probs=76.7
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc--ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
-..+|||+++...... ....+|..|+|||.... ..++.++|||||||+++||+||+.|+..........+.. ..
T Consensus 233 ~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-~~ 308 (371)
T 3q60_A 233 LMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR-PS 308 (371)
T ss_dssp EEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCB-CC
T ss_pred EEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhh-hh
Confidence 3479999998764321 13456799999999987 789999999999999999999999986432211111110 00
Q ss_pred cccccCCCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...........+ .....+++..+++ .|++.+|++||++.|+++
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 309 LRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTSCCCCSCCCTTSSCCCHHHHHHHH---HHTCSSTTTCCCHHHHTT
T ss_pred hhhccccccchhhccCCCHHHHHHHH---HHcCCChhhCCCHHHHhc
Confidence 000011111100 0122356666766 999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-13 Score=140.98 Aligned_cols=114 Identities=23% Similarity=0.361 Sum_probs=79.0
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
++|||+++...... ....++..|+|||......++.++|||||||+++||+| |+.|+...... .... .+..
T Consensus 330 l~DfG~a~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~--~i~~ 401 (450)
T 1k9a_A 330 VSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP--RVEK 401 (450)
T ss_dssp ECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHH--HHHT
T ss_pred EeeCCCcccccccc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--HHHc
Confidence 68999998654321 22357789999999999999999999999999999999 99998532211 1100 0000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
-..+..+ .....++.++++ .||+.+|++||++.|+++.|+.+.
T Consensus 402 ~~~~~~p---~~~~~~l~~li~---~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 402 GYKMDAP---DGCPPAVYDVMK---NCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp TCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCC---CcCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHH
Confidence 0111111 122356666666 999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-13 Score=134.02 Aligned_cols=118 Identities=27% Similarity=0.430 Sum_probs=74.8
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......++..|+|||...+..++.++|||||||+++||+| |+.|++...... ... .
T Consensus 157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~--~ 231 (327)
T 3lzb_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS--I 231 (327)
T ss_dssp EECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH--H
T ss_pred EEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH--H
Confidence 3689999988754322 2223456778999999999999999999999999999999 999985321110 000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
+.. ....+.+ .....++..+++ .|++.+|++||++.|+++.|+.+.
T Consensus 232 ~~~--~~~~~~~-~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 232 LEK--GERLPQP-PICTIDVYMIMR---KCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHT--TCCCCCC-TTBCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHc--CCCCCCC-ccCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHH
Confidence 000 0011111 112345666666 999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-13 Score=135.68 Aligned_cols=113 Identities=27% Similarity=0.468 Sum_probs=72.0
Q ss_pred ccccCcccccCCCCC--CcccccccccccCcccccc-----------ceecccceeeeeceeeeehhcCCCCCCcccCCC
Q 010736 371 TGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYT-----------MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS 437 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~-----------~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~ 437 (502)
.+|||+++....... ......||.+|+|||.... ..++.++|||||||+++||+||+.|++....
T Consensus 148 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-- 225 (343)
T 3dbq_A 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-- 225 (343)
T ss_dssp ECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--
T ss_pred EeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--
Confidence 689999998754332 2234679999999999865 6788999999999999999999999853111
Q ss_pred CCCCCcccccccccCCCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 438 SPSLNTDIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 438 ~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
.......++++..... .....+++..+++ .|++.+|++||++.||++.
T Consensus 226 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 226 -----QISKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----HHHHHHHHHCTTSCCCCCCCSCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred -----HHHHHHHHhcCCcccCCcccCCHHHHHHHH---HHcCCChhHCCCHHHHHhC
Confidence 0011122233222110 1112245556665 9999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.9e-13 Score=133.30 Aligned_cols=117 Identities=18% Similarity=0.285 Sum_probs=73.7
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......++..|+|||.......+.++||||||++++||+| |+.|++..... ..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~ 248 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--------EI 248 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--------HH
Confidence 3689999987654321 1223456788999999998889999999999999999999 89997532111 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
...+.............+++..+++ .|++.+|++||++.|+++.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 249 YNYLIGGNRLKQPPECMEEVYDLMY---QCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCccCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHH
Confidence 0111111110011112245666666 99999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.7e-13 Score=131.29 Aligned_cols=117 Identities=26% Similarity=0.487 Sum_probs=79.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccc--ccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELA--YTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~--~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++.... ......|+..|+|||.. .....+.++||||+|++++||+||+.|++........ .. ....
T Consensus 169 kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~-~~~~ 243 (287)
T 4f0f_A 169 KVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FI-NMIR 243 (287)
T ss_dssp EECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HH-HHHH
T ss_pred EeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HH-HHHh
Confidence 3689999875432 23446789999999998 4566889999999999999999999998532211000 00 0000
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..-..+.++. ...+++..+++ .|++.+|++||++.||+++|+++
T Consensus 244 ~~~~~~~~~~---~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLRPTIPE---DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCCCCCCT---TSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCCCCCCc---ccCHHHHHHHH---HHhcCChhhCcCHHHHHHHHHhC
Confidence 1112222221 12355666666 99999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.7e-13 Score=141.80 Aligned_cols=115 Identities=27% Similarity=0.475 Sum_probs=81.0
Q ss_pred ccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
++|||+++....... ......++..|+|||......++.++|||||||+++||+| |+.|+...... . +.
T Consensus 359 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~------~~ 429 (495)
T 1opk_A 359 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q------VY 429 (495)
T ss_dssp ECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G------HH
T ss_pred EeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---H------HH
Confidence 689999998754321 1223456788999999998999999999999999999999 99997532110 0 01
Q ss_pred cccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 449 EMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 449 ~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
+.+.. +...+ ....+++.++++ .|++.+|++||+|.||+++|+.+.
T Consensus 430 ~~~~~~~~~~~~-~~~~~~l~~li~---~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 430 ELLEKDYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHTTCCCCCC-TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHcCCCCCCC-CCCCHHHHHHHH---HHcCcChhHCcCHHHHHHHHHHHH
Confidence 11111 11111 122345666665 999999999999999999998863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.6e-13 Score=146.01 Aligned_cols=129 Identities=26% Similarity=0.401 Sum_probs=85.5
Q ss_pred CCCCeeeecCCcc---------ccccCcccccCCCCC---CcccccccccccCccccccceecccceeeeeceeeeehhc
Q 010736 358 PKLGALNISRNNI---------TGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK 425 (502)
Q Consensus 358 ~~L~~L~l~~N~l---------~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt 425 (502)
.++.|.||+..|| ++|||+++.+..... ..+...++..|+|||......++.++|||||||+++||+|
T Consensus 488 ~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 567 (635)
T 4fl3_A 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567 (635)
T ss_dssp TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 3566667766554 689999998754322 1233456788999999999899999999999999999999
Q ss_pred -CCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 426 -GKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 426 -g~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
|+.|+....... ... .+.....+..+ ....+++.++++ .|++.+|++||++.+|+++|+..
T Consensus 568 ~G~~Pf~~~~~~~---~~~--~i~~~~~~~~p---~~~~~~l~~li~---~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 568 YGQKPYRGMKGSE---VTA--MLEKGERMGCP---AGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TTCCSSTTCCHHH---HHH--HHHTTCCCCCC---TTCCHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH---HHH--HHHcCCCCCCC---CCCCHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHH
Confidence 999975321100 000 00010111111 122356666666 99999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=9.9e-14 Score=135.34 Aligned_cols=114 Identities=24% Similarity=0.362 Sum_probs=79.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||.+|+|||......++.++|||||||+++||+||+.|+...... ... ..+.+
T Consensus 181 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~--~~~~~ 255 (321)
T 2c30_A 181 KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAM--KRLRD 255 (321)
T ss_dssp EECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH--HHHHH
T ss_pred EEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH--HHHhc
Confidence 4789999988765443444567999999999999889999999999999999999999997531110 000 01111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+.+... ....+++..+++ .|++.+|++||++.||++
T Consensus 256 ~~~~~~~~~-~~~~~~l~~li~---~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 256 SPPPKLKNS-HKVSPVLRDFLE---RMLVRDPQERATAQELLD 294 (321)
T ss_dssp SSCCCCTTG-GGSCHHHHHHHH---HHSCSSTTTSCCHHHHHT
T ss_pred CCCCCcCcc-ccCCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 122222111 112345666666 999999999999999976
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=4.7e-14 Score=136.04 Aligned_cols=115 Identities=23% Similarity=0.360 Sum_probs=79.8
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............||..|+|||......++.++||||+||+++||+||+.|+....... ... .+.
T Consensus 155 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~--~~~ 229 (297)
T 3fxz_A 155 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALY--LIA 229 (297)
T ss_dssp EEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH--HHH
T ss_pred EEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH--HHH
Confidence 347899999887655544556789999999999999899999999999999999999999974211000 000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+.+..+ ....+++..+++ .|++.+|++||+++|+++
T Consensus 230 ~~~~~~~~~~-~~~~~~~~~li~---~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 230 TNGTPELQNP-EKLSAIFRDFLN---RCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHCSCCCSCG-GGSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred hCCCCCCCCc-cccCHHHHHHHH---HHccCChhHCcCHHHHhh
Confidence 0011111111 112245666666 999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.1e-13 Score=134.09 Aligned_cols=122 Identities=24% Similarity=0.356 Sum_probs=72.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||.......+.++||||||++++||+||+.|+...... ...... .+..
T Consensus 176 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~--~~~~ 252 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK--KIEQ 252 (310)
T ss_dssp EECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHH--HHHT
T ss_pred EEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHH--Hhhc
Confidence 3689999987754433333457899999999999888999999999999999999999997421100 000000 0011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
...+.... ....+++.++++ .|++.+|++||++.||++.|+.+++
T Consensus 253 ~~~~~~~~--~~~~~~l~~li~---~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 253 CDYPPLPS--DHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp TCSCCCCT--TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCCcc--cccCHHHHHHHH---HHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11111111 112345666666 9999999999999999999998743
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.8e-13 Score=137.25 Aligned_cols=113 Identities=27% Similarity=0.453 Sum_probs=73.7
Q ss_pred cccccCcccccCCCCC--CcccccccccccCcccccc-----------ceecccceeeeeceeeeehhcCCCCCCcccCC
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYT-----------MKITEKCDVYSFGVLVLEVIKGKHPRDFLSST 436 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~-----------~~~s~k~Dvysfgv~llElltg~~p~~~~~~~ 436 (502)
.++|||+++.+..... ......||..|+|||.... ..++.++|||||||+++||+||+.|++....
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~- 272 (390)
T 2zmd_A 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN- 272 (390)
T ss_dssp EECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-
T ss_pred EEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-
Confidence 3699999998754322 1234679999999999865 3688999999999999999999999853110
Q ss_pred CCCCCCcccccccccCCCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 437 SSPSLNTDIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 437 ~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.......++++..... .....+++..+++ .|++.+|++||++.||++
T Consensus 273 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 273 ------QISKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLA 320 (390)
T ss_dssp ------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHH---HHTCSSTTTSCCHHHHHT
T ss_pred ------HHHHHHHHhCccccCCCCccchHHHHHHHH---HHcccChhhCCCHHHHhh
Confidence 0011222333322110 0111245556665 999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.6e-13 Score=133.16 Aligned_cols=120 Identities=26% Similarity=0.320 Sum_probs=75.8
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......++..|+|||......++.++||||||++++||+| |+.|+...... ..
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~----- 258 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EM----- 258 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GH-----
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HH-----
Confidence 3689999987643321 1223457789999999998889999999999999999999 88887532111 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCC
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPS 500 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~ 500 (502)
...+.............+++..+++ .|++.+|++||++.|+++.|+.+..+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 259 YDYLLHGHRLKQPEDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHHTTCCCCCBTTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccccHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0111111110011112245666666 99999999999999999999987543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.4e-13 Score=136.88 Aligned_cols=117 Identities=25% Similarity=0.353 Sum_probs=79.7
Q ss_pred cccccCcccccCCC--CCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPD--SSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~--~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+... ........||..|+|||......++.++|||||||+++||+| |+.|+...... ..
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--------~~ 295 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EV 295 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence 36899999865321 112223567889999999988899999999999999999998 99997532110 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
...+.............+++.++++ .|++.+|++||++.||++.|+.+
T Consensus 296 ~~~i~~~~~~~~~~~~~~~l~~li~---~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 296 LEFVTSGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHH
Confidence 0011111000011112245556655 99999999999999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.2e-13 Score=131.02 Aligned_cols=117 Identities=25% Similarity=0.377 Sum_probs=80.9
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....++..|+|||...+...+.++||||+|++++||+| |+.|+...... .... .
T Consensus 190 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~--~ 264 (314)
T 2ivs_A 190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE---RLFN--L 264 (314)
T ss_dssp EECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH--H
T ss_pred EEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--H
Confidence 46899999877543221 223456788999999998899999999999999999999 99997532111 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+.....+..+ ....+++..+++ .|++.+|++||++.||++.|+++
T Consensus 265 ~~~~~~~~~~---~~~~~~~~~li~---~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 265 LKTGHRMERP---DNCSEEMYRLML---QCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp HHTTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcCCcCCCC---ccCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHH
Confidence 0000111111 112345666666 99999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1.7e-13 Score=132.89 Aligned_cols=119 Identities=25% Similarity=0.365 Sum_probs=81.5
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....|+..|+|||.......+.++||||||++++||+| |+.|+...... .... ..
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~-~~ 260 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---SKFY-KM 260 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---HHHH-HH
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch---hHHH-HH
Confidence 36899999877544321 123456788999999988899999999999999999999 99997532110 0000 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..+...+..+ ....+++..+++ .|++.+|++||++.||+++|+...
T Consensus 261 ~~~~~~~~~~---~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 261 IKEGFRMLSP---EHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHTCCCCCC---TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCCCCCc---ccCCHHHHHHHH---HHcCCCchhCcCHHHHHHHHHHHH
Confidence 0111111111 112345666666 999999999999999999998763
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.31 E-value=9.6e-14 Score=131.77 Aligned_cols=116 Identities=27% Similarity=0.486 Sum_probs=73.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... ....|+.+|+|||...+...+.++||||||++++|++||+.|+....... .... ....
T Consensus 156 kl~Dfg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~-~~~~ 229 (271)
T 3dtc_A 156 KITDFGLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---VAYG-VAMN 229 (271)
T ss_dssp EECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHH-HHTS
T ss_pred EEccCCcccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHh-hhcC
Confidence 3689999987654322 24578999999999998889999999999999999999999975321100 0000 0000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
-.....+ ....+++.++++ .|++.+|++||++.||+++|+.+
T Consensus 230 ~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KLALPIP---STCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCC---cccCHHHHHHHH---HHhcCCcccCcCHHHHHHHHhcC
Confidence 0111111 112345666666 99999999999999999999763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.6e-13 Score=141.00 Aligned_cols=124 Identities=16% Similarity=0.261 Sum_probs=82.3
Q ss_pred cccccCcccccCCCCCC-------cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSN-------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~-------~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
.++|||+++........ .....||..|+|||...+..++.++|||||||+++||+||+.|++...........
T Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 225 (483)
T 3sv0_A 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (483)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH
T ss_pred EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH
Confidence 37899999987543221 12467999999999999999999999999999999999999998643221100000
Q ss_pred cccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 443 TDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 443 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.... ...+...+........+++..+++ .|++.+|++||+|.+|+++|+.+
T Consensus 226 ~~i~-~~~~~~~~~~l~~~~p~~l~~li~---~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 226 EKIS-EKKVATSIEALCRGYPTEFASYFH---YCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHH-HHHHHSCHHHHHTTSCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHh-hccccccHHHHhcCCcHHHHHHHH---HHhcCChhhCcCHHHHHHHHHHH
Confidence 0000 000000000000011245555555 99999999999999999999886
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.30 E-value=2.2e-13 Score=130.13 Aligned_cols=117 Identities=27% Similarity=0.461 Sum_probs=80.0
Q ss_pred cccccCcccccCCCC-CCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++...... .......++..|+|||.......+.++||||+|++++||+| |+.|++...... .. ..+
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~--~~~ 234 (283)
T 3gen_A 160 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA--EHI 234 (283)
T ss_dssp EECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH--HHH
T ss_pred EEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HH--HHH
Confidence 368999998764321 11223456788999999998889999999999999999999 999975321100 00 000
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.+...+..+ ....+++.++++ .|++.+|++||+++|+++.|+++
T Consensus 235 ~~~~~~~~~---~~~~~~l~~li~---~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 235 AQGLRLYRP---HLASEKVYTIMY---SCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp HTTCCCCCC---TTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcccCCCCC---CcCCHHHHHHHH---HHccCChhHCcCHHHHHHHHHHH
Confidence 111111111 112245666666 99999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=3.1e-13 Score=129.47 Aligned_cols=117 Identities=25% Similarity=0.380 Sum_probs=81.5
Q ss_pred cccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++........ .....++..|+|||.......+.++||||||++++||+| |+.|+...... ....
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~-- 224 (287)
T 1u59_A 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA-- 224 (287)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH--
T ss_pred EECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHH--
Confidence 46899999887543221 123456789999999988899999999999999999999 99997532110 0000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.+.....+..+ ....+++..+++ .|++.+|++||++.||++.|+.+
T Consensus 225 ~i~~~~~~~~~---~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 225 FIEQGKRMECP---PECPPELYALMS---DCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp HHHTTCCCCCC---TTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCcCCCC---CCcCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHH
Confidence 00000111111 122356666666 99999999999999999999886
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=3.4e-13 Score=129.49 Aligned_cols=117 Identities=27% Similarity=0.405 Sum_probs=79.7
Q ss_pred cccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++........ .....++..|+|||.......+.++||||||++++||+| |+.|+....... ...
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~-- 231 (291)
T 1xbb_A 157 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA-- 231 (291)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH--
T ss_pred EEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--
Confidence 46899999877543321 122346788999999998899999999999999999999 999975321100 000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.+.....+..+ ....+++..+++ .|++.+|++||++.||+++|+..
T Consensus 232 ~~~~~~~~~~~---~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 232 MLEKGERMGCP---AGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHHTTCCCCCC---TTCCHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHcCCCCCCC---CCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHH
Confidence 00000111111 112355666666 99999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=3.8e-13 Score=128.19 Aligned_cols=115 Identities=22% Similarity=0.340 Sum_probs=74.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++...... ....++..|+|||...+...+.++||||||++++||+| |+.|+...... .... .+.
T Consensus 157 ~l~Dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~--~~~ 228 (278)
T 1byg_A 157 KVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP--RVE 228 (278)
T ss_dssp EECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH--HHT
T ss_pred EEeeccccccccccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--HHh
Confidence 468999987654322 23457889999999988889999999999999999999 99997532110 0000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.-..+..+ ....+++..+++ .|++.+|++||++.|+++.|++++
T Consensus 229 ~~~~~~~~---~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 229 KGYKMDAP---DGCPPAVYEVMK---NCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp TTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCc---ccCCHHHHHHHH---HHhcCChhhCCCHHHHHHHHHHHH
Confidence 11111111 122356666766 999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.30 E-value=3.5e-13 Score=130.86 Aligned_cols=119 Identities=25% Similarity=0.347 Sum_probs=81.0
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....||.+|+|||...+...+.++||||||++++||+| |+.|+....... .... .
T Consensus 188 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~--~ 263 (316)
T 2xir_A 188 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR--R 263 (316)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHH--H
T ss_pred EECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HHHH--H
Confidence 36899999877543321 223557889999999988889999999999999999999 999975321100 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
......+..+ .....++..++. .|++.+|++||++.||++.|+.+.
T Consensus 264 ~~~~~~~~~~---~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 264 LKEGTRMRAP---DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHHTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCccCCCC---CCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHH
Confidence 0010111111 112245556655 999999999999999999998863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.6e-13 Score=131.60 Aligned_cols=119 Identities=26% Similarity=0.452 Sum_probs=79.6
Q ss_pred cccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++........ .....++..|+|||.......+.++||||||++++||+| |+.|+...... .
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~ 232 (291)
T 1u46_A 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------Q 232 (291)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------H
T ss_pred EEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--------H
Confidence 46899999887543321 123457788999999998889999999999999999999 99997532110 0
Q ss_pred cccccc--CCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCC
Q 010736 446 ALDEML--DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPS 500 (502)
Q Consensus 446 ~~~~~~--d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~ 500 (502)
....+. ....+.+ ....+++..+++ .|++.+|++||++.|+++.|++.++.
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 233 ILHKIDKEGERLPRP-EDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHHHHTSCCCCCCC-TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHccCCCCCCC-cCcCHHHHHHHH---HHccCCcccCcCHHHHHHHHHHhCcc
Confidence 000110 0011111 112345666666 99999999999999999999988663
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=2e-13 Score=129.16 Aligned_cols=119 Identities=29% Similarity=0.456 Sum_probs=80.6
Q ss_pred cccccCcccccCCCC-CCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++...... .......++..|+|||.......+.++||||+|++++||+| |+.|+...... .... .+
T Consensus 144 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~--~i 218 (267)
T 3t9t_A 144 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE--DI 218 (267)
T ss_dssp EECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH--HH
T ss_pred EEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHH--HH
Confidence 368999998764321 11223456788999999988889999999999999999999 89997531110 0000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
..-..+..+ ....+++.++++ .|++.+|++||++.|+++.|+++..
T Consensus 219 ~~~~~~~~~---~~~~~~l~~li~---~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 219 STGFRLYKP---RLASTHVYQIMN---HCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HTTCCCCCC---TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCcCCCC---ccCcHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHh
Confidence 000011111 112245666666 9999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=2.6e-13 Score=132.97 Aligned_cols=118 Identities=25% Similarity=0.390 Sum_probs=80.2
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....|+.+|+|||...+...+.++||||||++++||+| |+.|++..... ..... .
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~-~ 279 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---SKFYK-L 279 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---HHHHH-H
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---HHHHH-H
Confidence 37899999876443221 123456789999999988889999999999999999999 89997532110 00000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..+...+..+ ....+++..+++ .|++.+|++||++.||++.|++.
T Consensus 280 ~~~~~~~~~~---~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 280 VKDGYQMAQP---AFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCCC---CCCCHHHHHHHH---HHhccChhhCcCHHHHHHHHHHH
Confidence 0111111111 112245666666 99999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=7.5e-14 Score=136.70 Aligned_cols=119 Identities=13% Similarity=0.190 Sum_probs=81.3
Q ss_pred cccccCcccccCCCCCC-------cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSN-------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~-------~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
..+|||+++........ .....||..|+|||...+...+.++|||||||+++||+||+.|+..........
T Consensus 150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~-- 227 (330)
T 2izr_A 150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE-- 227 (330)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH--
T ss_pred EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH--
Confidence 47899999976432211 235679999999999999889999999999999999999999986432111000
Q ss_pred cccccccccCCCCCCC----CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 443 TDIALDEMLDPRLPVP----SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 443 ~~~~~~~~~d~~l~~~----~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
....+.+.....+ ..... ++..+++ .|++.+|++||++.+|++.|+++
T Consensus 228 ---~~~~i~~~~~~~~~~~~~~~~p-~~~~li~---~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 228 ---RYQKIGDTKRATPIEVLCENFP-EMATYLR---YVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp ---HHHHHHHHHHHSCHHHHTTTCH-HHHHHHH---HHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ---HHHHHHhhhccCCHHHHhccCh-HHHHHHH---HHHhCCCCCCCCHHHHHHHHHHH
Confidence 0000100000000 00112 5555655 99999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=4.4e-13 Score=131.41 Aligned_cols=116 Identities=28% Similarity=0.446 Sum_probs=73.4
Q ss_pred cccccCcccccCCCCC---CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++....... ......++..|+|||.......+.++||||||++++||+| |+.|+...... .
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~ 258 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------E 258 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------H
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------H
Confidence 3689999988754322 1123346778999999988889999999999999999999 99997421110 0
Q ss_pred ccccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
....+.+. +.+.+ ....+++.++++ .|++.+|++||++.||+++|+.+
T Consensus 259 ~~~~~~~~~~~~~~-~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 259 VMKAINDGFRLPTP-MDCPSAIYQLMM---QCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp HHHHHHTTCCCCCC-TTCBHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHCCCcCCCc-ccCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHH
Confidence 00111111 11111 112245556655 99999999999999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=7.7e-13 Score=127.29 Aligned_cols=119 Identities=24% Similarity=0.325 Sum_probs=79.5
Q ss_pred cccccCcccccCCCC----CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDS----SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~----~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++...... .......++..|+|||...+...+.++||||||++++||+||+.|...... ......
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~-- 239 (298)
T 3pls_A 164 KVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTH-- 239 (298)
T ss_dssp EECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHH--
T ss_pred EeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHH--
Confidence 368999998664321 122345678899999999999999999999999999999997666321110 000000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..........+ ....+++.++++ .|++.+|++||+++|++++|+++.
T Consensus 240 ~~~~~~~~~~~---~~~~~~l~~li~---~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 240 FLAQGRRLPQP---EYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp HHHTTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCCCCCCC---ccchHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHH
Confidence 00000111111 112345666666 999999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.9e-13 Score=135.54 Aligned_cols=115 Identities=24% Similarity=0.336 Sum_probs=79.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||.+|+|||......++.++||||+||+++||+||+.|+...... ...... ...
T Consensus 153 kL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i-~~~ 228 (444)
T 3soa_A 153 KLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQI-KAG 228 (444)
T ss_dssp EECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH-HHT
T ss_pred EEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHH-HhC
Confidence 3689999988766555555678999999999999888999999999999999999999997421100 000000 000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+...+.. ....+++..+++ .|++.+|++||++.|+++
T Consensus 229 ~~~~~~~~~-~~~s~~~~~li~---~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 229 AYDFPSPEW-DTVTPEAKDLIN---KMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCCCTTTT-TTSCHHHHHHHH---HHSCSSTTTSCCHHHHHH
T ss_pred CCCCCcccc-ccCCHHHHHHHH---HHcCCChhHCCCHHHHhc
Confidence 011100000 112355666776 999999999999999875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.8e-14 Score=140.84 Aligned_cols=134 Identities=15% Similarity=0.156 Sum_probs=70.2
Q ss_pred CCCCEEECCCCcccccCCccCcC-----CCCCCEEEccCCcCcCCCCccc-CCCCCCcEEEccCCcCcccCCccc-----
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISN-----LTNLSILSLGGNQFSGNIPHEV-GLMSHLKILYIDSNQLDGSIPLEV----- 163 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~-----l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~~----- 163 (502)
+.|++|+|++|.++......+.. .++|++|+|++|.++......+ ..+++|++|+|++|+++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45677777777776433333222 2567777777777653322222 234566777777776654332222
Q ss_pred CCCCCCcEEEcccCccccc----CCcCCCCCCCCCeEEccccccccc----CCccCcCCccCCcccccccccc
Q 010736 164 GQLSSMVELALFSNNLNGS----VPHSLGNLTQISMLFLHDNSFSGF----IPPDIGNLKSISILSLAINQFS 228 (502)
Q Consensus 164 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 228 (502)
...++|++|+|++|.++.. ++..+..+++|++|+|++|.++.. ++..+...++|+.|++++|.++
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 2345666666666666431 222334455666666666665532 1223334444555555555544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=3.5e-13 Score=140.73 Aligned_cols=129 Identities=29% Similarity=0.459 Sum_probs=87.4
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GK 427 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~ 427 (502)
++.|.||+..|| ++|||+++....... ......++..|+|||......++.++|||||||+++||+| |+
T Consensus 383 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~ 462 (535)
T 2h8h_A 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462 (535)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTC
T ss_pred CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 455666655444 689999987753211 1123456788999999998899999999999999999999 89
Q ss_pred CCCCcccCCCCCCCCcccccccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 428 HPRDFLSSTSSPSLNTDIALDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 428 ~p~~~~~~~~~~~~~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
.|+...... .....+... ++..+ ....+++.++++ .|++.+|++||++.+|+++|+....
T Consensus 463 ~P~~~~~~~--------~~~~~i~~~~~~~~~-~~~~~~l~~li~---~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 463 VPYPGMVNR--------EVLDQVERGYRMPCP-PECPESLHDLMC---QCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CSSTTCCHH--------HHHHHHHTTCCCCCC-TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCHH--------HHHHHHHcCCCCCCC-CCCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHhh
Confidence 997532110 000011000 11111 112345666666 9999999999999999999998743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=2.9e-13 Score=133.00 Aligned_cols=129 Identities=19% Similarity=0.260 Sum_probs=79.6
Q ss_pred ccccccCcccccCCCCC----CcccccccccccCccccccc------eecccceeeeeceeeeehhcC----------CC
Q 010736 369 NITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTM------KITEKCDVYSFGVLVLEVIKG----------KH 428 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~------~~s~k~Dvysfgv~llElltg----------~~ 428 (502)
-..+|||+++....... ......||..|+|||..... ..+.++|||||||+++||+|| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 34789999987754332 12345789999999998765 455789999999999999999 44
Q ss_pred CCCcccCCCCC-CCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 429 PRDFLSSTSSP-SLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 429 p~~~~~~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
|+......... .............+.++... ...+....+.++...|++.+|++||++.||++.|+.+.
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 54321110000 00000001111223322110 11123334445555999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=2e-13 Score=134.33 Aligned_cols=120 Identities=23% Similarity=0.331 Sum_probs=82.1
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....||.+|+|||.......+.++||||||++++||+| |+.|+....... .... .
T Consensus 212 kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~-~ 287 (344)
T 1rjb_A 212 KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---NFYK-L 287 (344)
T ss_dssp EECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHH-H
T ss_pred EeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH---HHHH-H
Confidence 47899999877543321 123457789999999988889999999999999999999 999975321110 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
...-..+..+ ....+++..+++ .|++.+|++||++.||++.|+....
T Consensus 288 ~~~~~~~~~~---~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 288 IQNGFKMDQP---FYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp HHTTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HhcCCCCCCC---CCCCHHHHHHHH---HHcCCCchhCcCHHHHHHHHHHHHH
Confidence 0111111111 112355666666 9999999999999999999998744
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.9e-13 Score=131.79 Aligned_cols=113 Identities=23% Similarity=0.346 Sum_probs=75.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccce---ecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK---ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~---~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.............||..|+|||...... .+.++|||||||+++||+||+.|+...... .+.....
T Consensus 177 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~ 253 (298)
T 2zv2_A 177 KIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM---CLHSKIK 253 (298)
T ss_dssp EECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred EEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH---HHHHHHh
Confidence 4789999988765443344567999999999987654 478899999999999999999997521100 0000000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.... ..+.. ....+++..+++ .|++.+|++||++.||++
T Consensus 254 -~~~~--~~~~~-~~~~~~l~~li~---~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 254 -SQAL--EFPDQ-PDIAEDLKDLIT---RMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -HCCC--CCCSS-SCCCHHHHHHHH---HHTCSCTTTSCCHHHHTT
T ss_pred -cccC--CCCCc-cccCHHHHHHHH---HHhhcChhhCCCHHHHhc
Confidence 0000 11111 112355666666 999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.1e-12 Score=128.72 Aligned_cols=110 Identities=18% Similarity=0.252 Sum_probs=76.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++....... .....||..|+|||...+... +.++||||+||+++||+||+.|++....... .......
T Consensus 148 kl~DFG~s~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~i~~~ 223 (336)
T 3h4j_B 148 KIADFGLSNIMTDGNF-LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---FKKVNSC 223 (336)
T ss_dssp EECCSSCTBTTTTSBT-TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---BCCCCSS
T ss_pred EEEEeccceeccCCcc-cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---HHHHHcC
Confidence 3789999987754332 234579999999999987765 6899999999999999999999864221111 1100000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...++ .....++..+++ .|++.+|++||++.|+++
T Consensus 224 ---~~~~p---~~~s~~~~~li~---~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 ---VYVMP---DFLSPGAQSLIR---RMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ---CCCCC---TTSCHHHHHHHH---TTSCSSGGGSCCHHHHTT
T ss_pred ---CCCCc---ccCCHHHHHHHH---HHcCCChhHCcCHHHHHh
Confidence 01111 112245666776 999999999999999865
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.28 E-value=4.2e-13 Score=127.96 Aligned_cols=117 Identities=28% Similarity=0.437 Sum_probs=80.5
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++....... ......++..|+|||.......+.++||||||++++||+| |+.|+...... .... .+
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~--~~ 223 (279)
T 1qpc_A 149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQ--NL 223 (279)
T ss_dssp EECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH--HH
T ss_pred EECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHH--HH
Confidence 4689999988754321 1223456788999999988889999999999999999999 89997531110 0000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..-..+..+ ....+++.++++ .|++.+|++||++.+++++|++.
T Consensus 224 ~~~~~~~~~---~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 224 ERGYRMVRP---DNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp HTTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcccCCCCc---ccccHHHHHHHH---HHhccChhhCCCHHHHHHHHHHH
Confidence 000111111 122355666666 99999999999999999999886
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.28 E-value=7.1e-13 Score=127.62 Aligned_cols=119 Identities=25% Similarity=0.338 Sum_probs=77.9
Q ss_pred cccccCcccccCCCC----CCcccccccccccCccccccceecccceeeeeceeeeehhcCCC-CCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDS----SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH-PRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~----~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~-p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++...... ...+...++..|+|||...+...+.++||||+|++++|++||+. |+...... ...
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~-- 242 (298)
T 3f66_A 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DIT-- 242 (298)
T ss_dssp EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THH--
T ss_pred EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHH--
Confidence 368999998764322 12234567889999999998899999999999999999999555 44321111 000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
..+.............+++.++++ .|++.+|++||++.|++++|+++..
T Consensus 243 ---~~~~~~~~~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 243 ---VYLLQGRRLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---HHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHhcCCCCCCCccCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000000000001112345666666 9999999999999999999998743
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.7e-13 Score=135.53 Aligned_cols=122 Identities=15% Similarity=0.190 Sum_probs=82.7
Q ss_pred cccccCcccccCCCCC-------CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS-------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-------~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
..+|||+++.+..... ......||..|+|||...+..++.++|||||||+++||+||+.|+....... ....
T Consensus 201 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~ 279 (352)
T 2jii_A 201 TLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-EDIM 279 (352)
T ss_dssp EECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HHHH
T ss_pred EEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-HHHH
Confidence 4689999987753211 1234578999999999998899999999999999999999999986432110 0000
Q ss_pred cc-----cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 443 TD-----IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 443 ~~-----~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.. ....+..++.... ....+++.++++ .|++.+|++||++.||+++|+.+
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 280 KQKQKFVDKPGPFVGPCGHW--IRPSETLQKYLK---VVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp HHHHHHHHSCCCEECTTSCE--ECCCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhccCChhhhhhhcccc--CCCcHHHHHHHH---HHHhCChhhCCCHHHHHHHHHHH
Confidence 00 0001111111100 012356666666 99999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.27 E-value=6.2e-13 Score=133.13 Aligned_cols=114 Identities=28% Similarity=0.476 Sum_probs=75.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC-cccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN-TDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~-~~~~~~ 448 (502)
..+|||+++.............||..|+|||...+..++.++|+||+||+++||+||+.|++........... .+....
T Consensus 193 kL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~ 272 (396)
T 4dc2_A 193 KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272 (396)
T ss_dssp EECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH
T ss_pred EEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH
Confidence 3689999987443333345678999999999999999999999999999999999999998643221111000 000111
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
.+....+.-+. ....++..+++ .|++.+|++||+.
T Consensus 273 ~i~~~~~~~p~-~~s~~~~~li~---~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 273 VILEKQIRIPR-SLSVKAASVLK---SFLNKDPKERLGC 307 (396)
T ss_dssp HHHHCCCCCCT-TSCHHHHHHHH---HHTCSCTTTSTTC
T ss_pred HHhccccCCCC-cCCHHHHHHHH---HHhcCCHhHcCCC
Confidence 12222221111 12345667777 9999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.27 E-value=6.5e-13 Score=127.17 Aligned_cols=117 Identities=25% Similarity=0.419 Sum_probs=81.0
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++....... ......++..|+|||.......+.++||||+|++++||+| |+.|+...... .... .+
T Consensus 151 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~--~~ 225 (288)
T 3kfa_A 151 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE--LL 225 (288)
T ss_dssp EECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH--HH
T ss_pred EEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--HH
Confidence 3689999988754332 1223456788999999998899999999999999999999 89987532111 0000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.....+..+ ....+++.++++ .|++.+|++||++.||+++|+..
T Consensus 226 ~~~~~~~~~---~~~~~~l~~li~---~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 226 EKDYRMERP---EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HTTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCCCCCC---CCCCHHHHHHHH---HHhCCChhhCcCHHHHHHHHHHH
Confidence 111111111 112355666666 99999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=2.8e-13 Score=130.75 Aligned_cols=124 Identities=22% Similarity=0.325 Sum_probs=81.5
Q ss_pred cccccCcccccCCCCC---CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccC------CCCCC
Q 010736 370 ITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSS------TSSPS 440 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~------~~~~~ 440 (502)
..+|||+++....... ......||..|+|||...+...+.++||||+|++++||+||+.|...... .....
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc
Confidence 4689999988765432 12245678889999999999999999999999999999999998532100 00000
Q ss_pred CCccccc-ccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 441 LNTDIAL-DEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 441 ~~~~~~~-~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
....... ..+... ....+ ....+++..+++ .|++.+|++||++.||+++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLPCP-PNCPDEVYQLMR---KCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp GGHHHHHHHHHHTTCCCCCC-TTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCHHHHHHHHhccCCCCCC-CCCCHHHHHHHH---HHcCCCCCCCCCHHHHHHHHHHH
Confidence 0000000 001110 11111 122355666666 99999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.8e-13 Score=131.76 Aligned_cols=120 Identities=18% Similarity=0.264 Sum_probs=76.2
Q ss_pred cccccCcccccCCC-----CCCcccccccccccCcccccc---------ceecccceeeeeceeeeehhcCCCCCCcccC
Q 010736 370 ITGDFGIAKFLKPD-----SSNWTGFAGTYGYIAPELAYT---------MKITEKCDVYSFGVLVLEVIKGKHPRDFLSS 435 (502)
Q Consensus 370 l~~dfGl~~ll~~~-----~~~~~~~~gt~gy~aPE~~~~---------~~~s~k~Dvysfgv~llElltg~~p~~~~~~ 435 (502)
..+|||+++..... ........|+.+|+|||.... ..++.++||||||++++||+||+.|++....
T Consensus 169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 46899998765321 112234568999999999864 3478899999999999999999999753211
Q ss_pred CCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 436 TSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 436 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
. .... ....-..+..... ...+++..+++ .|++.+|++||++.||+++|+.+..
T Consensus 249 ~---~~~~--~~~~~~~~~~~~~--~~~~~l~~li~---~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 249 E---AIIW--QMGTGMKPNLSQI--GMGKEISDILL---FCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp H---HHHH--HHHTTCCCCCCCS--SCCTTHHHHHH---HHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred H---HHHH--HhccCCCCCCCcC--CCCHHHHHHHH---HHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0 0000 0011111221111 11234555555 9999999999999999999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=7.7e-14 Score=133.01 Aligned_cols=118 Identities=29% Similarity=0.398 Sum_probs=78.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||.......+.++||||||++++||+||+.|+...... .... .+.+
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~--~i~~ 230 (279)
T 2w5a_A 156 KLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAG--KIRE 230 (279)
T ss_dssp EECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH--HHHH
T ss_pred EEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHH--HHhh
Confidence 4689999987754332223456899999999998888999999999999999999999997532110 0000 0000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..-+.++ ....+++.++++ .|++.+|++||++.||++.+....
T Consensus 231 ~~~~~~~---~~~~~~l~~li~---~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 231 GKFRRIP---YRYSDELNEIIT---RMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp TCCCCCC---TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred cccccCC---cccCHHHHHHHH---HHcCCCcccCCCHHHHHhChhhhh
Confidence 0111121 112355666666 999999999999999988765543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.27 E-value=4.4e-13 Score=131.45 Aligned_cols=117 Identities=27% Similarity=0.391 Sum_probs=80.6
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......++..|+|||...+...+.++||||||++++||+| |+.|+...... .... .
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~--~ 271 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---ELFK--L 271 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH--H
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---HHHH--H
Confidence 4789999987754321 1223456788999999988889999999999999999999 99997532110 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+.....+..+ .....++..+++ .|++.+|++||++.||++.|+.+
T Consensus 272 ~~~~~~~~~~---~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 272 LKEGHRMDKP---ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCCC---ccCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHH
Confidence 0000111111 112245666666 99999999999999999999886
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=8e-13 Score=132.11 Aligned_cols=61 Identities=30% Similarity=0.432 Sum_probs=49.3
Q ss_pred ccccCcccccCCC----CCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPD----SSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~----~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
++|||+++.+... ....+...||..|+|||...+. .++.++||||+||+++||+||+.|+.
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 6999999987432 1223457899999999987765 46899999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.4e-13 Score=129.65 Aligned_cols=114 Identities=20% Similarity=0.197 Sum_probs=63.8
Q ss_pred cccccCcccccCCCCCC------------cccccccccccCcccc---ccceecccceeeeeceeeeehhcCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSN------------WTGFAGTYGYIAPELA---YTMKITEKCDVYSFGVLVLEVIKGKHPRDFLS 434 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~------------~~~~~gt~gy~aPE~~---~~~~~s~k~Dvysfgv~llElltg~~p~~~~~ 434 (502)
..+|||+++........ .....||..|+|||.. ....++.++|||||||+++||+||+.|++...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 47899999887542211 1134588999999998 56678899999999999999999999985321
Q ss_pred CCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 435 STSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 435 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
... ... ........ .....++..+++ .|++.+|++||++.||++.|+.+
T Consensus 258 ~~~---~~~-----~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 258 KLR---IVN-----GKYSIPPH---DTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ----------------CCCCTT---CCSSGGGHHHHH---HHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH---hhc-----CcccCCcc---cccchHHHHHHH---HHccCChhhCcCHHHHHHHHHHH
Confidence 110 000 00000000 011133455555 99999999999999999999886
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.26 E-value=6e-13 Score=129.63 Aligned_cols=118 Identities=21% Similarity=0.304 Sum_probs=80.2
Q ss_pred cccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++........ .....++..|+|||...+...+.++||||+|++++||+| |+.|+...... ..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~ 249 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------QV 249 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--------HH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--------HH
Confidence 46899999876432211 122346788999999988889999999999999999999 88887532110 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
...+.............+++..+++ .|++.+|++||++.||++.|++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 LRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHH---HHcCCCcccCcCHHHHHHHHHHhh
Confidence 0111111111111122345666666 999999999999999999998863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=4.6e-13 Score=130.85 Aligned_cols=126 Identities=23% Similarity=0.287 Sum_probs=81.8
Q ss_pred ccccccCcccccCCCCC---CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCC-----CC-C
Q 010736 369 NITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSST-----SS-P 439 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~-----~~-~ 439 (502)
-..+|||+++....... ......|+..|+|||...+...+.++||||+|++++||+||+.|+...... .. .
T Consensus 166 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 245 (327)
T 3lxl_A 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245 (327)
T ss_dssp EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred EEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc
Confidence 34789999998754332 122345788899999999889999999999999999999999996421100 00 0
Q ss_pred CCCcccccccccCCCC-CCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 440 SLNTDIALDEMLDPRL-PVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 440 ~~~~~~~~~~~~d~~l-~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.........+.+.... ........+++.++++ .|++.+|++||++.||++.|+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp -CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHC
T ss_pred ccccHHHHHHHhhcccCCCCCCcccHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHH
Confidence 0000000011111111 0001122345666666 99999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.25 E-value=6e-13 Score=132.81 Aligned_cols=103 Identities=13% Similarity=0.125 Sum_probs=72.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-----------eecccceeeeeceeeeehhcCCCCCCcccCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-----------KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS 438 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-----------~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~ 438 (502)
..+|||+++.... ..+...| .+|+|||..... .++.++|||||||+++||+||+.|+........
T Consensus 246 kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~ 321 (377)
T 3byv_A 246 FLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG 321 (377)
T ss_dssp EECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC
T ss_pred EEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc
Confidence 4799999986432 2234567 999999999887 899999999999999999999999753221111
Q ss_pred CCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 439 PSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 439 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+.. ... ...+++..+++ .|++.+|++||++.|+++
T Consensus 322 --------~~~~~~-~~~----~~~~~~~~li~---~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 322 --------SEWIFR-SCK----NIPQPVRALLE---GFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp --------SGGGGS-SCC----CCCHHHHHHHH---HHTCSSGGGCCCHHHHHT
T ss_pred --------hhhhhh-hcc----CCCHHHHHHHH---HHcCCCchhCCCHHHHhh
Confidence 011111 111 12245666666 999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.25 E-value=9.7e-13 Score=132.32 Aligned_cols=117 Identities=26% Similarity=0.325 Sum_probs=73.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCC-CCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSP-SLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~-~~~~~~~~~ 448 (502)
.++|||+++...... ..+...||..|+|||......++.++|||||||+++||+||+.|+......... .........
T Consensus 204 kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~ 282 (400)
T 1nxk_A 204 KLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282 (400)
T ss_dssp EECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred EEEecccccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence 378999998765322 234567899999999999889999999999999999999999998533221110 000000000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+. ... ....+++..+++ .|++.+|++||++.||++
T Consensus 283 ~~~~~~-~~~-~~~s~~~~~li~---~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 283 QYEFPN-PEW-SEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCCCCT-TTT-TTSCHHHHHHHH---TTSCSSGGGSCCHHHHHH
T ss_pred cccCCC-ccc-ccCCHHHHHHHH---HHCCCChhHCcCHHHHhc
Confidence 110010 000 112356667777 999999999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=5.5e-13 Score=126.32 Aligned_cols=101 Identities=24% Similarity=0.400 Sum_probs=69.1
Q ss_pred cccccccccCccccccceec---ccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHH
Q 010736 389 GFAGTYGYIAPELAYTMKIT---EKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEK 465 (502)
Q Consensus 389 ~~~gt~gy~aPE~~~~~~~s---~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 465 (502)
...||..|+|||.......+ .++||||||++++||+||+.|++...... ... ........+.++. ...++
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~-~~~~~~~~~~~~~---~~~~~ 239 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---IGM-KVALEGLRPTIPP---GISPH 239 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---HHH-HHHHSCCCCCCCT---TCCHH
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---HHH-HHHhcCCCCCCCC---CCCHH
Confidence 35688999999998765444 47999999999999999999975321100 000 0001111222221 12345
Q ss_pred HHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 466 LISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 466 ~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
+.++++ .|++.+|++||+++||++.|++++.
T Consensus 240 ~~~li~---~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 240 VSKLMK---ICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHH---HHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHH---HHcCCChhhCcCHHHHHHHHHHhhc
Confidence 666666 9999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-12 Score=125.83 Aligned_cols=119 Identities=23% Similarity=0.254 Sum_probs=77.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCC-------------
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSST------------- 436 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~------------- 436 (502)
..+|||+++...... ..+...||..|+|||......++.++||||+||+++||+||+.|+......
T Consensus 160 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 160 KLADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp EECSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 368999998775433 234567899999999998888999999999999999999999998521100
Q ss_pred CCCCCCccccc-ccccCCCCCCC----CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 437 SSPSLNTDIAL-DEMLDPRLPVP----SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 437 ~~~~~~~~~~~-~~~~d~~l~~~----~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....|...... ...+.+..+.+ .....+++.++++ .|++.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL---EMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHH---HHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHH---HHhcCCCccCCCHHHHhc
Confidence 00011100000 00011110000 0012245556666 999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.24 E-value=4.1e-13 Score=132.08 Aligned_cols=117 Identities=23% Similarity=0.328 Sum_probs=78.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||......++.++||||+||+++||+||+.|+..........+........
T Consensus 160 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 239 (342)
T 2qr7_A 160 RICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239 (342)
T ss_dssp EECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC
T ss_pred EEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC
Confidence 36899999987654444445678999999999988889999999999999999999999985321110000000000000
Q ss_pred c-cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 M-LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~-~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
. ...... ....+++..+++ .|++.+|++||++.||++
T Consensus 240 ~~~~~~~~---~~~s~~~~~li~---~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 240 FSLSGGYW---NSVSDTAKDLVS---KMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCCCSTTT---TTSCHHHHHHHH---HHTCSSTTTSCCHHHHTT
T ss_pred cccCcccc---ccCCHHHHHHHH---HHCCCChhHCcCHHHHhc
Confidence 0 000010 112356667777 999999999999999865
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=9.7e-13 Score=129.59 Aligned_cols=114 Identities=28% Similarity=0.470 Sum_probs=74.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC-cccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN-TDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~-~~~~~~ 448 (502)
..+|||+++.............||..|+|||......++.++|+||+||+++||+||+.|++........... ......
T Consensus 150 kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (345)
T 3a8x_A 150 KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 229 (345)
T ss_dssp EECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH
T ss_pred EEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH
Confidence 3689999987543333344578999999999999888999999999999999999999998643221111000 000011
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
.+......-+ .....++..+++ .|++.+|++||+.
T Consensus 230 ~i~~~~~~~p-~~~s~~~~~li~---~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 230 VILEKQIRIP-RSLSVKAASVLK---SFLNKDPKERLGC 264 (345)
T ss_dssp HHHHCCCCCC-TTSCHHHHHHHH---HHTCSSTTTSTTC
T ss_pred HHHcCCCCCC-CCCCHHHHHHHH---HHhcCCHhHCCCC
Confidence 1111111111 112345666766 9999999999995
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=4.9e-13 Score=129.15 Aligned_cols=113 Identities=27% Similarity=0.441 Sum_probs=78.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||.......+.++||||||++++||+||+.|+....... .. ..+..
T Consensus 159 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~--~~~~~ 233 (303)
T 3a7i_A 159 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VL--FLIPK 233 (303)
T ss_dssp EECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH--HHHHH
T ss_pred EEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HH--HHhhc
Confidence 47899999877654333345678999999999998899999999999999999999999975321100 00 00001
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
...+.+.. ....++..+++ .|++.+|++||++.||++.
T Consensus 234 ~~~~~~~~---~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 234 NNPPTLEG---NYSKPLKEFVE---ACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SCCCCCCS---SCCHHHHHHHH---HHCCSSGGGSCCHHHHTTC
T ss_pred CCCCCCcc---ccCHHHHHHHH---HHcCCChhhCcCHHHHhhC
Confidence 11112211 12245666666 9999999999999999763
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.24 E-value=7.6e-10 Score=110.93 Aligned_cols=280 Identities=13% Similarity=0.075 Sum_probs=186.2
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCc-------------------
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQ------------------- 130 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~------------------- 130 (502)
..++.+.++. +++ .|...+|.++++|+.++|..+ ++.+-...|.++++|+.+.+..+-
T Consensus 71 ~~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~~~~~ 147 (394)
T 4fs7_A 71 RKVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKEITIP 147 (394)
T ss_dssp TTEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSEEECC
T ss_pred CCceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccccccccC
Confidence 3688899874 354 677778999999999999865 665666778888888887765431
Q ss_pred --CcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccc---
Q 010736 131 --FSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSG--- 205 (502)
Q Consensus 131 --l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--- 205 (502)
.......+|.++++|+.+.+.++. .......|..+.+|+.+.+..| ++......|.++..|+.+.+..+...-
T Consensus 148 ~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~ 225 (394)
T 4fs7_A 148 EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDF 225 (394)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTT
T ss_pred ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehh
Confidence 111123457888999999997664 3355567888899999988766 554555667777777777665543221
Q ss_pred ------------------cCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccE
Q 010736 206 ------------------FIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTK 266 (502)
Q Consensus 206 ------------------~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~ 266 (502)
.-...+..+..++.+.+..+... .....|..+..++.+....+.+.. ..+.. ..|+.
T Consensus 226 ~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~---~~F~~~~~L~~ 301 (394)
T 4fs7_A 226 ALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE---KTFYGCSSLTE 301 (394)
T ss_dssp TTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT---TTTTTCTTCCE
T ss_pred hcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc---ccccccccccc
Confidence 11122333444444444433221 223344555555555554433221 12222 57888
Q ss_pred EECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCccc
Q 010736 267 LSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNF 346 (502)
Q Consensus 267 L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 346 (502)
+.+..+ ++.+....|..+.+|+.+++..+ ++..-..+|.+|.+|+.+.+..+ ++.....+|..+++|+.+++..+ +
T Consensus 302 i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~ 377 (394)
T 4fs7_A 302 VKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-L 377 (394)
T ss_dssp EEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-G
T ss_pred cccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-C
Confidence 888654 66666677888999999999754 66555678999999999999876 77677789999999999999765 3
Q ss_pred ccccCccccCCCCCCee
Q 010736 347 YGEISSNFGECPKLGAL 363 (502)
Q Consensus 347 ~~~~~~~~~~~~~L~~L 363 (502)
. .+..+|.++++|+.+
T Consensus 378 ~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 378 E-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp G-GGGGGBCTTCEEEEE
T ss_pred E-EhhheecCCCCCcEE
Confidence 3 334567777777654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.24 E-value=2.2e-12 Score=123.64 Aligned_cols=119 Identities=24% Similarity=0.270 Sum_probs=72.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCC------------
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSST------------ 436 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~------------ 436 (502)
..+|||+++.........+...||..|+|||...+. ..+.++||||+||+++||+||+.|+......
T Consensus 140 kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 219 (288)
T 1ob3_A 140 KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219 (288)
T ss_dssp EECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCC
Confidence 468999998775433333455789999999998654 5899999999999999999999998532100
Q ss_pred -CCCCCCcccccccccCCCCCCC--------CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 437 -SSPSLNTDIALDEMLDPRLPVP--------SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 437 -~~~~~~~~~~~~~~~d~~l~~~--------~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+... ......++..... .....+++..+++ .|++.+|++||+++|+++
T Consensus 220 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 220 PNSKNWPNV-TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTTSTTG-GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHH---HHTCSSTTTSCCHHHHHT
T ss_pred CChhhchhh-hcccccccccccccCccHHHHhhhcCHHHHHHHH---HHcCCCcccCCCHHHHhc
Confidence 00001000 0000111111100 0112345666666 999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=5.4e-13 Score=130.36 Aligned_cols=126 Identities=24% Similarity=0.339 Sum_probs=82.0
Q ss_pred cccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCccc-------CCCCC
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLS-------STSSP 439 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~-------~~~~~ 439 (502)
..+|||+++........ .....++..|+|||...+...+.++||||||++++||+||+.|..... .....
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCC
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccc
Confidence 46899999887543321 123456778999999998899999999999999999999998864210 00000
Q ss_pred CCCcccccccccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 440 SLNTDIALDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 440 ~~~~~~~~~~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
.......+.+.+.. +.+.+ ....+++..+++ .|++.+|++||++.||+++|+.++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~---~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 265 GQMIVFHLIELLKNNGRLPRP-DGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp THHHHHHHHHHHHTTCCCCCC-TTCCHHHHHHHH---HHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHhhcCCCCCCC-CcccHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00000000111111 11111 122355666666 9999999999999999999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=3.5e-13 Score=131.19 Aligned_cols=126 Identities=21% Similarity=0.271 Sum_probs=81.6
Q ss_pred cccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCC-----CCC-C
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSST-----SSP-S 440 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~-----~~~-~ 440 (502)
..+|||+++........ .....++..|+|||.......+.++||||+|++++||+||+.|+...... ... .
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 253 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence 46899999987543321 22345778899999999999999999999999999999999997521100 000 0
Q ss_pred CCcccccccccCCCCC-CCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 441 LNTDIALDEMLDPRLP-VPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 441 ~~~~~~~~~~~d~~l~-~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
........+.++.... ........++.++++ .|++.+|++||++.||++.|+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMK---NCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHHHHHhcccCCCCCccccHHHHHHHH---HHcCCCcccCcCHHHHHHHHHHHH
Confidence 0000001111111110 011122355666666 999999999999999999998863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.23 E-value=1.5e-12 Score=127.78 Aligned_cols=111 Identities=24% Similarity=0.367 Sum_probs=77.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||......++.++|+||+||+++||+||+.|+..... ......
T Consensus 145 kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~ 216 (337)
T 1o6l_A 145 KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFEL 216 (337)
T ss_dssp EECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHH
Confidence 468999998754433344557899999999999988899999999999999999999999742110 000011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
+......-+ .....++..+++ .|++.+|++|| +++||.+
T Consensus 217 i~~~~~~~p-~~~s~~~~~li~---~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 217 ILMEEIRFP-RTLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHCCCCCC-TTSCHHHHHHHH---HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHcCCCCCC-CCCCHHHHHHHH---HHhhcCHHHhcCCCCCCHHHHHc
Confidence 111111111 112356677777 99999999999 8888854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-12 Score=134.07 Aligned_cols=122 Identities=23% Similarity=0.351 Sum_probs=82.1
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p 429 (502)
++.|.||+..|| ++|||+++.............||.+|+|||...+..++.++|||||||+++||+||+.|
T Consensus 269 giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 348 (446)
T 4ejn_A 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348 (446)
T ss_dssp CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCC
Confidence 455556655444 68999998765444444567899999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
+..... ......+......-+ .....++..+++ .|++.+|++|| ++.|+++
T Consensus 349 f~~~~~--------~~~~~~i~~~~~~~p-~~~~~~~~~li~---~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 349 FYNQDH--------EKLFELILMEEIRFP-RTLGPEAKSLLS---GLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp SCCSSH--------HHHHHHHHHCCCCCC-TTSCHHHHHHHH---HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCH--------HHHHHHHHhCCCCCC-ccCCHHHHHHHH---HHcccCHHHhCCCCCCCHHHHHh
Confidence 742110 000011111111111 112245667776 99999999999 9998864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.23 E-value=6.4e-13 Score=126.83 Aligned_cols=114 Identities=24% Similarity=0.366 Sum_probs=82.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....|+.+|+|||...+...+.++||||||++++||+||+.|..... .....
T Consensus 162 kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------~~~~~ 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----------KFFTD 230 (284)
T ss_dssp EECCCTTCEESSCCSC-CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------HHHHH
T ss_pred EECcchhheecccccc-ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------HHHHH
Confidence 4789999988754332 234568999999999998889999999999999999999998853110 00011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCC
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPS 500 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~ 500 (502)
+.+..+.. ....++..+++ .|++.+|++||++.|+++.|+..+.+
T Consensus 231 ~~~~~~~~---~~~~~~~~li~---~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 231 LRDGIISD---IFDKKEKTLLQ---KLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHTTCCCT---TSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred hhcccccc---cCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11111211 11244556666 99999999999999999999987653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.8e-12 Score=128.05 Aligned_cols=43 Identities=35% Similarity=0.505 Sum_probs=37.9
Q ss_pred cccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 389 GFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 389 ~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
...||++|+|||...+. .++.++||||+||+++||+||+.|+.
T Consensus 205 ~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 205 PRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp -CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 35799999999988765 48899999999999999999999984
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=4.5e-13 Score=132.14 Aligned_cols=110 Identities=28% Similarity=0.474 Sum_probs=74.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++..... ....||..|+|||... ...++.++|||||||+++||+||+.|+...... .... .
T Consensus 194 kL~DfG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~~~--~ 264 (348)
T 1u5q_A 194 KLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALY--H 264 (348)
T ss_dssp EECCCTTCBSSSSB----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH--H
T ss_pred EEeeccCceecCCC----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHH--H
Confidence 36899999876542 2357899999999974 567889999999999999999999997421100 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
+..-..+.... ....+++..+++ .|++.+|++||++.|+++.
T Consensus 265 ~~~~~~~~~~~--~~~~~~l~~li~---~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 265 IAQNESPALQS--GHWSEYFRNFVD---SCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHSCCCCCCC--TTSCHHHHHHHH---HHTCSSGGGSCCHHHHTTC
T ss_pred HHhcCCCCCCC--CCCCHHHHHHHH---HHcccChhhCcCHHHHhhC
Confidence 00111111111 112345666666 9999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1e-12 Score=125.21 Aligned_cols=111 Identities=24% Similarity=0.391 Sum_probs=56.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||.......+.++||||||++++||+||+.|++....... ......
T Consensus 152 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~-- 226 (278)
T 3cok_A 152 KIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---LNKVVL-- 226 (278)
T ss_dssp EECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCS--
T ss_pred EEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---HHHHhh--
Confidence 478999998775433333346789999999999888899999999999999999999999863221110 000000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+...+. ....++..+++ .|++.+|++||++.||++
T Consensus 227 -~~~~~~~---~~~~~~~~li~---~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 -ADYEMPS---FLSIEAKDLIH---QLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -SCCCCCT---TSCHHHHHHHH---HHSCSSGGGSCCHHHHTT
T ss_pred -cccCCcc---ccCHHHHHHHH---HHcccCHhhCCCHHHHhc
Confidence 1111111 12245666666 999999999999999965
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-12 Score=139.89 Aligned_cols=128 Identities=22% Similarity=0.383 Sum_probs=83.7
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GK 427 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~ 427 (502)
++.|.||+..|| .+|||+++....... ......++..|+|||......++.++|||||||+++||+| |+
T Consensus 511 givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~ 590 (656)
T 2j0j_A 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 590 (656)
T ss_dssp TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCC
Confidence 455666665554 689999998754322 1223456789999999988899999999999999999997 99
Q ss_pred CCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 428 HPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 428 ~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.|+...... .... .+.....+.++ .....++..++. .|++.+|++||++.||+++|+.+
T Consensus 591 ~Pf~~~~~~---~~~~--~i~~~~~~~~~---~~~~~~l~~li~---~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 591 KPFQGVKNN---DVIG--RIENGERLPMP---PNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CTTTTCCHH---HHHH--HHHHTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHH---HHHH--HHHcCCCCCCC---ccccHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHH
Confidence 997532110 0000 00000011111 112245666666 99999999999999999999876
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.23 E-value=7.4e-13 Score=130.82 Aligned_cols=111 Identities=20% Similarity=0.267 Sum_probs=77.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||......++.++||||+||+++||+||+.|+..... .....
T Consensus 173 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~ 243 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEG 243 (351)
T ss_dssp EECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHH
T ss_pred EEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHH
Confidence 368999998876544334456799999999999988899999999999999999999999753110 00011
Q ss_pred ccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+......... ....+++..+++ .|++.+|++||++.|+++
T Consensus 244 i~~~~~~~~~~~~~~~s~~~~~li~---~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 244 IIKGKYKMNPRQWSHISESAKDLVR---RMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHH---HHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCCCCccccccCCHHHHHHHH---HHCCCChhHCcCHHHHhc
Confidence 1111110000 011245666666 999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.22 E-value=9.1e-13 Score=138.21 Aligned_cols=112 Identities=22% Similarity=0.275 Sum_probs=77.5
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc-
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE- 449 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~- 449 (502)
++|||+++.+..... .....||+.|+|||...+..++.++|+||+||+++||+||+.|+...... .........+
T Consensus 298 l~DFG~a~~~~~~~~-~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i~~~~~ 373 (573)
T 3uto_A 298 LIDFGLTAHLDPKQS-VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDW 373 (573)
T ss_dssp ECCCSSCEECCTTSE-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTTCC
T ss_pred EeeccceeEccCCCc-eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHhCCC
Confidence 689999998865432 34567999999999999999999999999999999999999998521110 0000000000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
-+++... ....++...+++ .|++.+|++||++.|+++
T Consensus 374 ~~~~~~~---~~~s~~~~dli~---~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 NMDDSAF---SGISEDGKDFIR---KLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCSGGG---TTSCHHHHHHHH---TTSCSSGGGSCCHHHHHH
T ss_pred CCCcccc---cCCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 0111110 112245667777 999999999999999865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=6.3e-13 Score=129.01 Aligned_cols=109 Identities=25% Similarity=0.293 Sum_probs=71.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-.++|||+++...... ......||.+|+|||...+ ..+.++|||||||+++||+||+.|....... ..+ ..
T Consensus 196 ~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~-----~~ 266 (311)
T 3p1a_A 196 CKLGDFGLLVELGTAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW--QQL-----RQ 266 (311)
T ss_dssp EEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH--HHH-----TT
T ss_pred EEEccceeeeecccCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHH-----hc
Confidence 3479999998775432 2234569999999998875 7899999999999999999997764311000 000 00
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+.... ...+++..+++ .|++.+|++||+++|+++
T Consensus 267 ~~~~~~~~~---~~~~~l~~li~---~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 267 GYLPPEFTA---GLSSELRSVLV---MMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TCCCHHHHT---TSCHHHHHHHH---HHSCSSTTTSCCHHHHHT
T ss_pred cCCCccccc---CCCHHHHHHHH---HHcCCChhhCcCHHHHHh
Confidence 011111110 11245566666 999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=7.9e-13 Score=129.22 Aligned_cols=117 Identities=26% Similarity=0.360 Sum_probs=78.5
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++....... ......|+.+|+|||.......+.++||||||++++||+| |+.|+...... ..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~ 254 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EV 254 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------HH
Confidence 3689999886543221 1223567889999999988889999999999999999999 89987531110 00
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
...+.............+++..+++ .|++.+|++||++.||++.|+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 255 LEFVTSGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHH---HHhcCChhhCcCHHHHHHHHHHH
Confidence 0001110000011112345666666 99999999999999999999876
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.22 E-value=9.8e-13 Score=128.62 Aligned_cols=111 Identities=23% Similarity=0.351 Sum_probs=76.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceec-ccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKIT-EKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s-~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
-.++|||+++...... ......||.+|+|||...+.... .++||||+||+++||+||+.|++..... ...
T Consensus 153 ~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~ 223 (328)
T 3fe3_A 153 IKIADFGFSNEFTVGG-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--------ELR 223 (328)
T ss_dssp EEECSTTCCGGGSSSC-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH
T ss_pred EEEeeccCceecCCCC-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence 3479999998775432 23456799999999999887765 7899999999999999999998532100 000
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+.......+. ....++..+++ .|++.+|++||++.|+++
T Consensus 224 ~~i~~~~~~~p~-~~s~~~~~li~---~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 224 ERVLRGKYRIPF-YMSTDCENLLK---RFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHCCCCCCT-TSCHHHHHHHH---HHCCSSTTTSCCHHHHTT
T ss_pred HHHHhCCCCCCC-CCCHHHHHHHH---HHCCCChhHCcCHHHHhc
Confidence 111111111111 12245666666 999999999999999965
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.9e-12 Score=127.00 Aligned_cols=105 Identities=25% Similarity=0.409 Sum_probs=76.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++....... .....||.+|+|||...+... +.++|||||||+++||+||+.|+.....
T Consensus 170 kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------- 235 (335)
T 3dls_A 170 KLIDFGSAAYLERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------- 235 (335)
T ss_dssp EECCCTTCEECCTTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------
T ss_pred EEeecccceECCCCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------
Confidence 4689999988765432 234679999999999887776 7899999999999999999999753211
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
........+ ....+++..+++ .|++.+|++||++.|+++.
T Consensus 236 -~~~~~~~~~-~~~~~~l~~li~---~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -TVEAAIHPP-YLVSKELMSLVS---GLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -GTTTCCCCS-SCCCHHHHHHHH---HHTCSSGGGSCCHHHHHHC
T ss_pred -HHhhccCCC-cccCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence 011111101 112245666766 9999999999999999763
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-12 Score=127.10 Aligned_cols=115 Identities=26% Similarity=0.352 Sum_probs=56.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccc----ccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELA----YTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~----~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++....... .....|+..|+|||.. ....++.++||||||++++||+||+.|++...... ... ..
T Consensus 166 kl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~-~~- 241 (327)
T 3aln_A 166 KLCDFGISGQLVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-DQL-TQ- 241 (327)
T ss_dssp EECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CC-
T ss_pred EEccCCCceecccccc-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-HHH-HH-
Confidence 3689999987654322 2334689999999998 45668899999999999999999999986322110 000 00
Q ss_pred ccccccCCCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 446 ALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 446 ~~~~~~d~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+.+... ......++..+++ .|++.+|++||++.||++
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 242 -VVKGDPPQLSNSEEREFSPSFINFVN---LCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCSCCCCCCCCSSCCCCHHHHHHHH---HHTCSSGGGSCCHHHHTT
T ss_pred -HhcCCCCCCCCcccccCCHHHHHHHH---HHhhCChhhCcCHHHHHh
Confidence 000011111110 0112345666666 999999999999999865
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.21 E-value=7.5e-13 Score=133.77 Aligned_cols=102 Identities=13% Similarity=0.122 Sum_probs=72.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccc----------ccceecccceeeeeceeeeehhcCCCCCCcccCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELA----------YTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSP 439 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~----------~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~ 439 (502)
.++|||+++..... .....| .+|+|||.. ....++.++|||||||+++||+||+.|+.......
T Consensus 251 kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~-- 324 (413)
T 3dzo_A 251 FLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG-- 324 (413)
T ss_dssp EECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS--
T ss_pred EEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh--
Confidence 37999998876433 234567 999999998 66678999999999999999999999985322111
Q ss_pred CCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHH
Q 010736 440 SLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491 (502)
Q Consensus 440 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~ 491 (502)
....++... . ...+++..+++ .|++.+|++||++.|++
T Consensus 325 ------~~~~~~~~~-~----~~~~~~~~li~---~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 325 ------GSEWIFRSC-K----NIPQPVRALLE---GFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp ------CSGGGGSSC-C----CCCHHHHHHHH---HHTCSSGGGSCCHHHHT
T ss_pred ------hHHHHHhhc-c----cCCHHHHHHHH---HHccCChhhCcCHHHHH
Confidence 011111111 0 12255666666 99999999999977764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=6.3e-13 Score=129.21 Aligned_cols=124 Identities=23% Similarity=0.383 Sum_probs=80.9
Q ss_pred ccccccCcccccCCCCCC---------cccccccccccCccccccc---eecccceeeeeceeeeehhcCCCCCCcccCC
Q 010736 369 NITGDFGIAKFLKPDSSN---------WTGFAGTYGYIAPELAYTM---KITEKCDVYSFGVLVLEVIKGKHPRDFLSST 436 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~---------~~~~~gt~gy~aPE~~~~~---~~s~k~Dvysfgv~llElltg~~p~~~~~~~ 436 (502)
-..+|||+++........ .....|+..|+|||..... .++.++||||||++++||+||+.|++.....
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 252 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence 346899988765321110 1234578999999997643 4788999999999999999999998532111
Q ss_pred CCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCCC
Q 010736 437 SSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPSL 501 (502)
Q Consensus 437 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~~ 501 (502)
.. .... .... ....+.. ....+++.++++ .|++.+|++||++.||++.|+.++++.
T Consensus 253 ~~-~~~~--~~~~--~~~~~~~-~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 253 GD-SVAL--AVQN--QLSIPQS-PRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp TS-CHHH--HHHC--C--CCCC-TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred cc-hhhH--Hhhc--cCCCCcc-ccCCHHHHHHHH---HHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00 0000 0000 0011111 112345666666 999999999999999999999987753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-12 Score=125.91 Aligned_cols=113 Identities=27% Similarity=0.468 Sum_probs=71.0
Q ss_pred cccccCcccccCCCCCC--cccccccccccCcccccc-----------ceecccceeeeeceeeeehhcCCCCCCcccCC
Q 010736 370 ITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYT-----------MKITEKCDVYSFGVLVLEVIKGKHPRDFLSST 436 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~-----------~~~s~k~Dvysfgv~llElltg~~p~~~~~~~ 436 (502)
..+|||+++........ .....|+..|+|||.... ...+.++||||||++++||+||+.|++....
T Consensus 166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~- 244 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN- 244 (313)
T ss_dssp EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-
T ss_pred EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-
Confidence 36899999877543221 224568999999999865 4688899999999999999999999753211
Q ss_pred CCCCCCcccccccccCCCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 437 SSPSLNTDIALDEMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 437 ~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.......++++..... .....+++..+++ .|++.+|++||++.||++
T Consensus 245 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 245 ------QISKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLA 292 (313)
T ss_dssp ------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHH---HHTCSSTTTSCCHHHHHT
T ss_pred ------HHHHHHHHHhcccccCCcccchHHHHHHHH---HHccCCcccCcCHHHHhc
Confidence 0001112222221110 0112345666666 999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.21 E-value=3e-13 Score=132.17 Aligned_cols=119 Identities=21% Similarity=0.317 Sum_probs=60.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||.+|+|||......++.++||||+||+++||+||+.|++.......... .......
T Consensus 149 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~~ 227 (325)
T 3kn6_A 149 KIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS-AVEIMKK 227 (325)
T ss_dssp EECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC-HHHHHHH
T ss_pred EEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc-HHHHHHH
Confidence 368999999876554444556789999999999988999999999999999999999999863221100000 0000111
Q ss_pred ccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+......... ....+++..+++ .|++.+|++||++.||++
T Consensus 228 i~~~~~~~~~~~~~~~s~~~~~li~---~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 228 IKKGDFSFEGEAWKNVSQEAKDLIQ---GLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTTTCCCCCSHHHHTSCHHHHHHHH---HHHCCCTTTCCCTTTSTT
T ss_pred HHcCCCCCCcccccCCCHHHHHHHH---HHCCCChhHCCCHHHHhc
Confidence 1221111110 011245666666 999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-12 Score=127.16 Aligned_cols=116 Identities=22% Similarity=0.308 Sum_probs=77.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++...... ......++..|+|||.......+.++||||+|++++||+| |+.|+...... .... .+.
T Consensus 182 kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~--~~~ 255 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE--KLP 255 (327)
T ss_dssp EECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH--HGG
T ss_pred EEcccCcCccccccc-cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHH--Hhh
Confidence 368999987543221 1223456789999999988889999999999999999999 99997532110 0000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.-..+..+ ....+++..+++ .|++.+|++||++.|+++.|+.+
T Consensus 256 ~~~~~~~~---~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 256 QGYRLEKP---LNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp GTCCCCCC---TTBCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCC---CCCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHH
Confidence 10111111 122355666666 99999999999999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.9e-12 Score=130.11 Aligned_cols=113 Identities=27% Similarity=0.381 Sum_probs=69.4
Q ss_pred ccccCcccccCCCCC---CcccccccccccCccccc---cceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCc
Q 010736 371 TGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~ 443 (502)
.+|||+++.+..... ..+...||.+|+|||... ....+.++|||||||+++||+| |+.|+....... .
T Consensus 164 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----~ 238 (432)
T 3p23_A 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----A 238 (432)
T ss_dssp ECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----H
T ss_pred EecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----H
Confidence 689999998754321 234567999999999987 4567789999999999999999 899874211000 0
Q ss_pred ccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...... .......+.......+..+++ .|++.+|++||++.||++
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 239 NILLGA-CSLDCLHPEKHEDVIARELIE---KMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHTTC-CCCTTSCTTCHHHHHHHHHHH---HHSCSSGGGSCCHHHHHT
T ss_pred HHHhcc-CCccccCccccccHHHHHHHH---HHHhCCHhhCCCHHHHHh
Confidence 000000 001111111122233455555 999999999999999973
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.20 E-value=1.2e-12 Score=125.46 Aligned_cols=113 Identities=27% Similarity=0.405 Sum_probs=65.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccc----ccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELA----YTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~----~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++....... .....||..|+|||.. .....+.++||||+|++++||+||+.|++..... .....
T Consensus 150 kl~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~ 224 (290)
T 3fme_A 150 KMCDFGISGYLVDDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQLK 224 (290)
T ss_dssp EBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHHHH
T ss_pred EEeecCCccccccccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHHHH
Confidence 4789999987754322 2234689999999995 5667889999999999999999999998531110 00000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.......+.... ....+++..+++ .|++.+|++||++.||++
T Consensus 225 ~~~~~~~~~~~~--~~~~~~~~~li~---~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 225 QVVEEPSPQLPA--DKFSAEFVDFTS---QCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHSCCCCCCT--TTSCHHHHHHHH---HHTCSSGGGSCCHHHHTT
T ss_pred HHhccCCCCccc--ccCCHHHHHHHH---HHhhcChhhCcCHHHHHh
Confidence 000001111111 112345666666 999999999999999976
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=2.9e-12 Score=124.26 Aligned_cols=120 Identities=18% Similarity=0.198 Sum_probs=75.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCCC----------
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS---------- 438 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~---------- 438 (502)
..+|||+++.........+...||..|+|||...+ ...+.++||||+||+++||+||+.|+........
T Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 238 (311)
T 3niz_A 159 KLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238 (311)
T ss_dssp EECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCC
T ss_pred EEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCC
Confidence 46899999987644444455678999999999865 4679999999999999999999999853221110
Q ss_pred ---CCCCccccc-------ccccCCCCC-CCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 439 ---PSLNTDIAL-------DEMLDPRLP-VPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 439 ---~~~~~~~~~-------~~~~d~~l~-~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+...... ....+.... .......+++.++++ .|++.+|++||+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLS---NMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHH---HHSCSCTTTSCCHHHHHT
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHH---HHcCCChhHCCCHHHHhc
Confidence 000000000 000000000 000011235556666 999999999999999976
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.20 E-value=1.5e-12 Score=129.21 Aligned_cols=113 Identities=27% Similarity=0.446 Sum_probs=76.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... ......||.+|+|||......++.++||||+||+++||+||+.|+...... ....... ..
T Consensus 171 kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~-~~ 245 (362)
T 2bdw_A 171 KLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIK-AG 245 (362)
T ss_dssp EECCCTTCBCCTTCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-HT
T ss_pred EEeecCcceEecCCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH-hC
Confidence 368999998775432 234568999999999999888999999999999999999999997421100 0000000 00
Q ss_pred ccCCCCCCCC-cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~-~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+ .+.+. ....+++..+++ .|++.+|++||++.|+++
T Consensus 246 ~~~--~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 246 AYD--YPSPEWDTVTPEAKSLID---SMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCC--CCTTGGGGSCHHHHHHHH---HHSCSSGGGSCCHHHHTT
T ss_pred CCC--CCcccccCCCHHHHHHHH---HHcCCChhhCcCHHHHhc
Confidence 000 00000 112345666666 999999999999999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.1e-12 Score=129.44 Aligned_cols=112 Identities=21% Similarity=0.269 Sum_probs=67.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... ......||.+|+|||...+..++.++|||||||+++||+||+.|+...... ......
T Consensus 191 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~ 262 (349)
T 2w4o_A 191 KIADFGLSKIVEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRR 262 (349)
T ss_dssp EECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHH
T ss_pred EEccCccccccCccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHH
Confidence 468999998765432 223467899999999999888999999999999999999999997421110 000011
Q ss_pred ccCCCC--CCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRL--PVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l--~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+..... ..+ ......++..+++ .|++.+|++||++.|+++
T Consensus 263 i~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 263 ILNCEYYFISPWWDEVSLNAKDLVR---KLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHTTCCCCCTTTTTTSCHHHHHHHH---TTSCSSGGGSCCHHHHHH
T ss_pred HHhCCCccCCchhhhCCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 111110 000 0112345666666 999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=7.7e-13 Score=129.09 Aligned_cols=113 Identities=25% Similarity=0.368 Sum_probs=68.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++.............|+..|+|||... ....+.++||||||++++||+||+.|+....... ..
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~ 243 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----AL 243 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----HH
Confidence 4689999987654332233457899999999986 5678899999999999999999999974211100 00
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+.....+.... ....+++..+++ .|++.+|++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~--~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 FLIPRNPAPRLKS--KKWSKKFQSFIE---SCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHSCCCCCSC--SCSCHHHHHHHH---HHCCSSGGGSCCHHHHHT
T ss_pred HHhhcCccccCCc--cccCHHHHHHHH---HHhccChhhCCCHHHHhh
Confidence 0000111111111 112356667776 999999999999999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.9e-12 Score=124.57 Aligned_cols=118 Identities=23% Similarity=0.332 Sum_probs=75.3
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++....... ......||..|+|||...+...+.++||||+|++++||+||+.|++...... .... ...
T Consensus 151 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~---~~~~-~~~ 226 (294)
T 4eqm_A 151 KIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS---IAIK-HIQ 226 (294)
T ss_dssp EECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH---HHHH-HHS
T ss_pred EEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHH-Hhh
Confidence 3689999987754322 2234578999999999998889999999999999999999999985321100 0000 000
Q ss_pred cccC---CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-CHHHHHHHHHhh
Q 010736 449 EMLD---PRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-TMKIVSQQLRIS 497 (502)
Q Consensus 449 ~~~d---~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-~m~~v~~~l~~~ 497 (502)
+... .... ....+++..++. .|++.+|++|| +++++.+.|+..
T Consensus 227 ~~~~~~~~~~~---~~~~~~l~~li~---~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 227 DSVPNVTTDVR---KDIPQSLSNVIL---RATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp SCCCCHHHHSC---TTSCHHHHHHHH---HHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred ccCCCcchhcc---cCCCHHHHHHHH---HHhcCCHhHccccHHHHHHHHHHH
Confidence 0000 0000 112245666665 99999999999 999999999876
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.19 E-value=5e-12 Score=121.33 Aligned_cols=61 Identities=20% Similarity=0.344 Sum_probs=50.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccce-ecccceeeeeceeeeehhcCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~-~s~k~Dvysfgv~llElltg~~p~ 430 (502)
..+|||+++.............||..|+|||...+.. .+.++||||+||+++||+||+.|+
T Consensus 141 kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 141 KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp EECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred EEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 4789999998764444445567899999999987765 799999999999999999998885
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=1.7e-12 Score=129.19 Aligned_cols=114 Identities=21% Similarity=0.307 Sum_probs=78.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||......++.++|+||+||+++||+||+.|+..... ......
T Consensus 179 kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~ 250 (373)
T 2r5t_A 179 VLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDN 250 (373)
T ss_dssp EECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHH
T ss_pred EEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHH
Confidence 368999998754433334457899999999999988899999999999999999999999742110 001111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
+....+.-+ .....++..+++ .|++.+|++||++.+.++.++
T Consensus 251 i~~~~~~~~-~~~~~~~~~li~---~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 251 ILNKPLQLK-PNITNSARHLLE---GLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp HHHSCCCCC-SSSCHHHHHHHH---HHTCSSGGGSTTTTTTHHHHH
T ss_pred HHhcccCCC-CCCCHHHHHHHH---HHcccCHHhCCCCCCCHHHHh
Confidence 221111111 112355667777 999999999999865554443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=4.4e-12 Score=123.32 Aligned_cols=63 Identities=25% Similarity=0.370 Sum_probs=51.6
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++.............||..|+|||...+ ...+.++||||+||+++||+||+.|+.
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 147 LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp EEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 347999999887544333445678999999999875 457899999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.7e-12 Score=125.79 Aligned_cols=120 Identities=19% Similarity=0.257 Sum_probs=70.7
Q ss_pred cccccCcccccCCCC-CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++...... .......|+..|+|||.......+.++||||||++++||+||+.|+...... .. ......
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~-~~~~~~ 249 (309)
T 2h34_A 174 YLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VM-GAHINQ 249 (309)
T ss_dssp EECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HH-HHHHHS
T ss_pred EEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HH-HHHhcc
Confidence 478999998765432 1223456899999999999888999999999999999999999997532110 00 000000
Q ss_pred cccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-CHHHHHHHHHhhcC
Q 010736 449 EMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRP-TMKIVSQQLRISAP 499 (502)
Q Consensus 449 ~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-~m~~v~~~l~~~~~ 499 (502)
....+ ... ....+++..+++ .|++.+|++|| ++.++++.|+....
T Consensus 250 ~~~~~~~~~---~~~~~~l~~li~---~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 250 AIPRPSTVR---PGIPVAFDAVIA---RGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp CCCCGGGTS---TTCCTHHHHHHH---HHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CCCCccccC---CCCCHHHHHHHH---HhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 00001 011 111235666666 99999999999 99999999988644
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.5e-12 Score=125.08 Aligned_cols=114 Identities=23% Similarity=0.364 Sum_probs=74.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccce--ecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK--ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~--~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++.............|+..|+|||...... .+.++||||||++++||+||+.|+........ .. .. ..
T Consensus 163 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~-~~-~~ 239 (295)
T 2clq_A 163 KISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AM-FK-VG 239 (295)
T ss_dssp EECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HH-HH-HH
T ss_pred EEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HH-Hh-hc
Confidence 4789999987754333334567899999999987643 78999999999999999999999753211000 00 00 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+.++. ...+++..+++ .|++.+|++||++.|+++
T Consensus 240 ~~~~~~~~~~---~~~~~~~~li~---~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 240 MFKVHPEIPE---SMSAEAKAFIL---KCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHCCCCCCCT---TSCHHHHHHHH---HTTCSSTTTSCCHHHHHT
T ss_pred cccccccccc---cCCHHHHHHHH---HHccCChhhCCCHHHHhc
Confidence 0012222221 12345666666 999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.2e-12 Score=129.30 Aligned_cols=106 Identities=26% Similarity=0.396 Sum_probs=69.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||......++.++|+||+||+++||+||+.|+..... ......
T Consensus 164 kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~ 235 (353)
T 3txo_A 164 KLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEA 235 (353)
T ss_dssp EECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 368999998754433334457899999999999988899999999999999999999999853211 001111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
+......-+ ....+++..+++ .|++.+|++||+.
T Consensus 236 i~~~~~~~p-~~~~~~~~~li~---~lL~~dP~~R~~~ 269 (353)
T 3txo_A 236 ILNDEVVYP-TWLHEDATGILK---SFMTKNPTMRLGS 269 (353)
T ss_dssp HHHCCCCCC-TTSCHHHHHHHH---HHTCSSGGGSTTS
T ss_pred HHcCCCCCC-CCCCHHHHHHHH---HHhhhCHHHccCC
Confidence 111111111 112245666776 9999999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.2e-12 Score=123.51 Aligned_cols=112 Identities=29% Similarity=0.442 Sum_probs=69.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....|+..|+|||... ...+.++||||+|++++||+||+.|+...... ..... ..
T Consensus 167 kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~---~~ 238 (285)
T 3is5_A 167 KIIDFGLAELFKSDEH-STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQK---AT 238 (285)
T ss_dssp EECCCCCCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HH
T ss_pred EEEeeecceecCCccc-CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhh---hc
Confidence 3689999987654322 23467899999999875 56889999999999999999999997531100 00000 00
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+..........+++..+++ .|++.+|++||++.||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 239 YKEPNYAVECRPLTPQAVDLLK---QMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HCCCCCCC--CCCCHHHHHHHH---HHTCSCTTTSCCHHHHHT
T ss_pred cCCcccccccCcCCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 0111111010112245666666 999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=1.3e-12 Score=125.53 Aligned_cols=111 Identities=24% Similarity=0.392 Sum_probs=78.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+.+|+|||.......+.++||||+|++++||+||+.|++..... .....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~ 226 (294)
T 2rku_A 155 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLR 226 (294)
T ss_dssp EECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred EEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 4689999988754433344567899999999998888999999999999999999999997532110 00011
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+.......+ .....++..+++ .|++.+|++||++.|+++
T Consensus 227 ~~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 227 IKKNEYSIP-KHINPVAASLIQ---KMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHTTCCCCC-TTSCHHHHHHHH---HHTCSSGGGSCCGGGGGG
T ss_pred HhhccCCCc-cccCHHHHHHHH---HHcccChhhCcCHHHHhh
Confidence 111111111 112245666666 999999999999999976
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=1.5e-12 Score=127.02 Aligned_cols=111 Identities=21% Similarity=0.305 Sum_probs=77.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... ......||+.|+|||.......+.++||||+||+++||+||+.|+...... .....
T Consensus 144 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~ 214 (321)
T 1tki_A 144 KIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIEN 214 (321)
T ss_dssp EECCCTTCEECCTTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred EEEECCCCeECCCCC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHH
Confidence 468999998875433 234467899999999999888999999999999999999999997531110 00111
Q ss_pred ccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+.......+. ....+++..+++ .|++.+|++||++.|+++
T Consensus 215 i~~~~~~~~~~~~~~~s~~~~~li~---~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 215 IMNAEYTFDEEAFKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHH---TTSCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCChhhhccCCHHHHHHHH---HHcCCChhHCcCHHHHhc
Confidence 1111111000 012245666666 999999999999999976
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.17 E-value=2.2e-12 Score=126.88 Aligned_cols=112 Identities=23% Similarity=0.280 Sum_probs=73.5
Q ss_pred cccccCcccccCCCCC----CcccccccccccCcccccc--ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 370 ITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
..+|||+++.+..... ......||..|+|||.... ..++.++||||||++++||+||+.|+......
T Consensus 210 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------- 282 (345)
T 3hko_A 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------- 282 (345)
T ss_dssp EECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred EEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-------
Confidence 4689999987643111 2234679999999999865 67889999999999999999999997532110
Q ss_pred ccccccccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+......... ....+++..+++ .|++.+|++||++.|+++
T Consensus 283 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 283 -DTISQVLNKKLCFENPNYNVLSPLARDLLS---NLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp -HHHHHHHHCCCCTTSGGGGGSCHHHHHHHH---HHSCSCTTTSCCHHHHHH
T ss_pred -HHHHHHHhcccccCCcccccCCHHHHHHHH---HHcCCChhHCCCHHHHhc
Confidence 001111111111000 012245666776 999999999999999976
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=2.5e-12 Score=128.11 Aligned_cols=111 Identities=21% Similarity=0.218 Sum_probs=77.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....||.+|+|||.......+.++|||||||+++||+||+.|+...... .....
T Consensus 229 kl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~ 299 (373)
T 2x4f_A 229 KIIDFGLARRYKPREK-LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETLNN 299 (373)
T ss_dssp EECCCSSCEECCTTCB-CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred EEEeCCCceecCCccc-cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 4689999998754332 23456999999999998888999999999999999999999997521110 00011
Q ss_pred ccCCCC--CCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRL--PVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l--~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+..... ... .....+++..+++ .|++.+|++||++.|+++
T Consensus 300 i~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 300 ILACRWDLEDEEFQDISEEAKEFIS---KLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHTCCCSCSGGGTTSCHHHHHHHH---TTSCSSGGGSCCHHHHHH
T ss_pred HHhccCCCChhhhccCCHHHHHHHH---HHcCCChhhCCCHHHHhc
Confidence 111000 000 0112356667776 999999999999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.7e-12 Score=122.64 Aligned_cols=62 Identities=26% Similarity=0.362 Sum_probs=44.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.............|+..|+|||...+ ...+.++||||+|++++||+||+.|+.
T Consensus 142 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 142 KLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp EECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 46899999887644433445678999999999875 567999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=3.2e-12 Score=125.12 Aligned_cols=120 Identities=24% Similarity=0.298 Sum_probs=69.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCCC--------CC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS--------PS 440 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~--------~~ 440 (502)
..+|||+++.+...........|+..|+|||...+. ..+.++||||+||+++||+||+.|+........ ..
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (331)
T 4aaa_A 164 KLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243 (331)
T ss_dssp EECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred EEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 368999998775443333456789999999998765 688999999999999999999999753211000 00
Q ss_pred CC--------cccccccccCCCCCCCC------cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 441 LN--------TDIALDEMLDPRLPVPS------CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 441 ~~--------~~~~~~~~~d~~l~~~~------~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.. ..........+.+.... ....+++..+++ .|++.+|++||+++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAK---KCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHH---HHTCSSGGGSCCGGGGGG
T ss_pred CChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHH---HHhccCcccCCCHHHHhc
Confidence 00 00000011111111000 011245556665 999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=2.2e-12 Score=125.92 Aligned_cols=113 Identities=23% Similarity=0.413 Sum_probs=75.1
Q ss_pred cccccCcccccCCCC--CCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+.... .......||..|+|||....... +.++||||+||+++||+||+.|++....... .
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~ 217 (323)
T 3tki_A 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------E 217 (323)
T ss_dssp EECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-------H
T ss_pred EEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-------H
Confidence 468999998764221 22235679999999999887765 7899999999999999999999863221100 0
Q ss_pred cccccCCCCC-CCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPRLP-VPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l~-~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.......... .......+++..+++ .|++.+|++||++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 218 YSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred HHHHhcccccCCccccCCHHHHHHHH---HHccCChhhCcCHHHHhh
Confidence 0000000000 000112245556666 999999999999999865
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.16 E-value=1.2e-11 Score=121.91 Aligned_cols=121 Identities=18% Similarity=0.210 Sum_probs=76.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccC-------------
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSS------------- 435 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~------------- 435 (502)
..+|||+++.+.......+...||..|+|||...+. ..+.++||||+||+++||+||+.|+.....
T Consensus 152 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~ 231 (346)
T 1ua2_A 152 KLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 231 (346)
T ss_dssp EECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC
Confidence 368999999875544444556789999999998654 478999999999999999999998752110
Q ss_pred CCCCCCCcccccccccC-CCCCCCC-----cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 436 TSSPSLNTDIALDEMLD-PRLPVPS-----CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 436 ~~~~~~~~~~~~~~~~d-~~l~~~~-----~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
.....|.......+.+. ...+... ....+++.++++ .|++.+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHH---HHHCSSTTTSCCHHHHHTS
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHH---HHhccChhhCCCHHHHhcC
Confidence 00001100000000000 0000000 111245666666 9999999999999999763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.2e-12 Score=127.09 Aligned_cols=115 Identities=23% Similarity=0.367 Sum_probs=78.3
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
-..+|||+++.............|+..|+|||.......+.++||||||++++||+||+.|+....... ......
T Consensus 164 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~ 238 (314)
T 3com_A 164 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFMIP 238 (314)
T ss_dssp EEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHH
T ss_pred EEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHh
Confidence 346899999877554333445678999999999998889999999999999999999999975311100 000000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+....+ ....+++..+++ .|++.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~-~~~~~~l~~li~---~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 239 TNPPPTFRKP-ELWSDNFTDFVK---QCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HSCCCCCSSG-GGSCHHHHHHHH---HHTCSCTTTSCCHHHHTT
T ss_pred cCCCcccCCc-ccCCHHHHHHHH---HHccCChhhCcCHHHHHh
Confidence 0111111111 112245666666 999999999999999965
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.16 E-value=2.2e-12 Score=135.26 Aligned_cols=117 Identities=21% Similarity=0.339 Sum_probs=78.1
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKH 428 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~ 428 (502)
++.|.||+-.|| ++|||+++.+..... ....||+.|+|||.... ..++.++|+||+||+++||+||+.
T Consensus 312 gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~--~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~ 389 (689)
T 3v5w_A 312 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389 (689)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC--CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CccccCCchHHeEEeCCCCEEecccceeeecCCCCC--CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 445555555444 699999998764432 34689999999999864 578999999999999999999999
Q ss_pred CCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC
Q 010736 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486 (502)
Q Consensus 429 p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~ 486 (502)
|+..........+ ...+......-+ .....++..+++ .|++.+|++|++
T Consensus 390 PF~~~~~~~~~~i-----~~~i~~~~~~~p-~~~S~~a~dLI~---~lL~~dP~~Rl~ 438 (689)
T 3v5w_A 390 PFRQHKTKDKHEI-----DRMTLTMAVELP-DSFSPELRSLLE---GLLQRDVNRRLG 438 (689)
T ss_dssp TTCGGGCCCHHHH-----HHHHHHCCCCCC-TTSCHHHHHHHH---HHTCSCGGGCTT
T ss_pred CCCCCChHHHHHH-----HHhhcCCCCCCC-ccCCHHHHHHHH---HHccCCHhHCCC
Confidence 9853221110000 011111111111 122356677777 999999999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.16 E-value=7.4e-12 Score=122.03 Aligned_cols=119 Identities=20% Similarity=0.244 Sum_probs=75.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCC------------
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS------------ 437 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~------------ 437 (502)
..+|||+++...... ......|+..|+|||.......+.++||||||++++||+||+.|+.......
T Consensus 160 kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 160 KLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp EECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEecCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 368999998764322 2234578999999999998889999999999999999999999985321000
Q ss_pred -CCCCCccccc-ccccC----CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 -SPSLNTDIAL-DEMLD----PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 -~~~~~~~~~~-~~~~d----~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+...... ...+. ..+........+++..+++ .|++.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH---HHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHH---HHcCCCcccCCCHHHHhc
Confidence 0000000000 00000 0000000112345666666 999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.16 E-value=2.8e-12 Score=129.76 Aligned_cols=111 Identities=26% Similarity=0.378 Sum_probs=68.1
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
.+|||+++...... ......||.+|+|||+.. ...++.++|||||||+++||+||+.|+....... ...
T Consensus 283 l~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~----- 354 (419)
T 3i6u_A 283 ITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLK----- 354 (419)
T ss_dssp ECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHH-----
T ss_pred EeecccceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHH-----
Confidence 68999999875432 233567999999999975 3567889999999999999999999985321110 000
Q ss_pred ccccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+......... ....+++..+++ .|++.+|++||+++|+++
T Consensus 355 ~~i~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 355 DQITSGKYNFIPEVWAEVSEKALDLVK---KLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHTTCCCCCHHHHTTSCHHHHHHHH---HHSCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCCCCchhhcccCHHHHHHHH---HHccCChhHCcCHHHHhC
Confidence 001111100000 011245556666 999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.16 E-value=2.6e-12 Score=122.47 Aligned_cols=107 Identities=27% Similarity=0.427 Sum_probs=72.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||++....... .....|+..|+|||...+...+.++||||+|++++||+||+.|++..... .....
T Consensus 149 ~l~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~ 218 (279)
T 3fdn_A 149 KIADFGWSVHAPSSR--RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKR 218 (279)
T ss_dssp EECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred EEEeccccccCCccc--ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHH
Confidence 368999986654322 23457899999999999888999999999999999999999997521100 00001
Q ss_pred c--cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 M--LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~--~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+ .....+ ....+++..+++ .|++.+|++||++.||++
T Consensus 219 ~~~~~~~~~---~~~~~~~~~li~---~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 219 ISRVEFTFP---DFVTEGARDLIS---RLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHTCCCCC---TTSCHHHHHHHH---HHCCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCC---CcCCHHHHHHHH---HHhccChhhCCCHHHHhh
Confidence 1 111111 112345666666 999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=4e-12 Score=125.47 Aligned_cols=106 Identities=25% Similarity=0.406 Sum_probs=73.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||......++.++|+||+||+++||+||+.|+..... ......
T Consensus 161 kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~ 232 (353)
T 2i0e_A 161 KIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQS 232 (353)
T ss_dssp EECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHH
Confidence 368999998754433334457899999999999988899999999999999999999999752110 001111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
+......-+ .....++..+++ .|++.+|++||+.
T Consensus 233 i~~~~~~~p-~~~s~~~~~li~---~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 233 IMEHNVAYP-KSMSKEAVAICK---GLMTKHPGKRLGC 266 (353)
T ss_dssp HHHCCCCCC-TTSCHHHHHHHH---HHTCSCTTSCTTC
T ss_pred HHhCCCCCC-CCCCHHHHHHHH---HHhhcCHHHcCCC
Confidence 111111111 112355666776 9999999999964
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=2.8e-12 Score=125.90 Aligned_cols=115 Identities=25% Similarity=0.342 Sum_probs=58.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCC-CCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSP-SLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~-~~~~~~~~~ 448 (502)
..+|||+++...... .....||..|+|||......++.++||||||++++||+||+.|+......... .........
T Consensus 171 kl~Dfg~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (336)
T 3fhr_A 171 KLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248 (336)
T ss_dssp EECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred EEeccccceeccccc--cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc
Confidence 368999998765322 23456899999999998889999999999999999999999998532221110 000000000
Q ss_pred cccCCCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.. ..+.+ .....+++..+++ .|++.+|++||++.|+++
T Consensus 249 ~~---~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 QY---GFPNPEWSEVSEDAKQLIR---LLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHH---HHSCSSGGGSCCHHHHHH
T ss_pred cc---ccCchhhccCCHHHHHHHH---HHCCCChhHCcCHHHHhc
Confidence 00 01100 0112345666666 999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=4.8e-12 Score=123.13 Aligned_cols=124 Identities=19% Similarity=0.249 Sum_probs=79.9
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccc--------cceecccceeeeeceeeeehhcCCCCCCcccCCCC----
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY--------TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS---- 438 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~--------~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~---- 438 (502)
.+|||+++....... .....||..|+|||... ...++.++|||||||+++||+||+.|+........
T Consensus 157 L~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 157 LTDFGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp ECCCTTCEECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred EccCCCceecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 689999998765432 23467999999999876 46788999999999999999999999753211100
Q ss_pred ---------CCCCccc-c-ccc--ccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 439 ---------PSLNTDI-A-LDE--MLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 439 ---------~~~~~~~-~-~~~--~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
....... . ... -.++.++... ....+.+..+++ .|++.+|++||+++|+++...+.+
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~---~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH---HHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHH---HhccCChhhhccHHHhhhccHHHh
Confidence 0000000 0 000 0011111111 122344555555 999999999999999998877643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.15 E-value=4.2e-12 Score=136.03 Aligned_cols=117 Identities=24% Similarity=0.388 Sum_probs=82.9
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p 429 (502)
++.|.||+..|| ++|||+++.............||..|+|||......++.++|+|||||+++||+||+.|
T Consensus 462 gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~P 541 (674)
T 3pfq_A 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541 (674)
T ss_dssp SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCC
Confidence 455666666655 68999999754444444567899999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
+..... ......+......-+ .....++..+++ .|++.+|++||++
T Consensus 542 f~~~~~--------~~~~~~i~~~~~~~p-~~~s~~~~~li~---~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 542 FEGEDE--------DELFQSIMEHNVAYP-KSMSKEAVAICK---GLMTKHPGKRLGC 587 (674)
T ss_dssp SCCSSH--------HHHHHHHHSSCCCCC-TTSCHHHHHHHH---HHSCSSSTTCTTC
T ss_pred CCCCCH--------HHHHHHHHhCCCCCC-ccCCHHHHHHHH---HHccCCHHHCCCC
Confidence 853111 011112222222111 122356777777 9999999999997
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=2.8e-12 Score=125.30 Aligned_cols=111 Identities=19% Similarity=0.259 Sum_probs=76.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....||..|+|||......++.++||||+||+++||+||+.|+...... .....
T Consensus 158 kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~ 228 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLAN 228 (326)
T ss_dssp EECCCTTCEECCTTSC-CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH
T ss_pred EEEECCCCeECCCCCc-cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHH
Confidence 4689999988754322 23467999999999998888999999999999999999999997421100 00000
Q ss_pred c--cCCCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 M--LDPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~--~d~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+ ........ .....+++..+++ .|++.+|++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 229 VSAVNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHH---HHSCSSGGGSCCHHHHHH
T ss_pred HHhcCCCcCccccccCCHHHHHHHH---HHccCChhhCCCHHHHhc
Confidence 0 00111000 0011245556666 999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=1.1e-12 Score=125.51 Aligned_cols=111 Identities=22% Similarity=0.369 Sum_probs=73.6
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCC-CcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPR-DFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~-~~~~~~~~~~~~~~~~~~ 448 (502)
.+|||+++.... .....|+.+|+|||.... ...+.++||||||++++||+||+.|. ..... .....
T Consensus 162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--------~~~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--------QRKLQ 229 (289)
T ss_dssp ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHH
T ss_pred eccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--------HHHHH
Confidence 578888765432 123568889999999887 67899999999999999999965553 21100 00000
Q ss_pred cc-cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 449 EM-LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 449 ~~-~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
.. ..+.++.. ..+++.++++ .|++.+|++||++.|+++.|+++..
T Consensus 230 ~~~~~~~~~~~---~~~~l~~li~---~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 FYEDRHQLPAP---KAAELANLIN---NCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHTTCCCCCC---SSCTTHHHHH---HHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HhhccCCCCCC---CCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 01111111 1123455555 9999999999999999999998744
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=4.1e-12 Score=124.13 Aligned_cols=111 Identities=24% Similarity=0.361 Sum_probs=71.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||.......+.++||||+||+++||+||+.|+..... ......
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~ 232 (327)
T 3a62_A 161 KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDK 232 (327)
T ss_dssp EECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHH
T ss_pred EEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 368999998654433333456799999999999888899999999999999999999999753110 000111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
+......-+ ....+++..+++ .|++.+|++|| ++.|+.+
T Consensus 233 i~~~~~~~p-~~~~~~~~~li~---~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 233 ILKCKLNLP-PYLTQEARDLLK---KLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHTCCCCC-TTSCHHHHHHHH---HHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHhCCCCCC-CCCCHHHHHHHH---HHHhcCHhhccCCCCCCHHHHHc
Confidence 111111111 112355666776 99999999999 6667653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=1.8e-12 Score=127.23 Aligned_cols=109 Identities=25% Similarity=0.398 Sum_probs=78.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............|+..|+|||.......+.++||||||++++||+||+.|++..... .....
T Consensus 181 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~ 252 (335)
T 2owb_A 181 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLR 252 (335)
T ss_dssp EECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred EEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHH
Confidence 4689999988764443344567999999999998888999999999999999999999997531100 00000
Q ss_pred cc--CCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 ML--DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~--d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+. ...++. ....++..+++ .|++.+|++||++.|+++
T Consensus 253 ~~~~~~~~~~---~~~~~~~~li~---~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 253 IKKNEYSIPK---HINPVAASLIQ---KMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHTCCCCCT---TSCHHHHHHHH---HHTCSSGGGSCCGGGGGG
T ss_pred HhcCCCCCCc---cCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 11 111111 12245666666 999999999999999976
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=1.6e-12 Score=128.00 Aligned_cols=107 Identities=25% Similarity=0.397 Sum_probs=75.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.............||..|+|||...+..++.++|+||+||+++||+||+.|+..... ......
T Consensus 158 kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~ 229 (345)
T 1xjd_A 158 KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHS 229 (345)
T ss_dssp EECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHH
Confidence 368999998754433334567899999999999988899999999999999999999999752110 000011
Q ss_pred c--cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHH-HH
Q 010736 450 M--LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK-IV 490 (502)
Q Consensus 450 ~--~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~-~v 490 (502)
+ ..+..+. ...+++..+++ .|++.+|++||++. ||
T Consensus 230 i~~~~~~~p~---~~s~~~~~li~---~lL~~dp~~R~~~~~~i 267 (345)
T 1xjd_A 230 IRMDNPFYPR---WLEKEAKDLLV---KLFVREPEKRLGVRGDI 267 (345)
T ss_dssp HHHCCCCCCT---TSCHHHHHHHH---HHSCSSGGGSBTTBSCG
T ss_pred HHhCCCCCCc---ccCHHHHHHHH---HHhcCCHhHcCCChHHH
Confidence 1 1112221 12345666766 99999999999987 55
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=3.6e-12 Score=124.65 Aligned_cols=62 Identities=21% Similarity=0.262 Sum_probs=45.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.........+...||..|+|||...+. .++.++||||+||+++||+||+.|+.
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp EECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 368999998875443344456789999999998764 47999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=3.2e-12 Score=122.04 Aligned_cols=114 Identities=26% Similarity=0.384 Sum_probs=76.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... ......|+.+|+|||...+...+.++||||+|++++||+||+.|+...... ....... ..
T Consensus 148 kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~-~~ 222 (284)
T 3kk8_A 148 KLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIK-AG 222 (284)
T ss_dssp EECCCTTCEECCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-HT
T ss_pred EEeeceeeEEcccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHH-hc
Confidence 368999998765432 233467999999999999988999999999999999999999997421110 0000000 00
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+.. ....+++..+++ .|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~-~~~~~~~~~li~---~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 223 AYDYPSPEW-DTVTPEAKSLID---SMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCCCCTTTT-TTSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred cccCCchhh-cccCHHHHHHHH---HHcccChhhCCCHHHHhc
Confidence 011000000 112345666666 999999999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=4e-12 Score=124.06 Aligned_cols=120 Identities=12% Similarity=0.167 Sum_probs=69.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCC------------
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSST------------ 436 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~------------ 436 (502)
..+|||+++.............||..|+|||...+ ..++.++||||+||+++||+||+.|+......
T Consensus 140 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 219 (324)
T 3mtl_A 140 KLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219 (324)
T ss_dssp EECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 47899999876544433445678999999999876 56799999999999999999999998532100
Q ss_pred -CCCCCCcccc---cccccCCCCCCC-----CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 437 -SSPSLNTDIA---LDEMLDPRLPVP-----SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 437 -~~~~~~~~~~---~~~~~d~~l~~~-----~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+..... ......+..... .....+++..+++ .|++.+|++||+++||++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLT---KLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHH---HHSCSSGGGSCCHHHHTT
T ss_pred CChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHH---HHcCcCcccCCCHHHHhc
Confidence 0000100000 000000110000 0011244556666 999999999999999965
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.7e-12 Score=128.91 Aligned_cols=114 Identities=17% Similarity=0.171 Sum_probs=73.3
Q ss_pred cccEEECcCCcCcccCCccc-----cCCCCCcEEEccCCccccc----cCcccccCCCCcEEeCCCCcccccc----Ccc
Q 010736 263 VLTKLSLDDNHFTSYLPQNI-----CRGGALQIFTVSENRFQGT----IPKSLRNCTSLIRVRLDGNNLTGNI----SKA 329 (502)
Q Consensus 263 ~L~~L~ls~N~l~~~~~~~~-----~~~~~L~~L~ls~n~l~~~----~~~~l~~l~~L~~L~l~~N~l~~~~----~~~ 329 (502)
.++.|++++|.++......+ ...++|+.|++++|.++.. ++..+..+++|++|+|++|.+++.. ...
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 45556666665544322222 2346778888888877642 3344566778888888888887532 344
Q ss_pred cCCCCCCcEEEccCcccccc----cCccccCCCCCCeeeecCCccccccCcc
Q 010736 330 FGIYPNLTFIDLSRNNFYGE----ISSNFGECPKLGALNISRNNITGDFGIA 377 (502)
Q Consensus 330 ~~~l~~L~~L~Ls~N~l~~~----~~~~~~~~~~L~~L~l~~N~l~~dfGl~ 377 (502)
+...++|+.|+|++|.|+.. +...+...+.|++||+++|+|. |.|..
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~-~~g~~ 257 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS-SEGRQ 257 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC-HHHHH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC-HHHHH
Confidence 55667888888888888653 2334456688899999988864 33443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.14 E-value=4.2e-12 Score=123.68 Aligned_cols=103 Identities=24% Similarity=0.411 Sum_probs=73.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++...... .....||..|+|||....... +.++||||||++++||+||+.|++.... ... ..
T Consensus 190 kL~Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~---~~ 259 (320)
T 3a99_A 190 KLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIR---GQ 259 (320)
T ss_dssp EECCCTTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH---CC
T ss_pred EEeeCcccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hhc---cc
Confidence 478999998775432 234578999999999877665 7889999999999999999999753110 000 00
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+ ...+++..+++ .|++.+|++||++.||++
T Consensus 260 ~~~~~-------~~~~~~~~li~---~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 VFFRQ-------RVSSECQHLIR---WCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCCSS-------CCCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred ccccc-------cCCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 00111 12245666666 999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.13 E-value=7.2e-12 Score=123.99 Aligned_cols=61 Identities=30% Similarity=0.415 Sum_probs=50.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++....... .....||.+|+|||...+. .++.++|||||||+++||+||+.|+.
T Consensus 172 kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp EECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 4789999988764332 2345789999999998654 48999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.13 E-value=9.5e-12 Score=125.94 Aligned_cols=119 Identities=22% Similarity=0.221 Sum_probs=75.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCCC-CCCCc----
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS-PSLNT---- 443 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~-~~~~~---- 443 (502)
.++|||+++.+..... .....||..|+|||...+. .++.++|||||||+++||+||+.|+........ ..+..
T Consensus 197 kl~DFG~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~ 275 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275 (420)
T ss_dssp EECCCTTCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EeccchhhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 3799999997754322 2345689999999998654 689999999999999999999999853211000 00000
Q ss_pred ---------ccccccccCCCCCCC------CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 ---------DIALDEMLDPRLPVP------SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ---------~~~~~~~~d~~l~~~------~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+...|.+... ......++..+++ .|++.+|++||++.|+++
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~---~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHH---HHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHH---HhccCChhHCCCHHHHhC
Confidence 000011111111100 0011245666666 999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.13 E-value=4.1e-12 Score=121.75 Aligned_cols=111 Identities=22% Similarity=0.368 Sum_probs=72.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++..... ......|+..|+|||... ...+.++||||+|++++||+||+.|+....... .... .....
T Consensus 172 kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~-~~~~~ 245 (290)
T 1t4h_A 172 KIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR-RVTSG 245 (290)
T ss_dssp EECCTTGGGGCCTT--SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH-HHTTT
T ss_pred EEeeCCCccccccc--ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHH-HHhcc
Confidence 46899999765432 223467899999999876 458999999999999999999999975321100 0000 00000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+... .....++..+++ .|++.+|++||++.||++
T Consensus 246 ~~~~~~~---~~~~~~l~~li~---~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPASFD---KVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGGGG---GCCCHHHHHHHH---HHSCSSGGGSCCHHHHHT
T ss_pred CCccccC---CCCCHHHHHHHH---HHccCChhhCCCHHHHhh
Confidence 0000110 011134556665 999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.13 E-value=2.3e-12 Score=128.88 Aligned_cols=113 Identities=22% Similarity=0.243 Sum_probs=77.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc-c
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL-D 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~-~ 448 (502)
..+|||+++....... .....||..|+|||.......+.++||||+||+++||+||+.|+...... ........ .
T Consensus 191 kL~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~~ 266 (387)
T 1kob_A 191 KIIDFGLATKLNPDEI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRCD 266 (387)
T ss_dssp EECCCTTCEECCTTSC-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHCC
T ss_pred EEEecccceecCCCcc-eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCC
Confidence 4689999998765332 23457999999999999888999999999999999999999997531110 00000000 0
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...++... ....+++..+++ .|++.+|++||++.|+++
T Consensus 267 ~~~~~~~~---~~~s~~~~~li~---~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 267 WEFDEDAF---SSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCCCSSTT---TTSCHHHHHHHH---TTSCSSGGGSCCHHHHHT
T ss_pred CCCCcccc---ccCCHHHHHHHH---HHcCCChhHCcCHHHHhh
Confidence 00111111 112345666766 999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=5.2e-12 Score=125.97 Aligned_cols=112 Identities=28% Similarity=0.447 Sum_probs=74.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc---ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT---MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~---~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
.++|||+++.+.... ......||.+|+|||.... ..++.++||||+||+++||+||+.|+.......... .
T Consensus 155 kL~DFG~a~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~-----~ 228 (384)
T 4fr4_A 155 HITDFNIAAMLPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE-----I 228 (384)
T ss_dssp EECCCTTCEECCTTC-CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH-----H
T ss_pred EEeccceeeeccCCC-ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH-----H
Confidence 368999999875433 2345789999999999864 347899999999999999999999985322111000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-HHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-MKIVS 491 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-m~~v~ 491 (502)
...+.......+ .....++..+++ .|++.+|++||+ +.+|.
T Consensus 229 ~~~~~~~~~~~p-~~~s~~~~~li~---~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 229 VHTFETTVVTYP-SAWSQEMVSLLK---KLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp HHHHHHCCCCCC-TTSCHHHHHHHH---HHSCSSGGGSCCSHHHHH
T ss_pred HHHHhhcccCCC-CcCCHHHHHHHH---HHhcCCHhHhcccHHHHH
Confidence 001101111101 112355667777 999999999998 66654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=8.8e-12 Score=127.74 Aligned_cols=61 Identities=28% Similarity=0.328 Sum_probs=46.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.++|||+++...... ..+...||..|+|||...+..++.++||||+||+++||+||+.|+.
T Consensus 204 kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 204 KILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp EECCCCCC-----CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEEEEeeeecCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 379999998775432 2345679999999999999999999999999999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=5.8e-12 Score=124.72 Aligned_cols=111 Identities=18% Similarity=0.249 Sum_probs=76.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... ......||.+|+|||......++.++||||+||+++||+||+.|+...... .....
T Consensus 159 kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~ 229 (361)
T 2yab_A 159 KLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLAN 229 (361)
T ss_dssp EECCCSSCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH
T ss_pred EEEecCCceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 368999998875432 234567999999999998888999999999999999999999997421100 00011
Q ss_pred ccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+......-+. ....+++..+++ .|+..+|++||++.|+++
T Consensus 230 i~~~~~~~~~~~~~~~s~~~~~li~---~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 230 ITAVSYDFDEEFFSQTSELAKDFIR---KLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHH---HHSCSSTTTSCCHHHHHT
T ss_pred HHhcCCCCCchhccCCCHHHHHHHH---HHCCCChhHCcCHHHHhc
Confidence 1111100000 012245666666 999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.12 E-value=5.5e-12 Score=126.68 Aligned_cols=123 Identities=20% Similarity=0.259 Sum_probs=79.6
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccccc--------ceecccceeeeeceeeeehhcCCCCCCcccCCCCC-CC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT--------MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSP-SL 441 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~--------~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~-~~ 441 (502)
.+|||+++....... .....||..|+|||.... ..++.++|||||||+++||+||+.|+......... ..
T Consensus 157 L~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 157 LTDFGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp ECCGGGCEECCCGGG-SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred EecCCCceEccCCCc-cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 689999988754322 234679999999999765 56788999999999999999999997532211100 00
Q ss_pred Cc-------ccc---cccc------cCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 442 NT-------DIA---LDEM------LDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 442 ~~-------~~~---~~~~------~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.. ... .... ..+.++... ....+.+..+++ .|++.+|++||++.|+++.++.+
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~---~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH---HHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHH---HhhccChhhhccHHHHHHHHHHH
Confidence 00 000 0000 011111111 112334555555 99999999999999999999876
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.3e-12 Score=127.72 Aligned_cols=110 Identities=21% Similarity=0.363 Sum_probs=72.5
Q ss_pred cccccCcccccCCCC------------CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCC
Q 010736 370 ITGDFGIAKFLKPDS------------SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS 437 (502)
Q Consensus 370 l~~dfGl~~ll~~~~------------~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~ 437 (502)
..+|||+++...... .......||..|+|||...+..++.++||||+||+++||+||..|.....
T Consensus 204 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--- 280 (332)
T 3qd2_B 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--- 280 (332)
T ss_dssp EECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---
T ss_pred EEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---
Confidence 468999999875432 11234569999999999998899999999999999999999987742100
Q ss_pred CCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 SPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+.....+........++..+++ .|++.+|++||++.|+++
T Consensus 281 -------~~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 281 -------RIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEATDIIE 325 (332)
T ss_dssp -------HHHHHHHTTCCCHHHHHHCHHHHHHHH---HHHCSSGGGSCCHHHHHH
T ss_pred -------HHHHHhhccCCCcccccCChhHHHHHH---HHccCCCCcCCCHHHHhh
Confidence 000111111111000011123444554 999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=1e-11 Score=126.08 Aligned_cols=59 Identities=20% Similarity=0.289 Sum_probs=50.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.++|||+++...... ....||..|+|||...+..++.++|||||||+++||+||+.|+.
T Consensus 242 kL~DFG~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 242 KVIDFGSSCYEHQRV---YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp EECCCTTCEETTCCC---CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEeecccceecCCcc---cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 468999998764322 24578999999999999999999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.12 E-value=6.9e-12 Score=119.11 Aligned_cols=113 Identities=23% Similarity=0.415 Sum_probs=74.6
Q ss_pred cccccCcccccCCCC--CCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++...... .......|+.+|+|||....... +.++||||||++++||+||+.|++....... .
T Consensus 145 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~ 217 (276)
T 2yex_A 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------E 217 (276)
T ss_dssp EECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-------H
T ss_pred EEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-------H
Confidence 468999998764321 12234678999999999887664 7899999999999999999999863221100 0
Q ss_pred cccccCCCC-CCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPRL-PVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l-~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......... ........+++.++++ .|++.+|++||+++||++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 218 YSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred HHHhhhcccccCchhhcCHHHHHHHH---HHCCCCchhCCCHHHHhc
Confidence 000000000 0000112345666666 999999999999999865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=2.7e-12 Score=124.49 Aligned_cols=115 Identities=24% Similarity=0.358 Sum_probs=66.9
Q ss_pred cccccCcccccCCCCC---CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+..... ......||..|+|||...+..++.++||||||++++||+||+.|+...... .......
T Consensus 156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~~~~~~ 232 (311)
T 3ork_A 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHV 232 (311)
T ss_dssp EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH
T ss_pred EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHh
Confidence 4789999987754322 122356899999999999889999999999999999999999997532110 0000000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+... .....+++..+++ .|++.+|++||+..++++
T Consensus 233 ~~~~~~~~~~--~~~~~~~l~~li~---~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 233 REDPIPPSAR--HEGLSADLDAVVL---KALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HCCCCCHHHH--STTCCHHHHHHHH---HHTCSSGGGSCSSHHHHH
T ss_pred cCCCCCcccc--cCCCCHHHHHHHH---HHHhcCHhhChhhHHHHH
Confidence 0000000000 0012245666666 999999999997776553
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.11 E-value=9.1e-12 Score=121.29 Aligned_cols=111 Identities=18% Similarity=0.248 Sum_probs=76.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....||..|+|||.......+.++||||+|++++||+||+.|+...... .....
T Consensus 159 kl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~ 229 (321)
T 2a2a_A 159 KLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLAN 229 (321)
T ss_dssp EECCCTTCEECCTTCC-CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH
T ss_pred EEccCccceecCcccc-ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHH
Confidence 3689999987754322 23457899999999998888999999999999999999999997421100 00001
Q ss_pred ccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+.......+. ....+++..+++ .|++.+|++||++.|+++
T Consensus 230 i~~~~~~~~~~~~~~~~~~~~~li~---~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 230 ITSVSYDFDEEFFSHTSELAKDFIR---KLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHTTCCCCCHHHHTTCCHHHHHHHH---TTSCSSTTTSCCHHHHHH
T ss_pred HHhcccccChhhhcccCHHHHHHHH---HHcCCChhhCcCHHHHhc
Confidence 1000000000 011245666666 999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.11 E-value=6.8e-12 Score=119.86 Aligned_cols=109 Identities=25% Similarity=0.333 Sum_probs=76.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... .....|+..|+|||...+...+.++||||||++++||+||+.|++..... .....
T Consensus 154 kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~ 223 (284)
T 2vgo_A 154 KIADFGWSVHAPSLR--RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRR 223 (284)
T ss_dssp EECCCTTCEECSSSC--BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred EEecccccccCcccc--cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHH
Confidence 468999987664322 23457899999999999888999999999999999999999997532110 00111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+......-+ ....+++..+++ .|++.+|++||++.|+++
T Consensus 224 ~~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 224 IVNVDLKFP-PFLSDGSKDLIS---KLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHTTCCCCC-TTSCHHHHHHHH---HHSCSSGGGSCCHHHHHT
T ss_pred HhccccCCC-CcCCHHHHHHHH---HHhhcCHhhCCCHHHHhh
Confidence 111111111 112245666666 999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=7.8e-12 Score=118.82 Aligned_cols=111 Identities=19% Similarity=0.320 Sum_probs=67.0
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
-..+|||+++....... .....|+..|+|||...+... +.++||||+|++++||+||+.|++..... ...
T Consensus 150 ~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~ 220 (276)
T 2h6d_A 150 AKIADFGLSNMMSDGEF-LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLF 220 (276)
T ss_dssp EEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH
T ss_pred EEEeecccccccCCCcc-eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHH
Confidence 34689999987754322 223568899999999887654 68999999999999999999997531100 000
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+.......+ .....++..+++ .|++.+|++||++.||++
T Consensus 221 ~~~~~~~~~~~-~~~~~~l~~li~---~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 221 KKIRGGVFYIP-EYLNRSVATLLM---HMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHCCCCCC-TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHH
T ss_pred HHhhcCcccCc-hhcCHHHHHHHH---HHccCChhhCCCHHHHHh
Confidence 01100000001 112245666666 999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.8e-11 Score=122.30 Aligned_cols=59 Identities=22% Similarity=0.284 Sum_probs=51.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++..... .....||..|+|||...+..++.++|||||||+++||+||+.|+.
T Consensus 201 kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp EECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 47899999887532 234678999999999999899999999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.10 E-value=9.4e-12 Score=127.60 Aligned_cols=111 Identities=23% Similarity=0.366 Sum_probs=77.1
Q ss_pred ccccccCcccccCCCCCCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
-..+|||+++....... .....||..|+|||...+... +.++||||+||+++||+||+.|++.... . ...
T Consensus 155 vkL~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~-----~~~ 225 (476)
T 2y94_A 155 AKIADFGLSNMMSDGEF-LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---P-----TLF 225 (476)
T ss_dssp EEECCCSSCEECCTTCC-BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---H-----HHH
T ss_pred eEEEeccchhhcccccc-ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---H-----HHH
Confidence 34799999998754332 234679999999999887655 6899999999999999999999853211 0 011
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+.+.....+ .....++..+++ .|++.+|++||++.|+++
T Consensus 226 ~~i~~~~~~~p-~~~s~~~~~Li~---~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 226 KKICDGIFYTP-QYLNPSVISLLK---HMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHTTCCCCC-TTCCHHHHHHHH---HHTCSSTTTSCCHHHHHT
T ss_pred HHHhcCCcCCC-ccCCHHHHHHHH---HHcCCCchhCcCHHHHHh
Confidence 11222211111 112245666666 999999999999999976
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.10 E-value=5.9e-12 Score=124.54 Aligned_cols=114 Identities=22% Similarity=0.405 Sum_probs=73.8
Q ss_pred cccccCcccccCCCC-CCcccccccccccCcccccc--ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDS-SNWTGFAGTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~-~~~~~~~gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++...... .......||..|+|||...+ ...+.++|||||||+++||+||+.|+......... .. .
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~-~ 274 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AE-I 274 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HH-H
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH---HH-H
Confidence 478999998764322 22234679999999999875 45788999999999999999999998532211110 00 0
Q ss_pred cccc--cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHHH
Q 010736 447 LDEM--LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQQ 493 (502)
Q Consensus 447 ~~~~--~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~~ 493 (502)
...+ ..+..+ .....++..+++ .|++.+|++|| ++.|+++.
T Consensus 275 ~~~~~~~~~~~~---~~~~~~~~~li~---~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 275 SRRILKSEPPYP---QEMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHHCCCCCC---TTSCHHHHHHHH---HHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHhccCCCCC---cccCHHHHHHHH---HHhhhCHHHhcCCCCCCHHHHHcC
Confidence 0111 111221 112245556666 99999999999 88988653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.10 E-value=9.7e-12 Score=123.73 Aligned_cols=61 Identities=31% Similarity=0.357 Sum_probs=42.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++...... ..+...||..|+|||...+..++.++||||+||+++||+||+.|+.
T Consensus 167 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 167 KILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp EECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEEeeccccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 368999998765322 2234578999999999998889999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=6.8e-12 Score=121.79 Aligned_cols=114 Identities=25% Similarity=0.353 Sum_probs=66.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++....... .....|+..|+|||... ...++.++||||||++++||+||+.|++...... ....
T Consensus 165 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~- 240 (318)
T 2dyl_A 165 KLCDFGISGRLVDDKA-KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLT- 240 (318)
T ss_dssp EECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHH-
T ss_pred EEEECCCchhccCCcc-ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHH-
Confidence 4689999987654322 23456899999999984 4567889999999999999999999975321100 0000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....-..+.++.. .....++..+++ .|++.+|++||++.|+++
T Consensus 241 -~~~~~~~~~~~~~-~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 241 -KVLQEEPPLLPGH-MGFSGDFQSFVK---DCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -HHHHSCCCCCCSS-SCCCHHHHHHHH---HHTCSCTTTSCCHHHHTT
T ss_pred -HHhccCCCCCCcc-CCCCHHHHHHHH---HHccCChhHCcCHHHHhh
Confidence 0000011112111 112345666666 999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.10 E-value=9.9e-12 Score=123.17 Aligned_cols=114 Identities=21% Similarity=0.315 Sum_probs=66.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceeccc-ceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEK-CDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k-~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++...... ......||..|+|||.........+ +||||+||+++||+||+.|+....... ... ....
T Consensus 158 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~--~~~~ 232 (361)
T 3uc3_A 158 KICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYR--KTIQ 232 (361)
T ss_dssp EECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHH--HHHH
T ss_pred EEeecCccccccccC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHH--HHHH
Confidence 368999998543322 1234569999999999887776655 899999999999999999985322111 000 0011
Q ss_pred cccCCC--CCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPR--LPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~--l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+.... .+.. .....++..+++ .|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~-~~~s~~~~~li~---~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 233 RILSVKYSIPDD-IRISPECCHLIS---RIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHTTCCCCCTT-SCCCHHHHHHHH---HHSCSCTTTSCCHHHHHT
T ss_pred HHhcCCCCCCCc-CCCCHHHHHHHH---HHccCChhHCcCHHHHHh
Confidence 111111 1111 112245666666 999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=6.2e-12 Score=119.64 Aligned_cols=110 Identities=23% Similarity=0.335 Sum_probs=73.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....||..|+|||...+. .+.++||||+|++++||+||+.|+...... .....
T Consensus 149 ~l~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~ 218 (277)
T 3f3z_A 149 KLIDFGLAARFKPGKM-MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLK 218 (277)
T ss_dssp EECCCTTCEECCTTSC-BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH
T ss_pred EEEecccceeccCccc-hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHH
Confidence 4689999987754332 2345789999999987654 899999999999999999999997531110 00011
Q ss_pred ccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+.......+. ....+++..+++ .|++.+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 219 IREGTFTFPEKDWLNVSPQAESLIR---RLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHCCCCCCHHHHTTSCHHHHHHHH---HHTCSSTTTSCCHHHHTT
T ss_pred HHhCCCCCCchhhhcCCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 1111110000 011245666666 999999999999999975
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.09 E-value=8.1e-09 Score=103.38 Aligned_cols=275 Identities=13% Similarity=0.116 Sum_probs=158.9
Q ss_pred cCcccCCCCC-CCCEEECCCCcccccCCccCcCCCCCCEEEccCCc---CcCCCCcccCCCCCCcEEEccCCcCcccCCc
Q 010736 86 LHAFSFSSFP-HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQ---FSGNIPHEVGLMSHLKILYIDSNQLDGSIPL 161 (502)
Q Consensus 86 l~~~~~~~l~-~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~---l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 161 (502)
|...+|.+.. .|+.+.+..+ ++.+-..+|.++++|+.+.++.|. ++..-..+|.++.+|+.+.+..+ ++.....
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~ 131 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE 131 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh
Confidence 4444566653 4777777543 555556667777777777776653 44333455666666666665543 3334444
Q ss_pred ccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCC
Q 010736 162 EVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNL 241 (502)
Q Consensus 162 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 241 (502)
.|..+.+|+.+.+..+ +.......|..+..|+.+.+..+ ++..-..+|.. ..|+.+.+..+-.. .....|.++.++
T Consensus 132 aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l 207 (394)
T 4gt6_A 132 AFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFAL 207 (394)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTC
T ss_pred hhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccc
Confidence 5666666666666533 23234445566666666666543 22222223322 33444444322111 112223333333
Q ss_pred cEEEeeCc------------------------------------cccccCCCCCcc-ccccEEECcCCcCcccCCccccC
Q 010736 242 KQFSLVYN------------------------------------NLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICR 284 (502)
Q Consensus 242 ~~L~l~~N------------------------------------~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~ 284 (502)
.......+ .++......|.. ..|+.+.+..+. .......|..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~-~~I~~~aF~~ 286 (394)
T 4gt6_A 208 STITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSV-VSIGTGAFMN 286 (394)
T ss_dssp CEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTC-CEECTTTTTT
T ss_pred ceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEeccccc-ceecCccccc
Confidence 32222111 111111122322 457777776543 3344566778
Q ss_pred CCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeee
Q 010736 285 GGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALN 364 (502)
Q Consensus 285 ~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~ 364 (502)
...|+.+.+. +.++..-...|.+|.+|+.+.+..+ ++.....+|..+.+|+.+.+..+ ++..-..+|.+|.+|+.++
T Consensus 287 c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 287 CPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIE 363 (394)
T ss_dssp CTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEE
T ss_pred ccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEE
Confidence 8889998886 4455455667889999999999754 66666778889999999999654 6655567899999999999
Q ss_pred ecCCcc
Q 010736 365 ISRNNI 370 (502)
Q Consensus 365 l~~N~l 370 (502)
+.++..
T Consensus 364 ~~~~~~ 369 (394)
T 4gt6_A 364 YSGSRS 369 (394)
T ss_dssp ESSCHH
T ss_pred ECCcee
Confidence 988754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.2e-11 Score=123.03 Aligned_cols=60 Identities=23% Similarity=0.307 Sum_probs=50.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~ 432 (502)
..+|||+++..... .+...||..|+|||...+..++.++|||||||+++||+||+.|++.
T Consensus 178 kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 178 KIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred EEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 36899999877542 2345789999999999988899999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.09 E-value=1.2e-11 Score=121.67 Aligned_cols=118 Identities=19% Similarity=0.306 Sum_probs=74.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecc-cceeeeeceeeeehhcCCCCCCcccCCC-C------CC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITE-KCDVYSFGVLVLEVIKGKHPRDFLSSTS-S------PS 440 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~-k~Dvysfgv~llElltg~~p~~~~~~~~-~------~~ 440 (502)
..+|||+++..... ......|+..|+|||..... ..+. ++||||||++++||+||+.|+....... . ..
T Consensus 192 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~ 269 (348)
T 2pml_X 192 KLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN 269 (348)
T ss_dssp EECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCC
T ss_pred EEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC
Confidence 46899999876543 22346789999999999877 5666 9999999999999999999986322100 0 00
Q ss_pred CCcccccccccCCCCCC----CCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 441 LNTDIALDEMLDPRLPV----PSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 441 ~~~~~~~~~~~d~~l~~----~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
............+.... .......++..+++ .|++.+|++||++.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK---LFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCCCCSSSSSTTTTCC--------CCCHHHHHHHH---HHCCSSGGGSCCHHHHHT
T ss_pred cCCccchhhhhccccccccccchhhcCHHHHHHHH---HHccCChhhCCCHHHHhc
Confidence 00000000000000000 00112345666666 999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=5.4e-12 Score=128.28 Aligned_cols=114 Identities=25% Similarity=0.408 Sum_probs=70.7
Q ss_pred cccccCcccccCCCCCC----cccccccccccCcccccc-------ceecccceeeeeceeeeehhc-CCCCCCcccCCC
Q 010736 370 ITGDFGIAKFLKPDSSN----WTGFAGTYGYIAPELAYT-------MKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTS 437 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~----~~~~~gt~gy~aPE~~~~-------~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~ 437 (502)
..+|||+++.+...... .....||.+|+|||...+ ...+.++|||||||+++||+| |+.|++......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 47899999987653321 234579999999999865 678999999999999999999 999975321100
Q ss_pred CCCCCcccccccccC-CCCCC-CCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 SPSLNTDIALDEMLD-PRLPV-PSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 ~~~~~~~~~~~~~~d-~~l~~-~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
........+ +.... .......++..+++ .|++.+|++||++.||++
T Consensus 248 ------~~i~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ------SNIIRGIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ------HHHHHTCCCCCCCTTCCCHHHHHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred ------HHHhcCCCCcccccccccccchHHHHHHHH---HHhhCChhhCCCHHHHHh
Confidence 000001111 11110 01112244555555 999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.09 E-value=7.4e-12 Score=130.03 Aligned_cols=110 Identities=25% Similarity=0.375 Sum_probs=76.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.+...........||..|+|||...+..++.++|+||+||+++||+||+.|+........ .......
T Consensus 329 kL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~ 404 (543)
T 3c4z_A 329 RISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQR 404 (543)
T ss_dssp EECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHH
T ss_pred EEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHH
Confidence 368999999876544444456899999999999988899999999999999999999999853211100 0000111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m 487 (502)
+......-+ .....++..+++ .|++.+|++||++
T Consensus 405 i~~~~~~~p-~~~s~~~~~li~---~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 405 VLEQAVTYP-DKFSPASKDFCE---ALLQKDPEKRLGF 438 (543)
T ss_dssp HHHCCCCCC-TTSCHHHHHHHH---HHSCSSGGGSCCC
T ss_pred HhhcccCCC-cccCHHHHHHHH---HhccCCHhHCCCC
Confidence 111111111 122356667777 9999999999976
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.2e-11 Score=119.98 Aligned_cols=119 Identities=17% Similarity=0.309 Sum_probs=70.7
Q ss_pred cccccCcccccCCCCC-------CcccccccccccCcccccc-----ceecccceeeeeceeeeehhcCCCCCCcccCCC
Q 010736 370 ITGDFGIAKFLKPDSS-------NWTGFAGTYGYIAPELAYT-----MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS 437 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-------~~~~~~gt~gy~aPE~~~~-----~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~ 437 (502)
..+|||+++....... ......||..|+|||.... ...+.++||||+||+++||+||+.|+.......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 233 (316)
T 2ac3_A 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233 (316)
T ss_dssp EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence 3689999887642211 1123468999999999865 567899999999999999999999986432111
Q ss_pred CCCCCcc--------cccccccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 SPSLNTD--------IALDEMLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 ~~~~~~~--------~~~~~~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
. .+... .....+.......+. .....++..+++ .|++.+|++||++.|+++
T Consensus 234 ~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 234 C-GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS---KLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp S-CC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH---HHSCSSTTTSCCHHHHHH
T ss_pred c-cccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHH---HHhhCChhhCCCHHHHhc
Confidence 0 01000 000111111111000 011245666666 999999999999999976
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.5e-11 Score=118.34 Aligned_cols=117 Identities=25% Similarity=0.414 Sum_probs=71.0
Q ss_pred cccccCcccccCCCCC-----CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCCCCC--C
Q 010736 370 ITGDFGIAKFLKPDSS-----NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPS--L 441 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-----~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~--~ 441 (502)
..+|||+++....... ......|+..|+|||.... ...+.++||||||++++||+||+.|++......... .
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 240 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh
Confidence 4689999987643211 1224568999999999875 467899999999999999999999986322110000 0
Q ss_pred Ccc--cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 442 NTD--IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 442 ~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
... .......++.... ...+++..+++ .|++.+|++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~---~~~~~~~~li~---~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLK---KYGKSFRKMIS---LCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC-----CCCC---CCCHHHHHHHH---HHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccccccccchhhh---hhhHHHHHHHH---HHccCChhhCcCHHHHhh
Confidence 000 0000111122211 12245666666 999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.08 E-value=9.9e-12 Score=123.38 Aligned_cols=111 Identities=23% Similarity=0.389 Sum_probs=73.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc------ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT------MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~------~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
..+|||+++.+..... .....||.+|+|||+..+ ..++.++|||||||+++||+||+.|+......
T Consensus 240 kl~DfG~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------- 311 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------- 311 (365)
T ss_dssp EECCCTTCEECCTTCC-BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred EEEecCcccccCCCcc-cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-------
Confidence 4689999987764332 334679999999999763 25788999999999999999999997421100
Q ss_pred ccccccccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+......... .....++..+++ .|++.+|++||++.|+++
T Consensus 312 -~~~~~i~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 -LMLRMIMEGQYQFSSPEWDDRSSTVKDLIS---RLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHHHHHHHTCCCCCHHHHSSSCHHHHHHHH---HHSCSSTTTSCCHHHHHH
T ss_pred -HHHHHHHhCCCCCCCcccccCCHHHHHHHH---HHcCCChhHCcCHHHHhc
Confidence 000001111100000 011234556666 999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.08 E-value=9.9e-12 Score=119.94 Aligned_cols=113 Identities=19% Similarity=0.282 Sum_probs=74.9
Q ss_pred ccccccCcccccCCCCC--CcccccccccccCccccccc--eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 369 NITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTM--KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~--~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
-..+|||+++....... ......|+..|+|||..... ..+.++||||+|++++||+||+.|++..... .
T Consensus 148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~---- 220 (305)
T 2wtk_C 148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---K---- 220 (305)
T ss_dssp EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---H----
T ss_pred EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---H----
Confidence 34689999987753221 22345689999999998754 3478999999999999999999997531100 0
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ 493 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~ 493 (502)
....+.......+ ....+++..+++ .|++.+|++||++.|+++.
T Consensus 221 -~~~~i~~~~~~~~-~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 221 -LFENIGKGSYAIP-GDCGPPLSDLLK---GMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHHHHHHCCCCCC-SSSCHHHHHHHH---HHTCSSTTTSCCHHHHHHS
T ss_pred -HHHHHhcCCCCCC-CccCHHHHHHHH---HHccCChhhCCCHHHHhcC
Confidence 0001111111101 112245666666 9999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.1e-11 Score=120.70 Aligned_cols=107 Identities=25% Similarity=0.374 Sum_probs=75.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++..... .....||..|+|||.......+.++|+||+||+++||+||+.|+..... ......
T Consensus 146 kL~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~ 214 (318)
T 1fot_A 146 KITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEK 214 (318)
T ss_dssp EECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH
T ss_pred EEeecCcceecCCc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 46899999876532 2346799999999999988899999999999999999999999742110 001111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVS 491 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~ 491 (502)
+......-+ ....+++..+++ .|++.+|++|| ++.||.
T Consensus 215 i~~~~~~~p-~~~~~~~~~li~---~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 215 ILNAELRFP-PFFNEDVKDLLS---RLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp HHHCCCCCC-TTSCHHHHHHHH---HHTCSCTTTCTTSSTTTTHHHH
T ss_pred HHhCCCCCC-CCCCHHHHHHHH---HHhccCHHHcCCCcCCCHHHHh
Confidence 221111111 112356667777 99999999999 788875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.3e-11 Score=122.05 Aligned_cols=119 Identities=24% Similarity=0.267 Sum_probs=74.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCC----------C
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS----------S 438 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~----------~ 438 (502)
..+|||+++.+..... .....||..|+|||...+. .++.++||||+||+++||+||+.|+....... .
T Consensus 182 kL~DFG~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260 (394)
T ss_dssp EECCCTTCEECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCCCcccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 3799999998754332 2345689999999988654 58999999999999999999999985321100 0
Q ss_pred CC---CCc-ccccccccCCCCCCC------CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 439 PS---LNT-DIALDEMLDPRLPVP------SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 439 ~~---~~~-~~~~~~~~d~~l~~~------~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.. +.. .....+..-+..... ......++..+++ .|++.+|++||++.|+++
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS---RLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHH---HHCCSSGGGSCCHHHHHT
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHH---HHhCCChhhCCCHHHHhc
Confidence 00 000 000000000111000 0012245666666 999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.08 E-value=5.5e-12 Score=124.90 Aligned_cols=60 Identities=27% Similarity=0.340 Sum_probs=51.5
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++...... ....||..|+|||...+..++.++||||+||+++||+||+.|+.
T Consensus 201 ~kl~DFG~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 201 IKLIDFGCATFKSDYH---GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp EEECCCTTCEETTSCC---CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEEeccCceecCCCC---cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 3479999998764322 34578999999999999999999999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.3e-11 Score=119.24 Aligned_cols=112 Identities=21% Similarity=0.288 Sum_probs=75.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++..... ......|+..|+|||.......+.++||||+|++++||+||+.|+...... ..........
T Consensus 149 kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~ 223 (304)
T 2jam_A 149 MITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEGY 223 (304)
T ss_dssp EBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHCC
T ss_pred EEccCCcceecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCC
Confidence 46899998765432 223456899999999999888999999999999999999999997521110 0000000000
Q ss_pred -ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 -MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 -~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....... ....+++..+++ .|++.+|++||++.|+++
T Consensus 224 ~~~~~~~~---~~~~~~~~~li~---~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 224 YEFESPFW---DDISESAKDFIC---HLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCCCTTTT---TTSCHHHHHHHH---HHHCSSTTTSCCHHHHHT
T ss_pred CCCCcccc---ccCCHHHHHHHH---HHcCCChhHCcCHHHHhc
Confidence 0011111 112355666666 999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=6e-12 Score=122.94 Aligned_cols=113 Identities=22% Similarity=0.309 Sum_probs=73.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....||.+|+|||.......+.++||||+|++++||+||+.|+....... ... .+..
T Consensus 174 kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~--~i~~ 247 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE-LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYL--NISQ 247 (327)
T ss_dssp EECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH--HHHH
T ss_pred EEeeCccccccCCccc-cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHH--HHHh
Confidence 4689999987754322 234679999999999998899999999999999999999999975311100 000 0000
Q ss_pred -ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 -MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 -~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+.... ......+++..+++ .|++.+|++||++.|+++
T Consensus 248 ~~~~~~~~-~~~~~~~~~~~li~---~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 VNVDYSEE-TFSSVSQLATDFIQ---SLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp TCCCCCTT-TTTTSCHHHHHHHH---HHSCSSGGGSCCHHHHTT
T ss_pred cccccCch-hhcccCHHHHHHHH---HHcCCChhhCcCHHHHhC
Confidence 0010000 00112345666666 999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.4e-11 Score=123.37 Aligned_cols=60 Identities=32% Similarity=0.407 Sum_probs=43.4
Q ss_pred cccccCcccccCCCC---------------------------CCcccccccccccCcccc-ccceecccceeeeeceeee
Q 010736 370 ITGDFGIAKFLKPDS---------------------------SNWTGFAGTYGYIAPELA-YTMKITEKCDVYSFGVLVL 421 (502)
Q Consensus 370 l~~dfGl~~ll~~~~---------------------------~~~~~~~gt~gy~aPE~~-~~~~~s~k~Dvysfgv~ll 421 (502)
.++|||+++...... ...+...||..|+|||.. ....++.++|||||||+++
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 379999999874221 112345789999999975 5567899999999999999
Q ss_pred ehhcCCCC
Q 010736 422 EVIKGKHP 429 (502)
Q Consensus 422 Elltg~~p 429 (502)
||+||..|
T Consensus 276 elltg~~~ 283 (458)
T 3rp9_A 276 ELLNMIKE 283 (458)
T ss_dssp HHHTTSTT
T ss_pred HHHHhccc
Confidence 99996443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=2.7e-11 Score=121.42 Aligned_cols=60 Identities=18% Similarity=0.204 Sum_probs=51.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~ 432 (502)
..+|||+++..... .+...||..|+|||...+..++.++|||||||+++||+||+.|++.
T Consensus 236 kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 295 (397)
T 1wak_A 236 KIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEP 295 (397)
T ss_dssp EECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred Eecccccccccccc---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence 46899999877532 2345789999999999988899999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=6.9e-12 Score=126.38 Aligned_cols=62 Identities=21% Similarity=0.370 Sum_probs=44.5
Q ss_pred cccccCcccccCCCC---CCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDS---SNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~---~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.++|||+++...... .......||..|+|||...+. .++.++|||||||+++||+||+.|+.
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 468999998875321 122346789999999998764 48999999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=2.7e-11 Score=120.20 Aligned_cols=114 Identities=12% Similarity=0.089 Sum_probs=79.4
Q ss_pred CccccccCcccccCC--CCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 368 NNITGDFGIAKFLKP--DSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 368 N~l~~dfGl~~ll~~--~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
.-.++|||+++.+.. .....+...||.+|+|||...+..++.++|||||||+++||+||+.|+...... ..
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~ 293 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-------EC 293 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-------EE
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-------ce
Confidence 345789999986642 222334567999999999999988999999999999999999999997422110 00
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCC-CCHHHHHHHHHhh
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESR-PTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~R-p~m~~v~~~l~~~ 497 (502)
. .+..+... ...+.+.++++ .|++.+|.+| |+++++.+.|+..
T Consensus 294 ~----~~~~~~~~--~~~~~~~~~~~---~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 K----PEGLFRRL--PHLDMWNEFFH---VMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp E----ECSCCTTC--SSHHHHHHHHH---HHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred e----echhcccc--CcHHHHHHHHH---HHcCCCCCCcchHHHHHHHHHHHH
Confidence 1 11111111 12455666777 7778888888 6788888877764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.07 E-value=1e-11 Score=122.50 Aligned_cols=108 Identities=20% Similarity=0.294 Sum_probs=75.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... ....||..|+|||......++.++|+||+||+++||+||+.|+..... ......
T Consensus 181 kL~DFg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~ 249 (350)
T 1rdq_E 181 QVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEK 249 (350)
T ss_dssp EECCCTTCEECSSCB---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EEcccccceeccCCc---ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHH
Confidence 368999998775432 346799999999999988899999999999999999999999752110 000111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-----HHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-----MKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-----m~~v~~ 492 (502)
+......-+ .....++..+++ .|++.+|++||+ +.||.+
T Consensus 250 i~~~~~~~p-~~~~~~~~~li~---~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 250 IVSGKVRFP-SHFSSDLKDLLR---NLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHCCCCCC-TTCCHHHHHHHH---HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHcCCCCCC-CCCCHHHHHHHH---HHhhcCHHhccCCccCCHHHHHh
Confidence 111111111 112356667777 999999999998 777753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=1.6e-11 Score=117.10 Aligned_cols=105 Identities=15% Similarity=0.256 Sum_probs=72.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++...... ...||..|+|||..... ..+.++||||||++++|+++|+.|...... + . .+.
T Consensus 174 kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~-~--~~~ 241 (289)
T 1x8b_A 174 KIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-----W-H--EIR 241 (289)
T ss_dssp EECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----H-H--HHH
T ss_pred EEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----H-H--HHH
Confidence 468999998775432 24589999999998765 567899999999999999999987431100 0 0 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.-..+.++ ....+++.++++ .|++.+|++||++.|+++
T Consensus 242 ~~~~~~~~---~~~~~~~~~li~---~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 242 QGRLPRIP---QVLSQEFTELLK---VMIHPDPERRPSAMALVK 279 (289)
T ss_dssp TTCCCCCS---SCCCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred cCCCCCCC---cccCHHHHHHHH---HHhCCCcccCCCHHHHhh
Confidence 11111221 112355666666 999999999999999975
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.7e-08 Score=98.57 Aligned_cols=285 Identities=11% Similarity=0.095 Sum_probs=178.1
Q ss_pred EEEEEecCCCCceecCcccCCCCCCCCEEECCCCc---ccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEE
Q 010736 72 VINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNK---LFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148 (502)
Q Consensus 72 v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~---l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 148 (502)
++.+.++.. ++ .|...+|.++++|+.+.+..|. ++.+-..+|.++.+|+.+.+..+ ++......|..+.+|+.+
T Consensus 66 L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i 142 (394)
T 4gt6_A 66 LTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTV 142 (394)
T ss_dssp CCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEE
T ss_pred CEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccc
Confidence 566666543 33 4566678888999999887653 66555677888888888887655 443455678888889988
Q ss_pred EccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccc---
Q 010736 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAIN--- 225 (502)
Q Consensus 149 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N--- 225 (502)
.+..+ +.......|..+.+|+.+.+..+ ++..-..+|. ..+|+.+.+..+-. ..-...|..+.++.......+
T Consensus 143 ~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~ 218 (394)
T 4gt6_A 143 TIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVT-RIGTNAFSECFALSTITSDSESYP 218 (394)
T ss_dssp ECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCC-EECTTTTTTCTTCCEEEECCSSSC
T ss_pred cccce-eeeecccceecccccccccccce-eeEecccccc-ccceeEEEECCccc-ccccchhhhccccceecccccccc
Confidence 88754 34355567888888888888655 4434444554 36788887765432 233344555544443322211
Q ss_pred ---------------------------------cccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcC
Q 010736 226 ---------------------------------QFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDD 271 (502)
Q Consensus 226 ---------------------------------~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~ 271 (502)
.++..-...|.++..|+.+.+..+... .....+.. ..|+.+.+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~- 296 (394)
T 4gt6_A 219 AIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS- 296 (394)
T ss_dssp BSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-
T ss_pred cccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-
Confidence 111112245677788888887655432 22333333 568888875
Q ss_pred CcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccC
Q 010736 272 NHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEIS 351 (502)
Q Consensus 272 N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 351 (502)
+.++.+....|..+.+|+.+.+..+ ++..-...|.+|.+|+.+.+..+ ++..-..+|..+.+|+.+++.++....
T Consensus 297 ~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--- 371 (394)
T 4gt6_A 297 SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW--- 371 (394)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---
T ss_pred CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---
Confidence 4566656667778888988888754 55455667888889998888644 665556788888899999888875432
Q ss_pred ccccCCCCCCeeeecCCcc
Q 010736 352 SNFGECPKLGALNISRNNI 370 (502)
Q Consensus 352 ~~~~~~~~L~~L~l~~N~l 370 (502)
..+..+.+|+.+.+..|.+
T Consensus 372 ~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 372 NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp HTCBCCCCC----------
T ss_pred hhhhccCCCCEEEeCCCCE
Confidence 3566677788877766543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.06 E-value=1.1e-11 Score=121.03 Aligned_cols=61 Identities=23% Similarity=0.340 Sum_probs=50.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++....... .....|+..|+|||.... ...+.++||||+||+++||+||+.|+.
T Consensus 171 kl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 171 RLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp EECCCTTCEECCTTCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred EEEeCCCceEcCCCCc-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 3789999988754332 234568899999999876 568999999999999999999999973
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=3.7e-11 Score=122.02 Aligned_cols=62 Identities=26% Similarity=0.370 Sum_probs=45.8
Q ss_pred cccccCcccccCCCCC----------------------CcccccccccccCcccc-ccceecccceeeeeceeeeehhcC
Q 010736 370 ITGDFGIAKFLKPDSS----------------------NWTGFAGTYGYIAPELA-YTMKITEKCDVYSFGVLVLEVIKG 426 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----------------------~~~~~~gt~gy~aPE~~-~~~~~s~k~Dvysfgv~llElltg 426 (502)
.++|||+++....... ..+...||..|+|||.. ....++.++||||+||+++||+||
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 3789999998753221 12456789999999985 556689999999999999999998
Q ss_pred CCCCC
Q 010736 427 KHPRD 431 (502)
Q Consensus 427 ~~p~~ 431 (502)
+.|+.
T Consensus 249 ~~p~~ 253 (432)
T 3n9x_A 249 LQSHI 253 (432)
T ss_dssp CTTTC
T ss_pred ccccc
Confidence 77653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.06 E-value=6.6e-12 Score=125.76 Aligned_cols=62 Identities=27% Similarity=0.385 Sum_probs=48.2
Q ss_pred cccccCcccccCCC---------------------CCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCC
Q 010736 370 ITGDFGIAKFLKPD---------------------SSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGK 427 (502)
Q Consensus 370 l~~dfGl~~ll~~~---------------------~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~ 427 (502)
..+|||+++.+... ....+...||..|+|||...+ ..++.++||||+||+++||+||+
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 228 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence 37899999876321 111234579999999999876 57899999999999999999999
Q ss_pred CCCC
Q 010736 428 HPRD 431 (502)
Q Consensus 428 ~p~~ 431 (502)
.|+.
T Consensus 229 ~pf~ 232 (388)
T 3oz6_A 229 PIFP 232 (388)
T ss_dssp CSCC
T ss_pred CCCC
Confidence 9985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=5e-11 Score=117.55 Aligned_cols=62 Identities=21% Similarity=0.275 Sum_probs=49.8
Q ss_pred cccccCcccccCCCC----CCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDS----SNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~----~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++.+.... .......||.+|+|||...+ ..++.++|||||||+++||+||+.|++
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 230 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence 478999998775321 22234678999999998865 457899999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.06 E-value=7.4e-12 Score=123.98 Aligned_cols=60 Identities=27% Similarity=0.460 Sum_probs=48.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++...... .....||..|+|||...+..++.++||||||++++||+||+.|+.
T Consensus 172 kl~Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 172 KLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp EECCCCCCHHHHHHC------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred EEEECCCCccccccc--ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 368999987653221 223578999999999999899999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.05 E-value=3.3e-11 Score=120.39 Aligned_cols=119 Identities=25% Similarity=0.271 Sum_probs=74.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCCC----------C
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS----------S 438 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~~----------~ 438 (502)
..+|||+++.+..... .....||..|+|||...+. ..+.++||||+||+++||+||+.|+....... .
T Consensus 182 kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 260 (383)
T 3eb0_A 182 KLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGT 260 (383)
T ss_dssp EECCCTTCEECCTTSC-CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEECCCCcccCCCCC-CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 4789999997754332 2345688999999988764 48999999999999999999999985321100 0
Q ss_pred CC---CCc-ccccccccCCCCCCC------CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 439 PS---LNT-DIALDEMLDPRLPVP------SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 439 ~~---~~~-~~~~~~~~d~~l~~~------~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.. +.. .....+..-|.+... .....+++..+++ .|++.+|++||++.|+++
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 261 PTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE---QILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH---HHCCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH---HHccCChhhCCCHHHHhc
Confidence 00 000 000000111111000 0012245666666 999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.05 E-value=2e-11 Score=118.19 Aligned_cols=103 Identities=26% Similarity=0.489 Sum_probs=73.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
..+|||+++...... .....|+..|+|||....... +.++||||+|++++||+||+.|++....
T Consensus 180 kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------- 244 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------- 244 (312)
T ss_dssp EECCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------
T ss_pred EEEEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------------
Confidence 468999998775432 234678999999999876665 4589999999999999999999752110
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+.+.....+ .....++..+++ .|++.+|++||++.||++
T Consensus 245 -~~~~~~~~~-~~~~~~~~~li~---~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -ILEAELHFP-AHVSPDCCALIR---RCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHHTCCCCC-TTSCHHHHHHHH---HHTCSSTTTSCCHHHHHH
T ss_pred -HhhhccCCc-ccCCHHHHHHHH---HHccCChhhCcCHHHHhc
Confidence 001111000 112245566666 999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.05 E-value=1.9e-11 Score=121.28 Aligned_cols=62 Identities=27% Similarity=0.446 Sum_probs=49.5
Q ss_pred cccccCcccccCCCCC---CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++....... ..+...||..|+|||.... ...+.++||||+||+++||+||+.|+.
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence 4689999987754221 1234579999999998654 448899999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=3.7e-12 Score=122.74 Aligned_cols=114 Identities=21% Similarity=0.353 Sum_probs=69.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++.............|+..|+|||... ....+.++||||||++++||+||+.|+....... ...
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~- 232 (302)
T 2j7t_A 157 RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLL- 232 (302)
T ss_dssp EECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH-
T ss_pred EEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH-
Confidence 4689998754321111112356899999999973 5667889999999999999999999975321100 000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.......+....+ .....++..+++ .|++.+|++||++.|+++
T Consensus 233 -~~~~~~~~~~~~~-~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 233 -KIAKSDPPTLLTP-SKWSVEFRDFLK---IALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -HHHHSCCCCCSSG-GGSCHHHHHHHH---HHSCSCTTTSCCHHHHTT
T ss_pred -HHhccCCcccCCc-cccCHHHHHHHH---HHcccChhhCCCHHHHhc
Confidence 0000011111101 112245666666 999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=1.4e-11 Score=128.49 Aligned_cols=112 Identities=21% Similarity=0.311 Sum_probs=77.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
.++|||+++.+..... .....||..|+|||......++.++||||+||+++||+||+.|+........ .......
T Consensus 326 KL~DFGla~~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~~~ 400 (576)
T 2acx_A 326 RISDLGLAVHVPEGQT-IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERL 400 (576)
T ss_dssp EECCCTTCEECCTTCC-EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHHHH
T ss_pred EEEecccceecccCcc-ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHHHH
Confidence 3789999988754332 3346799999999999998999999999999999999999999863221100 0000000
Q ss_pred c--cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 450 M--LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 450 ~--~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
+ .....+ .....++..+++ .|++.+|++|| +++||.+
T Consensus 401 i~~~~~~~p---~~~s~~~~dLI~---~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 401 VKEVPEEYS---ERFSPQARSLCS---QLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHCCCCCC---TTSCHHHHHHHH---HHTCSSGGGSTTCSSSHHHHHHT
T ss_pred hhcccccCC---ccCCHHHHHHHH---HhccCCHHHcCCCCCCCHHHHHh
Confidence 1 111121 112355667777 99999999999 6777753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=2.3e-11 Score=123.32 Aligned_cols=114 Identities=21% Similarity=0.269 Sum_probs=72.9
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
.++|||+++....... ..+...||.+|+|||+.. ...++.++|||||||+++||+||+.|+...... ....
T Consensus 215 kL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~ 291 (437)
T 4aw2_A 215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYG 291 (437)
T ss_dssp EECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH
T ss_pred EEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHH
Confidence 4799999987654332 223467999999999986 567899999999999999999999998521100 0000
Q ss_pred ccc--cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCC--CCCHHHHHH
Q 010736 444 DIA--LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPES--RPTMKIVSQ 492 (502)
Q Consensus 444 ~~~--~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~--Rp~m~~v~~ 492 (502)
... .....-|... ....+++..+++ .|+..+|++ ||++.|+.+
T Consensus 292 ~i~~~~~~~~~p~~~---~~~s~~~~dLi~---~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 292 KIMNHKERFQFPTQV---TDVSENAKDLIR---RLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHTHHHHCCCCSSC---CCSCHHHHHHHH---TTSSCGGGCTTTTTTHHHHT
T ss_pred hhhhccccccCCccc---ccCCHHHHHHHH---HHhcccccccCCCCHHHHhC
Confidence 000 0011111111 112356677777 555555666 999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=2.7e-11 Score=118.49 Aligned_cols=60 Identities=27% Similarity=0.419 Sum_probs=51.2
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
-..+|||+++...... ....||.+|+|||...+...+.++||||+|++++||+||+.|+.
T Consensus 176 ~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 176 IKVVDFGSATYDDEHH---STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp EEECCCSSCEETTSCC---CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ceEeeCcccccCcccc---ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 3478999998764322 34578999999999998889999999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.03 E-value=1.8e-11 Score=122.64 Aligned_cols=62 Identities=16% Similarity=0.174 Sum_probs=47.9
Q ss_pred ccccCcccccCCC-------CCCcccccccccccCcccccc--ceecccceeeeeceeeeehhcCCCCCCc
Q 010736 371 TGDFGIAKFLKPD-------SSNWTGFAGTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPRDF 432 (502)
Q Consensus 371 ~~dfGl~~ll~~~-------~~~~~~~~gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~~~ 432 (502)
.+|||.+...... ........||..|+|||.... ..++.++||||+||+++||+||+.|+..
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 6799987654211 111123468899999999877 5789999999999999999999999853
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.02 E-value=3.4e-11 Score=119.80 Aligned_cols=59 Identities=31% Similarity=0.524 Sum_probs=45.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++..... .+...||..|+|||...+ ...+.++||||+||+++||+||+.|++
T Consensus 184 kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 243 (371)
T 4exu_A 184 KILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243 (371)
T ss_dssp EECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEecCcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 36899999876432 234578999999999876 678999999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=4.1e-11 Score=123.72 Aligned_cols=113 Identities=23% Similarity=0.311 Sum_probs=73.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....||..|+|||...+ .++.++||||+||+++||+||+.|+...... ....... ..
T Consensus 164 kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~-~~ 237 (486)
T 3mwu_A 164 KIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVE-TG 237 (486)
T ss_dssp EECSCSCTTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-HT
T ss_pred EEEECCcCeECCCCCc-cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-hC
Confidence 3689999987754322 234579999999999875 5889999999999999999999997421100 0000000 00
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+.. ....+++..+++ .|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~-~~~s~~~~~li~---~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 238 KYAFDLPQW-RTISDDAKDLIR---KMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CCCSCSGGG-GGSCHHHHHHHH---HHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCccc-CCCCHHHHHHHH---HHcCCChhhCcCHHHHhc
Confidence 001111100 112345666776 999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=3e-11 Score=119.07 Aligned_cols=59 Identities=29% Similarity=0.482 Sum_probs=50.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++...... ....||..|+|||...+..++.++||||+||+++||+||+.|+.
T Consensus 182 kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 182 RVADFGSATFDHEHH---TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp EECCCTTCEETTSCC---CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEeecCccccccccc---cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 468999998754322 34678999999999998899999999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.01 E-value=2.9e-11 Score=115.23 Aligned_cols=111 Identities=20% Similarity=0.277 Sum_probs=72.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....|+..|+|||.......+.++||||||++++||+||+.|+...... .....
T Consensus 152 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~ 222 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTN 222 (283)
T ss_dssp EECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred EEEecccceeccCCCc-ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHH
Confidence 4689999987654322 23456899999999998888999999999999999999999997532110 00000
Q ss_pred cc--CCCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 ML--DPRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~--d~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+. ....... .....+++.++++ .|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 223 ISAVNYDFDEEYFSNTSELAKDFIR---RLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHTTCCCCCHHHHTTCCHHHHHHHH---TTSCSSGGGSCCHHHHHH
T ss_pred hHhcccCCcchhcccCCHHHHHHHH---HHccCCHhHCcCHHHHHh
Confidence 00 0000000 0011245566666 999999999999999986
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.01 E-value=5.2e-13 Score=125.09 Aligned_cols=139 Identities=17% Similarity=0.161 Sum_probs=64.3
Q ss_pred CCCccceeeeCCCC-CEEEEEecC---CCCceecCcccCCCCC---------CCCEEECCCCcccccCCccCcCCCCCCE
Q 010736 57 SPCAWSGISCNDAG-RVINISLRG---VGLKGKLHAFSFSSFP---------HLAYLDLRDNKLFGTIPPQISNLTNLSI 123 (502)
Q Consensus 57 ~~C~W~Gv~C~~~~-~v~~L~L~~---~~l~g~l~~~~~~~l~---------~L~~L~Ls~N~l~g~~p~~l~~l~~L~~ 123 (502)
..|.|.|+.|+..+ +|+.+...+ ..+.|.+.+..+..++ .-+.|||+. |...+.|+.
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~----------l~~dp~L~~ 145 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKG----------LRSDPDLVA 145 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTT----------GGGCHHHHH
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHH----------cCCCcchhh
Confidence 46899999998643 665555544 3344444433222211 123334332 222223332
Q ss_pred --EEccCCcCc---CCCCcccCCCCCCcEEEccCCcCcc--cCCcccCCCCCCcEEEcccCcccccCCcCCCCCC--CCC
Q 010736 124 --LSLGGNQFS---GNIPHEVGLMSHLKILYIDSNQLDG--SIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLT--QIS 194 (502)
Q Consensus 124 --L~Ls~N~l~---~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~ 194 (502)
++++.|... +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|++++. ..+..+. +|+
T Consensus 146 ~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~ 223 (267)
T 3rw6_A 146 QNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLE 223 (267)
T ss_dssp TTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCS
T ss_pred cCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcc
Confidence 344444221 1111111334555555555555554 2333444555555555555555533 1122222 555
Q ss_pred eEEcccccccccC
Q 010736 195 MLFLHDNSFSGFI 207 (502)
Q Consensus 195 ~L~L~~N~l~~~~ 207 (502)
+|+|++|.+.+.+
T Consensus 224 ~L~L~~Npl~~~~ 236 (267)
T 3rw6_A 224 ELWLDGNSLCDTF 236 (267)
T ss_dssp EEECTTSTTGGGC
T ss_pred eEEccCCcCcccc
Confidence 6666666555433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=2.6e-11 Score=119.65 Aligned_cols=62 Identities=26% Similarity=0.418 Sum_probs=47.9
Q ss_pred cccccCcccccCCCCC----------CcccccccccccCccccc-cceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS----------NWTGFAGTYGYIAPELAY-TMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----------~~~~~~gt~gy~aPE~~~-~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++....... ......||..|+|||... ....+.++|||||||+++||+||+.|+.
T Consensus 152 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 224 (353)
T 2b9h_A 152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224 (353)
T ss_dssp EECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence 4689999987753211 122356899999999765 4678999999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=2e-11 Score=120.51 Aligned_cols=117 Identities=20% Similarity=0.263 Sum_probs=71.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCC-----------
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS----------- 437 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~----------- 437 (502)
..+|||+++..... .+...||..|+|||...+ ...+.++||||+||+++||+||+.|+.......
T Consensus 166 kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 166 KILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242 (353)
T ss_dssp EECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred EEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 36899999876432 234578999999998876 678899999999999999999999985321000
Q ss_pred -CCCCC---ccc----ccccc---cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 -SPSLN---TDI----ALDEM---LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 -~~~~~---~~~----~~~~~---~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+. .+. ....+ ..+...........++..+++ .|++.+|++||+++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE---KMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHH---HHSCSCTTTSCCHHHHHT
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHH---HHcCCCcccCCCHHHHhc
Confidence 00000 000 00000 000111000112345666666 999999999999999964
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.01 E-value=1.5e-11 Score=122.17 Aligned_cols=117 Identities=23% Similarity=0.302 Sum_probs=74.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCC-----------
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS----------- 437 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~----------- 437 (502)
.++|||+++..... .+...||..|+|||...+ ..++.++||||+||+++||+||+.|+.......
T Consensus 168 kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 168 KILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244 (367)
T ss_dssp EECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeecccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 47999999876432 334678999999999876 678999999999999999999999975211000
Q ss_pred -CCCCCccc----------ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 -SPSLNTDI----------ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 -~~~~~~~~----------~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
...+.... ...+...............++..+++ .|++.+|++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~---~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHH---HHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH---HHccCChhHCCCHHHHhc
Confidence 00000000 00000000000000112245666666 999999999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=9.9e-12 Score=121.07 Aligned_cols=114 Identities=26% Similarity=0.366 Sum_probs=73.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc---cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY---TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~---~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++...... ......||..|+|||... ...++.++|||||||+++||+||+.|+....... .......
T Consensus 157 kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~ 233 (322)
T 2ycf_A 157 KITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT 233 (322)
T ss_dssp EECCCTTCEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH
T ss_pred EEccCccceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH
Confidence 368999998775321 123456899999999864 4567899999999999999999999985322110 0000000
Q ss_pred cccc-cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEM-LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~-~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.... ..+... ....+++.++++ .|++.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~---~~~~~~~~~li~---~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYNFIPEVW---AEVSEKALDLVK---KLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCCCCHHHH---TTSCHHHHHHHH---HHSCSSTTTSCCHHHHHT
T ss_pred hCccccCchhh---hhcCHHHHHHHH---HHcccCHhhCCCHHHHhh
Confidence 0000 000000 011245556666 999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.3e-11 Score=121.34 Aligned_cols=113 Identities=24% Similarity=0.305 Sum_probs=73.0
Q ss_pred cccccCcccccCCCCCC-cccccccccccCccccc-------cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSN-WTGFAGTYGYIAPELAY-------TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSL 441 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~-~~~~~gt~gy~aPE~~~-------~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~ 441 (502)
..+|||+++.+...... .....||..|+|||... ...++.++|+|||||+++||+||+.|+...... ..
T Consensus 202 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~ 278 (412)
T 2vd5_A 202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ET 278 (412)
T ss_dssp EECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH
T ss_pred EEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HH
Confidence 47899999887554332 23467999999999987 357899999999999999999999998531110 00
Q ss_pred Cccccc--ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCC---CCHHHHHH
Q 010736 442 NTDIAL--DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESR---PTMKIVSQ 492 (502)
Q Consensus 442 ~~~~~~--~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~R---p~m~~v~~ 492 (502)
...... ....-|... ....+++..+++ .|+. +|++| |+++|+.+
T Consensus 279 ~~~i~~~~~~~~~p~~~---~~~s~~~~dli~---~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 YGKIVHYKEHLSLPLVD---EGVPEEARDFIQ---RLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHTHHHHCCCC-------CCCHHHHHHHH---TTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHhcccCcCCCccc---cCCCHHHHHHHH---HHcC-ChhhcCCCCCHHHHhc
Confidence 000000 001111111 112356777777 8888 88887 68888753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=3.7e-11 Score=124.31 Aligned_cols=110 Identities=24% Similarity=0.358 Sum_probs=74.0
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc--c
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL--D 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~--~ 448 (502)
.+|||+++....... .....||..|+|||... ..++.++||||+||+++||+||+.|+...... ........ .
T Consensus 180 l~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~ 254 (494)
T 3lij_A 180 IVDFGLSAVFENQKK-MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILRKVEKGKY 254 (494)
T ss_dssp ECCCTTCEECBTTBC-BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCC
T ss_pred EEECCCCeECCCCcc-ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCC
Confidence 689999988754322 33467999999999876 46899999999999999999999997531110 00000000 0
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+... ...+++..+++ .|++.+|++||++.|+++
T Consensus 255 ~~~~~~~~----~~s~~~~~li~---~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 TFDSPEWK----NVSEGAKDLIK---QMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCCSGGGT----TSCHHHHHHHH---HHTCSSTTTSCCHHHHHT
T ss_pred CCCchhcc----cCCHHHHHHHH---HHCCCChhhCccHHHHhc
Confidence 00011111 12245666766 999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.9e-11 Score=116.36 Aligned_cols=120 Identities=23% Similarity=0.325 Sum_probs=72.8
Q ss_pred cccccCcccccCCCCC---CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCCC-------
Q 010736 370 ITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS------- 438 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~------- 438 (502)
..+|||+++....... ......++..|+|||.... ...+.++||||||++++||+||+.|+........
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 4689999988753211 1233457889999998765 6789999999999999999999999853211000
Q ss_pred -CCCCccc--c---------cccccCCCCC--CCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 439 -PSLNTDI--A---------LDEMLDPRLP--VPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 439 -~~~~~~~--~---------~~~~~d~~l~--~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....... . ......+..+ .......+++..+++ .|++.+|++||+++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE---QILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHH---TTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHH---HHcCCCccccCCHHHHhC
Confidence 0000000 0 0000001000 000012245666666 999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=98.99 E-value=3.6e-11 Score=119.40 Aligned_cols=59 Identities=29% Similarity=0.526 Sum_probs=39.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++..... .+...||..|+|||...+ ..++.++||||+||+++||+||+.|+.
T Consensus 172 kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 231 (367)
T 2fst_X 172 KILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231 (367)
T ss_dssp EECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEeecccccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 36899999876432 234678999999999876 678899999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=7.5e-11 Score=116.77 Aligned_cols=61 Identities=28% Similarity=0.325 Sum_probs=41.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++...... ..+...|+..|+|||.... ...+.++||||+||+++||+||+.|+.
T Consensus 174 kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 174 TICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp EECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 368999998654332 2234578899999998876 668999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=1.8e-11 Score=123.09 Aligned_cols=111 Identities=19% Similarity=0.321 Sum_probs=75.0
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccce----ecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMK----ITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~----~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++.+..... ......||..|+|||...... ++.++|||||||+++||+||+.|+......
T Consensus 208 kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------- 279 (410)
T 3v8s_A 208 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------- 279 (410)
T ss_dssp EECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--------
T ss_pred EEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--------
Confidence 4789999987754322 223567999999999987654 889999999999999999999998521100
Q ss_pred cccccccC----CCCCCCCcchHHHHHHHHHHhhccCCcCCCC--CCCHHHHHH
Q 010736 445 IALDEMLD----PRLPVPSCSVQEKLISIMEVGFSCLKESPES--RPTMKIVSQ 492 (502)
Q Consensus 445 ~~~~~~~d----~~l~~~~~~~~~~~~~~~~val~C~~~~p~~--Rp~m~~v~~ 492 (502)
.....+.. ...+.. ....+++..+++ .|+...|++ ||++.||.+
T Consensus 280 ~~~~~i~~~~~~~~~p~~-~~~s~~~~~li~---~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 280 GTYSKIMNHKNSLTFPDD-NDISKEAKNLIC---AFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHHHTHHHHCCCCTT-CCCCHHHHHHHH---HHSSCGGGCTTSSCHHHHHT
T ss_pred hHHHHHHhccccccCCCc-ccccHHHHHHHH---HHccChhhhCCCCCHHHHhc
Confidence 00011111 111111 112356667776 788888888 999999865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=5e-11 Score=113.99 Aligned_cols=113 Identities=23% Similarity=0.303 Sum_probs=73.6
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....|+..|+|||...+ ..+.++||||+|++++||+||+.|+...... ...... ...
T Consensus 164 kL~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~-~~~ 237 (287)
T 2wei_A 164 KIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRV-ETG 237 (287)
T ss_dssp EECSTTGGGTBCCCSS-CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH-HHC
T ss_pred EEeccCcceeecCCCc-cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHH-HcC
Confidence 3689999987654322 223458899999998765 4889999999999999999999997531110 000000 000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+.. ....+++..+++ .|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~-~~~~~~~~~li~---~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 238 KYAFDLPQW-RTISDDAKDLIR---KMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCCSGGG-TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHH
T ss_pred CCCCCchhh-hhcCHHHHHHHH---HHcccChhhCcCHHHHhc
Confidence 000011000 112245666666 999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=3.3e-10 Score=119.58 Aligned_cols=115 Identities=31% Similarity=0.318 Sum_probs=72.3
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccC----C------CCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSS----T------SSPS 440 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~----~------~~~~ 440 (502)
.+|||+++....... .....|+.+|+|||...+..++.++||||||++++|++||+.|+..... . ....
T Consensus 165 L~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 165 IIDLGYAKELDQGEL-CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp ECSCCCCCBTTSCCC-CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred Ecccccccccccccc-cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 689999988754332 2446789999999999999999999999999999999999999853100 0 0000
Q ss_pred -CCcccccccc-cCCCCCCC---CcchHHHHHHHHHHhhccCCcCCCCCCCHHH
Q 010736 441 -LNTDIALDEM-LDPRLPVP---SCSVQEKLISIMEVGFSCLKESPESRPTMKI 489 (502)
Q Consensus 441 -~~~~~~~~~~-~d~~l~~~---~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~ 489 (502)
...+.....+ +...++.+ .....+++..+++ .|++.+|++||++.|
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~---~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ---CMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHH---HHSCSSCC---CCTT
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHH---HHccCCHhhCcCHHH
Confidence 0000000000 11111111 1123456666766 999999999999977
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=2.8e-11 Score=116.32 Aligned_cols=111 Identities=21% Similarity=0.329 Sum_probs=73.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc------cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY------TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~------~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
..+|||+++....... .....|+..|+|||... ....+.++||||||++++||+||+.|+......
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------- 235 (298)
T 1phk_A 164 KLTDFGFSCQLDPGEK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------- 235 (298)
T ss_dssp EECCCTTCEECCTTCC-BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred EEecccchhhcCCCcc-cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-------
Confidence 4689999987754332 23457899999999875 345788999999999999999999997421100
Q ss_pred ccccccccCC--CCCCCC-cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDP--RLPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~--~l~~~~-~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+... ....+. ....+++.++++ .|++.+|++||++.|+++
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 236 -LMLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HHHHHHHHTCCCCCTTTGGGSCHHHHHHHH---HHCCSSGGGSCCHHHHTT
T ss_pred -HHHHHHhcCCcccCcccccccCHHHHHHHH---HHccCCcccCCCHHHHHh
Confidence 000000000 000000 112345666666 999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=98.97 E-value=5.1e-11 Score=123.58 Aligned_cols=110 Identities=24% Similarity=0.301 Sum_probs=74.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....||..|+|||... ..++.++||||+||+++||+||+.|+...... .....
T Consensus 189 kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK-LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DIIKK 258 (504)
T ss_dssp EECCCTTCEECCTTSC-BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH
T ss_pred EEEECCCCEEcCCCCc-cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 3689999988754322 33457999999999876 46899999999999999999999997531110 00011
Q ss_pred ccCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+.......+. ....+++..+++ .|++.+|++||++.|+++
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~---~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKYYFDFNDWKNISDEAKELIK---LMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCCCCCHHHHTTSCHHHHHHHH---HHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCCCCccccCCCCHHHHHHHH---HHcCCChhHCCCHHHHhc
Confidence 1111110000 012245666776 999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=2.7e-11 Score=124.96 Aligned_cols=113 Identities=24% Similarity=0.309 Sum_probs=75.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... ......||..|+|||...+ .++.++||||+||+++||+||+.|+...... ...... ...
T Consensus 169 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i-~~~ 242 (484)
T 3nyv_A 169 RIIDFGLSTHFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKV-EKG 242 (484)
T ss_dssp EECCTTHHHHBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH-HHC
T ss_pred EEEeeeeeEEccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH-HcC
Confidence 368999998775433 2334579999999999865 6889999999999999999999997531110 000000 000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......+.. ....+++..+++ .|++.+|++||++.|+++
T Consensus 243 ~~~~~~~~~-~~~s~~~~~li~---~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 243 KYTFELPQW-KKVSESAKDLIR---KMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCCCSGGG-GGSCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCccc-ccCCHHHHHHHH---HHCCCChhHCcCHHHHhh
Confidence 001111100 112355667777 999999999999999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.90 E-value=1.1e-10 Score=114.92 Aligned_cols=180 Identities=17% Similarity=0.207 Sum_probs=104.9
Q ss_pred CCCEEEEEecCCCCce-ec-------CcccCCCCCCCCEEECCCCccc---------ccCCccCcCCCCCCEEEccCCcC
Q 010736 69 AGRVINISLRGVGLKG-KL-------HAFSFSSFPHLAYLDLRDNKLF---------GTIPPQISNLTNLSILSLGGNQF 131 (502)
Q Consensus 69 ~~~v~~L~L~~~~l~g-~l-------~~~~~~~l~~L~~L~Ls~N~l~---------g~~p~~l~~l~~L~~L~Ls~N~l 131 (502)
..+|+.|.+...++.| .+ .. +...+++|+.|.+..+... +.++..+..+++|+.|+|++|.-
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~-s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~ 184 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVE-NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNN 184 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHT-THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBT
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHH-hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCC
Confidence 3468888887666553 11 11 2456789999988765331 22445567788999999988731
Q ss_pred cCCCCcccCCCCCCcEEEccCCcCcccCCcccC--CCCCCcEEEccc--Cccccc-----CCcCC--CCCCCCCeEEccc
Q 010736 132 SGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVG--QLSSMVELALFS--NNLNGS-----VPHSL--GNLTQISMLFLHD 200 (502)
Q Consensus 132 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~--~~l~~L~~L~L~~ 200 (502)
. .++. +. +++|++|+|..|.++......+. .+++|+.|+|+. |...+. +...+ ..+++|++|+|.+
T Consensus 185 l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~ 261 (362)
T 2ra8_A 185 L-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVD 261 (362)
T ss_dssp C-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEES
T ss_pred c-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCC
Confidence 1 2333 33 78899999988877643333333 678888888753 222111 00112 2467777777777
Q ss_pred ccccccCCccC---cCCccCCccccccccccCc----ccccccCCCCCcEEEeeCcccc
Q 010736 201 NSFSGFIPPDI---GNLKSISILSLAINQFSGP----IPLSLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 201 N~l~~~~p~~~---~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 252 (502)
|.+....+..+ ..+++|++|+++.|.+++. ++..+..+++|+.|++++|.++
T Consensus 262 ~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp CTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 77664322222 2356667777766666542 2223334566666666666554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=98.87 E-value=1.2e-10 Score=111.96 Aligned_cols=112 Identities=24% Similarity=0.353 Sum_probs=64.7
Q ss_pred cccccCcccccCCCC--------------CCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDS--------------SNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLS 434 (502)
Q Consensus 370 l~~dfGl~~ll~~~~--------------~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~ 434 (502)
..+|||+++...... .......|+..|+|||...+. ..+.++||||||++++||+| |+....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 468999998764211 112345688999999998754 68899999999999999999 332100
Q ss_pred CCCCCCCCcccc-cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 435 STSSPSLNTDIA-LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 435 ~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.. ........ ......+... .....++.++++ .|++.+|++||++.|+++
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~---~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ER--VNILKKLRSVSIEFPPDFD---DNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH--HHHHHHHHSTTCCCCTTCC---TTTSHHHHHHHH---HHTCSSGGGSCCHHHHHH
T ss_pred hH--HHHHHhccccccccCcccc---ccchHHHHHHHH---HHHhcCcccCcCHHHHhC
Confidence 00 00000000 0000111111 112244556666 999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=98.80 E-value=5.7e-10 Score=119.94 Aligned_cols=104 Identities=20% Similarity=0.192 Sum_probs=70.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++..... ....||.+|+|||...+.. +.++|||||||+++||++|..|+...... .
T Consensus 221 kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------~ 283 (681)
T 2pzi_A 221 KLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------G 283 (681)
T ss_dssp EECCCTTCEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------S
T ss_pred EEEecccchhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------c
Confidence 36899999877543 3457999999999987654 88999999999999999998886421100 0
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-HHHHHHHHHh
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-MKIVSQQLRI 496 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-m~~v~~~l~~ 496 (502)
+. ... +.....+++..+++ .|++.+|++||+ +.++...+..
T Consensus 284 ~~-~~~--~~~~~~~~l~~li~---~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 LP-EDD--PVLKTYDSYGRLLR---RAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CC-TTC--HHHHHCHHHHHHHH---HHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cc-ccc--cccccCHHHHHHHh---hhccCChhhCCCHHHHHHHHHHH
Confidence 00 000 00001134555555 999999999995 5556555544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.9e-06 Score=85.42 Aligned_cols=284 Identities=10% Similarity=0.060 Sum_probs=162.9
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
.++.+.++. +++ .|...+|.++.+|+.++|..+ ++.+-..+|.++ +|+.+.+..+ ++..-..+|.. .+|+.+.+
T Consensus 47 ~i~~v~ip~-~vt-~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~l 120 (379)
T 4h09_A 47 RISEVRVNS-GIT-SIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEF 120 (379)
T ss_dssp GCSEEEECT-TEE-EECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEEC
T ss_pred CCEEEEeCC-Ccc-ChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccC
Confidence 355555543 333 456667888888888888654 665556677776 5777776544 44233344544 36888887
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEccccccccc------------CCccCcCCccCC
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGF------------IPPDIGNLKSIS 218 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~------------~p~~~~~l~~L~ 218 (502)
..+ ++......|... +++.+.+..+ ++......|.....++.+.+..+..... ....+.....+.
T Consensus 121 p~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (379)
T 4h09_A 121 PGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGT 197 (379)
T ss_dssp CTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCS
T ss_pred CCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccccccc
Confidence 655 232333334433 4555554433 3334455566677777766654432211 011122222233
Q ss_pred ccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCc
Q 010736 219 ILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENR 297 (502)
Q Consensus 219 ~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~ 297 (502)
.+.+... ........+....+|+.+.+..+ +.......+.. ..|+.+.+..+ ++.+....+....+|+.+.+..+
T Consensus 198 ~~~~~~~-~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~- 273 (379)
T 4h09_A 198 EFTIPST-VKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK- 273 (379)
T ss_dssp EEECCTT-CCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-
T ss_pred ccccccc-eeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-
Confidence 3322221 11122334555666777666543 22122222322 56777777654 55555556677777888877543
Q ss_pred cccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCC
Q 010736 298 FQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368 (502)
Q Consensus 298 l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N 368 (502)
++..-...|.+|.+|+.+.+.++.++.....+|..+.+|+.++|..+ ++..-..+|.+|.+|+.+.+..+
T Consensus 274 i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 274 VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 44344556778888888888877777666778888888888888654 55555667888888888877543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.70 E-value=4.7e-09 Score=103.32 Aligned_cols=35 Identities=17% Similarity=0.189 Sum_probs=19.0
Q ss_pred CCCCEEECCCCcccc-c-------CCccCcCCCCCCEEEccCC
Q 010736 95 PHLAYLDLRDNKLFG-T-------IPPQISNLTNLSILSLGGN 129 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g-~-------~p~~l~~l~~L~~L~Ls~N 129 (502)
..++.|.+......| . +..++..+++|+.|.+..+
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~ 149 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDI 149 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCC
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCc
Confidence 356677766544332 1 1223445677777777654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.60 E-value=1.6e-09 Score=101.36 Aligned_cols=105 Identities=24% Similarity=0.267 Sum_probs=73.5
Q ss_pred CCCCCCCCE--EECCCCccc---ccCCccCcCCCCCCEEEccCCcCcC--CCCcccCCCCCCcEEEccCCcCcccCCccc
Q 010736 91 FSSFPHLAY--LDLRDNKLF---GTIPPQISNLTNLSILSLGGNQFSG--NIPHEVGLMSHLKILYIDSNQLDGSIPLEV 163 (502)
Q Consensus 91 ~~~l~~L~~--L~Ls~N~l~---g~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 163 (502)
|...+.|+. ++++.|... +.++....++++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 445555555 677777432 2233333568899999999999987 4566677889999999999999865 334
Q ss_pred CCCC--CCcEEEcccCcccccCCc-------CCCCCCCCCeEE
Q 010736 164 GQLS--SMVELALFSNNLNGSVPH-------SLGNLTQISMLF 197 (502)
Q Consensus 164 ~~l~--~L~~L~L~~N~l~~~~p~-------~~~~l~~L~~L~ 197 (502)
..+. +|++|+|++|.+.+.+|. .+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 899999999999876653 245566776665
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=1.1e-08 Score=98.19 Aligned_cols=79 Identities=23% Similarity=0.389 Sum_probs=48.2
Q ss_pred eecccceeeeeceeeeehhcCCCCCCcccCCCC-CCCCcccccccccCCCCCCCC---cchHHHHHHHHHHhhccCCcCC
Q 010736 406 KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS-PSLNTDIALDEMLDPRLPVPS---CSVQEKLISIMEVGFSCLKESP 481 (502)
Q Consensus 406 ~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~-~~~~~~~~~~~~~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p 481 (502)
.++.++||||+||+++||+||+.|+........ ..... .+.......+. ....+++..+++ .|++.+|
T Consensus 174 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~dP 245 (299)
T 3m2w_A 174 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-----RIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEP 245 (299)
T ss_dssp GGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-----SSCTTCCSSCHHHHTTSCHHHHHHHH---HHTCSST
T ss_pred cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-----HHhhccccCCchhcccCCHHHHHHHH---HHcccCh
Confidence 357789999999999999999999853221111 00000 00001110000 012245666666 9999999
Q ss_pred CCCCCHHHHHH
Q 010736 482 ESRPTMKIVSQ 492 (502)
Q Consensus 482 ~~Rp~m~~v~~ 492 (502)
++||++.|+++
T Consensus 246 ~~Rps~~e~l~ 256 (299)
T 3m2w_A 246 TQRMTITEFMN 256 (299)
T ss_dssp TTSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=98.59 E-value=7.3e-09 Score=98.92 Aligned_cols=116 Identities=6% Similarity=0.060 Sum_probs=70.2
Q ss_pred CCCCeeeecCCccc-cccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCC
Q 010736 358 PKLGALNISRNNIT-GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSST 436 (502)
Q Consensus 358 ~~L~~L~l~~N~l~-~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~ 436 (502)
.++.|.||+..||. .+-|-.++ ++.+|++| .+.++|||||||+++||+||+.|++.....
T Consensus 148 ~givH~Dikp~NIll~~~g~~kl------------~~~~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 148 AGVALSIDHPSRVRVSIDGDVVL------------AYPATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp TTCCCCCCSGGGEEEETTSCEEE------------CSCCCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred CCCccCCCCcccEEEcCCCCEEE------------EeccccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 35667777766653 33333332 24466655 688999999999999999999998643221
Q ss_pred CCCCCCcccccccccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 437 SSPSLNTDIALDEMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 437 ~~~~~~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
................+ .+. ....+++..+++ .|++.+|++| ++.|+++.|+....
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~---~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 209 SGLAPAERDTAGQPIEPADID---RDIPFQISAVAA---RSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CCSEECCBCTTSCBCCHHHHC---TTSCHHHHHHHH---HHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hhhHHHHHHhccCCCChhhcc---cCCCHHHHHHHH---HHcccCCccC-CHHHHHHHHHHHhc
Confidence 11000000000000000 000 112245666666 9999999999 99999999998643
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.51 E-value=8.9e-09 Score=91.49 Aligned_cols=114 Identities=19% Similarity=0.216 Sum_probs=69.3
Q ss_pred CCCCCCCCEEECCCC-ccccc----CCccCcCCCCCCEEEccCCcCcCC----CCcccCCCCCCcEEEccCCcCccc---
Q 010736 91 FSSFPHLAYLDLRDN-KLFGT----IPPQISNLTNLSILSLGGNQFSGN----IPHEVGLMSHLKILYIDSNQLDGS--- 158 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N-~l~g~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~--- 158 (502)
+...+.|++|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 566777888888887 77532 344566677788888888877632 233344456777777777777642
Q ss_pred -CCcccCCCCCCcEEEc--ccCcccccC----CcCCCCCCCCCeEEccccccc
Q 010736 159 -IPLEVGQLSSMVELAL--FSNNLNGSV----PHSLGNLTQISMLFLHDNSFS 204 (502)
Q Consensus 159 -~p~~~~~l~~L~~L~L--~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~ 204 (502)
+...+...++|++|+| ++|.+.... ...+...+.|++|+|++|.+.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2344555566667776 556665321 122333455666666666554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.50 E-value=2.2e-05 Score=77.68 Aligned_cols=275 Identities=12% Similarity=0.037 Sum_probs=177.2
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
.++.|+|+.+ ++ .|...+|.+. +|+.+.+..+ ++......|.+ .+|+.+.+..+- +..-...|.+. +|+.+.+
T Consensus 70 ~L~~I~lp~~-v~-~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~~-~~i~~~~F~~~-~l~~~~~ 142 (379)
T 4h09_A 70 NMTKVTVAST-VT-SIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGAT-TEIGNYIFYNS-SVKRIVI 142 (379)
T ss_dssp TCCEEEECTT-CC-EECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTTC-CEECTTTTTTC-CCCEEEE
T ss_pred CCCEEEeCCc-ce-EechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCcc-ccccccccccc-eeeeeec
Confidence 5788888653 44 5677778887 6888887654 55455556665 489999998663 32334445544 5666666
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCccccc------------CCcCCCCCCCCCeEEcccccccccCCccCcCCccCC
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGS------------VPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSIS 218 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~------------~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 218 (502)
..+ ++......|....+++.+.+..+..... ....+.....+..+.+.... .......+....+|+
T Consensus 143 ~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~ 220 (379)
T 4h09_A 143 PKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLK 220 (379)
T ss_dssp CTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCS
T ss_pred cce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccce-eEEeecccccccccc
Confidence 543 4445556677888888887765443211 11223334445555443332 223344566667777
Q ss_pred ccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCc
Q 010736 219 ILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENR 297 (502)
Q Consensus 219 ~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~ 297 (502)
.+.+..+ +.......+.++..|+.+.+..+ ++......+.. ..++.+.+..+ ++......|..+.+|+.+.+.++.
T Consensus 221 ~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~ 297 (379)
T 4h09_A 221 KITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSA 297 (379)
T ss_dssp EEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTT
T ss_pred eeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccc
Confidence 7777544 33344556778888888888765 44333334443 56788877543 555555677888999999998888
Q ss_pred cccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCC
Q 010736 298 FQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPK 359 (502)
Q Consensus 298 l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 359 (502)
++..-...|.+|.+|+.+.+..+ ++..-..+|..+.+|+.+.+..+ ++..-..+|.++..
T Consensus 298 i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~~ 357 (379)
T 4h09_A 298 IETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSSI 357 (379)
T ss_dssp CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSSC
T ss_pred cceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCCC
Confidence 87666778999999999999654 76666778999999999988654 55444556666543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.39 E-value=2.2e-08 Score=88.95 Aligned_cols=95 Identities=15% Similarity=0.137 Sum_probs=59.9
Q ss_pred cCCccCcCCCCCCEEEccCC-cCcCC----CCcccCCCCCCcEEEccCCcCccc----CCcccCCCCCCcEEEcccCccc
Q 010736 110 TIPPQISNLTNLSILSLGGN-QFSGN----IPHEVGLMSHLKILYIDSNQLDGS----IPLEVGQLSSMVELALFSNNLN 180 (502)
Q Consensus 110 ~~p~~l~~l~~L~~L~Ls~N-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 180 (502)
.+...+...+.|++|+|++| .+... +...+...++|++|+|++|++... +...+...++|++|+|++|.+.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34456777889999999998 88632 334456677888888888887642 2233444566777777777765
Q ss_pred cc----CCcCCCCCCCCCeEEc--cccccc
Q 010736 181 GS----VPHSLGNLTQISMLFL--HDNSFS 204 (502)
Q Consensus 181 ~~----~p~~~~~l~~L~~L~L--~~N~l~ 204 (502)
.. +...+...+.|++|+| ++|.++
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 32 2333444555666666 555554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=1e-05 Score=66.94 Aligned_cols=68 Identities=19% Similarity=0.155 Sum_probs=55.4
Q ss_pred cEEeCCCCccc-cccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCcccccCC
Q 010736 313 IRVRLDGNNLT-GNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFLKP 382 (502)
Q Consensus 313 ~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~~ll~~ 382 (502)
..++.+++.++ ..+|..+ .++|++|+|++|+|+...+..|..+++|++|+|++|++.||+.+.++..+
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~w 79 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAW 79 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHH
T ss_pred CEEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHH
Confidence 36778888886 2445433 25799999999999988888899999999999999999999999877643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.78 E-value=5e-06 Score=72.15 Aligned_cols=91 Identities=7% Similarity=-0.011 Sum_probs=57.7
Q ss_pred CCcEEEccCCccccccCcccccCCCCcEEeCCCCc-cccccCcccCCC----CCCcEEEccCcc-cccccCccccCCCCC
Q 010736 287 ALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNN-LTGNISKAFGIY----PNLTFIDLSRNN-FYGEISSNFGECPKL 360 (502)
Q Consensus 287 ~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~~~~L 360 (502)
.|+.|+++++.++..--..+..+++|+.|+|+++. +++.--..+..+ ++|++|+|+++. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555544333445667777777777764 554333334433 468888888764 665444456678888
Q ss_pred CeeeecCCccccccCcc
Q 010736 361 GALNISRNNITGDFGIA 377 (502)
Q Consensus 361 ~~L~l~~N~l~~dfGl~ 377 (502)
++|++++++-++|.|++
T Consensus 142 ~~L~L~~c~~Itd~gl~ 158 (176)
T 3e4g_A 142 KYLFLSDLPGVKEKEKI 158 (176)
T ss_dssp CEEEEESCTTCCCHHHH
T ss_pred CEEECCCCCCCCchHHH
Confidence 89999888888887764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.71 E-value=6.1e-06 Score=71.58 Aligned_cols=82 Identities=10% Similarity=0.066 Sum_probs=36.5
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCc-CcCCCCcccCCC----CCCcEEEccCCc-CcccCCcccCCCCCC
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQ-FSGNIPHEVGLM----SHLKILYIDSNQ-LDGSIPLEVGQLSSM 169 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L 169 (502)
+|++||++++.++..--..+.++++|++|+|++|. ++..--..++.+ ++|++|+|++|. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555554433445555555666655553 442211223332 235555555542 432222223334444
Q ss_pred cEEEcccC
Q 010736 170 VELALFSN 177 (502)
Q Consensus 170 ~~L~L~~N 177 (502)
+.|+++++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 44444443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=4.7e-05 Score=79.59 Aligned_cols=71 Identities=15% Similarity=-0.042 Sum_probs=39.4
Q ss_pred CCCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCC
Q 010736 358 PKLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH 428 (502)
Q Consensus 358 ~~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~ 428 (502)
.++.|.||+--|| ++|||+++.+..+....+...||++|++||...+ +...++|+||.|+..+++.+|..
T Consensus 358 ~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 358 QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 4566667766554 6899999988765555566789999999999865 46678999999999999887654
Q ss_pred C
Q 010736 429 P 429 (502)
Q Consensus 429 p 429 (502)
|
T Consensus 437 ~ 437 (569)
T 4azs_A 437 N 437 (569)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.05 E-value=9.9e-05 Score=65.19 Aligned_cols=112 Identities=13% Similarity=0.129 Sum_probs=62.3
Q ss_pred CCCCCCCCEEECCCC-cccc----cCCccCcCCCCCCEEEccCCcCcCC----CCcccCCCCCCcEEEccCCcCccc---
Q 010736 91 FSSFPHLAYLDLRDN-KLFG----TIPPQISNLTNLSILSLGGNQFSGN----IPHEVGLMSHLKILYIDSNQLDGS--- 158 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N-~l~g----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~--- 158 (502)
+.+-+.|+.|+|++| +|.. .+-..+..-+.|+.|+|++|+|... +-..+..-+.|++|+|++|+|...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 445567888888775 6643 2344556667788888888877632 222333456677777777777632
Q ss_pred -CCcccCCCCCCcEEEcccCc---ccc----cCCcCCCCCCCCCeEEccccc
Q 010736 159 -IPLEVGQLSSMVELALFSNN---LNG----SVPHSLGNLTQISMLFLHDNS 202 (502)
Q Consensus 159 -~p~~~~~l~~L~~L~L~~N~---l~~----~~p~~~~~l~~L~~L~L~~N~ 202 (502)
+-..+..-+.|++|+|++|. +.. .+...+..-+.|+.|+++.|.
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 22234444556677766542 221 111223334556666665554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0016 Score=53.48 Aligned_cols=36 Identities=19% Similarity=0.290 Sum_probs=17.0
Q ss_pred CCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcC
Q 010736 120 NLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQL 155 (502)
Q Consensus 120 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 155 (502)
+|++|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 344555555555433333444445555555555543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=96.94 E-value=7.6e-05 Score=72.45 Aligned_cols=56 Identities=11% Similarity=-0.003 Sum_probs=45.8
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeecee-eeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVL-VLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~-llElltg~~p~~ 431 (502)
.++|||+++..... ...||..|+|||...+.. +.++||||+++. ..++.+|..|+.
T Consensus 222 kL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 222 SIIDYTLSRLERDG-----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp EECCCTTCBEEETT-----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred EEeeccccEecCCC-----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 46899999987532 347899999999998666 889999998766 778889999974
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0011 Score=58.39 Aligned_cols=88 Identities=13% Similarity=0.206 Sum_probs=49.5
Q ss_pred cCCCCCcEEEccCCccccc----cCcccccCCCCcEEeCCCCccccc----cCcccCCCCCCcEEEccCc---cccc---
Q 010736 283 CRGGALQIFTVSENRFQGT----IPKSLRNCTSLIRVRLDGNNLTGN----ISKAFGIYPNLTFIDLSRN---NFYG--- 348 (502)
Q Consensus 283 ~~~~~L~~L~ls~n~l~~~----~~~~l~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N---~l~~--- 348 (502)
..-..|+.|+|++|.+... +...+..-+.|+.|+|++|.|... +.+++..-..|+.|+|++| .+..
T Consensus 67 ~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~ 146 (197)
T 1pgv_A 67 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE 146 (197)
T ss_dssp TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred hhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHH
Confidence 3445566666666666532 223344556677777777777643 2234445566777777654 2222
Q ss_pred -ccCccccCCCCCCeeeecCCcc
Q 010736 349 -EISSNFGECPKLGALNISRNNI 370 (502)
Q Consensus 349 -~~~~~~~~~~~L~~L~l~~N~l 370 (502)
.+...+..-+.|+.|+++.|.+
T Consensus 147 ~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 147 MDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHhCCCcCeEeccCCCc
Confidence 1233445556777777776654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=88.17 E-value=0.0092 Score=61.74 Aligned_cols=61 Identities=13% Similarity=0.069 Sum_probs=46.4
Q ss_pred cccccCcccccCCCCCC-------cccccccccccCcccccc--ceecccceeeeeceeeeehhcCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSN-------WTGFAGTYGYIAPELAYT--MKITEKCDVYSFGVLVLEVIKGKHPR 430 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~-------~~~~~gt~gy~aPE~~~~--~~~s~k~Dvysfgv~llElltg~~p~ 430 (502)
..+|||+++........ ...+.||..|+|||.... ..++.+.|.|+..+-.+|-+.+|.++
T Consensus 469 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 469 YIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 36899999988543211 124679999999999976 56778889999888888887777664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 502 | ||||
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-21 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-08 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-17 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-17 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-17 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-17 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-17 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-11 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-16 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-16 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-16 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-16 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-16 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-15 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-15 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-15 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-14 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-14 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-14 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-14 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-14 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-14 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-14 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-14 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-14 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-14 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-14 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-14 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-13 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-13 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-13 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-13 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-13 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-12 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-12 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-12 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-12 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-10 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-12 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-12 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-11 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-11 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-11 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-10 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-10 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-09 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-09 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-09 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-09 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-09 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-08 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-07 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-07 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-06 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-05 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-05 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-05 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 99.4 bits (246), Expect = 8e-24
Identities = 72/328 (21%), Positives = 116/328 (35%), Gaps = 33/328 (10%)
Query: 22 EEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVG 81
++ ALL+ K L N + LSSW ++ W G+ C+ +
Sbjct: 6 QDKQALLQIKKDL--GNPTTLSSW-----LPTTDCCNRTWLGVLCDTDTQTY-------- 50
Query: 82 LKGKLHAFSFSSFPHLAYLDLRDNKLFG--TIPPQISNLTNLSILSLGGN-QFSGNIPHE 138
+ LDL L IP ++NL L+ L +GG G IP
Sbjct: 51 --------------RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 139 VGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFL 198
+ ++ L LYI + G+IP + Q+ ++V L N L+G++P S+ +L + +
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 199 HDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS 258
N SG IP G+ + NL L N L G
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVL 216
Query: 259 LDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLD 318
+ T+ + ++ + L + NR GT+P+ L L + +
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 319 GNNLTGNISKAFGIYPNLTFIDLSRNNF 346
NNL G I G + N
Sbjct: 277 FNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 47.8 bits (112), Expect = 1e-06
Identities = 12/47 (25%), Positives = 18/47 (38%), Gaps = 1/47 (2%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIP 136
+ L L++ N L G I PQ NL + + N+ P
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.6 bits (226), Expect = 4e-21
Identities = 58/295 (19%), Positives = 93/295 (31%), Gaps = 29/295 (9%)
Query: 59 CAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNL 118
C + C+D G L P A LDL++NK+ NL
Sbjct: 10 CHLRVVQCSDLG---------------LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNL 54
Query: 119 TNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNN 178
NL L L N+ S P + L+ LY+ NQL L ++ EL + N
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE---LPEKMPKTLQELRVHENE 111
Query: 179 LNGSVPHSLGNLTQISMLFLHD--NSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLG 236
+ L Q+ ++ L SG +K +S + +A + + G
Sbjct: 112 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQG 168
Query: 237 NLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSEN 296
+L + L N + SL L + S + N
Sbjct: 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
Query: 297 RFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF------GIYPNLTFIDLSRNN 345
+P L + + V L NN++ S F + + + L N
Sbjct: 229 NKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.8 bits (190), Expect = 2e-16
Identities = 44/261 (16%), Positives = 83/261 (31%), Gaps = 32/261 (12%)
Query: 140 GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
L +L + +N++ + L ++ L L +N ++ P + L ++ L+L
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 200 DNSFSGFIPPDIGNLKSISILSLAIN-----------------------QFSGPIPLSLG 236
N L+ + + I + SG +
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 237 NLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSEN 296
+ L + N+ +IP L LT+L LD N T ++ L +S N
Sbjct: 148 GMKKLSYIRIADTNI-TTIPQGLPPS-LTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 297 RFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNF-- 354
SL N L + L+ N L + + L NN S++F
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK-YIQVVYLHNNNISAIGSNDFCP 264
Query: 355 ----GECPKLGALNISRNNIT 371
+ +++ N +
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.4 bits (176), Expect = 1e-14
Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 9/195 (4%)
Query: 182 SVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNL 241
VP L T + L L +N + D NLK++ L L N+ S P + L L
Sbjct: 24 KVPKDLPPDTAL--LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 242 KQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTS--YLPQNICRGGALQIFTVSENRFQ 299
++ L N L +P + + +L + +N T N + + +
Sbjct: 82 ERLYLSKNQL-KELPEKMPKTL-QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
Query: 300 GTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPK 359
G + + L +R+ N+T + G+ P+LT + L N +++
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 360 LGALNISRNNITGDF 374
L L +S N+I+
Sbjct: 197 LAKLGLSFNSISAVD 211
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.5 bits (171), Expect = 5e-14
Identities = 45/227 (19%), Positives = 84/227 (37%), Gaps = 6/227 (2%)
Query: 144 HLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSF 203
HL+++ L+ +P ++ L L +N + NL + L L +N
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 204 SGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV 263
S P L + L L+ NQ L L+ + S+ L+ ++
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 264 LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLT 323
+ +L + + L +++ TIP+ L SL + LDGN +T
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184
Query: 324 GNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNI 370
+ + NL + LS N+ + + P L L+++ N +
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 18/128 (14%), Positives = 34/128 (26%), Gaps = 1/128 (0%)
Query: 254 SIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLI 313
+P L L L +N T + L + N+ P + L
Sbjct: 24 KVPKDLPPD-TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 314 RVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373
R+ L N L K L + + + + + + +
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 374 FGIAKFLK 381
G + +K
Sbjct: 143 NGAFQGMK 150
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.8 bits (225), Expect = 4e-21
Identities = 31/135 (22%), Positives = 61/135 (45%), Gaps = 11/135 (8%)
Query: 372 GDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMK---ITEKCDVYSFGVLVLEVIKG 426
GDFG+A S + + +G+ ++APE+ + + DVY+FG+++ E++ G
Sbjct: 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205
Query: 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
+ P S+ ++ + L P L + + + +M CLK+ + RP
Sbjct: 206 QLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA---ECLKKKRDERPL 259
Query: 487 MKIVSQQLRISAPSL 501
+ + + A SL
Sbjct: 260 FPQILASIELLARSL 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (211), Expect = 3e-19
Identities = 28/117 (23%), Positives = 49/117 (41%), Gaps = 11/117 (9%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
GDFG+A+ L D+S F GT Y++PE M EK D++S G L+ E+ P
Sbjct: 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF- 214
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ + ++ + + ++L I+ L RP+++
Sbjct: 215 -------TAFSQKELAGKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVE 261
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.5 bits (205), Expect = 6e-18
Identities = 56/180 (31%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN 153
+L L L N+L +++LTNL+ L L NQ S P + ++ L L + +N
Sbjct: 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 273
Query: 154 QLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGN 213
Q+ PL L+++ L L N L P S NL ++ L L+ N+ S P + +
Sbjct: 274 QISNISPLA--GLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSS 327
Query: 214 LKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLV-LTKLSLDDN 272
L + L A N+ S SL NLTN+ S +N + P L NL +T+L L+D
Sbjct: 328 LTKLQRLFFANNKVSDVS--SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.9 bits (193), Expect = 2e-16
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ +S +L LDL +N++ P +S LT L+ L LG NQ S P L +
Sbjct: 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP----LAGLTALTN 289
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPP 209
++ N+ + L ++ L L+ NN++ P + +LT++ LF +N S
Sbjct: 290 LELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VS 345
Query: 210 DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYN 249
+ NL +I+ LS NQ S P L NLT + Q L
Sbjct: 346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 7e-16
Identities = 43/205 (20%), Positives = 77/205 (37%), Gaps = 15/205 (7%)
Query: 164 GQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLA 223
+L+++ L +N ++ P LT + L L+ N + +L +++ L LA
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 224 INQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNIC 283
NQ S PLS LT L + L N + I P LT L L++N P +
Sbjct: 250 NNQISNLAPLS--GLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNL 306
Query: 284 RGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSR 343
+ L T+ N P + + T L R+ N ++ + N+ ++
Sbjct: 307 KN--LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 344 NNFYGEISSNFGECPKLGALNISRN 368
N ++ L ++
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.5 bits (179), Expect = 1e-14
Identities = 47/203 (23%), Positives = 82/203 (40%), Gaps = 15/203 (7%)
Query: 142 MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
+++L+ L +NQ+ P +G L+++ EL+L N L +L +LT ++ L L +N
Sbjct: 196 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 202 SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN 261
S P + L ++ L L NQ S PL + N I P +
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPL---AGLTALTNLELNENQLEDISPISNL 306
Query: 262 LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNN 321
LT L+L N+ + P + LQ + N+ SL N T++ + N
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 322 LTGNISKAFGIYPNLTFIDLSRN 344
++ +T + L+
Sbjct: 363 ISDLT--PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.6 bits (161), Expect = 2e-12
Identities = 64/355 (18%), Positives = 115/355 (32%), Gaps = 59/355 (16%)
Query: 64 ISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSI 123
+S D +V + +G+K + + +L ++ +N+L P + NLT L
Sbjct: 38 VSQTDLDQVTTLQADRLGIK-SIDGVEY--LNNLTQINFSNNQLTDITP--LKNLTKLVD 92
Query: 124 LSLGGNQFS---------------------------------------GNIPHEVGLMSH 144
+ + NQ + N ++ +S
Sbjct: 93 ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSG 152
Query: 145 LKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS 204
L L S + + L+++ L + SN ++ + LT + L +N S
Sbjct: 153 LTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA--KLTNLESLIATNNQIS 210
Query: 205 GFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVL 264
P I ++ LSL NQ +L +LTNL L N + P S L
Sbjct: 211 DITPLGILT--NLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAPLS-GLTKL 265
Query: 265 TKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTG 324
T+L L N ++ P ++ I N +L + L NN++
Sbjct: 266 TELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS----NLKNLTYLTLYFNNISD 321
Query: 325 NISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKF 379
L + + N S+ + L+ N I+ +A
Sbjct: 322 ISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTPLANL 372
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.5 bits (135), Expect = 3e-09
Identities = 22/91 (24%), Positives = 37/91 (40%), Gaps = 6/91 (6%)
Query: 87 HAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLK 146
S+ +L YL L N + P +S+LT L L N+ S + ++++
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 147 ILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177
L NQ+ PL L+ + +L L
Sbjct: 355 WLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 3e-08
Identities = 51/340 (15%), Positives = 103/340 (30%), Gaps = 68/340 (20%)
Query: 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKIL 148
F+ ++ L + T+ ++L ++ L +I V +++L +
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQI 71
Query: 149 YIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPH----------------------- 185
+NQL PL L+ +V++ + +N + P
Sbjct: 72 NFSNNQLTDITPL--KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129
Query: 186 -------------SLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIP 232
++ +++ +S L G D+ L +++ L +
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189
Query: 233 LSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFT 292
+S+ + + NN I P L +LSL+ N + L
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 293 VSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNIS--------------------KAFGI 332
++ N+ P L T L ++L N ++
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 333 YPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
NLT++ L NN KL L + N ++
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.9 bits (199), Expect = 1e-17
Identities = 31/124 (25%), Positives = 49/124 (39%), Gaps = 11/124 (8%)
Query: 372 GDFGIAKFLKPDSSNW-TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430
DFG+A+ ++ + G + APE T K DV+SFG+L+ E++
Sbjct: 151 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
Query: 431 DFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIV 490
P + + + V + E+L +M C KE PE RPT +
Sbjct: 211 Y-------PGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYL 260
Query: 491 SQQL 494
L
Sbjct: 261 RSVL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.3 bits (195), Expect = 4e-17
Identities = 25/117 (21%), Positives = 51/117 (43%), Gaps = 12/117 (10%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
GD G+A + + GT ++APE+ Y K E DVY+FG+ +LE+ ++P
Sbjct: 157 GDLGLATLKRASFA--KAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP-- 211
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
S + + + + +++I C++++ + R ++K
Sbjct: 212 -YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE------GCIRQNKDERYSIK 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.6 bits (193), Expect = 7e-17
Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 15/127 (11%)
Query: 373 DFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGKH 428
DFG++K L+ D + + T + APE K + K DV+SFGVL+ E G+
Sbjct: 150 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
P + +++ R+ P+ ++ +M C E+RP
Sbjct: 210 PYRGMK-------GSEVTAMLEKGERMGCPA-GCPREMYDLMN---LCWTYDVENRPGFA 258
Query: 489 IVSQQLR 495
V +LR
Sbjct: 259 AVELRLR 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (193), Expect = 9e-17
Identities = 33/127 (25%), Positives = 51/127 (40%), Gaps = 14/127 (11%)
Query: 372 GDFGIAKFLKPDS----SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGK 427
DFG+A+ + N TG ++A E T K T K DV+SFGVL+ E++
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
Query: 428 HPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487
P P +NT +L R + + L +M C E RP+
Sbjct: 232 APPY-------PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML---KCWHPKAEMRPSF 281
Query: 488 KIVSQQL 494
+ ++
Sbjct: 282 SELVSRI 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 78.7 bits (193), Expect = 9e-17
Identities = 20/126 (15%), Positives = 49/126 (38%), Gaps = 12/126 (9%)
Query: 372 GDFGIAKFLKPDSSNW--TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFG+++ + A ++ PE + + T + DV+++GV++ E+
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489
+ + + + D + + +L ++M C + P RP+
Sbjct: 242 PY-------YGMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCS 291
Query: 490 VSQQLR 495
+ + L+
Sbjct: 292 IHRILQ 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (190), Expect = 2e-16
Identities = 33/125 (26%), Positives = 53/125 (42%), Gaps = 11/125 (8%)
Query: 372 GDFGIAKFLKPDSSNWT-GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430
DFG+ +F+ D + G + +PE+ + + K DV+SFGVL+ EV
Sbjct: 143 SDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 202
Query: 431 DFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIV 490
S N+++ D RL P + + ++ C KE PE RP +
Sbjct: 203 YENRS------NSEVVEDISTGFRLYKPRLASTH----VYQIMNHCWKERPEDRPAFSRL 252
Query: 491 SQQLR 495
+QL
Sbjct: 253 LRQLA 257
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (189), Expect = 2e-16
Identities = 53/294 (18%), Positives = 99/294 (33%), Gaps = 14/294 (4%)
Query: 58 PCAWSGISC-NDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQIS 116
PC C N+ + +G L A + L N++
Sbjct: 1 PCP-GACVCYNEPKVTTSCPQQG------LQAVPVGIPAASQRIFLHGNRISHVPAASFR 53
Query: 117 NLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSI-PLEVGQLSSMVELALF 175
NL+IL L N + ++ L+ L + N S+ P L + L L
Sbjct: 54 ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113
Query: 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSL 235
L P L + L+L DN+ +L +++ L L N+ S +
Sbjct: 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173
Query: 236 GNLTNLKQFSLVYNNLYGSIPPSLDNLVLTK-LSLDDNHFTSYLPQNICRGGALQIFTVS 294
L +L + L N + P + +L L L N+ ++ + + ALQ ++
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233
Query: 295 ENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYG 348
+N + + L + R + + ++ + L+ N+ G
Sbjct: 234 DNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (149), Expect = 2e-11
Identities = 45/235 (19%), Positives = 82/235 (34%), Gaps = 3/235 (1%)
Query: 140 GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH 199
G+ + + +++ N++ ++ L L SN L + L + L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 200 DNSFSGFIPP-DIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPS 258
DN+ + P L + L L P L L+ L N L +
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 259 LDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRL 317
+L LT L L N +S + +L + +NR P + R+ L+ + L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 318 DGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
NNL+ ++A L ++ L+ N + + L S + +
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPC 262
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (145), Expect = 8e-11
Identities = 44/192 (22%), Positives = 74/192 (38%), Gaps = 4/192 (2%)
Query: 182 SVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNL 241
+VP + +Q +FLH N S ++++IL L N + + L L
Sbjct: 25 AVPVGIPAASQR--IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 242 KQFSLVYNNLYGSIPPSL--DNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQ 299
+Q L N S+ P+ L L LD P ALQ + +N Q
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 300 GTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPK 359
+ R+ +L + L GN ++ +AF +L + L +N F + +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 360 LGALNISRNNIT 371
L L + NN++
Sbjct: 203 LMTLYLFANNLS 214
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.6 bits (190), Expect = 2e-16
Identities = 25/127 (19%), Positives = 45/127 (35%), Gaps = 13/127 (10%)
Query: 372 GDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH 428
DFG+++ L+ D +G + APE K T DV+SFG+++ EV+
Sbjct: 152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 211
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ L+ + + D + +M C ++ RP
Sbjct: 212 RPYW-------ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMM---QCWQQERARRPKFA 261
Query: 489 IVSQQLR 495
+ L
Sbjct: 262 DIVSILD 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.8 bits (186), Expect = 5e-16
Identities = 30/117 (25%), Positives = 43/117 (36%), Gaps = 14/117 (11%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG + SS T GT Y+ PE+ EK D++S GVL E + GK P
Sbjct: 148 ADFGWSVHA--PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-- 203
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ + P V E ++ LK +P RP ++
Sbjct: 204 ------FEANTYQETYKRISRVEFTFPD-FVTEGARDLIS---RLLKHNPSQRPMLR 250
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 5e-16
Identities = 25/147 (17%), Positives = 48/147 (32%), Gaps = 26/147 (17%)
Query: 372 GDFGIAKFLKPDSSNW----TGFAGTYGYIAPELAYTM------KITEKCDVYSFGVLVL 421
D G+A + GT Y+APE+ + ++ D+Y+ G++
Sbjct: 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209
Query: 422 EVIKGKHPRDFLSSTSSPSLNT-----------DIALDEMLDPRLP--VPSCSVQEKLIS 468
E+ + P + + ++ L P +P SC +
Sbjct: 210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 269
Query: 469 IMEVGFSCLKESPESRPTMKIVSQQLR 495
IM C + +R T + + L
Sbjct: 270 IMR---ECWYANGAARLTALRIKKTLS 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.9 bits (186), Expect = 6e-16
Identities = 30/127 (23%), Positives = 51/127 (40%), Gaps = 15/127 (11%)
Query: 373 DFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGKH 428
DFG++K L D S + + + APE K + + DV+S+GV + E + G+
Sbjct: 152 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
P + ++ R+ P +L ++M C E RP
Sbjct: 212 PYKKMK-------GPEVMAFIEQGKRMECPP-ECPPELYALMS---DCWIYKWEDRPDFL 260
Query: 489 IVSQQLR 495
V Q++R
Sbjct: 261 TVEQRMR 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (184), Expect = 9e-16
Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 13/126 (10%)
Query: 372 GDFGIAKFLKPDSSN-WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGKHP 429
DFG+++++ D G + PE+ K + K D+++FGVL+ E+ GK P
Sbjct: 142 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 201
Query: 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489
+ + N++ A RL P EK+ +IM SC E + RPT KI
Sbjct: 202 YERFT-------NSETAEHIAQGLRLYRPH-LASEKVYTIMY---SCWHEKADERPTFKI 250
Query: 490 VSQQLR 495
+ +
Sbjct: 251 LLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (184), Expect = 1e-15
Identities = 34/125 (27%), Positives = 55/125 (44%), Gaps = 13/125 (10%)
Query: 372 GDFGIAKFLKPD-SSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430
DFG+A+ ++ + + G + APE A + T K DV+SFG+L+ E+
Sbjct: 155 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 214
Query: 431 DFLSSTSSPSLNTDIALDEML-DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489
P + LD++ R+P P E L +M C ++ PE RPT +
Sbjct: 215 Y-------PGMVNREVLDQVERGYRMPCPP-ECPESLHDLMC---QCWRKEPEERPTFEY 263
Query: 490 VSQQL 494
+ L
Sbjct: 264 LQAFL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.0 bits (184), Expect = 1e-15
Identities = 28/116 (24%), Positives = 48/116 (41%), Gaps = 9/116 (7%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG + P+ S + GT ++APE+ K D++S G++ +E+I+G+ P +
Sbjct: 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--Y 216
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
L+ +L P L P + + CL E R + K
Sbjct: 217 LNENPLRALYLIATNGT---PELQNPE-KLSAIFRDFLN---RCLDMDVEKRGSAK 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.1 bits (176), Expect = 9e-15
Identities = 32/139 (23%), Positives = 51/139 (36%), Gaps = 18/139 (12%)
Query: 363 LNISRNNITGDFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYTMKITEKCDVYSFGVL 419
L GDFG+ + L + ++ + + APE T + D + FGV
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 420 VLEVI-KGKHPRDFLSSTSSPSLNTDIALDEML--DPRLPVPSCSVQEKLISIMEVGFSC 476
+ E+ G+ P LN L ++ RLP P + + ++M C
Sbjct: 204 LWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLPRPE-DCPQDIYNVMV---QC 251
Query: 477 LKESPESRPTMKIVSQQLR 495
PE RPT + L
Sbjct: 252 WAHKPEDRPTFVALRDFLL 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 72.5 bits (177), Expect = 1e-14
Identities = 35/130 (26%), Positives = 56/130 (43%), Gaps = 17/130 (13%)
Query: 372 GDFGIAKFLKPDSSNWT-----GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-K 425
DFG+++FL+ D+S+ T G + APE K T DV+S+G+++ EV+
Sbjct: 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP 485
G+ P ++ N D+ D RLP P L +M C ++ RP
Sbjct: 230 GERPYWDMT-------NQDVINAIEQDYRLPPPM-DCPSALHQLML---DCWQKDRNHRP 278
Query: 486 TMKIVSQQLR 495
+ L
Sbjct: 279 KFGQIVNTLD 288
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (177), Expect = 1e-14
Identities = 26/116 (22%), Positives = 45/116 (38%), Gaps = 12/116 (10%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG+ K + F GT YIAPE+ K D +SFGVL+ E++ G+ P
Sbjct: 146 DFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-- 203
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ + + P ++++ ++ PE R ++
Sbjct: 204 ------HGQDEEELFHSIRMDNPFYPR-WLEKEAKDLLV---KLFVREPEKRLGVR 249
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (177), Expect = 1e-14
Identities = 30/128 (23%), Positives = 55/128 (42%), Gaps = 17/128 (13%)
Query: 372 GDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGKH 428
DFG+A+ + DS+ ++APE + T K DV+S+G+L+ E+ G +
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 429 PRDFLSSTSSPSLNTDIALDEMLD--PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
P P + D +++ ++ P E++ IM+ SC RP+
Sbjct: 266 P--------YPGIPVDANFYKLIQNGFKMDQPF-YATEEIYIIMQ---SCWAFDSRKRPS 313
Query: 487 MKIVSQQL 494
++ L
Sbjct: 314 FPNLTSFL 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.1 bits (176), Expect = 2e-14
Identities = 31/125 (24%), Positives = 50/125 (40%), Gaps = 14/125 (11%)
Query: 373 DFGIAKFLKPDSSNW--TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGKHP 429
DFG+AK L + + G ++A E T + DV+S+GV V E++ G P
Sbjct: 154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213
Query: 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489
D + ++I+ RLP P + IM C +SRP +
Sbjct: 214 YDGIP-------ASEISSILEKGERLPQPP-ICTIDVYMIMV---KCWMIDADSRPKFRE 262
Query: 490 VSQQL 494
+ +
Sbjct: 263 LIIEF 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.2 bits (174), Expect = 2e-14
Identities = 28/124 (22%), Positives = 47/124 (37%), Gaps = 15/124 (12%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGKHPRD 431
DFG+ K SS + APE K + K DV+SFG+L+ E+ G+ P
Sbjct: 146 DFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491
+ D+ ++ P + +M+ +C RP+ +
Sbjct: 203 RIP-------LKDVVPRVEKGYKMDAPD-GCPPAVYEVMK---NCWHLDAAMRPSFLQLR 251
Query: 492 QQLR 495
+QL
Sbjct: 252 EQLE 255
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 71.8 bits (175), Expect = 2e-14
Identities = 18/130 (13%), Positives = 44/130 (33%), Gaps = 11/130 (8%)
Query: 373 DFGIAKFLKPDSSN-------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK 425
DFG+ KF + + +GT Y++ + + + D+ + G + + ++
Sbjct: 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 208
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP 485
G P L + ++ I + P + + E+ M + ++ P
Sbjct: 209 GSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA-GFPEEFYKYMH---YARNLAFDATP 264
Query: 486 TMKIVSQQLR 495
+
Sbjct: 265 DYDYLQGLFS 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.3 bits (174), Expect = 2e-14
Identities = 31/126 (24%), Positives = 51/126 (40%), Gaps = 13/126 (10%)
Query: 372 GDFGIAKFLKPDSSNWTG-FAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVI-KGKHP 429
GDFG++++++ + ++APE + T DV+ FGV + E++ G P
Sbjct: 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209
Query: 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489
+ N D+ RLP+P + L S+M C P RP
Sbjct: 210 FQGVK-------NNDVIGRIENGERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTE 258
Query: 490 VSQQLR 495
+ QL
Sbjct: 259 LKAQLS 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.0 bits (176), Expect = 2e-14
Identities = 29/149 (19%), Positives = 55/149 (36%), Gaps = 34/149 (22%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP-- 429
DFG++ L + F GT Y++PE + + D++S G+ ++E+ G++P
Sbjct: 147 CDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
Query: 430 ----------------------------RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCS 461
S+ +A+ E+LD + P
Sbjct: 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
Query: 462 VQEKLISIMEVGF--SCLKESPESRPTMK 488
+ + S+ F CL ++P R +K
Sbjct: 265 LPSGVFSLEFQDFVNKCLIKNPAERADLK 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.2 bits (174), Expect = 2e-14
Identities = 28/120 (23%), Positives = 50/120 (41%), Gaps = 12/120 (10%)
Query: 372 GDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKH 428
DFG+A + ++ GT Y+APEL + E DV+S G+++ ++ G+
Sbjct: 145 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 204
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
P D PS + D P + ++++ L E+P +R T+
Sbjct: 205 PWD------QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSARITIP 255
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.8 bits (173), Expect = 3e-14
Identities = 25/122 (20%), Positives = 49/122 (40%), Gaps = 14/122 (11%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-----KITEKCDVYSFGVLVLEVIKG 426
DFG++ F GT ++APE+ K DV+S G+ ++E+ +
Sbjct: 152 ADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 211
Query: 427 KHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
+ P L+ + + + + P L PS ++ CL+++ ++R T
Sbjct: 212 EPPHHELN-----PMRVLLKIAKSEPPTLAQPS-RWSSNFKDFLK---KCLEKNVDARWT 262
Query: 487 MK 488
Sbjct: 263 TS 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 70.5 bits (172), Expect = 4e-14
Identities = 29/126 (23%), Positives = 52/126 (41%), Gaps = 13/126 (10%)
Query: 372 GDFGIAKFLKPDSSN-WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430
DFG+++ + D+ G + APE K + K DV++FGVL+ E+
Sbjct: 157 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
Query: 431 DFLSSTSSPSLNTDIALDEML-DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489
P ++ + + D R+ P EK+ +M +C + +P RP+
Sbjct: 217 Y-------PGIDLSQVYELLEKDYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAE 265
Query: 490 VSQQLR 495
+ Q
Sbjct: 266 IHQAFE 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 70.0 bits (171), Expect = 7e-14
Identities = 38/120 (31%), Positives = 60/120 (50%), Gaps = 17/120 (14%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM---KITEKCDVYSFGVLVLEVIKGKH 428
GDFG A + P +S F GT ++APE+ M + K DV+S G+ +E+ + K
Sbjct: 157 GDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
P L + ++ S IA +E P L S E + ++ SCL++ P+ RPT +
Sbjct: 213 P---LFNMNAMSALYHIAQNE--SPALQSGHWS--EYFRNFVD---SCLQKIPQDRPTSE 262
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 69.1 bits (168), Expect = 1e-13
Identities = 21/130 (16%), Positives = 45/130 (34%), Gaps = 11/130 (8%)
Query: 373 DFGIAKFLKPDSSN-------WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK 425
DFG+AK + ++ GT Y + ++ + + D+ S G +++
Sbjct: 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP 485
G P L + + I+ +M P + + + + C + +P
Sbjct: 209 GSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK-GYPSEFATYLN---FCRSLRFDDKP 264
Query: 486 TMKIVSQQLR 495
+ Q R
Sbjct: 265 DYSYLRQLFR 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.5 bits (167), Expect = 2e-13
Identities = 25/118 (21%), Positives = 45/118 (38%), Gaps = 14/118 (11%)
Query: 373 DFGIAKFLKPDSSNW--TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430
DFG AK L P+S F GT Y++PEL + D+++ G ++ +++ G P
Sbjct: 151 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210
Query: 431 DFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ N + +++ P K ++E L R +
Sbjct: 211 --------RAGNEYLIFQKIIKLEYDFPE-KFFPKARDLVE---KLLVLDATKRLGCE 256
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 3e-13
Identities = 21/124 (16%), Positives = 44/124 (35%), Gaps = 11/124 (8%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+++ + G ++A E T DV+S+GVL+ E++
Sbjct: 169 ADFGLSRGQEVYVKKTMG-RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-- 225
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491
+ +++ + +++ +M C +E P RP+ +
Sbjct: 226 -----PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQIL 277
Query: 492 QQLR 495
L
Sbjct: 278 VSLN 281
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 68.2 bits (166), Expect = 4e-13
Identities = 29/116 (25%), Positives = 43/116 (37%), Gaps = 9/116 (7%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG+ L P S GT + APE+A + D++S GVL ++ G P F
Sbjct: 169 DFGLTAHLDPKQSVKV-TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP--F 225
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+L + D +D S E + L P +R T+
Sbjct: 226 GGENDDETLRNVKSCDWNMDDSAF-SGIS--EDGKDFIR---KLLLADPNTRMTIH 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 67.8 bits (165), Expect = 4e-13
Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 9/117 (7%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG++K P S T GT GY+APE+ ++ D +S GV+ ++ G P
Sbjct: 152 SDFGLSKMEDPGSVLST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-- 208
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ L I E S + + +++ PE R T +
Sbjct: 209 -FYDENDAKLFEQILKAEYEFDSPYWDDIS--DSAKDFIR---HLMEKDPEKRFTCE 259
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (161), Expect = 1e-12
Identities = 25/116 (21%), Positives = 49/116 (42%), Gaps = 9/116 (7%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG+A + + + GT ++APE+ + + D++S GV+ ++ G P F
Sbjct: 160 DFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--F 216
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
L T +L A++ + + S + L + P+ R T++
Sbjct: 217 LGDTKQETLANVSAVNYEFEDEYF-SNTS--ALAKDFIR---RLLVKDPKKRMTIQ 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 1e-12
Identities = 29/130 (22%), Positives = 52/130 (40%), Gaps = 13/130 (10%)
Query: 368 NNITGDFGIAKFLKPDSSNW--TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK 425
DFG+A+ +K DS+ ++APE + T + DV+S+G+ + E+
Sbjct: 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCS-VQEKLISIMEVGFSCLKESPESR 484
P + D +M+ + S ++ IM+ +C P R
Sbjct: 243 LGSSPY-------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKR 292
Query: 485 PTMKIVSQQL 494
PT K + Q +
Sbjct: 293 PTFKQIVQLI 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (160), Expect = 2e-12
Identities = 32/118 (27%), Positives = 52/118 (44%), Gaps = 7/118 (5%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG AK +S T T Y+APE+ K + CD++S GV++ ++ G P
Sbjct: 156 TDFGFAKETTSHNSLTT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214
Query: 432 FLSSTS-SPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ SP + T I + + P S E++ ++ + LK P R T+
Sbjct: 215 SNHGLAISPGMKTRIRMGQYEFPNPEWSEVS--EEVKMLIR---NLLKTEPTQRMTIT 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 64.8 bits (157), Expect = 3e-12
Identities = 32/127 (25%), Positives = 56/127 (44%), Gaps = 12/127 (9%)
Query: 373 DFGIAKFLKPDSSNWT---GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
DFGIA+ + ++ T GT Y++PE A + + DVYS G ++ EV+ G+ P
Sbjct: 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
Query: 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-TMK 488
+ S S+ ++ + P S L +++ L ++PE+R T
Sbjct: 214 ---FTGDSPVSVAYQHVREDPIPPSARHEGLS--ADLDAVVL---KALAKNPENRYQTAA 265
Query: 489 IVSQQLR 495
+ L
Sbjct: 266 EMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.4 bits (159), Expect = 3e-12
Identities = 24/117 (20%), Positives = 46/117 (39%), Gaps = 9/117 (7%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
+FG A+ LKP + Y APE+ ++ D++S G LV ++ G +P
Sbjct: 146 IEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-- 202
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ ++ + +I E S + + ++ L + +SR T
Sbjct: 203 -FLAETNQQIIENIMNAEYTFDEEAFKEIS--IEAMDFVD---RLLVKERKSRMTAS 253
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (154), Expect = 4e-12
Identities = 51/220 (23%), Positives = 78/220 (35%), Gaps = 6/220 (2%)
Query: 162 EVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILS 221
EV +++S +E+ NL ++P L T I L L +N F + ++ L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTI--LHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 222 LAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQN 281
L ++ G L L L +N L LT L + N TS
Sbjct: 62 L--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 282 ICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDL 341
+ G LQ + N + P L L ++ L NNLT + NL + L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 342 SRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFLK 381
N+ Y I F L + N + I F +
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRR 218
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 7e-10
Identities = 43/211 (20%), Positives = 68/211 (32%), Gaps = 9/211 (4%)
Query: 65 SCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSIL 124
+ + ++ L A L L +N L+ + T L+ L
Sbjct: 5 EVSKVASHLEVNCDKRNLT----ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 125 SLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVP 184
+L + + + L L + NQL L + V + N L
Sbjct: 61 NLDRAELTKLQVDGT--LPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPL 117
Query: 185 HSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQF 244
+L L ++ L+L N P + + LSLA N + L L NL
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 245 SLVYNNLYGSIPPSLDNLV-LTKLSLDDNHF 274
L N+LY +IP L L N +
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (154), Expect = 8e-12
Identities = 27/118 (22%), Positives = 46/118 (38%), Gaps = 21/118 (17%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVLVLEVIKGKHPR 430
DFG LK + +T F GT Y PE + Y V+S G+L+ +++ G P
Sbjct: 153 IDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
Query: 431 DFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ +E++ ++ V + ++ CL P RPT +
Sbjct: 211 E--------------HDEEIIRGQVFFRQ-RVSSECQHLIR---WCLALRPSDRPTFE 250
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 63.9 bits (155), Expect = 9e-12
Identities = 23/116 (19%), Positives = 43/116 (37%), Gaps = 9/116 (7%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG+A L PD T + APE+ + D+++ GVL ++ G P
Sbjct: 172 DFGLATKLNPDEIVKV-TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP--- 227
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ ++ + S S + ++ + L++ P R T+
Sbjct: 228 FAGEDDLETLQNVKRCDWEFDEDAFSSVS--PEAKDFIK---NLLQKEPRKRLTVH 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (153), Expect = 1e-11
Identities = 25/123 (20%), Positives = 44/123 (35%), Gaps = 12/123 (9%)
Query: 374 FGIAKFLKPDSSNWT--GFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
FG+A+ + ++APE + T + DV+SFGVL+ E+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491
P + + + + + +L +M C P RPT K +
Sbjct: 239 -------PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLV 288
Query: 492 QQL 494
+ L
Sbjct: 289 EDL 291
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.0 bits (152), Expect = 2e-11
Identities = 23/126 (18%), Positives = 48/126 (38%), Gaps = 12/126 (9%)
Query: 372 GDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP 429
GDFG+ + + +++PE T DV+SFGV++ E+
Sbjct: 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
Query: 430 RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489
L+ + L +++ L + + L +M C + +P+ RP+
Sbjct: 235 -------PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLE 284
Query: 490 VSQQLR 495
+ ++
Sbjct: 285 IISSIK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.1 bits (147), Expect = 7e-11
Identities = 28/126 (22%), Positives = 45/126 (35%), Gaps = 15/126 (11%)
Query: 374 FGIAKFLKPDSSNW--TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
FG+A+ + D ++APE + T + DV+SFGVL+ E+
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 432 FLSSTSSPSLNTDIALDEML--DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKI 489
P + D L R+ P + E + + C P RPT
Sbjct: 238 -------PGVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSE 286
Query: 490 VSQQLR 495
+ + L
Sbjct: 287 LVEHLG 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (142), Expect = 3e-10
Identities = 24/141 (17%), Positives = 40/141 (28%), Gaps = 16/141 (11%)
Query: 363 LNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLE 422
+ S DFG+A+ + + T Y APE+ D++S G + E
Sbjct: 149 VTSSGQIKLADFGLARIYSFQMALTS-VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 207
Query: 423 VIKGKHP-------------RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISI 469
+ + K D + D+AL I
Sbjct: 208 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE 267
Query: 470 MEVGF--SCLKESPESRPTMK 488
+ CL +P R +
Sbjct: 268 LGKDLLLKCLTFNPAKRISAY 288
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 57.4 bits (138), Expect = 8e-10
Identities = 23/123 (18%), Positives = 41/123 (33%), Gaps = 15/123 (12%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM------KITEKCDVYSFGVLVLEVIK 425
DFG + L P GT Y+APE+ ++ D++S GV++ ++
Sbjct: 152 TDFGFSCQLDPGEKL-REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP 485
G P + I S + + ++ L P+ R
Sbjct: 211 GSPP---FWHRKQMLMLRMIMSGNYQFGSPEWDDYS--DTVKDLVS---RFLVVQPQKRY 262
Query: 486 TMK 488
T +
Sbjct: 263 TAE 265
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (135), Expect = 2e-09
Identities = 25/116 (21%), Positives = 48/116 (41%), Gaps = 12/116 (10%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG+ K D + F GT Y+APE+ D + GV++ E++ G+ P
Sbjct: 148 DFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-- 205
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ + + + +L + P ++ + S++ LK+ P+ R
Sbjct: 206 ------YNQDHERLFELILMEEIRFPR-TLSPEAKSLLA---GLLKKDPKQRLGGG 251
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.3 bits (135), Expect = 3e-09
Identities = 29/115 (25%), Positives = 46/115 (40%), Gaps = 15/115 (13%)
Query: 372 GDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG AK++ GT YIAPE+ T + D +SFG+L+ E++ G P
Sbjct: 146 TDFGFAKYV---PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP-- 200
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT 486
F NT +++L+ L P E + ++ + R
Sbjct: 201 F------YDSNTMKTYEKILNAELRFPP-FFNEDVKDLLS---RLITRDLSQRLG 245
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 55.7 bits (133), Expect = 3e-09
Identities = 28/134 (20%), Positives = 46/134 (34%), Gaps = 18/134 (13%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+A+ +T T Y AP+ L + K + D++S G + E++ G
Sbjct: 143 DFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
Query: 432 FLSS------------TSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGF----- 474
+S T + ++ DP V E + ++
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
Query: 475 SCLKESPESRPTMK 488
LK P R T K
Sbjct: 263 KMLKLDPNQRITAK 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (134), Expect = 3e-09
Identities = 23/136 (16%), Positives = 44/136 (32%), Gaps = 23/136 (16%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHPRD 431
DFG+AK + +T T Y APEL + + D+++ G ++ E++
Sbjct: 143 DFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202
Query: 432 FLSST-------------------SSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEV 472
S SL + L + + L+ +++
Sbjct: 203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ- 261
Query: 473 GFSCLKESPESRPTMK 488
+P +R T
Sbjct: 262 --GLFLFNPCARITAT 275
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (130), Expect = 9e-09
Identities = 26/149 (17%), Positives = 46/149 (30%), Gaps = 18/149 (12%)
Query: 358 PKLGALNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSF 416
P+ +N DFG+A+ +T T Y APE L + D++S
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 417 GVLVLEVIKGKHPRDFLSS------------TSSPSLNTDIALDEMLDPRLPVPSCSVQE 464
G + E++ + S T + + P P +
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFS 249
Query: 465 KLISIMEVGF-----SCLKESPESRPTMK 488
K++ ++ L P R + K
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.0 bits (129), Expect = 2e-08
Identities = 24/116 (20%), Positives = 45/116 (38%), Gaps = 12/116 (10%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPE-LAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431
D G+A + + GT+GY+APE L + D +S G ++ ++++G P
Sbjct: 150 DLGLACDFSKKKPHASV--GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
Query: 432 FLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487
+ + L + +P S +L S++E L+ R
Sbjct: 208 -----QHKTKDKHEIDRMTLTMAVELPD-SFSPELRSLLE---GLLQRDVNRRLGC 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (124), Expect = 7e-08
Identities = 23/123 (18%), Positives = 41/123 (33%), Gaps = 8/123 (6%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDF 432
DFG AK L N + Y + T DV+S G ++ E++ G+
Sbjct: 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--- 222
Query: 433 LSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492
P + L E++ ++E + E F +K P ++
Sbjct: 223 -----FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 277
Query: 493 QLR 495
+
Sbjct: 278 EAI 280
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 2e-07
Identities = 23/120 (19%), Positives = 41/120 (34%), Gaps = 7/120 (5%)
Query: 99 YLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGS 158
L L L T+ + L ++ L L N+ P L + + + ++
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNALE 56
Query: 159 IPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSI 217
V L + EL L +N L + L + ++ +L L NS L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 4e-05
Identities = 24/107 (22%), Positives = 42/107 (39%), Gaps = 6/107 (5%)
Query: 146 KILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSG 205
++L++ L ++ + QL + L L N L P +L L + +L DN+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL-- 55
Query: 206 FIPPDIGNLKSISILSLAINQF-SGPIPLSLGNLTNLKQFSLVYNNL 251
+ NL + L L N+ L + L +L N+L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.002
Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 10/111 (9%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ +LDL N+L +PP ++ L L +L N + L+ L
Sbjct: 15 HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDGVAN--LPRLQELL 71
Query: 150 IDSNQL-DGSIPLEVGQLSSMVELALFSNNLNG------SVPHSLGNLTQI 193
+ +N+L + + +V L L N+L + L +++ I
Sbjct: 72 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.5 bits (81), Expect = 0.003
Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 6/115 (5%)
Query: 267 LSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326
L L T ++ + + +S NR + P +L L + ++
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVL--QASDNALEN 57
Query: 327 SKAFGIYPNLTFIDLSRNNF-YGEISSNFGECPKLGALNISRNNITGDFGIAKFL 380
P L + L N CP+L LN+ N++ + GI + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERL 112
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.5 bits (81), Expect = 0.004
Identities = 19/107 (17%), Positives = 38/107 (35%), Gaps = 7/107 (6%)
Query: 245 SLVYNNLYGSIPPSLDNLV-LTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIP 303
L + +L ++ L+ L+ +T L L N + P + + +
Sbjct: 4 HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNALENV 58
Query: 304 KSLRNCTSLIRVRLDGNNLTGNIS-KAFGIYPNLTFIDLSRNNFYGE 349
+ N L + L N L + + + P L ++L N+ E
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (117), Expect = 4e-07
Identities = 22/141 (15%), Positives = 44/141 (31%), Gaps = 31/141 (21%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHP-- 429
+FG+A+ ++ T Y P++ + K+ + D++S G + E+ P
Sbjct: 144 NFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 430 ---------------------RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEK-LI 467
+ S T P VP + + L+
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 468 SIMEVGFSCLKESPESRPTMK 488
+ LK +P R + +
Sbjct: 264 Q------NLLKCNPVQRISAE 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (117), Expect = 5e-07
Identities = 24/142 (16%), Positives = 49/142 (34%), Gaps = 29/142 (20%)
Query: 373 DFGIAKFLKPDSSNW---TGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKH 428
DFG+A+ PD + T + T Y APE+ T+ D++S G ++ E++ +
Sbjct: 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211
Query: 429 P----------------------RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKL 466
D + + N ++L + K
Sbjct: 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 271
Query: 467 ISIMEVGFSCLKESPESRPTMK 488
+ +++ L +P R ++
Sbjct: 272 LDLLD---KMLTFNPHKRIEVE 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (114), Expect = 1e-06
Identities = 18/145 (12%), Positives = 41/145 (28%), Gaps = 31/145 (21%)
Query: 372 GDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKG 426
DFG+A+ + +T T Y PEL + D++ G ++ E+
Sbjct: 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218
Query: 427 KHP---------------------RDFLSSTSSPSLNTDIALDEMLDPRLP--VPSCSVQ 463
+ + + L + L + ++ + +
Sbjct: 219 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD 278
Query: 464 EKLISIMEVGFSCLKESPESRPTMK 488
+ +++ L P R
Sbjct: 279 PYALDLID---KLLVLDPAQRIDSD 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (112), Expect = 2e-06
Identities = 26/119 (21%), Positives = 43/119 (36%), Gaps = 11/119 (9%)
Query: 372 GDFGIAKFLKPDSSNWTGFA-GTYGYIAPELAYTMK--ITEKCDVYSFGVLVLEVIKGKH 428
DFG++K D + GT Y+AP++ + D +S GVL+ E++ G
Sbjct: 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
Query: 429 PRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM 487
P F S +P P S +++ L + P+ R
Sbjct: 231 P--FTVDGEKNSQAEISRRILKSEPPYP-QEMS--ALAKDLIQ---RLLMKDPKKRLGC 281
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 34/325 (10%), Positives = 78/325 (24%), Gaps = 34/325 (10%)
Query: 89 FSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGN----IPHEVGLMSH 144
FS L + ++ + ++ + L GN + +
Sbjct: 3 FSIEGK-SLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 145 LKILYIDSNQ---LDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
L+I + IP + L + + + S + + FL +
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 202 SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN 261
+ + L + +A + N L+ N L
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 262 LVLTKLSLDDNHFTSY--------------LPQNICRGGALQIFTVSENRFQGTIPKSLR 307
+ L L + + +L+
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 308 NCTSLIRVRLDGNNLTGNISKAFGIY------PNLTFIDLSRNNFYGEISSNFGE----- 356
+ +L + L+ L+ + A L + L N +
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 357 CPKLGALNISRNNITGDFGIAKFLK 381
P L L ++ N + + + ++
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIR 325
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 4e-04
Identities = 16/91 (17%), Positives = 27/91 (29%), Gaps = 5/91 (5%)
Query: 61 WSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQI----- 115
+ + L G + AFS L L L+ N++ +
Sbjct: 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 298
Query: 116 SNLTNLSILSLGGNQFSGNIPHEVGLMSHLK 146
+ +L L L GN+FS +
Sbjct: 299 EKMPDLLFLELNGNRFSEEDDVVDEIREVFS 329
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 25/156 (16%), Positives = 48/156 (30%), Gaps = 10/156 (6%)
Query: 37 HNRSLLSSWIKDTSNVSSKISPCAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPH 96
+ L + + + + P + ++ D L + FS
Sbjct: 202 NLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE 261
Query: 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLD 156
L N I +L L++ N+ +P L L+ L N L
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL- 316
Query: 157 GSIPLEVGQLSSMVELALFSNNLNG--SVPHSLGNL 190
+P ++ +L + N L +P S+ +L
Sbjct: 317 AEVP---ELPQNLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 9e-05
Identities = 24/89 (26%), Positives = 35/89 (39%), Gaps = 10/89 (11%)
Query: 129 NQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLG 188
N S I L L+ L + +N+L +P +L L N+L VP
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQ 324
Query: 189 NLTQISMLFLHDNSFSGF--IPPDIGNLK 215
NL Q L + N F IP + +L+
Sbjct: 325 NLKQ---LHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 6e-04
Identities = 17/88 (19%), Positives = 29/88 (32%), Gaps = 8/88 (9%)
Query: 225 NQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICR 284
N S I +L++ ++ N L +P L +L NH +P+
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRL--ERLIASFNHLAE-VPELP-- 323
Query: 285 GGALQIFTVSENRFQGTIPKSLRNCTSL 312
L+ V N + P + L
Sbjct: 324 -QNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 44.4 bits (104), Expect = 2e-05
Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKH 428
D+G+A+F P + + + PEL + D++S G ++ +I K
Sbjct: 170 RLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 429 P 429
P
Sbjct: 229 P 229
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 2e-05
Identities = 27/226 (11%), Positives = 57/226 (25%), Gaps = 17/226 (7%)
Query: 117 NLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFS 176
L N ++ G + + + + + L + ++ L++++ L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQAD--LDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKD 72
Query: 177 NNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLG 236
N + P L + I + + +L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 237 NLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSEN 296
L + L G + + L +N
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYL---------SIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 297 RFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLS 342
+ P L + +LI V L N ++ NL + L+
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 4e-05
Identities = 30/225 (13%), Positives = 65/225 (28%), Gaps = 17/225 (7%)
Query: 142 MSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201
+++ + + + ++ L + L+ F + + L + L L DN
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 202 SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN 261
+ NL I+ L L+ N ++ + + +
Sbjct: 74 QI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 262 LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNN 321
VL + + G + +S Q + L N + L ++ D N
Sbjct: 132 QVL-------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 322 LTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNIS 366
++ PNL + L N L + ++
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 2e-04
Identities = 19/69 (27%), Positives = 31/69 (44%), Gaps = 5/69 (7%)
Query: 86 LHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHL 145
++ L L DNK+ P +++L NL + L NQ S P + S+L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 146 KILYIDSNQ 154
I+ + +NQ
Sbjct: 220 FIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 36.5 bits (83), Expect = 0.004
Identities = 31/197 (15%), Positives = 59/197 (29%), Gaps = 21/197 (10%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+ + + L + T + L NL L L NQ + P + L
Sbjct: 36 TQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELS 93
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSF------ 203
+ + +I + + ++ + +L L + +
Sbjct: 94 GNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNL 153
Query: 204 --------SGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSI 255
+ NL ++ L N+ S PL +L NL + L N +
Sbjct: 154 QYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQISDVS 211
Query: 256 PPSLDNLV-LTKLSLDD 271
P L N L ++L +
Sbjct: 212 P--LANTSNLFIVTLTN 226
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 3e-05
Identities = 29/290 (10%), Positives = 76/290 (26%), Gaps = 21/290 (7%)
Query: 100 LDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQL-DGS 158
LDL L + ++ + + + + ++ + + ++ + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 159 IPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSIS 218
+ + Q S + L+L L+ + ++L + + L L S
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 219 ILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYL 278
+ L ++ + ++ NL G + +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK--------------NLQKSDLS 168
Query: 279 PQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDG-NNLTGNISKAFGIYPNLT 337
+ + + + L + L ++ G P L
Sbjct: 169 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 228
Query: 338 FIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKFLKPDSSNW 387
+ + G + P L I+ ++ T K + W
Sbjct: 229 TLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEIW 275
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 4e-05
Identities = 25/153 (16%), Positives = 47/153 (30%), Gaps = 27/153 (17%)
Query: 358 PKLGALNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFG 417
P A+N DFG+A+ + + + + + M+ T+ D++S G
Sbjct: 149 PGNLAVNEDCELKILDFGLARQADSEMTGYVVT--RWYRAPEVILNWMRYTQTVDIWSVG 206
Query: 418 VLVLEVIKGKHP----------------------RDFLSSTSSPSLNTDIALDEMLDPRL 455
++ E+I GK S + N L E+
Sbjct: 207 CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF 266
Query: 456 PVPSCSVQEKLISIMEVGFSCLKESPESRPTMK 488
+ ++++E L E R T
Sbjct: 267 ASILTNASPLAVNLLE---KMLVLDAEQRVTAG 296
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 4e-05
Identities = 26/152 (17%), Positives = 46/152 (30%), Gaps = 4/152 (2%)
Query: 113 PQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEV-GQLSSMVE 171
P S L + + H + +L LYI++ Q + L L +
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 172 LALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPI 231
L + + L P + ++S L L N+ + S+ L L+ N
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 232 PLS-LGNLTNLKQFSLVYNNLYGSIPPSLDNL 262
L L + L L ++
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 43.3 bits (101), Expect = 4e-05
Identities = 23/123 (18%), Positives = 41/123 (33%), Gaps = 15/123 (12%)
Query: 363 LNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLE 422
++ DFG AK GT +APE+ + + D ++ GVL+ E
Sbjct: 174 IDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 423 VIKGKHPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPE 482
+ G P F + + I + E + L ++ + L+
Sbjct: 231 MAAGYPP--FFA-------DQPIQIYEKIVSGKVRFPSHFSSDLKDLLR---NLLQVDLT 278
Query: 483 SRP 485
R
Sbjct: 279 KRF 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 5e-05
Identities = 19/72 (26%), Positives = 31/72 (43%), Gaps = 1/72 (1%)
Query: 358 PKLGALNISRNNITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFG 417
P + DFG+A+ S T + T Y APE+ M E D++S G
Sbjct: 147 PSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205
Query: 418 VLVLEVIKGKHP 429
++ E+++ K
Sbjct: 206 CIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 3e-04
Identities = 20/138 (14%), Positives = 40/138 (28%), Gaps = 27/138 (19%)
Query: 373 DFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP--- 429
DFG+A+ D A + + M + D++S G ++ E++ G+
Sbjct: 164 DFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 430 -------------------RDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIM 470
+S + N +L +M + ++
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
Query: 471 EVGFSCLKESPESRPTMK 488
E L + R T
Sbjct: 282 E---KMLVLDSDKRITAA 296
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 3e-04
Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 11/93 (11%)
Query: 288 LQIFTVSENRFQGT----IPKSLRNCTSLIRVRLDGNNLTG----NISKAFGIYPNLTFI 339
+Q + + L+ C + RLD LT +IS A + P L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVV---RLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 340 DLSRNNFYGEISSNFGECPKLGALNISRNNITG 372
+L N + + + I + ++
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 4e-04
Identities = 11/85 (12%), Positives = 22/85 (25%), Gaps = 9/85 (10%)
Query: 91 FSSFPHLAYLDLRDNKL----FGTIPPQISNLTNLSILSLGGNQFSGNIPHEVG-----L 141
L L L D + ++ + +L L L N ++
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 142 MSHLKILYIDSNQLDGSIPLEVGQL 166
L+ L + + + L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 13/77 (16%), Positives = 24/77 (31%), Gaps = 7/77 (9%)
Query: 317 LDGNNLTGN-ISKAFGIYPNLTFIDLSRNNFYGE----ISSNFGECPKLGALNISRNNIT 371
+ L+ ++ + + L ISS P L LN+ N +
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68
Query: 372 --GDFGIAKFLKPDSSN 386
G + + L+ S
Sbjct: 69 DVGVHCVLQGLQTPSCK 85
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (84), Expect = 0.004
Identities = 18/91 (19%), Positives = 28/91 (30%), Gaps = 9/91 (9%)
Query: 189 NLTQISMLFLHDNSFSG----FIPPDIGNLKSISILSLAINQFSGPIPLSLG-----NLT 239
+ + +L+L D S + + S+ L L+ N L L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 240 NLKQFSLVYNNLYGSIPPSLDNLVLTKLSLD 270
L+Q L + L L K SL
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 19/91 (20%), Positives = 29/91 (31%), Gaps = 2/91 (2%)
Query: 368 NNITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK 425
IA ++T T Y +PE+ D++S L+ E+I
Sbjct: 165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
Query: 426 GKHPRDFLSSTSSPSLNTDIALDEMLDPRLP 456
G + S + IA L LP
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 4e-04
Identities = 24/111 (21%), Positives = 45/111 (40%), Gaps = 7/111 (6%)
Query: 90 SFSSFPHLAYLDL-----RDNKLFGTIPPQISNLTNLSILSLGGNQFSG--NIPHEVGLM 142
S P L ++ R + + T+ N+ L L+L N+ ++ V
Sbjct: 31 GLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKA 90
Query: 143 SHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQI 193
+LKIL + N+L L+ + + EL L N+L+ + ++ I
Sbjct: 91 PNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 4e-04
Identities = 24/135 (17%), Positives = 49/135 (36%), Gaps = 7/135 (5%)
Query: 90 SFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149
+++ LDLR K+ I + L + N+ L+ LK L
Sbjct: 13 QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLL 69
Query: 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNG-SVPHSLGNLTQISMLFLHD---NSFSG 205
+++N++ L + EL L +N+L L +L ++ L + +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 206 FIPPDIGNLKSISIL 220
+ I + + +L
Sbjct: 130 YRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 8e-04
Identities = 19/135 (14%), Positives = 40/135 (29%), Gaps = 7/135 (5%)
Query: 113 PQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVEL 172
Q +N L L G + I + + + N++ L + L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTL 68
Query: 173 ALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIG----NLKSISILSLAINQFS 228
+ +N + L ++ L L +NS D +L + IL +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 229 GPIPLSLGNLTNLKQ 243
+ + ++
Sbjct: 129 HYRLYVIYKVPQVRV 143
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.002
Identities = 8/43 (18%), Positives = 13/43 (30%)
Query: 84 GKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSL 126
+L F LD+ ++ + NL L S
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (83), Expect = 0.003
Identities = 14/60 (23%), Positives = 22/60 (36%), Gaps = 4/60 (6%)
Query: 199 HDNSFSGFIPPDI-GNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP 257
DN+ +P D+ IL ++ + L NL L+ S NL +P
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL-KKLPT 240
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.5 bits (83), Expect = 0.004
Identities = 27/184 (14%), Positives = 51/184 (27%), Gaps = 13/184 (7%)
Query: 189 NLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVY 248
+ L S + + L SI + + + L N+ + L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77
Query: 249 NNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRN 308
N L L NL D + L ++ ++S + L +
Sbjct: 78 NKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLK---KLKSLSLEHNGISDINGLVH 132
Query: 309 CTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368
L + L N +T + + + KL L +S+N
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLS----LEDNQISDIVPLAGLTKLQNLYLSKN 188
Query: 369 NITG 372
+I+
Sbjct: 189 HISD 192
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 502 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.69 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.68 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.68 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.67 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.67 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.66 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.65 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.65 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.65 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.64 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.64 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.63 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.62 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.62 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.61 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.61 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.61 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.61 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.61 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.6 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.6 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.6 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.57 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.56 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.54 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.53 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.52 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.52 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.51 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.48 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.47 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.46 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.46 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.44 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.44 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.44 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.44 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.42 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.41 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.39 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.38 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.37 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.37 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.37 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.36 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.35 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.34 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.32 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.3 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.25 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.25 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.2 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.16 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.13 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.13 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.11 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.09 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.02 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.01 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 98.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 98.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 98.77 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.37 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.34 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.68 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.45 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.83 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.42 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.3e-43 Score=343.05 Aligned_cols=292 Identities=28% Similarity=0.456 Sum_probs=234.7
Q ss_pred CCCHHHHHHHHHHHhhcCcCCCCCCCCCCCCCCCCCCCCCCC--ccceeeeCCC---CCEEEEEecCCCCce--ecCccc
Q 010736 18 SETNEEADALLKWKASLQIHNRSLLSSWIKDTSNVSSKISPC--AWSGISCNDA---GRVINISLRGVGLKG--KLHAFS 90 (502)
Q Consensus 18 ~~~~~d~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~C--~W~Gv~C~~~---~~v~~L~L~~~~l~g--~l~~~~ 90 (502)
-+.++|++||++||+++.++ ..+++|..+ .||| .|.||+|+.. .||+.|+|+++++.| .+|+.
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~--~~l~sW~~~-------~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~- 71 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNP--TTLSSWLPT-------TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS- 71 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCC--GGGTTCCTT-------SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGG-
T ss_pred CCCHHHHHHHHHHHHHCCCC--CcCCCCCCC-------CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChH-
Confidence 36789999999999999753 478999765 6899 5999999864 389999999999998 46775
Q ss_pred CCCCCCCCEEECCC-CcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCC
Q 010736 91 FSSFPHLAYLDLRD-NKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSM 169 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~-N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 169 (502)
++++++|++|+|++ |+++|.+|+.|+++++|++|+|++|++.+..|..+..+.+|+++++++|++.+.+|..+.+++++
T Consensus 72 l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L 151 (313)
T d1ogqa_ 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151 (313)
T ss_dssp GGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC
T ss_pred HhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccc
Confidence 99999999999986 89999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cEEEcccCcccccCCcCCCCCCCC-CeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeC
Q 010736 170 VELALFSNNLNGSVPHSLGNLTQI-SMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVY 248 (502)
Q Consensus 170 ~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 248 (502)
+.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .++++.+.+.+.+|..+..+++++.+++++
T Consensus 152 ~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~ 230 (313)
T d1ogqa_ 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230 (313)
T ss_dssp CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCS
T ss_pred ceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccc
Confidence 999999999999999988888776 789999999999888888776544 688888888888888888888888888888
Q ss_pred ccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCc
Q 010736 249 NNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNN 321 (502)
Q Consensus 249 N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~ 321 (502)
|.+.+.+|.......++.|++++|++++.+|..++++++|+.|++++|+++|.+|. ++.+++|+.+++++|+
T Consensus 231 ~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp SEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred ccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 88876654322224555555555555555555555555555555555555555543 3444555555555554
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=7.4e-33 Score=268.39 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=188.5
Q ss_pred CCCCEEECCCCcccc--cCCccCcCCCCCCEEEccC-CcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcE
Q 010736 95 PHLAYLDLRDNKLFG--TIPPQISNLTNLSILSLGG-NQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVE 171 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g--~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 171 (502)
.+++.|+|++|+++| .+|+.++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 468899999999987 5788999999999999986 8899899999999999999999999998888888888888888
Q ss_pred EEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccC-CccccccccccCcccccccCCCCCcEEEeeCcc
Q 010736 172 LALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSI-SILSLAINQFSGPIPLSLGNLTNLKQFSLVYNN 250 (502)
Q Consensus 172 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 250 (502)
+++++|++.+.+|..+.+++.++.+++++|.+.+.+|..+..+..+ +.++++.|++++..|..+..+
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l------------ 197 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL------------ 197 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC------------
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccc------------
Confidence 8888888888888888888888888888888887777776666554 555555555555555444443
Q ss_pred ccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCccc
Q 010736 251 LYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAF 330 (502)
Q Consensus 251 l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 330 (502)
....++++.+.+.+.+|..+..+++++.+++++|.+.+.++ .+..+++|+.|++++|++++.+|..+
T Consensus 198 ------------~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l 264 (313)
T d1ogqa_ 198 ------------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp ------------CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred ------------ccccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHH
Confidence 33344555555555555556666667777777777765544 46666777777777777777777777
Q ss_pred CCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccc
Q 010736 331 GIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGD 373 (502)
Q Consensus 331 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~d 373 (502)
+.+++|++|+|++|+|+|.+|. ++.+++|+.+++++|+..|.
T Consensus 265 ~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 265 TQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEES
T ss_pred hCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccC
Confidence 7777777777777777777763 46667777777777776544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.9e-26 Score=222.01 Aligned_cols=268 Identities=24% Similarity=0.328 Sum_probs=173.0
Q ss_pred CccceeeeCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcc
Q 010736 59 CAWSGISCNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHE 138 (502)
Q Consensus 59 C~W~Gv~C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 138 (502)
|.|.+|.|+. ++++ .+|+. +. +++++|+|++|+|+...+..|.++++|++|++++|.+....|..
T Consensus 10 c~~~~~~C~~-----------~~L~-~lP~~-l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~ 74 (305)
T d1xkua_ 10 CHLRVVQCSD-----------LGLE-KVPKD-LP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74 (305)
T ss_dssp EETTEEECTT-----------SCCC-SCCCS-CC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred ecCCEEEecC-----------CCCC-ccCCC-CC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence 6788898874 2333 44543 42 57889999999888666667888889999999999888777888
Q ss_pred cCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEccccccc--ccCCccCcCCcc
Q 010736 139 VGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFS--GFIPPDIGNLKS 216 (502)
Q Consensus 139 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~ 216 (502)
|.++++|++|++++|+++ .+|..+ ...+..|++..|.+.+..+..+.....+..++...|... ...+..+..+++
T Consensus 75 f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~ 151 (305)
T d1xkua_ 75 FAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151 (305)
T ss_dssp TTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTT
T ss_pred hhCCCccCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccc
Confidence 888888888888888887 344432 346777788888777655555555666666666665432 122233444444
Q ss_pred CCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCC
Q 010736 217 ISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSEN 296 (502)
Q Consensus 217 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n 296 (502)
|+.+++++|.+. .+|..+ ..+++.|++++|..+...+..+..++.++.|++++|
T Consensus 152 ------------------------L~~l~l~~n~l~-~l~~~~-~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n 205 (305)
T d1xkua_ 152 ------------------------LSYIRIADTNIT-TIPQGL-PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205 (305)
T ss_dssp ------------------------CCEEECCSSCCC-SCCSSC-CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSS
T ss_pred ------------------------cCccccccCCcc-ccCccc-CCccCEEECCCCcCCCCChhHhhccccccccccccc
Confidence 444444444443 222222 134555666666665555566666666677777777
Q ss_pred ccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCcc------ccCCCCCCeeeecCCcc
Q 010736 297 RFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSN------FGECPKLGALNISRNNI 370 (502)
Q Consensus 297 ~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------~~~~~~L~~L~l~~N~l 370 (502)
.+++..+..+.++++|++|+|++|+++ .+|..+..+++|++|+|++|+|+...... ....++|+.|++++|++
T Consensus 206 ~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~ 284 (305)
T d1xkua_ 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284 (305)
T ss_dssp CCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred cccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcC
Confidence 776666666666777777777777766 34556666777777777777766433222 23456677777777776
Q ss_pred c
Q 010736 371 T 371 (502)
Q Consensus 371 ~ 371 (502)
.
T Consensus 285 ~ 285 (305)
T d1xkua_ 285 Q 285 (305)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=2.8e-26 Score=227.76 Aligned_cols=277 Identities=22% Similarity=0.330 Sum_probs=176.4
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
..++.|++++++++. +. .+..+++|++|+|++|+|++.. .++++++|++|++++|.+++.. .++++++|+.|+
T Consensus 44 ~~l~~L~l~~~~I~~-l~--gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~ 116 (384)
T d2omza2 44 DQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT 116 (384)
T ss_dssp TTCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCC-cc--ccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--cccccccccccc
Confidence 468999999998873 42 3788999999999999999653 3999999999999999998643 388999999999
Q ss_pred ccCCcCcccCCc---------------------------------------------------------------ccCCC
Q 010736 150 IDSNQLDGSIPL---------------------------------------------------------------EVGQL 166 (502)
Q Consensus 150 Ls~N~l~~~~p~---------------------------------------------------------------~~~~l 166 (502)
+++|.+++..+. .+..+
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 196 (384)
T d2omza2 117 LFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccc
Confidence 999887643221 12234
Q ss_pred CCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEe
Q 010736 167 SSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSL 246 (502)
Q Consensus 167 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 246 (502)
++++.+++++|.+++..| +...++|++|++++|.++.. +.+..+++|+.+++++|.+++..+ +..+++|+.|++
T Consensus 197 ~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l 270 (384)
T d2omza2 197 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeec
Confidence 555556666665554433 23445566666666665532 245555666666666666654332 455566666666
Q ss_pred eCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCcccccc
Q 010736 247 VYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNI 326 (502)
Q Consensus 247 ~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 326 (502)
++|.+++. ++......++.+.++.|.+++. ..+..+++++.|++++|++++.. .+..+++|++|++++|++++.
T Consensus 271 ~~~~l~~~-~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l- 344 (384)
T d2omza2 271 GANQISNI-SPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV- 344 (384)
T ss_dssp CSSCCCCC-GGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-
T ss_pred cCcccCCC-Cccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-
Confidence 66665532 2222224555666666666542 23555566666666666666432 255666666666666666542
Q ss_pred CcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCC
Q 010736 327 SKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRN 368 (502)
Q Consensus 327 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N 368 (502)
..+..+++|++|++++|++++..| +..+++|+.|+|++|
T Consensus 345 -~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 345 -SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp -GGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred -hhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 245566666666666666665443 556666666666665
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=2.2e-25 Score=214.49 Aligned_cols=243 Identities=19% Similarity=0.287 Sum_probs=180.2
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALF 175 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 175 (502)
.++.+|-++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4566777777777 5666653 578888888888875555567788888888888888876667777777788888887
Q ss_pred cCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccc--c
Q 010736 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY--G 253 (502)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~ 253 (502)
+|+++ .+|..+ ...+..|++.+|.+.+..+..+. ....+..++...|... .
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~------------------------~~~~~~~l~~~~n~~~~~~ 140 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFN------------------------GLNQMIVVELGTNPLKSSG 140 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHT------------------------TCTTCCEEECCSSCCCGGG
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhhhh------------------------ccccccccccccccccccC
Confidence 77777 344332 34566666666666544333333 3333444444444322 1
Q ss_pred cCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCC
Q 010736 254 SIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGI 332 (502)
Q Consensus 254 ~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 332 (502)
..+..+.. ..++.+++++|.++.. |..+ .++|+.|++++|..++..+..+..++.++.|++++|.+++..+..+..
T Consensus 141 ~~~~~~~~l~~L~~l~l~~n~l~~l-~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~ 217 (305)
T d1xkua_ 141 IENGAFQGMKKLSYIRIADTNITTI-PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217 (305)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCCSC-CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred CCccccccccccCccccccCCcccc-Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccc
Confidence 22222332 5789999999998864 4333 578999999999999999999999999999999999999988889999
Q ss_pred CCCCcEEEccCcccccccCccccCCCCCCeeeecCCcccc
Q 010736 333 YPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITG 372 (502)
Q Consensus 333 l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~ 372 (502)
+++|++|+|++|+|+ .+|..+..+++|++|++++|+|..
T Consensus 218 l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 218 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred cccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence 999999999999998 567889999999999999999863
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.6e-26 Score=217.67 Aligned_cols=221 Identities=20% Similarity=0.200 Sum_probs=168.1
Q ss_pred EEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEcc-CC
Q 010736 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYID-SN 153 (502)
Q Consensus 75 L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls-~N 153 (502)
++.++.+++ .+|.. +. +.+++|+|++|+|+...+..|.++++|++|++++|++.+..+..+..+..++.++.. .|
T Consensus 16 v~c~~~~L~-~iP~~-ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVG-IP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EECCSSCCS-SCCTT-CC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEcCCCCCC-ccCCC-CC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 456666666 55543 32 568999999999997777789999999999999999998888888888888888764 66
Q ss_pred cCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccc
Q 010736 154 QLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPL 233 (502)
Q Consensus 154 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 233 (502)
.++...|..|.++++|++|++++|.+....+..+....+|+.+++++|.+++..+..|..+++|+.|++++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 67766677888899999999999988877777788888888899998888877777788888888888888888877777
Q ss_pred cccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcCcccCCccccCCCCCcEEEccCCccc
Q 010736 234 SLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQ 299 (502)
Q Consensus 234 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~ 299 (502)
.|.++++|+.+++++|++++..|..+.. .++++|++++|++.+..+..+..+.+|+.|++++|.+.
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 7888888888888888777666665554 45556666666665555555555555555555555554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.4e-25 Score=211.96 Aligned_cols=232 Identities=18% Similarity=0.171 Sum_probs=170.3
Q ss_pred EEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcc-cc
Q 010736 123 ILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLH-DN 201 (502)
Q Consensus 123 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N 201 (502)
.++.++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|++....+..+..+..+..+... .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 4566777776 6665543 457777777777776555667777777777777777776666666666666666543 44
Q ss_pred cccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCcc
Q 010736 202 SFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQN 281 (502)
Q Consensus 202 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~ 281 (502)
.++...+..|.++++|++|++++|.+....+..+...++ |+.+++++|+++++.+..
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~-----------------------L~~l~l~~N~l~~i~~~~ 148 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA-----------------------LQYLYLQDNALQALPDDT 148 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT-----------------------CCEEECCSSCCCCCCTTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcc-----------------------cchhhhccccccccChhH
Confidence 444444555555555555555555554444444444444 455555555555544556
Q ss_pred ccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCC
Q 010736 282 ICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLG 361 (502)
Q Consensus 282 ~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 361 (502)
+...++|+.|++++|++++..+..|.++++|+++++++|++++..|..|..+++|++||+++|++.+..+..+..+++|+
T Consensus 149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence 67778889999999999888788899999999999999999999899999999999999999999988888999999999
Q ss_pred eeeecCCccccccCccccc
Q 010736 362 ALNISRNNITGDFGIAKFL 380 (502)
Q Consensus 362 ~L~l~~N~l~~dfGl~~ll 380 (502)
+|++++|++.|||++.++.
T Consensus 229 ~L~l~~N~l~C~C~~~~l~ 247 (284)
T d1ozna_ 229 YLRLNDNPWVCDCRARPLW 247 (284)
T ss_dssp EEECCSSCEECSGGGHHHH
T ss_pred EEEecCCCCCCCccchHHH
Confidence 9999999999999987654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=4.1e-24 Score=211.93 Aligned_cols=277 Identities=21% Similarity=0.294 Sum_probs=205.6
Q ss_pred EecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcC
Q 010736 76 SLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQL 155 (502)
Q Consensus 76 ~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 155 (502)
.+...++++.+. ...+.+|++|++++++|+. + +.+..+++|++|+|++|+|++. | .++++++|++|++++|++
T Consensus 28 ~l~~~~~~~~~~---~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 28 VLGKTNVTDTVS---QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HTTCSSTTSEEC---HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred HhCCCCCCCccC---HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccc
Confidence 344455555554 3456789999999999985 3 4688999999999999999954 4 399999999999999999
Q ss_pred cccCCcccCCCCCCcEEEcccCcccccCCc--------------------------------------------------
Q 010736 156 DGSIPLEVGQLSSMVELALFSNNLNGSVPH-------------------------------------------------- 185 (502)
Q Consensus 156 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-------------------------------------------------- 185 (502)
++.. .++.+++|+.|++++|.+++..+.
T Consensus 101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (384)
T d2omza2 101 ADIT--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178 (384)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCC
T ss_pred cccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccc
Confidence 8643 388999999999998887642221
Q ss_pred -------------CCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccc
Q 010736 186 -------------SLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 186 -------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 252 (502)
.+..+++++.+++++|.+++..| +...++|+.|++++|+++.. ..+..+++|+.|++++|.++
T Consensus 179 ~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~ 254 (384)
T d2omza2 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS 254 (384)
T ss_dssp EEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred cccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccC
Confidence 12234566677777777765543 34556777777777777642 25667777788888877776
Q ss_pred ccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCC
Q 010736 253 GSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGI 332 (502)
Q Consensus 253 ~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 332 (502)
+..+ ......|+.+++++|++++.. .+..+..++.+.++.|.+++. ..+..+++++.+++++|++++.. .+..
T Consensus 255 ~~~~-~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~ 327 (384)
T d2omza2 255 NLAP-LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSS 327 (384)
T ss_dssp CCGG-GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGG
T ss_pred CCCc-ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--cccc
Confidence 4332 222356788888888777642 356677778888888877752 34778889999999999998754 3778
Q ss_pred CCCCcEEEccCcccccccCccccCCCCCCeeeecCCcccccc
Q 010736 333 YPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDF 374 (502)
Q Consensus 333 l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~df 374 (502)
+++|++|++++|++++ ++ .+..+++|++|++++|++++-.
T Consensus 328 l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 328 LTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCG
T ss_pred CCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCCh
Confidence 8999999999999975 33 5888999999999999987543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=7.9e-24 Score=199.26 Aligned_cols=211 Identities=22% Similarity=0.206 Sum_probs=150.1
Q ss_pred CCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCc
Q 010736 140 GLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISI 219 (502)
Q Consensus 140 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 219 (502)
.+...+...+.++++++ .+|..+. +++++|+|++|++++..+..|.++++|++|+|++|+++.. | .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence 34455566677777776 4555443 3566666666666655555566666666666666666533 2 2345555555
Q ss_pred cccccccccCcccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccc
Q 010736 220 LSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQ 299 (502)
Q Consensus 220 L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~ 299 (502)
|++++|++++ .+..+..+++|+.|++ ++|.+.+..+..+..+.+++.|++++|.++
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l-----------------------~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~ 137 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDV-----------------------SFNRLTSLPLGALRGLGELQELYLKGNELK 137 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEEC-----------------------CSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred cccccccccc-cccccccccccccccc-----------------------cccccceeeccccccccccccccccccccc
Confidence 5555555553 2334444555555554 444444445556666778888888888888
Q ss_pred cccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccccccCcccc
Q 010736 300 GTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNITGDFGIAKF 379 (502)
Q Consensus 300 ~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~dfGl~~l 379 (502)
...+..+..+++++.+++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++.|||.+.++
T Consensus 138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~~l 216 (266)
T d1p9ag_ 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYF 216 (266)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGHHH
T ss_pred eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcchHHH
Confidence 777777788899999999999999888888999999999999999998 7888888899999999999999999988765
Q ss_pred c
Q 010736 380 L 380 (502)
Q Consensus 380 l 380 (502)
.
T Consensus 217 ~ 217 (266)
T d1p9ag_ 217 R 217 (266)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=9.2e-24 Score=198.81 Aligned_cols=201 Identities=23% Similarity=0.281 Sum_probs=157.3
Q ss_pred eCCCCCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCC
Q 010736 66 CNDAGRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHL 145 (502)
Q Consensus 66 C~~~~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 145 (502)
|+...+..+++.++++|+ .+|+. +. +++++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|
T Consensus 6 ~~~~~~~~~v~C~~~~L~-~iP~~-lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L 79 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLT-ALPPD-LP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVL 79 (266)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSC-CC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTC
T ss_pred EcccCCCeEEEccCCCCC-eeCcC-cC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccc
Confidence 444445566788888888 46654 43 57899999999999777788999999999999999998 444 35788999
Q ss_pred cEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccc
Q 010736 146 KILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAIN 225 (502)
Q Consensus 146 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 225 (502)
++|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++++.+++++|
T Consensus 80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N 158 (266)
T d1p9ag_ 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (266)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred ccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccc
Confidence 99999999988 45667888899999999999988777777888888999999999888777777788888888888888
Q ss_pred cccCcccccccCCCCCcEEEeeCccccccCCCCCcc-ccccEEECcCCcC
Q 010736 226 QFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPPSLDN-LVLTKLSLDDNHF 274 (502)
Q Consensus 226 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~~L~~L~ls~N~l 274 (502)
++++..+..|..+++|++|+|++|+|+ .+|..+.. ..|+.|+|++|.+
T Consensus 159 ~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred cccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 888777777888888888888888887 55554433 4455555555544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=3.9e-19 Score=158.16 Aligned_cols=170 Identities=22% Similarity=0.208 Sum_probs=129.5
Q ss_pred EEecCCCCceecCcccCCCCCCCCEEECCCCcccccC-CccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCC
Q 010736 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTI-PPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSN 153 (502)
Q Consensus 75 L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 153 (502)
++.++++|+ .+|.. +. +++++|+|++|+|++.+ +..|.++++|++|+|++|.+.+..+..|..+++|++|+|++|
T Consensus 13 v~Cs~~~L~-~iP~~-lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EECTTSCCS-SCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEeCCCcC-ccCCC-CC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 334445565 56654 32 68999999999998644 567789999999999999999888999999999999999999
Q ss_pred cCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccc
Q 010736 154 QLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPL 233 (502)
Q Consensus 154 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 233 (502)
++++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....... .-...++.+.+..+.++...|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCCh
Confidence 999888888999999999999999999888888999999999999999887542211 1123355566666666655554
Q ss_pred cccCCCCCcEEEeeCcccc
Q 010736 234 SLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 234 ~~~~l~~L~~L~l~~N~l~ 252 (502)
.+ ..++.++++.|.+.
T Consensus 168 ~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 168 KV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp TT---TTSBGGGSCTTTCC
T ss_pred hh---cCCEeeecCHhhCc
Confidence 43 33445556666554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=3.3e-19 Score=158.58 Aligned_cols=167 Identities=22% Similarity=0.270 Sum_probs=142.0
Q ss_pred CccceeeeCCC----------CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccC
Q 010736 59 CAWSGISCNDA----------GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGG 128 (502)
Q Consensus 59 C~W~Gv~C~~~----------~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~ 128 (502)
|.|..|.|+.. ..++.|+|++|.+++.++...|..+++|++|+|++|++.+..+..|..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 67999999742 26899999999999888887799999999999999999999999999999999999999
Q ss_pred CcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCC
Q 010736 129 NQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIP 208 (502)
Q Consensus 129 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 208 (502)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+.. .-...++.+.+..|.++...|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCC
Confidence 9999888889999999999999999999988899999999999999999987543221 112335666777888877666
Q ss_pred ccCcCCccCCccccccccccC
Q 010736 209 PDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 209 ~~~~~l~~L~~L~ls~N~l~~ 229 (502)
.. +..++.++++.|.+.-
T Consensus 167 ~~---l~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 167 SK---VRDVQIKDLPHSEFKC 184 (192)
T ss_dssp TT---TTTSBGGGSCTTTCCC
T ss_pred hh---hcCCEeeecCHhhCcC
Confidence 54 4567788899888864
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.76 E-value=2.2e-16 Score=153.33 Aligned_cols=261 Identities=21% Similarity=0.239 Sum_probs=166.7
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
+++.|||++++++ .+|+. .++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .+.|++|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred CCCEEEeCCCCCC-CCCCC----CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 5778999999997 57642 578999999999998 677654 57999999999998 44431 246999999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCc
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP 230 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 230 (502)
++|.++ .+|. ++.+++|+.|++++|.+.... .. ...+..+.+..+.... ...+..++.++.+.++.|.+...
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~-~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP-DL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSC
T ss_pred cccccc-cccc-hhhhccceeeccccccccccc-cc---cccccchhhccccccc--cccccccccceeccccccccccc
Confidence 999998 4554 678999999999999887432 22 2334444444433321 22334444455555544443211
Q ss_pred ------------------ccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEE-
Q 010736 231 ------------------IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIF- 291 (502)
Q Consensus 231 ------------------~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L- 291 (502)
....+..++.|+.+++++|... .++... ..+..+.+..+.+.... . ....+...
T Consensus 178 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~-~~~~~~--~~l~~~~~~~~~~~~~~-~---~~~~l~~~~ 250 (353)
T d1jl5a_ 178 PDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLP--PSLEALNVRDNYLTDLP-E---LPQSLTFLD 250 (353)
T ss_dssp CCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCSCC--TTCCEEECCSSCCSCCC-C---CCTTCCEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccc-cccccc--ccccccccccccccccc-c---ccccccccc
Confidence 1123455677788888777665 233221 34555666666554321 1 11222333
Q ss_pred -------------------EccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCcEEEccCcccccccCc
Q 010736 292 -------------------TVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLTFIDLSRNNFYGEISS 352 (502)
Q Consensus 292 -------------------~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 352 (502)
++..+.+.+ ....+++|++|++++|+++. +|. .+++|+.|+|++|+|+ .+|.
T Consensus 251 ~~~~~~~~l~~l~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~ 321 (353)
T d1jl5a_ 251 VSENIFSGLSELPPNLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPE 321 (353)
T ss_dssp CCSSCCSEESCCCTTCCEEECCSSCCSE----ECCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCC
T ss_pred cccccccccccccchhcccccccCcccc----ccccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-cccc
Confidence 333333331 12335789999999999884 443 3678999999999987 4554
Q ss_pred cccCCCCCCeeeecCCccc
Q 010736 353 NFGECPKLGALNISRNNIT 371 (502)
Q Consensus 353 ~~~~~~~L~~L~l~~N~l~ 371 (502)
. +++|++|++++|++.
T Consensus 322 ~---~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 322 L---PQNLKQLHVEYNPLR 337 (353)
T ss_dssp C---CTTCCEEECCSSCCS
T ss_pred c---cCCCCEEECcCCcCC
Confidence 2 467999999999975
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=4.8e-18 Score=156.74 Aligned_cols=105 Identities=17% Similarity=0.189 Sum_probs=74.0
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCC-cccCCCCCCcEEEcc-
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIP-LEVGQLSSMVELALF- 175 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~- 175 (502)
+.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+...++ ..|..+++++++.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 56777777777 6666553 478888888888875555567888888888888887765443 356777777777765
Q ss_pred cCcccccCCcCCCCCCCCCeEEcccccccc
Q 010736 176 SNNLNGSVPHSLGNLTQISMLFLHDNSFSG 205 (502)
Q Consensus 176 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 205 (502)
.|++....+..|.++++|+++++++|.+..
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred cccccccccccccccccccccccchhhhcc
Confidence 356666666667777777777777777654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=8.9e-18 Score=154.93 Aligned_cols=152 Identities=12% Similarity=0.097 Sum_probs=101.3
Q ss_pred CEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCC-cCCCCCCCCCeEEcc-
Q 010736 122 SILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVP-HSLGNLTQISMLFLH- 199 (502)
Q Consensus 122 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~- 199 (502)
++++.+++.++ .+|..+. +++++|++++|+++...+..|.++++|++|++++|.+...++ ..|..+++++++.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 67888888888 7776653 578999999999986666678889999999999988876544 457778888888765
Q ss_pred cccccccCCccCcCCccCCccccccccccCcccc-cccCCCCCcEEEeeCccccccCCCCCcc--ccccEEECcCCcCcc
Q 010736 200 DNSFSGFIPPDIGNLKSISILSLAINQFSGPIPL-SLGNLTNLKQFSLVYNNLYGSIPPSLDN--LVLTKLSLDDNHFTS 276 (502)
Q Consensus 200 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~--~~L~~L~ls~N~l~~ 276 (502)
.|.+....+..|.++++|+.+++++|++....+. .+..+..+..+...++.+....+..+.. ..+..+++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 4677777777778888888888888877643222 2233344444444555554333333322 234445555555544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=5e-18 Score=155.11 Aligned_cols=202 Identities=21% Similarity=0.288 Sum_probs=120.0
Q ss_pred EEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCc
Q 010736 75 ISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQ 154 (502)
Q Consensus 75 L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 154 (502)
+++..+++++.++ +..+.+|+.|++.+|+++. ++ .+.++++|++|++++|.+++..| +.++++|+++++++|.
T Consensus 24 ~~l~~~~~~d~~~---~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 24 IAAGKSNVTDTVT---QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHTTCSSTTSEEC---HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHhCCCCcCCcCC---HHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 3444444544332 4456677777777777764 33 46777777777777777775433 6777777777777777
Q ss_pred CcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCccccc
Q 010736 155 LDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLS 234 (502)
Q Consensus 155 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 234 (502)
++. ++ .+..+++|+.++++++...+.. .+...+.+..+.++.+.+.... .+...++|+.|++++|.++... .
T Consensus 97 ~~~-i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~ 168 (227)
T d1h6ua2 97 LKN-VS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--P 168 (227)
T ss_dssp CSC-CG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--G
T ss_pred ccc-cc-cccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccch--h
Confidence 763 32 4666777777777777665432 2445566667777666665432 2455566666666666665332 2
Q ss_pred ccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcE
Q 010736 235 LGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIR 314 (502)
Q Consensus 235 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~ 314 (502)
++++++|+.|++++|++++ ++ .+..+++|+.|++++|++++. + .+.++++|+.
T Consensus 169 l~~l~~L~~L~Ls~n~l~~-l~------------------------~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~ 221 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISD-IS------------------------PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFI 221 (227)
T ss_dssp GTTCTTCCEEECCSSCCCC-CG------------------------GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCE
T ss_pred hcccccceecccCCCccCC-Ch------------------------hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCE
Confidence 5556666666666665542 21 244455566666666665532 2 2555666666
Q ss_pred EeCC
Q 010736 315 VRLD 318 (502)
Q Consensus 315 L~l~ 318 (502)
|+++
T Consensus 222 L~ls 225 (227)
T d1h6ua2 222 VTLT 225 (227)
T ss_dssp EEEE
T ss_pred EEee
Confidence 6654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=9.4e-18 Score=153.25 Aligned_cols=204 Identities=23% Similarity=0.354 Sum_probs=105.0
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 177 (502)
..++++.+++++.+ .+..+.+|++|++++|.++. ++ .+..+++|++|++++|++++..| +..+++|+.+++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 44566666666543 34566777777777777773 33 46777777777777777765433 666667777777766
Q ss_pred cccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccccccCCC
Q 010736 178 NLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGSIPP 257 (502)
Q Consensus 178 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 257 (502)
.++. ++ .+..+++|+.+.++++...+.. .+...+.+..+.++.+.+.... .+..+++
T Consensus 96 ~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~----------------- 152 (227)
T d1h6ua2 96 PLKN-VS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTN----------------- 152 (227)
T ss_dssp CCSC-CG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTT-----------------
T ss_pred cccc-cc-cccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhccccc-----------------
Confidence 6652 22 3555666666666655544321 1223333333333333332211 1222222
Q ss_pred CCccccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcEEeCCCCccccccCcccCCCCCCc
Q 010736 258 SLDNLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIRVRLDGNNLTGNISKAFGIYPNLT 337 (502)
Q Consensus 258 ~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 337 (502)
++.|++++|.++.. ..+..+++|+.|++++|++++ ++ .+..+++|++|++++|++++.. .+..+++|+
T Consensus 153 ------L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~ 220 (227)
T d1h6ua2 153 ------LQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLF 220 (227)
T ss_dssp ------CCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCC
T ss_pred ------cccccccccccccc--hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCC
Confidence 33333333333221 124444555555555555553 22 2455555555555555555332 244555555
Q ss_pred EEEcc
Q 010736 338 FIDLS 342 (502)
Q Consensus 338 ~L~Ls 342 (502)
+|+++
T Consensus 221 ~L~ls 225 (227)
T d1h6ua2 221 IVTLT 225 (227)
T ss_dssp EEEEE
T ss_pred EEEee
Confidence 55543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=5.5e-20 Score=173.13 Aligned_cols=127 Identities=24% Similarity=0.416 Sum_probs=82.3
Q ss_pred cccccCcccccCCCC--CCcccccccccccCcccccc---ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYT---MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~---~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
.++|||+++...... ...+...||+.|+|||...+ ..++.++|||||||++|||+||+.|++...... ....
T Consensus 144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~ 220 (276)
T d1uwha_ 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIF 220 (276)
T ss_dssp EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHH
T ss_pred EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHH
Confidence 379999999875432 23345789999999999854 357899999999999999999999985321100 0000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCCCC
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPSLD 502 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~~~ 502 (502)
........|.+........+++.+++. .||+.+|++||||+||+++|+.++.+++
T Consensus 221 ~~~~~~~~p~~~~~~~~~~~~l~~li~---~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 221 MVGRGYLSPDLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HHHHTSCCCCGGGSCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHhcCCCCCcchhccccchHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 001112222221111122355666666 9999999999999999999999876654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.1e-17 Score=147.78 Aligned_cols=146 Identities=23% Similarity=0.390 Sum_probs=70.5
Q ss_pred CCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEE
Q 010736 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELA 173 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 173 (502)
+.+|++|++++|.++... .+..+++|++|+|++|+|++. + .++.+++|++|++++|++++ +| .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccc
Confidence 345555555555555321 245555555555555555532 2 24555555555555555553 22 345555555555
Q ss_pred cccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccc
Q 010736 174 LFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNL 251 (502)
Q Consensus 174 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 251 (502)
+++|.+.. + ..+..++.++.+++++|.+++. ..+..+++|+.+++++|++++.. .+.++++|+.|++++|++
T Consensus 119 l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHI 190 (210)
T ss_dssp CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred cccccccc-c-cccccccccccccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECCCCCC
Confidence 55555442 1 2344455555555555555432 22334444555555555544321 134444444444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=5.3e-17 Score=146.23 Aligned_cols=163 Identities=26% Similarity=0.359 Sum_probs=139.1
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEc
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYI 150 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 150 (502)
.++.+++++++++. ++ .+..+++|++|+|++|++++.. .++++++|++|++++|++++ +| .+..+++|+.|++
T Consensus 47 ~L~~L~l~~~~i~~-l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp TCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CccEEECcCCCCCC-ch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 57889999998874 33 2788999999999999999644 37899999999999999984 45 5889999999999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCc
Q 010736 151 DSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGP 230 (502)
Q Consensus 151 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 230 (502)
++|.+.. + ..+..+++++.+++++|.+++. ..+..+++|+++++++|++++.. .+.++++|+.|++++|+++.
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~- 192 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD- 192 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-
T ss_pred ccccccc-c-cccccccccccccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-
Confidence 9999873 3 4688899999999999999853 35678999999999999998643 38899999999999999985
Q ss_pred ccccccCCCCCcEEEeeC
Q 010736 231 IPLSLGNLTNLKQFSLVY 248 (502)
Q Consensus 231 ~p~~~~~l~~L~~L~l~~ 248 (502)
+| .+.++++|+.|++++
T Consensus 193 l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CG-GGTTCTTCSEEEEEE
T ss_pred Ch-hhcCCCCCCEEEccC
Confidence 55 589999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=5.1e-17 Score=145.08 Aligned_cols=147 Identities=24% Similarity=0.400 Sum_probs=73.3
Q ss_pred CCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEE
Q 010736 94 FPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELA 173 (502)
Q Consensus 94 l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 173 (502)
++++++|++++|+++. ++ .+..+++|++|++++|++++..| ++++++|++|++++|.+.. ++ .+..+++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccc
Confidence 4455555555555552 21 34555555555555555553222 5555555555555555542 22 245555555555
Q ss_pred cccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccc
Q 010736 174 LFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLY 252 (502)
Q Consensus 174 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 252 (502)
+++|.+... ..+..+++|+.|++++|++... +.+..+++|+.|++.+|++++.. .++++++|+.|++++|+++
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence 555555432 1244555555555555555421 23444555555555555554321 2444555555555555443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=8.5e-17 Score=143.61 Aligned_cols=160 Identities=24% Similarity=0.403 Sum_probs=135.8
Q ss_pred CCEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEE
Q 010736 70 GRVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILY 149 (502)
Q Consensus 70 ~~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 149 (502)
.+++.|++++++++ .++ .+..+++|++|++++|++++..| ++++++|++|++++|.+.. ++ .++++++|+.|+
T Consensus 40 ~~l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT 112 (199)
T ss_dssp TTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred cCCCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccc
Confidence 46889999999987 343 37889999999999999997543 8999999999999999984 44 488999999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccC
Q 010736 150 IDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 150 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
+++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|+.|++.+|++++.. .++++++|++|++++|+++.
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC
Confidence 999998753 347889999999999999974 33 5889999999999999998753 48899999999999999985
Q ss_pred cccccccCCCCCcEE
Q 010736 230 PIPLSLGNLTNLKQF 244 (502)
Q Consensus 230 ~~p~~~~~l~~L~~L 244 (502)
++ .++++++|+.|
T Consensus 187 -i~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 -IS-VLAKLTNLESL 199 (199)
T ss_dssp -CG-GGGGCTTCSEE
T ss_pred -Cc-cccCCCCCCcC
Confidence 43 57888888875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.2e-18 Score=164.79 Aligned_cols=118 Identities=21% Similarity=0.291 Sum_probs=73.5
Q ss_pred cccccCcccccCCCCC---CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
.++|||+++.+..... ......||..|+|||+.....++.++|||||||++|||+||+.|...... ....
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~~ 222 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEV 222 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHH
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------HHHH
Confidence 4799999998754322 22345689999999999999999999999999999999997666421110 0000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
...+.+...+..+....+++.++++ .||+.+|++||+|.||+++|+.+
T Consensus 223 ~~~i~~~~~~~~~~~~~~~l~~li~---~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 223 MKAINDGFRLPTPMDCPSAIYQLMM---QCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHHHHTTCCCCCCTTCBHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHhccCCCCCchhhHHHHHHHHH---HHCcCCHhHCcCHHHHHHHHHHH
Confidence 1111111111111122345555555 99999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.7e-18 Score=162.56 Aligned_cols=118 Identities=27% Similarity=0.376 Sum_probs=81.0
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.++|||+++.+..... ..+...||..|+|||...+..++.|+|||||||+++||+||+.|...... ...... .+.
T Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~--~i~ 224 (272)
T d1qpca_ 149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQ--NLE 224 (272)
T ss_dssp EECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHH--HHH
T ss_pred eeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHH--HHH
Confidence 3799999998865332 23456789999999999999999999999999999999997666421110 000000 011
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.-..+..+ ....+++.++++ .|++.+|++||||+||+++|+..
T Consensus 225 ~~~~~~~p---~~~~~~l~~li~---~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 225 RGYRMVRP---DNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCc---ccChHHHHHHHH---HHcCCCHhHCcCHHHHHHHhhhh
Confidence 11111111 122345666555 99999999999999999999863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=9.3e-19 Score=163.66 Aligned_cols=121 Identities=29% Similarity=0.397 Sum_probs=72.1
Q ss_pred ccccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhcCCCC-CCcccCCCCCCCCcccc
Q 010736 369 NITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHP-RDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p-~~~~~~~~~~~~~~~~~ 446 (502)
-.++|||+++....... ......||..|+|||......++.|+|||||||+++||+||+.| ++.... ..+...
T Consensus 140 ~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~-- 214 (263)
T d1sm2a_ 140 IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVED-- 214 (263)
T ss_dssp EEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHH--
T ss_pred eEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHH--
Confidence 34799999998754332 22346789999999999999999999999999999999996544 321110 000000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCC
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPS 500 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~ 500 (502)
+..-..+..+ ....+++.++++ .||+.+|++||+|+||+++|+++++|
T Consensus 215 i~~~~~~~~p---~~~~~~l~~li~---~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 215 ISTGFRLYKP---RLASTHVYQIMN---HCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHTCCCCCC---TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCc---cccCHHHHHHHH---HHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0111111111 112245555555 99999999999999999999987653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.67 E-value=1.1e-14 Score=140.93 Aligned_cols=244 Identities=23% Similarity=0.273 Sum_probs=156.6
Q ss_pred CCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEc
Q 010736 95 PHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELAL 174 (502)
Q Consensus 95 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 174 (502)
.++++|||++|+++ .+|+. .++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 36899999999998 57863 578999999999999 778654 57999999999998 33321 246999999
Q ss_pred ccCcccccCCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCcccccc
Q 010736 175 FSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNLYGS 254 (502)
Q Consensus 175 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 254 (502)
++|.+. .+|. ++.+++|++|++++|.+.... .. ...+..+.+..+... .+..+..++.++.+++..|.....
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~-~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP-DL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred cccccc-cccc-hhhhccceeeccccccccccc-cc---cccccchhhcccccc--ccccccccccceeccccccccccc
Confidence 999998 5664 688999999999999987543 22 345556666655543 334567788889999988877532
Q ss_pred CCCCCc--------------------cccccEEECcCCcCcccCCccccCCCCCcEEEccCCccccccCcccccCCCCcE
Q 010736 255 IPPSLD--------------------NLVLTKLSLDDNHFTSYLPQNICRGGALQIFTVSENRFQGTIPKSLRNCTSLIR 314 (502)
Q Consensus 255 ~p~~~~--------------------~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~l~~L~~ 314 (502)
+.... ...++.+++++|..... +. ...++..+.+..+.+... +. ....+..
T Consensus 178 -~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~-~~---~~~~l~~~~~~~~~~~~~-~~---~~~~l~~ 248 (353)
T d1jl5a_ 178 -PDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLTDL-PE---LPQSLTF 248 (353)
T ss_dssp -CCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCSCC-CC---CCTTCCE
T ss_pred -cccccccccccccccccccccccccccccccccccccccccc-cc---cccccccccccccccccc-cc---ccccccc
Confidence 21110 02344444444443321 11 123344444444444321 11 1122333
Q ss_pred EeCCCCccccc----------------cCcccCCCCCCcEEEccCcccccccCccccCCCCCCeeeecCCccc
Q 010736 315 VRLDGNNLTGN----------------ISKAFGIYPNLTFIDLSRNNFYGEISSNFGECPKLGALNISRNNIT 371 (502)
Q Consensus 315 L~l~~N~l~~~----------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~N~l~ 371 (502)
.++..+.+.+. +......+++|++|+|++|++. .+|. .+++|++|++++|+|+
T Consensus 249 ~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~ 317 (353)
T d1jl5a_ 249 LDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA 317 (353)
T ss_dssp EECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS
T ss_pred cccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC
Confidence 33333322211 1111234578999999999987 4553 3578999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.67 E-value=3.7e-18 Score=162.44 Aligned_cols=116 Identities=28% Similarity=0.482 Sum_probs=71.6
Q ss_pred cccccCcccccCCCCCC-----cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCc
Q 010736 370 ITGDFGIAKFLKPDSSN-----WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~-----~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~ 443 (502)
.++|||+++.+...... .....||+.|+|||...+..++.++|||||||+++||+| |+.|+...... ..
T Consensus 168 Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~-- 242 (299)
T d1jpaa_ 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DV-- 242 (299)
T ss_dssp EECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH--
T ss_pred EECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HH--
Confidence 37999999988653321 123457889999999999999999999999999999998 89997532110 00
Q ss_pred cccccccc-CCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 444 DIALDEML-DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 444 ~~~~~~~~-d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
...+. +.+++.+ ....+++.++++ .||+.+|++||+|+||++.|+.+
T Consensus 243 ---~~~i~~~~~~~~~-~~~~~~l~~li~---~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 243 ---INAIEQDYRLPPP-MDCPSALHQLML---DCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ---HHHHHTTCCCCCC-TTCCHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---HHHHHcCCCCCCC-ccchHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHH
Confidence 01111 1112111 122355666655 99999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=6.8e-18 Score=161.45 Aligned_cols=119 Identities=28% Similarity=0.358 Sum_probs=82.8
Q ss_pred ccccCcccccCCCCC----CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 371 TGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
.+|||+++.+..... ..+...||..|+|||...+..++.|+||||||++++||+||+.|+...... ..+..
T Consensus 171 L~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~--- 245 (311)
T d1r0pa_ 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV--- 245 (311)
T ss_dssp ECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---
T ss_pred EecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH---
Confidence 699999998754322 223467899999999999999999999999999999999988886422111 11110
Q ss_pred cccccC-CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcCC
Q 010736 447 LDEMLD-PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAPS 500 (502)
Q Consensus 447 ~~~~~d-~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~~ 500 (502)
.+.. .+...+ ....+++.++++ .||+.+|++||+|.||++.|+.+..+
T Consensus 246 --~i~~g~~~~~p-~~~~~~l~~li~---~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 246 --YLLQGRRLLQP-EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --HHHTTCCCCCC-TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHHcCCCCCCc-ccCcHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1111 111111 122345666655 99999999999999999999987543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.65 E-value=4.7e-18 Score=162.13 Aligned_cols=119 Identities=18% Similarity=0.273 Sum_probs=81.7
Q ss_pred cccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhcCCC-CCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH-PRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~-p~~~~~~~~~~~~~~~~~ 446 (502)
.++|||+++.+..... ..+...|+..|+|||......++.|+|||||||+++||+||.. |+..... ...
T Consensus 180 Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~--------~e~ 251 (301)
T d1lufa_ 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--------EEV 251 (301)
T ss_dssp EECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHH
T ss_pred EEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH--------HHH
Confidence 4799999997754322 2234678899999999999999999999999999999999964 5532110 001
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
...+.+...+..+.....++..++. .||+.+|++||+|.||+++|+.+.+
T Consensus 252 ~~~v~~~~~~~~p~~~~~~~~~li~---~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 252 IYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHcCCCCCCCccchHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1122222222111122345555555 9999999999999999999998753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=6.9e-18 Score=159.24 Aligned_cols=118 Identities=25% Similarity=0.379 Sum_probs=83.5
Q ss_pred ccccccCcccccCCCCC---CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcc
Q 010736 369 NITGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~ 444 (502)
..++|||+++.+..... ..+...||+.|+|||......++.++|||||||+++||+| |+.|+...... ....
T Consensus 148 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~- 223 (285)
T d1u59a_ 148 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA- 223 (285)
T ss_dssp EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH-
T ss_pred eeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH-
Confidence 34799999998864322 1234568899999999999999999999999999999998 89998532111 0000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.+.+-..+..+ ....+++.++++ .||+.+|++||+|.+|++.|+..
T Consensus 224 -~i~~~~~~~~p---~~~~~~l~~li~---~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 224 -FIEQGKRMECP---PECPPELYALMS---DCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -HHHTTCCCCCC---TTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHcCCCCCCC---CcCCHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHH
Confidence 01111111222 122356666666 99999999999999999999875
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=2.6e-19 Score=180.62 Aligned_cols=308 Identities=17% Similarity=0.183 Sum_probs=201.8
Q ss_pred CEEEEEecCCCCceecCcccCCCCCCCCEEECCCCcccc----cCCccCcCCCCCCEEEccCCcCcCC----CCcccC-C
Q 010736 71 RVINISLRGVGLKGKLHAFSFSSFPHLAYLDLRDNKLFG----TIPPQISNLTNLSILSLGGNQFSGN----IPHEVG-L 141 (502)
Q Consensus 71 ~v~~L~L~~~~l~g~l~~~~~~~l~~L~~L~Ls~N~l~g----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~-~ 141 (502)
+++.||++++++++.--..-+..++++++|+|++|+++. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 478899999999864212225667889999999998873 3456678899999999999988631 222232 2
Q ss_pred CCCCcEEEccCCcCccc----CCcccCCCCCCcEEEcccCcccccCCcC-------------------------------
Q 010736 142 MSHLKILYIDSNQLDGS----IPLEVGQLSSMVELALFSNNLNGSVPHS------------------------------- 186 (502)
Q Consensus 142 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~------------------------------- 186 (502)
..+|++|+|++|+++.. ++..+..+++|++|++++|.++......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 34799999999998753 4556778899999999998865311000
Q ss_pred --CCCCCCCCeEEccccccccc---------------------------------CCccCcCCccCCccccccccccC--
Q 010736 187 --LGNLTQISMLFLHDNSFSGF---------------------------------IPPDIGNLKSISILSLAINQFSG-- 229 (502)
Q Consensus 187 --~~~l~~L~~L~L~~N~l~~~---------------------------------~p~~~~~l~~L~~L~ls~N~l~~-- 229 (502)
+.....++.++++++..... ....+...+.++.++++.|++..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 01123455566555443210 00011233556777777776532
Q ss_pred ---cccccccCCCCCcEEEeeCccccccCCCC----Cc-cccccEEECcCCcCcccCCccc-----cCCCCCcEEEccCC
Q 010736 230 ---PIPLSLGNLTNLKQFSLVYNNLYGSIPPS----LD-NLVLTKLSLDDNHFTSYLPQNI-----CRGGALQIFTVSEN 296 (502)
Q Consensus 230 ---~~p~~~~~l~~L~~L~l~~N~l~~~~p~~----~~-~~~L~~L~ls~N~l~~~~~~~~-----~~~~~L~~L~ls~n 296 (502)
..+........++.+++++|.+....... +. ...++.+++++|.++......+ .....|+.++++++
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 12333455678999999999876432111 11 2568899999999865322211 23457999999999
Q ss_pred ccccccCc----ccccCCCCcEEeCCCCccccc----cCcccC-CCCCCcEEEccCcccccc----cCccccCCCCCCee
Q 010736 297 RFQGTIPK----SLRNCTSLIRVRLDGNNLTGN----ISKAFG-IYPNLTFIDLSRNNFYGE----ISSNFGECPKLGAL 363 (502)
Q Consensus 297 ~l~~~~~~----~l~~l~~L~~L~l~~N~l~~~----~~~~~~-~l~~L~~L~Ls~N~l~~~----~~~~~~~~~~L~~L 363 (502)
.++..... .+....+|++|+|++|++++. +.+.+. ..+.|++|+|++|+|+.. +...+..+++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 88754322 345667899999999998753 223333 457799999999999753 34456678999999
Q ss_pred eecCCccccccCcccc
Q 010736 364 NISRNNITGDFGIAKF 379 (502)
Q Consensus 364 ~l~~N~l~~dfGl~~l 379 (502)
|+++|+|. |.|...+
T Consensus 403 ~Ls~N~i~-~~g~~~l 417 (460)
T d1z7xw1 403 DLSNNCLG-DAGILQL 417 (460)
T ss_dssp ECCSSSCC-HHHHHHH
T ss_pred ECCCCcCC-HHHHHHH
Confidence 99999874 5454433
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=8.3e-18 Score=158.18 Aligned_cols=116 Identities=28% Similarity=0.425 Sum_probs=80.3
Q ss_pred cccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 370 ITGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
..+|||+++.+...... .....||+.|+|||......++.++|||||||+++||+| |+.|+...... ..
T Consensus 147 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~---- 219 (277)
T d1xbba_ 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV---- 219 (277)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----
T ss_pred cccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HH----
Confidence 47899999987543321 224578999999999999999999999999999999998 89997532110 00
Q ss_pred ccccccC-CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 446 ALDEMLD-PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 446 ~~~~~~d-~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
...+.. .++..+ ....+++.++++ .||+.+|++||+|+||+++|+..
T Consensus 220 -~~~i~~~~~~~~p-~~~~~~~~~li~---~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 220 -TAMLEKGERMGCP-AGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -HHHHHTTCCCCCC-TTCCHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHHHcCCCCCCC-cccCHHHHHHHH---HHcCCCHhHCcCHHHHHHHhhCH
Confidence 001111 111111 122355666665 99999999999999999998763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.2e-17 Score=159.12 Aligned_cols=131 Identities=19% Similarity=0.260 Sum_probs=85.1
Q ss_pred CCccccccCcccccCCCCC----CcccccccccccCccccccc------eecccceeeeeceeeeehhcCCCCCCcccCC
Q 010736 367 RNNITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTM------KITEKCDVYSFGVLVLEVIKGKHPRDFLSST 436 (502)
Q Consensus 367 ~N~l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~------~~s~k~Dvysfgv~llElltg~~p~~~~~~~ 436 (502)
++..++|||+++....... ......||.+|+|||+.... .++.|+|||||||++|||+||+.|+......
T Consensus 145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence 3445799999998754322 22346799999999998653 4788999999999999999999886532221
Q ss_pred CCCC--CCc-c--------cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 437 SSPS--LNT-D--------IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 437 ~~~~--~~~-~--------~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.... ... . ....+..+|.++... ...+....+.+++..||+.+|++||+|.||+++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhhcccccchHHHHHHHHhccccCCCCCccc-CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1110 000 0 001122333333211 11234445666677999999999999999999998863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=2e-17 Score=153.82 Aligned_cols=115 Identities=29% Similarity=0.499 Sum_probs=81.9
Q ss_pred ccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
++|||+++.+..... ..+...||..|+|||......++.|+|||||||+++||+| |+.|++..... .. ..
T Consensus 141 l~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~-----~~ 212 (258)
T d1k2pa_ 141 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ET-----AE 212 (258)
T ss_dssp ECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH-----HH
T ss_pred ECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HH-----HH
Confidence 799999998754332 3335678999999999999999999999999999999998 79997532111 00 01
Q ss_pred cccCC-CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 449 EMLDP-RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 449 ~~~d~-~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.+... ++..+ ....+++.++++ .||+.+|++||||.|+++.|.++
T Consensus 213 ~i~~~~~~~~p-~~~~~~l~~li~---~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 213 HIAQGLRLYRP-HLASEKVYTIMY---SCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHTTCCCCCC-TTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHhCCCCCCc-ccccHHHHHHHH---HHccCCHhHCcCHHHHHHHhhCC
Confidence 11111 11111 122355666666 99999999999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=1.1e-17 Score=157.04 Aligned_cols=116 Identities=26% Similarity=0.451 Sum_probs=79.7
Q ss_pred ccccCcccccCCCCCC---cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccc
Q 010736 371 TGDFGIAKFLKPDSSN---WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~---~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~ 446 (502)
.+|||+++.+...... .....|+..|+|||.......+.++|||||||+++||+| |+.|+....... .
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--------~ 223 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------I 223 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------H
T ss_pred eccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--------H
Confidence 6999999987553321 223567889999999999999999999999999999998 899975211100 0
Q ss_pred cccccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 447 LDEMLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 447 ~~~~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
...+... +.+.+ .....++.++++ .||+.+|++||||.||++.|++++
T Consensus 224 ~~~i~~~~~~~~~~-~~~~~~l~~li~---~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 224 LHKIDKEGERLPRP-EDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp HHHHHTSCCCCCCC-TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCCc-ccccHHHHHHHH---HHcCCChhHCcCHHHHHHHHHhcC
Confidence 0111000 11111 122345666666 999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=6.9e-18 Score=157.94 Aligned_cols=112 Identities=26% Similarity=0.393 Sum_probs=74.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
.++|||+++.+...........||++|+|||...+..++.++|||||||+++||+||+.|++..... . ....
T Consensus 154 kl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~-----~~~~ 225 (269)
T d2java1 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---E-----LAGK 225 (269)
T ss_dssp EECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---H-----HHHH
T ss_pred EEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---H-----HHHH
Confidence 3799999998866544445678999999999999989999999999999999999999998532110 0 0111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+........+....+++..+++ .|++.+|++||++.|+++
T Consensus 226 i~~~~~~~~~~~~s~~l~~li~---~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 226 IREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCCCCCcccCHHHHHHHH---HHcCCChhHCcCHHHHHh
Confidence 1111111111122356777776 999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=3.9e-17 Score=152.03 Aligned_cols=116 Identities=22% Similarity=0.337 Sum_probs=75.4
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
...+|||+++...... ....++..|+|||+..+..++.++|||||||+++||+| |+.|++..... .+.. .+
T Consensus 142 ~kl~dfg~s~~~~~~~---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~--~i 213 (262)
T d1byga_ 142 AKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP--RV 213 (262)
T ss_dssp EEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH--HH
T ss_pred EeecccccceecCCCC---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHH--HH
Confidence 3479999998765432 23567889999999999999999999999999999999 67775432111 1100 11
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
..-..+.++. ....++.++++ .||+.+|++||+|+||+++|+.++
T Consensus 214 ~~~~~~~~~~---~~~~~~~~li~---~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 214 EKGYKMDAPD---GCPPAVYEVMK---NCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TTTCCCCCCT---TCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCc---cCCHHHHHHHH---HHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111222221 12356666666 999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.61 E-value=3.5e-17 Score=154.67 Aligned_cols=119 Identities=23% Similarity=0.334 Sum_probs=82.0
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.++|||+++....+.. ..+...|+..|+|||...+..++.|+|||||||+++||+||+.|...... ..... . .+.
T Consensus 155 Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~-~-~i~ 230 (287)
T d1opja_ 155 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY-E-LLE 230 (287)
T ss_dssp EECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH-H-HHH
T ss_pred EEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHH-H-HHh
Confidence 3799999998865433 23345688999999999999999999999999999999998777531110 00000 0 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhc
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISA 498 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~ 498 (502)
.-..+..+ ....+++.++++ .|++.+|++||+|+||++.|+.+.
T Consensus 231 ~~~~~~~~---~~~~~~l~~li~---~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 231 KDYRMERP---EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp TTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCCCCCC---ccchHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHH
Confidence 10111111 122355666665 999999999999999999998763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.4e-17 Score=160.52 Aligned_cols=117 Identities=24% Similarity=0.338 Sum_probs=81.9
Q ss_pred ccccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~ 445 (502)
-.++|||+++........ .....||+.|+|||...+..++.++|||||||+++||+| |+.|+...... .....
T Consensus 203 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~---~~~~~- 278 (325)
T d1rjba_ 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD---ANFYK- 278 (325)
T ss_dssp EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---HHHHH-
T ss_pred EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH---HHHHH-
Confidence 347999999987654332 234568999999999999999999999999999999998 89997532111 00000
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHH
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLR 495 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~ 495 (502)
.+..-..+..+ ....+++.++++ .|++.+|++||||+||++.|.
T Consensus 279 ~~~~~~~~~~p---~~~~~~l~~li~---~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 279 LIQNGFKMDQP---FYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHTTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcCCCCCCC---CcCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHh
Confidence 00111111111 122356666666 999999999999999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=4.1e-17 Score=155.42 Aligned_cols=129 Identities=25% Similarity=0.300 Sum_probs=80.7
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhcCC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGK 427 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~ 427 (502)
++.|.||+..|| ++|||+++....... ..+...||..|+|||...+..++.++|||||||+++||+||+
T Consensus 154 ~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 154 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCC
Confidence 445555554443 799999998754332 234567999999999999999999999999999999999975
Q ss_pred -CCCCcccCCCCCCCCcccccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 428 -HPRDFLSSTSSPSLNTDIALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 428 -~p~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.|+...... .... ..+.+-..+..+. ...+++.+++. .|++.+|++||||+||+++|+.+
T Consensus 234 ~~p~~~~~~~---~~~~-~~~~~~~~~~~~~---~~~~~l~~li~---~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 234 ASPYPGVKID---EEFC-RRLKEGTRMRAPD---YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCSSTTCCCS---HHHH-HHHHHTCCCCCCT---TCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHH---HHHH-HHHhcCCCCCCCc---cCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHH
Confidence 455321110 0000 0011111122221 12245555555 99999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=3.7e-17 Score=156.93 Aligned_cols=116 Identities=27% Similarity=0.429 Sum_probs=79.0
Q ss_pred ccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
++|||+++.+...... .....||..|+|||...+..++.++|||||||+++||+| |+.|++...... +.. .+
T Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~--~i 226 (317)
T d1xkka_ 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS--IL 226 (317)
T ss_dssp ECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH--HH
T ss_pred eeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH--HH
Confidence 7999999988653332 234568999999999999999999999999999999999 788875322110 000 00
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.. ..+++.+ ....+++..+++ .||+.+|++||+|+||++.|+.+
T Consensus 227 ~~--~~~~~~p-~~~~~~~~~li~---~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 227 EK--GERLPQP-PICTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HH--TCCCCCC-TTBCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hc--CCCCCCC-cccCHHHHHHHH---HhCCCChhhCcCHHHHHHHHHHH
Confidence 00 1111111 122345555555 99999999999999999988765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=4.3e-17 Score=153.08 Aligned_cols=116 Identities=22% Similarity=0.387 Sum_probs=71.5
Q ss_pred ccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCcccccc
Q 010736 371 TGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.+|||+++.+..... ..+...||+.|+|||......++.++|||||||+++||+| |+.|++...... ... .+.
T Consensus 149 l~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~--~i~ 223 (273)
T d1mp8a_ 149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG--RIE 223 (273)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH--HHH
T ss_pred EccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH--HHH
Confidence 799999998754322 2345678899999999999999999999999999999998 888875322111 000 000
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
+-..+.++ ....+++.++++ .|++.+|++||+|.||++.|+.+
T Consensus 224 ~~~~~~~~---~~~~~~~~~li~---~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 224 NGERLPMP---PNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp TTCCCCCC---TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCC---CCCCHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHH
Confidence 10111111 122356677766 99999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=4.7e-17 Score=153.35 Aligned_cols=118 Identities=25% Similarity=0.336 Sum_probs=74.9
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.++|||+++.+..... ..+...||..|+|||+.....++.++|||||||+++||+||+.|....... ..... .+.
T Consensus 153 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~--~i~ 228 (285)
T d1fmka3 153 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLD--QVE 228 (285)
T ss_dssp EECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH--HHH
T ss_pred EEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHH--HHH
Confidence 4799999998754332 233467899999999999999999999999999999999987664321100 00000 001
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
....+..+ ....+++.+++. .|++.+|++||+|+||+++|+..
T Consensus 229 ~~~~~~~~---~~~~~~l~~li~---~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 229 RGYRMPCP---PECPESLHDLMC---QCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp TTCCCCCC---TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTT
T ss_pred hcCCCCCC---cccCHHHHHHHH---HHcccCHhHCcCHHHHHHHHhhh
Confidence 11111121 122345555555 99999999999999999999875
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=7.9e-18 Score=169.60 Aligned_cols=280 Identities=16% Similarity=0.168 Sum_probs=186.9
Q ss_pred CCCEEECCCCccccc-CCccCcCCCCCCEEEccCCcCcC----CCCcccCCCCCCcEEEccCCcCccc----CCcccC-C
Q 010736 96 HLAYLDLRDNKLFGT-IPPQISNLTNLSILSLGGNQFSG----NIPHEVGLMSHLKILYIDSNQLDGS----IPLEVG-Q 165 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~-~p~~l~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~-~ 165 (502)
+|++||+++|++++. +..-+..++++++|+|++|+++. .+...+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 588999999999864 23446678999999999999873 3445577899999999999998632 222332 2
Q ss_pred CCCCcEEEcccCccccc----CCcCCCCCCCCCeEEcccccccccCCcc-------------------------------
Q 010736 166 LSSMVELALFSNNLNGS----VPHSLGNLTQISMLFLHDNSFSGFIPPD------------------------------- 210 (502)
Q Consensus 166 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~------------------------------- 210 (502)
..+|++|++++|+++.. ++..+..+++|++|++++|.++......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35899999999999753 4556788899999999999875320000
Q ss_pred --CcCCccCCcccccccccc-----------------------------Cc----ccccccCCCCCcEEEeeCccccccC
Q 010736 211 --IGNLKSISILSLAINQFS-----------------------------GP----IPLSLGNLTNLKQFSLVYNNLYGSI 255 (502)
Q Consensus 211 --~~~l~~L~~L~ls~N~l~-----------------------------~~----~p~~~~~l~~L~~L~l~~N~l~~~~ 255 (502)
+.....++.++++.+... .. ....+...+.++.+++.+|.+....
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 001123333444332211 00 0011234567889999988764221
Q ss_pred -----CCCCc-cccccEEECcCCcCcccC----CccccCCCCCcEEEccCCccccccCccc-----ccCCCCcEEeCCCC
Q 010736 256 -----PPSLD-NLVLTKLSLDDNHFTSYL----PQNICRGGALQIFTVSENRFQGTIPKSL-----RNCTSLIRVRLDGN 320 (502)
Q Consensus 256 -----p~~~~-~~~L~~L~ls~N~l~~~~----~~~~~~~~~L~~L~ls~n~l~~~~~~~l-----~~l~~L~~L~l~~N 320 (502)
+.... ...++.+++++|.+.... ...+...+.++.+++++|.++......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 11111 257899999999887542 2234567889999999999874322222 23467999999999
Q ss_pred ccccccCc----ccCCCCCCcEEEccCcccccc----cCcccc-CCCCCCeeeecCCccccccCc
Q 010736 321 NLTGNISK----AFGIYPNLTFIDLSRNNFYGE----ISSNFG-ECPKLGALNISRNNITGDFGI 376 (502)
Q Consensus 321 ~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~----~~~~~~-~~~~L~~L~l~~N~l~~dfGl 376 (502)
.++..... .+...++|++|+|++|++... +...+. ..+.|++|++++|+|+ |.|+
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~-~~~~ 386 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS-DSSC 386 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC-HHHH
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC-hHHH
Confidence 98765333 234567899999999998753 223332 4678999999999874 4443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=6.4e-17 Score=154.56 Aligned_cols=120 Identities=21% Similarity=0.287 Sum_probs=83.0
Q ss_pred ccccccCcccccCCCCCCc--ccccccccccCccccccceecccceeeeeceeeeehhcCC-CCCCcccCCCCCCCCccc
Q 010736 369 NITGDFGIAKFLKPDSSNW--TGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGK-HPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~--~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~-~p~~~~~~~~~~~~~~~~ 445 (502)
-.+||||+++.+....... +...||+.|+|||...+...+.++||||||++++||+||+ .|+.... ...
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------~~~ 243 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------NEQ 243 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------HHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--------HHH
Confidence 3479999999875433322 2346889999999999999999999999999999999985 5543211 011
Q ss_pred ccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhhcC
Q 010736 446 ALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRISAP 499 (502)
Q Consensus 446 ~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~~~ 499 (502)
....+.+...+.......+++.+++. .||+.+|++||+|.||+++|+....
T Consensus 244 ~~~~i~~~~~~~~p~~~~~~l~~li~---~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 VLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHhCCCCCCcccchHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11222232222111122345555555 9999999999999999999998643
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=2.7e-15 Score=122.47 Aligned_cols=103 Identities=24% Similarity=0.368 Sum_probs=73.2
Q ss_pred CEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 010736 98 AYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177 (502)
Q Consensus 98 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 177 (502)
|+|+|++|+++ .++ .+.++++|++|++++|+|+ .+|..++.+++|+.|++++|+|+. +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 46788888887 334 3777788888888888887 566677778888888888888774 33 4777777777777777
Q ss_pred cccccC-CcCCCCCCCCCeEEcccccccc
Q 010736 178 NLNGSV-PHSLGNLTQISMLFLHDNSFSG 205 (502)
Q Consensus 178 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~~ 205 (502)
+++... ...+..+++|++|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 776432 2346667777777777777663
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.1e-15 Score=131.28 Aligned_cols=112 Identities=21% Similarity=0.234 Sum_probs=74.1
Q ss_pred CCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCc
Q 010736 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 170 (502)
|.+..++++|+|++|+|+. +|..+..+++|++|+|++|+|+. ++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 5566677777777777774 45555667777777777777773 33 467777777777777777754444455677777
Q ss_pred EEEcccCcccccCC-cCCCCCCCCCeEEcccccccc
Q 010736 171 ELALFSNNLNGSVP-HSLGNLTQISMLFLHDNSFSG 205 (502)
Q Consensus 171 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ 205 (502)
.|++++|+++.... ..+..+++|++|++++|.++.
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCcccc
Confidence 77777777763211 245566666667766666653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.4e-16 Score=152.29 Aligned_cols=115 Identities=22% Similarity=0.279 Sum_probs=78.6
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCC-CCCcccCCCCCCCCccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKH-PRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~-p~~~~~~~~~~~~~~~~~~~~ 449 (502)
++|||+++....... .....||..|+|||......++.++|||||||+++||+||.. |+..... ..+.. .+.+
T Consensus 168 l~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~--~i~~ 241 (309)
T d1fvra_ 168 IADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE--KLPQ 241 (309)
T ss_dssp ECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH--HGGG
T ss_pred Ecccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHH--HHHh
Confidence 799999987653222 224568999999999999999999999999999999999765 5432110 00000 0111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
-..+..+ ....+++.++++ .|++.+|++||+|+||++.|+.+
T Consensus 242 ~~~~~~~---~~~~~~~~~li~---~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 242 GYRLEKP---LNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp TCCCCCC---TTBCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCC---ccCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHH
Confidence 1112221 123356777777 99999999999999999998775
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1.7e-15 Score=129.94 Aligned_cols=130 Identities=15% Similarity=0.174 Sum_probs=103.4
Q ss_pred cCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCC
Q 010736 114 QISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQI 193 (502)
Q Consensus 114 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 193 (502)
.+.++.+|++|+|++|+|+ .+|..+..+++|++|+|++|+|+. + +.|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 4678889999999999998 557667889999999999999984 3 358889999999999999986555556678999
Q ss_pred CeEEcccccccccCC-ccCcCCccCCccccccccccCcc---cccccCCCCCcEEEe
Q 010736 194 SMLFLHDNSFSGFIP-PDIGNLKSISILSLAINQFSGPI---PLSLGNLTNLKQFSL 246 (502)
Q Consensus 194 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~---p~~~~~l~~L~~L~l 246 (502)
++|++++|+++.... ..+..+++|++|++++|.++... +..+..+++|+.||-
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 999999999875422 45778888999999998886432 224667788888763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3.2e-16 Score=149.05 Aligned_cols=116 Identities=28% Similarity=0.395 Sum_probs=81.1
Q ss_pred ccccCcccccCCCCC--CcccccccccccCccccccceecccceeeeeceeeeehhc-CCCCCCcccCCCCCCCCccccc
Q 010736 371 TGDFGIAKFLKPDSS--NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIK-GKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~--~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llEllt-g~~p~~~~~~~~~~~~~~~~~~ 447 (502)
++|||+++....... ......|+..|+|||...+..++.|+|||||||+++||+| |+.|+...... .... .+
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~~~--~i 250 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELFK--LL 250 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH--HH
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HHHH--HH
Confidence 689999998754322 2234678899999999999999999999999999999999 67776421110 0000 01
Q ss_pred ccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 448 DEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 448 ~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
.+-..+..+ ....+++.+++. .|++.+|++||||.||+++|+.+
T Consensus 251 ~~~~~~~~p---~~~~~~l~~li~---~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 251 KEGHRMDKP---SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HTTCCCCCC---SSCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCCC---ccchHHHHHHHH---HHccCCHhHCcCHHHHHHHHHHH
Confidence 111111111 122345666666 99999999999999999999876
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=8e-15 Score=119.65 Aligned_cols=103 Identities=18% Similarity=0.273 Sum_probs=84.4
Q ss_pred CEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCCCCCCCeEEcccc
Q 010736 122 SILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGNLTQISMLFLHDN 201 (502)
Q Consensus 122 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 201 (502)
|+|+|++|+++ .++ .+..+++|++|++++|+++ .+|..++.+++|+.|++++|++++ +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 67999999998 555 4888999999999999998 567788899999999999999984 44 4888899999999999
Q ss_pred cccccC-CccCcCCccCCccccccccccC
Q 010736 202 SFSGFI-PPDIGNLKSISILSLAINQFSG 229 (502)
Q Consensus 202 ~l~~~~-p~~~~~l~~L~~L~ls~N~l~~ 229 (502)
+++... ...+..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 888543 2456777888888888887763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.7e-16 Score=146.32 Aligned_cols=109 Identities=27% Similarity=0.403 Sum_probs=78.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++...... .....||+.|+|||...+..++.++|||||||+++||+||+.|++..... .....
T Consensus 146 kl~DFG~a~~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~ 215 (263)
T d2j4za1 146 KIADFGWSVHAPSSR--RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKR 215 (263)
T ss_dssp EECCCCSCSCCCCCC--CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred eecccceeeecCCCc--ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--------HHHHH
Confidence 369999998775432 34567999999999999988999999999999999999999998521100 00111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+......-+ ....+++..++. .|++.+|++|||++||++
T Consensus 216 i~~~~~~~p-~~~s~~~~~li~---~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 216 ISRVEFTFP-DFVTEGARDLIS---RLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHTTCCCCC-TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCCCC-ccCCHHHHHHHH---HHccCCHhHCcCHHHHHc
Confidence 111111111 112356677777 999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=3.6e-16 Score=149.55 Aligned_cols=119 Identities=23% Similarity=0.325 Sum_probs=80.9
Q ss_pred CccccccCcccccCCCCCC--cccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccc
Q 010736 368 NNITGDFGIAKFLKPDSSN--WTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDI 445 (502)
Q Consensus 368 N~l~~dfGl~~ll~~~~~~--~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~ 445 (502)
+..++|||+++........ .+...||+.|+|||.......+.++|||||||+++||+|++.|....... ..
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-------~~ 255 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-------DS 255 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-------SH
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-------HH
Confidence 3447999999987653322 23467899999999999999999999999999999999965553211110 00
Q ss_pred ccccccCCCCC-CCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHh
Q 010736 446 ALDEMLDPRLP-VPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRI 496 (502)
Q Consensus 446 ~~~~~~d~~l~-~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~ 496 (502)
.+.++++...+ ..+....+++..++. .||+.+|++||+|.||+++|++
T Consensus 256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~---~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 256 KFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCcccccHHHHHHHH---HHcCCChhHCcCHHHHHHHHHH
Confidence 11111111110 001122355666665 9999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=3.7e-16 Score=146.02 Aligned_cols=113 Identities=23% Similarity=0.419 Sum_probs=76.6
Q ss_pred cccccCcccccCCCC--CCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+.... ...+...||+.|+|||...+... +.++||||+||+++||+||+.|++...... . .
T Consensus 143 KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~-----~ 215 (271)
T d1nvra_ 143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--Q-----E 215 (271)
T ss_dssp EECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--H-----H
T ss_pred EEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--H-----H
Confidence 379999999875332 22345789999999999887765 678999999999999999999985322110 0 0
Q ss_pred cccccCCC-CCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPR-LPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~-l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
........ ...+.....+++.++++ .|++.+|++|||++||++
T Consensus 216 ~~~~~~~~~~~~~~~~~s~~~~~li~---~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 216 YSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred HHHHhcCCCCCCccccCCHHHHHHHH---HHcCCChhHCcCHHHHhc
Confidence 00011110 00011122355666766 999999999999999854
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=4e-16 Score=145.79 Aligned_cols=110 Identities=22% Similarity=0.387 Sum_probs=74.1
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.+|||+++..... ......||+.|+|||.... +++.++|||||||+++||+||+.|+...... ...... .....
T Consensus 156 l~DFGla~~~~~~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~-i~~~~ 229 (270)
T d1t4ha_ 156 IGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRR-VTSGV 229 (270)
T ss_dssp ECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHH-HTTTC
T ss_pred EeecCcceeccCC--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHH-HHcCC
Confidence 6999999976543 2345789999999998865 6999999999999999999999998521110 000000 00000
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+... ....+++.++++ .|++.+|++|||++|+++
T Consensus 230 ~~~~~~---~~~~~~~~~li~---~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 230 KPASFD---KVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCGGGG---GCCCHHHHHHHH---HHSCSSGGGSCCHHHHHT
T ss_pred CCcccC---ccCCHHHHHHHH---HHccCCHhHCcCHHHHhC
Confidence 111111 011245666666 999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=2.5e-16 Score=148.82 Aligned_cols=114 Identities=24% Similarity=0.367 Sum_probs=80.3
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.+...........||+.|+|||...+..++.++||||+||+++||+||+.|+...... .... .+..
T Consensus 156 kl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~--~~~~ 230 (293)
T d1yhwa1 156 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALY--LIAT 230 (293)
T ss_dssp EECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH--HHHH
T ss_pred eeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---HHHH--HHHh
Confidence 3799999998866554555678999999999999989999999999999999999999997421100 0000 0000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
-..+.+..+ ....+++..+++ .|++.+|++||++.|+++
T Consensus 231 ~~~~~~~~~-~~~s~~~~~li~---~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 231 NGTPELQNP-EKLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HCSCCCSSG-GGSCHHHHHHHH---HHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCc-ccCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 011111111 112356667777 999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=7e-16 Score=146.99 Aligned_cols=109 Identities=28% Similarity=0.478 Sum_probs=74.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc---ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT---MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~---~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
.++|||+++..... ....||+.|+|||...+ ..++.++|||||||+++||+||+.|+...... .... .
T Consensus 155 Kl~DFG~a~~~~~~----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~~--~ 225 (309)
T d1u5ra_ 155 KLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALY--H 225 (309)
T ss_dssp EECCCTTCBSSSSB----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH--H
T ss_pred EEeecccccccCCC----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHHH--H
Confidence 37999999876542 23579999999999753 45889999999999999999999997421100 0000 0
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+..-..+.+... ...+++..+++ .|++.+|++|||+.|+++
T Consensus 226 i~~~~~~~~~~~--~~s~~~~~li~---~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 226 IAQNESPALQSG--HWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHSCCCCCSCT--TSCHHHHHHHH---HHTCSSGGGSCCHHHHTT
T ss_pred HHhCCCCCCCCC--CCCHHHHHHHH---HHCcCChhHCcCHHHHHh
Confidence 001111222111 12356777777 999999999999999865
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=3.6e-15 Score=140.58 Aligned_cols=60 Identities=12% Similarity=0.119 Sum_probs=34.8
Q ss_pred CCCCcEEEccCC-ccccccCcccccCCCCcEEeCCC-CccccccCcccCCCCCCcEEEccCc
Q 010736 285 GGALQIFTVSEN-RFQGTIPKSLRNCTSLIRVRLDG-NNLTGNISKAFGIYPNLTFIDLSRN 344 (502)
Q Consensus 285 ~~~L~~L~ls~n-~l~~~~~~~l~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~Ls~N 344 (502)
+++|+.|+++++ .+++.....+..+++|++|++++ +.+++.....++.+|+|+.|+++++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 455666666553 34544455556666666666666 3455444445556667777776655
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=2.2e-15 Score=143.35 Aligned_cols=112 Identities=25% Similarity=0.356 Sum_probs=65.5
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.+|||+++....... .....||+.|+|||...+..++.++||||+||+++||+||+.|+....... ........+.
T Consensus 151 l~DFG~a~~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~~~~ 226 (307)
T d1a06a_ 151 ISDFGLSKMEDPGSV-LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQILKAEY 226 (307)
T ss_dssp ECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHTTCC
T ss_pred EeccceeEEccCCCe-eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHhccCC
Confidence 689999998754332 234679999999999999899999999999999999999999985211100 0000000000
Q ss_pred -cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 451 -LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 451 -~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.++... ....+++..+++ .|++.+|++|||++|+++
T Consensus 227 ~~~~~~~---~~~s~~~~~li~---~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 EFDSPYW---DDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCTTTT---TTSCHHHHHHHH---HHSCSSGGGSCCHHHHHH
T ss_pred CCCCccc---cCCCHHHHHHHH---HHccCCHhHCcCHHHHhc
Confidence 111111 112355667777 999999999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=3.5e-16 Score=147.64 Aligned_cols=114 Identities=22% Similarity=0.347 Sum_probs=75.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccc-----cceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAY-----TMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTD 444 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~-----~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~ 444 (502)
..+|||+++.............||+.|+|||... ...++.++|||||||+++||+||+.|+...... ....
T Consensus 150 Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~- 225 (288)
T d2jfla1 150 KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLL- 225 (288)
T ss_dssp EECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHH-
T ss_pred EEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHH-
Confidence 4799999987643222223467999999999873 445789999999999999999999997532111 0000
Q ss_pred cccccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 445 IALDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 445 ~~~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+...-.+.+..+ ....+++..+++ .|++.+|++|||++|+++
T Consensus 226 -~i~~~~~~~~~~~-~~~s~~~~~li~---~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 226 -KIAKSEPPTLAQP-SRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -HHHHSCCCCCSSG-GGSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred -HHHcCCCCCCCcc-ccCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 0000011122111 122356777777 999999999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=6.4e-15 Score=141.92 Aligned_cols=115 Identities=28% Similarity=0.392 Sum_probs=78.0
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCC-CCCCccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSS-PSLNTDIALDE 449 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~-~~~~~~~~~~~ 449 (502)
.+|||+++....... .....||+.|+|||...+..++.++||||+||+++||+||+.|+........ ..+.......
T Consensus 155 l~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~- 232 (335)
T d2ozaa1 155 LTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG- 232 (335)
T ss_dssp ECCCTTCEECCCCCC-CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC-
T ss_pred ccccceeeeccCCCc-cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC-
Confidence 689999998765433 3456799999999999999999999999999999999999999853221111 0010000000
Q ss_pred ccCCCCCCCC-cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLDPRLPVPS-CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~-~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+.+. ....+++..+++ .|++.+|++||++.|+++
T Consensus 233 --~~~~~~~~~~~~s~~~~~li~---~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 --QYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --SSSCCTTHHHHSCHHHHHHHH---HHSCSSTTTSCCHHHHHH
T ss_pred --CCCCCCcccccCCHHHHHHHH---HHccCChhHCcCHHHHHc
Confidence 11111110 011245666666 999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.7e-15 Score=144.10 Aligned_cols=121 Identities=17% Similarity=0.224 Sum_probs=81.1
Q ss_pred ccccCcccccCCCCC-------CcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 371 TGDFGIAKFLKPDSS-------NWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~-------~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
.+|||+++.+..... ......||+.|+|||...+..++.++|||||||+++||+||+.|+.............
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~ 226 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH
T ss_pred eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH
Confidence 489999998754321 1234679999999999999999999999999999999999999986432221111100
Q ss_pred ccccccccC--CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 444 DIALDEMLD--PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 444 ~~~~~~~~d--~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
......... +.+. ....+++.++++ .|++.+|++||++.++.+.|+..
T Consensus 227 ~~~~~~~~~~~~~~~---~~~p~~~~~li~---~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 227 RISEKKMSTPIEVLC---KGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHHHHHSCHHHHT---TTSCHHHHHHHH---HHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HhhcccCCCChhHhc---cCCCHHHHHHHH---HHccCChhHCcCHHHHHHHHHHH
Confidence 000000000 0111 012256667776 99999999999999998888764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=2.3e-15 Score=144.51 Aligned_cols=59 Identities=27% Similarity=0.479 Sum_probs=50.2
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
++|||+++.+.... .+...||..|+|||...+..++.++||||+||+++||+||+.|+.
T Consensus 146 l~DFGla~~~~~~~--~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 146 LCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp ECCCCCCHHHHHHT--C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred EeeCCCccccCCCc--cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 79999999764322 234689999999999999999999999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=1.9e-15 Score=142.45 Aligned_cols=108 Identities=22% Similarity=0.370 Sum_probs=74.8
Q ss_pred cccccCcccccCCCC--CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccc
Q 010736 370 ITGDFGIAKFLKPDS--SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIAL 447 (502)
Q Consensus 370 l~~dfGl~~ll~~~~--~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~ 447 (502)
..+|||+++.+.... ...+...||+.|+|||...+..++.++||||+||+++||+||+.|+...... . ..
T Consensus 148 kl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~-----~~ 219 (288)
T d1uu3a_ 148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---L-----IF 219 (288)
T ss_dssp EECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H-----HH
T ss_pred EecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---H-----HH
Confidence 368999999885432 2234567999999999999999999999999999999999999998521100 0 00
Q ss_pred ccccC--CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHH
Q 010736 448 DEMLD--PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVS 491 (502)
Q Consensus 448 ~~~~d--~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~ 491 (502)
..+.. +.++. ...+++..+++ .|++.+|++|||++|+.
T Consensus 220 ~~i~~~~~~~p~---~~s~~~~~li~---~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 220 QKIIKLEYDFPE---KFFPKARDLVE---KLLVLDATKRLGCEEME 259 (288)
T ss_dssp HHHHTTCCCCCT---TCCHHHHHHHH---TTSCSSGGGSTTSGGGT
T ss_pred HHHHcCCCCCCc---cCCHHHHHHHH---HHccCCHhHCcCHHHHc
Confidence 11111 12221 12356667777 99999999999999864
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=1e-14 Score=137.47 Aligned_cols=232 Identities=14% Similarity=0.147 Sum_probs=106.2
Q ss_pred CCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCC-CCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 010736 97 LAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGN-IPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALF 175 (502)
Q Consensus 97 L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 175 (502)
+..+.++...+..... ......+|++|||+++.++.. ++..+..+++|++|+++++.++...+..++.+++|++|+++
T Consensus 25 ~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 3444555444432222 223344566666666555432 22334555566666666665555555555555556666655
Q ss_pred cC-ccccc-CCcCCCCCCCCCeEEcccc-ccccc-CCccCcC-CccCCccccccc--cccCc-ccccccCCCCCcEEEee
Q 010736 176 SN-NLNGS-VPHSLGNLTQISMLFLHDN-SFSGF-IPPDIGN-LKSISILSLAIN--QFSGP-IPLSLGNLTNLKQFSLV 247 (502)
Q Consensus 176 ~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~-l~~L~~L~ls~N--~l~~~-~p~~~~~l~~L~~L~l~ 247 (502)
++ .++.. +...+..+++|++|+++++ .++.. +...+.. .+.|+.|+++++ .++.. +...+.++++
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~------- 176 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN------- 176 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTT-------
T ss_pred ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccc-------
Confidence 53 33211 1111223455555555553 22211 0011111 133444444432 11110 1111122334
Q ss_pred CccccccCCCCCccccccEEECcCC-cCcccCCccccCCCCCcEEEccC-CccccccCcccccCCCCcEEeCCCCccccc
Q 010736 248 YNNLYGSIPPSLDNLVLTKLSLDDN-HFTSYLPQNICRGGALQIFTVSE-NRFQGTIPKSLRNCTSLIRVRLDGNNLTGN 325 (502)
Q Consensus 248 ~N~l~~~~p~~~~~~~L~~L~ls~N-~l~~~~~~~~~~~~~L~~L~ls~-n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~ 325 (502)
|++|+++++ .+++.....+.++++|++|++++ +.+++.....+..+++|+.|+++++ ++..
T Consensus 177 ----------------L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~ 239 (284)
T d2astb2 177 ----------------LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG 239 (284)
T ss_dssp ----------------CSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT
T ss_pred ----------------ccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHH
Confidence 444444443 23433444556667777777777 3565555556677777888887765 3221
Q ss_pred -cCcccCCCCCCcEEEccCcccccccCccccC
Q 010736 326 -ISKAFGIYPNLTFIDLSRNNFYGEISSNFGE 356 (502)
Q Consensus 326 -~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 356 (502)
+......+|+|+ +..++++...+..++.
T Consensus 240 ~l~~l~~~lp~L~---i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 240 TLQLLKEALPHLQ---INCSHFTTIARPTIGN 268 (284)
T ss_dssp CHHHHHHHSTTSE---ESCCCSCCTTCSSCSS
T ss_pred HHHHHHHhCcccc---ccCccCCCCCCCccCc
Confidence 111112345554 4566666555544443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=5.9e-15 Score=143.15 Aligned_cols=253 Identities=15% Similarity=0.187 Sum_probs=153.5
Q ss_pred cCCccCcCCCCCCEEEccCCcCcCC----CCcccCCCCCCcEEEccCCcCcccC----------CcccCCCCCCcEEEcc
Q 010736 110 TIPPQISNLTNLSILSLGGNQFSGN----IPHEVGLMSHLKILYIDSNQLDGSI----------PLEVGQLSSMVELALF 175 (502)
Q Consensus 110 ~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~----------p~~~~~l~~L~~L~L~ 175 (502)
.+...+.+...|+.|+|++|.++.. +-..+...++|+.|+++++...... ...+...++|++|+++
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 3455677789999999999988632 2345677889999999887654221 1234556788888888
Q ss_pred cCccccc----CCcCCCCCCCCCeEEcccccccccCCccCcCCccCCccccccccccCcccccccCCCCCcEEEeeCccc
Q 010736 176 SNNLNGS----VPHSLGNLTQISMLFLHDNSFSGFIPPDIGNLKSISILSLAINQFSGPIPLSLGNLTNLKQFSLVYNNL 251 (502)
Q Consensus 176 ~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 251 (502)
+|.+... +...+...++|++|++++|.+...-...++. .+..+... ......+.|+.+++++|.+
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~~---------~~~~~~~~L~~l~l~~n~i 170 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAVN---------KKAKNAPPLRSIICGRNRL 170 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHHH---------HHHHTCCCCCEEECCSSCC
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccc--cccccccc---------cccccCcccceeecccccc
Confidence 8877643 2222345577888888877765221111100 00000000 0112334556666666655
Q ss_pred cccCCCCC----c-cccccEEECcCCcCccc-----CCccccCCCCCcEEEccCCccccc----cCcccccCCCCcEEeC
Q 010736 252 YGSIPPSL----D-NLVLTKLSLDDNHFTSY-----LPQNICRGGALQIFTVSENRFQGT----IPKSLRNCTSLIRVRL 317 (502)
Q Consensus 252 ~~~~p~~~----~-~~~L~~L~ls~N~l~~~-----~~~~~~~~~~L~~L~ls~n~l~~~----~~~~l~~l~~L~~L~l 317 (502)
+......+ . ...++.|++++|+++.. +...+...++|+.|++++|.++.. +...+..+++|++|++
T Consensus 171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~L 250 (344)
T d2ca6a1 171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250 (344)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhh
Confidence 42211111 1 13566677777666532 223456677888899998887632 3455678889999999
Q ss_pred CCCccccccCc----ccC--CCCCCcEEEccCccccccc----Cccc-cCCCCCCeeeecCCccccc
Q 010736 318 DGNNLTGNISK----AFG--IYPNLTFIDLSRNNFYGEI----SSNF-GECPKLGALNISRNNITGD 373 (502)
Q Consensus 318 ~~N~l~~~~~~----~~~--~l~~L~~L~Ls~N~l~~~~----~~~~-~~~~~L~~L~l~~N~l~~d 373 (502)
++|.+++.-.. .+. ..+.|+.|++++|++...- ...+ ...+.|++|++++|.+..+
T Consensus 251 s~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred hcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 99988754222 222 3467999999999886432 2223 2567899999999998643
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=4.3e-15 Score=144.12 Aligned_cols=238 Identities=13% Similarity=0.125 Sum_probs=130.7
Q ss_pred CCCCCCCCEEECCCCccccc----CCccCcCCCCCCEEEccCCcCcCC----------CCcccCCCCCCcEEEccCCcCc
Q 010736 91 FSSFPHLAYLDLRDNKLFGT----IPPQISNLTNLSILSLGGNQFSGN----------IPHEVGLMSHLKILYIDSNQLD 156 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~~~----------~p~~l~~l~~L~~L~Ls~N~l~ 156 (502)
+.....|+.|+|++|.+... +...+...++|+.|+++++.+... +...+...++|++|+|++|.++
T Consensus 27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 106 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 106 (344)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccc
Confidence 55567788888888877532 334566778888888887755321 1123456678888888888876
Q ss_pred cc----CCcccCCCCCCcEEEcccCcccccCCcC-------------CCCCCCCCeEEccccccccc----CCccCcCCc
Q 010736 157 GS----IPLEVGQLSSMVELALFSNNLNGSVPHS-------------LGNLTQISMLFLHDNSFSGF----IPPDIGNLK 215 (502)
Q Consensus 157 ~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~ 215 (502)
.. +...+...++|++|++++|.+....... ....+.|+.+.+++|+++.. +...+...+
T Consensus 107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~ 186 (344)
T d2ca6a1 107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186 (344)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred cccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhh
Confidence 53 2233445678888888888764211111 12345666777777665422 112233344
Q ss_pred cCCccccccccccCc-----ccccccCCCCCcEEEeeCccccccCCCCCccccccEEECcCCcCcccCCccccCCCCCcE
Q 010736 216 SISILSLAINQFSGP-----IPLSLGNLTNLKQFSLVYNNLYGSIPPSLDNLVLTKLSLDDNHFTSYLPQNICRGGALQI 290 (502)
Q Consensus 216 ~L~~L~ls~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~~~~~~~~~~L~~ 290 (502)
.|+.|++++|+++.. +...+..+++|+.|++++|.++..... .+...+...++|+.
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~-------------------~L~~~l~~~~~L~~ 247 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS-------------------ALAIALKSWPNLRE 247 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH-------------------HHHHHGGGCTTCCE
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccc-------------------cccccccccccchh
Confidence 555566655555421 122334444555555555544321000 01223444566666
Q ss_pred EEccCCccccccC----ccccc--CCCCcEEeCCCCcccccc----Cccc-CCCCCCcEEEccCcccc
Q 010736 291 FTVSENRFQGTIP----KSLRN--CTSLIRVRLDGNNLTGNI----SKAF-GIYPNLTFIDLSRNNFY 347 (502)
Q Consensus 291 L~ls~n~l~~~~~----~~l~~--l~~L~~L~l~~N~l~~~~----~~~~-~~l~~L~~L~Ls~N~l~ 347 (502)
|++++|.+++.-. ..+.. ...|+.|++++|+++..- ...+ ...++|++|+|++|++.
T Consensus 248 L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred hhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 6666666654311 12222 345777777777765432 1122 14567777888777775
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.7e-14 Score=137.39 Aligned_cols=119 Identities=19% Similarity=0.221 Sum_probs=76.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCC-------------
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSST------------- 436 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~------------- 436 (502)
.++|||+++...... ......||+.|+|||......++.++||||+||+++||+||+.|+......
T Consensus 156 kl~dfg~~~~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 156 KLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp EECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eecchhhhhhhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 378999988764322 234567999999999999999999999999999999999999998532100
Q ss_pred CCCCCCcccc-----cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 437 SSPSLNTDIA-----LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 437 ~~~~~~~~~~-----~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+..... .................+++..+++ .|++.+|++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~---~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH---HHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHH---HHCcCChhHCcCHHHHhc
Confidence 0000000000 0000000000000112245566666 899999999999999865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.5e-14 Score=137.44 Aligned_cols=119 Identities=18% Similarity=0.202 Sum_probs=75.9
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCCcccCC-------------
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRDFLSST------------- 436 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~~~~~~------------- 436 (502)
.+|||+++.............||..|+|||..... .++.++||||+||+++||+||+.|+......
T Consensus 141 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~ 220 (299)
T d1ua2a_ 141 LADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220 (299)
T ss_dssp ECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCC
Confidence 68999998876544444456799999999988654 5789999999999999999999997521100
Q ss_pred CCCCCCccccccc-ccCCCCCCCC-----cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 437 SSPSLNTDIALDE-MLDPRLPVPS-----CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 437 ~~~~~~~~~~~~~-~~d~~l~~~~-----~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
....+........ ..-...+... ....+++..+++ .|++.+|++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~---~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALK 279 (299)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHH---HHHCSSTTTSCCHHHHHT
T ss_pred ChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHH---HHccCChhhCcCHHHHhC
Confidence 0000000000000 0000000000 011245666676 999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=9.3e-15 Score=136.81 Aligned_cols=101 Identities=27% Similarity=0.466 Sum_probs=74.2
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccccccee-cccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKI-TEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~-s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
.+|||+++..... ..+...||..|+|||+..+... +.++||||+||+++||+||+.|++.... .....
T Consensus 152 l~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i~~~~ 220 (273)
T d1xwsa_ 152 LIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIRGQ 220 (273)
T ss_dssp ECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HHHCC
T ss_pred ECccccceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------Hhhcc
Confidence 7999999876543 2345789999999999887665 5778999999999999999999753110 00001
Q ss_pred -ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 -MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 -~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.+.+. ..+++.++++ .|++.+|++|||++|+++
T Consensus 221 ~~~~~~-------~s~~~~~li~---~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 VFFRQR-------VSSECQHLIR---WCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCCSSC-------CCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred cCCCCC-------CCHHHHHHHH---HHccCCHhHCcCHHHHhc
Confidence 11111 1256667777 999999999999999865
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=5.6e-13 Score=113.15 Aligned_cols=89 Identities=20% Similarity=0.197 Sum_probs=61.9
Q ss_pred CCCCCCCCEEECCCC-cccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCC
Q 010736 91 FSSFPHLAYLDLRDN-KLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSM 169 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N-~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 169 (502)
+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+. +|.......+|
T Consensus 27 l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~-l~~~~~~~~~l 105 (156)
T d2ifga3 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSL 105 (156)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCCC
T ss_pred ccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcc-cChhhhccccc
Confidence 667778888888655 4776666677778888888888888876667777777777777777777773 33333333356
Q ss_pred cEEEcccCccc
Q 010736 170 VELALFSNNLN 180 (502)
Q Consensus 170 ~~L~L~~N~l~ 180 (502)
+.|+|++|.+.
T Consensus 106 ~~L~L~~Np~~ 116 (156)
T d2ifga3 106 QELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCC
T ss_pred cccccCCCccc
Confidence 66666666653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=1.1e-12 Score=111.20 Aligned_cols=104 Identities=15% Similarity=0.097 Sum_probs=84.7
Q ss_pred EEECCCCcccccCCccCcCCCCCCEEEccCC-cCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 010736 99 YLDLRDNKLFGTIPPQISNLTNLSILSLGGN-QFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSN 177 (502)
Q Consensus 99 ~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 177 (502)
.++.+++++. ..|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3455555555 45677888999999999866 588666778999999999999999999888888999999999999999
Q ss_pred cccccCCcCCCCCCCCCeEEccccccc
Q 010736 178 NLNGSVPHSLGNLTQISMLFLHDNSFS 204 (502)
Q Consensus 178 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 204 (502)
+|+. +|.......+|++|+|++|.+.
T Consensus 91 ~l~~-l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 91 ALES-LSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCSC-CCSTTTCSCCCCEEECCSSCCC
T ss_pred CCcc-cChhhhccccccccccCCCccc
Confidence 9995 4444444457999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.38 E-value=1e-14 Score=136.95 Aligned_cols=120 Identities=25% Similarity=0.348 Sum_probs=74.2
Q ss_pred cccccCcccccCCCC---CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDS---SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~---~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||.++...... .......||..|+|||...+..++.++||||+||+++||+||+.|++..... .......
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~~~ 227 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHV 227 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH---HHHHHHH
Confidence 368999988764322 1233567999999999999889999999999999999999999998521110 0000000
Q ss_pred cccccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-CHHHHHHHHHhh
Q 010736 447 LDEMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-TMKIVSQQLRIS 497 (502)
Q Consensus 447 ~~~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-~m~~v~~~l~~~ 497 (502)
..+...+.... ....+++.++++ .|++.+|++|| +++++...|..+
T Consensus 228 ~~~~~~~~~~~--~~~s~~l~~li~---~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 228 REDPIPPSARH--EGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HCCCCCGGGTS--SSCCHHHHHHHH---HHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred hcCCCCCchhc--cCCCHHHHHHHH---HHccCCHhHCHhHHHHHHHHHHHH
Confidence 01111111100 112356677777 99999999999 899998888754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.37 E-value=1.6e-14 Score=139.82 Aligned_cols=112 Identities=22% Similarity=0.279 Sum_probs=77.7
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.+|||+++.+..... .....||..|+|||...+..++.++||||+||+++||+||+.|+...... .........+.
T Consensus 167 L~DFG~a~~~~~~~~-~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~ 242 (350)
T d1koaa2 167 LIDFGLTAHLDPKQS-VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDW 242 (350)
T ss_dssp ECCCTTCEECCTTSC-EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCC
T ss_pred Eeecchheecccccc-cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCC
Confidence 699999998765432 34568999999999999989999999999999999999999997521100 00000000000
Q ss_pred -cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 451 -LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 451 -~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.++... ....+++..+++ .|++.+|++|||++|+++
T Consensus 243 ~~~~~~~---~~~s~~~~~li~---~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 243 NMDDSAF---SGISEDGKDFIR---KLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CSCCGGG---GGCCHHHHHHHH---HHCCSSGGGSCCHHHHHH
T ss_pred CCCcccc---cCCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 111110 112245667777 999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=2.2e-14 Score=135.65 Aligned_cols=111 Identities=19% Similarity=0.248 Sum_probs=76.9
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++....... .....||..|+|||......++.++|||||||+++||+||+.|+....... ....
T Consensus 157 kl~DfG~a~~~~~~~~-~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~ 227 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLAN 227 (293)
T ss_dssp EECCCTTCEECTTSCB-CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHH
T ss_pred EecchhhhhhcCCCcc-ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--------HHHH
Confidence 3689999998754332 334678999999999998899999999999999999999999975211100 0000
Q ss_pred ccC--CCCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 450 MLD--PRLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 450 ~~d--~~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
+.. ...+.. ......++..+++ .|++.+|++||+++|+++
T Consensus 228 i~~~~~~~~~~~~~~~s~~~~~li~---~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 228 VSAVNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHH---TTSCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCchhcCCCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 100 010000 0011245666777 999999999999999965
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=4.4e-14 Score=135.86 Aligned_cols=110 Identities=26% Similarity=0.373 Sum_probs=77.4
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.+|||+++.............||+.|+|||...+..++.++|+||+||+++||+||+.|+...... ........
T Consensus 146 l~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~i~~--- 219 (337)
T d1o6la_ 146 ITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILM--- 219 (337)
T ss_dssp ECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH---
T ss_pred EeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHHHHhc---
Confidence 699999998765444445678999999999999999999999999999999999999997521110 00000000
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-----HHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-----MKIVSQ 492 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-----m~~v~~ 492 (502)
..+.++. ....++..+++ .|++.+|++||+ ..|+.+
T Consensus 220 ~~~~~p~---~~s~~~~dli~---~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 220 EEIRFPR---TLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCCCT---TSCHHHHHHHH---HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCc---cCCHHHHHHHH---hhccCCchhhcccccccHHHHHc
Confidence 1112221 12245667777 899999999995 566654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.36 E-value=4.7e-14 Score=137.33 Aligned_cols=111 Identities=22% Similarity=0.319 Sum_probs=75.0
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALD 448 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~ 448 (502)
.++|||+++.+.... .....||+.|+|||.... ..++.++||||+||+++||+||+.|+.......... ...
T Consensus 147 Kl~DFGla~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-----~~~ 219 (364)
T d1omwa3 147 RISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----IDR 219 (364)
T ss_dssp EECCCTTCEECSSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-----HHH
T ss_pred EEeeeceeeecCCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHH
Confidence 379999999775433 234679999999999864 568999999999999999999999985322111000 001
Q ss_pred cccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCH-----HHHH
Q 010736 449 EMLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTM-----KIVS 491 (502)
Q Consensus 449 ~~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m-----~~v~ 491 (502)
.........+ ....+++..+++ .|++.+|++||++ .|+.
T Consensus 220 ~~~~~~~~~~-~~~s~~~~~li~---~~L~~dP~~R~t~~~~~a~eil 263 (364)
T d1omwa3 220 MTLTMAVELP-DSFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVK 263 (364)
T ss_dssp HSSSCCCCCC-SSSCHHHHHHHH---HHTCSSTTTSTTTSSSTHHHHH
T ss_pred hcccCCCCCC-CCCCHHHHHHHH---HHcccCHHHhCCCcccCHHHHH
Confidence 1111111111 122356777777 9999999999994 6664
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=1.3e-14 Score=138.84 Aligned_cols=110 Identities=27% Similarity=0.401 Sum_probs=79.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.........+...||..|+|||...+..++.++||||+||+++||+||+.|+...... .......
T Consensus 143 kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~--- 216 (320)
T d1xjda_ 143 KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIR--- 216 (320)
T ss_dssp EECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---
T ss_pred eccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHH---
Confidence 4799999997765555555678999999999999999999999999999999999999998521100 0000000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHH-HHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMK-IVS 491 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~-~v~ 491 (502)
.-.+..+. ....++..+++ .|++.+|++||++. |+.
T Consensus 217 ~~~~~~p~---~~s~~~~dli~---~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 217 MDNPFYPR---WLEKEAKDLLV---KLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp HCCCCCCT---TSCHHHHHHHH---HHSCSSGGGSBTTBSCGG
T ss_pred cCCCCCCc---cCCHHHHHHHH---HhcccCCCCCcCHHHHHH
Confidence 01222221 12356777777 99999999999985 664
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.35 E-value=2.5e-14 Score=138.56 Aligned_cols=112 Identities=21% Similarity=0.252 Sum_probs=78.3
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.+|||+++.+..... .....||..|+|||...+..++.++||||+||+++||+||+.|+...... ...........
T Consensus 170 L~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~ 245 (352)
T d1koba_ 170 IIDFGLATKLNPDEI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRCDW 245 (352)
T ss_dssp ECCCTTCEECCTTSC-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHCCC
T ss_pred EeecccceecCCCCc-eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCC
Confidence 689999998865433 34567999999999999999999999999999999999999998521110 00000000000
Q ss_pred -cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 451 -LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 451 -~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
..+... .....++..+++ .|++.+|++||++.|+++
T Consensus 246 ~~~~~~~---~~~s~~~~~li~---~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 246 EFDEDAF---SSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCCSSTT---TTSCHHHHHHHH---TTSCSSGGGSCCHHHHHT
T ss_pred CCCcccc---cCCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 111111 122356667777 999999999999999965
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=2.6e-15 Score=133.34 Aligned_cols=110 Identities=25% Similarity=0.333 Sum_probs=58.1
Q ss_pred CCCCCCCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCc
Q 010736 91 FSSFPHLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMV 170 (502)
Q Consensus 91 ~~~l~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 170 (502)
+..+++|++|+|++|+|+. ++ .|.++++|++|+|++|.|+ .+|..+..+++|++|++++|+++.. ..+..+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSS
T ss_pred HhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccccc
Confidence 5555666666666666653 33 3555666666666666665 3443333344566666666665532 2244555555
Q ss_pred EEEcccCcccccCC-cCCCCCCCCCeEEcccccccc
Q 010736 171 ELALFSNNLNGSVP-HSLGNLTQISMLFLHDNSFSG 205 (502)
Q Consensus 171 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ 205 (502)
.|++++|+++.... ..+..+++|++|++++|++..
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccchhccccccccccCCCccceeecCCCcccc
Confidence 56665555542211 234555555555555555543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.34 E-value=4e-14 Score=135.12 Aligned_cols=108 Identities=25% Similarity=0.406 Sum_probs=76.1
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCccccccc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDE 449 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~ 449 (502)
..+|||+++.+.... +...||+.|+|||...+..++.++||||+||+++||+||+.|+...... .....
T Consensus 144 kL~DFG~a~~~~~~~---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~ 212 (316)
T d1fota_ 144 KITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEK 212 (316)
T ss_dssp EECCCSSCEECSSCB---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred EEecCccceEecccc---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--------HHHHH
Confidence 379999999875432 3468999999999999889999999999999999999999998531110 00111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 450 MLDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 450 ~~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
+......-+. ...+++..+++ .|++.+|++|| +++|+.+
T Consensus 213 i~~~~~~~p~-~~s~~~~~li~---~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 213 ILNAELRFPP-FFNEDVKDLLS---RLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHCCCCCCT-TSCHHHHHHHH---HHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHcCCCCCCC-CCCHHHHHHHH---HHhhhCHHhccccchhhHHHHHc
Confidence 1111111111 12245666777 99999999996 8888754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=2.7e-13 Score=128.40 Aligned_cols=128 Identities=20% Similarity=0.252 Sum_probs=80.5
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccce-ecccceeeeeceeeeehhcCCCCCCcccC------------C
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHPRDFLSS------------T 436 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~-~s~k~Dvysfgv~llElltg~~p~~~~~~------------~ 436 (502)
..+|||+++.............||..|+|||...... .+.++|+||+||+++||+||+.|++.... .
T Consensus 142 kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~ 221 (298)
T d1gz8a_ 142 KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221 (298)
T ss_dssp EECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 3689999998865544445568999999999866554 57899999999999999999999852110 0
Q ss_pred CCC-CCCcccccccccCCCCC---CCC-----cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHH--HHhhcCCC
Q 010736 437 SSP-SLNTDIALDEMLDPRLP---VPS-----CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQ--LRISAPSL 501 (502)
Q Consensus 437 ~~~-~~~~~~~~~~~~d~~l~---~~~-----~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~--l~~~~~~~ 501 (502)
... .+.......+ ..+..+ ... ....+++.++++ .|++.+|++|||+.|+.+- ++++..++
T Consensus 222 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dll~---~mL~~dP~~R~t~~ell~H~ff~~~~~p~ 293 (298)
T d1gz8a_ 222 PDEVVWPGVTSMPD-YKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALAHPFFQDVTKPV 293 (298)
T ss_dssp CCTTTSTTGGGSTT-CCTTSCCCCCCCHHHHSTTCCHHHHHHHH---HHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred Cchhhccccccccc-cccccccccccchhhhccCCCHHHHHHHH---HHccCChhHCcCHHHHhCCHhhccCCCCC
Confidence 000 0000000000 000000 000 011144566666 8999999999999999773 55554443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.32 E-value=4.7e-14 Score=133.36 Aligned_cols=122 Identities=15% Similarity=0.225 Sum_probs=81.9
Q ss_pred cccccCcccccCCCC-------CCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCC
Q 010736 370 ITGDFGIAKFLKPDS-------SNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLN 442 (502)
Q Consensus 370 l~~dfGl~~ll~~~~-------~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~ 442 (502)
..+|||+++...... .....+.||+.|+|||...+..++.++|||||||+++||+||+.|++...........
T Consensus 146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~ 225 (293)
T d1csna_ 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225 (293)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH
Confidence 368999999875321 1123467999999999999999999999999999999999999998632221110000
Q ss_pred ccccc-ccccC-CCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHHHHHhh
Q 010736 443 TDIAL-DEMLD-PRLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQQLRIS 497 (502)
Q Consensus 443 ~~~~~-~~~~d-~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~~l~~~ 497 (502)
..... ..... +.+. ...++++.++++ .|+..+|++||+.+.+.+.+++.
T Consensus 226 ~~i~~~~~~~~~~~l~---~~~p~~l~~ii~---~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 226 ERIGEKKQSTPLRELC---AGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHHHHHHSCHHHHT---TTSCHHHHHHHH---HHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhccCCCChHHhc---CCCCHHHHHHHH---HHhcCCcccCcCHHHHHHHHHHH
Confidence 00000 00000 0111 012256777777 89999999999999988888764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=3.3e-15 Score=132.73 Aligned_cols=131 Identities=21% Similarity=0.310 Sum_probs=107.0
Q ss_pred cCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccCCcccCCCCCCcEEEcccCcccccCCcCCCC
Q 010736 110 TIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSIPLEVGQLSSMVELALFSNNLNGSVPHSLGN 189 (502)
Q Consensus 110 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 189 (502)
.+|.++..+++|++|+|++|+|+ .++ .+..+++|++|+|++|+++ .+|..+..+++|+.|++++|+++. ++ .+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccc
Confidence 34567889999999999999998 455 5889999999999999998 566555566789999999999985 33 4778
Q ss_pred CCCCCeEEcccccccccCC-ccCcCCccCCccccccccccCccccc----------ccCCCCCcEEE
Q 010736 190 LTQISMLFLHDNSFSGFIP-PDIGNLKSISILSLAINQFSGPIPLS----------LGNLTNLKQFS 245 (502)
Q Consensus 190 l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~----------~~~l~~L~~L~ 245 (502)
+++|++|++++|+++.... ..+..+++|+.|++++|.+....+.. +..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 8999999999999986422 46788999999999999887544332 56788999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.30 E-value=7.6e-14 Score=135.07 Aligned_cols=107 Identities=21% Similarity=0.288 Sum_probs=75.8
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
++|||+++.+... .....||+.|+|||...+..++.++||||+||+++||+||+.|+..... ......+
T Consensus 182 L~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i 250 (350)
T d1rdqe_ 182 VTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKI 250 (350)
T ss_dssp ECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred eeeceeeeecccc---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHH
Confidence 7999999987543 2346799999999999999999999999999999999999999752110 0001111
Q ss_pred cCCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCC-----CHHHHHH
Q 010736 451 LDPRLPVPSCSVQEKLISIMEVGFSCLKESPESRP-----TMKIVSQ 492 (502)
Q Consensus 451 ~d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp-----~m~~v~~ 492 (502)
.......+ ....+++..+++ .|++.+|++|+ +++|+.+
T Consensus 251 ~~~~~~~p-~~~s~~~~~li~---~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 251 VSGKVRFP-SHFSSDLKDLLR---NLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHCCCCCC-TTCCHHHHHHHH---HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred hcCCCCCC-ccCCHHHHHHHH---HHhhhCHHhccccccccHHHHHc
Confidence 11111111 112356777777 99999999994 8888864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.25 E-value=7.2e-13 Score=124.66 Aligned_cols=131 Identities=22% Similarity=0.271 Sum_probs=77.3
Q ss_pred CCCeeeecCCcc---------ccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCC
Q 010736 359 KLGALNISRNNI---------TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKH 428 (502)
Q Consensus 359 ~L~~L~l~~N~l---------~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~ 428 (502)
++.|.||+..|| .+|||++..............|+..|+|||..... ..+.++||||+||+++||+||+.
T Consensus 120 ~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~ 199 (286)
T d1ob3a_ 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199 (286)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCC
Confidence 345555555544 68999998876544333445688899999998654 56899999999999999999999
Q ss_pred CCCcccC-------------CCCCCCCccccc---ccccCCCCCC----CCcchHHHHHHHHHHhhccCCcCCCCCCCHH
Q 010736 429 PRDFLSS-------------TSSPSLNTDIAL---DEMLDPRLPV----PSCSVQEKLISIMEVGFSCLKESPESRPTMK 488 (502)
Q Consensus 429 p~~~~~~-------------~~~~~~~~~~~~---~~~~d~~l~~----~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~ 488 (502)
|+..... .....+...... .......-+. .......++..+++ .|++.+|++|||++
T Consensus 200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~---~~L~~dP~~R~s~~ 276 (286)
T d1ob3a_ 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAK 276 (286)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHH---HHTCSSTTTSCCHH
T ss_pred CCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHH---HHccCChhHCcCHH
Confidence 9852210 000011000000 0000000000 00112245666777 99999999999999
Q ss_pred HHHH
Q 010736 489 IVSQ 492 (502)
Q Consensus 489 ~v~~ 492 (502)
|+++
T Consensus 277 ell~ 280 (286)
T d1ob3a_ 277 QALE 280 (286)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.25 E-value=1.8e-13 Score=127.93 Aligned_cols=111 Identities=21% Similarity=0.318 Sum_probs=75.2
Q ss_pred cccccCcccccCCCCCCcccccccccccCcccccc------ceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCc
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT------MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNT 443 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~------~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~ 443 (502)
.++|||+++.+..... .+...||..|+|||+..+ ..++.++||||+||+++||+||+.|+......
T Consensus 150 kl~DFG~a~~~~~~~~-~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------- 221 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------- 221 (277)
T ss_dssp EECCCTTCEECCTTCC-BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred EEccchheeEccCCCc-eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------
Confidence 3689999998765432 345679999999999863 34678999999999999999999998521100
Q ss_pred ccccccccCC--CCCCC-CcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 444 DIALDEMLDP--RLPVP-SCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 444 ~~~~~~~~d~--~l~~~-~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+... ..+.+ .....+++.++++ .|++.+|++||++.||++
T Consensus 222 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~---~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 222 -LMLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -HHHHHHHHTCCCCCTTTGGGSCHHHHHHHH---HHCCSSGGGSCCHHHHTT
T ss_pred -HHHHHHHhCCCCCCCcccccCCHHHHHHHH---HHccCChhHCcCHHHHHc
Confidence 000001100 11110 0122356666666 999999999999999854
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=4.5e-13 Score=128.01 Aligned_cols=110 Identities=20% Similarity=0.306 Sum_probs=76.8
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccccccc
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIALDEM 450 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~~~~~ 450 (502)
.+|||+++....... .....||..|+|||...+..++.++||||+||+++||+||+.|+...... .....+
T Consensus 145 l~DFG~~~~~~~~~~-~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i 215 (321)
T d1tkia_ 145 IIEFGQARQLKPGDN-FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENI 215 (321)
T ss_dssp ECCCTTCEECCTTCE-EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHH
T ss_pred EcccchhhccccCCc-ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence 689999988754332 23457889999999999999999999999999999999999998532110 001111
Q ss_pred cCCCCCCCC---cchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 451 LDPRLPVPS---CSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 451 ~d~~l~~~~---~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
......-+. ....+++..+++ .|++.+|++||++.|+++
T Consensus 216 ~~~~~~~~~~~~~~~s~~~~~li~---~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 216 MNAEYTFDEEAFKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHH---TTSCSSGGGSCCHHHHHH
T ss_pred HhCCCCCChhhccCCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 111110000 011245666777 999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=3.2e-12 Score=122.08 Aligned_cols=62 Identities=21% Similarity=0.274 Sum_probs=48.9
Q ss_pred cccccCcccccCCCCC----CcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSS----NWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~----~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.++|||+++....... ......||..|+|||..... .++.|+||||+||+++||+||+.|++
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 4699999987754221 11235689999999998655 57899999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=6.9e-12 Score=121.36 Aligned_cols=118 Identities=23% Similarity=0.251 Sum_probs=74.3
Q ss_pred ccccCcccccCCCCCCcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCCcccCCC------------
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRDFLSSTS------------ 437 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~~~~~~~------------ 437 (502)
++|||+++.+...... ....|+..|+|||.... ...+.++||||+||+++||+||+.|+.......
T Consensus 164 l~DFG~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 164 LCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp ECCCTTCEECCTTSCC-CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EecccchhhccCCccc-ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 7999999987554332 33578999999998764 568999999999999999999999985321000
Q ss_pred CCCCCccc--ccccccCCCCCC------CCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 438 SPSLNTDI--ALDEMLDPRLPV------PSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 438 ~~~~~~~~--~~~~~~d~~l~~------~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
........ ...+..-+.... ......+++.++++ .|+..+|++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~---~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHH---HHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 00000000 000000000000 00012245666776 999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=6.1e-12 Score=118.50 Aligned_cols=120 Identities=17% Similarity=0.193 Sum_probs=74.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccce-ecccceeeeeceeeeehhcCCCCCCcccC-------------
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHPRDFLSS------------- 435 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~-~s~k~Dvysfgv~llElltg~~p~~~~~~------------- 435 (502)
..+|||.++.............++..|.|||...... .+.++||||+||+++||+||+.|+.....
T Consensus 141 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 220 (292)
T d1unla_ 141 KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_dssp EECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred eeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC
Confidence 3689999998765444444456778899999887655 68999999999999999999999521100
Q ss_pred -CCCCCCCccccccc-----ccCC--CCCCCCcchHHHHHHHHHHhhccCCcCCCCCCCHHHHHH
Q 010736 436 -TSSPSLNTDIALDE-----MLDP--RLPVPSCSVQEKLISIMEVGFSCLKESPESRPTMKIVSQ 492 (502)
Q Consensus 436 -~~~~~~~~~~~~~~-----~~d~--~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~m~~v~~ 492 (502)
.....+.......+ .... ..........+++.++++ .|++.+|++|||++||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~---~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHH---HHSCSSGGGSCCHHHHTT
T ss_pred CCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 00000000000000 0000 000000112245666666 899999999999999865
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.11 E-value=2.6e-12 Score=122.65 Aligned_cols=113 Identities=24% Similarity=0.434 Sum_probs=74.3
Q ss_pred cccccCcccccCCCCC-CcccccccccccCccccccc--eecccceeeeeceeeeehhcCCCCCCcccCCCCCCCCcccc
Q 010736 370 ITGDFGIAKFLKPDSS-NWTGFAGTYGYIAPELAYTM--KITEKCDVYSFGVLVLEVIKGKHPRDFLSSTSSPSLNTDIA 446 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~-~~~~~~gt~gy~aPE~~~~~--~~s~k~Dvysfgv~llElltg~~p~~~~~~~~~~~~~~~~~ 446 (502)
..+|||+++.+..... ......|+..|++||..... ..+.++||||+||+++||+||+.|+......... ...
T Consensus 169 kL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i- 244 (322)
T d1vzoa_ 169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEI- 244 (322)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHH-
T ss_pred EEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH-
Confidence 3789999987754322 22346789999999998644 4678999999999999999999998543221110 000
Q ss_pred ccccc--CCCCCCCCcchHHHHHHHHHHhhccCCcCCCCCCC-----HHHHHH
Q 010736 447 LDEML--DPRLPVPSCSVQEKLISIMEVGFSCLKESPESRPT-----MKIVSQ 492 (502)
Q Consensus 447 ~~~~~--d~~l~~~~~~~~~~~~~~~~val~C~~~~p~~Rp~-----m~~v~~ 492 (502)
..... .+.++. ...+++..+++ .|++.+|++||+ ++|+.+
T Consensus 245 ~~~~~~~~~~~~~---~~s~~~~~li~---~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 245 SRRILKSEPPYPQ---EMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHCCCCCCT---TSCHHHHHHHH---HHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHhcccCCCCCcc---cCCHHHHHHHH---HHcccCHHHcCCCCcccHHHHHc
Confidence 01111 122221 12356777777 999999999995 677764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=3.6e-12 Score=123.23 Aligned_cols=59 Identities=32% Similarity=0.505 Sum_probs=49.4
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++..... .+...||..|+|||...+. ..+.++||||+||+++||+||+.|+.
T Consensus 161 kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 161 KILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp EECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 36899999876532 3456799999999988654 56899999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=1.4e-11 Score=119.37 Aligned_cols=61 Identities=28% Similarity=0.328 Sum_probs=42.7
Q ss_pred cccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 370 ITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 370 l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
..+|||+++...... ..+...||..|+|||...+...+.++||||+||+++||++|+.|+.
T Consensus 159 kl~df~~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 159 KILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp EECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeechhhhhcccccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence 368899888664322 2344678999999999999999999999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.01 E-value=1.6e-11 Score=118.46 Aligned_cols=61 Identities=28% Similarity=0.464 Sum_probs=48.9
Q ss_pred ccccCcccccCCCCC---CcccccccccccCcccccc-ceecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSS---NWTGFAGTYGYIAPELAYT-MKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~---~~~~~~gt~gy~aPE~~~~-~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
++|||+++....... ......||..|+|||.... ...+.++||||+||+++||+||+.|++
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 789999987754221 2234668999999998744 456889999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=98.97 E-value=4.4e-11 Score=114.49 Aligned_cols=60 Identities=23% Similarity=0.379 Sum_probs=50.0
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccce-ecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMK-ITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~-~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.+|||+++....... .....||..|+|||...... .+.++|+||+||+++|+++|+.|+.
T Consensus 171 l~DFG~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 171 LIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp ECCGGGCEECCTTCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ecccccceeccCCCc-ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 699999998765432 34467899999999987654 6899999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.96 E-value=3e-11 Score=117.39 Aligned_cols=58 Identities=24% Similarity=0.317 Sum_probs=48.8
Q ss_pred ccccCcccccCCCCCCcccccccccccCccccccceecccceeeeeceeeeehhcCCCCCC
Q 010736 371 TGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTMKITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 371 ~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
.+|||.++...... ....||..|+|||.......+.++|+||+||+++||+||+.|+.
T Consensus 173 l~dfg~s~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 173 IADLGNACWYDEHY---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp ECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred Eeeccccccccccc---ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence 57899987654322 34679999999999998889999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=7.2e-11 Score=113.95 Aligned_cols=60 Identities=27% Similarity=0.476 Sum_probs=44.3
Q ss_pred ccccccCcccccCCCCCCcccccccccccCccccccc-eecccceeeeeceeeeehhcCCCCCC
Q 010736 369 NITGDFGIAKFLKPDSSNWTGFAGTYGYIAPELAYTM-KITEKCDVYSFGVLVLEVIKGKHPRD 431 (502)
Q Consensus 369 ~l~~dfGl~~ll~~~~~~~~~~~gt~gy~aPE~~~~~-~~s~k~Dvysfgv~llElltg~~p~~ 431 (502)
...+|||++...... .....|+..|+|||..... ..+.++||||+||+++||+||+.|+.
T Consensus 160 ~kl~dfg~a~~~~~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 160 LKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp EEECCC----CCTGG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccchhcccCcc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 346899988765322 2346788999999986655 46889999999999999999999975
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.37 E-value=3.1e-09 Score=90.12 Aligned_cols=9 Identities=11% Similarity=0.338 Sum_probs=4.1
Q ss_pred CCCCCcEEE
Q 010736 237 NLTNLKQFS 245 (502)
Q Consensus 237 ~l~~L~~L~ 245 (502)
.+++|+.||
T Consensus 144 ~~P~L~~LD 152 (162)
T d1koha1 144 RFPKLLRLD 152 (162)
T ss_dssp TSTTCCEET
T ss_pred HCCCCCEEC
Confidence 344444443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.34 E-value=7.3e-09 Score=87.77 Aligned_cols=121 Identities=17% Similarity=0.094 Sum_probs=62.0
Q ss_pred CCCEEECCCCcccccCCccCcCCCCCCEEEccCCcCcCCCCcccCCCCCCcEEEccCCcCcccC--CcccCCCCCCcEEE
Q 010736 96 HLAYLDLRDNKLFGTIPPQISNLTNLSILSLGGNQFSGNIPHEVGLMSHLKILYIDSNQLDGSI--PLEVGQLSSMVELA 173 (502)
Q Consensus 96 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~ 173 (502)
+.+.|+++++... +.+..+..+..++..++... .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455666554321 12344444444444444333 33333445667777777777776432 23345566677777
Q ss_pred cccCcccccCCcCCCCCCCCCeEEcccccccccCCcc-------CcCCccCCccc
Q 010736 174 LFSNNLNGSVPHSLGNLTQISMLFLHDNSFSGFIPPD-------IGNLKSISILS 221 (502)
Q Consensus 174 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------~~~l~~L~~L~ 221 (502)
+++|+++...+-.+....+|+.|++++|.++...... +..+++|+.||
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 7777666332212223345666666666665433211 33455565554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.68 E-value=4.8e-06 Score=70.19 Aligned_cols=88 Identities=15% Similarity=0.166 Sum_probs=48.8
Q ss_pred CCCCCCEEECCCC-ccccc----CCccCcCCCCCCEEEccCCcCcCC----CCcccCCCCCCcEEEccCCcCccc----C
Q 010736 93 SFPHLAYLDLRDN-KLFGT----IPPQISNLTNLSILSLGGNQFSGN----IPHEVGLMSHLKILYIDSNQLDGS----I 159 (502)
Q Consensus 93 ~l~~L~~L~Ls~N-~l~g~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~ 159 (502)
+.++|++|+|+++ .++.. +-..+...+.|++|+|++|.+... +...+...+.|++|+|++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4466777777763 34421 233455666777777777776532 112234456677777777766532 1
Q ss_pred CcccCCCCCCcEEEcccCccc
Q 010736 160 PLEVGQLSSMVELALFSNNLN 180 (502)
Q Consensus 160 p~~~~~l~~L~~L~L~~N~l~ 180 (502)
-..+...+.|++|++++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 123444556666666665443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.45 E-value=1e-05 Score=68.16 Aligned_cols=88 Identities=14% Similarity=0.069 Sum_probs=51.1
Q ss_pred cCCCCCCEEEccCC-cCcCC----CCcccCCCCCCcEEEccCCcCcccCC----cccCCCCCCcEEEcccCcccccC---
Q 010736 116 SNLTNLSILSLGGN-QFSGN----IPHEVGLMSHLKILYIDSNQLDGSIP----LEVGQLSSMVELALFSNNLNGSV--- 183 (502)
Q Consensus 116 ~~l~~L~~L~Ls~N-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~--- 183 (502)
.+.++|++|+|+++ .++.. +-..+...++|++|+|++|.+..... ..+...+.|++|++++|.++...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45678888888864 45422 22345666778888888887763222 22334566777777777665321
Q ss_pred -CcCCCCCCCCCeEEcccccc
Q 010736 184 -PHSLGNLTQISMLFLHDNSF 203 (502)
Q Consensus 184 -p~~~~~l~~L~~L~L~~N~l 203 (502)
-..+...+.|++|++++|.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSS
T ss_pred HHHHHHhCCcCCEEECCCCcC
Confidence 12244445566666665543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.83 E-value=5.9e-05 Score=63.13 Aligned_cols=83 Identities=19% Similarity=0.277 Sum_probs=43.8
Q ss_pred CCCCCCCEEECCC-Cccccc----CCccCcCCCCCCEEEccCCcCcCCC----CcccCCCCCCcEEEccCCcCccc----
Q 010736 92 SSFPHLAYLDLRD-NKLFGT----IPPQISNLTNLSILSLGGNQFSGNI----PHEVGLMSHLKILYIDSNQLDGS---- 158 (502)
Q Consensus 92 ~~l~~L~~L~Ls~-N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~---- 158 (502)
.+.+.|++|+|++ +.++.. +-..+...++|++|+|++|.++... -..+...+.++.+++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456677777776 345321 2334456667777777777665321 12234455666666666665432
Q ss_pred CCcccCCCCCCcEEEc
Q 010736 159 IPLEVGQLSSMVELAL 174 (502)
Q Consensus 159 ~p~~~~~l~~L~~L~L 174 (502)
+-..+...++|+.++|
T Consensus 94 l~~~l~~~~~L~~l~L 109 (166)
T d1io0a_ 94 LVEALQSNTSLIELRI 109 (166)
T ss_dssp HHHGGGGCSSCCEEEC
T ss_pred HHHHHHhCccccEEee
Confidence 1123444455555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.42 E-value=0.00013 Score=60.83 Aligned_cols=67 Identities=12% Similarity=0.071 Sum_probs=39.2
Q ss_pred cCcCCCCCCEEEccC-CcCcCC----CCcccCCCCCCcEEEccCCcCcccCC----cccCCCCCCcEEEcccCccc
Q 010736 114 QISNLTNLSILSLGG-NQFSGN----IPHEVGLMSHLKILYIDSNQLDGSIP----LEVGQLSSMVELALFSNNLN 180 (502)
Q Consensus 114 ~l~~l~~L~~L~Ls~-N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~ 180 (502)
...+.++|++|+|++ +.++.. +-..+...++|++|++++|.++...- ..+...+.++.+++++|.+.
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 345667888888886 456422 22334566777788888777653221 22334456666666666554
|